1	From	IN	O	from	dep	9	SENT_1	[p1l95t1182r160b1203],
2	the	DT	O	the	det	6	SENT_1	[p1l170t1179r211b1203],
3	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_1	[p1l224t1179r418b1203],
4	General	NNP	ORGANIZATION	General	nn	6	SENT_1	[p1l429t1179r529b1203],
5	Hospital	NNP	ORGANIZATION	Hospital	nn	6	SENT_1	[p1l543t1182r629b1210, p1l92t1217r123b1241],
6	Cancer	NNP	ORGANIZATION	Cancer	pobj	1	SENT_1	[p1l133t1219r224b1241],
7	Center	NNP	ORGANIZATION	Center	nn	9	SENT_1	[p1l232t1219r318b1241],
8	(	NNP	O	(	nn	9	SENT_1	[p1l328t1219r402b1248],
9	S.M.	NNP	PERSON	S.M.	_	0	SENT_1	[p1l328t1219r402b1248],
10	,	,	O	,	_	0	SENT_1	[p1l328t1219r402b1248],
11	L.V.S.	NNP	LOCATION	L.V.S.	appos	9	SENT_1	[p1l414t1219r490b1245],
12	,	,	O	,	_	0	SENT_1	[p1l414t1219r490b1245],
13	L.U.	NNP	LOCATION	L.U.	nn	18	SENT_1	[p1l503t1219r559b1245],
14	,	,	O	,	_	0	SENT_1	[p1l503t1219r559b1245],
15	B.B.	NNP	PERSON	B.B.	appos	18	SENT_1	[p1l571t1219r627b1245],
16	,	,	O	,	_	0	SENT_1	[p1l571t1219r627b1245],
17	E.	NNP	O	E.	appos	18	SENT_1	[p1l95t1257r140b1282],
18	|	NNP	O	|	appos	9	SENT_1	[p1l95t1257r140b1282],
19	.	.	O	.	_	0	SENT_1	[p1l95t1257r140b1282],

1	,	,	O	,	_	0	SENT_2	[p1l95t1257r140b1282],
2	S.	NNP	PERSON	S.	nn	3	SENT_2	[p1l150t1256r171b1278],
3	Diederichs	NNP	PERSON	Diederichs	dep	17	SENT_2	[p1l183t1254r326b1282],
4	,	,	O	,	_	0	SENT_2	[p1l183t1254r326b1282],
5	D.W.B.	NNP	O	D.W.B.	appos	3	SENT_2	[p1l338t1257r428b1282],
6	,	,	O	,	_	0	SENT_2	[p1l338t1257r428b1282],
7	S.	NNP	PERSON	S.	nn	8	SENT_2	[p1l438t1256r459b1278],
8	Digumarthy	NNP	PERSON	Digumarthy	appos	3	SENT_2	[p1l471t1254r627b1286],
9	,	,	O	,	_	0	SENT_2	[p1l471t1254r627b1286],
10	A.M.	NNP	O	A.M.	appos	3	SENT_2	[p1l92t1294r226b1322],
11	,	,	O	,	_	0	SENT_2	[p1l92t1294r226b1322],
12	J.S.	NNP	LOCATION	J.S.	appos	3	SENT_2	[p1l92t1294r226b1322],
13	,	,	O	,	_	0	SENT_2	[p1l92t1294r226b1322],
14	T.J.L.	NNP	O	T.J.L.	appos	3	SENT_2	[p1l241t1294r312b1322],
15	,	,	O	,	_	0	SENT_2	[p1l241t1294r312b1322],
16	D.A.H.	NNP	O	D.A.H.	nn	17	SENT_2	[p1l330t1294r434b1323],
17	)	NNP	O	)	_	0	SENT_2	[p1l330t1294r434b1323],
18	,	,	O	,	_	0	SENT_2	[p1l330t1294r434b1323],
19	Biomicroe	NNP	O	Biomicroe	appos	17	SENT_2	[p1l452t1292r629b1316, p1l92t1329r279b1353],
20	|	CD	NUMBER	|	num	19	SENT_2	[p1l452t1292r629b1316, p1l92t1329r279b1353],
21	ectromechanical	JJ	O	ectromechanical	amod	26	SENT_2	[p1l452t1292r629b1316, p1l92t1329r279b1353],
22	Systems	NNPS	ORGANIZATION	Systems	nn	26	SENT_2	[p1l293t1331r399b1360],
23	Resource	NNP	ORGANIZATION	Resource	nn	26	SENT_2	[p1l414t1332r531b1353],
24	Center	NNP	ORGANIZATION	Center	nn	26	SENT_2	[p1l544t1331r629b1353],
25	(	CD	NUMBER	(	num	26	SENT_2	[p1l96t1369r166b1398],
26	S.N.	NNP	PERSON	S.N.	dep	17	SENT_2	[p1l96t1369r166b1398],
27	,	,	O	,	_	0	SENT_2	[p1l96t1369r166b1398],
28	c.v.c.	NNP	O	c.v.c.	nn	31	SENT_2	[p1l181t1369r264b1395],
29	,	,	O	,	_	0	SENT_2	[p1l181t1369r264b1395],
30	D.	NNP	O	D.	appos	31	SENT_2	[p1l281t1369r331b1395],
31	|	NNP	O	|	appos	26	SENT_2	[p1l281t1369r331b1395],
32	.	.	O	.	_	0	SENT_2	[p1l281t1369r331b1395],

1	,	,	O	,	_	0	SENT_3	[p1l281t1369r331b1395],
2	R.G.T.	NNP	O	R.G.T.	dep	5	SENT_3	[p1l348t1369r429b1395],
3	,	,	O	,	_	0	SENT_3	[p1l348t1369r429b1395],
4	M.T.	NNP	LOCATION	M.T.	nn	5	SENT_3	[p1l446t1369r515b1398],
5	)	NNP	O	)	_	0	SENT_3	[p1l446t1369r515b1398],
6	,	,	O	,	_	0	SENT_3	[p1l446t1369r515b1398],
7	Departments	NNP	O	Departments	nn	8	SENT_3	[p1l532t1369r629b1398, p1l95t1409r174b1429],
8	ofsurgery	NN	O	ofsurgery	appos	5	SENT_3	[p1l184t1405r316b1436],
9	(	CD	NUMBER	(	num	8	SENT_3	[p1l326t1407r400b1436],
10	S.M.	NNP	LOCATION	S.M.	nn	15	SENT_3	[p1l326t1407r400b1436],
11	,	,	O	,	_	0	SENT_3	[p1l326t1407r400b1436],
12	S.N.	NNP	PERSON	S.N.	appos	15	SENT_3	[p1l411t1407r472b1433],
13	,	,	O	,	_	0	SENT_3	[p1l411t1407r472b1433],
14	D.	NNP	O	D.	appos	15	SENT_3	[p1l484t1407r534b1433],
15	|	NNP	O	|	dep	5	SENT_3	[p1l484t1407r534b1433],
16	.	.	O	.	_	0	SENT_3	[p1l484t1407r534b1433],

1	,	,	O	,	_	0	SENT_4	[p1l484t1407r534b1433],
2	R.G.T.	NNP	O	R.G.T.	_	0	SENT_4	[p1l546t1407r627b1433],
3	,	,	O	,	_	0	SENT_4	[p1l546t1407r627b1433],

1	M.T.	NNP	O	M.T.	nn	6	SENT_5	[p1l95t1478r165b1507],
2	)	NNP	O	)	nn	6	SENT_5	[p1l95t1478r165b1507],
3	,	,	O	,	_	0	SENT_5	[p1l95t1478r165b1507],
4	Medicine	NNP	O	Medicine	appos	6	SENT_5	[p1l186t1476r305b1500],
5	(	CD	NUMBER	(	num	6	SENT_5	[p1l325t1478r412b1507],
6	L.V.S.	NNP	O	L.V.S.	_	0	SENT_5	[p1l325t1478r412b1507],
7	,	,	O	,	_	0	SENT_5	[p1l325t1478r412b1507],
8	T.J.L.	NNP	O	T.J.L.	appos	6	SENT_5	[p1l431t1478r502b1507],
9	,	,	O	,	_	0	SENT_5	[p1l431t1478r502b1507],
10	D.A.H.	NNP	O	D.A.H.	nn	11	SENT_5	[p1l523t1478r627b1507],
11	)	NNP	O	)	appos	6	SENT_5	[p1l523t1478r627b1507],
12	,	,	O	,	_	0	SENT_5	[p1l523t1478r627b1507],
13	Pathology	NNP	O	Pathology	nn	16	SENT_5	[p1l95t1514r221b1545],
14	(	NNP	O	(	nn	16	SENT_5	[p1l232t1515r316b1545],
15	A.J.	NNP	PERSON	A.J.	nn	16	SENT_5	[p1l232t1515r316b1545],
16	|	NNP	O	|	appos	6	SENT_5	[p1l232t1515r316b1545],
17	.	.	O	.	_	0	SENT_5	[p1l232t1515r316b1545],
18	)	NN	O	)	dep	16	SENT_5	[p1l232t1515r316b1545],

1	,	,	O	,	_	0	SENT_6	[p1l232t1515r316b1545],
2	and	CC	O	and	dep	3	SENT_6	[p1l327t1514r372b1538],
3	Radiology	NNP	O	Radiology	_	0	SENT_6	[p1l384t1514r508b1545],
4	(	CD	NUMBER	(	dep	3	SENT_6	[p1l519t1516r549b1545],
5	5	CD	NUMBER	5	rcmod	4	SENT_6	[p1l519t1516r549b1545],
6	.	.	O	.	_	0	SENT_6	[p1l519t1516r549b1545],

1	Digumarthy	NNP	O	Digumarthy	nn	2	SENT_7	[p1l561t1516r629b1545, p1l95t1551r200b1582],
2	)	NNP	O	)	_	0	SENT_7	[p1l561t1516r629b1545, p1l95t1551r200b1582],
3	,	,	O	,	_	0	SENT_7	[p1l561t1516r629b1545, p1l95t1551r200b1582],
4	and	CC	O	and	_	0	SENT_7	[p1l219t1551r265b1575],
5	Biostatistics	NNP	O	Biostatistics	nn	6	SENT_7	[p1l287t1554r445b1575],
6	Unit	NNP	O	Unit	conj_and	2	SENT_7	[p1l466t1554r519b1575],
7	(	CD	NUMBER	(	num	8	SENT_7	[p1l540t1553r627b1582],
8	A.M.	NNP	O	A.M.	dep	2	SENT_7	[p1l540t1553r627b1582],
9	)	CD	NUMBER	)	num	8	SENT_7	[p1l540t1553r627b1582],
10	,	,	O	,	_	0	SENT_7	[p1l540t1553r627b1582],
11	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	13	SENT_7	[p1l95t1589r282b1613],
12	General	NNP	ORGANIZATION	General	nn	13	SENT_7	[p1l293t1589r390b1613],
13	Hospital	NNP	ORGANIZATION	Hospital	dep	2	SENT_7	[p1l403t1589r507b1620],
14	and	CC	O	and	_	0	SENT_7	[p1l519t1589r563b1613],
15	Harvard	NNP	ORGANIZATION	Harvard	nn	17	SENT_7	[p1l577t1591r629b1613, p1l93t1626r145b1650],
16	Medical	NNP	ORGANIZATION	Medical	nn	17	SENT_7	[p1l163t1626r263b1650],
17	School	NNP	ORGANIZATION	School	dep	2	SENT_7	[p1l281t1626r376b1654],
18	;	:	O	;	_	0	SENT_7	[p1l281t1626r376b1654],
19	Shriners	NNP	ORGANIZATION	Shriners	nn	20	SENT_7	[p1l393t1626r500b1650],
20	Hospital	NNP	ORGANIZATION	Hospital	conj_and	8	SENT_7	[p1l519t1626r627b1657],
21	for	IN	O	for	_	0	SENT_7	[p1l93t1664r129b1688],
22	Children	NNP	O	Children	prep_for	20	SENT_7	[p1l139t1664r248b1688],
23	(	CD	NUMBER	(	num	22	SENT_7	[p1l262t1666r354b1695],
24	R.G.T.	NNP	O	R.G.T.	nn	27	SENT_7	[p1l262t1666r354b1695],
25	,	,	O	,	_	0	SENT_7	[p1l262t1666r354b1695],
26	M.T.	NNP	O	M.T.	appos	27	SENT_7	[p1l369t1666r438b1695],
27	)	NNP	O	)	dep	20	SENT_7	[p1l369t1666r438b1695],
28	;	:	O	;	_	0	SENT_7	[p1l369t1666r438b1695],
29	and	CC	O	and	_	0	SENT_7	[p1l450t1664r496b1688],
30	the	DT	O	the	det	31	SENT_7	[p1l507t1664r548b1688],
31	Howard	NNP	PERSON	Howard	conj_and	8	SENT_7	[p1l561t1666r629b1688, p1l94t1771r132b1795],

1	Hughes	NNP	ORGANIZATION	Hughes	nn	5	SENT_8	[p1l153t1771r252b1803],
2	Medical	NNP	ORGANIZATION	Medical	nn	5	SENT_8	[p1l272t1771r372b1795],
3	Institute	NNP	ORGANIZATION	Institute	nn	5	SENT_8	[p1l393t1774r500b1795],
4	(	NN	O	(	nn	5	SENT_8	[p1l520t1773r626b1802],
5	D.A.H.	NNP	O	D.A.H.	_	0	SENT_8	[p1l520t1773r626b1802],
6	)	CD	NUMBER	)	number	7	SENT_8	[p1l520t1773r626b1802],
7	—	CD	NUMBER	—	dep	5	SENT_8	[p1l92t1809r158b1833],
8	all	DT	O	all	dep	7	SENT_8	[p1l92t1809r158b1833],
9	in	IN	O	in	_	0	SENT_8	[p1l168t1811r189b1832],
10	Boston	NNP	LOCATION	Boston	prep_in	5	SENT_8	[p1l201t1811r298b1833],
11	.	.	O	.	_	0	SENT_8	[p1l201t1811r298b1833],

1	Address	NN	O	address	nsubj	2	SENT_9	[p1l306t1809r412b1833],
2	reprint	VB	O	reprint	_	0	SENT_9	[p1l422t1811r509b1840],
3	requests	NNS	O	request	dobj	2	SENT_9	[p1l518t1813r628b1840],
4	to	TO	O	to	_	0	SENT_9	[p1l92t1851r117b1870],
5	Dr.	NNP	O	Dr.	nn	6	SENT_9	[p1l134t1849r169b1870],
6	Haber	NNP	PERSON	Haber	prep_to	2	SENT_9	[p1l186t1846r265b1870],
7	at	IN	O	at	_	0	SENT_9	[p1l279t1851r302b1870],
8	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	12	SENT_9	[p1l317t1846r512b1870],
9	General	NNP	ORGANIZATION	General	nn	12	SENT_9	[p1l527t1846r627b1870],
10	Hospital	NNP	ORGANIZATION	Hospital	nn	12	SENT_9	[p1l95t1884r201b1915],
11	Cancer	NNP	ORGANIZATION	Cancer	nn	12	SENT_9	[p1l212t1886r301b1908],
12	Center	NNP	ORGANIZATION	Center	prep_at	6	SENT_9	[p1l310t1886r399b1912],
13	,	,	O	,	_	0	SENT_9	[p1l310t1886r399b1912],
14	CNY-7	NN	O	cny-7	appos	12	SENT_9	[p1l410t1886r493b1912],
15	,	,	O	,	_	0	SENT_9	[p1l410t1886r493b1912],
16	Bldg	NNP	O	Bldg	appos	14	SENT_9	[p1l506t1884r568b1915],
17	.	.	O	.	_	0	SENT_9	[p1l506t1884r568b1915],

1	149	CD	NUMBER	149	_	0	SENT_10	[p1l580t1886r627b1912],
2	,	,	O	,	_	0	SENT_10	[p1l580t1886r627b1912],
3	13th	JJ	ORDINAL	13th	amod	4	SENT_10	[p1l95t1921r148b1945],
4	St.	NNP	O	St.	appos	1	SENT_10	[p1l165t1923r204b1949],
5	,	,	O	,	_	0	SENT_10	[p1l165t1923r204b1949],
6	Charlestown	NNP	LOCATION	Charlestown	appos	1	SENT_10	[p1l220t1921r391b1949],
7	,	,	O	,	_	0	SENT_10	[p1l220t1921r391b1949],
8	MA	NNP	LOCATION	MA	appos	1	SENT_10	[p1l409t1923r452b1945],
9	02129	CD	DATE	02129	num	8	SENT_10	[p1l466t1923r549b1949],
10	,	,	O	,	_	0	SENT_10	[p1l466t1923r549b1949],
11	or	CC	O	or	_	0	SENT_10	[p1l565t1929r592b1945],
12	at	IN	O	at	amod	15	SENT_10	[p1l606t1926r629b1945],
13	haber@he	JJ	O	haber@he	amod	15	SENT_10	[p1l94t1955r501b1986],
14	|	NN	O	|	nn	15	SENT_10	[p1l94t1955r501b1986],
15	ix.mgh.harvard.edu	NN	O	ix.mgh.harvard.edu	conj_or	4	SENT_10	[p1l94t1955r501b1986],
16	.	.	O	.	_	0	SENT_10	[p1l94t1955r501b1986],

1	Drs.	NNP	O	Drs.	nn	2	SENT_11	[p1l95t2032r146b2054],
2	Maheswaran	NNP	PERSON	Maheswaran	nsubj	8	SENT_11	[p1l161t2030r333b2058],
3	,	,	O	,	_	0	SENT_11	[p1l161t2030r333b2058],
4	Sequist	NNP	O	Sequist	conj_and	2	SENT_11	[p1l347t2032r450b2061],
5	,	,	O	,	_	0	SENT_11	[p1l347t2032r450b2061],
6	and	CC	O	and	_	0	SENT_11	[p1l464t2030r509b2054],
7	Nagrath	NNP	PERSON	Nagrath	nsubj	8	SENT_11	[p1l525t2030r627b2061],
8	contributed	VBD	O	contribute	_	0	SENT_11	[p1l93t2067r244b2091],
9	equally	RB	O	equally	advmod	8	SENT_11	[p1l254t2067r345b2098],
10	to	TO	O	to	_	0	SENT_11	[p1l353t2072r378b2091],
11	this	DT	O	this	det	12	SENT_11	[p1l387t2067r434b2091],
12	article	NN	O	article	prep_to	8	SENT_11	[p1l444t2067r531b2091],
13	.	.	O	.	_	0	SENT_11	[p1l444t2067r531b2091],

1	This	DT	O	this	det	2	SENT_12	[p1l92t2142r144b2166],
2	article	NN	O	article	_	0	SENT_12	[p1l153t2142r227b2166],
3	(	CD	NUMBER	(	num	4	SENT_12	[p1l238t2144r395b2173],
4	10.1056	CD	NUMBER	10.1056	ccomp	2	SENT_12	[p1l238t2144r395b2173],
5	/	:	O	/	punct	4	SENT_12	[p1l238t2144r395b2173],
6	NEJ	NN	O	nej	nn	8	SENT_12	[p1l238t2144r395b2173],
7	Moa0800668	NN	O	moa0800668	nn	8	SENT_12	[p1l401t2144r571b2173],
8	)	NN	O	)	nsubjpass	10	SENT_12	[p1l401t2144r571b2173],
9	was	VBD	O	be	auxpass	10	SENT_12	[p1l581t2151r628b2166],
10	published	VBN	O	publish	dep	4	SENT_12	[p1l95t2180r213b2211],
11	at	IN	O	at	_	0	SENT_12	[p1l222t2185r244b2204],
12	www.nejm.org	NN	O	www.nejm.org	prep_at	10	SENT_12	[p1l250t2182r431b2211],
13	onjuly	JJ	O	onjuly	amod	12	SENT_12	[p1l438t2180r519b2211],
14	2,2008	CD	NUMBER	2,2008	tmod	13	SENT_12	[p1l526t2181r622b2208],
15	.	.	O	.	_	0	SENT_12	[p1l526t2181r622b2208],

1	N	NN	MISC	n	nn	3	SENT_13	[p1l95t2257r113b2279],
2	Englj	NNP	MISC	Englj	nn	3	SENT_13	[p1l126t2255r194b2287],
3	Med	NNP	O	Med	_	0	SENT_13	[p1l208t2255r263b2279],
4	2008	CD	DATE	2008	num	3	SENT_13	[p1l273t2257r492b2283],
5	;	:	O	;	_	0	SENT_13	[p1l273t2257r492b2283],
6	359:366	CD	NUMBER	359:366	number	7	SENT_13	[p1l273t2257r492b2283],
7	—	CD	NUMBER	—	dep	3	SENT_13	[p1l273t2257r492b2283],
8	77	CD	NUMBER	77	dep	7	SENT_13	[p1l273t2257r492b2283],
9	.	.	O	.	_	0	SENT_13	[p1l273t2257r492b2283],

1	Copyright	NN	O	copyright	_	0	SENT_14	[p1l94t2298r187b2323],
2	©	CD	NUMBER	©	num	6	SENT_14	[p1l196t2300r217b2321],
3	2008	CD	DATE	2008	num	6	SENT_14	[p1l227t2299r276b2317],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_14	[p1l285t2298r425b2317],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_14	[p1l434t2297r511b2317],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_14	[p1l519t2298r591b2322],
7	.	.	O	.	_	0	SENT_14	[p1l519t2298r591b2322],

1	The	DT	O	the	det	4	SENT_15	[p1l960t81r1005b102],
2	NEW	NNP	O	NEW	nn	4	SENT_15	[p1l1024t83r1109b102],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_15	[p1l1128t83r1316b102],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_15	[p1l1335t83r1515b109],
5	of	IN	O	of	_	0	SENT_15	[p1l1534t81r1563b108],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_15	[p1l1575t83r1774b102],

1	I	PRP	O	I	nsubj	2	SENT_16	[p1l667t186r669b303],
2	ORIGINAL	VBP	O	original	_	0	SENT_16	[p1l1156t234r1379b260],
3	ARTICLE	NN	O	article	nsubj	4	SENT_16	[p1l1392t234r1578b260],
4	I	PRP	O	I	xcomp	2	SENT_16	[p1l2065t186r2067b303],

1	Detection	NN	O	detection	_	0	SENT_17	[p1l880t379r1171b433],
2	of	IN	O	of	_	0	SENT_17	[p1l1201t378r1271b433],
3	Mutations	NNS	MISC	mutation	prep_of	1	SENT_17	[p1l1286t379r1592b434],
4	in	IN	O	in	_	0	SENT_17	[p1l1622t379r1680b432],
5	EGFR	NN	ORGANIZATION	egfr	prep_in	3	SENT_17	[p1l1707t383r1858b434],
6	in	IN	O	in	dep	1	SENT_17	[p1l859t462r917b515],
7	Circulating	VBG	MISC	circulate	amod	9	SENT_17	[p1l946t461r1284b531],
8	Lung-Cancer	NNP	MISC	Lung-Cancer	nn	9	SENT_17	[p1l1310t465r1702b531],
9	Cells	NNS	MISC	cell	pobj	6	SENT_17	[p1l1729t461r1873b516],

1	Shyamala	NNP	PERSON	Shyamala	nn	2	SENT_18	[p1l837t584r998b625],
2	Maheswaran	NNP	PERSON	Maheswaran	_	0	SENT_18	[p1l1015t584r1239b621],
3	,	,	O	,	_	0	SENT_18	[p1l1015t584r1239b621],
4	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_18	[p1l1256t584r1355b621],
5	,	,	O	,	_	0	SENT_18	[p1l1256t584r1355b621],
6	Lecia	NNP	PERSON	Lecia	nn	8	SENT_18	[p1l1372t587r1454b615],
7	V.	NNP	PERSON	V.	nn	8	SENT_18	[p1l1467t587r1498b615],
8	Sequist	NNP	PERSON	Sequist	appos	2	SENT_18	[p1l1513t586r1646b625],
9	,	,	O	,	_	0	SENT_18	[p1l1513t586r1646b625],
10	M.D.	NNP	O	M.D.	appos	2	SENT_18	[p1l1663t587r1753b621],
11	,	,	O	,	_	0	SENT_18	[p1l1663t587r1753b621],
12	M.P.H.	NNP	O	M.P.H.	appos	2	SENT_18	[p1l1770t587r1897b621],
13	,	,	O	,	_	0	SENT_18	[p1l1770t587r1897b621],
14	Sunitha	NNP	PERSON	Sunitha	nn	15	SENT_18	[p1l795t634r923b665],
15	Nagrath	NNP	PERSON	Nagrath	appos	2	SENT_18	[p1l940t634r1084b675],
16	,	,	O	,	_	0	SENT_18	[p1l940t634r1084b675],
17	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_18	[p1l1102t634r1200b670],
18	,	,	O	,	_	0	SENT_18	[p1l1102t634r1200b670],
19	Lindsey	NNP	PERSON	Lindsey	nn	20	SENT_18	[p1l1218t634r1344b674],
20	Ulkus	NNP	PERSON	Ulkus	appos	2	SENT_18	[p1l1358t634r1461b670],
21	,	,	O	,	_	0	SENT_18	[p1l1358t634r1461b670],
22	B.S.	NNP	O	B.S.	appos	2	SENT_18	[p1l1478t636r1548b670],
23	,	,	O	,	_	0	SENT_18	[p1l1478t636r1548b670],
24	Brian	NNP	PERSON	Brian	nn	25	SENT_18	[p1l1566t637r1650b665],
25	Brannigan	NNP	PERSON	Brannigan	appos	2	SENT_18	[p1l1667t637r1848b675],
26	,	,	O	,	_	0	SENT_18	[p1l1667t637r1848b675],
27	B.A.	NNP	O	B.A.	appos	2	SENT_18	[p1l1865t636r1938b670],
28	,	,	O	,	_	0	SENT_18	[p1l1865t636r1938b670],
29	Chey	NNP	PERSON	Chey	nn	31	SENT_18	[p1l777t683r858b724],
30	V.	NNP	PERSON	V.	nn	31	SENT_18	[p1l869t686r900b714],
31	Collura	NNP	PERSON	Collura	appos	2	SENT_18	[p1l915t683r1044b720],
32	,	,	O	,	_	0	SENT_18	[p1l915t683r1044b720],
33	M.S.	NNP	LOCATION	M.S.	appos	2	SENT_18	[p1l1061t685r1144b720],
34	,	,	O	,	_	0	SENT_18	[p1l1061t685r1144b720],
35	Elizabeth	NNP	PERSON	Elizabeth	nn	36	SENT_18	[p1l1161t683r1312b714],
36	lnserra	NNP	O	lnserra	appos	2	SENT_18	[p1l1329t686r1454b720],
37	,	,	O	,	_	0	SENT_18	[p1l1329t686r1454b720],
38	B.S.	NNP	O	B.S.	appos	2	SENT_18	[p1l1471t685r1542b720],
39	,	,	O	,	_	0	SENT_18	[p1l1471t685r1542b720],
40	Sven	NNP	PERSON	Sven	nn	43	SENT_18	[p1l1557t685r1634b714],
41	Diederichs	NNP	PERSON	Diederichs	nn	43	SENT_18	[p1l1652t683r1840b720],
42	,	,	O	,	_	0	SENT_18	[p1l1652t683r1840b720],
43	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_18	[p1l1857t683r1956b720],
44	,	,	O	,	_	0	SENT_18	[p1l1857t683r1956b720],

1	A.	NN	O	a.	nn	2	SENT_19	[p1l701t732r822b773],
2	john	NN	O	john	_	0	SENT_19	[p1l701t732r822b773],
3	lafrate	JJ	O	lafrate	dep	2	SENT_19	[p1l840t732r953b769],
4	,	,	O	,	_	0	SENT_19	[p1l840t732r953b769],
5	M.D.	NNP	O	M.D.	nn	11	SENT_19	[p1l970t735r1060b769],
6	,	,	O	,	_	0	SENT_19	[p1l970t735r1060b769],
7	Ph.D.	NNP	O	Ph.D.	appos	11	SENT_19	[p1l1078t732r1177b769],
8	,	,	O	,	_	0	SENT_19	[p1l1078t732r1177b769],
9	Daphne	NNP	PERSON	Daphne	appos	11	SENT_19	[p1l1194t732r1325b773],
10	W.	NNP	PERSON	W.	nn	11	SENT_19	[p1l1336t735r1379b764],
11	Bell	NNP	PERSON	Bell	appos	3	SENT_19	[p1l1396t732r1463b769],
12	,	,	O	,	_	0	SENT_19	[p1l1396t732r1463b769],
13	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_19	[p1l1481t732r1579b769],
14	,	,	O	,	_	0	SENT_19	[p1l1481t732r1579b769],
15	Subba	NNP	PERSON	Subba	nn	18	SENT_19	[p1l1595t732r1699b764],
16	Digumarthy	NNP	PERSON	Digumarthy	nn	18	SENT_19	[p1l1715t732r1923b774],
17	,	,	O	,	_	0	SENT_19	[p1l1715t732r1923b774],
18	M.D.	NNP	O	M.D.	appos	3	SENT_19	[p1l1940t735r2030b769],
19	,	,	O	,	_	0	SENT_19	[p1l1940t735r2030b769],

1	Alona	NNP	PERSON	Alona	nn	2	SENT_20	[p1l762t782r859b813],
2	Muzikansky	NNP	PERSON	Muzikansky	_	0	SENT_20	[p1l875t782r1082b823],
3	,	,	O	,	_	0	SENT_20	[p1l875t782r1082b823],
4	M.S.	NNP	LOCATION	M.S.	appos	2	SENT_20	[p1l1100t785r1182b819],
5	,	,	O	,	_	0	SENT_20	[p1l1100t785r1182b819],
6	Daniel	NNP	PERSON	Daniel	nn	7	SENT_20	[p1l1200t782r1304b813],
7	lrimia	NNP	O	lrimia	appos	4	SENT_20	[p1l1321t785r1426b819],
8	,	,	O	,	_	0	SENT_20	[p1l1321t785r1426b819],
9	Ph.D.	NNP	O	Ph.D.	appos	4	SENT_20	[p1l1444t782r1661b823],
10	,	,	O	,	_	0	SENT_20	[p1l1444t782r1661b823],
11	Jeffrey	NNP	PERSON	Jeffrey	nn	12	SENT_20	[p1l1444t782r1661b823],
12	Settleman	NNP	PERSON	Settleman	appos	4	SENT_20	[p1l1673t782r1853b819],
13	,	,	O	,	_	0	SENT_20	[p1l1673t782r1853b819],
14	Ph.D.	NNP	O	Ph.D.	appos	4	SENT_20	[p1l1871t782r1970b819],
15	,	,	O	,	_	0	SENT_20	[p1l1871t782r1970b819],
16	Ronald	NNP	PERSON	Ronald	nn	18	SENT_20	[p1l733t832r847b863],
17	G.	NNP	PERSON	G.	nn	18	SENT_20	[p1l862t834r897b863],
18	Tompkins	NNP	PERSON	Tompkins	appos	4	SENT_20	[p1l910t832r1090b873],
19	,	,	O	,	_	0	SENT_20	[p1l910t832r1090b873],
20	M.D.	NNP	O	M.D.	appos	4	SENT_20	[p1l1107t835r1197b869],
21	,	,	O	,	_	0	SENT_20	[p1l1107t835r1197b869],
22	Thomas	NNP	PERSON	Thomas	nn	23	SENT_20	[p1l1210t832r1381b872],
23	]	NNP	O	]	appos	4	SENT_20	[p1l1210t832r1381b872],
24	.	.	O	.	_	0	SENT_20	[p1l1210t832r1381b872],

1	Lynch	NNP	PERSON	Lynch	nn	6	SENT_21	[p1l1398t832r1502b873],
2	,	,	O	,	_	0	SENT_21	[p1l1398t832r1502b873],
3	M.D.	NNP	O	M.D.	appos	6	SENT_21	[p1l1519t835r1609b869],
4	,	,	O	,	_	0	SENT_21	[p1l1519t835r1609b869],
5	Mehmet	NNP	PERSON	Mehmet	appos	6	SENT_21	[p1l1626t832r1767b863],
6	Toner	NNP	PERSON	Toner	_	0	SENT_21	[p1l1778t835r1886b869],
7	,	,	O	,	_	0	SENT_21	[p1l1778t835r1886b869],
8	Ph.D.	NNP	O	Ph.D.	dep	6	SENT_21	[p1l1903t832r2002b869],
9	,	,	O	,	_	0	SENT_21	[p1l1903t832r2002b869],

1	and	CC	O	and	dep	4	SENT_22	[p1l1083t882r1143b913],
2	Daniel	NNP	PERSON	Daniel	nn	4	SENT_22	[p1l1160t882r1264b913],
3	A.	NNP	PERSON	A.	nn	4	SENT_22	[p1l1278t884r1310b913],
4	Haber	NNP	PERSON	Haber	_	0	SENT_22	[p1l1327t882r1437b919],
5	,	,	O	,	_	0	SENT_22	[p1l1327t882r1437b919],
6	M.D.	NNP	O	M.D.	nn	8	SENT_22	[p1l1454t885r1544b919],
7	,	,	O	,	_	0	SENT_22	[p1l1454t885r1544b919],
8	Ph.D.	NNP	O	Ph.D.	appos	4	SENT_22	[p1l1562t882r1650b913],
9	.	.	O	.	_	0	SENT_22	[p1l1562t882r1650b913],

1	ABSTRACT	NN	O	abstract	_	0	SENT_23	[p1l1256t1017r1478b1040],

1	BAC	NN	O	bac	nn	2	SENT_24	[p1l670t1141r725b1160],
2	KG	NN	O	kg	nsubjpass	37	SENT_24	[p1l731t1141r767b1160],
3	no	DT	O	no	det	5	SENT_24	[p1l773t1141r813b1160],
4	u	NN	O	u	nn	5	SENT_24	[p1l819t1141r835b1160],
5	N	NN	O	n	nsubj	6	SENT_24	[p1l843t1141r859b1160],
6	D	NN	O	d	rcmod	2	SENT_24	[p1l867t1141r885b1160],
7	The	DT	O	the	det	8	SENT_24	[p1l667t1172r729b1202],
8	use	NN	O	use	dobj	6	SENT_24	[p1l741t1182r796b1203],
9	of	IN	O	of	_	0	SENT_24	[p1l808t1172r846b1203],
10	tyrosine	NN	O	tyrosine	nn	12	SENT_24	[p1l851t1172r985b1211],
11	kinase	NN	O	kinase	nn	12	SENT_24	[p1l997t1172r1105b1203],
12	inhibitors	NNS	O	inhibitor	prep_of	8	SENT_24	[p1l1117t1172r1280b1203],
13	to	TO	O	to	aux	14	SENT_24	[p1l1293t1178r1324b1203],
14	target	VB	O	target	xcomp	6	SENT_24	[p1l1337t1178r1436b1211],
15	the	DT	O	the	det	23	SENT_24	[p1l1446t1172r1497b1202],
16	epidermal	JJ	O	epidermal	amod	23	SENT_24	[p1l1509t1172r1677b1211],
17	growth	NN	O	growth	nn	23	SENT_24	[p1l1688t1172r1810b1211],
18	factor	NN	O	factor	nn	23	SENT_24	[p1l1822t1172r1919b1203],
19	receptor	NN	O	receptor	nn	23	SENT_24	[p1l1929t1178r2067b1211],
20	gene	NN	O	gene	nn	23	SENT_24	[p1l668t1232r745b1261],
21	(	CD	NUMBER	(	num	23	SENT_24	[p1l762t1225r864b1257],
22	EGFR	NN	ORGANIZATION	egfr	nn	23	SENT_24	[p1l762t1225r864b1257],
23	)	NN	O	)	dobj	14	SENT_24	[p1l762t1225r864b1257],
24	in	IN	O	in	_	0	SENT_24	[p1l880t1222r912b1252],
25	patients	NNS	O	patient	prep_in	23	SENT_24	[p1l926t1222r1058b1261],
26	with	IN	O	with	_	0	SENT_24	[p1l1072t1222r1148b1253],
27	non	JJ	O	non	amod	33	SENT_24	[p1l1162t1222r1411b1253],
28	—	JJ	O	—	amod	33	SENT_24	[p1l1162t1222r1411b1253],
29	small	JJ	O	small	amod	33	SENT_24	[p1l1162t1222r1411b1253],
30	—	NN	O	—	nn	33	SENT_24	[p1l1162t1222r1411b1253],
31	cell	NN	O	cell	nn	33	SENT_24	[p1l1162t1222r1411b1253],
32	lung	NN	O	lung	nn	33	SENT_24	[p1l1425t1222r1500b1261],
33	cancer	NN	O	cancer	prep_with	14	SENT_24	[p1l1513t1232r1622b1252],
34	is	VBZ	O	be	auxpass	35	SENT_24	[p1l1635t1222r1661b1252],
35	effective	JJ	O	effective	_	0	SENT_24	[p1l1676t1222r1815b1253],
36	but	CC	O	but	_	0	SENT_24	[p1l1830t1222r1884b1253],
37	limited	VBN	O	limit	conj_but	35	SENT_24	[p1l1896t1222r2016b1253],
38	by	IN	O	by	_	0	SENT_24	[p1l2030t1222r2068b1261],
39	the	DT	O	the	det	40	SENT_24	[p1l668t1272r720b1302],
40	emergence	NN	O	emergence	prep_by	37	SENT_24	[p1l732t1282r911b1311],
41	of	IN	O	of	_	0	SENT_24	[p1l922t1272r961b1303],
42	drug	NN	O	drug	nn	45	SENT_24	[p1l965t1272r1223b1311],
43	—	NN	O	—	nn	45	SENT_24	[p1l965t1272r1223b1311],
44	resistance	NN	O	resistance	nn	45	SENT_24	[p1l965t1272r1223b1311],
45	mutations	NNS	O	mutation	prep_of	40	SENT_24	[p1l1235t1272r1413b1303],
46	.	.	O	.	_	0	SENT_24	[p1l1235t1272r1413b1303],

1	Molecular	JJ	O	molecular	amod	2	SENT_25	[p1l1425t1272r1594b1303],
2	characterization	NN	O	characterization	nsubj	8	SENT_25	[p1l1605t1272r1876b1303],
3	of	IN	O	of	_	0	SENT_25	[p1l1888t1272r1926b1303],
4	circulating	VBG	O	circulate	prepc_of	2	SENT_25	[p1l1931t1272r2066b1303, p1l668t1322r722b1361],
5	tumor	NN	O	tumor	nn	6	SENT_25	[p1l735t1328r839b1353],
6	cells	NNS	O	cell	dobj	4	SENT_25	[p1l853t1322r925b1352],
7	may	MD	O	may	aux	8	SENT_25	[p1l941t1332r1010b1361],
8	provide	VB	O	provide	_	0	SENT_25	[p1l1022t1322r1145b1361],
9	a	DT	O	a	det	10	SENT_25	[p1l1160t1332r1177b1352],
10	strategy	NN	O	strategy	dobj	8	SENT_25	[p1l1191t1328r1325b1361],
11	for	IN	O	for	_	0	SENT_25	[p1l1337t1322r1385b1353],
12	noninvasive	JJ	O	noninvasive	amod	14	SENT_25	[p1l1398t1322r1594b1353],
13	serial	NN	O	serial	nn	14	SENT_25	[p1l1609t1322r1699b1352],
14	monitoring	NN	O	monitoring	prep_for	10	SENT_25	[p1l1713t1322r1904b1361],
15	of	IN	O	of	_	0	SENT_25	[p1l1917t1322r1956b1353],
16	tumor	NN	O	tumor	nn	17	SENT_25	[p1l1963t1328r2067b1353],
17	genotypes	NNS	O	genotype	prep_of	14	SENT_25	[p1l668t1378r838b1412],
18	during	IN	O	during	_	0	SENT_25	[p1l852t1372r964b1412],
19	treatment	NN	O	treatment	prep_during	8	SENT_25	[p1l976t1378r1148b1403],
20	.	.	O	.	_	0	SENT_25	[p1l976t1378r1148b1403],

1	METHODS	NNS	O	method	nsubj	28	SENT_26	[p1l671t1507r823b1526],
2	We	PRP	O	we	nsubj	3	SENT_26	[p1l667t1553r718b1581],
3	captured	VBD	O	capture	rcmod	1	SENT_26	[p1l731t1550r876b1589],
4	highly	RB	O	highly	advmod	5	SENT_26	[p1l888t1550r994b1589],
5	purified	VBN	O	purify	amod	21	SENT_26	[p1l1003t1550r1138b1589],
6	circulating	VBG	O	circulate	dep	5	SENT_26	[p1l1150t1550r1332b1589],
7	tumor	NN	O	tumor	nn	8	SENT_26	[p1l1342t1557r1446b1581],
8	cells	NNS	O	cell	dobj	6	SENT_26	[p1l1457t1550r1529b1581],
9	from	IN	O	from	_	0	SENT_26	[p1l1542t1550r1623b1581],
10	the	DT	O	the	det	11	SENT_26	[p1l1635t1550r1687b1581],
11	blood	NN	O	blood	prep_from	6	SENT_26	[p1l1699t1550r1793b1581],
12	of	IN	O	of	_	0	SENT_26	[p1l1805t1550r1844b1581],
13	patients	NNS	O	patient	prep_of	11	SENT_26	[p1l1847t1551r1980b1589],
14	with	IN	O	with	_	0	SENT_26	[p1l1990t1550r2066b1581],
15	non	JJ	O	non	amod	19	SENT_26	[p1l668t1600r918b1631],
16	—	JJ	O	—	amod	19	SENT_26	[p1l668t1600r918b1631],
17	small	JJ	O	small	amod	19	SENT_26	[p1l668t1600r918b1631],
18	—	NN	O	—	nn	19	SENT_26	[p1l668t1600r918b1631],
19	cell	NN	O	cell	prep_with	13	SENT_26	[p1l668t1600r918b1631],
20	lung	NN	O	lung	nn	21	SENT_26	[p1l928t1600r1003b1639],
21	cancer	NN	O	cancer	dobj	3	SENT_26	[p1l1014t1610r1123b1631],
22	using	VBG	O	use	xcomp	3	SENT_26	[p1l1133t1601r1225b1640],
23	a	DT	O	a	det	25	SENT_26	[p1l1235t1610r1253b1631],
24	microﬂuidic	JJ	O	microﬂuidic	amod	25	SENT_26	[p1l1264t1600r1471b1631],
25	device	NN	O	device	dobj	22	SENT_26	[p1l1482t1600r1584b1631],
26	containing	VBG	O	contain	xcomp	22	SENT_26	[p1l1596t1601r1778b1640],
27	microposts	NNS	O	micropost	dobj	26	SENT_26	[p1l1788t1601r1974b1639],
28	coated	VBN	O	coat	_	0	SENT_26	[p1l1987t1607r2066b1631, p1l669t1650r706b1681],
29	with	IN	O	with	_	0	SENT_26	[p1l717t1650r793b1681],
30	antibodies	NNS	O	antibody	prep_with	28	SENT_26	[p1l806t1650r980b1681],
31	against	IN	O	against	_	0	SENT_26	[p1l994t1651r1116b1690],
32	epithelial	JJ	O	epithelial	amod	33	SENT_26	[p1l1128t1650r1283b1689],
33	cells	NNS	O	cell	prep_against	30	SENT_26	[p1l1296t1650r1378b1681],
34	.	.	O	.	_	0	SENT_26	[p1l1296t1650r1378b1681],

1	We	PRP	O	we	nsubj	2	SENT_27	[p1l1392t1653r1443b1681],
2	performed	VBD	O	perform	_	0	SENT_27	[p1l1456t1650r1633b1689],
3	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_27	[p1l1645t1653r1727b1681],
4	mutational	JJ	O	mutational	amod	5	SENT_27	[p1l1738t1650r1921b1681],
5	analysis	NN	O	analysis	dobj	2	SENT_27	[p1l1934t1650r2065b1689],
6	on	IN	O	on	_	0	SENT_27	[p1l669t1780r710b1801],
7	DNA	NN	O	dna	prep_on	5	SENT_27	[p1l727t1773r807b1801],
8	recovered	VBN	O	recover	dep	7	SENT_27	[p1l824t1770r982b1801],
9	from	IN	O	from	_	0	SENT_27	[p1l999t1770r1081b1801],
10	circulating	VBG	O	circulate	prepc_from	8	SENT_27	[p1l1099t1770r1280b1810],
11	tumor	NN	O	tumor	nn	12	SENT_27	[p1l1296t1777r1400b1801],
12	cells	NNS	O	cell	dobj	10	SENT_27	[p1l1417t1770r1489b1801],
13	using	VBG	O	use	xcomp	10	SENT_27	[p1l1507t1771r1599b1810],
14	allele	NN	O	allele	nn	16	SENT_27	[p1l1615t1770r1845b1809],
15	—	NN	O	—	nn	16	SENT_27	[p1l1615t1770r1845b1809],
16	speciflc	NN	O	speciflc	dobj	13	SENT_27	[p1l1615t1770r1845b1809],
17	polymerasechain	NN	O	polymerasechain	nn	20	SENT_27	[p1l1862t1770r2066b1809, p1l669t1820r904b1851],
18	—	CD	NUMBER	—	num	20	SENT_27	[p1l1862t1770r2066b1809, p1l669t1820r904b1851],
19	reaction	NN	O	reaction	nn	20	SENT_27	[p1l1862t1770r2066b1809, p1l669t1820r904b1851],
20	ampliﬁcation	NN	O	ampliﬁcation	dep	16	SENT_27	[p1l916t1820r1137b1859],
21	and	CC	O	and	_	0	SENT_27	[p1l1149t1820r1210b1851],
22	compared	VBN	O	compare	conj_and	8	SENT_27	[p1l1223t1820r1385b1859],
23	the	DT	O	the	det	24	SENT_27	[p1l1398t1820r1448b1851],
24	results	NNS	O	result	dobj	22	SENT_27	[p1l1461t1820r1568b1851],
25	with	IN	O	with	_	0	SENT_27	[p1l1580t1820r1654b1851],
26	those	DT	O	those	prep_with	22	SENT_27	[p1l1667t1820r1755b1851],
27	from	IN	O	from	_	0	SENT_27	[p1l1767t1820r1848b1851],
28	concurrently	RB	O	concurrently	advmod	29	SENT_27	[p1l1861t1820r2068b1859],
29	isolated	VBN	O	isolate	amod	40	SENT_27	[p1l668t1870r798b1901],
30	free	JJ	O	free	amod	31	SENT_27	[p1l811t1870r874b1901],
31	plasma	NN	O	plasma	nn	40	SENT_27	[p1l887t1870r1007b1909],
32	DNA	NN	MISC	dna	dep	31	SENT_27	[p1l1019t1873r1100b1901],
33	and	CC	O	and	_	0	SENT_27	[p1l1112t1870r1173b1901],
34	from	IN	O	from	conj_and	31	SENT_27	[p1l1187t1870r1268b1901],
35	the	DT	O	the	det	39	SENT_27	[p1l1282t1870r1333b1901],
36	original	JJ	O	original	amod	39	SENT_27	[p1l1347t1870r1478b1909],
37	tumor	NN	O	tumor	nn	39	SENT_27	[p1l1492t1870r1717b1909],
38	—	NN	O	—	nn	39	SENT_27	[p1l1492t1870r1717b1909],
39	biopsy	NN	O	biopsy	pobj	34	SENT_27	[p1l1492t1870r1717b1909],
40	specimens	NNS	O	specimen	prep_from	26	SENT_27	[p1l1729t1871r1912b1909],
41	.	.	O	.	_	0	SENT_27	[p1l1729t1871r1912b1909],

1	RESULTS	NNS	O	result	nsubj	3	SENT_28	[p1l670t1967r798b1986],
2	We	PRP	O	we	nsubj	3	SENT_28	[p1l667t2013r718b2040],
3	isolated	VBD	O	isolate	_	0	SENT_28	[p1l730t2010r859b2041],
4	circulating	VBG	O	circulate	xcomp	3	SENT_28	[p1l871t2010r1052b2049],
5	tumor	NN	O	tumor	nn	6	SENT_28	[p1l1062t2017r1166b2041],
6	cells	NNS	O	cell	dobj	4	SENT_28	[p1l1176t2010r1249b2040],
7	from	IN	O	from	_	0	SENT_28	[p1l1261t2010r1343b2041],
8	27	CD	NUMBER	27	num	9	SENT_28	[p1l1354t2012r1392b2040],
9	patients	NNS	O	patient	prep_from	4	SENT_28	[p1l1403t2010r1535b2049],
10	with	IN	O	with	_	0	SENT_28	[p1l1546t2010r1622b2041],
11	metastatic	JJ	O	metastatic	amod	13	SENT_28	[p1l1633t2010r1806b2040],
12	non	JJ	O	non	amod	13	SENT_28	[p1l1817t2010r2066b2041],
13	—	NN	O	—	prep_with	9	SENT_28	[p1l1817t2010r2066b2041],
14	small	JJ	O	small	amod	21	SENT_28	[p1l1817t2010r2066b2041],
15	—	NN	O	—	nn	21	SENT_28	[p1l1817t2010r2066b2041],
16	cell	NN	O	cell	nn	21	SENT_28	[p1l1817t2010r2066b2041],
17	lung	NN	O	lung	nn	21	SENT_28	[p1l668t2060r743b2099],
18	cancer	NN	O	cancer	nn	21	SENT_28	[p1l760t2070r869b2090],
19	(	CD	NUMBER	(	num	21	SENT_28	[p1l887t2060r1023b2095],
20	median	JJ	O	median	amod	21	SENT_28	[p1l887t2060r1023b2095],
21	number	NN	O	number	tmod	4	SENT_28	[p1l1041t2060r1179b2097],
22	,	,	O	,	_	0	SENT_28	[p1l1041t2060r1179b2097],
23	74	CD	NUMBER	74	num	24	SENT_28	[p1l1199t2062r1235b2091],
24	cells	NNS	O	cell	appos	21	SENT_28	[p1l1253t2060r1326b2090],
25	per	IN	O	per	_	0	SENT_28	[p1l1344t2070r1399b2099],
26	milliliter	NN	O	milliliter	nn	27	SENT_28	[p1l1415t2060r1582b2095],
27	)	NN	O	)	prep_per	24	SENT_28	[p1l1415t2060r1582b2095],
28	.	.	O	.	_	0	SENT_28	[p1l1415t2060r1582b2095],

1	We	PRP	O	we	nsubj	2	SENT_29	[p1l1601t2063r1653b2090],
2	identified	VBD	O	identify	_	0	SENT_29	[p1l1670t2060r1832b2091],
3	the	DT	O	the	det	5	SENT_29	[p1l1850t2060r1902b2090],
4	expected	JJ	O	expected	amod	5	SENT_29	[p1l1920t2060r2066b2099],
5	EGFR	NN	ORGANIZATION	egfr	dobj	2	SENT_29	[p1l668t2113r750b2141],
6	activating	VBG	O	activate	partmod	5	SENT_29	[p1l764t2110r927b2149],
7	mutation	NN	O	mutation	dobj	6	SENT_29	[p1l942t2110r1095b2141],
8	in	IN	O	in	_	0	SENT_29	[p1l1111t2110r1143b2140],
9	circulating	VBG	O	circulate	prepc_in	6	SENT_29	[p1l1160t2110r1341b2149],
10	tumor	NN	O	tumor	nn	11	SENT_29	[p1l1356t2116r1460b2141],
11	cells	NNS	O	cell	dobj	9	SENT_29	[p1l1475t2110r1548b2140],
12	from	IN	O	from	_	0	SENT_29	[p1l1565t2110r1646b2141],
13	11	CD	TIME	11	prep_from	9	SENT_29	[p1l1664t2112r1701b2140],
14	of	IN	TIME	of	_	0	SENT_29	[p1l1718t2110r1757b2141],
15	12	CD	TIME	12	num	16	SENT_29	[p1l1767t2112r1805b2140],
16	patients	NNS	O	patient	prep_of	13	SENT_29	[p1l1821t2110r1954b2149],
17	(	IN	O	(	_	0	SENT_29	[p1l1973t2112r2064b2145],
18	92	CD	PERCENT	92	num	19	SENT_29	[p1l1973t2112r2064b2145],
19	%	NN	PERCENT	%	prep_(	9	SENT_29	[p1l1973t2112r2064b2145],
20	)	CD	NUMBER	)	dep	19	SENT_29	[p1l1973t2112r2064b2145],
21	and	CC	O	and	_	0	SENT_29	[p1l668t2160r729b2191],
22	in	IN	O	in	_	0	SENT_29	[p1l745t2160r777b2190],
23	matched	VBN	O	match	amod	26	SENT_29	[p1l793t2160r936b2191],
24	free	JJ	O	free	amod	26	SENT_29	[p1l951t2160r1014b2190],
25	plasma	NN	O	plasma	nn	26	SENT_29	[p1l1030t2160r1150b2199],
26	DNA	NN	O	dna	prepc_in	6	SENT_29	[p1l1165t2163r1245b2191],
27	from	IN	O	from	_	0	SENT_29	[p1l1260t2160r1342b2191],
28	4	CD	TIME	4	prep_from	26	SENT_29	[p1l1357t2162r1376b2191],
29	of	IN	TIME	of	_	0	SENT_29	[p1l1392t2160r1431b2191],
30	12	CD	TIME	12	num	31	SENT_29	[p1l1441t2162r1479b2190],
31	patients	NNS	O	patient	prep_of	26	SENT_29	[p1l1494t2160r1627b2199],
32	(	CD	PERCENT	(	number	33	SENT_29	[p1l1645t2162r1736b2195],
33	33	CD	PERCENT	33	num	34	SENT_29	[p1l1645t2162r1736b2195],
34	%	NN	PERCENT	%	dep	31	SENT_29	[p1l1645t2162r1736b2195],
35	)	CD	NUMBER	)	number	36	SENT_29	[p1l1645t2162r1736b2195],
36	(	CD	NUMBER	(	num	37	SENT_29	[p1l1756t2162r1931b2195],
37	P	NN	O	p	npadvmod	38	SENT_29	[p1l1756t2162r1931b2195],
38	=	JJ	O	=	amod	34	SENT_29	[p1l1756t2162r1931b2195],
39	0.009	CD	NUMBER	0.009	num	40	SENT_29	[p1l1756t2162r1931b2195],
40	)	NN	O	)	dep	34	SENT_29	[p1l1756t2162r1931b2195],
41	.	.	O	.	_	0	SENT_29	[p1l1756t2162r1931b2195],

1	We	PRP	O	we	nsubj	2	SENT_30	[p1l1948t2163r1999b2190],
2	detected	VBD	O	detect	_	0	SENT_30	[p1l2015t2160r2066b2191, p1l668t2210r768b2241],
3	the	DT	O	the	det	5	SENT_30	[p1l785t2210r837b2240],
4	T790M	NN	O	t790m	nn	5	SENT_30	[p1l853t2212r970b2241],
5	mutation	NN	O	mutation	dobj	2	SENT_30	[p1l988t2210r1149b2247],
6	,	,	O	,	_	0	SENT_30	[p1l988t2210r1149b2247],
7	which	WDT	O	which	nsubj	8	SENT_30	[p1l1167t2210r1269b2241],
8	confers	VBZ	O	confer	rcmod	5	SENT_30	[p1l1287t2210r1408b2241],
9	drug	NN	O	drug	nn	10	SENT_30	[p1l1427t2210r1506b2249],
10	resistance	NN	O	resistance	dobj	8	SENT_30	[p1l1522t2210r1697b2247],
11	,	,	O	,	_	0	SENT_30	[p1l1522t2210r1697b2247],
12	in	IN	O	in	_	0	SENT_30	[p1l1716t2210r1748b2240],
13	circulating	VBG	O	circulate	prepc_in	2	SENT_30	[p1l1766t2210r1947b2249],
14	tumor	NN	O	tumor	nn	15	SENT_30	[p1l1963t2217r2067b2241],
15	cells	NNS	O	cell	dobj	13	SENT_30	[p1l669t2260r741b2291],
16	collected	VBN	O	collect	partmod	15	SENT_30	[p1l754t2260r902b2291],
17	from	IN	O	from	_	0	SENT_30	[p1l914t2260r995b2291],
18	patients	NNS	O	patient	prep_from	16	SENT_30	[p1l1007t2261r1139b2299],
19	with	IN	O	with	_	0	SENT_30	[p1l1150t2260r1226b2291],
20	EGFR	NN	ORGANIZATION	egfr	nn	21	SENT_30	[p1l1238t2263r1320b2291],
21	mutations	NNS	O	mutation	prep_with	18	SENT_30	[p1l1330t2260r1498b2291],
22	who	WP	O	who	nsubj	24	SENT_30	[p1l1509t2260r1580b2291],
23	had	VBD	O	have	aux	24	SENT_30	[p1l1593t2260r1653b2291],
24	received	VBN	O	receive	rcmod	15	SENT_30	[p1l1665t2260r1799b2291],
25	tyrosine	NN	O	tyrosine	nn	27	SENT_30	[p1l1812t2261r1946b2299],
26	kinase	NN	O	kinase	nn	27	SENT_30	[p1l1958t2260r2066b2291],
27	inhibitors	NNS	O	inhibitor	dobj	24	SENT_30	[p1l668t2311r841b2342],
28	.	.	O	.	_	0	SENT_30	[p1l668t2311r841b2342],

1	When	WRB	O	when	advmod	4	SENT_31	[p1l857t2311r956b2341],
2	T79OM	NN	O	t79om	nsubj	4	SENT_31	[p1l969t2313r1087b2342],
3	was	VBD	O	be	cop	4	SENT_31	[p1l1101t2321r1164b2342],
4	detectable	JJ	O	detectable	advcl	17	SENT_31	[p1l1180t2311r1348b2342],
5	in	IN	O	in	_	0	SENT_31	[p1l1363t2311r1395b2341],
6	pretreatment	NN	O	pretreatment	nn	10	SENT_31	[p1l1409t2317r1629b2350],
7	tumor	NN	O	tumor	nn	10	SENT_31	[p1l1642t2311r1867b2350],
8	—	CD	NUMBER	—	num	10	SENT_31	[p1l1642t2311r1867b2350],
9	biopsy	NN	O	biopsy	nn	10	SENT_31	[p1l1642t2311r1867b2350],
10	specimens	NNS	O	specimen	prep_in	4	SENT_31	[p1l1881t2311r2064b2350],
11	,	,	O	,	_	0	SENT_31	[p1l1881t2311r2064b2350],
12	the	DT	O	the	det	13	SENT_31	[p1l669t2351r720b2381],
13	presence	NN	O	presence	nsubj	17	SENT_31	[p1l733t2361r878b2390],
14	of	IN	O	of	_	0	SENT_31	[p1l892t2351r931b2382],
15	the	DT	O	the	det	16	SENT_31	[p1l937t2351r988b2381],
16	mutation	NN	O	mutation	prep_of	13	SENT_31	[p1l1002t2351r1154b2382],
17	correlated	VBD	O	correlate	_	0	SENT_31	[p1l1167t2351r1334b2382],
18	with	IN	O	with	_	0	SENT_31	[p1l1346t2351r1422b2382],
19	reduced	VBN	O	reduce	amod	20	SENT_31	[p1l1435t2351r1565b2382],
20	progression	NN	O	progression	prep_with	17	SENT_31	[p1l1578t2351r1852b2390],
21	—	CD	NUMBER	—	num	23	SENT_31	[p1l1578t2351r1852b2390],
22	free	JJ	O	free	amod	23	SENT_31	[p1l1578t2351r1852b2390],
23	survival	NN	O	survival	dep	20	SENT_31	[p1l1866t2351r1995b2382],
24	(	CD	NUMBER	(	number	25	SENT_31	[p1l2010t2354r2066b2386],
25	7.7	CD	DURATION	7.7	num	26	SENT_31	[p1l2010t2354r2066b2386],
26	months	NNS	NUMBER	month	dobj	17	SENT_31	[p1l668t2391r795b2422],
27	vs.	CC	O	vs.	prep	26	SENT_31	[p1l806t2401r848b2422],
28	16.5	CD	DURATION	16.5	num	29	SENT_31	[p1l863t2393r929b2422],
29	months	NNS	NUMBER	month	dep	27	SENT_31	[p1l942t2391r1078b2428],
30	,	,	O	,	_	0	SENT_31	[p1l942t2391r1078b2428],
31	P	NN	O	p	dep	32	SENT_31	[p1l1092t2393r1243b2426],
32	<	JJR	O	<	appos	29	SENT_31	[p1l1092t2393r1243b2426],
33	0.001	CD	NUMBER	0.001	num	34	SENT_31	[p1l1092t2393r1243b2426],
34	)	NN	O	)	dep	32	SENT_31	[p1l1092t2393r1243b2426],
35	.	.	O	.	_	0	SENT_31	[p1l1092t2393r1243b2426],

1	Serial	JJ	O	serial	amod	2	SENT_32	[p1l1257t2391r1350b2422],
2	analysis	NN	O	analysis	nsubj	7	SENT_32	[p1l1361t2391r1493b2430],
3	of	IN	O	of	_	0	SENT_32	[p1l1506t2391r1544b2422],
4	circulating	VBG	O	circulate	prepc_of	2	SENT_32	[p1l1549t2391r1730b2430],
5	tumor	NN	O	tumor	nn	6	SENT_32	[p1l1741t2397r1845b2422],
6	cells	NNS	O	cell	dobj	4	SENT_32	[p1l1855t2391r1928b2421],
7	showed	VBD	O	show	_	0	SENT_32	[p1l1941t2391r2066b2422],
8	that	IN	O	that	complm	18	SENT_32	[p1l669t2431r735b2461],
9	a	DT	O	a	det	10	SENT_32	[p1l746t2441r764b2461],
10	reduction	NN	O	reduction	nsubjpass	18	SENT_32	[p1l776t2431r935b2462],
11	in	IN	O	in	_	0	SENT_32	[p1l948t2431r980b2461],
12	the	DT	O	the	det	13	SENT_32	[p1l993t2431r1045b2461],
13	number	NN	O	number	prep_in	10	SENT_32	[p1l1058t2431r1189b2462],
14	of	IN	O	of	_	0	SENT_32	[p1l1201t2431r1240b2462],
15	captured	VBN	O	capture	amod	16	SENT_32	[p1l1246t2431r1392b2470],
16	cells	NNS	O	cell	prep_of	13	SENT_32	[p1l1405t2431r1478b2461],
17	was	VBD	O	be	auxpass	18	SENT_32	[p1l1490t2441r1553b2462],
18	associated	VBN	O	associate	ccomp	7	SENT_32	[p1l1567t2431r1739b2462],
19	with	IN	O	with	_	0	SENT_32	[p1l1751t2431r1826b2462],
20	a	DT	O	a	det	23	SENT_32	[p1l1839t2441r1857b2461],
21	radiographic	JJ	O	radiographic	amod	23	SENT_32	[p1l1869t2431r2066b2470, p1l668t2471r695b2501],
22	tumor	NN	O	tumor	nn	23	SENT_32	[p1l710t2477r814b2502],
23	response	NN	O	response	prep_with	18	SENT_32	[p1l829t2481r986b2510],
24	;	:	O	;	_	0	SENT_32	[p1l829t2481r986b2510],
25	an	DT	O	a	det	26	SENT_32	[p1l1003t2481r1043b2501],
26	increase	NN	O	increase	nsubjpass	33	SENT_32	[p1l1058t2471r1195b2501],
27	in	IN	O	in	_	0	SENT_32	[p1l1210t2471r1242b2501],
28	the	DT	O	the	det	29	SENT_32	[p1l1258t2471r1310b2501],
29	number	NN	O	number	prep_in	26	SENT_32	[p1l1325t2471r1456b2502],
30	of	IN	O	of	_	0	SENT_32	[p1l1471t2471r1510b2502],
31	cells	NNS	O	cell	prep_of	29	SENT_32	[p1l1519t2471r1591b2501],
32	was	VBD	O	be	auxpass	33	SENT_32	[p1l1606t2481r1669b2502],
33	associated	VBN	O	associate	parataxis	7	SENT_32	[p1l1685t2471r1858b2502],
34	with	IN	O	with	_	0	SENT_32	[p1l1872t2471r1948b2502],
35	tumor	NN	O	tumor	nn	36	SENT_32	[p1l1963t2477r2067b2502],
36	progression	NN	O	progression	prep_with	33	SENT_32	[p1l668t2511r875b2550],
37	,	,	O	,	_	0	SENT_32	[p1l668t2511r875b2550],
38	with	IN	O	with	_	0	SENT_32	[p1l889t2511r965b2542],
39	the	DT	O	the	det	40	SENT_32	[p1l978t2511r1030b2541],
40	emergence	NN	O	emergence	prep_with	33	SENT_32	[p1l1043t2521r1222b2550],
41	of	IN	O	of	_	0	SENT_32	[p1l1236t2511r1275b2542],
42	additional	JJ	O	additional	amod	44	SENT_32	[p1l1281t2511r1450b2542],
43	EGFR	NN	ORGANIZATION	egfr	nn	44	SENT_32	[p1l1462t2514r1545b2542],
44	mutations	NNS	O	mutation	prep_of	40	SENT_32	[p1l1556t2511r1724b2542],
45	in	IN	O	in	_	0	SENT_32	[p1l1738t2512r1770b2541],
46	some	DT	O	some	det	47	SENT_32	[p1l1784t2521r1871b2542],
47	cases	NNS	O	case	prep_in	44	SENT_32	[p1l1885t2521r1981b2542],
48	.	.	O	.	_	0	SENT_32	[p1l1885t2521r1981b2542],

1	CONCLUSIONS	NNS	O	conclusion	nn	3	SENT_33	[p1l669t2611r895b2631],
2	Molecular	JJ	O	molecular	amod	3	SENT_33	[p1l667t2653r836b2685],
3	analysis	NN	O	analysis	nsubj	16	SENT_33	[p1l849t2653r981b2693],
4	of	IN	O	of	_	0	SENT_33	[p1l996t2653r1035b2684],
5	circulating	VBG	O	circulate	prepc_of	3	SENT_33	[p1l1042t2653r1223b2693],
6	tumor	NN	O	tumor	nn	7	SENT_33	[p1l1237t2660r1340b2685],
7	cells	NNS	O	cell	dobj	5	SENT_33	[p1l1354t2653r1426b2684],
8	from	IN	O	from	_	0	SENT_33	[p1l1441t2653r1523b2684],
9	the	DT	O	the	det	10	SENT_33	[p1l1537t2653r1589b2684],
10	blood	NN	O	blood	prep_from	5	SENT_33	[p1l1603t2653r1698b2684],
11	of	IN	O	of	_	0	SENT_33	[p1l1712t2653r1751b2684],
12	patients	NNS	O	patient	prep_of	10	SENT_33	[p1l1757t2654r1890b2693],
13	with	IN	O	with	_	0	SENT_33	[p1l1903t2653r1979b2685],
14	lung	NN	O	lung	nn	15	SENT_33	[p1l1993t2653r2068b2693],
15	cancer	NN	O	cancer	prep_with	12	SENT_33	[p1l669t2713r778b2734],
16	offers	VBZ	O	offer	_	0	SENT_33	[p1l792t2703r887b2734],
17	the	DT	O	the	det	18	SENT_33	[p1l903t2703r955b2734],
18	possibility	NN	O	possibility	dobj	16	SENT_33	[p1l970t2703r1144b2743],
19	of	IN	O	of	_	0	SENT_33	[p1l1157t2703r1196b2734],
20	monitoring	NN	O	monitoring	nn	21	SENT_33	[p1l1204t2704r1396b2743],
21	changes	NNS	O	change	prep_of	18	SENT_33	[p1l1410t2703r1544b2743],
22	in	IN	O	in	_	0	SENT_33	[p1l1560t2704r1592b2734],
23	epithelial	JJ	O	epithelial	amod	25	SENT_33	[p1l1608t2703r1763b2743],
24	tumor	NN	O	tumor	nn	25	SENT_33	[p1l1778t2710r1882b2734],
25	genotypes	NNS	O	genotype	prep_in	21	SENT_33	[p1l1896t2710r2065b2743],
26	during	IN	O	during	_	0	SENT_33	[p1l669t2753r781b2793],
27	the	DT	O	the	det	28	SENT_33	[p1l793t2753r844b2784],
28	course	NN	O	course	prep_during	16	SENT_33	[p1l858t2763r966b2784],
29	of	IN	O	of	_	0	SENT_33	[p1l980t2753r1019b2784],
30	treatment	NN	O	treatment	prep_of	28	SENT_33	[p1l1025t2760r1198b2784],
31	.	.	O	.	_	0	SENT_33	[p1l1025t2760r1198b2784],

1	N	NN	O	n	nn	3	SENT_34	[p1l879t2879r893b2894],
2	ENGLJ	NN	O	englj	nn	3	SENT_34	[p1l907t2879r985b2901],
3	MED	NN	O	med	_	0	SENT_34	[p1l1000t2879r1052b2894],
4	359	CD	NUMBER	359	num	6	SENT_34	[p1l1062t2879r1128b2901],
5	;	:	O	;	_	0	SENT_34	[p1l1062t2879r1128b2901],
6	4	CD	NUMBER	4	dep	3	SENT_34	[p1l1062t2879r1128b2901],
7	WWW.NEjM.oRG	NNP	O	WWW.NEjM.oRG	nn	8	SENT_34	[p1l1160t2879r1361b2901],
8	JULY	NNP	DATE	JULY	dep	3	SENT_34	[p1l1392t2879r1449b2901],
9	24	CD	DATE	24	num	8	SENT_34	[p1l1460t2879r1495b2901],
10	,	,	DATE	,	_	0	SENT_34	[p1l1460t2879r1495b2901],
11	2008	CD	DATE	2008	num	8	SENT_34	[p1l1507t2873r1570b2895],

1	The	DT	O	the	det	5	SENT_35	[p1l881t2936r932b2960],
2	New	NNP	O	New	nn	5	SENT_35	[p1l941t2937r1003b2960],
3	England	NNP	O	England	nn	5	SENT_35	[p1l1012t2936r1123b2967],
4	J	NNP	O	J	nn	5	SENT_35	[p1l1131t2937r1144b2960],
5	oumal	NN	O	oumal	_	0	SENT_35	[p1l1145t2936r1229b2960],
6	of	IN	O	of	_	0	SENT_35	[p1l1238t2936r1267b2960],
7	Medicine	NN	O	medicine	prep_of	5	SENT_35	[p1l1274t2936r1399b2960],

1	Copyright	NN	O	copyright	_	0	SENT_36	[p1l673t3018r808b3049],
2	©	CD	NUMBER	©	num	6	SENT_36	[p1l817t3018r840b3042],
3	2008	CD	DATE	2008	num	6	SENT_36	[p1l850t3018r915b3042],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_36	[p1l925t3018r1116b3042],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_36	[p1l1126t3018r1234b3042],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_36	[p1l1244t3018r1349b3049],
7	.	.	O	.	_	0	SENT_36	[p1l1244t3018r1349b3049],

1	All	DT	O	all	det	2	SENT_37	[p1l1360t3018r1402b3042],
2	rights	NNS	O	rights	nsubj	3	SENT_37	[p1l1411t3018r1485b3049],
3	reserved	VBN	O	reserve	_	0	SENT_37	[p1l1495t3018r1614b3042],
4	.	.	O	.	_	0	SENT_37	[p1l1495t3018r1614b3042],

1	DETECTION	NN	O	detection	_	0	SENT_38	[p1l451t3124r641b3143],
2	OF	IN	O	of	_	0	SENT_38	[p1l657t3124r696b3143],
3	MUTATIONS	NNP	O	MUTATIONS	prep_of	1	SENT_38	[p1l710t3124r905b3143],
4	IN	IN	O	in	_	0	SENT_38	[p1l921t3124r958b3143],
5	EGFR	NN	O	egfr	prep_in	1	SENT_38	[p1l973t3124r1044b3143],
6	IN	IN	O	in	dep	1	SENT_38	[p1l1057t3124r1094b3143],
7	CIRCULATING	VBG	O	circulate	pcomp	6	SENT_38	[p1l1109t3124r1341b3143],
8	LUNG-CANCER	NN	O	lung-cancer	nn	9	SENT_38	[p1l1355t3124r1600b3143],
9	CELLS	NNS	O	cell	dobj	7	SENT_38	[p1l1612t3124r1708b3143],

1	NCREASING	VBG	O	ncrease	_	0	SENT_39	[p1l171t3351r710b3408],
2	KNOWLEDGE	NN	O	knowledge	dobj	1	SENT_39	[p1l764t3351r1354b3409],
3	OF	IN	O	of	_	0	SENT_39	[p1l1406t3351r1520b3408],
4	MOLECULAR	NN	MISC	molecular	prep_of	2	SENT_39	[p1l1571t3351r2138b3408],

1	abnormalities	NNS	O	abnormality	_	0	SENT_40	[p1l167t3458r763b3537],
2	that	WDT	O	that	nsubj	3	SENT_40	[p1l817t3458r989b3537],
3	drive	VBP	O	drive	rcmod	1	SENT_40	[p1l1035t3458r1242b3537],
4	human	JJ	O	human	amod	6	SENT_40	[p1l1293t3458r1597b3537],
5	cancers	NNS	O	cancer	nn	6	SENT_40	[p1l1648t3484r1968b3537],
6	offers	NNS	O	offer	dobj	3	SENT_40	[p1l2022t3458r2132b3537, p1l168t3587r323b3666],

1	the	DT	O	the	det	2	SENT_41	[p1l360t3587r493b3666],
2	promise	NN	O	promise	_	0	SENT_41	[p1l528t3589r878b3688],
3	of	IN	O	of	_	0	SENT_41	[p1l915t3587r1015b3666],
4	therapies	NNS	O	therapy	prep_of	2	SENT_41	[p1l1032t3587r1421b3688],
5	targeted	VBN	O	target	partmod	4	SENT_41	[p1l1459t3587r1814b3688],
6	at	IN	O	at	_	0	SENT_41	[p1l1849t3604r1928b3666],
7	specific	JJ	O	specific	prep_at	5	SENT_41	[p1l1960t3613r2132b3688, p2l12t21r196b100],

1	genetic	JJ	O	genetic	amod	2	SENT_42	[p2l266t22r575b122],
2	lesions	NNS	O	lesion	_	0	SENT_42	[p2l644t21r1062b100],
3	.	.	O	.	_	0	SENT_42	[p2l644t21r1062b100],

1	”	NNP	O	”	nn	3	SENT_43	[p2l644t21r1062b100],
2	Genetic	NNP	O	Genetic	nn	3	SENT_43	[p2l1135t22r1465b100],
3	abnormalities	NNS	O	abnormality	nsubj	5	SENT_43	[p2l1534t21r2131b100],
4	may	MD	O	may	aux	5	SENT_43	[p2l11t175r190b250],
5	define	VB	O	define	_	0	SENT_43	[p2l221t149r491b228],
6	a	DT	O	a	det	7	SENT_43	[p2l525t176r569b228],
7	cancer	NN	O	cancer	dobj	5	SENT_43	[p2l603t175r884b228],
8	at	IN	O	at	_	0	SENT_43	[p2l915t166r994b228],
9	diagnosis	NN	O	diagnosis	prep_at	5	SENT_43	[p2l1024t149r1459b250],
10	,	,	O	,	_	0	SENT_43	[p2l1024t149r1459b250],
11	but	CC	O	but	_	0	SENT_43	[p2l1499t149r1640b228],
12	mutations	NNS	O	mutation	nsubj	24	SENT_43	[p2l1669t150r2128b245],
13	,	,	O	,	_	0	SENT_43	[p2l1669t150r2128b245],
14	some	DT	O	some	nsubj	17	SENT_43	[p2l13t303r237b356],
15	of	IN	O	of	_	0	SENT_43	[p2l276t277r376b356],
16	which	WDT	O	which	prep_of	14	SENT_43	[p2l393t277r655b357],
17	lead	VBP	O	lead	rcmod	12	SENT_43	[p2l693t277r866b356],
18	to	TO	O	to	_	0	SENT_43	[p2l906t294r987b356],
19	acquired	VBN	O	acquire	amod	21	SENT_43	[p2l1027t277r1397b378],
20	drug	NN	O	drug	nn	21	SENT_43	[p2l1437t277r1640b378],
21	resistance	NN	O	resistance	prep_to	17	SENT_43	[p2l1676t278r2128b373],
22	,	,	O	,	_	0	SENT_43	[p2l1676t278r2128b373],
23	may	MD	O	may	aux	24	SENT_43	[p2l11t431r190b506],
24	emerge	VB	O	emerge	conj_but	5	SENT_43	[p2l225t431r536b506],
25	during	IN	O	during	_	0	SENT_43	[p2l576t405r865b506],
26	treatment	NN	O	treatment	prep_during	24	SENT_43	[p2l899t422r1343b484],
27	.	.	O	.	_	0	SENT_43	[p2l899t422r1343b484],

1	For	IN	O	for	_	0	SENT_44	[p2l1386t413r1529b484],
2	many	JJ	O	many	amod	4	SENT_44	[p2l1564t431r1803b506],
3	epithelial	JJ	O	epithelial	amod	4	SENT_44	[p2l1837t405r2132b506, p2l10t533r145b612],
4	cancers	NNS	O	cancer	prep_for	9	SENT_44	[p2l184t559r528b629],
5	,	,	O	,	_	0	SENT_44	[p2l184t559r528b629],
6	minimally	RB	O	minimally	advmod	7	SENT_44	[p2l573t533r1022b634],
7	invasive	JJ	O	invasive	amod	8	SENT_44	[p2l1057t534r1391b612],
8	biopsies	NNS	O	biopsy	nsubj	9	SENT_44	[p2l1431t533r1775b634],
9	provide	VBP	O	provide	_	0	SENT_44	[p2l1815t533r2133b634],
10	insufficient	JJ	O	insufficient	amod	11	SENT_44	[p2l11t661r512b740],
11	material	NN	O	material	dobj	9	SENT_44	[p2l538t661r897b740],
12	for	IN	O	for	_	0	SENT_44	[p2l928t661r1051b740],
13	molecular	JJ	O	molecular	amod	14	SENT_44	[p2l1080t661r1514b740],
14	analysis	NN	O	analysis	prep_for	9	SENT_44	[p2l1541t661r1881b762],
15	at	IN	O	at	_	0	SENT_44	[p2l1914t678r1993b740],
16	diagnosis	NN	O	diagnosis	prep_at	14	SENT_44	[p2l2020t661r2132b740, p2l11t790r359b890],
17	,	,	O	,	_	0	SENT_44	[p2l2020t661r2132b740, p2l11t790r359b890],
18	and	CC	O	and	_	0	SENT_44	[p2l417t789r575b868],
19	tumors	NNS	O	tumor	nsubjpass	23	SENT_44	[p2l627t806r935b868],
20	typically	RB	O	typically	advmod	23	SENT_44	[p2l990t789r1355b890],
21	are	VBP	O	be	auxpass	23	SENT_44	[p2l1402t815r1531b868],
22	not	RB	O	not	neg	23	SENT_44	[p2l1583t806r1726b868],
23	sampled	VBN	O	sample	conj_and	9	SENT_44	[p2l1775t789r2134b890],
24	repeatedly	RB	O	repeatedly	advmod	23	SENT_44	[p2l11t917r456b1018],
25	during	IN	O	during	_	0	SENT_44	[p2l492t917r780b1018],
26	treatment	NN	O	treatment	prep_during	23	SENT_44	[p2l816t934r1240b996],
27	to	TO	O	to	aux	28	SENT_44	[p2l1275t934r1356b996],
28	monitor	VB	O	monitor	xcomp	23	SENT_44	[p2l1396t918r1747b996],
29	changes	NNS	O	change	dobj	28	SENT_44	[p2l1784t917r2131b1018],
30	in	IN	O	in	_	0	SENT_44	[p2l11t1046r94b1123],
31	genetic	JJ	O	genetic	amod	32	SENT_44	[p2l143t1046r451b1146],
32	abnormalities	NNS	O	abnormality	prep_in	28	SENT_44	[p2l500t1045r1120b1124],
33	.	.	O	.	_	0	SENT_44	[p2l500t1045r1120b1124],

1	Although	IN	O	although	dep	103	SENT_45	[p2l1173t1045r1580b1146],
2	tumor	NN	O	tumor	dep	103	SENT_45	[p2l1629t1062r1897b1124],
3	cells	NNS	O	cell	dep	103	SENT_45	[p2l1944t1045r2131b1124],
4	are	VBP	O	be	dep	103	SENT_45	[p2l11t1199r139b1252],
5	known	VBN	O	know	dep	103	SENT_45	[p2l185t1173r482b1253],
6	to	TO	O	to	dep	103	SENT_45	[p2l528t1190r609b1252],
7	circulate	VB	O	circulate	dep	103	SENT_45	[p2l657t1173r1023b1252],
8	in	IN	O	in	dep	103	SENT_45	[p2l1068t1174r1151b1251],
9	the	DT	O	the	dep	103	SENT_45	[p2l1197t1173r1330b1252],
10	blood	NN	O	blood	dep	103	SENT_45	[p2l1376t1173r1618b1252],
11	of	IN	O	of	dep	103	SENT_45	[p2l1664t1173r1764b1252],
12	patients	NNS	O	patient	dep	103	SENT_45	[p2l1789t1174r2131b1274],
13	with	IN	O	with	dep	103	SENT_45	[p2l7t1301r202b1381],
14	metastatic	JJ	O	metastatic	dep	103	SENT_45	[p2l240t1302r687b1380],
15	cancer,-3	NN	O	cancer,-3	dep	103	SENT_45	[p2l725t1307r1063b1397],
16	their	PRP$	O	they	dep	103	SENT_45	[p2l1105t1301r1309b1380],
17	use	NN	O	use	dep	103	SENT_45	[p2l1343t1328r1484b1380],
18	in	IN	O	in	dep	103	SENT_45	[p2l1522t1302r1605b1379],
19	monitoring	NN	O	monitoring	dep	103	SENT_45	[p2l1644t1302r2137b1402],
20	of	IN	O	of	dep	103	SENT_45	[p2l12t1429r112b1508],
21	tumor	NN	O	tumor	dep	103	SENT_45	[p2l123t1446r391b1508],
22	genotypes	NNS	O	genotype	dep	103	SENT_45	[p2l417t1446r854b1530],
23	has	VBZ	O	have	dep	103	SENT_45	[p2l886t1429r1030b1508],
24	been	VBN	O	be	dep	103	SENT_45	[p2l1062t1429r1264b1508],
25	limited	VBN	O	limit	dep	103	SENT_45	[p2l1293t1429r1600b1508],
26	by	IN	O	by	dep	103	SENT_45	[p2l1631t1429r1728b1530],
27	relatively	RB	O	relatively	dep	103	SENT_45	[p2l1753t1429r2138b1530],
28	insensitive	JJ	O	insensitive	dep	103	SENT_45	[p2l11t1558r464b1636],
29	detection	NN	O	detection	dep	103	SENT_45	[p2l510t1557r906b1636],
30	strategies	NNS	O	strategy	dep	103	SENT_45	[p2l953t1558r1485b1658],
31	.45	CD	NUMBER	.45	dep	103	SENT_45	[p2l953t1558r1485b1658],
32	The	DT	O	the	dep	103	SENT_45	[p2l1530t1557r1691b1636],
33	detection	NN	O	detection	dep	103	SENT_45	[p2l1737t1557r2133b1636],
34	of	IN	O	of	dep	103	SENT_45	[p2l12t1685r112b1764],
35	circulating	VBG	O	circulate	dep	103	SENT_45	[p2l134t1685r601b1786],
36	tumor	NN	O	tumor	dep	103	SENT_45	[p2l638t1702r906b1764],
37	cells	NNS	O	cell	dep	103	SENT_45	[p2l943t1685r1131b1764],
38	in	IN	O	in	dep	103	SENT_45	[p2l1172t1686r1255b1763],
39	some	DT	O	some	dep	103	SENT_45	[p2l1297t1711r1520b1764],
40	patients	NNS	O	patient	dep	103	SENT_45	[p2l1559t1686r1901b1786],
41	with	IN	O	with	dep	103	SENT_45	[p2l1938t1685r2133b1765],
42	the	DT	O	the	dep	103	SENT_45	[p2l12t1813r144b1892],
43	use	NN	O	use	dep	103	SENT_45	[p2l181t1840r322b1892],
44	of	IN	O	of	dep	103	SENT_45	[p2l359t1813r460b1892],
45	magnetic	JJ	O	magnetic	dep	103	SENT_45	[p2l478t1814r879b1914],
46	bead	NN	O	bead	dep	103	SENT_45	[p2l916t1813r1645b1914],
47	—	NN	O	—	dep	103	SENT_45	[p2l916t1813r1645b1914],
48	conjugated	VBN	O	conjugate	dep	103	SENT_45	[p2l916t1813r1645b1914],
49	antibodies	NNS	O	antibody	dep	103	SENT_45	[p2l1681t1813r2131b1892],
50	against	IN	O	against	dep	103	SENT_45	[p2l11t1942r319b2042],
51	epithelial	JJ	O	epithelial	dep	103	SENT_45	[p2l341t1941r910b2042],
52	—	NN	O	—	dep	103	SENT_45	[p2l341t1941r910b2042],
53	cell	NN	O	cell	dep	103	SENT_45	[p2l341t1941r910b2042],
54	adhesion	NN	O	adhesion	dep	103	SENT_45	[p2l934t1941r1312b2020],
55	molecule	NN	O	molecule	dep	103	SENT_45	[p2l1338t1941r1716b2020],
56	(	CD	NUMBER	(	dep	103	SENT_45	[p2l1747t1947r2128b2042],
57	EpCAM	NN	O	epcam	dep	103	SENT_45	[p2l1747t1947r2128b2042],
58	)	NN	O	)	dep	103	SENT_45	[p2l1747t1947r2128b2042],
59	may	MD	O	may	dep	103	SENT_45	[p2l11t2095r190b2170],
60	be	VB	O	be	dep	103	SENT_45	[p2l233t2069r329b2148],
61	useful	JJ	O	useful	dep	103	SENT_45	[p2l376t2069r640b2148],
62	as	IN	O	as	dep	103	SENT_45	[p2l685t2096r771b2148],
63	a	DT	O	a	dep	103	SENT_45	[p2l819t2096r864b2148],
64	prognostic	JJ	O	prognostic	dep	103	SENT_45	[p2l907t2070r1372b2170],
65	marker	NN	O	marker	dep	103	SENT_45	[p2l1418t2069r1853b2149],
66	.6	NN	NUMBER	.6	dep	103	SENT_45	[p2l1418t2069r1853b2149],
67	'	''	O	'	_	0	SENT_45	[p2l1418t2069r1853b2149],
68	9	CD	NUMBER	9	dep	103	SENT_45	[p2l1418t2069r1853b2149],
69	However	RB	O	however	dep	103	SENT_45	[p2l1900t2077r2132b2148, p2l12t2223r201b2293],
70	,	,	O	,	_	0	SENT_45	[p2l1900t2077r2132b2148, p2l12t2223r201b2293],
71	the	DT	O	the	dep	103	SENT_45	[p2l239t2197r371b2276],
72	small	JJ	O	small	dep	103	SENT_45	[p2l405t2197r639b2276],
73	number	NN	O	number	dep	103	SENT_45	[p2l670t2197r1008b2276],
74	of	IN	O	of	dep	103	SENT_45	[p2l1037t2197r1137b2276],
75	circulating	VBG	O	circulate	dep	103	SENT_45	[p2l1151t2197r1618b2298],
76	tumor	NN	O	tumor	dep	103	SENT_45	[p2l1647t2214r1915b2276],
77	cells	NNS	O	cell	dep	103	SENT_45	[p2l1944t2197r2131b2276],
78	isolated	VBN	O	isolate	dep	103	SENT_45	[p2l11t2325r344b2404],
79	by	IN	O	by	dep	103	SENT_45	[p2l399t2325r496b2426],
80	this	DT	O	this	dep	103	SENT_45	[p2l546t2325r706b2404],
81	method	NN	O	method	dep	103	SENT_45	[p2l763t2325r1094b2404],
82	is	VBZ	O	be	dep	103	SENT_45	[p2l1147t2326r1213b2404],
83	below	IN	O	below	dep	103	SENT_45	[p2l1271t2325r1527b2404],
84	the	DT	O	the	dep	103	SENT_45	[p2l1578t2325r1711b2404],
85	dynamic	JJ	O	dynamic	dep	103	SENT_45	[p2l1766t2325r2134b2426],
86	range	NN	O	range	dep	103	SENT_45	[p2l11t2480r247b2555],
87	required	VBN	O	require	dep	103	SENT_45	[p2l278t2454r632b2555],
88	for	IN	O	for	dep	103	SENT_45	[p2l662t2454r783b2533],
89	measuring	VBG	O	measure	dep	103	SENT_45	[p2l810t2455r1263b2555],
90	treatment	NN	O	treatment	dep	103	SENT_45	[p2l1290t2471r1706b2533],
91	response	NN	O	response	dep	103	SENT_45	[p2l1731t2480r2127b2555],
92	,	,	O	,	_	0	SENT_45	[p2l1731t2480r2127b2555],
93	and	CC	O	and	dep	103	SENT_45	[p2l11t2582r168b2661],
94	the	DT	O	the	dep	103	SENT_45	[p2l204t2582r336b2661],
95	low	JJ	O	low	dep	103	SENT_45	[p2l372t2582r527b2661],
96	purity	NN	O	purity	dep	103	SENT_45	[p2l558t2583r818b2683],
97	of	IN	O	of	dep	103	SENT_45	[p2l850t2582r950b2661],
98	such	JJ	O	such	dep	103	SENT_45	[p2l969t2582r1162b2661],
99	cells	NNS	O	cell	dep	103	SENT_45	[p2l1199t2582r1386b2661],
100	prevents	VBZ	O	prevent	dep	103	SENT_45	[p2l1422t2599r1781b2683],
101	reliable	JJ	O	reliable	dep	103	SENT_45	[p2l1819t2582r2133b2661],
102	molecular	JJ	O	molecular	dep	103	SENT_45	[p2l11t2710r444b2789],
103	analyses	NNS	O	analysis	_	0	SENT_45	[p2l475t2710r936b2811],
104	.	.	O	.	_	0	SENT_45	[p2l475t2710r936b2811],

1	“	NN	O	“	_	0	SENT_46	[p2l475t2710r936b2811],

1	We	PRP	O	we	nsubj	3	SENT_47	[p2l136t2846r267b2917],
2	recently	RB	DATE	recently	advmod	3	SENT_47	[p2l305t2838r630b2939],
3	developed	VBD	O	develop	_	0	SENT_47	[p2l663t2838r1073b2939],
4	a	DT	O	a	det	6	SENT_47	[p2l1110t2865r1154b2917],
5	microﬂuidic	JJ	O	microﬂuidic	amod	6	SENT_47	[p2l1190t2838r1969b2917],
6	—	NN	O	—	dobj	3	SENT_47	[p2l1190t2838r1969b2917],
7	based	VBN	O	base	prep	3	SENT_47	[p2l1190t2838r1969b2917],
8	device	NN	O	device	nn	9	SENT_47	[p2l2007t2838r2132b2917, p2l7t2967r164b3045],
9	(	NN	O	(	nsubj	10	SENT_47	[p2l196t2966r460b3057],
10	called	VBD	O	call	pcomp	7	SENT_47	[p2l196t2966r460b3057],
11	the	DT	O	the	det	15	SENT_47	[p2l487t2966r615b3045],
12	CTC	NNP	O	CTC	nn	15	SENT_47	[p2l643t2966r1057b3067],
13	—	CD	NUMBER	—	num	15	SENT_47	[p2l643t2966r1057b3067],
14	chip	NN	O	chip	nn	15	SENT_47	[p2l643t2966r1057b3067],
15	)	NN	O	)	dobj	10	SENT_47	[p2l643t2966r1057b3067],
16	that	WDT	O	that	nsubj	20	SENT_47	[p2l1089t2966r1255b3045],
17	can	MD	O	can	aux	18	SENT_47	[p2l1277t2992r1422b3045],
18	isolate	VB	O	isolate	rcmod	15	SENT_47	[p2l1449t2966r1734b3062],
19	,	,	O	,	_	0	SENT_47	[p2l1449t2966r1734b3062],
20	quantify	VB	O	quantify	conj_and	18	SENT_47	[p2l1767t2966r2127b3067],
21	,	,	O	,	_	0	SENT_47	[p2l1767t2966r2127b3067],
22	and	CC	O	and	_	0	SENT_47	[p2l11t3094r168b3173],
23	analyze	VB	O	analyze	conj_and	18	SENT_47	[p2l200t3094r523b3195],
24	circulating	VBG	O	circulate	xcomp	23	SENT_47	[p2l556t3094r1024b3195],
25	tumor	NN	O	tumor	nn	26	SENT_47	[p2l1053t3111r1321b3173],
26	cells	NNS	O	cell	dobj	24	SENT_47	[p2l1351t3094r1538b3173],
27	from	IN	O	from	_	0	SENT_47	[p2l1573t3094r1783b3173],
28	a	DT	O	a	det	30	SENT_47	[p2l1815t3121r1859b3173],
29	blood	NN	O	blood	nn	30	SENT_47	[p2l1891t3094r2134b3173],
30	sample	NN	O	sample	prep_from	24	SENT_47	[p2l13t3222r331b3323],
31	.	.	O	.	_	0	SENT_47	[p2l13t3222r331b3323],

1	In	IN	O	in	_	0	SENT_48	[p2l368t3230r456b3300],
2	the	DT	O	the	det	5	SENT_48	[p2l489t3222r619b3301],
3	CTC	NNP	O	CTC	nn	5	SENT_48	[p2l652t3222r1072b3323],
4	—	CD	NUMBER	—	num	5	SENT_48	[p2l652t3222r1072b3323],
5	chip	NN	O	chip	prep_in	8	SENT_48	[p2l652t3222r1072b3323],
6	,	,	O	,	_	0	SENT_48	[p2l652t3222r1072b3323],
7	blood	NN	O	blood	nsubj	8	SENT_48	[p2l1111t3222r1349b3301],
8	flows	VBZ	O	flow	_	0	SENT_48	[p2l1382t3222r1613b3301],
9	past	JJ	DATE	past	amod	11	SENT_48	[p2l1647t3239r1824b3323],
10	78,000	CD	NUMBER	78,000	num	11	SENT_48	[p2l1853t3228r2133b3318],
11	EpCAM	NN	O	epcam	nsubj	14	SENT_48	[p2l9t3350r656b3451],
12	—	CD	NUMBER	—	num	14	SENT_48	[p2l9t3350r656b3451],
13	coated	JJ	O	coated	amod	14	SENT_48	[p2l9t3350r656b3451],
14	microposts	NNS	O	micropost	xcomp	8	SENT_48	[p2l688t3351r1167b3451],
15	under	IN	O	under	_	0	SENT_48	[p2l1200t3350r1451b3429],
16	controlled	JJ	O	controlled	amod	17	SENT_48	[p2l1480t3350r1917b3429],
17	conditions	NNS	O	condition	prep_under	14	SENT_48	[p2l1948t3376r2132b3429, p2l12t3478r307b3557],
18	that	WDT	O	that	nsubj	19	SENT_48	[p2l355t3478r527b3557],
19	optimize	VBP	O	optimize	rcmod	17	SENT_48	[p2l568t3479r952b3579],
20	the	DT	O	the	det	21	SENT_48	[p2l998t3478r1131b3557],
21	capture	NN	O	capture	dobj	19	SENT_48	[p2l1177t3495r1496b3579],
22	of	IN	O	of	_	0	SENT_48	[p2l1543t3478r1643b3557],
23	circulating	VBG	O	circulate	prepc_of	21	SENT_48	[p2l1670t3478r2137b3579],
24	tumor	NN	O	tumor	nn	25	SENT_48	[p2l12t3623r270b3685],
25	cells	NNS	O	cell	dobj	23	SENT_48	[p2l303t3606r578b3685],
26	.	.	O	.	_	0	SENT_48	[p2l303t3606r578b3685],

1	“	NN	O	“	nsubj	6	SENT_49	[p2l303t3606r578b3685],
2	An	DT	O	a	det	3	SENT_49	[p2l609t3614r731b3684],
3	average	NN	O	average	dep	1	SENT_49	[p2l764t3632r1069b3707],
4	of	IN	O	of	_	0	SENT_49	[p2l1104t3606r1202b3685],
5	132	CD	NUMBER	132	prep_of	1	SENT_49	[p2l1222t3612r1364b3685],
6	circulating	VBG	O	circulate	partmod	20	SENT_49	[p2l1400t3606r1845b3707],
7	tumor	NN	O	tumor	nn	8	SENT_49	[p2l1877t3623r2136b3685],
8	cells	NNS	O	cell	dobj	6	SENT_49	[p3l12t20r194b99],
9	per	IN	O	per	_	0	SENT_49	[p3l230t46r367b121],
10	milliliter	NN	O	milliliter	nn	12	SENT_49	[p3l399t20r772b99],
11	(	CD	NUMBER	(	num	12	SENT_49	[p3l808t20r1173b116],
12	median	NN	O	median	prep_per	8	SENT_49	[p3l808t20r1173b116],
13	,	,	O	,	_	0	SENT_49	[p3l808t20r1173b116],
14	67	CD	NUMBER	67	num	15	SENT_49	[p3l1213t26r1310b99],
15	cells	NNS	O	cell	nsubjpass	20	SENT_49	[p3l1346t20r1528b99],
16	per	IN	O	per	_	0	SENT_49	[p3l1564t46r1701b121],
17	milliliter	NN	O	milliliter	nn	18	SENT_49	[p3l1733t20r2128b112],
18	)	NN	O	)	prep_per	15	SENT_49	[p3l1733t20r2128b112],
19	are	VBP	O	be	auxpass	20	SENT_49	[p3l11t174r137b227],
20	isolated	VBN	O	isolate	_	0	SENT_49	[p3l168t148r495b227],
21	at	IN	O	at	_	0	SENT_49	[p3l527t165r604b227],
22	high	JJ	O	high	amod	23	SENT_49	[p3l631t148r822b249],
23	purity	NN	O	purity	prep_at	20	SENT_49	[p3l853t149r1107b249],
24	from	IN	O	from	_	0	SENT_49	[p3l1134t148r1342b227],
25	Virtually	RB	O	virtually	advmod	26	SENT_49	[p3l1369t148r1724b249],
26	all	DT	O	all	prep_from	20	SENT_49	[p3l1751t148r1853b227],
27	tested	VBN	O	test	partmod	26	SENT_49	[p3l1885t148r2133b227],
28	patients	NNS	O	patient	dobj	27	SENT_49	[p3l10t277r351b377],
29	with	IN	O	with	_	0	SENT_49	[p3l412t276r607b356],
30	metastatic	JJ	O	metastatic	amod	31	SENT_49	[p3l670t277r1116b355],
31	cancers	NNS	O	cancer	nsubj	32	SENT_49	[p3l1179t302r1500b355],
32	—	VBP	O	—	prepc_with	27	SENT_49	[p3l1561t321r1668b329],
33	including	VBG	O	include	_	0	SENT_49	[p3l1726t276r2137b377],
34	non	JJ	O	non	amod	40	SENT_49	[p3l11t404r625b483],
35	—	JJ	O	—	amod	40	SENT_49	[p3l11t404r625b483],
36	small	JJ	O	small	amod	40	SENT_49	[p3l11t404r625b483],
37	—	NN	O	—	nn	40	SENT_49	[p3l11t404r625b483],
38	cell	NN	O	cell	nn	40	SENT_49	[p3l11t404r625b483],
39	lung	NN	O	lung	nn	40	SENT_49	[p3l654t404r842b505],
40	cancer	NN	O	cancer	prep_including	32	SENT_49	[p3l870t430r1140b483],
41	and	CC	O	and	_	0	SENT_49	[p3l1166t404r1320b483],
42	prostate	NN	O	prostate	nn	46	SENT_49	[p3l1349t421r1705b505],
43	,	,	O	,	_	0	SENT_49	[p3l1349t421r1705b505],
44	pancreas	NN	O	pancreas	dep	46	SENT_49	[p3l1739t430r2128b505],
45	,	,	O	,	_	0	SENT_49	[p3l1739t430r2128b505],
46	breast	NN	O	breast	prep_including	32	SENT_49	[p3l12t531r295b626],
47	,	,	O	,	_	0	SENT_49	[p3l12t531r295b626],
48	and	CC	O	and	_	0	SENT_49	[p3l350t531r508b609],
49	colorectal	JJ	O	colorectal	amod	50	SENT_49	[p3l558t531r978b609],
50	cancers	NNS	O	cancer	nsubj	51	SENT_49	[p3l1028t557r1349b609],
51	—	VBP	O	—	conj_and	32	SENT_49	[p3l1397t576r1505b584],
52	but	CC	O	but	_	0	SENT_49	[p3l1551t531r1691b610],
53	not	RB	O	not	_	0	SENT_49	[p3l1736t548r1879b609],
54	from	IN	O	from	_	0	SENT_49	[p3l1923t531r2134b609],
55	healthy	JJ	O	healthy	amod	56	SENT_49	[p3l11t659r328b760],
56	controls	NNS	O	control	prep_from	20	SENT_49	[p3l372t659r822b738],
57	.	.	O	.	_	0	SENT_49	[p3l372t659r822b738],

1	“	NN	O	“	nsubj	20	SENT_50	[p3l372t659r822b738],
2	The	DT	O	the	det	3	SENT_50	[p3l867t659r1027b738],
3	prevalence	NN	O	prevalence	dep	1	SENT_50	[p3l1073t659r1526b760],
4	and	CC	O	and	_	0	SENT_50	[p3l1573t659r1730b738],
5	quantity	NN	O	quantity	nsubj	20	SENT_50	[p3l1778t660r2138b760],
6	of	IN	O	of	_	0	SENT_50	[p3l12t787r112b866],
7	circulating	VBG	O	circulate	prepc_of	5	SENT_50	[p3l134t787r602b888],
8	tumor	NN	O	tumor	nn	9	SENT_50	[p3l639t804r906b866],
9	cells	NNS	O	cell	dobj	7	SENT_50	[p3l944t787r1131b866],
10	that	WDT	O	that	nsubjpass	12	SENT_50	[p3l1174t787r1346b866],
11	are	VBP	O	be	auxpass	12	SENT_50	[p3l1381t813r1510b866],
12	isolated	VBN	O	isolate	rcmod	9	SENT_50	[p3l1549t787r1884b866],
13	from	IN	O	from	_	0	SENT_50	[p3l1923t787r2134b866],
14	patients	NNS	O	patient	prep_from	12	SENT_50	[p3l10t916r351b1016],
15	with	IN	O	with	_	0	SENT_50	[p3l389t915r584b995],
16	advanced	JJ	O	advanced	amod	17	SENT_50	[p3l623t915r1019b995],
17	cancer	NN	O	cancer	prep_with	14	SENT_50	[p3l1059t941r1340b994],
18	may	MD	O	may	aux	20	SENT_50	[p3l1377t941r1556b1016],
19	thus	RB	O	thus	advmod	20	SENT_50	[p3l1591t915r1774b994],
20	provide	VB	O	provide	_	0	SENT_50	[p3l1815t915r2133b1016],
21	a	DT	O	a	det	22	SENT_50	[p3l11t1070r55b1122],
22	measure	NN	O	measure	dobj	20	SENT_50	[p3l94t1069r455b1122],
23	of	IN	O	of	_	0	SENT_50	[p3l497t1043r597b1122],
24	tumor	NN	O	tumor	nn	25	SENT_50	[p3l620t1060r887b1122],
25	response	NN	O	response	prep_of	22	SENT_50	[p3l925t1069r1328b1144],
26	,	,	O	,	_	0	SENT_50	[p3l925t1069r1328b1144],
27	whereas	IN	O	whereas	mark	34	SENT_50	[p3l1370t1043r1721b1122],
28	the	DT	O	the	det	30	SENT_50	[p3l1765t1043r1897b1122],
29	high	JJ	O	high	amod	30	SENT_50	[p3l1938t1043r2133b1144],
30	purity	NN	O	purity	nsubj	34	SENT_50	[p3l10t1172r270b1272],
31	of	IN	O	of	_	0	SENT_50	[p3l314t1171r414b1250],
32	such	JJ	O	such	amod	33	SENT_50	[p3l445t1171r638b1250],
33	cells	NNS	O	cell	prep_of	30	SENT_50	[p3l687t1171r874b1250],
34	allows	VBZ	O	allow	advcl	20	SENT_50	[p3l924t1171r1197b1251],
35	repeated	JJ	O	repeated	amod	36	SENT_50	[p3l1247t1171r1614b1272],
36	analysis	NN	O	analysis	dobj	34	SENT_50	[p3l1661t1171r2001b1272],
37	of	IN	O	of	_	0	SENT_50	[p3l2052t1171r2152b1250],
38	molecular	JJ	O	molecular	amod	39	SENT_50	[p3l11t1299r444b1378],
39	markers	NNS	O	marker	prep_of	36	SENT_50	[p3l480t1299r856b1379],
40	.	.	O	.	_	0	SENT_50	[p3l480t1299r856b1379],

1	Tumor	NN	O	tumor	nn	2	SENT_51	[p3l137t1427r904b1506],
2	—	NN	O	—	nsubj	16	SENT_51	[p3l137t1427r904b1506],
3	associated	VBN	O	associate	partmod	2	SENT_51	[p3l137t1427r904b1506],
4	activating	VBG	O	activate	xcomp	3	SENT_51	[p3l943t1428r1365b1528],
5	mutations	NNS	O	mutation	dobj	4	SENT_51	[p3l1401t1428r1836b1506],
6	in	IN	O	in	_	0	SENT_51	[p3l1877t1428r1960b1505],
7	the	DT	O	the	det	11	SENT_51	[p3l2001t1427r2133b1506],
8	epidermal	JJ	O	epidermal	amod	11	SENT_51	[p3l12t1555r443b1656],
9	growth	NN	O	growth	nn	11	SENT_51	[p3l504t1555r818b1656],
10	factor	NN	O	factor	nn	11	SENT_51	[p3l879t1555r1129b1634],
11	receptor	NN	O	receptor	prep_in	4	SENT_51	[p3l1187t1572r1543b1656],
12	(	CD	NUMBER	(	num	15	SENT_51	[p3l1606t1562r1868b1647],
13	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_51	[p3l1606t1562r1868b1647],
14	)	NN	O	)	nn	15	SENT_51	[p3l1606t1562r1868b1647],
15	gene	NN	O	gene	nsubj	16	SENT_51	[p3l1934t1581r2133b1656],
16	identify	VBP	O	identify	ccomp	53	SENT_51	[p3l11t1683r343b1784],
17	patients	NNS	O	patient	dobj	16	SENT_51	[p3l387t1684r728b1784],
18	with	IN	O	with	_	0	SENT_51	[p3l776t1683r971b1763],
19	non	JJ	O	non	amod	25	SENT_51	[p3l1021t1683r1663b1762],
20	—	JJ	O	—	amod	25	SENT_51	[p3l1021t1683r1663b1762],
21	small	JJ	O	small	amod	25	SENT_51	[p3l1021t1683r1663b1762],
22	—	NN	O	—	nn	25	SENT_51	[p3l1021t1683r1663b1762],
23	cell	NN	O	cell	nn	25	SENT_51	[p3l1021t1683r1663b1762],
24	lung	NN	O	lung	nn	25	SENT_51	[p3l1711t1683r1905b1784],
25	cancer	NN	O	cancer	prep_with	17	SENT_51	[p3l1952t1709r2132b1762, p3l12t1837r139b1890],
26	who	WP	O	who	nsubj	27	SENT_51	[p3l179t1811r362b1891],
27	have	VBP	O	have	rcmod	25	SENT_51	[p3l412t1811r601b1890],
28	a	DT	O	a	det	30	SENT_51	[p3l649t1838r693b1890],
29	dramatic	JJ	O	dramatic	amod	30	SENT_51	[p3l741t1811r1125b1890],
30	response	NN	O	response	dobj	27	SENT_51	[p3l1173t1837r1553b1912],
31	to	TO	O	to	_	0	SENT_51	[p3l1602t1828r1684b1890],
32	EGFR	NN	ORGANIZATION	egfr	nn	35	SENT_51	[p3l1731t1817r1987b1895],
33	tyrosine	NN	O	tyrosine	nn	35	SENT_51	[p3l2025t1828r2132b1912, p3l11t1940r274b2018],
34	kinase	NN	O	kinase	nn	35	SENT_51	[p3l362t1939r640b2019],
35	inhibitors	NNS	O	inhibitor	prep_to	30	SENT_51	[p3l728t1939r1173b2035],
36	,	,	O	,	_	0	SENT_51	[p3l728t1939r1173b2035],
37	including	VBG	O	include	_	0	SENT_51	[p3l1266t1939r1676b2040],
38	gefitinib	NN	O	gefitinib	nn	41	SENT_51	[p3l1760t1939r2132b2040],
39	(	CD	NUMBER	(	num	41	SENT_51	[p3l16t2073r324b2157],
40	Iressa	NNP	O	Iressa	nn	41	SENT_51	[p3l16t2073r324b2157],
41	)	NN	O	)	prep_including	30	SENT_51	[p3l16t2073r324b2157],
42	and	CC	O	and	_	0	SENT_51	[p3l401t2066r559b2144],
43	erlotinib	NN	O	erlotinib	nn	45	SENT_51	[p3l632t2066r999b2144],
44	(	CD	NUMBER	(	num	45	SENT_51	[p3l1077t2071r1661b2157],
45	Tarceva	NNP	O	Tarceva	prep_with	17	SENT_51	[p3l1077t2071r1661b2157],
46	)	CD	NUMBER	)	number	47	SENT_51	[p3l1077t2071r1661b2157],
47	.12	CD	NUMBER	.12	num	48	SENT_51	[p3l1077t2071r1661b2157],
48	'14	CD	NUMBER	'14	dep	45	SENT_51	[p3l1077t2071r1661b2157],
49	However	RB	O	however	advmod	16	SENT_51	[p3l1733t2074r2128b2161],
50	,	,	O	,	_	0	SENT_51	[p3l1733t2074r2128b2161],
51	most	RBS	O	most	advmod	52	SENT_51	[p3l11t2211r227b2273],
52	patients	NNS	O	patient	nsubj	53	SENT_51	[p3l263t2195r604b2295],
53	have	VBP	O	have	_	0	SENT_51	[p3l648t2194r838b2273],
54	a	DT	O	a	det	55	SENT_51	[p3l880t2221r924b2273],
55	relapse	NN	O	relapse	dobj	53	SENT_51	[p3l964t2194r1266b2295],
56	within	IN	O	within	_	0	SENT_51	[p3l1304t2194r1588b2273],
57	1	CD	DURATION	1	num	58	SENT_51	[p3l1634t2200r1678b2272],
58	year	NN	NUMBER	year	prep_within	55	SENT_51	[p3l1716t2220r1896b2295],
59	after	IN	O	after	_	0	SENT_51	[p3l1934t2194r2136b2273],
60	the	DT	O	the	det	61	SENT_51	[p3l12t2322r144b2401],
61	initiation	NN	O	initiation	prep_after	58	SENT_51	[p3l189t2323r588b2401],
62	of	IN	O	of	_	0	SENT_51	[p3l634t2322r734b2401],
63	therapy	NN	O	therapy	prep_of	61	SENT_51	[p3l761t2322r1172b2423],
64	.15	CD	NUMBER	.15	num	65	SENT_51	[p3l761t2322r1172b2423],
65	Studies	NNS	O	study	nsubj	70	SENT_51	[p3l1223t2322r1530b2401],
66	of	IN	O	of	_	0	SENT_51	[p3l1578t2322r1678b2401],
67	tumors	NNS	O	tumor	prep_of	65	SENT_51	[p3l1705t2339r2013b2401],
68	at	IN	O	at	_	0	SENT_51	[p3l2060t2339r2138b2401],
69	relapse	NN	O	relapse	prep_at	67	SENT_51	[p3l10t2449r314b2549],
70	show	VBP	O	show	rcmod	55	SENT_51	[p3l348t2449r575b2529],
71	the	DT	O	the	det	72	SENT_51	[p3l604t2449r738b2527],
72	acquisition	NN	O	acquisition	dobj	70	SENT_51	[p3l770t2450r1246b2549],
73	of	IN	O	of	_	0	SENT_51	[p3l1280t2448r1381b2528],
74	a	DT	O	a	det	77	SENT_51	[p3l1394t2475r1439b2527],
75	secondary	JJ	O	secondary	amod	77	SENT_51	[p3l1471t2449r1912b2549],
76	EGFR	NN	ORGANIZATION	egfr	nn	77	SENT_51	[p3l1939t2456r2153b2529],
77	mutation	NN	O	mutation	prep_of	72	SENT_51	[p3l10t2578r428b2673],
78	,	,	O	,	_	0	SENT_51	[p3l10t2578r428b2673],
79	in	IN	O	in	_	0	SENT_51	[p3l466t2578r550b2655],
80	which	WDT	O	which	rel	83	SENT_51	[p3l578t2577r842b2657],
81	methionine	NN	O	methionine	nsubjpass	83	SENT_51	[p3l876t2577r1376b2656],
82	is	VBZ	O	be	auxpass	83	SENT_51	[p3l1409t2578r1475b2655],
83	substituted	VBN	O	substitute	rcmod	77	SENT_51	[p3l1512t2577r1992b2656],
84	for	IN	O	for	_	0	SENT_51	[p3l2025t2576r2149b2656],
85	threonine	NN	O	threonine	prep_for	83	SENT_51	[p3l11t2706r425b2785],
86	at	IN	O	at	_	0	SENT_51	[p3l456t2723r534b2784],
87	position	NN	O	position	prep_at	83	SENT_51	[p3l559t2707r906b2806],
88	790	CD	NUMBER	790	number	89	SENT_51	[p3l939t2712r1089b2785],
89	(	CD	NUMBER	(	num	91	SENT_51	[p3l1126t2712r1507b2797],
90	T79OM	NN	O	t79om	nn	91	SENT_51	[p3l1126t2712r1507b2797],
91	)	NN	O	)	dep	83	SENT_51	[p3l1126t2712r1507b2797],
92	.	.	O	.	_	0	SENT_51	[p3l1126t2712r1507b2797],

1	This	DT	O	this	det	2	SENT_52	[p3l1540t2706r1725b2784],
2	mutation	NN	O	mutation	nsubj	9	SENT_52	[p3l1759t2707r2146b2785],
3	hinders	VBZ	O	hinder	_	0	SENT_52	[p3l10t2835r328b2914],
4	drug	NN	O	drug	nn	5	SENT_52	[p3l378t2835r580b2936],
5	binding	NN	O	binding	dobj	3	SENT_52	[p3l625t2835r958b2936],
6	but	CC	O	but	_	0	SENT_52	[p3l1002t2835r1141b2914],
7	may	MD	O	may	aux	9	SENT_52	[p3l1182t2861r1360b2935],
8	be	VB	O	be	cop	9	SENT_52	[p3l1404t2835r1499b2914],
9	susceptible	JJ	O	susceptible	conj_but	3	SENT_52	[p3l1548t2835r2015b2935],
10	to	TO	O	to	_	0	SENT_52	[p3l2063t2852r2145b2914],
11	second	JJ	ORDINAL	second	amod	20	SENT_52	[p3l11t2963r832b3064],
12	—	NN	O	—	nn	20	SENT_52	[p3l11t2963r832b3064],
13	generation	NN	O	generation	nn	20	SENT_52	[p3l11t2963r832b3064],
14	,	,	O	,	_	0	SENT_52	[p3l11t2963r832b3064],
15	“	NN	O	“	nn	20	SENT_52	[p3l877t2963r1442b3042],
16	irreversible	JJ	O	irreversible	amod	20	SENT_52	[p3l877t2963r1442b3042],
17	”	NN	O	”	nn	20	SENT_52	[p3l877t2963r1442b3042],
18	tyrosine	NN	O	tyrosine	nn	20	SENT_52	[p3l1482t2964r1830b3063],
19	kinase	NN	O	kinase	nn	20	SENT_52	[p3l1865t2963r2145b3042],
20	inhibitors	NNS	O	inhibitor	prep_to	9	SENT_52	[p3l10t3090r459b3186],
21	,	,	O	,	_	0	SENT_52	[p3l10t3090r459b3186],
22	which	WDT	O	which	nsubj	23	SENT_52	[p3l499t3090r763b3169],
23	form	VBP	O	form	rcmod	20	SENT_52	[p3l802t3089r1012b3169],
24	covalent	JJ	O	covalent	amod	27	SENT_52	[p3l1052t3090r1409b3169],
25	cross	NN	O	cross	nn	27	SENT_52	[p3l1443t3090r1913b3169],
26	—	NN	O	—	nn	27	SENT_52	[p3l1443t3090r1913b3169],
27	linl	NN	O	linl	nsubj	29	SENT_52	[p3l1443t3090r1913b3169],
28	<	JJR	O	<	amod	29	SENT_52	[p3l1443t3090r1913b3169],
29	s	NNS	O	s	xcomp	23	SENT_52	[p3l1443t3090r1913b3169],
30	with	IN	O	with	_	0	SENT_52	[p3l1949t3090r2146b3169],
31	the	DT	O	the	det	32	SENT_52	[p3l11t3218r140b3296],
32	receptors	NNS	O	receptor	prep_with	29	SENT_52	[p3l175t3222r746b3318],
33	.16	CD	NUMBER	.16	number	34	SENT_52	[p3l175t3222r746b3318],
34	'18	CD	NUMBER	'18	num	36	SENT_52	[p3l175t3222r746b3318],
35	Other	JJ	O	other	amod	36	SENT_52	[p3l782t3218r1023b3297],
36	mechanisms	NNS	O	mechanism	nsubjpass	46	SENT_52	[p3l1055t3218r1582b3296],
37	of	IN	O	of	_	0	SENT_52	[p3l1619t3217r1718b3297],
38	resistance	NN	O	resistance	prep_of	36	SENT_52	[p3l1734t3219r2145b3296],
39	to	TO	O	to	_	0	SENT_52	[p3l11t3364r92b3426],
40	tyrosine	NN	O	tyrosine	nn	42	SENT_52	[p3l139t3348r488b3447],
41	kinase	NN	O	kinase	nn	42	SENT_52	[p3l533t3347r813b3427],
42	inhibitors	NNS	O	inhibitor	prep_to	38	SENT_52	[p3l857t3347r1282b3426],
43	have	VBP	O	have	aux	46	SENT_52	[p3l1329t3347r1520b3426],
44	also	RB	O	also	advmod	46	SENT_52	[p3l1565t3347r1736b3426],
45	been	VBN	O	be	auxpass	46	SENT_52	[p3l1784t3347r1986b3426],
46	reported	VBN	O	report	ccomp	9	SENT_52	[p3l2031t3373r2144b3425, p3l8t3475r490b3575],
47	.19	CD	NUMBER	.19	num	48	SENT_52	[p3l2031t3373r2144b3425, p3l8t3475r490b3575],
48	’	NN	O	’	dobj	46	SENT_52	[p3l2031t3373r2144b3425, p3l8t3475r490b3575],
49	2	CD	NUMBER	2	number	50	SENT_52	[p3l2031t3373r2144b3425, p3l8t3475r490b3575],
50	°	CD	NUMBER	°	dep	48	SENT_52	[p3l2031t3373r2144b3425, p3l8t3475r490b3575],
51	We	PRP	O	we	nsubj	52	SENT_52	[p3l529t3483r662b3553],
52	tested	VBD	O	test	rcmod	48	SENT_52	[p3l704t3475r959b3554],
53	the	DT	O	the	det	54	SENT_52	[p3l1001t3475r1135b3553],
54	ability	NN	O	ability	dobj	52	SENT_52	[p3l1176t3475r1448b3575],
55	of	IN	O	of	_	0	SENT_52	[p3l1486t3474r1586b3554],
56	microfluidic	JJ	O	microfluidic	amod	57	SENT_52	[p3l1609t3474r2146b3555],
57	techniques	NNS	O	technique	prep_of	54	SENT_52	[p3l11t3603r477b3703],
58	to	TO	O	to	aux	59	SENT_52	[p3l521t3620r603b3682],
59	isolate	VB	O	isolate	xcomp	52	SENT_52	[p3l646t3603r925b3682],
60	a	DT	O	a	det	62	SENT_52	[p3l966t3629r1011b3681],
61	sufficient	JJ	O	sufficient	amod	62	SENT_52	[p3l1052t3602r1466b3682],
62	number	NN	O	number	dobj	59	SENT_52	[p3l1502t3603r1842b3683],
63	of	IN	O	of	_	0	SENT_52	[p3l1881t3602r1982b3682],
64	circulating	VBG	O	circulate	prepc_of	62	SENT_52	[p3l2005t3604r2144b3681, p4l11t22r359b124],

1	tumor	NN	O	tumor	nn	2	SENT_53	[p4l422t39r687b102],
2	cells	NNS	O	cell	_	0	SENT_53	[p4l751t22r934b101],
3	from	IN	O	from	_	0	SENT_53	[p4l1002t21r1211b102],
4	patients	NNS	O	patient	prep_from	2	SENT_53	[p4l1274t23r1610b123],
5	with	IN	O	with	_	0	SENT_53	[p4l1674t22r1866b102],
6	nonsmall	JJ	O	nonsmall	amod	10	SENT_53	[p4l1932t48r2149b102, p4l11t151r423b229],
7	—	NN	O	—	nn	10	SENT_53	[p4l1932t48r2149b102, p4l11t151r423b229],
8	cell	NN	O	cell	nn	10	SENT_53	[p4l1932t48r2149b102, p4l11t151r423b229],
9	lung	NN	O	lung	nn	10	SENT_53	[p4l458t151r649b252],
10	cancer	NN	O	cancer	prep_with	4	SENT_53	[p4l683t177r960b229],
11	to	TO	O	to	aux	12	SENT_53	[p4l994t168r1075b230],
12	permit	VB	O	permit	infmod	2	SENT_53	[p4l1112t152r1400b251],
13	mutational	JJ	O	mutational	amod	14	SENT_53	[p4l1431t151r1898b230],
14	analysis	NN	O	analysis	dobj	12	SENT_53	[p4l1933t151r2144b229, p4l6t279r159b378],
15	of	IN	O	of	_	0	SENT_53	[p4l201t277r301b357],
16	EGFR	NN	ORGANIZATION	egfr	prep_of	14	SENT_53	[p4l321t285r551b358],
17	.	.	O	.	_	0	SENT_53	[p4l321t285r551b358],

1	METHODS	NNS	O	method	_	0	SENT_54	[p4l804t575r1350b635],

1	PATIENTS	NNS	O	patient	nsubjpass	16	SENT_55	[p4l16t811r384b862],
2	AND	CC	O	and	_	0	SENT_55	[p4l416t812r586b861],
3	CLINICAL	JJ	O	clinical	amod	5	SENT_55	[p4l621t811r990b862],
4	SPECIMENS	NNS	O	specimen	nn	5	SENT_55	[p4l1022t811r1477b862],
5	Patients	NNS	O	patient	nsubjpass	16	SENT_55	[p4l8t912r350b989],
6	with	IN	O	with	_	0	SENT_55	[p4l385t911r581b990],
7	advanced	JJ	O	advanced	amod	9	SENT_55	[p4l617t911r1016b990],
8	non	JJ	O	non	amod	9	SENT_55	[p4l1052t911r1699b990],
9	—	NN	O	—	prep_with	5	SENT_55	[p4l1052t911r1699b990],
10	small	JJ	O	small	amod	14	SENT_55	[p4l1052t911r1699b990],
11	—	NN	O	—	nn	14	SENT_55	[p4l1052t911r1699b990],
12	cell	NN	O	cell	nn	14	SENT_55	[p4l1052t911r1699b990],
13	lung	NN	O	lung	nn	14	SENT_55	[p4l1735t911r1929b1012],
14	cancer	NN	O	cancer	dep	1	SENT_55	[p4l1963t937r2144b989, p4l11t1065r138b1118],
15	were	VBD	O	be	auxpass	16	SENT_55	[p4l162t1065r365b1119],
16	recruited	VBN	O	recruit	_	0	SENT_55	[p4l397t1039r785b1119],
17	according	VBG	O	accord	_	0	SENT_55	[p4l816t1039r1245b1141],
18	to	TO	O	to	prepc_according_to	16	SENT_55	[p4l1273t1056r1355b1119],
19	one	CD	TIME	one	pobj	16	SENT_55	[p4l1388t1065r1541b1119],
20	of	IN	TIME	of	_	0	SENT_55	[p4l1573t1038r1673b1119],
21	two	CD	TIME	two	num	22	SENT_55	[p4l1687t1056r1845b1119],
22	protocols	NNS	O	protocol	prep_of	19	SENT_55	[p4l1876t1056r2144b1140, p4l11t1168r176b1247],
23	that	WDT	O	that	nsubjpass	25	SENT_55	[p4l225t1168r399b1246],
24	were	VBD	O	be	auxpass	25	SENT_55	[p4l437t1194r640b1247],
25	approved	VBN	O	approve	rcmod	22	SENT_55	[p4l686t1168r1078b1268],
26	by	IN	O	by	_	0	SENT_55	[p4l1126t1168r1224b1268],
27	the	DT	O	the	det	30	SENT_55	[p4l1267t1168r1400b1246],
28	institutional	JJ	O	institutional	amod	30	SENT_55	[p4l1448t1168r1984b1247],
29	review	NN	O	review	nn	30	SENT_55	[p4l2031t1194r2144b1246, p4l6t1297r205b1376],
30	board	NN	O	board	agent	25	SENT_55	[p4l254t1296r527b1375],
31	.	.	O	.	_	0	SENT_55	[p4l254t1296r527b1375],

1	A	DT	O	a	det	2	SENT_56	[p4l581t1304r647b1374],
2	total	NN	O	total	dep	31	SENT_56	[p4l696t1296r894b1375],
3	of	IN	O	of	_	0	SENT_56	[p4l947t1295r1047b1375],
4	31	CD	NUMBER	31	num	5	SENT_56	[p4l1082t1302r1178b1375],
5	patients	NNS	O	patient	prep_of	2	SENT_56	[p4l1229t1297r1573b1396],
6	in	IN	O	in	_	0	SENT_56	[p4l1626t1297r1710b1374],
7	Group	NNP	O	Group	nn	10	SENT_56	[p4l1762t1302r2032b1396],
8	A	NNP	O	A	nn	10	SENT_56	[p4l2083t1304r2149b1374],
9	(	CD	NUMBER	(	num	10	SENT_56	[p4l15t1426r385b1516],
10	Patients	NNS	O	patient	prep_in	5	SENT_56	[p4l15t1426r385b1516],
11	1	CD	NUMBER	1	number	13	SENT_56	[p4l426t1431r470b1503],
12	to	TO	O	to	dep	13	SENT_56	[p4l506t1442r588b1504],
13	27	CD	NUMBER	27	num	10	SENT_56	[p4l624t1431r723b1503],
14	and	CC	O	and	_	0	SENT_56	[p4l757t1425r916b1504],
15	43	CD	NUMBER	43	number	18	SENT_56	[p4l948t1431r1045b1504],
16	to	TO	O	to	dep	18	SENT_56	[p4l1083t1442r1165b1504],
17	46	CD	NUMBER	46	number	18	SENT_56	[p4l1199t1431r1356b1521],
18	)	CD	NUMBER	)	conj_and	10	SENT_56	[p4l1199t1431r1356b1521],
19	,	,	O	,	_	0	SENT_56	[p4l1199t1431r1356b1521],
20	who	WP	O	who	nsubjpass	22	SENT_56	[p4l1392t1425r1576b1504],
21	were	VBD	O	be	auxpass	22	SENT_56	[p4l1608t1451r1810b1504],
22	treated	VBN	O	treat	rcmod	2	SENT_56	[p4l1845t1425r2145b1504],
23	at	IN	O	at	_	0	SENT_56	[p4l10t1571r89b1632],
24	the	DT	O	the	det	29	SENT_56	[p4l142t1554r276b1632],
25	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	29	SENT_56	[p4l332t1554r963b1633],
26	General	NNP	ORGANIZATION	General	nn	29	SENT_56	[p4l1024t1554r1364b1633],
27	Hospital	NNP	ORGANIZATION	Hospital	nn	29	SENT_56	[p4l1422t1554r1790b1654],
28	Cancer	NNP	ORGANIZATION	Cancer	nn	29	SENT_56	[p4l1848t1560r2149b1633],
29	Center	NNP	ORGANIZATION	Center	prep_at	22	SENT_56	[p4l10t1688r312b1778],
30	,	,	O	,	_	0	SENT_56	[p4l10t1688r312b1778],
31	donated	VBD	O	donate	_	0	SENT_56	[p4l360t1682r707b1761],
32	10	CD	NUMBER	10	num	33	SENT_56	[p4l752t1688r846b1761],
33	ml	NN	O	ml	dobj	31	SENT_56	[p4l888t1682r1002b1760],
34	of	IN	O	of	_	0	SENT_56	[p4l1044t1681r1144b1761],
35	blood	NN	O	blood	prep_of	33	SENT_56	[p4l1168t1682r1412b1761],
36	on	IN	O	on	_	0	SENT_56	[p4l1454t1708r1560b1761],
37	one	CD	NUMBER	one	num	40	SENT_56	[p4l1603t1708r1755b1761],
38	or	CC	O	or	_	0	SENT_56	[p4l1797t1708r1887b1761],
39	more	JJR	O	more	conj_or	37	SENT_56	[p4l1925t1708r2146b1761],
40	occasions	NNS	O	occasion	prep_on	31	SENT_56	[p4l11t1811r428b1889],
41	for	IN	O	for	_	0	SENT_56	[p4l473t1809r597b1889],
42	CTC	NNP	O	CTC	prep_for	40	SENT_56	[p4l637t1810r1045b1910],
43	—	CD	NUMBER	—	num	45	SENT_56	[p4l637t1810r1045b1910],
44	chip	NN	O	chip	nn	45	SENT_56	[p4l637t1810r1045b1910],
45	analysis	NN	O	analysis	nsubj	31	SENT_56	[p4l1088t1810r1455b1910],
46	.	.	O	.	_	0	SENT_56	[p4l1088t1810r1455b1910],

1	Blood	NN	O	blood	nn	2	SENT_57	[p4l1501t1810r1753b1889],
2	samples	NNS	O	sample	nsubjpass	4	SENT_57	[p4l1797t1810r2143b1910],
3	Were	VBD	O	be	auxpass	4	SENT_57	[p4l6t1965r209b2019],
4	analyzed	VBN	O	analyze	_	0	SENT_57	[p4l247t1939r629b2040],
5	for	IN	O	for	_	0	SENT_57	[p4l668t1938r792b2019],
6	the	DT	O	the	det	7	SENT_57	[p4l829t1939r963b2018],
7	quantity	NN	O	quantity	prep_for	4	SENT_57	[p4l1003t1940r1364b2040],
8	of	IN	O	of	_	0	SENT_57	[p4l1400t1938r1500b2019],
9	circulating	VBG	O	circulate	prepc_of	7	SENT_57	[p4l1522t1939r1991b2041],
10	tumor	NN	O	tumor	nn	11	SENT_57	[p4l2028t1956r2144b2019, p4l10t2093r187b2146],
11	cells	NNS	O	cell	nsubj	12	SENT_57	[p4l224t2067r489b2145],
12	“	VBP	O	“	ccomp	9	SENT_57	[p4l224t2067r489b2145],
13	(	NN	O	(	dobj	12	SENT_57	[p4l534t2066r685b2158],
14	for	IN	O	for	_	0	SENT_57	[p4l534t2066r685b2158],
15	details	NNS	O	detail	prep_for	12	SENT_57	[p4l721t2067r1030b2163],
16	,	,	O	,	_	0	SENT_57	[p4l721t2067r1030b2163],
17	see	VBP	O	see	dep	12	SENT_57	[p4l1077t2093r1208b2146],
18	the	DT	O	the	det	20	SENT_57	[p4l1248t2067r1381b2145],
19	Methods	NNS	O	method	nn	20	SENT_57	[p4l1418t2067r1796b2146],
20	section	NN	O	section	dobj	12	SENT_57	[p4l1840t2068r2146b2146],
21	in	IN	O	in	_	0	SENT_57	[p4l10t2197r93b2274],
22	the	DT	O	the	det	24	SENT_57	[p4l146t2196r280b2274],
23	Supplementary	NNP	O	Supplementary	nn	24	SENT_57	[p4l334t2196r985b2296],
24	Appendix	NNP	O	Appendix	prep_in	20	SENT_57	[p4l1029t2196r1470b2296],
25	,	,	O	,	_	0	SENT_57	[p4l1029t2196r1470b2296],
26	available	JJ	O	available	dep	12	SENT_57	[p4l1527t2196r1901b2276],
27	with	IN	O	with	_	0	SENT_57	[p4l1949t2196r2146b2275],
28	the	DT	O	the	det	30	SENT_57	[p4l11t2325r144b2404],
29	full	JJ	O	full	amod	30	SENT_57	[p4l179t2324r328b2405],
30	text	NN	O	text	prep_with	26	SENT_57	[p4l363t2342r524b2404],
31	of	IN	O	of	_	0	SENT_57	[p4l555t2324r655b2405],
32	this	DT	O	this	det	33	SENT_57	[p4l672t2325r832b2404],
33	article	NN	O	article	prep_of	30	SENT_57	[p4l868t2325r1137b2404],
34	at	IN	O	at	_	0	SENT_57	[p4l1171t2342r1251b2404],
35	WWW.nejm.org	NNP	O	WWW.nejm.org	prep_at	26	SENT_57	[p4l1275t2326r1975b2427],
36	)	CD	NUMBER	)	num	35	SENT_57	[p4l1275t2326r1975b2427],
37	.	.	O	.	_	0	SENT_57	[p4l1275t2326r1975b2427],

1	We	PRP	O	we	nsubj	2	SENT_58	[p4l2012t2333r2145b2404],
2	analyzed	VBD	O	analyze	_	0	SENT_58	[p4l10t2454r391b2555],
3	circulating	VBG	O	circulate	xcomp	2	SENT_58	[p4l458t2454r928b2556],
4	tumor	NN	O	tumor	nn	5	SENT_58	[p4l990t2471r1260b2534],
5	cells	NNS	O	cell	dobj	3	SENT_58	[p4l1323t2454r1536b2551],
6	,	,	O	,	_	0	SENT_58	[p4l1323t2454r1536b2551],
7	free	JJ	O	free	amod	9	SENT_58	[p4l1608t2453r1770b2533],
8	plasma	NN	O	plasma	nn	9	SENT_58	[p4l1835t2454r2147b2555],
9	DNA	NN	MISC	dna	conj_or	5	SENT_58	[p4l9t2589r240b2678],
10	,	,	O	,	_	0	SENT_58	[p4l9t2589r240b2678],
11	archived	JJ	O	archived	amod	16	SENT_58	[p4l282t2582r646b2661],
12	paraffin	NN	O	paraffin	nn	16	SENT_58	[p4l682t2581r1526b2682],
13	—	NN	O	—	nn	16	SENT_58	[p4l682t2581r1526b2682],
14	embedded	JJ	O	embedded	amod	16	SENT_58	[p4l682t2581r1526b2682],
15	tumor	NN	O	tumor	nn	16	SENT_58	[p4l1565t2599r1834b2661],
16	tissue	NN	O	tissue	dobj	3	SENT_58	[p4l1869t2583r2140b2678],
17	,	,	O	,	_	0	SENT_58	[p4l1869t2583r2140b2678],
18	or	CC	O	or	_	0	SENT_58	[p4l11t2737r100b2791],
19	all	DT	O	all	det	21	SENT_58	[p4l134t2711r240b2790],
20	three	CD	NUMBER	three	num	21	SENT_58	[p4l278t2711r499b2790],
21	specimens	NNS	O	specimen	dobj	3	SENT_58	[p4l539t2712r990b2812],
22	for	IN	O	for	_	0	SENT_58	[p4l1030t2710r1154b2791],
23	EGFR	NN	ORGANIZATION	egfr	nn	24	SENT_58	[p4l1187t2718r1401b2792],
24	mutations	NNS	O	mutation	prep_for	3	SENT_58	[p4l1433t2712r1870b2791],
25	using	VBG	O	use	partmod	24	SENT_58	[p4l1910t2712r2149b2813],
26	the	DT	O	the	det	31	SENT_58	[p4l11t2839r144b2917],
27	Scorpion	NNP	O	Scorpion	nn	31	SENT_58	[p4l189t2840r570b2939],
28	Amplification	NNP	O	Amplification	nn	31	SENT_58	[p4l608t2838r1217b2939],
29	Refractory	NNP	O	Refractory	nn	31	SENT_58	[p4l1257t2838r1714b2939],
30	Mutation	NN	O	mutation	nn	31	SENT_58	[p4l1749t2840r2147b2919],
31	System	NNP	O	System	nsubj	38	SENT_58	[p4l12t2974r314b3068],
32	(	CD	NUMBER	(	num	38	SENT_58	[p4l354t2974r733b3059],
33	SARMS	NNP	O	SARMS	nn	38	SENT_58	[p4l354t2974r733b3059],
34	)	CD	NUMBER	)	num	38	SENT_58	[p4l354t2974r733b3059],
35	technology	NN	O	technology	nn	38	SENT_58	[p4l775t2968r1257b3069],
36	(	CD	NUMBER	(	num	38	SENT_58	[p4l1293t2974r1546b3064],
37	DxS	NN	O	dx	nn	38	SENT_58	[p4l1293t2974r1546b3064],
38	)	NN	O	)	xcomp	25	SENT_58	[p4l1293t2974r1546b3064],
39	,	,	O	,	_	0	SENT_58	[p4l1293t2974r1546b3064],
40	standard	JJ	O	standard	amod	42	SENT_58	[p4l1589t2968r1970b3047],
41	nucleotide	NN	O	nucleotide	nn	42	SENT_58	[p4l2006t2994r2144b3047, p4l11t3096r345b3175],
42	sequencing	NN	O	sequencing	prep_for	3	SENT_58	[p4l381t3097r889b3197],
43	,	,	O	,	_	0	SENT_58	[p4l381t3097r889b3197],
44	or	CC	O	or	_	0	SENT_58	[p4l930t3122r1020b3175],
45	both	DT	O	both	prep_for	3	SENT_58	[p4l1052t3096r1274b3175],
46	.	.	O	.	_	0	SENT_58	[p4l1052t3096r1274b3175],

1	The	DT	O	the	det	2	SENT_59	[p4l137t3223r298b3301],
2	number	NN	O	number	nsubjpass	20	SENT_59	[p4l343t3223r683b3303],
3	of	IN	O	of	_	0	SENT_59	[p4l726t3222r827b3302],
4	tumor	NN	O	tumor	nn	7	SENT_59	[p4l853t3223r1437b3323],
5	—	CD	NUMBER	—	num	7	SENT_59	[p4l853t3223r1437b3323],
6	biopsy	NN	O	biopsy	nn	7	SENT_59	[p4l853t3223r1437b3323],
7	specimens	NNS	O	specimen	prep_of	2	SENT_59	[p4l1479t3224r1930b3323],
8	that	WDT	O	that	nsubj	10	SENT_59	[p4l1978t3223r2151b3301],
9	were	VBD	O	be	cop	10	SENT_59	[p4l6t3377r209b3431],
10	available	JJ	O	available	rcmod	2	SENT_59	[p4l252t3351r625b3431],
11	for	IN	O	for	_	0	SENT_59	[p4l669t3350r794b3430],
12	comparison	NN	O	comparison	prep_for	10	SENT_59	[p4l835t3352r1347b3451],
13	of	IN	O	of	_	0	SENT_59	[p4l1392t3350r1492b3430],
14	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_59	[p4l1516t3358r1730b3431],
15	sequencing	NN	O	sequencing	prep_of	12	SENT_59	[p4l1768t3377r2144b3451, p4l10t3481r148b3581],
16	and	CC	O	and	_	0	SENT_59	[p4l182t3480r340b3559],
17	SARMS	NN	O	sarm	nn	18	SENT_59	[p4l380t3486r697b3563],
18	analysis	NN	O	analysis	prep_of	12	SENT_59	[p4l738t3480r1072b3580],
19	was	VBD	O	be	auxpass	20	SENT_59	[p4l1108t3506r1269b3559],
20	extended	VBN	O	extend	_	0	SENT_59	[p4l1312t3480r1691b3559],
21	by	IN	O	by	_	0	SENT_59	[p4l1730t3480r1827b3580],
22	the	DT	O	the	det	23	SENT_59	[p4l1862t3480r1993b3558],
23	inclusion	NN	O	inclusion	agent	20	SENT_59	[p4l2031t3481r2144b3558, p4l11t3607r310b3686],
24	of	IN	O	of	_	0	SENT_59	[p4l346t3606r446b3686],
25	15	CD	NUMBER	15	num	26	SENT_59	[p4l468t3613r563b3686],
26	patients	NNS	O	patient	prep_of	23	SENT_59	[p4l602t3608r946b3707],
27	in	IN	O	in	_	0	SENT_59	[p4l985t3608r1068b3685],
28	Group	NN	O	group	nn	29	SENT_59	[p4l1105t3613r1377b3707],
29	B	NN	O	b	prep_in	26	SENT_59	[p4l1413t3614r1469b3685],
30	(	CD	NUMBER	(	num	31	SENT_59	[p4l1514t3608r1884b3698],
31	Patients	NNS	O	patient	dep	29	SENT_59	[p4l1514t3608r1884b3698],
32	28	CD	NUMBER	28	dep	31	SENT_59	[p4l1924t3613r2023b3686],
33	to	TO	O	to	prep	20	SENT_59	[p4l2063t3624r2145b3686],

1	42	CD	NUMBER	42	num	2	SENT_60	[p5l8t27r133b112],
2	)	NN	O	)	nsubj	16	SENT_60	[p5l8t27r133b112],
3	who	WP	O	who	nsubj	5	SENT_60	[p5l169t21r351b101],
4	had	VBD	O	have	aux	5	SENT_60	[p5l388t21r543b100],
5	participated	VBN	O	participate	ccomp	2	SENT_60	[p5l577t21r1086b121],
6	in	IN	O	in	_	0	SENT_60	[p5l1121t22r1203b99],
7	a	DT	O	a	det	10	SENT_60	[p5l1238t47r1282b99],
8	multicenter	JJ	O	multicenter	amod	10	SENT_60	[p5l1317t21r1805b100],
9	clinical	JJ	O	clinical	amod	10	SENT_60	[p5l1839t21r2147b99],
10	trial	NN	O	trial	prep_in	5	SENT_60	[p5l11t150r189b229],
11	of	IN	O	of	_	0	SENT_60	[p5l230t149r330b230],
12	gefitinib21	NN	O	gefitinib21	prep_of	10	SENT_60	[p5l351t149r803b252],
13	but	CC	O	but	advmod	16	SENT_60	[p5l844t150r985b230],
14	were	VBD	O	be	cop	16	SENT_60	[p5l1016t176r1219b230],
15	not	RB	O	not	neg	16	SENT_60	[p5l1259t167r1403b230],
16	available	JJ	O	available	_	0	SENT_60	[p5l1437t150r1810b230],
17	for	IN	O	for	_	0	SENT_60	[p5l1851t149r1975b230],
18	the	DT	O	the	det	19	SENT_60	[p5l2013t150r2146b229],
19	analysis	NN	O	analysis	prep_for	16	SENT_60	[p5l10t279r351b380],
20	of	IN	O	of	_	0	SENT_60	[p5l395t278r496b359],
21	circulating	VBG	O	circulate	prepc_of	19	SENT_60	[p5l519t279r989b381],
22	tumor	NN	O	tumor	nn	23	SENT_60	[p5l1027t296r1296b359],
23	cells	NNS	O	cell	dobj	21	SENT_60	[p5l1335t279r1548b359],
24	.	.	O	.	_	0	SENT_60	[p5l1335t279r1548b359],

1	We	PRP	O	we	nsubj	2	SENT_61	[p5l1591t287r1725b358],
2	reviewed	VBD	O	review	_	0	SENT_61	[p5l1766t279r2146b359],
3	the	DT	O	the	det	5	SENT_61	[p5l11t407r144b485],
4	medical	JJ	O	medical	amod	5	SENT_61	[p5l188t407r530b486],
5	charts	NNS	O	chart	dobj	2	SENT_61	[p5l574t407r841b485],
6	of	IN	O	of	_	0	SENT_61	[p5l887t406r988b486],
7	all	DT	O	all	det	8	SENT_61	[p5l1013t407r1118b485],
8	patients	NNS	O	patient	prep_of	5	SENT_61	[p5l1160t408r1528b507],
9	,	,	O	,	_	0	SENT_61	[p5l1160t408r1528b507],
10	and	CC	O	and	_	0	SENT_61	[p5l1577t407r1735b486],
11	an	DT	O	a	det	13	SENT_61	[p5l1779t433r1882b485],
12	independent	JJ	O	independent	amod	13	SENT_61	[p5l1926t407r2144b486, p5l9t536r362b637],
13	radiologist	NN	O	radiologist	nsubj	14	SENT_61	[p5l390t536r859b638],
14	quantified	VBD	O	quantify	conj_and	2	SENT_61	[p5l888t535r1339b637],
15	the	DT	O	the	det	17	SENT_61	[p5l1373t536r1507b615],
16	tumor	NN	O	tumor	nn	17	SENT_61	[p5l1541t553r1810b616],
17	burden	NN	O	burden	dobj	14	SENT_61	[p5l1841t536r2146b616],
18	at	IN	O	at	_	0	SENT_61	[p5l10t682r89b743],
19	various	JJ	O	various	amod	20	SENT_61	[p5l134t666r446b744],
20	times	NNS	O	time	prep_at	14	SENT_61	[p5l503t666r741b744],
21	as	IN	O	as	_	0	SENT_61	[p5l797t691r882b743],
22	the	DT	O	the	det	23	SENT_61	[p5l940t665r1073b743],
23	sum	NN	O	sum	prep_as	14	SENT_61	[p5l1130t691r1312b744],
24	of	IN	O	of	_	0	SENT_61	[p5l1368t664r1468b744],
25	the	DT	O	the	det	27	SENT_61	[p5l1505t665r1638b744],
26	unidimen	JJ	O	unidimen	amod	27	SENT_61	[p5l1693t665r2144b744],
27	—	NN	O	—	prep_of	23	SENT_61	[p5l1693t665r2144b744],

1	sional	JJ	O	sional	amod	2	SENT_62	[p5l11t792r268b871],
2	size	NN	O	size	nsubjpass	40	SENT_62	[p5l303t793r466b870],
3	of	IN	O	of	_	0	SENT_62	[p5l499t791r600b871],
4	all	DT	O	all	det	7	SENT_62	[p5l614t792r719b870],
5	measurable	JJ	O	measurable	amod	7	SENT_62	[p5l751t792r1247b871],
6	tumor	NN	O	tumor	nn	7	SENT_62	[p5l1280t809r1550b871],
7	sites	NNS	O	site	prep_of	2	SENT_62	[p5l1581t793r1792b888],
8	,	,	O	,	_	0	SENT_62	[p5l1581t793r1792b888],
9	according	VBG	O	accord	_	0	SENT_62	[p5l1830t792r2144b871, p5l10t922r150b1022],
10	to	TO	O	to	prepc_according_to	18	SENT_62	[p5l189t938r271b1000],
11	the	DT	O	the	det	14	SENT_62	[p5l315t921r449b999],
12	Response	NN	O	response	nn	14	SENT_62	[p5l490t927r903b1021],
13	Evaluation	NN	O	evaluation	nn	14	SENT_62	[p5l944t921r1398b1000],
14	Criteria	NNS	O	criterion	pobj	18	SENT_62	[p5l1440t922r1765b1000],
15	in	IN	O	in	_	0	SENT_62	[p5l1805t922r1888b999],
16	Solid	JJ	MISC	solid	amod	17	SENT_62	[p5l1933t921r2146b1000],
17	Tumors	NNS	MISC	tumor	prep_in	14	SENT_62	[p5l6t1055r332b1129],
18	(	VBP	O	(	parataxis	40	SENT_62	[p5l377t1055r865b1140],
19	RECIST	NN	O	recist	dobj	18	SENT_62	[p5l377t1055r865b1140],
20	)	CD	NUMBER	)	number	21	SENT_62	[p5l377t1055r865b1140],
21	.22	CD	NUMBER	.22	num	22	SENT_62	[p5l377t1055r865b1140],
22	Patients	NNS	O	patient	nsubj	18	SENT_62	[p5l903t1050r1237b1127],
23	who	WP	O	who	nsubjpass	26	SENT_62	[p5l1273t1049r1454b1129],
24	had	VBD	O	have	aux	26	SENT_62	[p5l1494t1049r1649b1128],
25	been	VBN	O	be	auxpass	26	SENT_62	[p5l1688t1049r1887b1128],
26	treated	VBN	O	treat	rcmod	22	SENT_62	[p5l1926t1066r2144b1127, p5l11t1178r107b1258],
27	with	IN	O	with	_	0	SENT_62	[p5l137t1178r334b1258],
28	an	DT	O	a	det	35	SENT_62	[p5l369t1204r473b1257],
29	EGFR	NN	ORGANIZATION	egfr	nn	35	SENT_62	[p5l508t1184r766b1262],
30	tyrosine	NN	O	tyrosine	nn	35	SENT_62	[p5l792t1179r1140b1279],
31	kinase	NN	O	kinase	nn	35	SENT_62	[p5l1176t1178r1457b1258],
32	inhibitor	NN	O	inhibitor	nn	35	SENT_62	[p5l1492t1178r1877b1258],
33	(	NN	O	(	nn	35	SENT_62	[p5l1915t1177r2144b1280],
34	geﬁ	NN	O	geﬁ	nn	35	SENT_62	[p5l1915t1177r2144b1280],
35	tinib	NN	O	tinib	prep_with	26	SENT_62	[p5l11t1307r214b1386],
36	or	CC	O	or	_	0	SENT_62	[p5l257t1333r346b1386],
37	erlotinib	NN	O	erlotinib	nn	38	SENT_62	[p5l385t1307r780b1398],
38	)	NN	O	)	conj_or	35	SENT_62	[p5l385t1307r780b1398],
39	were	VBD	O	be	auxpass	40	SENT_62	[p5l822t1333r1025b1387],
40	assessed	VBN	O	assess	_	0	SENT_62	[p5l1066t1307r1437b1386],
41	for	IN	O	for	_	0	SENT_62	[p5l1478t1306r1602b1386],
42	the	DT	O	the	det	44	SENT_62	[p5l1640t1307r1774b1385],
43	best	JJS	O	best	amod	44	SENT_62	[p5l1817t1307r1995b1386],
44	response	NN	O	response	prep_for	40	SENT_62	[p5l2031t1333r2144b1386, p5l11t1461r308b1535],
45	to	TO	O	to	_	0	SENT_62	[p5l348t1452r430b1514],
46	therapy	NN	O	therapy	prep_to	44	SENT_62	[p5l472t1435r795b1535],
47	with	IN	O	with	_	0	SENT_62	[p5l826t1435r1023b1515],
48	the	DT	O	the	det	49	SENT_62	[p5l1063t1435r1196b1513],
49	use	NN	O	use	prep_with	40	SENT_62	[p5l1236t1461r1377b1515],
50	of	IN	O	of	_	0	SENT_62	[p5l1418t1434r1518b1514],
51	RECIST	NN	O	recist	prep_of	49	SENT_62	[p5l1539t1441r1888b1519],
52	.	.	O	.	_	0	SENT_62	[p5l1539t1441r1888b1519],

1	N	NN	O	n	nn	3	SENT_63	[p5l542t1621r555b1636],
2	ENGLJ	NN	O	englj	nn	3	SENT_63	[p5l570t1621r648b1643],
3	MED	NN	O	med	_	0	SENT_63	[p5l663t1621r715b1636],
4	359	CD	NUMBER	359	num	6	SENT_63	[p5l725t1621r790b1643],
5	;	:	O	;	_	0	SENT_63	[p5l725t1621r790b1643],
6	4	CD	NUMBER	4	dep	3	SENT_63	[p5l725t1621r790b1643],
7	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	8	SENT_63	[p5l822t1621r1024b1643],
8	LY	NNP	O	LY	dep	6	SENT_63	[p5l1088t1621r1112b1636],
9	24	CD	NUMBER	24	num	8	SENT_63	[p5l1122t1621r1158b1643],
10	,	,	O	,	_	0	SENT_63	[p5l1122t1621r1158b1643],
11	2008	CD	DATE	2008	num	8	SENT_63	[p5l1169t1615r1233b1637],
12	367	CD	NUMBER	367	dep	3	SENT_63	[p5l1959t1610r2016b1634],

1	The	DT	O	the	det	4	SENT_64	[p5l702t1654r753b1678],
2	New	NNP	LOCATION	New	nn	4	SENT_64	[p5l762t1655r824b1678],
3	England	NNP	LOCATION	England	nn	4	SENT_64	[p5l833t1654r944b1685],
4	J	NNP	O	J	_	0	SENT_64	[p5l952t1655r965b1678],
5	oum	NNP	O	oum	nn	7	SENT_64	[p5l966t1662r1026b1678],
6	Medicine	NNP	O	Medicine	nn	7	SENT_64	[p5l1095t1654r1220b1678],
7	al	NNP	O	al	dep	4	SENT_64	[p5l1033t1736r1055b1760],
8	S	NN	O	s	dep	4	SENT_64	[p5l1065t1736r1081b1760],

1	Copyright	NN	O	copyright	nn	5	SENT_65	[p5l494t1736r629b1767],
2	©	CD	NUMBER	©	num	5	SENT_65	[p5l638t1736r661b1760],
3	2008	CD	DATE	2008	num	5	SENT_65	[p5l671t1736r736b1760],
4	Massachusetts	NNP	LOCATION	Massachusetts	nn	5	SENT_65	[p5l746t1736r937b1760],
5	Medic	NNP	MISC	Medic	_	0	SENT_65	[p5l947t1736r1031b1760],
6	ociety	NN	O	ociety	dep	5	SENT_65	[p5l1083t1736r1170b1767],
7	.	.	O	.	_	0	SENT_65	[p5l1083t1736r1170b1767],

1	All	DT	O	all	det	2	SENT_66	[p5l1181t1736r1223b1760],
2	rights	NNS	O	rights	nsubj	3	SENT_66	[p5l1232t1736r1306b1767],
3	reserved	VBN	O	reserve	_	0	SENT_66	[p5l1316t1736r1435b1760],
4	.	.	O	.	_	0	SENT_66	[p5l1316t1736r1435b1760],

1	The	DT	O	the	det	4	SENT_67	[p5l813t1778r859b1799],
2	NEW	NNP	O	NEW	nn	4	SENT_67	[p5l877t1780r962b1799],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_67	[p5l981t1780r1170b1799],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_67	[p5l1189t1780r1368b1806],
5	of	IN	O	of	_	0	SENT_67	[p5l1388t1778r1416b1805],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_67	[p5l1428t1780r1627b1799],

1	M	NN	O	m	_	0	SENT_68	[p5l381t1881r566b1901],
2	°	NN	O	°	rcmod	1	SENT_68	[p5l381t1881r566b1901],
3	'	''	O	'	_	0	SENT_68	[p5l381t1881r566b1901],
4	-	:	O	-	_	0	SENT_68	[p5l381t1881r566b1901],
5	ECU	NN	O	ecu	dep	2	SENT_68	[p5l381t1881r566b1901],
6	‘	SYM	O	‘	dep	2	SENT_68	[p5l381t1881r566b1901],
7	-	:	O	-	_	0	SENT_68	[p5l381t1881r566b1901],
8	AR	NN	O	ar	dep	1	SENT_68	[p5l381t1881r566b1901],
9	AN	DT	O	a	dep	8	SENT_68	[p5l579t1881r724b1901],
10	“	SYM	O	“	dep	19	SENT_68	[p5l579t1881r724b1901],
11	-	:	O	-	_	0	SENT_68	[p5l579t1881r724b1901],
12	V5	NN	O	v5	nsubjpass	19	SENT_68	[p5l579t1881r724b1901],
13	'	''	O	'	_	0	SENT_68	[p5l579t1881r724b1901],
14	5	CD	NUMBER	5	num	15	SENT_68	[p5l579t1881r724b1901],
15	DNA	NN	O	dna	dep	12	SENT_68	[p5l1240t1884r1321b1912],
16	from	IN	O	from	_	0	SENT_68	[p5l1337t1881r1418b1912],
17	plasma	NN	O	plasma	prep_from	15	SENT_68	[p5l1435t1882r1556b1920],
18	was	VBD	O	be	auxpass	19	SENT_68	[p5l1571t1892r1634b1912],
19	isolated	VBN	O	isolate	dep	62	SENT_68	[p5l1652t1881r1781b1912],
20	with	IN	O	with	_	0	SENT_68	[p5l1797t1881r1873b1912],
21	the	DT	O	the	det	22	SENT_68	[p5l1890t1881r1942b1912],
22	use	NN	O	use	prep_with	19	SENT_68	[p5l1959t1892r2014b1912],
23	of	IN	O	of	_	0	SENT_68	[p5l2032t1881r2070b1912],
24	DNA	NN	MISC	dna	prep_of	22	SENT_68	[p5l377t1933r458b1961],
25	that	WDT	O	that	nsubjpass	27	SENT_68	[p5l474t1930r541b1961],
26	was	VBD	O	be	auxpass	27	SENT_68	[p5l554t1940r617b1961],
27	extracted	VBN	O	extract	rcmod	22	SENT_68	[p5l635t1930r787b1961],
28	from	IN	O	from	_	0	SENT_68	[p5l804t1930r885b1961],
29	captured	VBN	O	capture	prepc_from	27	SENT_68	[p5l902t1930r1048b1970],
30	circulat	NN	O	circulat	nn	32	SENT_68	[p5l1065t1930r1200b1961],
31	—	NN	O	—	nn	32	SENT_68	[p5l1065t1930r1200b1961],
32	plasma	NN	O	plasma	dobj	29	SENT_68	[p5l1240t1931r1360b1970],
33	preparation	NN	O	preparation	nn	34	SENT_68	[p5l1377t1931r1572b1970],
34	tubes	NNS	O	tube	nsubj	35	SENT_68	[p5l1590t1931r1679b1962],
35	(	VBP	O	(	rcmod	32	SENT_68	[p5l1700t1931r1890b1967],
36	Vacutainer	NNP	O	Vacutainer	nn	38	SENT_68	[p5l1700t1931r1890b1967],
37	PPT	NNP	O	PPT	nn	38	SENT_68	[p5l1906t1933r1982b1967],
38	)	NN	O	)	dobj	35	SENT_68	[p5l1906t1933r1982b1967],
39	and	CC	O	and	_	0	SENT_68	[p5l2002t1931r2063b1962],
40	ing	NN	O	ing	nn	42	SENT_68	[p5l378t1981r432b2020],
41	tumor	NN	O	tumor	nn	42	SENT_68	[p5l446t1987r550b2011],
42	cells	NNS	O	cell	dobj	35	SENT_68	[p5l565t1980r638b2011],
43	with	IN	O	with	_	0	SENT_68	[p5l652t1980r728b2011],
44	the	DT	O	the	det	45	SENT_68	[p5l744t1980r795b2011],
45	use	NN	O	use	prep_with	35	SENT_68	[p5l811t1990r866b2011],
46	of	IN	O	of	_	0	SENT_68	[p5l882t1980r920b2011],
47	a	DT	O	a	det	49	SENT_68	[p5l929t1990r946b2011],
48	PicoPure	NN	O	picopure	nn	49	SENT_68	[p5l960t1981r1106b2011],
49	DNA	NN	O	dna	prep_of	45	SENT_68	[p5l1121t1983r1202b2011],
50	the	DT	O	the	det	55	SENT_68	[p5l1241t1981r1291b2012],
51	QIAmp	NN	O	qiamp	nn	55	SENT_68	[p5l1303t1983r1422b2020],
52	DNA	NN	O	dna	nn	55	SENT_68	[p5l1434t1984r1514b2012],
53	Blood	NN	O	blood	nn	55	SENT_68	[p5l1524t1981r1619b2012],
54	Midi	NNP	O	Midi	nn	55	SENT_68	[p5l1630t1981r1706b2012],
55	Kit	NN	O	kit	dep	49	SENT_68	[p5l1717t1981r1767b2013],
56	(	CD	NUMBER	(	num	61	SENT_68	[p5l1779t1981r1889b2017],
57	Fisher	NNP	O	Fisher	nn	61	SENT_68	[p5l1779t1981r1889b2017],
58	Scientific	NNP	O	Scientific	nn	61	SENT_68	[p5l1901t1981r2061b2017],
59	)	NNP	O	)	nn	61	SENT_68	[p5l1901t1981r2061b2017],
60	Extraction	NNP	O	Extraction	nn	61	SENT_68	[p5l377t2031r550b2061],
61	Kit	NN	O	kit	nsubj	62	SENT_68	[p5l563t2031r613b2061],
62	(	VBZ	O	(	rcmod	8	SENT_68	[p5l627t2030r806b2065],
63	Molecular	JJ	O	molecular	amod	64	SENT_68	[p5l627t2030r806b2065],
64	Devices	NNPS	O	Devices	dobj	62	SENT_68	[p5l817t2031r954b2065],
65	)	NN	O	)	nsubjpass	67	SENT_68	[p5l817t2031r954b2065],
66	was	VBD	O	be	auxpass	67	SENT_68	[p5l968t2040r1031b2061],
67	subjected	VBN	O	subject	rcmod	64	SENT_68	[p5l1046t2030r1200b2069],
68	and	CC	O	and	_	0	SENT_68	[p5l1240t2031r1301b2061],
69	a	DT	O	a	det	71	SENT_68	[p5l1318t2041r1336b2061],
70	standard	JJ	O	standard	amod	71	SENT_68	[p5l1354t2031r1498b2061],
71	method	NN	O	method	nsubj	72	SENT_68	[p5l1516t2031r1643b2061],
72	using	VBG	O	use	rcmod	8	SENT_68	[p5l1661t2031r1751b2070],
73	proteinase	NNP	O	proteinase	nn	74	SENT_68	[p5l1768t2031r1939b2070],
74	K.	NNP	O	K.	dep	72	SENT_68	[p5l1957t2034r1990b2062],
75	For	IN	O	for	dep	74	SENT_68	[p5l2010t2034r2064b2061],
76	to	TO	O	to	pcomp	75	SENT_68	[p5l378t2086r410b2110],
77	two	CD	NUMBER	two	num	78	SENT_68	[p5l434t2086r495b2110],
78	rounds	NNS	O	round	pobj	76	SENT_68	[p5l520t2079r635b2110],
79	of	IN	O	of	_	0	SENT_68	[p5l661t2079r699b2110],
80	linear	JJ	O	linear	amod	81	SENT_68	[p5l716t2079r813b2110],
81	amplification	NN	O	amplification	prep_of	78	SENT_68	[p5l836t2079r1062b2118],
82	with	IN	O	with	_	0	SENT_68	[p5l1085t2079r1160b2110],
83	a	DT	O	a	det	84	SENT_68	[p5l1184t2089r1201b2110],
84	identification	NN	O	identification	prep_with	72	SENT_68	[p5l1240t2080r1466b2110],
85	of	IN	O	of	_	0	SENT_68	[p5l1478t2080r1516b2110],
86	EGFR	NN	ORGANIZATION	egfr	nn	87	SENT_68	[p5l1519t2083r1602b2111],
87	mutations	NNS	O	mutation	prep_of	84	SENT_68	[p5l1610t2080r1779b2111],
88	with	IN	O	with	_	0	SENT_68	[p5l1789t2080r1864b2111],
89	the	DT	O	the	det	93	SENT_68	[p5l1875t2080r1927b2110],
90	SARMS	NNP	MISC	SARMS	nn	93	SENT_68	[p5l1939t2082r2062b2112],
91	TransPlex	NNP	MISC	TransPlex	nn	93	SENT_68	[p5l376t2128r540b2159],
92	ampliﬁcation	NN	O	ampliﬁcation	nn	93	SENT_68	[p5l551t2128r778b2167],
93	kit	NN	O	kit	prep_with	72	SENT_68	[p5l791t2128r835b2159],
94	(	CD	NUMBER	(	num	97	SENT_68	[p5l848t2128r998b2163],
95	Rubicon	NNP	ORGANIZATION	Rubicon	nn	97	SENT_68	[p5l848t2128r998b2163],
96	Genomics	NNP	ORGANIZATION	Genomics	nn	97	SENT_68	[p5l1011t2129r1198b2163],
97	)	NN	O	)	dep	93	SENT_68	[p5l1011t2129r1198b2163],
98	.	.	O	.	_	0	SENT_68	[p5l1011t2129r1198b2163],

1	assay	NN	O	assay	nsubjpass	8	SENT_69	[p5l1240t2139r1333b2168],
2	,	,	O	,	_	0	SENT_69	[p5l1240t2139r1333b2168],
3	1.5	CD	NUMBER	1.5	num	4	SENT_69	[p5l1352t2131r1398b2159],
4	ng	NN	O	ng	nsubjpass	8	SENT_69	[p5l1415t2139r1457b2168],
5	of	IN	O	of	_	0	SENT_69	[p5l1472t2129r1510b2159],
6	DNA	NN	MISC	dna	prep_of	4	SENT_69	[p5l1518t2131r1599b2160],
7	was	VBD	O	be	auxpass	8	SENT_69	[p5l1611t2139r1674b2160],
8	analyzed	VBN	O	analyze	_	0	SENT_69	[p5l1690t2129r1837b2168],
9	with	IN	O	with	_	0	SENT_69	[p5l1850t2129r1926b2160],
10	the	DT	O	the	det	11	SENT_69	[p5l1941t2129r1993b2159],
11	use	NN	O	use	prep_with	8	SENT_69	[p5l2008t2139r2063b2160],

1	Table	NNP	O	Table	_	0	SENT_70	[p6l116t59r190b84],
2	1	CD	NUMBER	1	dep	1	SENT_70	[p6l200t62r221b84],
3	.	.	O	.	_	0	SENT_70	[p6l200t62r221b84],

1	Detection	NN	O	detection	_	0	SENT_71	[p6l233t60r362b85],
2	of	IN	O	of	_	0	SENT_71	[p6l373t59r404b85],
3	Circulating	VBG	O	circulate	prepc_of	1	SENT_71	[p6l407t59r557b92],
4	Tumor	NN	O	tumor	nn	5	SENT_71	[p6l564t62r657b85],
5	Cells	NNS	O	cell	dobj	3	SENT_71	[p6l665t59r730b85],
6	in	IN	O	in	_	0	SENT_71	[p6l741t60r763b84],
7	Patients	NNS	O	patient	prep_in	3	SENT_71	[p6l776t60r884b85],
8	with	IN	O	with	_	0	SENT_71	[p6l893t59r951b85],
9	Non	NN	O	non	prep_with	7	SENT_71	[p6l963t59r1174b85],
10	.	.	O	.	_	0	SENT_71	[p6l963t59r1174b85],

1	—	NN	O	—	_	0	SENT_72	[p6l963t59r1174b85],
2	.	.	O	.	_	0	SENT_72	[p6l963t59r1174b85],

1	Small-Cell	JJ	O	small-cell	amod	2	SENT_73	[p6l963t59r1174b85],
2	Lung	NN	O	lung	_	0	SENT_73	[p6l1187t62r1254b92],
3	Cancer	NN	O	cancer	dep	2	SENT_73	[p6l1262t61r1382b85],
4	.	.	O	.	_	0	SENT_73	[p6l1262t61r1382b85],

1	*	NN	O	*	nn	3	SENT_74	[p6l1262t61r1382b85],
2	Patient	NN	O	patient	nn	3	SENT_74	[p6l122t135r216b160],
3	No.	NN	O	no.	_	0	SENT_74	[p6l228t137r275b160],
4	and	CC	O	and	_	0	SENT_74	[p6l286t135r335b160],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_74	[p6l348t137r425b160],
6	Time	NN	O	time	conj_and	3	SENT_74	[p6l1053t135r1122b160],
7	since	IN	O	since	_	0	SENT_74	[p6l1133t135r1203b160],
8	Previous	JJ	O	previous	amod	10	SENT_74	[p6l1274t135r1390b160],
9	Systemic	JJ	O	systemic	amod	10	SENT_74	[p6l1401t135r1523b168],
10	Tumor	NN	O	tumor	prep_since	3	SENT_74	[p6l1625t137r1718b160],
11	Circulating	VBG	O	circulate	partmod	10	SENT_74	[p6l1842t135r1992b168],
12	Mutation	NN	O	mutation	nn	18	SENT_74	[p6l163t173r285b197],
13	Status	NN	O	status	nn	18	SENT_74	[p6l297t174r383b197],
14	Sex	NN	O	sex	nn	18	SENT_74	[p6l458t174r506b197],
15	Age	NN	O	age	nn	18	SENT_74	[p6l577t175r629b205],
16	Histologic	JJ	O	histologic	amod	18	SENT_74	[p6l708t172r846b205],
17	Features	NNS	O	feature	nn	18	SENT_74	[p6l858t175r974b197],
18	Diagnosis	NN	O	diagnosis	dobj	11	SENT_74	[p6l1062t173r1196b205],
19	Therapy'i	NN	O	therapy'us	nn	21	SENT_74	[p6l1333t172r1461b205],
20	‘	CD	NUMBER	‘	num	21	SENT_74	[p6l1333t172r1461b205],
21	Burden	NN	O	burden	dep	18	SENT_74	[p6l1614t172r1730b205],
22	:	:	O	:	_	0	SENT_74	[p6l1614t172r1730b205],
23	§	CD	NUMBER	§	dep	18	SENT_74	[p6l1614t172r1730b205],
24	:	:	O	:	_	0	SENT_74	[p6l1614t172r1730b205],
25	Tumor	NN	O	tumor	nn	30	SENT_74	[p6l1824t175r1917b197],
26	Cellsﬁ	NN	O	cellsﬁ	nn	30	SENT_74	[p6l1926t172r2008b206],
27	yr	NN	DURATION	yr	nn	30	SENT_74	[p6l593t239r617b263],
28	mo	NN	DURATION	mo	nn	30	SENT_74	[p6l1108t239r1149b255],
29	cm	NN	O	cm	nn	30	SENT_74	[p6l1652t239r1690b255],
30	no.	NN	O	no.	dep	23	SENT_74	[p6l1852t239r1888b255],
31	per	IN	O	per	_	0	SENT_74	[p6l1900t239r1942b263],
32	ml	NN	O	ml	prep_per	30	SENT_74	[p6l1950t230r1984b255],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_75	[p6l118t290r194b313],
2	mutation	NN	O	mutation	_	0	SENT_75	[p6l204t290r326b313],
3	present	JJ	DATE	present	amod	2	SENT_75	[p6l339t293r440b321],

1	1	CD	NUMBER	1	num	2	SENT_76	[p6l169t348r180b370],
2	58	CD	NUMBER	58	_	0	SENT_76	[p6l589t347r619b371],
3	Adeno	NNP	O	Adeno	dep	2	SENT_76	[p6l795t346r883b371],
4	.	.	O	.	_	0	SENT_76	[p6l1135t367r1140b371],

1	156	CD	NUMBER	156	_	0	SENT_77	[p6l1895t348r1941b371],
2	55	CD	NUMBER	55	dep	1	SENT_77	[p6l588t406r617b428],
3	Adeno	NNP	O	Adeno	rcmod	2	SENT_77	[p6l795t403r883b428],
4	,	,	O	,	_	0	SENT_77	[p6l1393t424r1397b433],
5	.	.	O	.	_	0	SENT_77	[p6l1670t424r1674b428],

1	50	CD	NUMBER	50	_	0	SENT_78	[p6l1910t405r1941b428],
2	66	CD	NUMBER	66	dep	1	SENT_78	[p6l589t463r619b486],
3	Adeno	NNP	O	Adeno	rcmod	2	SENT_78	[p6l795t461r883b486],
4	,	,	O	,	_	0	SENT_78	[p6l1393t482r1397b491],
5	.	.	O	.	_	0	SENT_78	[p6l1670t482r1674b486],

1	9	CD	NUMBER	9	num	2	SENT_79	[p6l1927t463r1940b486],
2	59	CD	NUMBER	59	_	0	SENT_79	[p6l588t521r619b544],
3	Adeno/BAC	NN	O	adeno/bac	dep	2	SENT_79	[p6l759t519r920b551],
4	.	.	O	.	_	0	SENT_79	[p6l1670t540r1674b544],

1	771	CD	NUMBER	771	num	2	SENT_80	[p6l1894t521r1939b544],
2	57	CD	NUMBER	57	_	0	SENT_80	[p6l588t578r619b601],
3	Adeno	NNP	O	Adeno	dep	2	SENT_80	[p6l795t576r883b601],
4	.	.	O	.	_	0	SENT_80	[p6l1670t597r1674b601],

1	152	CD	NUMBER	152	num	2	SENT_81	[p6l1895t578r1940b601],
2	74	CD	NUMBER	74	_	0	SENT_81	[p6l589t636r619b659],
3	Adeno	NNP	O	Adeno	dep	2	SENT_81	[p6l795t634r883b659],
4	.	.	O	.	_	0	SENT_81	[p6l1670t655r1674b659],

1	5	CD	NUMBER	5	num	2	SENT_82	[p6l1927t636r1939b659],
2	64	CD	NUMBER	64	_	0	SENT_82	[p6l588t694r619b717],
3	NSCLC	NN	ORGANIZATION	nsclc	nn	5	SENT_82	[p6l793t693r889b717],
4	70	CD	NUMBER	70	num	5	SENT_82	[p6l589t751r619b774],
5	Adeno	NNP	O	Adeno	dep	2	SENT_82	[p6l795t749r883b774],
6	.	.	O	.	_	0	SENT_82	[p6l1135t770r1140b774],

1	.	.	O	.	_	0	SENT_83	[p6l1670t770r1674b774],

1	175	CD	NUMBER	175	number	2	SENT_84	[p6l1895t751r1939b774],
2	63	CD	NUMBER	63	num	5	SENT_84	[p6l588t809r617b832],
3	Adeno	NNP	ORGANIZATION	Adeno	nn	5	SENT_84	[p6l795t807r883b832],
4	66	CD	NUMBER	66	num	5	SENT_84	[p6l588t866r619b890],
5	Adeno/BAC	NN	O	adeno/bac	_	0	SENT_84	[p6l758t864r920b897],
6	74	CD	NUMBER	74	num	7	SENT_84	[p6l589t924r619b947],
7	Adeno/BAC	NN	O	adeno/bac	dep	5	SENT_84	[p6l758t922r920b955],
8	62	CD	NUMBER	62	num	9	SENT_84	[p6l588t982r618b1005],
9	Adeno/BAC	NN	O	adeno/bac	dep	5	SENT_84	[p6l758t980r920b1013],
10	27	CD	NUMBER	27	num	31	SENT_84	[p6l588t1040r619b1062],
11	Adeno	NNP	ORGANIZATION	Adeno	nn	31	SENT_84	[p6l795t1037r883b1062],
12	55	CD	NUMBER	55	num	31	SENT_84	[p6l588t1097r617b1120],
13	Adeno	NNP	ORGANIZATION	Adeno	nn	31	SENT_84	[p6l795t1095r883b1120],
14	70	CD	NUMBER	70	num	31	SENT_84	[p6l589t1154r619b1178],
15	Adeno/BAC	NN	O	adeno/bac	nn	31	SENT_84	[p6l758t1153r920b1186],
16	53	CD	NUMBER	53	num	31	SENT_84	[p6l588t1212r617b1235],
17	Adeno/BAC	NN	O	adeno/bac	nn	31	SENT_84	[p6l758t1210r920b1243],
18	60	CD	NUMBER	60	num	31	SENT_84	[p6l588t1269r619b1293],
19	Adeno/BAC	NN	O	adeno/bac	nn	31	SENT_84	[p6l758t1268r920b1301],
20	37	CD	NUMBER	37	num	31	SENT_84	[p6l588t1328r619b1350],
21	Adeno	NNP	ORGANIZATION	Adeno	nn	31	SENT_84	[p6l795t1325r883b1351],
22	66	CD	NUMBER	66	num	31	SENT_84	[p6l588t1385r619b1408],
23	Adeno/BAC	NN	O	adeno/bac	nn	31	SENT_84	[p6l758t1383r920b1416],
24	63	CD	NUMBER	63	num	31	SENT_84	[p6l588t1443r617b1466],
25	Adeno	NNP	ORGANIZATION	Adeno	nn	31	SENT_84	[p6l795t1441r883b1466],
26	58	CD	NUMBER	58	num	31	SENT_84	[p6l588t1500r618b1524],
27	Adeno	NNP	ORGANIZATION	Adeno	nn	31	SENT_84	[p6l795t1498r883b1524],
28	86	CD	NUMBER	86	num	31	SENT_84	[p6l588t1558r618b1581],
29	Adeno	NNP	O	Adeno	nn	31	SENT_84	[p6l795t1556r883b1581],
30	65	CD	NUMBER	65	num	31	SENT_84	[p6l588t1616r617b1639],
31	NSCLC	NN	O	nsclc	rcmod	9	SENT_84	[p6l793t1615r888b1639],

1	S	NN	O	s	_	0	SENT_85	[p6l166t406r198b890],
2	\	NN	O	\	dep	1	SENT_85	[p6l166t406r198b890],
3	.	.	O	.	_	0	SENT_85	[p6l166t406r198b890],

1	D06	CD	NUMBER	d06	number	2	SENT_86	[p6l166t406r198b890],
2	\	CD	NUMBER	\	_	0	SENT_86	[p6l166t406r198b890],
3	lO	NN	O	lo	dep	2	SENT_86	[p6l166t406r198b890],
4	'	''	O	'	_	0	SENT_86	[p6l166t406r198b890],
5	\	CD	NUMBER	\	dep	2	SENT_86	[p6l166t406r198b890],
6	U	NNP	O	U	poss	8	SENT_86	[p6l166t406r198b890],
7	'	POS	O	'	_	0	SENT_86	[p6l166t406r198b890],
8	I-hi	NN	O	i-hus	dep	5	SENT_86	[p6l166t406r198b890],
9	.	.	O	.	_	0	SENT_86	[p6l166t406r198b890],

1	»	SYM	O	»	dep	3	SENT_87	[p6l166t406r198b890],
2	-	:	O	-	_	0	SENT_87	[p6l166t406r198b890],
3	Ilxl	NN	PERSON	ilxl	_	0	SENT_87	[p6l166t406r198b890],
4	.	.	O	.	_	0	SENT_87	[p6l169t924r180b947],

1	_	NN	O	_	_	0	SENT_88	[p6l169t924r180b947],
2	.	.	O	.	_	0	SENT_88	[p6l169t924r180b947],

1	,	,	O	,	_	0	SENT_89	[p6l185t924r196b947],
2	_	IN	O	_	dep	8	SENT_89	[p6l185t924r196b947],
3	a	DT	O	a	det	4	SENT_89	[p6l185t924r196b947],
4	l	NN	O	l	pobj	2	SENT_89	[p6l168t1040r180b1062],
5	—	CD	NUMBER	—	number	6	SENT_89	[p6l168t1040r180b1062],
6	‘	CD	NUMBER	‘	num	4	SENT_89	[p6l168t1040r180b1062],
7	U	NNP	O	U	nn	8	SENT_89	[p6l184t1039r196b1062],
8	)	NNP	O	)	_	0	SENT_89	[p6l184t1039r196b1062],
9	|	NN	O	|	dep	8	SENT_89	[p6l168t1097r180b1120],
10	.	.	O	.	_	0	SENT_89	[p6l168t1097r180b1120],

1	—	NN	O	—	_	0	SENT_90	[p6l168t1097r180b1120],
2	.	.	O	.	_	0	SENT_90	[p6l168t1097r180b1120],
3	'	''	O	'	_	0	SENT_90	[p6l168t1097r180b1120],

1	-	:	O	-	_	0	SENT_91	[p6l183t1097r197b1120],
2	l	NN	O	l	_	0	SENT_91	[p6l183t1097r197b1120],
3	>	JJR	O	>	amod	4	SENT_91	[p6l183t1097r197b1120],
4	l	NN	O	l	tmod	24	SENT_91	[p6l168t1155r180b1177],
5	—	CD	NUMBER	—	number	6	SENT_91	[p6l168t1155r180b1177],
6	‘	CD	NUMBER	‘	num	9	SENT_91	[p6l168t1155r180b1177],
7	U	NNP	O	U	poss	9	SENT_91	[p6l184t1155r196b1178],
8	'	POS	O	'	_	0	SENT_91	[p6l184t1155r196b1178],
9	|	NN	O	|	nsubj	24	SENT_91	[p6l184t1155r196b1178],
10	II	CD	NUMBER	ii	num	13	SENT_91	[p6l168t1212r180b1235],
11	—	NN	O	—	nn	13	SENT_91	[p6l168t1212r180b1235],
12	'	''	O	'	_	0	SENT_91	[p6l168t1212r180b1235],
13	CD	NNP	O	CD	dep	9	SENT_91	[p6l184t1212r197b1235],
14	I	PRP	O	I	nsubj	15	SENT_91	[p6l168t1270r179b1293],
15	—	VBP	O	—	rcmod	9	SENT_91	[p6l168t1270r179b1293],
16	‘	CD	NUMBER	‘	num	18	SENT_91	[p6l168t1270r179b1293],
17	\	CD	NUMBER	\	num	18	SENT_91	[p6l185t1270r197b1293],
18	l	NN	O	l	nsubj	23	SENT_91	[p6l185t1270r197b1293],
19	l	NN	O	l	tmod	18	SENT_91	[p6l168t1328r179b1350],
20	—	NN	O	—	nn	22	SENT_91	[p6l168t1328r179b1350],
21	'	''	O	'	_	0	SENT_91	[p6l168t1328r179b1350],
22	oo	NN	O	oo	dep	18	SENT_91	[p6l183t1327r197b1351],
23	I	PRP	O	I	xcomp	15	SENT_91	[p6l168t1385r179b1408],
24	—	VBP	O	—	rcmod	2	SENT_91	[p6l168t1385r179b1408],
25	'	''	O	'	_	0	SENT_91	[p6l168t1385r179b1408],
26	to	TO	O	to	_	0	SENT_91	[p6l183t1385r197b1408],
27	N	NN	O	n	nn	28	SENT_91	[p6l166t1443r180b1465],
28	O	NN	O	o	prep_to	24	SENT_91	[p6l183t1442r198b1466],
29	N	NN	O	n	nn	33	SENT_91	[p6l166t1501r180b1523],
30	l	NN	O	l	nn	33	SENT_91	[p6l185t1501r196b1523],
31	—	NN	O	—	nn	33	SENT_91	[p6l185t1501r196b1523],
32	'	''	O	'	_	0	SENT_91	[p6l185t1501r196b1523],
33	ix	NN	O	ix	dep	28	SENT_91	[p6l166t1558r180b1581],
34	)	CD	NUMBER	)	dobj	24	SENT_91	[p6l166t1558r180b1581],
35	I	PRP	O	I	nsubj	36	SENT_91	[p6l183t1558r197b1581],
36	\	VBP	O	\	rcmod	34	SENT_91	[p6l183t1558r197b1581],
37	)	CD	NUMBER	)	dobj	36	SENT_91	[p6l183t1558r197b1581],

1	M	NN	O	m	nn	3	SENT_92	[p6l471t348r493b370],
2	M	NN	O	m	nn	3	SENT_92	[p6l471t406r493b428],
3	F	NN	O	f	_	0	SENT_92	[p6l476t463r489b486],
4	M	NN	O	m	nn	15	SENT_92	[p6l470t521r493b543],
5	M	NN	O	m	nn	15	SENT_92	[p6l470t578r493b601],
6	F	NN	O	f	nn	15	SENT_92	[p6l476t636r489b659],
7	M	NN	O	m	nn	15	SENT_92	[p6l470t694r493b716],
8	F	NN	O	f	nn	15	SENT_92	[p6l476t751r489b774],
9	F	NN	O	f	nn	15	SENT_92	[p6l476t809r489b832],
10	F	NN	O	f	nn	15	SENT_92	[p6l476t867r489b889],
11	F	NN	O	f	nn	15	SENT_92	[p6l476t924r489b947],
12	12	CD	NUMBER	12	num	15	SENT_92	[p6l169t982r197b1004],
13	F	NN	O	f	nn	15	SENT_92	[p6l476t982r489b1004],
14	M	NN	O	m	nn	15	SENT_92	[p6l470t1040r493b1062],
15	F	NN	O	f	dep	3	SENT_92	[p6l476t1097r489b1120],
16	F	NN	O	f	nn	24	SENT_92	[p6l476t1155r489b1177],
17	M	NN	O	m	nn	24	SENT_92	[p6l470t1212r493b1235],
18	F	NN	O	f	nn	24	SENT_92	[p6l476t1270r489b1293],
19	F	NN	O	f	nn	24	SENT_92	[p6l476t1328r489b1350],
20	M	NN	O	m	nn	24	SENT_92	[p6l470t1385r493b1408],
21	M	NN	O	m	nn	24	SENT_92	[p6l470t1443r493b1465],
22	F	NN	O	f	nn	24	SENT_92	[p6l476t1501r489b1523],
23	M	NN	O	m	nn	24	SENT_92	[p6l470t1558r492b1581],
24	M	NN	O	m	dep	3	SENT_92	[p6l470t1616r492b1638],

1	23	CD	NUMBER	23	num	3	SENT_93	[p6l166t1616r196b1639],
2	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_93	[p6l118t1673r193b1697],
3	mutation	NN	O	mutation	_	0	SENT_93	[p6l204t1674r326b1697],
4	absent	JJ	O	absent	amod	7	SENT_93	[p6l337t1671r428b1697],
5	24	CD	NUMBER	24	number	6	SENT_93	[p6l166t1731r197b1754],
6	65	CD	NUMBER	65	dep	4	SENT_93	[p6l588t1731r617b1754],
7	Adeno	NNP	ORGANIZATION	Adeno	dep	3	SENT_93	[p6l795t1729r883b1754],
8	25	CD	NUMBER	25	number	9	SENT_93	[p6l166t1789r196b1812],
9	71	CD	NUMBER	71	num	7	SENT_93	[p6l589t1789r617b1812],
10	Adeno	NNP	ORGANIZATION	Adeno	dep	3	SENT_93	[p6l795t1787r883b1812],
11	26	CD	NUMBER	26	number	12	SENT_93	[p6l166t1846r197b1870],
12	47	CD	NUMBER	47	num	16	SENT_93	[p6l587t1847r618b1869],
13	Adeno	NNP	ORGANIZATION	Adeno	nn	16	SENT_93	[p6l795t1844r883b1870],
14	27	CD	NUMBER	27	number	15	SENT_93	[p6l166t1904r197b1927],
15	70	CD	NUMBER	70	amod	16	SENT_93	[p6l589t1904r619b1927],
16	Adeno	NN	O	adeno	dep	10	SENT_93	[p6l795t1902r883b1927],

1	*	NN	O	*	nn	2	SENT_94	[p6l89t1989r104b2004],
2	Adeno	NN	O	adeno	nsubj	3	SENT_94	[p6l114t1987r202b2012],
3	denotes	VBZ	O	denote	_	0	SENT_94	[p6l213t1987r320b2012],
4	adenocarcinoma	NN	O	adenocarcinoma	dobj	3	SENT_94	[p6l333t1987r568b2016],
5	,	,	O	,	_	0	SENT_94	[p6l333t1987r568b2016],
6	Adeno/BAC	NN	O	adeno/bac	nn	7	SENT_94	[p6l580t1987r741b2020],
7	adenocarcinoma	NN	O	adenocarcinoma	dobj	3	SENT_94	[p6l753t1987r980b2012],
8	with	IN	O	with	_	0	SENT_94	[p6l991t1987r1047b2012],
9	bronchoalveolar	JJ	O	bronchoalveolar	amod	10	SENT_94	[p6l1061t1987r1281b2012],
10	features	NNS	O	feature	prep_with	7	SENT_94	[p6l1291t1987r1407b2016],
11	,	,	O	,	_	0	SENT_94	[p6l1291t1987r1407b2016],
12	C	NN	O	c	nn	13	SENT_94	[p6l1420t1989r1438b2012],
13	chemotherapy	NN	O	chemotherapy	dobj	3	SENT_94	[p6l1449t1987r1651b2020],
14	,	,	O	,	_	0	SENT_94	[p6l1449t1987r1651b2020],
15	E	NN	O	e	nn	16	SENT_94	[p6l1666t1989r1679b2012],
16	erlotinib	NN	O	erlotinib	conj_and	4	SENT_94	[p6l1691t1987r1811b2017],
17	,	,	O	,	_	0	SENT_94	[p6l1691t1987r1811b2017],
18	G	NN	O	g	nn	19	SENT_94	[p6l1824t1989r1843b2012],
19	gefitinib	NNS	O	gefitinib	conj_and	4	SENT_94	[p6l1856t1987r1974b2020],
20	,	,	O	,	_	0	SENT_94	[p6l1856t1987r1974b2020],
21	NSCLC	NNP	O	NSCLC	dobj	3	SENT_94	[p6l117t2026r212b2050],
22	non	JJ	O	non	amod	26	SENT_94	[p6l225t2024r421b2050],
23	—	NN	O	—	nn	26	SENT_94	[p6l225t2024r421b2050],
24	small-cell	NN	O	small-cell	nn	26	SENT_94	[p6l225t2024r421b2050],
25	lung	NN	O	lung	nn	26	SENT_94	[p6l435t2024r494b2058],
26	cancer	NN	O	cancer	dep	21	SENT_94	[p6l504t2033r594b2050],
27	not	RB	O	not	neg	29	SENT_94	[p6l605t2029r648b2050],
28	otherwise	RB	O	otherwise	advmod	29	SENT_94	[p6l659t2024r791b2050],
29	speciﬁed	VBN	O	speciﬁed	partmod	21	SENT_94	[p6l803t2024r930b2058],
30	,	,	O	,	_	0	SENT_94	[p6l803t2024r930b2058],
31	and	CC	O	and	_	0	SENT_94	[p6l943t2024r991b2050],
32	o	NN	O	o	dep	33	SENT_94	[p6l1004t2026r1027b2050],
33	other	JJ	O	other	conj_and	4	SENT_94	[p6l1039t2024r1110b2050],
34	or	CC	O	or	_	0	SENT_94	[p6l1121t2033r1148b2050],
35	experimental	JJ	O	experimental	amod	36	SENT_94	[p6l1159t2024r1333b2058],
36	agent	NN	O	agent	conj_or	33	SENT_94	[p6l1347t2029r1428b2058],
37	.	.	O	.	_	0	SENT_94	[p6l1347t2029r1428b2058],

1	1	CD	NUMBER	1	number	2	SENT_95	[p6l91t2064r106b2095],
2	‘	CD	NUMBER	‘	num	5	SENT_95	[p6l91t2064r106b2095],
3	Previous	JJ	O	previous	amod	5	SENT_95	[p6l117t2064r232b2087],
4	systemic	JJ	O	systemic	amod	5	SENT_95	[p6l244t2064r362b2095],
5	therapies	NNS	O	therapy	nsubjpass	7	SENT_95	[p6l372t2062r498b2095],
6	are	VBP	O	be	auxpass	7	SENT_95	[p6l511t2071r551b2087],
7	listed	VBN	O	list	_	0	SENT_95	[p6l563t2062r634b2087],
8	in	IN	O	in	_	0	SENT_95	[p6l648t2064r669b2087],
9	the	DT	O	the	det	10	SENT_95	[p6l681t2062r724b2087],
10	order	NN	O	order	prep_in	7	SENT_95	[p6l735t2062r807b2087],
11	they	PRP	O	they	nsubjpass	13	SENT_95	[p6l817t2062r874b2095],
12	were	VBD	O	be	auxpass	13	SENT_95	[p6l883t2071r947b2087],
13	administered	VBN	O	administer	rcmod	10	SENT_95	[p6l959t2062r1146b2087],
14	.	.	O	.	_	0	SENT_95	[p6l959t2062r1146b2087],

1	It	PRP	O	it	nsubj	20	SENT_96	[p6l91t2101r106b2132],
2	The	DT	O	the	det	4	SENT_96	[p6l114t2099r165b2124],
3	tumor	NN	O	tumor	nn	4	SENT_96	[p6l175t2104r260b2124],
4	burden	NN	O	burden	nsubjpass	6	SENT_96	[p6l272t2099r366b2124],
5	was	VBD	O	be	auxpass	6	SENT_96	[p6l377t2108r428b2124],
6	measured	VBN	O	measure	parataxis	20	SENT_96	[p6l442t2099r575b2124],
7	by	IN	O	by	_	0	SENT_96	[p6l589t2099r617b2132],
8	unidimensional	JJ	O	unidimensional	amod	9	SENT_96	[p6l629t2099r839b2124],
9	diameter	NN	O	diameter	agent	6	SENT_96	[p6l852t2099r980b2128],
10	,	,	O	,	_	0	SENT_96	[p6l852t2099r980b2128],
11	according	VBG	O	accord	_	0	SENT_96	[p6l993t2099r1127b2132],
12	to	TO	O	to	prepc_according_to	6	SENT_96	[p6l1137t2104r1164b2124],
13	the	DT	O	the	det	16	SENT_96	[p6l1174t2099r1217b2124],
14	Response	NN	O	response	nn	16	SENT_96	[p6l1230t2101r1360b2132],
15	Evaluation	NN	O	evaluation	nn	16	SENT_96	[p6l1374t2099r1513b2124],
16	Criteria	NNS	O	criterion	pobj	6	SENT_96	[p6l1526t2101r1624b2124],
17	in	IN	O	in	_	0	SENT_96	[p6l1637t2101r1659b2124],
18	Solid	JJ	MISC	solid	amod	19	SENT_96	[p6l1672t2099r1738b2124],
19	Tumors	NNS	MISC	tumor	prep_in	16	SENT_96	[p6l1749t2101r1856b2124],
20	(	VBP	O	(	_	0	SENT_96	[p6l1871t2101r2000b2132],
21	RECIST	NN	O	recist	nn	22	SENT_96	[p6l1871t2101r2000b2132],
22	)	NN	O	)	dobj	20	SENT_96	[p6l1871t2101r2000b2132],
23	.	.	O	.	_	0	SENT_96	[p6l1871t2101r2000b2132],

1	§	NN	O	§	nsubjpass	10	SENT_97	[p6l90t2135r101b2169],
2	The	DT	O	the	det	3	SENT_97	[p6l114t2135r164b2161],
3	number	NN	O	number	dep	1	SENT_97	[p6l176t2135r281b2161],
4	ofcirculating	VBG	O	ofcirculate	partmod	1	SENT_97	[p6l290t2135r465b2169],
5	tumor	NN	O	tumor	nn	6	SENT_97	[p6l474t2140r558b2161],
6	cells	NNS	O	cell	dobj	4	SENT_97	[p6l568t2135r625b2161],
7	per	IN	O	per	_	0	SENT_97	[p6l638t2144r680b2169],
8	milliliter	NN	O	milliliter	prep_per	6	SENT_97	[p6l691t2135r799b2161],
9	was	VBD	O	be	auxpass	10	SENT_97	[p6l808t2144r858b2161],
10	calculated	VBN	O	calculate	_	0	SENT_97	[p6l870t2135r1002b2161],
11	on	IN	O	on	_	0	SENT_97	[p6l1014t2144r1046b2161],
12	the	DT	O	the	det	16	SENT_97	[p6l1058t2135r1099b2161],
13	basis	NN	O	basis	nn	16	SENT_97	[p6l1111t2135r1177b2161],
14	ofthe	NN	O	ofthe	nn	16	SENT_97	[p6l1189t2135r1265b2161],
15	analysis	NN	O	analysis	nn	16	SENT_97	[p6l1276t2135r1380b2169],
16	ofl	NN	O	ofl	prep_on	10	SENT_97	[p6l1391t2135r1440b2161],
17	to	TO	O	to	_	0	SENT_97	[p6l1451t2140r1477b2161],
18	5	CD	NUMBER	5	num	21	SENT_97	[p6l1489t2138r1501b2161],
19	ml	NN	O	ml	nn	21	SENT_97	[p6l1515t2135r1545b2161],
20	ofwhole	NN	O	ofwhole	nn	21	SENT_97	[p6l1558t2135r1671b2161],
21	blood	NN	O	blood	prep_to	10	SENT_97	[p6l1683t2135r1756b2161],
22	per	IN	O	per	_	0	SENT_97	[p6l1769t2144r1811b2169],
23	patient	NN	O	patient	prep_per	21	SENT_97	[p6l1822t2138r1920b2169],
24	.	.	O	.	_	0	SENT_97	[p6l1822t2138r1920b2169],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_98	[p6l1934t2138r2040b2161],
2	are	VBP	O	be	auxpass	3	SENT_98	[p6l116t2181r156b2198],
3	listed	VBN	O	list	_	0	SENT_98	[p6l168t2172r239b2198],
4	in	IN	O	in	_	0	SENT_98	[p6l253t2175r274b2198],
5	the	DT	O	the	det	6	SENT_98	[p6l286t2172r329b2198],
6	order	NN	O	order	prep_in	3	SENT_98	[p6l340t2172r413b2198],
7	of	IN	O	of	_	0	SENT_98	[p6l423t2172r453b2198],
8	specimen	NN	O	specimen	nn	9	SENT_98	[p6l460t2175r589b2206],
9	collection	NN	O	collection	prep_of	6	SENT_98	[p6l602t2172r741b2198],
10	.	.	O	.	_	0	SENT_98	[p6l602t2172r741b2198],

1	Each	DT	O	each	det	3	SENT_99	[p6l755t2172r816b2198],
2	blood	NN	O	blood	nn	3	SENT_99	[p6l830t2172r904b2198],
3	sample	NN	O	sample	nsubjpass	5	SENT_99	[p6l918t2172r1015b2206],
4	was	VBD	O	be	auxpass	5	SENT_99	[p6l1026t2181r1077b2198],
5	processed	VBN	O	process	_	0	SENT_99	[p6l1090t2172r1226b2206],
6	once	RB	DATE	once	advmod	5	SENT_99	[p6l1239t2181r1303b2198],
7	through	IN	O	through	_	0	SENT_99	[p6l1314t2172r1421b2206],
8	the	DT	O	the	det	9	SENT_99	[p6l1433t2172r1475b2198],
9	CTC-chip	NN	O	ctc-chip	prep_through	5	SENT_99	[p6l1487t2172r1618b2206],
10	.	.	O	.	_	0	SENT_99	[p6l1487t2172r1618b2206],

1	There	EX	O	there	expl	2	SENT_100	[p6l1630t2172r1707b2198],
2	was	VBD	O	be	_	0	SENT_100	[p6l1717t2181r1768b2198],
3	no	DT	O	no	det	4	SENT_100	[p6l1782t2181r1814b2198],
4	correlation	NN	O	correlation	nsubj	2	SENT_100	[p6l1826t2172r1971b2198],
5	between	IN	O	between	_	0	SENT_100	[p6l1985t2172r2024b2198, p6l114t2214r194b2235],
6	the	DT	O	the	det	8	SENT_100	[p6l206t2209r248b2235],
7	tumor	NN	O	tumor	nn	8	SENT_100	[p6l258t2214r344b2235],
8	burden	NN	O	burden	prep_between	4	SENT_100	[p6l355t2209r449b2235],
9	and	CC	O	and	_	0	SENT_100	[p6l462t2209r510b2235],
10	the	DT	O	the	det	11	SENT_100	[p6l522t2209r565b2235],
11	number	NN	O	number	nsubj	15	SENT_100	[p6l578t2209r684b2235],
12	ofcirculating	VBG	O	ofcirculate	partmod	11	SENT_100	[p6l694t2209r873b2243],
13	tumor	NN	O	tumor	nn	14	SENT_100	[p6l883t2214r969b2235],
14	cells	NNS	O	cell	dobj	12	SENT_100	[p6l979t2209r1037b2235],
15	(	VBP	O	(	conj_and	2	SENT_100	[p6l1052t2211r1223b2243],
16	Spearman	NNP	PERSON	Spearman	poss	19	SENT_100	[p6l1052t2211r1223b2243],
17	’s	POS	O	’s	_	0	SENT_100	[p6l1052t2211r1223b2243],
18	correlation	NN	O	correlation	nn	19	SENT_100	[p6l1235t2209r1380b2235],
19	coefficient	NN	O	coefficient	dobj	15	SENT_100	[p6l1393t2209r1540b2239],
20	,	,	O	,	_	0	SENT_100	[p6l1393t2209r1540b2239],
21	-0.02	CD	NUMBER	-0.02	appos	19	SENT_100	[p6l1552t2211r1635b2239],
22	;	:	O	;	_	0	SENT_100	[p6l1552t2211r1635b2239],
23	P	NN	O	p	dep	19	SENT_100	[p6l1649t2211r1768b2243],
24	=	JJ	O	=	amod	26	SENT_100	[p6l1649t2211r1768b2243],
25	0.88	CD	NUMBER	0.88	tmod	24	SENT_100	[p6l1649t2211r1768b2243],
26	)	NN	O	)	dep	23	SENT_100	[p6l1649t2211r1768b2243],
27	.	.	O	.	_	0	SENT_100	[p6l1649t2211r1768b2243],

1	353	CD	NUMBER	353	num	4	SENT_101	[p6l91t2346r147b2370],
2	N	NN	O	n	nn	4	SENT_101	[p6l876t2357r890b2372],
3	ENGLJ	NN	O	englj	nn	4	SENT_101	[p6l904t2357r982b2379],
4	MED	NN	O	med	_	0	SENT_101	[p6l997t2357r1049b2372],
5	359	CD	NUMBER	359	num	7	SENT_101	[p6l1059t2357r1125b2379],
6	;	:	O	;	_	0	SENT_101	[p6l1059t2357r1125b2379],
7	4	CD	NUMBER	4	dep	4	SENT_101	[p6l1059t2357r1125b2379],
8	WWW.NEjM.oRG	NNP	O	WWW.NEjM.oRG	nn	9	SENT_101	[p6l1157t2357r1358b2379],
9	JULY	NNP	DATE	JULY	dep	4	SENT_101	[p6l1389t2357r1446b2379],
10	24	CD	DATE	24	num	9	SENT_101	[p6l1457t2357r1492b2379],
11	,	,	DATE	,	_	0	SENT_101	[p6l1457t2357r1492b2379],
12	2008	CD	DATE	2008	num	9	SENT_101	[p6l1504t2351r1567b2373],

1	The	DT	O	the	det	4	SENT_102	[p6l878t2414r929b2438],
2	New	NNP	O	New	nn	4	SENT_102	[p6l938t2415r1000b2438],
3	England	NNP	O	England	nn	4	SENT_102	[p6l1009t2414r1120b2445],
4	Journal	NNP	O	Journal	_	0	SENT_102	[p6l1128t2414r1226b2438],
5	of	IN	O	of	_	0	SENT_102	[p6l1235t2414r1264b2438],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_102	[p6l1271t2414r1396b2438],

1	Copyright	NN	O	copyright	_	0	SENT_103	[p6l670t2496r805b2527],
2	©	CD	NUMBER	©	num	6	SENT_103	[p6l814t2496r837b2520],
3	2008	CD	DATE	2008	num	6	SENT_103	[p6l847t2496r912b2520],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_103	[p6l922t2496r1113b2520],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_103	[p6l1123t2496r1231b2520],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_103	[p6l1241t2496r1346b2527],
7	.	.	O	.	_	0	SENT_103	[p6l1241t2496r1346b2527],

1	All	DT	O	all	det	2	SENT_104	[p6l1357t2496r1399b2520],
2	rights	NNS	O	rights	nsubj	3	SENT_104	[p6l1408t2496r1482b2527],
3	reserved	VBN	O	reserve	_	0	SENT_104	[p6l1492t2496r1611b2520],
4	.	.	O	.	_	0	SENT_104	[p6l1492t2496r1611b2520],

1	DETECTION	NN	O	detection	_	0	SENT_105	[p6l451t2602r641b2621],
2	OF	IN	O	of	_	0	SENT_105	[p6l657t2602r696b2621],
3	MUTATIONS	NNP	O	MUTATIONS	prep_of	1	SENT_105	[p6l710t2602r905b2621],
4	IN	IN	O	in	_	0	SENT_105	[p6l921t2602r958b2621],
5	EGFR	NN	O	egfr	prep_in	1	SENT_105	[p6l973t2602r1044b2621],
6	IN	IN	O	in	dep	1	SENT_105	[p6l1057t2602r1094b2621],
7	CIRCULATING	VBG	O	circulate	pcomp	6	SENT_105	[p6l1109t2602r1341b2621],
8	LUNG-CANCER	NN	O	lung-cancer	nn	9	SENT_105	[p6l1355t2602r1600b2621],
9	CELLS	NNS	O	cell	dobj	7	SENT_105	[p6l1612t2602r1708b2621],

1	of	IN	O	of	_	0	SENT_106	[p6l12t2815r112b2895],
2	ABI	NNP	O	ABI	pobj	1	SENT_106	[p6l123t2823r282b2894],
3	7500	CD	NUMBER	7500	num	2	SENT_106	[p6l315t2822r519b2895],
4	Real	NNP	O	Real	dep	2	SENT_106	[p6l551t2816r985b2900],
5	.	.	O	.	_	0	SENT_106	[p6l551t2816r985b2900],

1	—	NN	O	—	_	0	SENT_107	[p6l551t2816r985b2900],
2	.	.	O	.	_	0	SENT_107	[p6l551t2816r985b2900],

1	Time	NNP	MISC	Time	nn	6	SENT_108	[p6l551t2816r985b2900],
2	PCR	NN	MISC	pcr	nn	6	SENT_108	[p6l1017t2822r1209b2900],
3	System	NNP	MISC	System	nn	6	SENT_108	[p6l1234t2822r1533b2916],
4	(	NNP	O	(	nn	6	SENT_108	[p6l1571t2816r1928b2916],
5	Applied	NNP	O	Applied	nn	6	SENT_108	[p6l1571t2816r1928b2916],
6	Biosystems	NNP	O	Biosystems	_	0	SENT_108	[p6l1960t2817r2132b2895, p6l12t2952r380b3045],
7	)	NN	O	)	dep	6	SENT_108	[p6l1960t2817r2132b2895, p6l12t2952r380b3045],
8	.	.	O	.	_	0	SENT_108	[p6l1960t2817r2132b2895, p6l12t2952r380b3045],

1	The	DT	O	the	det	2	SENT_109	[p6l409t2945r566b3023],
2	assay	NN	O	assay	nsubj	3	SENT_109	[p6l592t2971r811b3045],
3	detects	VBZ	O	detect	_	0	SENT_109	[p6l835t2945r1119b3024],
4	grouped	VBN	O	group	dep	3	SENT_109	[p6l1148t2945r1492b3046],
5	deletions	NNS	O	deletion	nsubj	17	SENT_109	[p6l1520t2945r1889b3024],
6	Within	IN	DATE	within	_	0	SENT_109	[p6l1914t2945r2132b3024, p6l11t3073r91b3149],
7	exon	NN	DATE	exon	prep_within	17	SENT_109	[p6l124t3097r324b3150],
8	19	CD	DATE	19	num	7	SENT_109	[p6l361t3078r477b3167],
9	,	,	O	,	_	0	SENT_109	[p6l361t3078r477b3167],
10	insertions	NNS	O	insertion	prep_within	17	SENT_109	[p6l515t3073r946b3150],
11	within	IN	O	within	_	0	SENT_109	[p6l978t3072r1262b3151],
12	exon	NN	O	exon	prep_within	10	SENT_109	[p6l1297t3097r1497b3150],
13	20	CD	NUMBER	20	num	12	SENT_109	[p6l1531t3078r1653b3167],
14	,	,	O	,	_	0	SENT_109	[p6l1531t3078r1653b3167],
15	and	CC	O	and	_	0	SENT_109	[p6l1691t3072r1849b3150],
16	mutations	NNS	O	mutation	conj_and	7	SENT_109	[p6l1883t3088r2132b3151, p6l12t3201r223b3279],
17	affecting	VBG	O	affect	dep	4	SENT_109	[p6l257t3199r646b3301],
18	codon	NN	O	codon	dobj	17	SENT_109	[p6l675t3200r937b3279],
19	719	CD	NUMBER	719	number	20	SENT_109	[p6l971t3206r1120b3279],
20	(	CD	NUMBER	(	num	22	SENT_109	[p6l1158t3206r1519b3296],
21	G719X	NN	O	g719x	nn	22	SENT_109	[p6l1158t3206r1519b3296],
22	)	NN	O	)	dep	18	SENT_109	[p6l1158t3206r1519b3296],
23	,	,	O	,	_	0	SENT_109	[p6l1158t3206r1519b3296],
24	as	IN	O	as	_	0	SENT_109	[p6l1556t3226r1641b3278],
25	Well	NNP	O	Well	prep_as	18	SENT_109	[p6l1671t3200r1849b3279],
26	as	IN	O	as	_	0	SENT_109	[p6l1880t3226r1965b3278],
27	the	DT	O	the	det	30	SENT_109	[p6l2001t3200r2133b3278],
28	individual	JJ	O	individual	amod	30	SENT_109	[p6l11t3328r442b3407],
29	mutations	NNS	O	mutation	nn	30	SENT_109	[p6l475t3329r909b3407],
30	T79OM	NN	O	t79om	prep_as	4	SENT_109	[p6l941t3334r1268b3424],
31	,	,	O	,	_	0	SENT_109	[p6l941t3334r1268b3424],
32	L858R	NN	O	l858r	dobj	4	SENT_109	[p6l1306t3334r1600b3424],
33	,	,	O	,	_	0	SENT_109	[p6l1306t3334r1600b3424],
34	L861Q	NN	O	l861q	dobj	4	SENT_109	[p6l1637t3334r1938b3426],
35	,	,	O	,	_	0	SENT_109	[p6l1637t3334r1938b3426],
36	and	CC	O	and	_	0	SENT_109	[p6l1976t3328r2134b3407],
37	S7681	NN	O	s7681	dobj	4	SENT_109	[p6l13t3461r265b3534],
38	.	.	O	.	_	0	SENT_109	[p6l13t3461r265b3534],

1	The	DT	O	the	det	2	SENT_110	[p6l305t3455r465b3533],
2	rate	NN	O	rate	nsubjpass	10	SENT_110	[p6l503t3472r664b3533],
3	of	IN	O	of	_	0	SENT_110	[p6l702t3454r802b3534],
4	amplification	NN	O	amplification	prep_of	2	SENT_110	[p6l821t3454r1405b3555],
5	of	IN	O	of	_	0	SENT_110	[p6l1444t3454r1543b3534],
6	these	DT	O	these	det	8	SENT_110	[p6l1563t3455r1787b3533],
7	mutant	JJ	O	mutant	amod	8	SENT_110	[p6l1825t3472r2138b3535],
8	alleles	NNS	O	allele	prep_of	4	SENT_110	[p6l11t3583r276b3661],
9	was	VBD	O	be	auxpass	10	SENT_110	[p6l306t3609r468b3663],
10	compared	VBN	O	compare	_	0	SENT_110	[p6l503t3583r929b3683],
11	with	IN	O	with	_	0	SENT_110	[p6l956t3583r1152b3663],
12	that	DT	O	that	prep_with	10	SENT_110	[p6l1184t3583r1356b3661],
13	of	IN	O	of	_	0	SENT_110	[p6l1384t3582r1484b3662],
14	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_110	[p6l1496t3590r1708b3663],
15	exon	NN	O	exon	prep_of	12	SENT_110	[p6l1734t3609r1934b3662],
16	2	CD	NUMBER	2	num	15	SENT_110	[p6l1966t3589r2013b3661],
17	as	IN	O	as	_	0	SENT_110	[p6l2046t3609r2131b3661],
18	an	DT	O	a	det	20	SENT_110	[p6l11t3739r113b3791],
19	internal	JJ	O	internal	amod	20	SENT_110	[p6l142t3713r482b3791],
20	control	NN	O	control	prep_as	10	SENT_110	[p6l512t3713r840b3792],
21	.	.	O	.	_	0	SENT_110	[p6l512t3713r840b3792],

1	Standard	NNP	O	Standard	_	0	SENT_111	[p6l879t3713r1265b3792],
2	bidirectional	JJ	O	bidirectional	amod	3	SENT_111	[p6l1295t3713r1844b3792],
3	nucleotide	NN	O	nucleotide	dep	1	SENT_111	[p6l1873t3713r2132b3792, p7l12t35r224b114],

1	sequencing	NN	O	sequencing	nsubjpass	3	SENT_112	[p7l264t36r749b136],
2	was	VBD	O	be	auxpass	3	SENT_112	[p7l779t61r941b114],
3	performed	VBN	O	perform	_	0	SENT_112	[p7l980t34r1436b135],
4	with	IN	O	with	_	0	SENT_112	[p7l1469t35r1665b114],
5	the	DT	O	the	det	6	SENT_112	[p7l1703t35r1835b114],
6	use	NN	O	use	prep_with	3	SENT_112	[p7l1873t61r2014b114],
7	of	IN	O	of	_	0	SENT_112	[p7l2052t34r2152b114],
8	dye	VB	O	dye	prepc_of	6	SENT_112	[p7l12t163r148b262],
9	terminator	JJ	O	terminator	amod	10	SENT_112	[p7l176t164r633b241],
10	chemistry	NN	O	chemistry	nsubj	20	SENT_112	[p7l658t163r1078b262],
11	and	CC	O	and	_	0	SENT_112	[p7l1100t163r1256b241],
12	a	DT	O	a	det	14	SENT_112	[p7l1281t189r1325b241],
13	Capillary	JJ	O	capillary	amod	14	SENT_112	[p7l1351t163r1734b262],
14	ABI	NN	O	abus	conj_and	10	SENT_112	[p7l1752t169r1910b241],
15	3100	CD	NUMBER	3100	num	16	SENT_112	[p7l1936t169r2133b242],
16	sequencer	NN	O	sequencer	dep	14	SENT_112	[p7l12t317r440b390],
17	(	CD	NUMBER	(	num	20	SENT_112	[p7l476t291r834b390],
18	Applied	NNP	O	Applied	nn	20	SENT_112	[p7l476t291r834b390],
19	Biosystems	NNP	O	Biosystems	nn	20	SENT_112	[p7l866t292r1396b390],
20	)	NN	O	)	xcomp	8	SENT_112	[p7l866t292r1396b390],
21	.	.	O	.	_	0	SENT_112	[p7l866t292r1396b390],

1	STATISTICAL	JJ	O	statistical	amod	2	SENT_113	[p7l11t565r500b615],
2	ANALYSIS	NN	O	analysis	nsubjpass	16	SENT_113	[p7l530t565r905b615],
3	The	DT	O	the	det	4	SENT_113	[p7l7t673r168b751],
4	relationship	NN	O	relationship	npadvmod	2	SENT_113	[p7l214t673r729b773],
5	between	IN	O	between	_	0	SENT_113	[p7l777t673r1136b752],
6	the	DT	O	the	det	7	SENT_113	[p7l1182t673r1314b751],
7	quantity	NN	O	quantity	prep_between	2	SENT_113	[p7l1362t674r1721b773],
8	of	IN	O	of	_	0	SENT_113	[p7l1764t672r1863b751],
9	circulating	VBG	O	circulate	prepc_of	7	SENT_113	[p7l1892t674r2132b752, p7l10t801r262b902],
10	tumor	NN	O	tumor	nn	11	SENT_113	[p7l309t817r577b880],
11	cells	NNS	O	cell	dobj	9	SENT_113	[p7l625t801r812b879],
12	and	CC	O	and	_	0	SENT_113	[p7l863t801r1021b879],
13	tumor	NN	O	tumor	nn	14	SENT_113	[p7l1071t817r1339b880],
14	burden	NN	O	burden	conj_and	11	SENT_113	[p7l1387t801r1689b880],
15	was	VBD	O	be	auxpass	16	SENT_113	[p7l1735t827r1897b880],
16	analyzed	VBN	O	analyze	_	0	SENT_113	[p7l1949t826r2132b879, p7l10t929r230b1029],
17	with	IN	O	with	_	0	SENT_113	[p7l262t929r457b1008],
18	the	DT	O	the	det	19	SENT_113	[p7l495t929r627b1007],
19	use	NN	O	use	prep_with	16	SENT_113	[p7l664t955r804b1008],
20	of	IN	O	of	_	0	SENT_113	[p7l842t928r941b1007],
21	Spearman	NNP	PERSON	Spearman	poss	24	SENT_113	[p7l962t934r1457b1029],
22	’s	POS	O	’s	_	0	SENT_113	[p7l962t934r1457b1029],
23	correlation	NN	O	correlation	nn	24	SENT_113	[p7l1497t929r1966b1007],
24	coefficient	NN	O	coefficient	prep_of	19	SENT_113	[p7l2003t954r2132b1007, p7l12t1056r392b1135],
25	.	.	O	.	_	0	SENT_113	[p7l2003t954r2132b1007, p7l12t1056r392b1135],

1	Fisher	NNP	PERSON	Fisher	poss	4	SENT_114	[p7l429t1057r754b1135],
2	’s	POS	O	’s	_	0	SENT_114	[p7l429t1057r754b1135],
3	exact	JJ	O	exact	amod	4	SENT_114	[p7l790t1074r1010b1135],
4	test	NN	O	test	nsubjpass	6	SENT_114	[p7l1039t1073r1193b1135],
5	was	VBD	O	be	auxpass	6	SENT_114	[p7l1217t1083r1380b1136],
6	used	VBN	O	use	_	0	SENT_114	[p7l1415t1057r1612b1136],
7	to	TO	O	to	aux	8	SENT_114	[p7l1646t1074r1728b1135],
8	compare	VB	O	compare	xcomp	6	SENT_114	[p7l1763t1082r2133b1157],
9	mutations	NNS	O	mutation	dobj	8	SENT_114	[p7l11t1186r445b1264],
10	that	WDT	O	that	nsubjpass	12	SENT_114	[p7l482t1185r654b1263],
11	were	VBD	O	be	auxpass	12	SENT_114	[p7l678t1211r879b1264],
12	identified	VBN	O	identify	rcmod	9	SENT_114	[p7l912t1184r1329b1263],
13	in	IN	O	in	_	0	SENT_114	[p7l1362t1186r1446b1262],
14	different	JJ	O	different	amod	15	SENT_114	[p7l1480t1184r1857b1263],
15	populations	NNS	O	population	prep_in	12	SENT_114	[p7l1884t1210r2132b1285, p7l10t1313r323b1390],
16	.	.	O	.	_	0	SENT_114	[p7l1884t1210r2132b1285, p7l10t1313r323b1390],

1	The	DT	O	the	det	2	SENT_115	[p7l362t1313r523b1390],
2	relationship	NN	O	relationship	nsubjpass	35	SENT_115	[p7l559t1313r1074b1412],
3	between	IN	O	between	_	0	SENT_115	[p7l1111t1313r1469b1392],
4	patients	NNS	O	patient	prep_between	2	SENT_115	[p7l1503t1314r1868b1412],
5	’	RB	O	’	advmod	8	SENT_115	[p7l1503t1314r1868b1412],
6	baseline	NN	O	baseline	nn	8	SENT_115	[p7l1909t1313r2132b1390, p7l10t1441r169b1519],
7	T79OM	NN	O	t79om	nn	8	SENT_115	[p7l208t1446r510b1519],
8	status	NN	O	status	rcmod	4	SENT_115	[p7l555t1457r807b1520],
9	and	CC	O	and	_	0	SENT_115	[p7l851t1441r1009b1519],
10	progression	NN	O	progression	rcmod	4	SENT_115	[p7l1049t1440r1758b1542],
11	—	CD	NUMBER	—	num	13	SENT_115	[p7l1049t1440r1758b1542],
12	free	JJ	O	free	amod	13	SENT_115	[p7l1049t1440r1758b1542],
13	survival	NN	O	survival	dep	4	SENT_115	[p7l1802t1441r2134b1520],
14	(	IN	O	(	_	0	SENT_115	[p7l16t1569r173b1660],
15	the	DT	O	the	det	16	SENT_115	[p7l16t1569r173b1660],
16	time	NN	O	time	prep_(	13	SENT_115	[p7l204t1570r397b1647],
17	between	IN	O	between	_	0	SENT_115	[p7l429t1569r786b1648],
18	the	DT	O	the	det	19	SENT_115	[p7l817t1569r950b1647],
19	initiation	NN	O	initiation	prep_between	16	SENT_115	[p7l980t1570r1379b1647],
20	of	IN	O	of	_	0	SENT_115	[p7l1410t1568r1510b1647],
21	therapy	NN	O	therapy	prep_of	19	SENT_115	[p7l1523t1569r1844b1669],
22	with	IN	O	with	_	0	SENT_115	[p7l1866t1569r2061b1648],
23	a	DT	O	a	det	26	SENT_115	[p7l2091t1595r2135b1647],
24	tyrosine	NN	O	tyrosine	nn	26	SENT_115	[p7l12t1697r358b1796],
25	kinase	NN	O	kinase	nn	26	SENT_115	[p7l403t1697r682b1776],
26	inhibitor	NN	O	inhibitor	prep_with	21	SENT_115	[p7l727t1697r1109b1774],
27	and	CC	O	and	_	0	SENT_115	[p7l1151t1697r1309b1774],
28	either	CC	O	either	preconj	30	SENT_115	[p7l1355t1697r1602b1774],
29	tumor	NN	O	tumor	nn	30	SENT_115	[p7l1645t1713r1912b1776],
30	progression	NN	O	progression	prep_between	2	SENT_115	[p7l1954t1722r2132b1796, p7l11t1825r374b1926],
31	or	CC	O	or	_	0	SENT_115	[p7l427t1850r515b1903],
32	death	NN	O	death	nn	33	SENT_115	[p7l567t1825r829b1916],
33	)	NN	O	)	conj_or	30	SENT_115	[p7l567t1825r829b1916],
34	was	VBD	O	be	auxpass	35	SENT_115	[p7l883t1851r1046b1904],
35	analyzed	VBN	O	analyze	_	0	SENT_115	[p7l1101t1825r1480b1925],
36	with	IN	O	with	_	0	SENT_115	[p7l1528t1825r1723b1904],
37	a	DT	O	a	det	40	SENT_115	[p7l1775t1851r1820b1903],
38	multivariate	JJ	O	multivariate	amod	40	SENT_115	[p7l1872t1825r2132b1904, p7l7t1954r294b2031],
39	Cox	NN	ORGANIZATION	cox	nn	40	SENT_115	[p7l329t1958r493b2030],
40	model	NN	O	model	prep_with	35	SENT_115	[p7l526t1953r794b2030],
41	and	CC	O	and	_	0	SENT_115	[p7l828t1953r986b2030],
42	the	DT	O	the	det	43	SENT_115	[p7l1022t1953r1153b2030],
43	Kaplan	NNP	PERSON	Kaplan	prep_with	35	SENT_115	[p7l1186t1953r1777b2052],
44	.	.	O	.	_	0	SENT_115	[p7l1186t1953r1777b2052],

1	—	NN	O	—	_	0	SENT_116	[p7l1186t1953r1777b2052],
2	.	.	O	.	_	0	SENT_116	[p7l1186t1953r1777b2052],

1	Meier	JJR	PERSON	meier	amod	2	SENT_117	[p7l1186t1953r1777b2052],
2	method	NN	O	method	nsubj	14	SENT_117	[p7l1807t1953r2133b2030],
3	with	IN	O	with	_	0	SENT_117	[p7l7t2081r199b2160],
4	a	DT	O	a	det	7	SENT_117	[p7l240t2107r285b2159],
5	log	NN	O	log	nn	7	SENT_117	[p7l324t2081r687b2182],
6	—	CD	NUMBER	—	num	7	SENT_117	[p7l324t2081r687b2182],
7	ranl	NN	O	ranl	prep_with	2	SENT_117	[p7l324t2081r687b2182],
8	<	JJR	O	<	amod	10	SENT_117	[p7l324t2081r687b2182],
9	test	NN	O	test	nn	10	SENT_117	[p7l724t2097r875b2159],
10	(	NN	O	(	dep	2	SENT_117	[p7l918t2080r1063b2172],
11	for	IN	O	for	_	0	SENT_117	[p7l918t2080r1063b2172],
12	details	NNS	O	detail	prep_for	10	SENT_117	[p7l1103t2081r1410b2176],
13	,	,	O	,	_	0	SENT_117	[p7l1103t2081r1410b2176],
14	see	VBP	O	see	_	0	SENT_117	[p7l1462t2107r1592b2159],
15	the	DT	O	the	det	18	SENT_117	[p7l1637t2081r1769b2159],
16	Supplementary	NNP	O	Supplementary	nn	18	SENT_117	[p7l1816t2081r2132b2181, p7l11t2225r371b2308],
17	Appendix	NNP	O	Appendix	nn	18	SENT_117	[p7l398t2209r863b2308],
18	)	NN	O	)	dobj	14	SENT_117	[p7l398t2209r863b2308],
19	.	.	O	.	_	0	SENT_117	[p7l398t2209r863b2308],

1	RESULTS	NNS	O	result	_	0	SENT_118	[p7l835t2498r1310b2557],

1	IDENTIFICATION	NN	O	identification	_	0	SENT_119	[p7l17t2725r666b2775],
2	or	CC	O	or	_	0	SENT_119	[p7l707t2726r810b2775],
3	CIRCULATING	VBG	O	circulate	conj_or	1	SENT_119	[p7l844t2725r1377b2775],
4	TUMOR	NN	O	tumor	nn	5	SENT_119	[p7l1411t2726r1701b2775],
5	CELLS	NNS	O	cell	dobj	3	SENT_119	[p7l1735t2726r1963b2775],
6	Blood	NN	O	blood	nn	7	SENT_119	[p7l10t2823r259b2902],
7	samples	NNS	O	sample	nsubjpass	9	SENT_119	[p7l310t2823r654b2923],
8	were	VBD	O	be	auxpass	9	SENT_119	[p7l701t2849r903b2903],
9	obtained	VBN	O	obtain	rcmod	5	SENT_119	[p7l954t2823r1332b2902],
10	from	IN	O	from	_	0	SENT_119	[p7l1381t2822r1591b2902],
11	23	CD	NUMBER	23	num	12	SENT_119	[p7l1640t2829r1738b2902],
12	patients	NNS	O	patient	prep_from	9	SENT_119	[p7l1789t2824r2130b2923],
13	with	IN	O	with	_	0	SENT_119	[p7l7t2952r195b3031],
14	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_119	[p7l219t2958r425b3032],
15	mutant	JJ	O	mutant	amod	16	SENT_119	[p7l444t2969r746b3031],
16	tumors	NNS	O	tumor	prep_with	9	SENT_119	[p7l767t2969r1086b3048],
17	,	,	O	,	_	0	SENT_119	[p7l767t2969r1086b3048],
18	including	VBG	O	include	_	0	SENT_119	[p7l1116t2952r1510b3053],
19	5	CD	NUMBER	5	num	20	SENT_119	[p7l1534t2960r1577b3031],
20	patients	NNS	O	patient	prep_including	9	SENT_119	[p7l1604t2953r1930b3052],
21	who	WP	O	who	nsubj	23	SENT_119	[p7l1953t2952r2132b3031],
22	had	VBD	O	have	aux	23	SENT_119	[p7l11t3080r166b3159],
23	undergone	VBN	O	undergo	rcmod	20	SENT_119	[p7l196t3080r647b3181],
24	no	DT	O	no	det	26	SENT_119	[p7l678t3106r782b3159],
25	previous	JJ	O	previous	amod	26	SENT_119	[p7l813t3081r1168b3180],
26	treatment	NN	O	treatment	dobj	23	SENT_119	[p7l1201t3097r1636b3176],
27	,	,	O	,	_	0	SENT_119	[p7l1201t3097r1636b3176],
28	10	CD	NUMBER	10	num	29	SENT_119	[p7l1676t3086r1768b3159],
29	patients	NNS	O	patient	conj_and	20	SENT_119	[p7l1798t3081r2132b3180],
30	who	WP	O	who	nsubjpass	34	SENT_119	[p7l7t3208r189b3287],
31	had	VBD	O	have	aux	34	SENT_119	[p7l220t3208r376b3286],
32	previously	RB	DATE	previously	advmod	34	SENT_119	[p7l404t3208r844b3307],
33	been	VBN	O	be	auxpass	34	SENT_119	[p7l870t3208r1071b3286],
34	treated	VBN	O	treat	rcmod	29	SENT_119	[p7l1101t3208r1399b3286],
35	with	IN	O	with	_	0	SENT_119	[p7l1424t3208r1619b3287],
36	erlotinib	NN	O	erlotinib	prep_with	34	SENT_119	[p7l1649t3208r2016b3286],
37	or	CC	O	or	_	0	SENT_119	[p7l2048t3234r2137b3286],
38	gefitinib	NN	O	gefitinib	conj_or	36	SENT_119	[p7l11t3335r404b3437],
39	,	,	O	,	_	0	SENT_119	[p7l11t3335r404b3437],
40	and	CC	O	and	_	0	SENT_119	[p7l439t3336r597b3415],
41	8	CD	NUMBER	8	num	42	SENT_119	[p7l626t3342r672b3415],
42	patients	NNS	O	patient	prep_including	9	SENT_119	[p7l702t3337r1043b3436],
43	who	WP	O	who	nsubjpass	47	SENT_119	[p7l1070t3336r1253b3415],
44	had	VBD	O	have	aux	47	SENT_119	[p7l1283t3336r1440b3415],
45	previously	RB	DATE	previously	advmod	47	SENT_119	[p7l1467t3336r1907b3436],
46	been	VBN	O	be	auxpass	47	SENT_119	[p7l1932t3336r2133b3415],
47	treated	VBN	O	treat	rcmod	42	SENT_119	[p7l12t3464r310b3543],
48	with	IN	O	with	_	0	SENT_119	[p7l335t3464r530b3543],
49	another	DT	O	another	det	51	SENT_119	[p7l559t3464r895b3543],
50	chemotherapy	NN	O	chemotherapy	nn	51	SENT_119	[p7l922t3464r1533b3564],
51	agent	NN	O	agent	prep_with	47	SENT_119	[p7l1557t3481r1794b3565],
52	or	CC	O	or	_	0	SENT_119	[p7l1819t3490r1908b3543],
53	multiple	JJ	O	multiple	amod	54	SENT_119	[p7l1934t3464r2132b3543, p7l12t3592r192b3692],
54	regimens	NNS	O	regimen	prep_with	47	SENT_119	[p7l226t3593r640b3693],
55	,	,	O	,	_	0	SENT_119	[p7l226t3593r640b3693],
56	including	VBG	O	include	_	0	SENT_119	[p7l679t3592r1081b3693],
57	both	DT	O	both	det	60	SENT_119	[p7l1112t3592r1306b3671],
58	tyrosine	NN	O	tyrosine	nn	60	SENT_119	[p7l1340t3593r1679b3692],
59	kinase	NN	O	kinase	nn	60	SENT_119	[p7l1712t3592r1986b3671],
60	inhibitors	NNS	O	inhibitor	prep_including	20	SENT_119	[p7l2019t3593r2132b3670, p8l11t20r335b98],

1	and	CC	O	and	_	0	SENT_120	[p8l383t20r539b98],
2	chemotherapy	NN	O	chemotherapy	dep	1	SENT_120	[p8l586t20r1196b119],
3	.	.	O	.	_	0	SENT_120	[p8l586t20r1196b119],

1	Four	CD	NUMBER	four	num	2	SENT_121	[p8l1247t27r1443b99],
2	patients	NNS	O	patient	nsubjpass	12	SENT_121	[p8l1485t21r1819b119],
3	Whose	WP$	O	whose	poss	4	SENT_121	[p8l1863t20r2133b99],
4	tumors	NNS	O	tumor	nsubj	5	SENT_121	[p8l12t165r319b227],
5	had	VBD	O	have	rcmod	2	SENT_121	[p8l367t148r523b226],
6	Wild	NNP	O	Wild	nsubj	9	SENT_121	[p8l564t148r970b247],
7	—	CD	NUMBER	—	num	9	SENT_121	[p8l564t148r970b247],
8	type	NN	O	type	nn	9	SENT_121	[p8l564t148r970b247],
9	EGFR	NN	ORGANIZATION	egfr	xcomp	5	SENT_121	[p8l1014t154r1226b227],
10	were	VBD	O	be	auxpass	12	SENT_121	[p8l1261t174r1462b227],
11	also	RB	O	also	advmod	12	SENT_121	[p8l1507t148r1679b226],
12	analyzed	VBN	O	analyze	_	0	SENT_121	[p8l1725t148r2128b247],
13	.	.	O	.	_	0	SENT_121	[p8l1725t148r2128b247],

1	(	NN	O	(	nn	2	SENT_122	[p8l16t283r105b367],
2	A	NN	O	a	_	0	SENT_122	[p8l16t283r105b367],
3	schematic	JJ	O	schematic	amod	4	SENT_122	[p8l138t276r568b354],
4	depiction	NN	O	depiction	nsubjpass	22	SENT_122	[p8l603t276r1001b376],
5	of	IN	O	of	_	0	SENT_122	[p8l1036t275r1136b355],
6	the	DT	O	the	det	7	SENT_122	[p8l1152t276r1284b354],
7	strategy	NN	O	strategy	prep_of	4	SENT_122	[p8l1320t293r1665b377],
8	for	IN	O	for	_	0	SENT_122	[p8l1694t275r1817b355],
9	microfluidic	JJ	O	microfluidic	amod	10	SENT_122	[p8l1848t277r2132b355, p8l11t403r291b483],
10	isolation	NN	O	isolation	prep_for	7	SENT_122	[p8l341t404r714b483],
11	of	IN	O	of	_	0	SENT_122	[p8l768t403r867b483],
12	circulating	VBG	O	circulate	prepc_of	10	SENT_122	[p8l902t404r1369b505],
13	tumor	NN	O	tumor	nn	14	SENT_122	[p8l1418t421r1685b483],
14	cells	NNS	O	cell	dobj	12	SENT_122	[p8l1735t404r1922b482],
15	and	CC	O	and	_	0	SENT_122	[p8l1976t404r2134b483],
16	representative	JJ	O	representative	amod	17	SENT_122	[p8l11t533r612b632],
17	images	NNS	O	image	prep_for	7	SENT_122	[p8l637t533r942b633],
18	of	IN	O	of	_	0	SENT_122	[p8l970t531r1070b611],
19	captured	VBN	O	capture	amod	20	SENT_122	[p8l1079t532r1455b632],
20	cells	NNS	O	cell	prep_of	17	SENT_122	[p8l1481t532r1668b610],
21	are	VBP	O	be	auxpass	22	SENT_122	[p8l1695t558r1824b610],
22	shown	VBN	O	show	rcmod	2	SENT_122	[p8l1851t532r2133b611],
23	in	IN	O	in	_	0	SENT_122	[p8l11t661r94b738],
24	Figure	NNP	O	Figure	prep_in	22	SENT_122	[p8l127t661r404b761],
25	1	CD	NUMBER	1	num	24	SENT_122	[p8l445t666r489b738],
26	in	IN	O	in	_	0	SENT_122	[p8l525t661r608b738],
27	the	DT	O	the	det	31	SENT_122	[p8l643t660r776b738],
28	Supplementary	NNP	O	Supplementary	nn	31	SENT_122	[p8l813t660r1460b760],
29	Appendix	NNP	O	Appendix	nn	31	SENT_122	[p8l1486t660r1952b760],
30	.	.	O	.	_	0	SENT_122	[p8l1486t660r1952b760],
31	)	NN	O	)	prep_in	22	SENT_122	[p8l1486t660r1952b760],

1	Circulating	VBG	O	circulate	amod	3	SENT_123	[p8l140t788r626b889],
2	tumor	NN	O	tumor	nn	3	SENT_123	[p8l666t805r933b867],
3	cells	NNS	O	cell	nsubjpass	5	SENT_123	[p8l974t788r1161b867],
4	were	VBD	O	be	auxpass	5	SENT_123	[p8l1201t814r1403b867],
5	identified	VBN	O	identify	conj_or	5	SENT_123	[p8l1445t787r1862b867],
6	in	IN	O	in	_	0	SENT_123	[p8l1904t789r1987b866],
7	all	DT	O	all	det	8	SENT_123	[p8l2029t788r2134b866],
8	patients	NNS	O	patient	prep_in	5	SENT_123	[p8l9t916r376b1015],
9	,	,	O	,	_	0	SENT_123	[p8l9t916r376b1015],
10	with	IN	O	with	_	0	SENT_123	[p8l416t915r611b995],
11	a	DT	O	a	det	12	SENT_123	[p8l650t941r694b993],
12	median	NN	O	median	prep_with	8	SENT_123	[p8l732t915r1056b994],
13	of	IN	O	of	_	0	SENT_123	[p8l1095t914r1195b994],
14	74	CD	NUMBER	74	num	15	SENT_123	[p8l1218t922r1310b994],
15	cells	NNS	O	cell	prep_of	12	SENT_123	[p8l1350t915r1537b993],
16	per	IN	O	per	_	0	SENT_123	[p8l1577t941r1717b1015],
17	milliliter	NN	O	milliliter	nn	19	SENT_123	[p8l1753t915r2137b993],
18	(	CD	NUMBER	(	num	19	SENT_123	[p8l16t1051r296b1140],
19	mean	NN	O	mean	prep_per	15	SENT_123	[p8l16t1051r296b1140],
20	,	,	O	,	_	0	SENT_123	[p8l16t1051r296b1140],
21	133	CD	NUMBER	133	appos	19	SENT_123	[p8l340t1050r507b1140],
22	;	:	O	;	_	0	SENT_123	[p8l340t1050r507b1140],
23	range	NN	O	range	dep	21	SENT_123	[p8l545t1070r803b1145],
24	,	,	O	,	_	0	SENT_123	[p8l545t1070r803b1145],
25	5	CD	NUMBER	5	number	28	SENT_123	[p8l845t1052r887b1123],
26	to	TO	O	to	dep	28	SENT_123	[p8l925t1061r1006b1123],
27	771	CD	NUMBER	771	number	28	SENT_123	[p8l1042t1050r1238b1140],
28	)	CD	NUMBER	)	appos	23	SENT_123	[p8l1042t1050r1238b1140],
29	,	,	O	,	_	0	SENT_123	[p8l1042t1050r1238b1140],
30	with	IN	O	with	_	0	SENT_123	[p8l1273t1044r1465b1123],
31	a	DT	O	a	det	33	SENT_123	[p8l1499t1070r1543b1122],
32	similar	JJ	O	similar	amod	33	SENT_123	[p8l1578t1044r1877b1122],
33	number	NN	O	number	prep_with	5	SENT_123	[p8l1908t1070r2132b1123, p8l12t1172r149b1250],
34	in	IN	O	in	_	0	SENT_123	[p8l186t1173r269b1249],
35	patients	NNS	O	patient	prep_in	33	SENT_123	[p8l309t1173r650b1271],
36	with	IN	O	with	_	0	SENT_123	[p8l688t1172r883b1251],
37	or	CC	O	or	_	0	SENT_123	[p8l924t1198r1013b1250],
38	without	IN	O	without	_	0	SENT_123	[p8l1046t1172r1386b1251],
39	EGFR	NN	ORGANIZATION	egfr	nn	41	SENT_123	[p8l1419t1178r1632b1251],
40	mutant	JJ	O	mutant	amod	41	SENT_123	[p8l1666t1188r1980b1251],
41	tumors	NNS	O	tumor	prep_without	5	SENT_123	[p8l2016t1188r2132b1251, p8l11t1326r227b1379],
42	(	VBP	O	(	_	0	SENT_123	[p8l266t1300r528b1391],
43	Table	NNP	O	Table	dobj	42	SENT_123	[p8l266t1300r528b1391],
44	1	CD	NUMBER	1	num	43	SENT_123	[p8l567t1306r662b1391],
45	)	CD	NUMBER	)	nsubj	42	SENT_123	[p8l567t1306r662b1391],
46	.	.	O	.	_	0	SENT_123	[p8l567t1306r662b1391],

1	The	DT	O	the	det	2	SENT_124	[p8l697t1300r857b1378],
2	number	NN	O	number	nsubj	23	SENT_124	[p8l889t1300r1227b1379],
3	of	IN	O	of	_	0	SENT_124	[p8l1258t1299r1358b1379],
4	circulating	VBG	O	circulate	prepc_of	2	SENT_124	[p8l1373t1300r1839b1401],
5	tumor	NN	O	tumor	nn	6	SENT_124	[p8l1869t1317r2137b1379],
6	cells	NNS	O	cell	dobj	4	SENT_124	[p8l12t1427r190b1505],
7	that	WDT	O	that	nsubjpass	9	SENT_124	[p8l226t1427r393b1505],
8	were	VBD	O	be	auxpass	9	SENT_124	[p8l417t1453r612b1507],
9	isolated	VBN	O	isolate	rcmod	6	SENT_124	[p8l646t1427r965b1506],
10	from	IN	O	from	_	0	SENT_124	[p8l999t1426r1203b1506],
11	this	DT	O	this	det	12	SENT_124	[p8l1237t1427r1390b1505],
12	series	NN	O	series	prep_from	9	SENT_124	[p8l1428t1428r1656b1505],
13	of	IN	O	of	_	0	SENT_124	[p8l1693t1426r1791b1506],
14	patients	NNS	O	patient	prep_of	12	SENT_124	[p8l1805t1428r2131b1527],
15	with	IN	O	with	_	0	SENT_124	[p8l7t1556r195b1635],
16	lung	NN	O	lung	nn	17	SENT_124	[p8l223t1556r410b1657],
17	cancers	NNS	O	cancer	prep_with	9	SENT_124	[p8l435t1582r743b1634],
18	enriched	VBN	O	enrich	partmod	17	SENT_124	[p8l774t1556r1131b1635],
19	for	IN	O	for	_	0	SENT_124	[p8l1159t1555r1278b1635],
20	EGFR	NN	ORGANIZATION	egfr	nn	21	SENT_124	[p8l1302t1563r1507b1636],
21	mutations	NNS	O	mutation	prep_for	18	SENT_124	[p8l1530t1557r1947b1635],
22	was	VBD	O	be	cop	23	SENT_124	[p8l1973t1582r2131b1635],
23	similar	JJ	O	similar	_	0	SENT_124	[p8l12t1683r313b1761],
24	to	TO	O	to	_	0	SENT_124	[p8l341t1700r421b1762],
25	that	DT	O	that	prep_to	23	SENT_124	[p8l453t1683r622b1761],
26	from	IN	O	from	_	0	SENT_124	[p8l648t1682r855b1762],
27	patients	NNS	O	patient	prep_from	25	SENT_124	[p8l884t1684r1218b1783],
28	with	IN	O	with	_	0	SENT_124	[p8l1246t1683r1438b1763],
29	other	JJ	O	other	amod	30	SENT_124	[p8l1469t1683r1692b1762],
30	cancers	NNS	O	cancer	prep_with	23	SENT_124	[p8l1721t1688r2134b1762],
31	.	.	O	.	_	0	SENT_124	[p8l1721t1688r2134b1762],

1	“	NN	O	“	_	0	SENT_125	[p8l1721t1688r2134b1762],
2	The	DT	O	the	det	4	SENT_125	[p8l7t1812r166b1891],
3	tumor	NN	O	tumor	nn	4	SENT_125	[p8l199t1829r463b1891],
4	burden	NN	O	burden	nsubj	34	SENT_125	[p8l493t1812r790b1891],
5	on	IN	O	on	_	0	SENT_125	[p8l824t1838r928b1891],
6	matched	VBN	O	match	amod	8	SENT_125	[p8l961t1812r1324b1891],
7	radiographic	JJ	O	radiographic	amod	8	SENT_125	[p8l1356t1812r1894b1913],
8	measurements	NNS	O	measurement	prep_on	4	SENT_125	[p8l1926t1838r2132b1890, p8l12t1956r455b2018],
9	that	WDT	O	that	nsubjpass	11	SENT_125	[p8l491t1939r663b2017],
10	were	VBD	O	be	auxpass	11	SENT_125	[p8l687t1965r889b2019],
11	performed	VBN	O	perform	rcmod	8	SENT_125	[p8l921t1938r1377b2039],
12	close	RB	O	close	_	0	SENT_125	[p8l1411t1939r1623b2018],
13	to	TO	O	to	_	0	SENT_125	[p8l1658t1956r1738b2018],
14	the	DT	O	the	det	15	SENT_125	[p8l1774t1939r1907b2017],
15	time	NN	O	time	prep_close_to	11	SENT_125	[p8l1940t1940r2133b2017],
16	of	IN	O	of	_	0	SENT_125	[p8l12t2067r113b2147],
17	analysis	NN	O	analysis	prep_of	15	SENT_125	[p8l140t2068r487b2168],
18	of	IN	O	of	_	0	SENT_125	[p8l537t2067r638b2147],
19	circulating	VBG	O	circulate	prepc_of	17	SENT_125	[p8l666t2068r1144b2169],
20	tumor	NN	O	tumor	nn	21	SENT_125	[p8l1187t2085r1460b2147],
21	cells	NNS	O	cell	dobj	19	SENT_125	[p8l1503t2068r1695b2147],
22	(	CD	NUMBER	(	num	23	SENT_125	[p8l1748t2068r2128b2164],
23	median	NN	O	median	dep	21	SENT_125	[p8l1748t2068r2128b2164],
24	,	,	O	,	_	0	SENT_125	[p8l1748t2068r2128b2164],
25	8	CD	DURATION	8	num	26	SENT_125	[p8l12t2202r57b2275],
26	days	NNS	NUMBER	day	appos	21	SENT_125	[p8l98t2196r308b2296],
27	;	:	O	;	_	0	SENT_125	[p8l98t2196r308b2296],
28	range	NN	O	range	dep	21	SENT_125	[p8l350t2222r613b2297],
29	,	,	O	,	_	0	SENT_125	[p8l350t2222r613b2297],
30	o	NN	O	o	appos	28	SENT_125	[p8l657t2202r705b2275],
31	to	TO	O	to	_	0	SENT_125	[p8l745t2213r826b2275],
32	38	CD	NUMBER	38	num	33	SENT_125	[p8l867t2202r993b2287],
33	)	NN	O	)	prep_to	19	SENT_125	[p8l867t2202r993b2287],
34	showed	VBD	O	show	rcmod	1	SENT_125	[p8l1038t2196r1360b2275],
35	that	IN	O	that	complm	50	SENT_125	[p8l1400t2196r1572b2274],
36	the	DT	O	the	det	37	SENT_125	[p8l1606t2196r1738b2274],
37	quantity	NN	O	quantity	nsubjpass	50	SENT_125	[p8l1778t2197r2137b2296],
38	of	IN	O	of	_	0	SENT_125	[p8l12t2323r113b2403],
39	circulating	VBG	O	circulate	prepc_of	37	SENT_125	[p8l138t2324r606b2425],
40	tumor	NN	O	tumor	nn	41	SENT_125	[p8l644t2341r912b2403],
41	cells	NNS	O	cell	dobj	39	SENT_125	[p8l951t2324r1138b2402],
42	at	IN	O	at	_	0	SENT_125	[p8l1182t2341r1260b2402],
43	a	DT	O	a	det	46	SENT_125	[p8l1296t2350r1340b2402],
44	single	JJ	O	single	amod	46	SENT_125	[p8l1382t2324r1633b2425],
45	time	NN	O	time	nn	46	SENT_125	[p8l1676t2325r1868b2402],
46	point	NN	O	point	prep_at	39	SENT_125	[p8l1908t2325r2139b2424],
47	was	VBD	O	be	auxpass	50	SENT_125	[p8l7t2478r169b2531],
48	not	RB	O	not	neg	50	SENT_125	[p8l218t2469r362b2530],
49	well	RB	O	well	advmod	50	SENT_125	[p8l399t2452r576b2531],
50	correlated	VBN	O	correlate	ccomp	34	SENT_125	[p8l624t2452r1055b2530],
51	with	IN	O	with	_	0	SENT_125	[p8l1097t2452r1293b2531],
52	simple	JJ	O	simple	amod	54	SENT_125	[p8l1342t2452r1622b2551],
53	tumor	NN	O	tumor	nn	54	SENT_125	[p8l1670t2469r1938b2531],
54	Volume	NN	O	volume	prep_with	50	SENT_125	[p8l1978t2452r2132b2531, p8l11t2605r196b2659],
55	(	CD	NUMBER	(	dep	1	SENT_125	[p8l234t2585r757b2679],
56	Spearman	NNP	PERSON	Spearman	poss	59	SENT_125	[p8l234t2585r757b2679],
57	’s	POS	O	’s	_	0	SENT_125	[p8l234t2585r757b2679],
58	correlation	NN	O	correlation	nn	59	SENT_125	[p8l793t2579r1262b2658],
59	coefficient	NN	O	coefficient	dep	55	SENT_125	[p8l1297t2578r1778b2675],
60	,	,	O	,	_	0	SENT_125	[p8l1297t2578r1778b2675],
61	-0.028	CD	NUMBER	-0.028	appos	55	SENT_125	[p8l1815t2585r2129b2675],
62	;	:	O	;	_	0	SENT_125	[p8l1815t2585r2129b2675],
63	P	NN	O	p	dep	1	SENT_125	[p8l9t2714r381b2799],
64	=	JJ	O	=	amod	65	SENT_125	[p8l9t2714r381b2799],
65	O.	NNP	O	O.	dep	63	SENT_125	[p8l9t2714r381b2799],
66	88	CD	NUMBER	88	number	67	SENT_125	[p8l9t2714r381b2799],
67	)	CD	NUMBER	)	dep	65	SENT_125	[p8l9t2714r381b2799],
68	.	.	O	.	_	0	SENT_125	[p8l9t2714r381b2799],

1	This	DT	O	this	det	2	SENT_126	[p8l425t2708r612b2786],
2	finding	NN	O	finding	nsubj	3	SENT_126	[p8l656t2707r980b2809],
3	suggested	VBD	O	suggest	_	0	SENT_126	[p8l1020t2708r1447b2809],
4	that	IN	O	that	complm	16	SENT_126	[p8l1489t2708r1661b2786],
5	additional	JJ	O	additional	amod	7	SENT_126	[p8l1697t2708r2134b2787],
6	tumor	NN	O	tumor	nn	7	SENT_126	[p8l12t2852r279b2914],
7	characteristics	NNS	O	characteristic	nsubj	16	SENT_126	[p8l325t2835r971b2930],
8	,	,	O	,	_	0	SENT_126	[p8l325t2835r971b2930],
9	such	JJ	O	such	_	0	SENT_126	[p8l1026t2835r1220b2914],
10	as	IN	O	as	_	0	SENT_126	[p8l1267t2861r1352b2912],
11	invasiveness	NN	O	invasiveness	prep_such_as	7	SENT_126	[p8l1402t2836r1925b2914],
12	and	CC	O	and	_	0	SENT_126	[p8l1975t2835r2133b2913],
13	vascularity	NN	O	vascularity	prep_such_as	7	SENT_126	[p8l7t2962r488b3062],
14	,	,	O	,	_	0	SENT_126	[p8l7t2962r488b3062],
15	probably	RB	O	probably	advmod	16	SENT_126	[p8l544t2962r921b3062],
16	influenced	VBD	O	influence	ccomp	3	SENT_126	[p8l968t2961r1428b3042],
17	the	DT	O	the	det	18	SENT_126	[p8l1480t2962r1613b3041],
18	number	NN	O	number	dobj	16	SENT_126	[p8l1664t2962r2002b3042],
19	of	IN	O	of	_	0	SENT_126	[p8l2051t2961r2151b3041],
20	circulating	VBG	O	circulate	prepc_of	18	SENT_126	[p8l12t3091r479b3192],
21	tumor	NN	O	tumor	nn	22	SENT_126	[p8l515t3108r783b3170],
22	cells	NNS	O	cell	dobj	20	SENT_126	[p8l821t3091r1032b3170],
23	.	.	O	.	_	0	SENT_126	[p8l821t3091r1032b3170],

1	DETECTION	NN	O	detection	nn	4	SENT_127	[p8l16t3366r463b3416],
2	or	CC	O	or	_	0	SENT_127	[p8l503t3366r606b3416],
3	EGFR	NN	O	egfr	nn	4	SENT_127	[p8l641t3366r837b3416],
4	MUTATIONS	NNS	O	mutation	nsubj	8	SENT_127	[p8l878t3366r1342b3416],
5	IN	IN	O	in	_	0	SENT_127	[p8l1382t3367r1457b3415],
6	TUMORS	NNS	O	tumor	prep_in	8	SENT_127	[p8l1495t3366r1832b3416],
7	We	PRP	O	we	nsubj	8	SENT_127	[p8l7t3472r140b3542],
8	tested	VBD	O	test	_	0	SENT_127	[p8l203t3464r456b3543],
9	the	DT	O	the	det	10	SENT_127	[p8l518t3464r651b3542],
10	suitability	NN	O	suitability	dobj	8	SENT_127	[p8l714t3464r1145b3564],
11	of	IN	O	of	_	0	SENT_127	[p8l1203t3463r1302b3543],
12	the	DT	O	the	det	17	SENT_127	[p8l1346t3464r1479b3542],
13	allele	NN	O	allele	nn	17	SENT_127	[p8l1540t3463r2134b3564],
14	—	NN	O	—	nn	17	SENT_127	[p8l1540t3463r2134b3564],
15	specific	JJ	O	specific	amod	17	SENT_127	[p8l1540t3463r2134b3564],
16	SARMS	NN	O	sarm	nn	17	SENT_127	[p8l13t3599r332b3676],
17	assay23	NN	O	assay23	prep_of	10	SENT_127	[p8l377t3599r673b3693],
18	for	IN	O	for	_	0	SENT_127	[p8l719t3592r842b3672],
19	detecting	VBG	O	detect	prepc_for	8	SENT_127	[p8l883t3593r1284b3694],
20	EGFR	NN	ORGANIZATION	egfr	nn	21	SENT_127	[p8l1322t3600r1534b3673],
21	mutations	NNS	O	mutation	dobj	19	SENT_127	[p8l1571t3594r2005b3672],
22	in	IN	O	in	_	0	SENT_127	[p8l2050t3594r2133b3671],
23	rare	JJ	O	rare	amod	25	SENT_127	[p9l11t46r178b99],
24	cell	NN	O	cell	nn	25	SENT_127	[p9l212t20r358b98],
25	populations	NNS	O	population	prep_in	19	SENT_127	[p9l390t20r927b120],
26	.	.	O	.	_	0	SENT_127	[p9l390t20r927b120],

1	This	DT	O	this	det	2	SENT_128	[p9l963t20r1150b98],
2	test	NN	O	test	nsubjpass	4	SENT_128	[p9l1186t37r1341b99],
3	is	VBZ	O	be	auxpass	4	SENT_128	[p9l1368t21r1434b98],
4	designed	VBN	O	design	_	0	SENT_128	[p9l1470t20r1852b121],
5	to	TO	O	to	aux	6	SENT_128	[p9l1886t37r1967b99],
6	detect	VB	O	detect	xcomp	4	SENT_128	[p9l2003t20r2132b99, p9l12t165r168b226],
7	multiple	JJ	O	multiple	amod	10	SENT_128	[p9l202t148r558b248],
8	drug	NN	O	drug	nn	10	SENT_128	[p9l598t148r801b249],
9	sensitivity	NN	O	sensitivity	nn	10	SENT_128	[p9l838t148r1747b248],
10	—	NN	O	—	nsubj	11	SENT_128	[p9l838t148r1747b248],
11	associated	JJ	O	associated	ccomp	6	SENT_128	[p9l838t148r1747b248],
12	types	NNS	O	type	dobj	11	SENT_128	[p9l1787t165r2010b248],
13	of	IN	O	of	_	0	SENT_128	[p9l2051t147r2151b227],
14	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_128	[p9l9t283r221b356],
15	mutation	NN	O	mutation	prep_of	12	SENT_128	[p9l261t277r677b372],
16	,	,	O	,	_	0	SENT_128	[p9l261t277r677b372],
17	including	VBG	O	include	_	0	SENT_128	[p9l728t276r1138b377],
18	the	DT	O	the	det	19	SENT_128	[p9l1182t276r1315b355],
19	multiple	JJ	O	multiple	prep_including	4	SENT_128	[p9l1361t276r1716b376],
20	in	IN	O	in	_	0	SENT_128	[p9l1762t275r2133b354],
21	—	CD	NUMBER	—	num	23	SENT_128	[p9l1762t275r2133b354],
22	frame	NN	O	frame	nn	23	SENT_128	[p9l1762t275r2133b354],
23	exon	NN	O	exon	prep_in	19	SENT_128	[p9l12t430r212b482],
24	19	CD	NUMBER	19	num	25	SENT_128	[p9l254t410r350b482],
25	deletions	NNS	O	deletion	dep	23	SENT_128	[p9l391t404r777b482],
26	(	CD	NUMBER	(	num	19	SENT_128	[p9l823t404r1322b503],
27	collectively	RB	O	collectively	advmod	28	SENT_128	[p9l823t404r1322b503],
28	analyzed	VBN	O	analyze	partmod	19	SENT_128	[p9l1356t404r1735b503],
29	as	IN	O	as	_	0	SENT_128	[p9l1774t430r1859b481],
30	“	CD	NUMBER	“	num	33	SENT_128	[p9l1904t404r2129b482],
31	Del	NNP	O	Del	nn	33	SENT_128	[p9l1904t404r2129b482],
32	”	CD	NUMBER	”	num	33	SENT_128	[p9l1904t404r2129b482],
33	mutations	NNS	O	mutation	prep_as	28	SENT_128	[p9l11t532r472b621],
34	)	CD	NUMBER	)	dep	33	SENT_128	[p9l11t532r472b621],
35	and	CC	O	and	_	0	SENT_128	[p9l533t531r691b609],
36	the	DT	O	the	det	39	SENT_128	[p9l747t531r880b608],
37	L858R	NN	O	l858r	nn	39	SENT_128	[p9l935t537r1216b614],
38	missense	NN	O	missense	nn	39	SENT_128	[p9l1262t532r1656b609],
39	mutation	NN	O	mutation	prep_as	28	SENT_128	[p9l1712t532r2128b626],
40	,	,	O	,	_	0	SENT_128	[p9l1712t532r2128b626],
41	which	WDT	O	which	nsubj	43	SENT_128	[p9l7t659r269b738],
42	together	RB	O	together	advmod	43	SENT_128	[p9l298t659r661b760],
43	comprise	VBP	O	comprise	rcmod	39	SENT_128	[p9l687t660r1080b759],
44	90	CD	PERCENT	90	number	45	SENT_128	[p9l1109t664r1298b738],
45	%	NN	PERCENT	%	amod	47	SENT_128	[p9l1109t664r1298b738],
46	ofEGFR	NN	O	ofegfr	nn	47	SENT_128	[p9l1326t658r1647b739],
47	mutations	NNS	O	mutation	dobj	43	SENT_128	[p9l1669t660r2128b738],
48	.	.	O	.	_	0	SENT_128	[p9l1669t660r2128b738],

1	The	DT	O	the	det	2	SENT_129	[p9l7t788r168b866],
2	test	NN	O	test	nsubj	4	SENT_129	[p9l201t805r355b866],
3	also	RB	O	also	advmod	4	SENT_129	[p9l381t788r553b867],
4	detects	VBZ	O	detect	_	0	SENT_129	[p9l587t788r884b867],
5	the	DT	O	the	det	7	SENT_129	[p9l919t788r1052b866],
6	T79OM	NN	O	t79om	nn	7	SENT_129	[p9l1080t794r1383b867],
7	mutation	NN	O	mutation	dobj	4	SENT_129	[p9l1416t789r1809b867],
8	associated	VBN	O	associate	partmod	7	SENT_129	[p9l1840t789r2132b867, p9l11t916r189b994],

1	With	IN	O	with	_	0	SENT_130	[p9l239t916r434b995],
2	resistance	NN	O	resistance	prep_with	20	SENT_130	[p9l489t917r918b994],
3	to	TO	O	to	_	0	SENT_130	[p9l973t932r1055b994],
4	tyrosine	NN	O	tyrosine	nn	6	SENT_130	[p9l1111t917r1457b1015],
5	kinase	NN	O	kinase	nn	6	SENT_130	[p9l1512t916r1791b995],
6	inhibitors	NNS	O	inhibitor	prep_to	2	SENT_130	[p9l1846t916r2132b994, p9l12t1048r376b1123],
7	.16	CD	NUMBER	.16	number	8	SENT_130	[p9l1846t916r2132b994, p9l12t1048r376b1123],
8	'13	CD	NUMBER	'13	num	6	SENT_130	[p9l1846t916r2132b994, p9l12t1048r376b1123],
9	To	TO	O	to	aux	10	SENT_130	[p9l426t1050r532b1123],
10	validate	VB	O	validate	infmod	2	SENT_130	[p9l581t1044r914b1123],
11	the	DT	O	the	det	12	SENT_130	[p9l967t1044r1100b1122],
12	results	NNS	O	result	dobj	10	SENT_130	[p9l1152t1044r1435b1123],
13	of	IN	O	of	_	0	SENT_130	[p9l1490t1043r1590b1123],
14	the	DT	O	the	det	16	SENT_130	[p9l1624t1044r1757b1122],
15	SARMS	NN	O	sarm	nn	16	SENT_130	[p9l1812t1050r2130b1128],
16	assay	NN	O	assay	prep_of	12	SENT_130	[p9l11t1197r251b1271],
17	,	,	O	,	_	0	SENT_130	[p9l11t1197r251b1271],
18	we	PRP	O	we	nsubj	20	SENT_130	[p9l305t1197r423b1251],
19	first	RB	ORDINAL	first	advmod	20	SENT_130	[p9l477t1170r661b1249],
20	analyzed	VBD	O	analyze	_	0	SENT_130	[p9l709t1171r1088b1271],
21	26	CD	NUMBER	26	num	22	SENT_130	[p9l1142t1177r1240b1250],
22	paraffin	NN	O	paraffin	dobj	20	SENT_130	[p9l1294t1170r2133b1271],
23	—	CD	NUMBER	—	num	25	SENT_130	[p9l1294t1170r2133b1271],
24	embedded	JJ	O	embedded	amod	25	SENT_130	[p9l1294t1170r2133b1271],
25	tumors	NNS	O	tumor	nsubj	44	SENT_130	[p9l12t1317r319b1379],
26	of	IN	O	of	_	0	SENT_130	[p9l350t1299r450b1379],
27	non	JJ	O	non	amod	33	SENT_130	[p9l460t1300r1102b1379],
28	—	JJ	O	—	amod	33	SENT_130	[p9l460t1300r1102b1379],
29	small	JJ	O	small	amod	33	SENT_130	[p9l460t1300r1102b1379],
30	—	NN	O	—	nn	33	SENT_130	[p9l460t1300r1102b1379],
31	cell	NN	O	cell	nn	33	SENT_130	[p9l460t1300r1102b1379],
32	lung	NN	O	lung	nn	33	SENT_130	[p9l1129t1300r1323b1401],
33	cancers	NNS	O	cancer	prep_of	25	SENT_130	[p9l1348t1326r1669b1378],
34	previously	RB	DATE	previously	advmod	35	SENT_130	[p9l1698t1300r2138b1400],
35	identified	VBN	O	identify	partmod	33	SENT_130	[p9l11t1427r418b1507],
36	as	IN	O	as	_	0	SENT_130	[p9l444t1454r528b1506],
37	having	VBG	O	have	prepc_as	35	SENT_130	[p9l556t1428r842b1529],
38	the	DT	O	the	det	40	SENT_130	[p9l866t1428r996b1506],
39	EGFR	NN	ORGANIZATION	egfr	nn	40	SENT_130	[p9l1021t1435r1230b1508],
40	mutation	NN	O	mutation	dobj	37	SENT_130	[p9l1250t1429r1635b1507],
41	and	CC	O	and	_	0	SENT_130	[p9l1661t1428r1817b1507],
42	8	CD	NUMBER	8	num	43	SENT_130	[p9l1844t1434r1889b1507],
43	specimens	NNS	O	specimen	dobj	37	SENT_130	[p9l1919t1454r2132b1528, p9l11t1557r264b1635],
44	reported	VBD	O	report	rcmod	22	SENT_130	[p9l300t1556r666b1656],
45	as	IN	O	as	_	0	SENT_130	[p9l701t1582r786b1634],
46	having	VBG	O	have	prepc_as	44	SENT_130	[p9l823t1556r1114b1657],
47	Wild	NNP	O	Wild	dobj	46	SENT_130	[p9l1142t1556r1547b1656],
48	—	CD	NUMBER	—	num	50	SENT_130	[p9l1142t1556r1547b1656],
49	type	NN	O	type	nn	50	SENT_130	[p9l1142t1556r1547b1656],
50	alleles	NNS	O	allele	dep	47	SENT_130	[p9l1582t1556r1848b1634],
51	by	IN	O	by	_	0	SENT_130	[p9l1886t1556r1983b1656],
52	sequencing	NN	O	sequencing	nn	54	SENT_130	[p9l2015t1582r2132b1634, p9l12t1685r397b1785],
53	(	CD	NUMBER	(	num	54	SENT_130	[p9l423t1684r674b1775],
54	Table	NNP	O	Table	prep_by	46	SENT_130	[p9l423t1684r674b1775],
55	2	CD	NUMBER	2	number	56	SENT_130	[p9l699t1690r795b1775],
56	)	CD	NUMBER	)	dep	54	SENT_130	[p9l699t1690r795b1775],
57	.	.	O	.	_	0	SENT_130	[p9l699t1690r795b1775],

1	The	DT	O	the	det	3	SENT_131	[p9l822t1684r980b1763],
2	SARMS	NN	O	sarm	nn	3	SENT_131	[p9l1007t1690r1319b1767],
3	assay	NN	O	assay	nsubj	6	SENT_131	[p9l1347t1710r1568b1784],
4	and	CC	O	and	_	0	SENT_131	[p9l1587t1684r1742b1763],
5	sequencing	NN	O	sequencing	nsubj	6	SENT_131	[p9l1769t1710r2132b1784, p9l11t1813r150b1913],
6	identified	VBD	O	identify	_	0	SENT_131	[p9l199t1811r616b1891],
7	the	DT	O	the	det	9	SENT_131	[p9l670t1812r803b1890],
8	same	JJ	O	same	amod	9	SENT_131	[p9l858t1838r1078b1891],
9	mutation	NN	O	mutation	dobj	6	SENT_131	[p9l1132t1813r1524b1891],
10	in	IN	O	in	_	0	SENT_131	[p9l1578t1813r1661b1890],
11	25	CD	NUMBER	25	num	13	SENT_131	[p9l1714t1818r1812b1891],
12	tumor	NN	O	tumor	nn	13	SENT_131	[p9l1868t1829r2137b1891],
13	specimens	NNS	O	specimen	prep_in	6	SENT_131	[p9l12t1941r484b2039],
14	,	,	O	,	_	0	SENT_131	[p9l12t1941r484b2039],
15	whereas	IN	O	whereas	mark	23	SENT_131	[p9l525t1940r876b2019],
16	all	DT	O	all	quantmod	17	SENT_131	[p9l916t1940r1021b2018],
17	8	CD	NUMBER	8	num	21	SENT_131	[p9l1060t1946r1105b2018],
18	Wild	NNP	O	Wild	nn	21	SENT_131	[p9l1142t1940r1548b2039],
19	—	CD	NUMBER	—	num	21	SENT_131	[p9l1142t1940r1548b2039],
20	type	NN	O	type	nn	21	SENT_131	[p9l1142t1940r1548b2039],
21	tumors	NNS	O	tumor	nsubjpass	23	SENT_131	[p9l1587t1956r1894b2019],
22	were	VBD	O	be	auxpass	23	SENT_131	[p9l1931t1966r2133b2019],
23	confirmed	VBN	O	confirm	advcl	6	SENT_131	[p9l12t2067r465b2147],
24	as	IN	O	as	_	0	SENT_131	[p9l502t2094r588b2146],
25	being	VBG	O	be	cop	26	SENT_131	[p9l628t2068r869b2169],
26	negative	JJ	O	negative	prepc_as	23	SENT_131	[p9l903t2069r1279b2169],
27	,	,	O	,	_	0	SENT_131	[p9l903t2069r1279b2169],
28	yielding	VBG	O	yield	xcomp	6	SENT_131	[p9l1319t2068r1666b2169],
29	a	DT	O	a	det	30	SENT_131	[p9l1700t2094r1744b2146],
30	sensitivity	NN	O	sensitivity	dobj	28	SENT_131	[p9l1782t2069r2132b2147, p9l11t2197r118b2296],
31	of	IN	O	of	_	0	SENT_131	[p9l154t2195r254b2275],
32	96	CD	PERCENT	96	num	33	SENT_131	[p9l275t2201r460b2275],
33	%	NN	PERCENT	%	prep_of	30	SENT_131	[p9l275t2201r460b2275],
34	and	CC	O	and	_	0	SENT_131	[p9l498t2196r656b2275],
35	a	DT	O	a	det	36	SENT_131	[p9l694t2222r739b2274],
36	specificity	NN	O	specificity	dobj	28	SENT_131	[p9l778t2195r1219b2296],
37	of	IN	O	of	_	0	SENT_131	[p9l1255t2195r1355b2275],
38	100	CD	PERCENT	100	num	39	SENT_131	[p9l1379t2201r1639b2275],
39	%	NN	PERCENT	%	prep_of	36	SENT_131	[p9l1379t2201r1639b2275],
40	.	.	O	.	_	0	SENT_131	[p9l1379t2201r1639b2275],

1	The	DT	O	the	det	3	SENT_132	[p9l1680t2196r1840b2274],
2	single	JJ	O	single	amod	3	SENT_132	[p9l1882t2196r2134b2297],
3	discrepancy	NN	O	discrepancy	nsubj	5	SENT_132	[p9l12t2324r524b2423],
4	was	VBD	O	be	cop	5	SENT_132	[p9l554t2350r716b2403],
5	due	JJ	O	due	_	0	SENT_132	[p9l759t2324r907b2403],
6	to	TO	O	to	_	0	SENT_132	[p9l947t2340r1029b2402],
7	a	DT	O	a	det	10	SENT_132	[p9l1068t2350r1113b2401],
8	rare	JJ	O	rare	amod	10	SENT_132	[p9l1150t2350r1318b2402],
9	deletion	NN	O	deletion	nn	10	SENT_132	[p9l1357t2324r1702b2402],
10	mutation	NN	O	mutation	prep_to	5	SENT_132	[p9l1740t2325r2133b2403],
11	that	WDT	O	that	nsubj	12	SENT_132	[p9l12t2451r184b2529],
12	was	VBD	O	be	rcmod	10	SENT_132	[p9l210t2477r372b2531],
13	not	RB	O	not	neg	12	SENT_132	[p9l411t2468r553b2530],
14	Within	IN	O	within	_	0	SENT_132	[p9l579t2451r864b2531],
15	the	DT	O	the	det	17	SENT_132	[p9l901t2451r1033b2529],
16	detection	NN	O	detection	nn	17	SENT_132	[p9l1070t2451r1466b2530],
17	capacity	NN	O	capacity	prep_within	12	SENT_132	[p9l1503t2452r1852b2551],
18	of	IN	O	of	_	0	SENT_132	[p9l1884t2450r1983b2530],
19	the	DT	O	the	det	21	SENT_132	[p9l2001t2451r2134b2529],
20	SARMS	NN	O	sarm	nn	21	SENT_132	[p9l13t2586r332b2663],
21	assay	NN	O	assay	prep_of	17	SENT_132	[p9l369t2606r608b2679],
22	.	.	O	.	_	0	SENT_132	[p9l369t2606r608b2679],

1	Using	VBG	O	use	partmod	8	SENT_133	[p9l140t2709r392b2809],
2	the	DT	O	the	det	4	SENT_133	[p9l430t2708r562b2787],
3	SARMS	NNP	MISC	SARMS	nn	4	SENT_133	[p9l606t2714r924b2791],
4	test	NN	O	test	dobj	1	SENT_133	[p9l969t2725r1144b2804],
5	,	,	O	,	_	0	SENT_133	[p9l969t2725r1144b2804],
6	we	PRP	O	we	nsubj	8	SENT_133	[p9l1186t2734r1303b2787],
7	were	VBD	O	be	cop	8	SENT_133	[p9l1341t2734r1542b2787],
8	able	JJ	O	able	_	0	SENT_133	[p9l1583t2708r1754b2787],
9	to	TO	O	to	aux	10	SENT_133	[p9l1796t2725r1877b2787],
10	identify	VB	O	identify	xcomp	8	SENT_133	[p9l1919t2708r2132b2787, p9l12t2834r158b2935],
11	rare	JJ	O	rare	amod	14	SENT_133	[p9l189t2861r356b2913],
12	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_133	[p9l390t2842r603b2915],
13	mutant	JJ	O	mutant	amod	14	SENT_133	[p9l632t2852r945b2915],
14	alleles	NNS	O	allele	dobj	10	SENT_133	[p9l975t2835r1240b2913],
15	below	IN	O	below	_	0	SENT_133	[p9l1279t2835r1536b2915],
16	the	DT	O	the	det	18	SENT_133	[p9l1568t2835r1701b2913],
17	detection	NN	O	detection	nn	18	SENT_133	[p9l1737t2835r2134b2914],
18	limit	NN	O	limit	prep_below	10	SENT_133	[p9l10t2964r219b3042],
19	of	IN	O	of	_	0	SENT_133	[p9l256t2963r355b3043],
20	standard	JJ	O	standard	amod	21	SENT_133	[p9l380t2964r758b3043],
21	sequencing	NN	O	sequencing	prep_of	18	SENT_133	[p9l800t2965r1305b3065],
22	.	.	O	.	_	0	SENT_133	[p9l800t2965r1305b3065],

1	In	IN	O	in	_	0	SENT_134	[p9l1350t2972r1439b3042],
2	addition	NN	O	addition	_	0	SENT_134	[p9l1479t2964r1835b3043],
3	to	TO	O	to	_	0	SENT_134	[p9l1876t2981r1958b3043],
4	the	DT	O	the	det	8	SENT_134	[p9l2001t2964r2133b3042],
5	known	JJ	O	known	amod	8	SENT_134	[p9l11t3091r313b3171],
6	primary	JJ	O	primary	amod	8	SENT_134	[p9l372t3092r728b3191],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_134	[p9l782t3098r998b3171],
8	mutation	NN	O	mutation	prep_in_addition_to	15	SENT_134	[p9l1051t3092r1475b3187],
9	,	,	O	,	_	0	SENT_134	[p9l1051t3092r1475b3187],
10	low	JJ	O	low	amod	11	SENT_134	[p9l1540t3091r1698b3171],
11	levels	NNS	O	level	nsubjpass	15	SENT_134	[p9l1752t3091r1988b3171],
12	of	IN	O	of	_	0	SENT_134	[p9l2051t3090r2152b3170],
13	T79OM	NN	O	t79om	prep_of	11	SENT_134	[p9l8t3226r301b3298],
14	were	VBD	O	be	auxpass	15	SENT_134	[p9l336t3246r531b3299],
15	detected	VBN	O	detect	_	0	SENT_134	[p9l568t3220r911b3298],
16	in	IN	O	in	_	0	SENT_134	[p9l947t3221r1029b3297],
17	pretreatment	NN	O	pretreatment	nn	19	SENT_134	[p9l1063t3236r1605b3319],
18	tumor	NN	O	tumor	nn	19	SENT_134	[p9l1637t3236r1897b3299],
19	samples	NNS	O	sample	prep_in	15	SENT_134	[p9l1932t3246r2132b3297, p9l10t3347r171b3447],
20	from	IN	O	from	_	0	SENT_134	[p9l211t3346r421b3426],
21	10	CD	NUMBER	10	prep_from	15	SENT_134	[p9l465t3353r557b3426],
22	of	IN	O	of	_	0	SENT_134	[p9l599t3346r699b3426],
23	26	CD	NUMBER	26	num	24	SENT_134	[p9l720t3353r819b3426],
24	patients	NNS	O	patient	prep_of	21	SENT_134	[p9l858t3348r1200b3447],
25	(	IN	O	(	_	0	SENT_134	[p9l1247t3352r1510b3438],
26	38	CD	PERCENT	38	num	27	SENT_134	[p9l1247t3352r1510b3438],
27	%	NN	PERCENT	%	prep_(	15	SENT_134	[p9l1247t3352r1510b3438],
28	)	CD	NUMBER	)	dep	27	SENT_134	[p9l1247t3352r1510b3438],
29	.	.	O	.	_	0	SENT_134	[p9l1247t3352r1510b3438],

1	The	DT	O	the	det	4	SENT_135	[p9l1552t3347r1713b3425],
2	relatively	RB	O	relatively	advmod	3	SENT_135	[p9l1753t3347r2138b3447],
3	high	JJ	O	high	amod	4	SENT_135	[p9l11t3476r206b3577],
4	number	NN	O	number	nsubj	14	SENT_135	[p9l258t3476r596b3555],
5	of	IN	O	of	_	0	SENT_135	[p9l646t3475r746b3555],
6	ampliﬁcation	NN	O	ampliﬁcation	nn	7	SENT_135	[p9l779t3475r1363b3576],
7	cycles	NNS	O	cycle	prep_of	4	SENT_135	[p9l1416t3476r1661b3576],
8	that	WDT	O	that	nsubjpass	10	SENT_135	[p9l1716t3476r1889b3554],
9	were	VBD	O	be	auxpass	10	SENT_135	[p9l1931t3502r2133b3555],
10	required	VBN	O	require	rcmod	7	SENT_135	[p9l11t3604r373b3704],
11	to	TO	O	to	aux	12	SENT_135	[p9l413t3621r495b3683],
12	detect	VB	O	detect	xcomp	10	SENT_135	[p9l537t3604r796b3683],
13	T79OM	NN	O	t79om	dobj	12	SENT_135	[p9l828t3610r1130b3683],
14	suggests	VBZ	O	suggest	_	0	SENT_135	[p9l1174t3621r1541b3705],
15	that	IN	O	that	advmod	14	SENT_135	[p9l1583t3604r1756b3682],
16	the	DT	O	the	det	17	SENT_135	[p9l1792t3604r1924b3683],
17	mutation	NN	O	mutation	pobj	15	SENT_135	[p9l1965t3630r2132b3683, p10l12t21r264b99],

1	is	VBZ	O	be	cop	2	SENT_136	[p10l298t21r363b98],
2	present	JJ	DATE	present	_	0	SENT_136	[p10l399t37r719b120],
3	in	IN	O	in	_	0	SENT_136	[p10l748t21r831b98],
4	only	RB	O	only	advmod	7	SENT_136	[p10l867t20r1051b120],
5	a	DT	O	a	det	7	SENT_136	[p10l1081t46r1125b98],
6	small	JJ	O	small	amod	7	SENT_136	[p10l1160t20r1394b98],
7	number	NN	O	number	prep_in	2	SENT_136	[p10l1428t20r1766b99],
8	of	IN	O	of	_	0	SENT_136	[p10l1799t19r1899b99],
9	cells	NNS	O	cell	prep_of	7	SENT_136	[p10l1916t20r2128b99],
10	.	.	O	.	_	0	SENT_136	[p10l1916t20r2128b99],

1	Indeed	RB	O	indeed	advmod	19	SENT_137	[p10l10t149r326b245],
2	,	,	O	,	_	0	SENT_137	[p10l10t149r326b245],
3	the	DT	O	the	det	4	SENT_137	[p10l391t149r523b227],
4	sequencing	NN	O	sequencing	nsubj	19	SENT_137	[p10l585t150r1070b250],
5	of	IN	O	of	_	0	SENT_137	[p10l1127t148r1227b228],
6	cloned	VBN	O	clone	prepc_of	4	SENT_137	[p10l1268t149r1550b228],
7	polymerasechain	NN	O	polymerasechain	nn	9	SENT_137	[p10l1607t149r2132b249, p10l12t276r632b355],
8	—	NN	O	—	nn	9	SENT_137	[p10l1607t149r2132b249, p10l12t276r632b355],
9	reaction	NN	O	reaction	nsubj	13	SENT_137	[p10l1607t149r2132b249, p10l12t276r632b355],
10	(	CD	NUMBER	(	num	13	SENT_137	[p10l671t282r914b367],
11	PCR	NN	O	pcr	nn	13	SENT_137	[p10l671t282r914b367],
12	)	NN	O	)	nn	13	SENT_137	[p10l671t282r914b367],
13	products	NNS	O	product	xcomp	6	SENT_137	[p10l952t276r1327b376],
14	from	IN	O	from	_	0	SENT_137	[p10l1363t275r1573b355],
15	one	CD	NUMBER	one	prep_from	13	SENT_137	[p10l1608t302r1759b355],
16	of	IN	O	of	_	0	SENT_137	[p10l1794t275r1894b355],
17	these	DT	O	these	det	18	SENT_137	[p10l1910t276r2134b354],
18	tumors	NNS	O	tumor	prep_of	15	SENT_137	[p10l12t421r319b484],
19	identified	VBD	O	identify	_	0	SENT_137	[p10l369t403r786b483],
20	only	RB	O	only	quantmod	21	SENT_137	[p10l835t404r1018b504],
21	one	CD	NUMBER	one	num	23	SENT_137	[p10l1063t430r1214b483],
22	T79OM	NN	O	t79om	nn	23	SENT_137	[p10l1258t410r1560b483],
23	mutation	NN	O	mutation	dobj	19	SENT_137	[p10l1610t405r2003b484],
24	in	IN	O	in	_	0	SENT_137	[p10l2050t405r2134b482],
25	500	CD	NUMBER	500	num	27	SENT_137	[p10l13t539r165b612],
26	EGFR	NN	ORGANIZATION	egfr	nn	27	SENT_137	[p10l201t540r413b613],
27	alleles	NNS	O	allele	prep_in	19	SENT_137	[p10l443t533r733b612],
28	.	.	O	.	_	0	SENT_137	[p10l443t533r733b612],

1	The	DT	O	the	det	2	SENT_138	[p10l772t533r932b611],
2	presence	NN	O	presence	nsubj	7	SENT_138	[p10l968t559r1342b633],
3	of	IN	O	of	_	0	SENT_138	[p10l1380t532r1480b612],
4	the	DT	O	the	det	6	SENT_138	[p10l1498t533r1631b611],
5	drug	NN	O	drug	nn	6	SENT_138	[p10l1668t533r2132b634],
6	—	NN	O	—	prep_of	2	SENT_138	[p10l1668t533r2132b634],
7	resis	VBZ	O	resis	_	0	SENT_138	[p10l1668t533r2132b634],
8	—	CD	NUMBER	—	num	10	SENT_138	[p10l1668t533r2132b634],
9	tance	NN	O	tance	nn	10	SENT_138	[p10l12t677r241b738],
10	mutation	NN	O	mutation	nsubj	18	SENT_138	[p10l284t661r677b740],
11	at	IN	O	at	_	0	SENT_138	[p10l720t677r798b738],
12	such	PDT	O	such	predet	15	SENT_138	[p10l839t660r1032b740],
13	a	DT	O	a	det	15	SENT_138	[p10l1075t686r1119b738],
14	low	JJ	O	low	amod	15	SENT_138	[p10l1160t660r1316b740],
15	frequency	NN	O	frequency	prep_at	10	SENT_138	[p10l1355t659r1779b760],
16	did	VBD	O	do	aux	18	SENT_138	[p10l1818t660r1952b739],
17	not	RB	O	not	neg	18	SENT_138	[p10l1996t677r2139b739],
18	preclude	VB	O	preclude	dep	7	SENT_138	[p10l10t789r359b889],
19	significant	JJ	O	significant	amod	20	SENT_138	[p10l403t788r849b890],
20	responses	NNS	O	response	dobj	18	SENT_138	[p10l885t815r1292b889],
21	to	TO	O	to	_	0	SENT_138	[p10l1335t806r1414b868],
22	therapy	NN	O	therapy	prep_to	18	SENT_138	[p10l1458t789r1767b889],
23	with	IN	O	with	_	0	SENT_138	[p10l1800t789r1988b868],
24	tyrosine	NN	O	tyrosine	nn	26	SENT_138	[p10l2030t806r2132b889, p10l11t918r264b996],
25	kinase	NN	O	kinase	nn	26	SENT_138	[p10l297t917r566b996],
26	inhibitors	NNS	O	inhibitor	prep_with	22	SENT_138	[p10l599t917r1001b996],
27	among	IN	O	among	_	0	SENT_138	[p10l1036t943r1327b1018],
28	patients	NNS	O	patient	prep_among	18	SENT_138	[p10l1356t918r1683b1017],
29	with	IN	O	with	_	0	SENT_138	[p10l1713t917r1902b996],
30	EGFR	NN	ORGANIZATION	egfr	nn	32	SENT_138	[p10l1934t923r2140b997],
31	mutant	JJ	O	mutant	amod	32	SENT_138	[p10l11t1061r319b1124],
32	tumors	NNS	O	tumor	prep_with	28	SENT_138	[p10l347t1062r673b1139],
33	,	,	O	,	_	0	SENT_138	[p10l347t1062r673b1139],
34	but	CC	O	but	_	0	SENT_138	[p10l712t1045r850b1124],
35	it	PRP	O	it	nsubjpass	37	SENT_138	[p10l876t1046r935b1123],
36	was	VBD	O	be	auxpass	37	SENT_138	[p10l958t1071r1118b1124],
37	associated	VBN	O	associate	conj_but	18	SENT_138	[p10l1152t1045r1587b1124],
38	with	IN	O	with	_	0	SENT_138	[p10l1615t1045r1807b1124],
39	a	DT	O	a	det	40	SENT_138	[p10l1839t1071r1884b1123],
40	strikN	NN	O	strikn	prep_with	37	SENT_138	[p10l1916t1045r2132b1124, p10l542t1225r555b1240],

1	ENGLJ	NNP	O	ENGLJ	nn	2	SENT_139	[p10l570t1225r648b1247],
2	MED	NNP	O	MED	_	0	SENT_139	[p10l663t1225r715b1240],
3	359	CD	NUMBER	359	num	2	SENT_139	[p10l725t1225r790b1247],
4	;	:	O	;	_	0	SENT_139	[p10l725t1225r790b1247],
5	4	CD	NUMBER	4	num	7	SENT_139	[p10l725t1225r790b1247],
6	WWW.NEJM.ORG	NN	O	www.nejm.org	nn	7	SENT_139	[p10l822t1225r1024b1247],
7	ULY	NN	O	uly	dep	2	SENT_139	[p10l1069t1225r1112b1241],
8	24	CD	NUMBER	24	dep	7	SENT_139	[p10l1122t1225r1158b1247],
9	,	,	O	,	_	0	SENT_139	[p10l1122t1225r1158b1247],
10	2008	CD	DATE	2008	num	11	SENT_139	[p10l1169t1219r1233b1241],
11	369	CD	NUMBER	369	appos	8	SENT_139	[p10l1959t1214r2016b1238],

1	The	DT	O	the	det	6	SENT_140	[p10l702t1258r753b1282],
2	New	NNP	O	New	nn	6	SENT_140	[p10l762t1259r824b1282],
3	England	NNP	O	England	nn	6	SENT_140	[p10l833t1258r944b1289],
4	J	NNP	O	J	nn	6	SENT_140	[p10l952t1259r965b1282],
5	ouma	NN	O	ouma	nn	6	SENT_140	[p10l966t1266r1041b1282],
6	o	NN	O	o	_	0	SENT_140	[p10l1059t1266r1075b1282],
7	Medicine	NN	O	medicine	dep	6	SENT_140	[p10l1095t1258r1220b1282],

1	Copyright	NN	O	copyright	_	0	SENT_141	[p10l494t1340r629b1371],
2	©	CD	NUMBER	©	num	6	SENT_141	[p10l638t1340r661b1364],
3	2008	CD	DATE	2008	num	6	SENT_141	[p10l671t1340r736b1364],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_141	[p10l746t1340r937b1364],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_141	[p10l947t1340r1055b1364],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_141	[p10l1065t1340r1170b1371],
7	.	.	O	.	_	0	SENT_141	[p10l1065t1340r1170b1371],

1	All	DT	O	all	det	2	SENT_142	[p10l1181t1340r1223b1364],
2	rights	NNS	O	rights	nsubj	3	SENT_142	[p10l1232t1340r1306b1371],
3	reserved	VBN	O	reserve	_	0	SENT_142	[p10l1316t1340r1435b1364],
4	.	.	O	.	_	0	SENT_142	[p10l1316t1340r1435b1364],

1	The	DT	O	the	det	4	SENT_143	[p10l673t1446r718b1467],
2	NEW	NNP	O	NEW	nn	4	SENT_143	[p10l737t1448r822b1467],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_143	[p10l841t1448r1029b1467],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_143	[p10l1048t1448r1227b1474],
5	of	IN	O	of	_	0	SENT_143	[p10l1247t1446r1275b1473],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_143	[p10l1287t1448r1486b1467],

1	ing	NN	O	ing	nn	2	SENT_144	[p10l10t1671r149b1772],
2	difference	NN	O	difference	nsubj	26	SENT_144	[p10l182t1669r608b1750],
3	in	IN	O	in	_	0	SENT_144	[p10l643t1671r726b1748],
4	progression	NN	O	progression	npadvmod	6	SENT_144	[p10l760t1669r1459b1772],
5	—	CD	NUMBER	—	num	4	SENT_144	[p10l760t1669r1459b1772],
6	free	JJ	O	free	amod	7	SENT_144	[p10l760t1669r1459b1772],
7	survival	NN	O	survival	prep_in	2	SENT_144	[p10l1495t1670r1844b1767],
8	,	,	O	,	_	0	SENT_144	[p10l1495t1670r1844b1767],
9	With	IN	O	with	mark	19	SENT_144	[p10l1881t1670r2075b1750],
10	a	DT	O	a	det	11	SENT_144	[p10l2110t1697r2154b1749],
11	median	NN	O	median	nsubj	19	SENT_144	[p10l11t1800r337b1880],
12	of	IN	O	of	_	0	SENT_144	[p10l379t1799r480b1880],
13	7.7	CD	DURATION	7.7	num	14	SENT_144	[p10l505t1808r618b1880],
14	months	NNS	NUMBER	month	prep_of	11	SENT_144	[p10l661t1800r991b1880],
15	in	IN	O	in	_	0	SENT_144	[p10l1034t1801r1119b1879],
16	patients	NNS	O	patient	prep_in	14	SENT_144	[p10l1159t1801r1503b1901],
17	with	IN	O	with	_	0	SENT_144	[p10l1543t1800r1740b1880],
18	a	DT	O	a	prep_with	16	SENT_144	[p10l1781t1827r1826b1879],
19	detect	VB	O	detect	dep	26	SENT_144	[p10l1867t1800r2152b1880],
20	—	CD	NUMBER	—	npadvmod	21	SENT_144	[p10l1867t1800r2152b1880],
21	able	JJ	O	able	amod	23	SENT_144	[p10l10t1929r183b2008],
22	T79OM	NN	O	t79om	nn	23	SENT_144	[p10l206t1935r512b2008],
23	allele	NN	O	allele	dobj	19	SENT_144	[p10l540t1929r789b2025],
24	,	,	O	,	_	0	SENT_144	[p10l540t1929r789b2025],
25	as	IN	O	as	advmod	26	SENT_144	[p10l821t1955r907b2007],
26	compared	VBN	O	compare	_	0	SENT_144	[p10l938t1929r1368b2029],
27	with	IN	O	with	_	0	SENT_144	[p10l1391t1929r1588b2008],
28	16.5	CD	DURATION	16.5	num	29	SENT_144	[p10l1619t1935r1790b2008],
29	months	NNS	NUMBER	month	prep_with	26	SENT_144	[p10l1821t1929r2150b2008],
30	in	IN	O	in	_	0	SENT_144	[p10l10t2059r94b2136],
31	those	DT	O	those	prep_in	29	SENT_144	[p10l131t2058r364b2137],
32	Without	IN	O	without	_	0	SENT_144	[p10l396t2058r739b2138],
33	a	DT	O	a	det	38	SENT_144	[p10l769t2084r814b2136],
34	detectable	JJ	O	detectable	amod	38	SENT_144	[p10l849t2058r1286b2137],
35	allele	NN	O	allele	nn	38	SENT_144	[p10l1322t2058r1547b2136],
36	(	NN	O	(	nn	38	SENT_144	[p10l1589t2058r1917b2149],
37	hazard	NN	O	hazard	nn	38	SENT_144	[p10l1589t2058r1917b2149],
38	ratio	NN	O	ratio	prep_without	26	SENT_144	[p10l1953t2059r2152b2137],
39	for	IN	O	for	_	0	SENT_144	[p10l11t2186r135b2267],
40	progression	NN	O	progression	prep_for	38	SENT_144	[p10l174t2188r690b2289],
41	for	IN	O	for	_	0	SENT_144	[p10l733t2186r858b2267],
42	the	DT	O	the	det	44	SENT_144	[p10l898t2187r1032b2266],
43	T79OM	NN	O	t79om	nn	44	SENT_144	[p10l1072t2194r1377b2267],
44	allele	NN	O	allele	prep_for	26	SENT_144	[p10l1421t2187r1670b2284],
45	,	,	O	,	_	0	SENT_144	[p10l1421t2187r1670b2284],
46	11.5	CD	NUMBER	11.5	appos	44	SENT_144	[p10l1722t2193r1921b2284],
47	;	:	O	;	_	0	SENT_144	[p10l1722t2193r1921b2284],
48	95	CD	PERCENT	95	num	51	SENT_144	[p10l1968t2193r2154b2267],
49	%	NN	PERCENT	%	nn	51	SENT_144	[p10l1968t2193r2154b2267],
50	confidence	NN	O	confidence	nn	51	SENT_144	[p10l11t2315r488b2396],
51	interval	NN	O	interval	dep	44	SENT_144	[p10l533t2316r885b2413],
52	,	,	O	,	_	0	SENT_144	[p10l533t2316r885b2413],
53	2.94	CD	NUMBER	2.94	number	55	SENT_144	[p10l937t2323r1118b2396],
54	to	TO	O	to	dep	55	SENT_144	[p10l1165t2333r1247b2396],
55	45.1	CD	NUMBER	45.1	appos	51	SENT_144	[p10l1293t2323r1493b2413],
56	;	:	O	;	_	0	SENT_144	[p10l1293t2323r1493b2413],
57	P	NN	O	p	dep	44	SENT_144	[p10l1542t2322r1909b2408],
58	<	JJR	O	<	dep	57	SENT_144	[p10l1542t2322r1909b2408],
59	0.001	CD	NUMBER	0.001	num	60	SENT_144	[p10l1542t2322r1909b2408],
60	)	NN	O	)	dep	44	SENT_144	[p10l1542t2322r1909b2408],
61	(	CD	NUMBER	(	num	62	SENT_144	[p10l1966t2317r2147b2418],
62	Fig	NN	O	fig	dep	60	SENT_144	[p10l1966t2317r2147b2418],
63	.	.	O	.	_	0	SENT_144	[p10l1966t2317r2147b2418],

1	1	CD	NUMBER	1	_	0	SENT_145	[p10l14t2451r110b2536],
2	)	NN	O	)	dep	1	SENT_145	[p10l14t2451r110b2536],
3	.	.	O	.	_	0	SENT_145	[p10l14t2451r110b2536],

1	It	PRP	O	it	nsubj	3	SENT_146	[p10l157t2453r222b2523],
2	seems	VBZ	O	seem	cop	3	SENT_146	[p10l261t2471r523b2523],
3	likely	JJ	O	likely	_	0	SENT_146	[p10l566t2445r800b2545],
4	that	IN	O	that	complm	10	SENT_146	[p10l838t2445r1012b2523],
5	therapy	NN	O	therapy	nsubj	10	SENT_146	[p10l1050t2445r1374b2545],
6	with	IN	O	with	_	0	SENT_146	[p10l1408t2445r1605b2524],
7	tyrosine	NN	O	tyrosine	nn	9	SENT_146	[p10l1647t2446r1997b2545],
8	kinase	NN	O	kinase	nn	9	SENT_146	[p10l2039t2445r2152b2525, p10l11t2601r198b2654],
9	inhibitors	NNS	O	inhibitor	prep_with	5	SENT_146	[p10l238t2575r644b2655],
10	results	VBZ	O	result	ccomp	3	SENT_146	[p10l685t2575r958b2655],
11	in	IN	O	in	_	0	SENT_146	[p10l999t2576r1081b2654],
12	the	DT	O	the	det	13	SENT_146	[p10l1122t2575r1251b2654],
13	selection	NN	O	selection	prep_in	10	SENT_146	[p10l1293t2575r1657b2655],
14	of	IN	O	of	_	0	SENT_146	[p10l1698t2574r1796b2655],
15	the	DT	O	the	det	19	SENT_146	[p10l1818t2575r1948b2654],
16	pre	JJ	O	pre	amod	19	SENT_146	[p10l1986t2601r2152b2676],
17	—	NN	O	—	nn	19	SENT_146	[p10l1986t2601r2152b2676],
18	existing	VBG	O	exist	amod	19	SENT_146	[p10l11t2706r343b2807],
19	T79OM	NN	O	t79om	prep_of	13	SENT_146	[p10l381t2711r687b2785],
20	resistance	NN	O	resistance	nn	21	SENT_146	[p10l735t2706r1167b2784],
21	allele	NN	O	allele	dep	19	SENT_146	[p10l1215t2705r1463b2785],
22	.	.	O	.	_	0	SENT_146	[p10l1215t2705r1463b2785],

1	Such	JJ	O	such	amod	2	SENT_147	[p10l1519t2705r1722b2785],
2	selection	NN	O	selection	nsubjpass	5	SENT_147	[p10l1771t2705r2153b2785],
3	would	MD	O	would	aux	5	SENT_147	[p10l6t2834r274b2913],
4	be	VB	O	be	auxpass	5	SENT_147	[p10l317t2834r415b2913],
5	predicted	VBN	O	predict	_	0	SENT_147	[p10l455t2834r863b2934],
6	to	TO	O	to	aux	7	SENT_147	[p10l905t2851r987b2913],
7	contribute	VB	O	contribute	xcomp	5	SENT_147	[p10l1032t2834r1477b2913],
8	to	TO	O	to	_	0	SENT_147	[p10l1520t2851r1602b2913],
9	variation	NN	O	variation	prep_to	7	SENT_147	[p10l1641t2835r2028b2913],
10	in	IN	O	in	_	0	SENT_147	[p10l2069t2835r2153b2912],
11	the	DT	O	the	det	12	SENT_147	[p10l11t2964r145b3043],
12	duration	NN	O	duration	prep_in	9	SENT_147	[p10l178t2964r548b3044],
13	of	IN	O	of	_	0	SENT_147	[p10l580t2963r680b3044],
14	response	NN	O	response	prep_of	12	SENT_147	[p10l694t2990r1078b3065],
15	to	TO	O	to	_	0	SENT_147	[p10l1111t2981r1192b3044],
16	therapy	NN	O	therapy	prep_to	7	SENT_147	[p10l1227t2964r1551b3065],
17	with	IN	O	with	_	0	SENT_147	[p10l1574t2964r1770b3044],
18	tyrosine	NN	O	tyrosine	nn	20	SENT_147	[p10l1803t2965r2153b3065],
19	kinase	NN	O	kinase	nn	20	SENT_147	[p10l8t3089r278b3168],
20	inhibitors	NNS	O	inhibitor	prep_with	7	SENT_147	[p10l314t3089r720b3167],
21	in	IN	O	in	_	0	SENT_147	[p10l757t3089r839b3166],
22	patients	NNS	O	patient	prep_in	20	SENT_147	[p10l873t3089r1202b3189],
23	with	IN	O	with	_	0	SENT_147	[p10l1236t3089r1426b3168],
24	sensitizing	VBG	O	sensitize	amod	26	SENT_147	[p10l1465t3089r1915b3189],
25	EGFR	NN	ORGANIZATION	egfr	nn	26	SENT_147	[p10l1947t3095r2154b3168],
26	mutations	NNS	O	mutation	prep_with	22	SENT_147	[p10l8t3212r471b3291],
27	.	.	O	.	_	0	SENT_147	[p10l8t3212r471b3291],

1	DETECTION	NN	O	detection	_	0	SENT_148	[p10l13t3486r464b3535],
2	OF	IN	O	of	_	0	SENT_148	[p10l505t3486r608b3535],
3	EGFR	NN	O	egfr	nn	4	SENT_148	[p10l643t3486r841b3535],
4	MUTATIONS	NNS	O	mutation	prep_of	1	SENT_148	[p10l882t3486r1351b3535],
5	IN	IN	O	in	dep	1	SENT_148	[p10l1390t3486r1466b3535],
6	CIRCULATING	VBG	O	circulate	pcomp	5	SENT_148	[p10l1507t3486r2045b3535],
7	TUMOR	NN	O	tumor	nn	8	SENT_148	[p10l6t3571r298b3622],
8	CELLS	NNS	O	cell	dobj	6	SENT_148	[p10l333t3571r563b3622],
9	Having	VBG	O	have	aux	10	SENT_148	[p10l7t3680r321b3780],
10	established	VBN	O	establish	xcomp	6	SENT_148	[p10l361t3679r847b3758],
11	the	DT	O	the	det	12	SENT_148	[p10l890t3680r1023b3758],
12	reliability	NN	O	reliability	dobj	10	SENT_148	[p10l1066t3679r1483b3780],
13	of	IN	O	of	_	0	SENT_148	[p10l1521t3679r1621b3758],
14	the	DT	O	the	det	15	SENT_148	[p10l1646t3680r1779b3758],
15	SARMS	NNS	O	sarm	prep_of	12	SENT_148	[p10l1824t3685r2145b3763],

1	assay	NN	O	assay	nsubj	4	SENT_149	[p11l7t47r250b121],
2	,	,	O	,	_	0	SENT_149	[p11l7t47r250b121],
3	we	PRP	O	we	nsubj	4	SENT_149	[p11l288t47r407b100],
4	applied	VBD	O	apply	_	0	SENT_149	[p11l443t20r758b121],
5	it	PRP	O	it	dobj	4	SENT_149	[p11l795t21r854b99],
6	to	TO	O	to	_	0	SENT_149	[p11l886t37r968b99],
7	the	DT	O	the	det	8	SENT_149	[p11l1007t21r1141b99],
8	analysis	NN	O	analysis	prep_to	4	SENT_149	[p11l1177t21r1520b121],
9	of	IN	O	of	_	0	SENT_149	[p11l1560t20r1660b99],
10	circulating	VBG	O	circulate	prepc_of	8	SENT_149	[p11l1680t21r2150b121],
11	tumor	NN	O	tumor	nn	12	SENT_149	[p11l9t165r279b228],
12	cells	NNS	O	cell	dobj	10	SENT_149	[p11l324t149r512b227],
13	isolated	VBN	O	isolate	partmod	12	SENT_149	[p11l561t148r898b227],
14	from	IN	O	from	_	0	SENT_149	[p11l946t148r1157b227],
15	peripheral	JJ	O	peripheral	amod	16	SENT_149	[p11l1203t149r1648b249],
16	blood	NN	O	blood	prep_from	13	SENT_149	[p11l1696t149r1964b227],
17	.	.	O	.	_	0	SENT_149	[p11l1696t149r1964b227],

1	We	PRP	O	we	nsubj	3	SENT_150	[p11l2013t156r2148b227],
2	first	RB	ORDINAL	first	advmod	3	SENT_150	[p11l8t276r194b355],
3	compared	VBD	O	compare	_	0	SENT_150	[p11l240t276r670b377],
4	the	DT	O	the	det	6	SENT_150	[p11l721t277r854b355],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_150	[p11l904t283r1118b356],
6	mutations	NNS	O	mutation	dobj	3	SENT_150	[p11l1162t277r1600b356],
7	detected	VBN	O	detect	partmod	6	SENT_150	[p11l1653t276r2014b355],
8	in	IN	O	in	_	0	SENT_150	[p11l2064t277r2148b354],
9	circulating	VBG	O	circulate	prepc_in	7	SENT_150	[p11l10t405r480b505],
10	tumor	NN	O	tumor	nn	11	SENT_150	[p11l513t421r782b484],
11	cells	NNS	O	cell	dobj	9	SENT_150	[p11l816t405r1005b483],
12	by	IN	O	by	_	0	SENT_150	[p11l1043t405r1141b505],
13	SARMS	NN	O	sarm	prep_by	9	SENT_150	[p11l1175t410r1496b488],
14	with	IN	O	with	_	0	SENT_150	[p11l1530t405r1727b484],
15	those	DT	O	those	prep_with	9	SENT_150	[p11l1764t405r1997b483],
16	reported	VBN	O	report	partmod	15	SENT_150	[p11l2033t431r2146b483, p11l7t533r292b633],
17	for	IN	O	for	_	0	SENT_150	[p11l324t532r448b611],
18	the	DT	O	the	det	20	SENT_150	[p11l478t533r612b611],
19	tumor	NN	O	tumor	nn	20	SENT_150	[p11l644t549r914b612],
20	specimen	NN	O	specimen	prep_for	16	SENT_150	[p11l945t533r1354b633],
21	using	VBG	O	use	partmod	20	SENT_150	[p11l1386t533r1625b633],
22	either	CC	O	either	prep	21	SENT_150	[p11l1655t533r1903b611],
23	stanTable	JJ	O	stantable	dep	22	SENT_150	[p11l1934t549r2146b611, p11l119t690r193b715],

1	2	LS	NUMBER	2	_	0	SENT_151	[p11l202t693r224b715],
2	.	.	O	.	_	0	SENT_151	[p11l202t693r224b715],

1	Allele-Speciﬁc	JJ	O	allele-speciﬁc	amod	3	SENT_152	[p11l234t690r425b723],
2	SARMS	NNP	O	SARMS	nn	3	SENT_152	[p11l433t692r536b715],
3	Analysis	NN	O	analysis	_	0	SENT_152	[p11l544t690r658b723],
4	ofEGFR	NN	O	ofegfr	nn	5	SENT_152	[p11l667t690r780b715],
5	Mutations	NNS	O	mutation	dep	3	SENT_152	[p11l790t691r929b715],
6	in	IN	O	in	_	0	SENT_152	[p11l939t691r962b715],
7	Tumor	NN	O	tumor	nn	8	SENT_152	[p11l972t692r1064b715],
8	Samples	NNS	O	sample	prep_in	5	SENT_152	[p11l1072t690r1189b723],
9	and	CC	O	and	_	0	SENT_152	[p11l1198t690r1247b715],
10	Best	JJS	O	best	amod	12	SENT_152	[p11l1259t692r1317b715],
11	Clinical	JJ	O	clinical	amod	12	SENT_152	[p11l1326t690r1425b715],
12	Response	NN	O	response	prep_in	5	SENT_152	[p11l1437t692r1593b723],
13	.	.	O	.	_	0	SENT_152	[p11l1437t692r1593b723],

1	‘	SYM	O	‘	dep	3	SENT_153	[p11l1437t692r1593b723],
2	-	:	O	-	_	0	SENT_153	[p11l1437t692r1593b723],
3	"	``	O	"	_	0	SENT_153	[p11l1437t692r1593b723],
4	‘	IN	O	‘	prep	3	SENT_153	[p11l1437t692r1593b723],

1	Patient	NN	O	patient	nn	2	SENT_154	[p11l126t803r220b828],
2	No.	NN	O	no.	_	0	SENT_154	[p11l232t805r279b828],
3	and	CC	O	and	_	0	SENT_154	[p11l290t803r339b828],
4	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_154	[p11l352t805r429b828],
5	Mutation	NN	O	mutation	nn	6	SENT_154	[p11l167t841r289b865],
6	Status	NN	O	status	conj_and	2	SENT_154	[p11l301t842r387b865],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_155	[p11l121t1053r195b1076],
2	mutation	NN	O	mutation	_	0	SENT_155	[p11l204t1053r321b1076],
3	present	JJ	DATE	present	amod	2	SENT_155	[p11l333t1056r430b1084],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_156	[p11l541t805r618b828],
2	Mutation	NN	O	mutation	_	0	SENT_156	[p11l630t803r753b828],
3	by	IN	O	by	dep	2	SENT_156	[p11l548t840r578b873],
4	Sequencing	NN	O	sequencing	pobj	3	SENT_156	[p11l588t841r748b873],

1	Del	NNP	O	Del	_	0	SENT_157	[p11l517t1109r559b1134],
2	T751	CD	NUMBER	t751	num	1	SENT_157	[p11l569t1111r712b1135],
3	_	CD	NUMBER	_	num	4	SENT_157	[p11l569t1111r712b1135],
4	|	NN	O	|	dep	1	SENT_157	[p11l569t1111r712b1135],
5	759	CD	NUMBER	759	num	6	SENT_157	[p11l569t1111r712b1135],
6	insS	NN	O	inss	dep	1	SENT_157	[p11l724t1111r779b1134],

1	C7195	NN	O	c7195	nn	2	SENT_158	[p11l603t1168r691b1192],
2	L858R	NN	O	l858r	_	0	SENT_158	[p11l608t1226r689b1249],

1	Del	NNP	O	Del	nn	2	SENT_159	[p11l546t1282r587b1307],
2	E746Ji750	NNP	O	E746Ji750	_	0	SENT_159	[p11l601t1283r751b1308],

1	L861Q	NN	O	l861q	_	0	SENT_160	[p11l605t1341r692b1371],

1	Del	NNP	O	Del	_	0	SENT_161	[p11l546t1397r587b1422],
2	E746_A750	CD	NUMBER	e746_a750	dep	1	SENT_161	[p11l601t1398r751b1424],

1	L858R	NN	O	l858r	_	0	SENT_162	[p11l608t1456r689b1480],

1	Del	NNP	O	Del	nn	5	SENT_163	[p11l546t1512r587b1537],
2	E746_A750	NNP	O	E746_A750	nn	5	SENT_163	[p11l601t1514r751b1539],
3	Del	NNP	O	Del	nn	5	SENT_163	[p11l546t1570r587b1595],
4	E746_A750	NNP	O	E746_A750	nn	5	SENT_163	[p11l601t1571r751b1596],
5	Del	NNP	O	Del	_	0	SENT_163	[p11l514t1627r555b1653],
6	L747_P753	NNP	O	L747_P753	nn	11	SENT_163	[p11l569t1629r714b1654],
7	insS	NNP	O	insS	nn	11	SENT_163	[p11l727t1629r782b1653],
8	Del	NNP	O	Del	nn	11	SENT_163	[p11l513t1685r554b1710],
9	E746_S752	NNP	O	E746_S752	nn	11	SENT_163	[p11l568t1687r715b1712],
10	insV	NNP	O	insV	nn	11	SENT_163	[p11l727t1687r785b1710],
11	Del	NNP	O	Del	dep	5	SENT_163	[p11l546t1743r587b1768],
12	E746_A750	CD	NUMBER	e746_a750	dep	5	SENT_163	[p11l601t1744r751b1769],

1	L858R	NN	O	l858r	_	0	SENT_164	[p11l608t1802r689b1826],

1	Del	NNP	O	Del	_	0	SENT_165	[p11l546t1858r587b1883],
2	E746_A750	CD	NUMBER	e746_a750	dep	1	SENT_165	[p11l601t1860r751b1885],

1	L858R	NN	O	l858r	_	0	SENT_166	[p11l608t1917r689b1941],
2	L858R	NN	O	l858r	nn	3	SENT_166	[p11l608t1975r689b1999],
3	G719A	NN	O	g719a	dep	1	SENT_166	[p11l602t2033r694b2056],

1	Del	NNP	O	Del	dep	10	SENT_167	[p11l546t2088r587b2114],
2	E7464	CD	NUMBER	e7464	num	1	SENT_167	[p11l601t2090r751b2115],
3	°	CD	NUMBER	°	dep	1	SENT_167	[p11l601t2090r751b2115],
4	\	NN	O	\	dep	10	SENT_167	[p11l601t2090r751b2115],
5	750	CD	NUMBER	750	num	4	SENT_167	[p11l601t2090r751b2115],
6	Del	NNP	O	Del	nn	10	SENT_167	[p11l546t2146r587b2171],
7	E746_A750	NNP	O	E746_A750	nn	10	SENT_167	[p11l601t2148r751b2173],
8	Del	NNP	O	Del	nn	10	SENT_167	[p11l546t2204r587b2229],
9	E746_A750	NNP	O	E746_A750	nn	10	SENT_167	[p11l601t2205r751b2230],
10	Del	NNP	O	Del	_	0	SENT_167	[p11l546t2261r587b2287],
11	E7464	CD	NUMBER	e7464	number	12	SENT_167	[p11l601t2263r751b2288],
12	°	CD	NUMBER	°	dep	10	SENT_167	[p11l601t2263r751b2288],
13	\	NN	O	\	dep	12	SENT_167	[p11l601t2263r751b2288],
14	750	CD	NUMBER	750	num	13	SENT_167	[p11l601t2263r751b2288],

1	L858R	NN	O	l858r	_	0	SENT_168	[p11l608t2321r689b2344],

1	Del	NNP	O	Del	_	0	SENT_169	[p11l548t2377r589b2402],
2	L747_T751	CD	NUMBER	l747_t751	dep	1	SENT_169	[p11l603t2379r748b2403],

1	L858R	NN	O	l858r	_	0	SENT_170	[p11l608t2436r689b2460],

1	Del	NNP	O	Del	nn	4	SENT_171	[p11l546t2492r587b2517],
2	E746_A750	NNP	O	E746_A750	nn	4	SENT_171	[p11l601t2493r751b2519],
3	Del	NNP	O	Del	nn	4	SENT_171	[p11l507t2550r549b2575],
4	E746_A750	NNP	O	E746_A750	dep	5	SENT_171	[p11l562t2551r713b2576],
5	ins	VBZ	O	in	_	0	SENT_171	[p11l723t2552r790b2575],
6	|	CD	NUMBER	|	num	7	SENT_171	[p11l723t2552r790b2575],
7	P	NN	O	p	nsubj	5	SENT_171	[p11l723t2552r790b2575],

1	Duration	NN	O	duration	_	0	SENT_172	[p11l1544t766r1663b790],
2	of	IN	O	of	_	0	SENT_172	[p11l1675t765r1706b790],
3	Therapy	NN	O	therapy	prep_of	1	SENT_172	[p11l1710t765r1821b798],
4	with	IN	O	with	_	0	SENT_172	[p11l1541t803r1598b828],
5	Tyrosine	NN	ORGANIZATION	tyrosine	nn	10	SENT_172	[p11l1608t803r1723b836],
6	Kinase	NN	ORGANIZATION	kinase	nn	10	SENT_172	[p11l1735t803r1822b828],
7	Best	NN	ORGANIZATION	best	nn	10	SENT_172	[p11l1853t805r1911b828],
8	Clinical	JJ	ORGANIZATION	clinical	amod	10	SENT_172	[p11l1920t803r2019b828],
9	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_172	[p11l960t842r1037b865],
10	Mutation	NN	O	mutation	prep_with	3	SENT_172	[p11l1049t841r1172b865],
11	by	IN	O	by	_	0	SENT_172	[p11l1185t840r1214b873],
12	SARMS	NNP	O	SARMS	nn	13	SENT_172	[p11l1224t842r1327b865],
13	Assay'i	NNP	O	Assay'i	poss	15	SENT_172	[p11l1337t842r1434b873],
14	'	POS	O	'	_	0	SENT_172	[p11l1337t842r1434b873],
15	lnhibitor	NN	O	lnhibitor	prep_by	10	SENT_172	[p11l1615t840r1749b873],
16	:	:	O	:	_	0	SENT_172	[p11l1615t840r1749b873],
17	§	CD	NUMBER	§	dep	1	SENT_172	[p11l1615t840r1749b873],
18	:	:	O	:	_	0	SENT_172	[p11l1615t840r1749b873],
19	Response	NN	O	response	nn	21	SENT_172	[p11l1871t842r2002b873],
20	Primary	JJ	O	primary	amod	21	SENT_172	[p11l931t900r1034b931],
21	Mutation	NN	O	mutation	dep	17	SENT_172	[p11l920t938r1042b961],
22	T79OM	NN	O	t79om	dep	21	SENT_172	[p11l1159t937r1253b961],
23	Other	JJ	O	other	amod	22	SENT_172	[p11l1386t935r1465b961],

1	None	NN	O	none	nn	2	SENT_173	[p11l876t1111r948b1134],
2	detectedll	NN	O	detectedll	_	0	SENT_173	[p11l958t1109r1087b1141],

1	G719X	NN	O	g719x	nn	2	SENT_174	[p11l936t1168r1027b1192],
2	L858R	NN	O	l858r	_	0	SENT_174	[p11l941t1226r1023b1249],
3	Del	NNP	O	Del	nn	5	SENT_174	[p11l960t1282r1002b1307],
4	L861Q	NNP	O	L861Q	nn	5	SENT_174	[p11l938t1341r1025b1371],
5	Del	NNP	O	Del	dep	2	SENT_174	[p11l960t1397r1002b1422],
6	L858R	NNP	O	L858R	nn	8	SENT_174	[p11l941t1456r1023b1480],
7	Del	NNP	O	Del	nn	8	SENT_174	[p11l960t1512r1002b1537],
8	Del	NNP	O	Del	dep	2	SENT_174	[p11l960t1570r1002b1595],

1	Del	NNP	PERSON	Del	nn	2	SENT_175	[p11l960t1685r1002b1710],
2	Del	NNP	PERSON	Del	_	0	SENT_175	[p11l960t1743r1002b1768],

1	Del	NNP	O	Del	_	0	SENT_176	[p11l960t1858r1002b1883],

1	N	NN	O	n	nn	3	SENT_177	[p11l879t2711r893b2726],
2	ENGLJ	NN	O	englj	nn	3	SENT_177	[p11l908t2711r985b2733],
3	MED	NN	O	med	_	0	SENT_177	[p11l1000t2711r1052b2726],
4	359	CD	NUMBER	359	dep	3	SENT_177	[p11l1062t2711r1128b2733],
5	;	:	O	;	_	0	SENT_177	[p11l1062t2711r1128b2733],
6	/	:	O	/	punct	15	SENT_177	[p11l1062t2711r1128b2733],
7	1	CD	NUMBER	1	dep	15	SENT_177	[p11l1062t2711r1128b2733],
8	,	,	O	,	_	0	SENT_177	[p11l1062t2711r1128b2733],
9	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	10	SENT_177	[p11l1160t2711r1361b2733],
10	JULY	NNP	DATE	JULY	appos	7	SENT_177	[p11l1392t2711r1450b2733],
11	24	CD	DATE	24	num	10	SENT_177	[p11l1460t2711r1496b2733],
12	,	,	DATE	,	_	0	SENT_177	[p11l1460t2711r1496b2733],
13	2008	CD	DATE	2008	num	10	SENT_177	[p11l1507t2705r1570b2727],
14	The	DT	O	the	det	15	SENT_177	[p11l881t2744r932b2768],
15	New	NNP	LOCATION	New	dep	17	SENT_177	[p11l941t2745r1003b2768],
16	England	NNP	LOCATION	England	nn	17	SENT_177	[p11l1012t2744r1123b2775],
17	Joumal	NNP	O	Joumal	dep	4	SENT_177	[p11l1132t2744r1229b2768],
18	of	IN	O	of	_	0	SENT_177	[p11l1239t2744r1268b2768],
19	Medicine	NNP	O	Medicine	prep_of	17	SENT_177	[p11l1274t2744r1399b2768],

1	Copyright	NN	O	copyright	_	0	SENT_178	[p11l673t2826r808b2857],
2	©	CD	NUMBER	©	num	6	SENT_178	[p11l817t2826r840b2850],
3	2008	CD	DATE	2008	num	6	SENT_178	[p11l851t2826r915b2850],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_178	[p11l925t2826r1116b2850],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_178	[p11l1126t2826r1234b2850],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_178	[p11l1245t2826r1349b2857],
7	.	.	O	.	_	0	SENT_178	[p11l1245t2826r1349b2857],

1	All	DT	O	all	det	2	SENT_179	[p11l1361t2826r1402b2850],
2	rights	NNS	O	rights	nsubj	3	SENT_179	[p11l1411t2826r1486b2857],
3	reserved	VBN	O	reserve	_	0	SENT_179	[p11l1495t2826r1614b2850],
4	.	.	O	.	_	0	SENT_179	[p11l1495t2826r1614b2850],

1	DETECTION	NN	O	detection	_	0	SENT_180	[p11l308t2869r498b2888],
2	OF	IN	O	of	_	0	SENT_180	[p11l514t2869r553b2888],
3	MUTATIONS	NNP	O	MUTATIONS	prep_of	1	SENT_180	[p11l567t2869r762b2888],
4	IN	IN	O	in	_	0	SENT_180	[p11l778t2869r815b2888],
5	EGFR	NN	O	egfr	prep_in	1	SENT_180	[p11l830t2869r901b2888],
6	IN	IN	O	in	dep	1	SENT_180	[p11l914t2869r951b2888],
7	CIRCULATING	VBG	O	circulate	pcomp	6	SENT_180	[p11l966t2869r1197b2888],
8	LUNG-CANCER	NN	O	lung-cancer	nn	9	SENT_180	[p11l1212t2869r1457b2888],
9	CELLS	NNS	O	cell	dobj	7	SENT_180	[p11l1469t2869r1565b2888],

1	Table	NNP	O	Table	_	0	SENT_181	[p12l119t71r193b96],
2	2	CD	NUMBER	2	dep	1	SENT_181	[p12l202t74r225b96],
3	.	.	O	.	_	0	SENT_181	[p12l202t74r225b96],

1	(	RB	O	(	advmod	2	SENT_182	[p12l236t71r404b104],
2	Continued	VBN	O	continue	_	0	SENT_182	[p12l236t71r404b104],
3	.	.	O	.	_	0	SENT_182	[p12l236t71r404b104],
4	)	SYM	O	)	dep	2	SENT_182	[p12l236t71r404b104],

1	Duration	NN	O	duration	_	0	SENT_183	[p12l1544t147r1663b172],
2	of	IN	O	of	_	0	SENT_183	[p12l1675t146r1706b172],
3	Therapy	NN	O	therapy	prep_of	1	SENT_183	[p12l1710t146r1821b179],

1	Patient	NN	O	patient	nn	2	SENT_184	[p12l126t185r220b209],
2	No.	NN	O	no.	_	0	SENT_184	[p12l232t186r279b209],
3	and	CC	O	and	_	0	SENT_184	[p12l290t184r339b209],
4	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_184	[p12l352t186r429b209],
5	EGFR	NN	O	egfr	nn	6	SENT_184	[p12l542t186r619b209],
6	Mutation	NN	O	mutation	conj_and	2	SENT_184	[p12l630t185r753b209],
7	with	IN	O	with	_	0	SENT_184	[p12l1541t184r1598b209],
8	Tyrosine	NN	O	tyrosine	nn	13	SENT_184	[p12l1608t185r1724b217],
9	Kinase	NN	O	kinase	nn	13	SENT_184	[p12l1735t185r1822b209],
10	Best	NN	O	best	nn	13	SENT_184	[p12l1853t186r1911b209],
11	Clinical	JJ	O	clinical	amod	13	SENT_184	[p12l1920t184r2019b209],
12	Mutation	NN	O	mutation	nn	13	SENT_184	[p12l167t222r289b247],
13	Status	NN	O	status	prep_with	2	SENT_184	[p12l301t223r387b247],
14	by	IN	O	by	_	0	SENT_184	[p12l548t221r578b254],
15	Sequencing	NN	O	sequencing	nn	17	SENT_184	[p12l588t222r748b254],
16	EGFR	NN	O	egfr	nn	17	SENT_184	[p12l960t223r1037b247],
17	Mutation	NN	O	mutation	prep_by	13	SENT_184	[p12l1049t222r1172b247],
18	by	IN	O	by	_	0	SENT_184	[p12l1185t221r1214b254],
19	SARMS	NNP	O	SARMS	nn	20	SENT_184	[p12l1225t223r1327b247],
20	Assay'i	NNP	O	Assay'i	poss	22	SENT_184	[p12l1337t224r1435b255],
21	'	POS	O	'	_	0	SENT_184	[p12l1337t224r1435b255],
22	lnhibitor	NN	O	lnhibitor	prep_by	17	SENT_184	[p12l1615t221r1749b255],
23	:	:	O	:	_	0	SENT_184	[p12l1615t221r1749b255],
24	§	CD	NUMBER	§	dep	2	SENT_184	[p12l1615t221r1749b255],
25	:	:	O	:	_	0	SENT_184	[p12l1615t221r1749b255],
26	Response	NN	O	response	dep	24	SENT_184	[p12l1872t224r2002b254],

1	Primary	JJ	O	primary	amod	3	SENT_185	[p12l931t281r1034b312],
2	Mutation	NN	O	mutation	nn	3	SENT_185	[p12l920t319r1042b342],
3	T790M	NN	O	t790m	_	0	SENT_185	[p12l1159t318r1253b342],
4	Other	JJ	O	other	dep	3	SENT_185	[p12l1386t317r1465b342],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_186	[p12l122t435r197b458],
2	mutation	NN	O	mutation	_	0	SENT_186	[p12l208t435r330b458],
3	absent	JJ	O	absent	amod	2	SENT_186	[p12l341t433r432b458],

1	24	CD	NUMBER	24	num	2	SENT_187	[p12l170t493r201b515],
2	None	NN	O	none	nsubj	40	SENT_187	[p12l535t493r608b516],
3	(	CD	NUMBER	(	num	5	SENT_187	[p12l621t490r683b523],
4	wild	JJ	O	wild	amod	5	SENT_187	[p12l621t490r683b523],
5	type	NN	O	type	nsubj	24	SENT_187	[p12l693t493r759b523],
6	)	CD	NUMBER	)	num	7	SENT_187	[p12l693t493r759b523],
7	None	NN	O	none	nsubj	8	SENT_187	[p12l883t493r955b516],
8	detected	VBD	O	detect	rcmod	5	SENT_187	[p12l965t490r1080b516],
9	25	CD	NUMBER	25	num	10	SENT_187	[p12l170t550r199b573],
10	None	NN	O	none	dobj	8	SENT_187	[p12l535t550r608b573],
11	(	CD	NUMBER	(	num	13	SENT_187	[p12l621t548r683b581],
12	wild	JJ	O	wild	amod	13	SENT_187	[p12l621t548r683b581],
13	type	NN	O	type	dep	16	SENT_187	[p12l693t550r759b581],
14	)	CD	NUMBER	)	num	15	SENT_187	[p12l693t550r759b581],
15	None	NN	O	none	dep	13	SENT_187	[p12l883t550r955b573],
16	detected	VBD	O	detect	dep	8	SENT_187	[p12l965t548r1080b573],
17	26	CD	NUMBER	26	num	18	SENT_187	[p12l170t608r201b631],
18	None	NN	O	none	dobj	16	SENT_187	[p12l535t608r608b631],
19	(	CD	NUMBER	(	num	23	SENT_187	[p12l621t606r683b639],
20	wild	JJ	O	wild	amod	23	SENT_187	[p12l621t606r683b639],
21	type	NN	O	type	nn	23	SENT_187	[p12l693t608r759b639],
22	)	CD	NUMBER	)	num	23	SENT_187	[p12l693t608r759b639],
23	None	NN	O	none	nsubj	16	SENT_187	[p12l883t608r955b631],
24	detected	VBD	O	detect	rcmod	2	SENT_187	[p12l965t606r1080b631],
25	27	CD	NUMBER	27	num	26	SENT_187	[p12l170t666r201b688],
26	None	NN	O	none	dobj	24	SENT_187	[p12l535t666r608b689],
27	(	CD	NUMBER	(	num	29	SENT_187	[p12l621t663r683b696],
28	wild	JJ	O	wild	amod	29	SENT_187	[p12l621t663r683b696],
29	type	NN	O	type	dep	32	SENT_187	[p12l693t665r759b696],
30	)	CD	NUMBER	)	num	31	SENT_187	[p12l693t665r759b696],
31	None	NN	O	none	dep	29	SENT_187	[p12l883t666r955b689],
32	detected	VBD	O	detect	dep	24	SENT_187	[p12l965t663r1080b689],
33	41	CD	NUMBER	41	num	34	SENT_187	[p12l170t723r200b746],
34	None	NN	O	none	dobj	32	SENT_187	[p12l535t723r608b746],
35	(	CD	NUMBER	(	num	39	SENT_187	[p12l621t721r683b754],
36	wild	JJ	O	wild	amod	39	SENT_187	[p12l621t721r683b754],
37	type	NN	O	type	nn	39	SENT_187	[p12l693t723r759b754],
38	)	CD	NUMBER	)	num	39	SENT_187	[p12l693t723r759b754],
39	None	NN	O	none	nsubj	32	SENT_187	[p12l883t723r955b746],
40	detected	VBD	O	detect	_	0	SENT_187	[p12l965t721r1080b746],
41	42	CD	NUMBER	42	num	42	SENT_187	[p12l170t781r201b803],
42	None	NN	O	none	dobj	40	SENT_187	[p12l535t781r608b804],
43	(	CD	NUMBER	(	num	45	SENT_187	[p12l621t779r683b812],
44	wild	JJ	O	wild	amod	45	SENT_187	[p12l621t779r683b812],
45	type	NN	O	type	nsubj	64	SENT_187	[p12l693t781r759b812],
46	)	CD	NUMBER	)	num	47	SENT_187	[p12l693t781r759b812],
47	None	NN	O	none	nsubj	48	SENT_187	[p12l883t781r955b804],
48	detected	VBD	O	detect	rcmod	45	SENT_187	[p12l965t779r1080b804],
49	43	CD	NUMBER	43	num	50	SENT_187	[p12l170t838r199b861],
50	None	NN	O	none	dobj	48	SENT_187	[p12l535t839r608b861],
51	(	CD	NUMBER	(	num	53	SENT_187	[p12l621t836r683b869],
52	wild	JJ	O	wild	amod	53	SENT_187	[p12l621t836r683b869],
53	type	NN	O	type	dep	56	SENT_187	[p12l693t838r759b869],
54	)	CD	NUMBER	)	num	55	SENT_187	[p12l693t838r759b869],
55	None	NN	O	none	dep	53	SENT_187	[p12l883t839r955b861],
56	detected	VBD	O	detect	dep	48	SENT_187	[p12l965t836r1080b861],
57	44	CD	NUMBER	44	num	58	SENT_187	[p12l170t896r201b919],
58	None	NN	O	none	dobj	56	SENT_187	[p12l535t896r608b919],
59	(	CD	NUMBER	(	num	63	SENT_187	[p12l621t894r683b927],
60	wild	JJ	O	wild	amod	63	SENT_187	[p12l621t894r683b927],
61	type	NN	O	type	nn	63	SENT_187	[p12l693t896r759b927],
62	)	CD	NUMBER	)	num	63	SENT_187	[p12l693t896r759b927],
63	None	NN	O	none	nsubj	56	SENT_187	[p12l883t896r955b919],
64	detected	VBD	O	detect	rcmod	42	SENT_187	[p12l965t894r1080b919],

1	*	NN	O	*	nsubjpass	7	SENT_188	[p12l93t981r108b996],
2	The	DT	O	the	det	5	SENT_188	[p12l117t979r168b1004],
3	best	JJS	O	best	amod	5	SENT_188	[p12l180t979r236b1004],
4	clinical	JJ	O	clinical	amod	5	SENT_188	[p12l247t979r339b1004],
5	response	NN	O	response	dep	1	SENT_188	[p12l353t988r476b1011],
6	was	VBD	O	be	auxpass	7	SENT_188	[p12l486t988r537b1004],
7	defined	VBN	O	define	_	0	SENT_188	[p12l550t978r649b1004],
8	accordin	NN	O	accordin	nsubj	12	SENT_188	[p12l662t979r777b1004],
9	the	DT	O	the	det	12	SENT_188	[p12l843t979r886b1004],
10	Response	NN	O	response	nn	12	SENT_188	[p12l899t981r1029b1012],
11	Evaluation	NN	O	evaluation	nn	12	SENT_188	[p12l1043t979r1182b1004],
12	Criteria	NNS	O	criterion	xcomp	7	SENT_188	[p12l1195t981r1293b1004],
13	in	IN	O	in	_	0	SENT_188	[p12l1306t981r1328b1004],
14	Solid	JJ	O	solid	amod	16	SENT_188	[p12l1341t979r1407b1004],
15	Tumor	NN	O	tumor	nn	16	SENT_188	[p12l1419t981r1512b1004],
16	ECIST	NN	O	ecist	prep_in	12	SENT_188	[p12l1571t981r1670b1012],
17	)	CD	NUMBER	)	dep	16	SENT_188	[p12l1571t981r1670b1012],
18	.	.	O	.	_	0	SENT_188	[p12l1571t981r1670b1012],

1	CR	JJ	O	cr	nsubj	2	SENT_189	[p12l1682t981r1719b1004],
2	denotes	VBZ	O	denote	_	0	SENT_189	[p12l1731t979r1838b1004],
3	complete	JJ	O	complete	amod	4	SENT_189	[p12l1851t979r1977b1012],
4	response	NN	O	response	dobj	2	SENT_189	[p12l1990t988r2022b1004, p12l119t1025r223b1050],
5	,	,	O	,	_	0	SENT_189	[p12l1990t988r2022b1004, p12l119t1025r223b1050],
6	Del	NNP	O	Del	nn	7	SENT_189	[p12l238t1016r279b1042],
7	deletions	NNS	O	deletion	conj_and	4	SENT_189	[p12l292t1016r416b1042],
8	in	IN	O	in	_	0	SENT_189	[p12l429t1019r451b1041],
9	ex	FW	O	ex	prep_in	7	SENT_189	[p12l463t1025r491b1042],
10	9	CD	NUMBER	9	dep	7	SENT_189	[p12l554t1018r576b1046],
11	,	,	O	,	_	0	SENT_189	[p12l554t1018r576b1046],
12	NA	NNP	O	NA	conj_and	4	SENT_189	[p12l591t1018r632b1042],
13	not	RB	O	not	neg	14	SENT_189	[p12l644t1021r687b1042],
14	applic	JJ	O	applic	amod	12	SENT_189	[p12l699t1016r780b1050],
15	,	,	O	,	_	0	SENT_189	[p12l839t1038r843b1046],
16	PD	NN	O	pd	nn	18	SENT_189	[p12l858t1019r895b1041],
17	progressive	JJ	O	progressive	amod	18	SENT_189	[p12l909t1019r1065b1050],
18	disease	NN	O	disease	conj_and	4	SENT_189	[p12l1076t1016r1184b1046],
19	,	,	O	,	_	0	SENT_189	[p12l1076t1016r1184b1046],
20	PR	NN	O	pr	nn	22	SENT_189	[p12l1199t1019r1232b1041],
21	partial	JJ	O	partial	amod	22	SENT_189	[p12l1245t1016r1328b1049],
22	response	NN	O	response	conj_and	4	SENT_189	[p12l1342t1025r1472b1049],
23	,	,	O	,	_	0	SENT_189	[p12l1342t1025r1472b1049],
24	S	NN	O	s	nn	30	SENT_189	[p12l1485t1018r1499b1042],
25	S	NN	O	s	nn	30	SENT_189	[p12l1571t1018r1586b1042],
26	Scorpion	NNP	O	Scorpion	nn	30	SENT_189	[p12l1598t1018r1718b1049],
27	Ampliﬁcation	NNP	O	Ampliﬁcation	nn	30	SENT_189	[p12l1730t1016r1912b1050],
28	Refractory	NNP	O	Refractory	nn	30	SENT_189	[p12l1927t1016r2063b1050],
29	ation	NN	O	ation	nn	30	SENT_189	[p12l177t1056r243b1079],
30	System	NNP	O	System	dobj	2	SENT_189	[p12l256t1056r361b1087],
31	,	,	O	,	_	0	SENT_189	[p12l256t1056r361b1087],
32	and	CC	O	and	_	0	SENT_189	[p12l374t1054r422b1079],
33	SD	NN	O	sd	conj_and	4	SENT_189	[p12l435t1056r474b1079],
34	le	DT	O	le	det	35	SENT_189	[p12l545t1054r566b1079],
35	disease	NN	O	disease	dep	33	SENT_189	[p12l577t1054r685b1079],
36	.	.	O	.	_	0	SENT_189	[p12l577t1054r685b1079],

1	1	CD	NUMBER	1	num	5	SENT_190	[p12l94t1094r110b1125],
2	‘	CD	NUMBER	‘	num	5	SENT_190	[p12l94t1094r110b1125],
3	SARMS	NN	O	sarm	nn	5	SENT_190	[p12l180t1093r280b1117],
4	assay	NN	O	assay	nn	5	SENT_190	[p12l293t1100r366b1125],
5	groups	NNS	O	group	nsubj	9	SENT_190	[p12l377t1100r471b1125],
6	all	DT	O	all	det	8	SENT_190	[p12l483t1091r511b1117],
7	variant	JJ	O	variant	amod	8	SENT_190	[p12l523t1094r617b1117],
8	breakpoints	NNS	O	breakpoint	dep	5	SENT_190	[p12l629t1091r788b1125],
9	ofthe	VBP	O	ofthe	_	0	SENT_190	[p12l800t1091r878b1117],
10	in-fram	JJ	O	in-fram	amod	11	SENT_190	[p12l890t1091r986b1117],
11	x	NN	O	x	dobj	9	SENT_190	[p12l1041t1101r1054b1116],
12	9	CD	NUMBER	9	num	16	SENT_190	[p12l1117t1093r1141b1125],
13	)	CD	NUMBER	)	num	16	SENT_190	[p12l1117t1093r1141b1125],
14	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_190	[p12l1157t1093r1232b1117],
15	deletion	NN	O	deletion	nn	16	SENT_190	[p12l1243t1091r1351b1117],
16	mutations	NNS	O	mutation	dep	21	SENT_190	[p12l1365t1094r1502b1117],
17	as	IN	O	as	_	0	SENT_190	[p12l1515t1100r1542b1117],
18	a	DT	O	a	det	19	SENT_190	[p12l1555t1100r1567b1117],
19	si	FW	O	si	prep_as	16	SENT_190	[p12l1580t1094r1599b1117],
20	Del	NNP	O	Del	dep	21	SENT_190	[p12l1673t1091r1714b1117],
21	ation	NN	O	ation	dep	9	SENT_190	[p12l1784t1094r1850b1117],
22	and	CC	O	and	_	0	SENT_190	[p12l1863t1091r1911b1117],
23	all	DT	O	all	det	24	SENT_190	[p12l1925t1091r1952b1117],
24	mutations	NNS	O	mutation	conj_and	21	SENT_190	[p12l1967t1096r2044b1117, p12l118t1131r185b1153],
25	at	IN	O	at	_	0	SENT_190	[p12l197t1133r222b1153],
26	codon	NN	O	codon	prep_at	9	SENT_190	[p12l232t1128r315b1153],
27	719	CD	NUMBER	719	num	26	SENT_190	[p12l330t1130r375b1154],
28	as	IN	O	as	_	0	SENT_190	[p12l388t1137r415b1153],
29	G719X	NN	O	g719x	prep_as	26	SENT_190	[p12l427t1130r525b1154],
30	.	.	O	.	_	0	SENT_190	[p12l427t1130r525b1154],

1	The	DT	O	the	det	2	SENT_191	[p12l536t1128r587b1153],
2	presence	NN	O	presence	nsubj	7	SENT_191	[p12l599t1137r720b1161],
3	or	CC	O	or	_	0	SENT_191	[p12l731t1137r759b1153],
4	absence	NN	O	absence	nn	5	SENT_191	[p12l770t1128r880b1153],
5	ofT79O	NN	O	oft79o	nsubj	7	SENT_191	[p12l891t1128r994b1154],
6	'	''	O	'	_	0	SENT_191	[p12l1035t1131r1039b1134],
7	‘	JJ	O	‘	_	0	SENT_191	[p12l1067t1131r1071b1134],
8	icated	VBN	O	icate	partmod	7	SENT_191	[p12l1112t1128r1199b1153],
9	.	.	O	.	_	0	SENT_191	[p12l1112t1128r1199b1153],

1	Other	JJ	O	other	amod	2	SENT_192	[p12l1211t1128r1290b1153],
2	mutations	NNS	O	mutation	_	0	SENT_192	[p12l1302t1131r1440b1153],
3	that	WDT	O	that	dep	7	SENT_192	[p12l1451t1128r1504b1153],
4	were	VBD	O	be	cop	7	SENT_192	[p12l1514t1137r1578b1153],
5	i	FW	O	i	nn	7	SENT_192	[p12l1590t1131r1594b1153],
6	iﬁed	FW	O	iﬁed	nn	7	SENT_192	[p12l1661t1128r1715b1153],
7	w	FW	O	w	dep	2	SENT_192	[p12l1727t1131r1755b1153],
8	"	``	O	"	punct	12	SENT_192	[p12l1727t1131r1755b1153],
9	the	DT	O	the	det	12	SENT_192	[p12l1795t1128r1838b1153],
10	use	NN	O	use	nn	12	SENT_192	[p12l1850t1137r1895b1153],
11	ofthe	NN	O	ofthe	nn	12	SENT_192	[p12l1907t1128r1985b1153],
12	n	NN	O	n	dep	7	SENT_192	[p12l576t1174r589b1190],
13	they	PRP	O	they	nsubj	7	SENT_192	[p12l601t1165r658b1198],

1	SARMS	NN	O	sarm	nn	2	SENT_193	[p12l119t1166r220b1190],
2	assay	NN	O	assay	nsubjpass	4	SENT_193	[p12l232t1174r305b1198],
3	are	VBP	O	be	auxpass	4	SENT_193	[p12l316t1174r357b1190],
4	listed	VBN	O	list	_	0	SENT_193	[p12l369t1165r439b1190],
5	only	RB	O	only	prep	4	SENT_193	[p12l452t1165r508b1198],
6	whe	RB	O	whe	advmod	7	SENT_193	[p12l518t1165r572b1190],
7	present	JJ	DATE	present	pobj	5	SENT_193	[p12l744t1170r851b1198],
8	.	.	O	.	_	0	SENT_193	[p12l744t1170r851b1198],

1	Ii	NN	O	ii	_	0	SENT_194	[p12l94t1205r110b1236],
2	:	:	O	:	_	0	SENT_194	[p12l94t1205r110b1236],
3	When	WRB	O	when	advmod	9	SENT_194	[p12l118t1202r195b1228],
4	the	DT	O	the	det	5	SENT_194	[p12l207t1202r250b1228],
5	number	NN	O	number	nsubjpass	9	SENT_194	[p12l263t1202r369b1228],
6	of	IN	O	of	_	0	SENT_194	[p12l379t1202r409b1228],
7	months	NNS	DURATION	month	prep_of	5	SENT_194	[p12l417t1202r520b1228],
8	is	VBZ	O	be	auxpass	9	SENT_194	[p12l533t1205r552b1228],
9	preceded	VBN	O	precede	advcl	16	SENT_194	[p12l566t1202r688b1235],
10	“	CD	NUMBER	“	npadvmod	11	SENT_194	[p12l742t1204r793b1232],
11	>	JJR	O	>	acomp	9	SENT_194	[p12l742t1204r793b1232],
12	,	,	O	,	_	0	SENT_194	[p12l742t1204r793b1232],
13	”	NN	O	”	nn	14	SENT_194	[p12l742t1204r793b1232],
14	therapy	NN	O	therapy	nsubj	16	SENT_194	[p12l805t1202r907b1236],
15	was	VBD	O	be	aux	16	SENT_194	[p12l916t1211r967b1228],
16	oing	VBG	O	oe	dep	1	SENT_194	[p12l1033t1205r1099b1236],
17	.	.	O	.	_	0	SENT_194	[p12l1033t1205r1099b1236],

1	§	NN	O	§	nn	2	SENT_195	[p12l94t1239r104b1273],
2	mutation	NN	O	mutation	nsubj	11	SENT_195	[p12l181t1242r302b1265],
3	identified	VBN	O	identify	partmod	2	SENT_195	[p12l316t1239r441b1265],
4	by	IN	O	by	_	0	SENT_195	[p12l455t1239r484b1273],
5	sequencing	NN	O	sequencing	agent	3	SENT_195	[p12l495t1242r651b1273],
6	in	IN	O	in	_	0	SENT_195	[p12l663t1242r684b1264],
7	Patient	NN	O	patient	prep_in	5	SENT_195	[p12l699t1242r792b1265],
8	2	CD	NUMBER	2	num	7	SENT_195	[p12l803t1242r817b1264],
9	was	VBD	O	be	cop	11	SENT_195	[p12l828t1248r879b1265],
10	not	RB	O	not	neg	11	SENT_195	[p12l893t1244r936b1265],
11	wi	NN	O	wus	_	0	SENT_195	[p12l946t1242r974b1265],
12	i	FW	O	i	dep	11	SENT_195	[p12l1007t1242r1010b1264],
13	th	DT	O	th	det	14	SENT_195	[p12l1040t1239r1066b1265],
14	tection	NN	O	tection	dep	12	SENT_195	[p12l1127t1242r1219b1265],
15	capaci	FW	O	capaci	nn	14	SENT_195	[p12l1232t1242r1316b1272],
16	y	FW	O	y	dep	14	SENT_195	[p12l1329t1249r1342b1273],
17	the	DT	O	the	det	19	SENT_195	[p12l1388t1239r1431b1265],
18	SARMS	NN	O	sarm	nn	19	SENT_195	[p12l1443t1241r1543b1265],
19	assay	NN	O	assay	dep	12	SENT_195	[p12l1556t1248r1635b1273],
20	.	.	O	.	_	0	SENT_195	[p12l1556t1248r1635b1273],

1	In	IN	O	in	_	0	SENT_196	[p12l1650t1242r1672b1264],
2	Patients	NNS	O	patient	pobj	1	SENT_196	[p12l1687t1242r1794b1265],
3	30	CD	NUMBER	30	num	2	SENT_196	[p12l1807t1241r1838b1265],
4	and	CC	O	and	_	0	SENT_196	[p12l1849t1239r1897b1265],
5	31	CD	NUMBER	31	conj_and	2	SENT_196	[p12l1911t1241r1948b1269],
6	,	,	O	,	_	0	SENT_196	[p12l1911t1241r1948b1269],
7	a	DT	O	a	det	8	SENT_196	[p12l1961t1248r1974b1265],
8	secR	NN	O	secr	appos	2	SENT_196	[p12l1987t1248r2038b1265, p12l385t1279r401b1301],

1	all	DT	O	all	nsubj	2	SENT_197	[p12l412t1276r440b1302],
2	cted	VBD	O	cted	_	0	SENT_197	[p12l614t1276r669b1302],
3	at	IN	O	at	_	0	SENT_197	[p12l682t1281r706b1302],
4	low	JJ	O	low	prep_at	2	SENT_197	[p12l718t1276r764b1302],
5	the	DT	O	the	det	8	SENT_197	[p12l1227t1276r1270b1302],
6	pre	JJ	O	pre	amod	8	SENT_197	[p12l1283t1285r1324b1309],
7	activating	VBG	O	activate	amod	8	SENT_197	[p12l182t1279r314b1310],
8	EGF	NN	ORGANIZATION	egf	dobj	2	SENT_197	[p12l326t1278r384b1302],
9	ele	NN	O	ele	nsubj	12	SENT_197	[p12l444t1276r481b1302],
10	was	VBD	O	be	cop	12	SENT_197	[p12l491t1285r542b1302],
11	dete	JJ	O	dete	amod	12	SENT_197	[p12l554t1276r612b1302],
12	frequency	NN	O	frequency	rcmod	8	SENT_197	[p12l774t1276r907b1310],
13	(	CD	NUMBER	(	num	15	SENT_197	[p12l920t1276r1019b1310],
14	other	JJ	O	other	amod	15	SENT_197	[p12l920t1276r1019b1310],
15	)	NN	O	)	dep	12	SENT_197	[p12l920t1276r1019b1310],
16	,	,	O	,	_	0	SENT_197	[p12l920t1276r1019b1310],
17	in	IN	O	in	_	0	SENT_197	[p12l1033t1279r1055b1301],
18	ition	NN	O	ition	prep_in	12	SENT_197	[p12l1120t1279r1178b1302],
19	to	TO	O	to	_	0	SENT_197	[p12l1190t1281r1217b1302],
20	nt	NNS	O	nt	prep_to	18	SENT_197	[p12l1382t1281r1408b1302],
21	activating	VBG	O	activate	partmod	20	SENT_197	[p12l1419t1279r1550b1310],
22	mutation	NN	O	mutation	dobj	21	SENT_197	[p12l1563t1279r1684b1302],
23	(	CD	NUMBER	(	num	25	SENT_197	[p12l1700t1278r1814b1310],
24	primary	JJ	O	primary	amod	25	SENT_197	[p12l1700t1278r1814b1310],
25	mutati	NNS	O	mutatus	dep	22	SENT_197	[p12l1826t1279r1913b1302],
26	.	.	O	.	_	0	SENT_197	[p12l1965t1298r1969b1302],

1	1	CD	NUMBER	1	num	2	SENT_198	[p12l94t1313r110b1346],
2	]	CD	NUMBER	]	nsubjpass	11	SENT_198	[p12l94t1313r110b1346],
3	In	IN	O	in	dep	2	SENT_198	[p12l121t1316r143b1338],
4	these	DT	O	these	det	5	SENT_198	[p12l155t1313r228b1339],
5	patients	NNS	O	patient	pobj	3	SENT_198	[p12l241t1316r356b1347],
6	,	,	O	,	_	0	SENT_198	[p12l241t1316r356b1347],
7	either	CC	O	either	dep	3	SENT_198	[p12l368t1313r446b1339],
8	geﬁtini	NNS	O	geﬁtini	conj	3	SENT_198	[p12l457t1313r548b1347],
9	erlotinib	NN	O	erlotinib	dep	8	SENT_198	[p12l617t1313r729b1339],
10	was	VBD	O	be	auxpass	11	SENT_198	[p12l740t1322r791b1339],
11	administered	VBN	O	administer	_	0	SENT_198	[p12l803t1313r982b1339],
12	as	IN	O	as	_	0	SENT_198	[p12l995t1322r1022b1339],
13	second-line	NN	O	second-line	prep_as	11	SENT_198	[p12l1035t1313r1191b1339],
14	or	CC	O	or	_	0	SENT_198	[p12l1202t1322r1230b1339],
15	third-line	JJ	O	third-line	amod	16	SENT_198	[p12l1240t1313r1363b1339],
16	therapy	NN	O	therapy	conj_or	13	SENT_198	[p12l1373t1313r1482b1347],
17	.	.	O	.	_	0	SENT_198	[p12l1373t1313r1482b1347],

1	In	IN	O	in	_	0	SENT_199	[p12l1497t1316r1519b1338],
2	all	DT	O	all	det	4	SENT_199	[p12l1532t1313r1560b1339],
3	other	JJ	O	other	amod	4	SENT_199	[p12l1573t1313r1644b1339],
4	patients	NNS	O	patient	prep_in	9	SENT_199	[p12l1656t1316r1771b1346],
5	,	,	O	,	_	0	SENT_199	[p12l1656t1316r1771b1346],
6	the	DT	O	the	det	7	SENT_199	[p12l1783t1313r1826b1339],
7	drugs	NNS	O	drug	nsubj	9	SENT_199	[p12l1837t1313r1913b1347],
8	e	LS	O	e	dep	9	SENT_199	[p12l1974t1322r1988b1339],
9	administered	VBN	O	administer	_	0	SENT_199	[p12l1999t1313r2040b1339, p12l120t1350r263b1375],
10	as	IN	O	as	_	0	SENT_199	[p12l277t1359r304b1375],
11	first-line	JJ	O	first-line	amod	12	SENT_199	[p12l316t1350r427b1375],
12	therapy	NN	O	therapy	prep_as	9	SENT_199	[p12l438t1350r540b1383],
13	dvanced	JJ	O	dvanced	amod	14	SENT_199	[p12l614t1350r725b1375],
14	cancers	NNS	O	cancer	dep	12	SENT_199	[p12l738t1359r849b1375],
15	.	.	O	.	_	0	SENT_199	[p12l738t1359r849b1375],

1	dard	NN	O	dard	_	0	SENT_200	[p12l8t1606r204b1685],
2	sequencing	NN	O	sequencing	dep	1	SENT_200	[p12l254t1607r743b1707],
3	or	CC	O	or	_	0	SENT_200	[p12l790t1632r879b1685],
4	SARMS	NN	O	sarm	dep	1	SENT_200	[p12l927t1611r1274b1689],
5	.	.	O	.	_	0	SENT_200	[p12l927t1611r1274b1689],

1	Among	IN	O	among	_	0	SENT_201	[p12l1324t1613r1647b1707],
2	specimens	NNS	O	specimen	prep_among	18	SENT_201	[p12l1694t1607r2145b1706],
3	from	IN	O	from	_	0	SENT_201	[p12l7t1733r219b1813],
4	20	CD	NUMBER	20	num	5	SENT_201	[p12l258t1740r358b1813],
5	patients	NNS	O	patient	prep_from	2	SENT_201	[p12l397t1735r741b1834],
6	that	WDT	O	that	nsubj	8	SENT_201	[p12l783t1734r956b1812],
7	were	VBD	O	be	cop	8	SENT_201	[p12l985t1760r1189b1813],
8	available	JJ	O	available	rcmod	5	SENT_201	[p12l1227t1734r1602b1813],
9	for	IN	O	for	_	0	SENT_201	[p12l1641t1733r1765b1813],
10	molecular	JJ	O	molecular	amod	11	SENT_201	[p12l1801t1734r2145b1813, p12l6t1862r123b1941],
11	analysis	NN	O	analysis	prep_for	8	SENT_201	[p12l172t1862r515b1963],
12	of	IN	O	of	_	0	SENT_201	[p12l571t1861r672b1941],
13	circulating	VBG	O	circulate	prepc_of	11	SENT_201	[p12l707t1862r1178b1964],
14	tumor	NN	O	tumor	nn	15	SENT_201	[p12l1228t1879r1498b1942],
15	cells	NNS	O	cell	dobj	13	SENT_201	[p12l1549t1862r1762b1959],
16	,	,	O	,	_	0	SENT_201	[p12l1549t1862r1762b1959],
17	SARMS	NN	O	sarm	nsubj	18	SENT_201	[p12l1824t1868r2144b1946],
18	identified	VBD	O	identify	_	0	SENT_201	[p12l7t1990r427b2070],
19	EGFR	NN	ORGANIZATION	egfr	nn	20	SENT_201	[p12l475t1998r689b2071],
20	mutations	NNS	O	mutation	dobj	18	SENT_201	[p12l733t1992r1170b2070],
21	in	IN	O	in	_	0	SENT_201	[p12l1222t1992r1305b2068],
22	19	CD	NUMBER	19	num	23	SENT_201	[p12l1358t1996r1455b2070],
23	patients	NNS	O	patient	prep_in	18	SENT_201	[p12l1504t1992r1849b2091],
24	(	IN	O	(	_	0	SENT_201	[p12l1905t1996r2141b2082],
25	95	CD	PERCENT	95	num	26	SENT_201	[p12l1905t1996r2141b2082],
26	%	NN	PERCENT	%	prep_(	18	SENT_201	[p12l1905t1996r2141b2082],
27	)	CD	NUMBER	)	dep	26	SENT_201	[p12l1905t1996r2141b2082],

1	(	RB	O	(	advmod	4	SENT_202	[p12l12t2119r277b2210],
2	Table	NNP	O	Table	dep	3	SENT_202	[p12l12t2119r277b2210],
3	3	CD	NUMBER	3	amod	4	SENT_202	[p12l327t2124r426b2210],
4	)	NN	O	)	_	0	SENT_202	[p12l327t2124r426b2210],
5	.	.	O	.	_	0	SENT_202	[p12l327t2124r426b2210],

1	In	IN	O	in	_	0	SENT_203	[p12l478t2126r567b2196],
2	addition	NN	O	addition	_	0	SENT_203	[p12l613t2119r972b2198],
3	to	TO	O	to	_	0	SENT_203	[p12l1020t2136r1102b2198],
4	the	DT	O	the	det	7	SENT_203	[p12l1151t2119r1284b2197],
5	primary	JJ	O	primary	amod	7	SENT_203	[p12l1331t2120r1683b2219],
6	activating	VBG	O	activate	amod	7	SENT_203	[p12l1725t2120r2150b2220],
7	mutation	NN	O	mutation	prep_in_addition_to	11	SENT_203	[p12l7t2248r426b2343],
8	,	,	O	,	_	0	SENT_203	[p12l7t2248r426b2343],
9	T790M	NN	O	t790m	nsubjpass	11	SENT_203	[p12l465t2252r770b2326],
10	was	VBD	O	be	auxpass	11	SENT_203	[p12l803t2273r967b2326],
11	detected	VBN	O	detect	_	0	SENT_203	[p12l1007t2247r1367b2326],
12	in	IN	O	in	_	0	SENT_203	[p12l1403t2248r1487b2324],
13	circulating	VBG	O	circulate	prepc_in	11	SENT_203	[p12l1524t2247r1995b2348],
14	tumor	NN	O	tumor	nn	15	SENT_203	[p12l2029t2264r2145b2326, p12l7t2401r185b2453],
15	cells	NNS	O	cell	dobj	13	SENT_203	[p12l223t2375r412b2453],
16	from	IN	O	from	_	0	SENT_203	[p12l455t2374r667b2454],
17	2	CD	TIME	2	prep_from	13	SENT_203	[p12l708t2381r755b2452],
18	of	IN	TIME	of	_	0	SENT_203	[p12l798t2374r899b2454],
19	6	CD	TIME	6	num	20	SENT_203	[p12l921t2381r968b2454],
20	patients	NNS	O	patient	prep_of	17	SENT_203	[p12l1009t2376r1353b2475],
21	(	CD	NUMBER	(	number	22	SENT_203	[p12l1401t2380r1637b2466],
22	330/0	CD	NUMBER	330/0	num	23	SENT_203	[p12l1401t2380r1637b2466],
23	)	NN	O	)	dep	20	SENT_203	[p12l1401t2380r1637b2466],
24	who	WP	O	who	nsubj	25	SENT_203	[p12l1679t2375r1863b2455],
25	had	VBD	O	have	rcmod	20	SENT_203	[p12l1905t2375r2063b2454],
26	a	DT	O	a	det	27	SENT_203	[p12l2103t2401r2148b2453],
27	response	NN	O	response	dobj	25	SENT_203	[p12l7t2529r391b2603],
28	to	TO	O	to	_	0	SENT_203	[p12l432t2520r515b2582],
29	tyrosine	NN	O	tyrosine	nn	31	SENT_203	[p12l557t2504r906b2603],
30	kinase	NN	O	kinase	nn	31	SENT_203	[p12l946t2503r1228b2582],
31	inhibitors	NNS	O	inhibitor	prep_to	27	SENT_203	[p12l1268t2503r1693b2582],
32	and	CC	O	and	_	0	SENT_203	[p12l1735t2503r1894b2582],
33	from	IN	O	from	_	0	SENT_203	[p12l1935t2502r2146b2582],
34	9	CD	TIME	9	prep_from	27	SENT_203	[p12l7t2637r55b2711],
35	of	IN	TIME	of	_	0	SENT_203	[p12l94t2630r195b2710],
36	14	CD	TIME	14	num	37	SENT_203	[p12l217t2637r310b2710],
37	patients	NNS	O	patient	prep_of	34	SENT_203	[p12l346t2632r690b2732],
38	(	IN	O	(	_	0	SENT_203	[p12l735t2636r972b2723],
39	64	CD	PERCENT	64	num	41	SENT_203	[p12l735t2636r972b2723],
40	%	NN	PERCENT	%	nn	41	SENT_203	[p12l735t2636r972b2723],
41	)	NN	O	)	prep_(	25	SENT_203	[p12l735t2636r972b2723],
42	who	WP	O	who	nsubj	43	SENT_203	[p12l1011t2631r1195b2711],
43	had	VBD	O	have	rcmod	41	SENT_203	[p12l1234t2631r1391b2710],
44	clinical	JJ	O	clinical	amod	45	SENT_203	[p12l1430t2631r1746b2710],
45	progression	NN	O	progression	dobj	43	SENT_203	[p12l1781t2657r2145b2733, p12l9t2761r186b2840],
46	(	CD	NUMBER	(	num	49	SENT_203	[p12l231t2766r634b2852],
47	P	NN	O	p	nn	49	SENT_203	[p12l231t2766r634b2852],
48	=	JJ	O	=	amod	49	SENT_203	[p12l231t2766r634b2852],
49	O.	NNP	O	O.	dep	45	SENT_203	[p12l231t2766r634b2852],
50	34	CD	NUMBER	34	number	51	SENT_203	[p12l231t2766r634b2852],
51	)	CD	NUMBER	)	dep	49	SENT_203	[p12l231t2766r634b2852],
52	.	.	O	.	_	0	SENT_203	[p12l231t2766r634b2852],

1	This	DT	O	this	det	2	SENT_204	[p12l677t2760r866b2839],
2	finding	NN	O	finding	nsubj	4	SENT_204	[p12l909t2759r1236b2862],
3	was	VBD	O	be	cop	4	SENT_204	[p12l1268t2786r1433b2840],
4	consistent	JJ	O	consistent	_	0	SENT_204	[p12l1476t2761r1919b2839],
5	with	IN	O	with	_	0	SENT_204	[p12l1950t2760r2146b2840],
6	the	DT	O	the	det	8	SENT_204	[p12l8t2889r142b2967],
7	reported	VBN	O	report	amod	8	SENT_204	[p12l174t2889r543b2989],
8	prevalence	NN	O	prevalence	prep_with	4	SENT_204	[p12l573t2889r1031b2989],
9	of	IN	O	of	_	0	SENT_204	[p12l1063t2888r1164b2968],
10	T	NN	O	t	prep_of	8	SENT_204	[p12l1174t2895r1236b2966],
11	790M	CD	NUMBER	790m	number	12	SENT_204	[p12l1240t2895r1478b2968],
12	(	CD	NUMBER	(	num	10	SENT_204	[p12l1517t2889r1787b2980],
13	about	IN	O	about	_	0	SENT_204	[p12l1517t2889r1787b2980],
14	50	CD	PERCENT	50	number	15	SENT_204	[p12l1816t2894r2026b2980],
15	%	NN	PERCENT	%	amod	16	SENT_204	[p12l1816t2894r2026b2980],
16	)	CD	NUMBER	)	prep_about	8	SENT_204	[p12l1816t2894r2026b2980],
17	in	IN	O	in	_	0	SENT_204	[p12l2063t2890r2147b2966],
18	patients	NNS	O	patient	prep_in	16	SENT_204	[p12l6t3019r350b3118],
19	with	IN	O	with	_	0	SENT_204	[p12l377t3018r573b3097],
20	the	DT	O	the	det	22	SENT_204	[p12l603t3018r737b3096],
21	EGFR	NN	ORGANIZATION	egfr	nn	22	SENT_204	[p12l764t3024r979b3098],
22	mutation	NN	O	mutation	prep_with	18	SENT_204	[p12l1001t3019r1396b3097],
23	Who	WP	O	who	nsubj	25	SENT_204	[p12l1422t3018r1606b3097],
24	were	VBD	O	be	aux	25	SENT_204	[p12l1631t3044r1835b3097],
25	undergoing	VBG	O	undergo	rcmod	16	SENT_204	[p12l1864t3018r2145b3097, p12l7t3147r257b3248],
26	repeat	NN	O	repeat	nn	28	SENT_204	[p12l287t3163r556b3247],
27	tumor	NN	O	tumor	nn	28	SENT_204	[p12l586t3163r855b3226],
28	biopsy	NN	O	biopsy	dobj	25	SENT_204	[p12l886t3146r1167b3247],
29	after	IN	O	after	_	0	SENT_204	[p12l1196t3145r1399b3225],
30	the	DT	O	the	det	31	SENT_204	[p12l1430t3146r1564b3225],
31	development	NN	O	development	prep_after	28	SENT_204	[p12l1599t3146r2152b3247],
32	of	IN	O	of	_	0	SENT_204	[p12l8t3274r109b3353],
33	resistance	NN	O	resistance	prep_of	31	SENT_204	[p12l125t3276r557b3353],
34	to	TO	O	to	_	0	SENT_204	[p12l593t3292r675b3354],
35	tyrosine	NN	O	tyrosine	nn	37	SENT_204	[p12l712t3276r1061b3375],
36	kinase	NN	O	kinase	nn	37	SENT_204	[p12l1095t3275r1377b3355],
37	inhibitors	NNS	O	inhibitor	prep_to	25	SENT_204	[p12l1411t3275r1938b3354],
38	.	.	O	.	_	0	SENT_204	[p12l1411t3275r1938b3354],

1	”	NN	O	”	_	0	SENT_205	[p12l1411t3275r1938b3354],

1	A	DT	O	a	det	3	SENT_206	[p12l134t3411r200b3480],
2	recent	JJ	O	recent	amod	3	SENT_206	[p12l235t3420r502b3481],
3	study	NN	O	study	nsubj	4	SENT_206	[p12l536t3403r768b3503],
4	reported	VBD	O	report	_	0	SENT_206	[p12l802t3403r1171b3503],
5	the	DT	O	the	det	6	SENT_206	[p12l1209t3403r1343b3481],
6	detection	NN	O	detection	dobj	4	SENT_206	[p12l1382t3403r1782b3482],
7	of	IN	O	of	_	0	SENT_206	[p12l1821t3402r1921b3482],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_206	[p12l1939t3410r2153b3483],
9	mutations	NNS	O	mutation	prep_of	6	SENT_206	[p12l7t3532r446b3610],
10	with	IN	O	with	_	0	SENT_206	[p12l491t3531r688b3610],
11	the	DT	O	the	det	12	SENT_206	[p12l735t3531r869b3609],
12	use	NN	O	use	prep_with	4	SENT_206	[p12l917t3557r1058b3610],
13	of	IN	O	of	_	0	SENT_206	[p12l1107t3530r1208b3610],
14	the	DT	O	the	det	16	SENT_206	[p12l1237t3531r1371b3609],
15	SARMS	NN	O	sarm	nn	16	SENT_206	[p12l1421t3537r1742b3614],
16	assay	NN	O	assay	prep_of	12	SENT_206	[p12l1792t3557r2021b3631],
17	in	IN	O	in	_	0	SENT_206	[p12l2063t3532r2148b3608],
18	free	JJ	O	free	amod	20	SENT_206	[p12l7t3658r171b3737],
19	plasma	NN	O	plasma	nn	20	SENT_206	[p12l213t3659r526b3759],
20	DNA	NN	O	dna	prep_in	16	SENT_206	[p12l567t3666r777b3738],
21	from	IN	O	from	_	0	SENT_206	[p12l817t3658r1029b3738],
22	patients	NNS	O	patient	prep_from	4	SENT_206	[p12l1071t3660r1416b3759],
23	with	IN	O	with	_	0	SENT_206	[p12l1457t3659r1654b3738],
24	metastatic	JJ	O	metastatic	amod	29	SENT_206	[p12l1697t3660r2148b3737],
25	non	JJ	O	non	amod	29	SENT_206	[p13l7t21r641b100],
26	—	NN	O	—	nn	29	SENT_206	[p13l7t21r641b100],
27	small-cell	NN	O	small-cell	nn	29	SENT_206	[p13l7t21r641b100],
28	lung	NN	O	lung	nn	29	SENT_206	[p13l677t21r868b123],
29	cancer	NN	O	cancer	prep_with	22	SENT_206	[p13l902t26r1275b100],
30	.	.	O	.	_	0	SENT_206	[p13l902t26r1275b100],

1	“	NN	O	“	ccomp	5	SENT_207	[p13l902t26r1275b100],
2	Therefore	RB	O	therefore	advmod	1	SENT_207	[p13l1307t20r1741b118],
3	,	,	O	,	_	0	SENT_207	[p13l1307t20r1741b118],
4	we	PRP	O	we	nsubj	5	SENT_207	[p13l1779t47r1897b101],
5	studied	VBD	O	study	dep	38	SENT_207	[p13l1935t21r2145b101, p13l7t150r131b228],
6	the	DT	O	the	det	7	SENT_207	[p13l176t150r309b228],
7	accuracy	NN	O	accuracy	dobj	5	SENT_207	[p13l354t176r729b250],
8	of	IN	O	of	_	0	SENT_207	[p13l771t149r872b229],
9	mutational	JJ	O	mutational	amod	10	SENT_207	[p13l898t150r1375b229],
10	analysis	NN	O	analysis	prep_of	7	SENT_207	[p13l1419t150r1762b250],
11	in	IN	O	in	_	0	SENT_207	[p13l1809t151r1893b227],
12	purified	VBN	O	purify	prep_in	5	SENT_207	[p13l1937t151r2145b250, p13l7t277r171b358],
13	circulating	VBG	O	circulate	xcomp	12	SENT_207	[p13l207t278r667b380],
14	tumor	NN	O	tumor	nn	15	SENT_207	[p13l699t295r964b358],
15	cells	NNS	O	cell	dobj	13	SENT_207	[p13l997t278r1182b357],
16	and	CC	O	and	_	0	SENT_207	[p13l1218t278r1374b357],
17	free	JJ	O	free	amod	19	SENT_207	[p13l1409t277r1569b357],
18	plasma	NN	O	plasma	nn	19	SENT_207	[p13l1603t278r1910b379],
19	DNA	NN	O	dna	nsubj	20	SENT_207	[p13l1942t285r2150b358],
20	using	VBG	O	use	conj_and	12	SENT_207	[p13l7t408r247b509],
21	blood	NN	O	blood	nn	22	SENT_207	[p13l280t407r525b487],
22	samples	NNS	O	sample	dobj	20	SENT_207	[p13l562t407r910b508],
23	from	IN	O	from	_	0	SENT_207	[p13l947t406r1160b486],
24	18	CD	NUMBER	18	num	25	SENT_207	[p13l1199t413r1293b486],
25	patients	NNS	O	patient	prep_from	20	SENT_207	[p13l1331t408r1674b508],
26	with	IN	O	with	_	0	SENT_207	[p13l1709t407r1906b487],
27	EGFR	NN	ORGANIZATION	egfr	nn	29	SENT_207	[p13l1939t414r2154b487],
28	mutant	JJ	O	mutant	amod	29	SENT_207	[p13l7t554r323b616],
29	tumors	NNS	O	tumor	prep_with	25	SENT_207	[p13l379t554r689b616],
30	and	CC	O	and	_	0	SENT_207	[p13l750t537r909b615],
31	3	CD	NUMBER	3	num	32	SENT_207	[p13l970t542r1014b616],
32	controls	NNS	O	control	prep_in	5	SENT_207	[p13l1078t537r1428b616],
33	With	IN	O	with	_	0	SENT_207	[p13l1485t537r1682b616],
34	wild	JJ	O	wild	amod	37	SENT_207	[p13l1738t537r2147b637],
35	—	NN	O	—	nn	37	SENT_207	[p13l1738t537r2147b637],
36	type	NN	O	type	nn	37	SENT_207	[p13l1738t537r2147b637],
37	tumors	NNS	O	tumor	prep_with	32	SENT_207	[p13l9t682r317b744],
38	(	VBP	O	(	_	0	SENT_207	[p13l377t665r640b756],
39	Table	NNP	O	Table	dobj	38	SENT_207	[p13l377t665r640b756],
40	3	CD	NUMBER	3	num	41	SENT_207	[p13l696t671r794b756],
41	)	NN	O	)	nsubj	38	SENT_207	[p13l696t671r794b756],
42	.	.	O	.	_	0	SENT_207	[p13l696t671r794b756],

1	The	DT	O	the	det	3	SENT_208	[p13l849t665r1011b743],
2	SARMS	NN	O	sarm	nn	3	SENT_208	[p13l1066t671r1385b748],
3	assay	NN	O	assay	nsubj	4	SENT_208	[p13l1440t691r1668b765],
4	identified	VBD	O	identify	dep	27	SENT_208	[p13l1716t664r2134b743],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_208	[p13l7t800r216b873],
6	mutations	NNS	O	mutation	dobj	4	SENT_208	[p13l243t794r670b872],
7	in	IN	O	in	_	0	SENT_208	[p13l705t794r787b870],
8	17	CD	TIME	17	prep_in	4	SENT_208	[p13l824t799r917b871],
9	of	IN	TIME	of	_	0	SENT_208	[p13l953t792r1052b872],
10	18	CD	TIME	18	num	11	SENT_208	[p13l1071t799r1163b872],
11	specimens	NNS	O	specimen	prep_of	8	SENT_208	[p13l1201t794r1641b893],
12	of	IN	O	of	_	0	SENT_208	[p13l1677t792r1776b872],
13	circulating	VBG	O	circulate	prepc_of	11	SENT_208	[p13l1793t793r2132b872, p13l8t922r143b1022],
14	tumor	NN	O	tumor	nn	15	SENT_208	[p13l176t938r436b1000],
15	cells	NNS	O	cell	nsubj	16	SENT_208	[p13l469t921r648b999],
16	(	VBP	O	(	ccomp	13	SENT_208	[p13l691t926r918b1012],
17	94	CD	PERCENT	94	num	18	SENT_208	[p13l691t926r918b1012],
18	%	NN	PERCENT	%	dobj	16	SENT_208	[p13l691t926r918b1012],
19	)	CD	NUMBER	)	tmod	16	SENT_208	[p13l691t926r918b1012],
20	and	CC	O	and	_	0	SENT_208	[p13l959t921r1113b1000],
21	in	IN	O	in	_	0	SENT_208	[p13l1147t922r1229b998],
22	7	CD	TIME	7	conj_and	8	SENT_208	[p13l1266t929r1312b999],
23	of	IN	TIME	of	_	0	SENT_208	[p13l1349t920r1447b1000],
24	18	CD	TIME	18	num	26	SENT_208	[p13l1468t927r1559b1000],
25	plasma	NN	O	plasma	nn	26	SENT_208	[p13l1596t921r1896b1021],
26	samples	NNS	O	sample	prep_of	22	SENT_208	[p13l1932t947r2132b999, p13l7t1049r168b1149],
27	(	VBP	O	(	_	0	SENT_208	[p13l214t1054r476b1140],
28	39	CD	PERCENT	39	num	29	SENT_208	[p13l214t1054r476b1140],
29	%	NN	PERCENT	%	dobj	27	SENT_208	[p13l214t1054r476b1140],
30	)	CD	NUMBER	)	nsubj	27	SENT_208	[p13l214t1054r476b1140],
31	.	.	O	.	_	0	SENT_208	[p13l214t1054r476b1140],

1	Among	IN	O	among	_	0	SENT_209	[p13l521t1057r843b1150],
2	12	CD	NUMBER	12	num	3	SENT_209	[p13l885t1055r983b1126],
3	patients	NNS	O	patient	prep_among	29	SENT_209	[p13l1026t1050r1367b1149],
4	for	IN	O	for	_	0	SENT_209	[p13l1412t1048r1536b1128],
5	Whom	WP	O	whom	dobj	20	SENT_209	[p13l1571t1049r1842b1128],
6	specimens	NNS	O	specimen	nsubj	20	SENT_209	[p13l1887t1050r2132b1149, p13l8t1203r236b1255],
7	of	IN	O	of	_	0	SENT_209	[p13l291t1176r391b1256],
8	the	DT	O	the	det	10	SENT_209	[p13l425t1177r558b1255],
9	primary	JJ	O	primary	amod	10	SENT_209	[p13l609t1178r959b1277],
10	tumor	NN	O	tumor	prep_of	6	SENT_209	[p13l1008t1194r1293b1273],
11	,	,	O	,	_	0	SENT_209	[p13l1008t1194r1293b1273],
12	circulating	VBG	O	circulate	partmod	6	SENT_209	[p13l1351t1177r1819b1278],
13	tumor	NN	O	tumor	nn	14	SENT_209	[p13l1868t1194r2137b1256],
14	cells	NNS	O	cell	dobj	12	SENT_209	[p13l9t1305r221b1401],
15	,	,	O	,	_	0	SENT_209	[p13l9t1305r221b1401],
16	and	CC	O	and	_	0	SENT_209	[p13l266t1305r424b1383],
17	plasma	NN	O	plasma	conj_and	6	SENT_209	[p13l462t1305r773b1405],
18	were	VBD	O	be	cop	20	SENT_209	[p13l806t1331r1009b1384],
19	all	DT	O	all	dep	20	SENT_209	[p13l1048t1305r1153b1383],
20	available	JJ	O	available	prepc_for	3	SENT_209	[p13l1191t1305r1563b1384],
21	for	IN	O	for	_	0	SENT_209	[p13l1603t1304r1727b1384],
22	analysis	NN	O	analysis	prep_for	20	SENT_209	[p13l1763t1305r2128b1405],
23	,	,	O	,	_	0	SENT_209	[p13l1763t1305r2128b1405],
24	genotyping	NN	O	genotyping	nsubj	29	SENT_209	[p13l8t1434r499b1534],
25	of	IN	O	of	_	0	SENT_209	[p13l534t1432r633b1512],
26	circulating	VBG	O	circulate	prepc_of	24	SENT_209	[p13l653t1433r1121b1534],
27	tumor	NN	O	tumor	nn	28	SENT_209	[p13l1155t1450r1423b1512],
28	cells	NNS	O	cell	dobj	26	SENT_209	[p13l1458t1433r1646b1511],
29	had	VBD	O	have	_	0	SENT_209	[p13l1685t1433r1841b1512],
30	a	DT	O	a	det	31	SENT_209	[p13l1878t1459r1922b1511],
31	sensitivity	NN	O	sensitivity	iobj	29	SENT_209	[p13l1960t1459r2132b1511, p13l10t1562r303b1661],
32	of	IN	O	of	_	0	SENT_209	[p13l349t1560r450b1640],
33	92	CD	PERCENT	92	num	34	SENT_209	[p13l481t1566r668b1640],
34	%	NN	PERCENT	%	prep_of	31	SENT_209	[p13l481t1566r668b1640],
35	(	CD	NUMBER	(	dobj	29	SENT_209	[p13l722t1562r835b1652],
36	in	IN	O	in	_	0	SENT_209	[p13l722t1562r835b1652],
37	11	CD	TIME	11	prep_in	29	SENT_209	[p13l888t1567r985b1638],
38	of	IN	TIME	of	_	0	SENT_209	[p13l1036t1560r1137b1640],
39	12	CD	TIME	12	num	40	SENT_209	[p13l1172t1567r1270b1638],
40	patients	NNS	O	patient	prep_of	37	SENT_209	[p13l1320t1562r1722b1661],
41	)	RB	O	)	dep	46	SENT_209	[p13l1320t1562r1722b1661],
42	,	,	O	,	_	0	SENT_209	[p13l1320t1562r1722b1661],
43	Whereas	IN	O	whereas	mark	46	SENT_209	[p13l1772t1561r2131b1640],
44	plasma	NN	O	plasma	nn	45	SENT_209	[p13l7t1689r323b1789],
45	genotyping	NN	O	genotyping	nsubj	46	SENT_209	[p13l357t1690r849b1790],
46	had	VBD	O	have	parataxis	29	SENT_209	[p13l879t1689r1035b1768],
47	a	DT	O	a	det	48	SENT_209	[p13l1068t1715r1113b1767],
48	sensitivity	NN	O	sensitivity	dobj	46	SENT_209	[p13l1146t1690r1580b1789],
49	of	IN	O	of	_	0	SENT_209	[p13l1609t1688r1709b1768],
50	33	CD	PERCENT	33	num	51	SENT_209	[p13l1726t1694r1907b1768],
51	%	NN	PERCENT	%	prep_of	48	SENT_209	[p13l1726t1694r1907b1768],
52	(	CD	NUMBER	(	number	53	SENT_209	[p13l1945t1695r2018b1780],
53	4	CD	TIME	4	num	51	SENT_209	[p13l1945t1695r2018b1780],
54	of	IN	TIME	of	_	0	SENT_209	[p13l2052t1688r2152b1768],
55	12	CD	TIME	12	num	56	SENT_209	[p13l12t1822r109b1893],
56	patients	NNS	O	patient	prep_of	51	SENT_209	[p13l149t1818r517b1916],
57	)	IN	O	)	_	0	SENT_209	[p13l149t1818r517b1916],
58	(	CD	NUMBER	(	num	59	SENT_209	[p13l566t1822r1020b1907],
59	P	NN	O	p	prep_)	46	SENT_209	[p13l566t1822r1020b1907],
60	=	JJ	O	=	advmod	29	SENT_209	[p13l566t1822r1020b1907],
61	0.009	CD	NUMBER	0.009	num	62	SENT_209	[p13l566t1822r1020b1907],
62	)	NN	O	)	dep	60	SENT_209	[p13l566t1822r1020b1907],
63	.	.	O	.	_	0	SENT_209	[p13l566t1822r1020b1907],

1	The	DT	O	the	det	4	SENT_210	[p13l134t1945r293b2023],
2	sensitive	JJ	O	sensitive	amod	4	SENT_210	[p13l328t1946r684b2024],
3	SARMS	NN	O	sarm	nn	4	SENT_210	[p13l721t1951r1035b2028],
4	assay	NN	O	assay	nsubj	6	SENT_210	[p13l1072t1971r1295b2045],
5	also	RB	O	also	advmod	6	SENT_210	[p13l1324t1945r1492b2024],
6	identified	VBD	O	identify	_	0	SENT_210	[p13l1527t1944r1935b2024],
7	rare	JJ	O	rare	amod	9	SENT_210	[p13l1969t1971r2133b2023],
8	secondary	JJ	O	secondary	amod	9	SENT_210	[p13l10t2073r440b2173],
9	EGFR	NN	ORGANIZATION	egfr	dobj	6	SENT_210	[p13l493t2079r702b2152],
10	activating	VBG	O	activate	partmod	9	SENT_210	[p13l754t2074r1167b2174],
11	mutations	NNS	O	mutation	dobj	10	SENT_210	[p13l1223t2074r1650b2152],
12	in	IN	O	in	_	0	SENT_210	[p13l1710t2074r1792b2150],
13	a	DT	O	a	det	14	SENT_210	[p13l1851t2099r1895b2151],
14	subgroup	NN	O	subgroup	prep_in	10	SENT_210	[p13l1955t2073r2132b2152, p13l8t2227r256b2302],
15	of	IN	O	of	_	0	SENT_210	[p13l291t2200r391b2280],
16	tumor	NN	O	tumor	nn	17	SENT_210	[p13l407t2218r675b2280],
17	samples	NNS	O	sample	prep_of	14	SENT_210	[p13l707t2201r1077b2301],
18	,	,	O	,	_	0	SENT_210	[p13l707t2201r1077b2301],
19	circulating	VBG	O	circulate	partmod	6	SENT_210	[p13l1117t2201r1585b2302],
20	tumor	NN	O	tumor	nn	21	SENT_210	[p13l1616t2218r1884b2280],
21	cells	NNS	O	cell	dobj	19	SENT_210	[p13l1916t2201r2128b2297],
22	,	,	O	,	_	0	SENT_210	[p13l1916t2201r2128b2297],
23	and	CC	O	and	_	0	SENT_210	[p13l8t2329r166b2408],
24	plasma	NN	O	plasma	dep	26	SENT_210	[p13l205t2329r516b2429],
25	(	CD	NUMBER	(	num	24	SENT_210	[p13l560t2329r866b2420],
26	Tables	NNS	O	table	conj_and	6	SENT_210	[p13l560t2329r866b2420],
27	2	CD	NUMBER	2	num	26	SENT_210	[p13l911t2334r959b2406],
28	and	CC	O	and	_	0	SENT_210	[p13l1002t2329r1163b2408],
29	3	CD	DATE	3	conj_and	6	SENT_210	[p13l1207t2334r1250b2408],
30	and	CC	O	and	_	0	SENT_210	[p13l1295t2329r1453b2408],
31	Fig	NN	O	fig	conj_and	6	SENT_210	[p13l1492t2330r1646b2430],
32	.	.	O	.	_	0	SENT_210	[p13l1492t2330r1646b2430],

1	2A	NN	O	2a	_	0	SENT_211	[p13l1695t2334r1814b2406],
2	and	CC	O	and	_	0	SENT_211	[p13l1854t2329r2014b2408],
3	3	CD	NUMBER	3	dep	1	SENT_211	[p13l2058t2334r2128b2425],
4	,	,	O	,	_	0	SENT_211	[p13l2058t2334r2128b2425],
5	and	CC	O	and	_	0	SENT_211	[p13l8t2457r166b2535],
6	Table	NNP	O	Table	dep	1	SENT_211	[p13l199t2457r430b2535],
7	1	CD	NUMBER	1	num	6	SENT_211	[p13l470t2462r515b2533],
8	in	IN	O	in	_	0	SENT_211	[p13l552t2458r635b2533],
9	the	DT	O	the	det	12	SENT_211	[p13l672t2457r805b2534],
10	Supplementary	NNP	O	Supplementary	nn	12	SENT_211	[p13l845t2457r1492b2556],
11	Appendix	NNP	O	Appendix	nn	12	SENT_211	[p13l1522t2457r1988b2556],
12	)	NN	O	)	prep_in	6	SENT_211	[p13l1522t2457r1988b2556],
13	.	.	O	.	_	0	SENT_211	[p13l1522t2457r1988b2556],

1	To	TO	O	to	aux	2	SENT_212	[p13l2027t2463r2132b2535],
2	assess	VB	O	assess	purpcl	10	SENT_212	[p13l8t2611r272b2663],
3	the	DT	O	the	det	4	SENT_212	[p13l327t2585r459b2663],
4	significance	NN	O	significance	dobj	2	SENT_212	[p13l514t2584r1038b2686],
5	of	IN	O	of	_	0	SENT_212	[p13l1092t2584r1191b2664],
6	these	DT	O	these	det	7	SENT_212	[p13l1226t2585r1450b2663],
7	mutations	NNS	O	mutation	prep_of	4	SENT_212	[p13l1502t2586r1961b2681],
8	,	,	O	,	_	0	SENT_212	[p13l1502t2586r1961b2681],
9	We	PRP	O	we	nsubj	10	SENT_212	[p13l2015t2611r2133b2664],
10	monitored	VBD	O	monitor	_	0	SENT_212	[p13l8t2713r459b2792],
11	genotypes	NNS	O	genotype	dobj	10	SENT_212	[p13l505t2730r942b2814],
12	of	IN	O	of	_	0	SENT_212	[p13l991t2712r1092b2792],
13	circulating	VBG	O	circulate	prepc_of	11	SENT_212	[p13l1120t2713r1588b2814],
14	tumor	NN	O	tumor	nn	15	SENT_212	[p13l1632t2730r1900b2792],
15	cells	NNS	O	cell	dobj	13	SENT_212	[p13l1944t2713r2131b2791],
16	and	CC	O	and	_	0	SENT_212	[p13l8t2841r161b2920],
17	quantity	NN	O	quantity	conj_and	15	SENT_212	[p13l197t2842r542b2941],
18	over	IN	O	over	_	0	SENT_212	[p13l574t2867r746b2920],
19	time	NN	O	time	prep_over	15	SENT_212	[p13l778t2842r964b2919],
20	in	IN	O	in	_	0	SENT_212	[p13l1000t2842r1080b2918],
21	a	DT	O	a	det	22	SENT_212	[p13l1115t2867r1159b2919],
22	subgroup	NN	O	subgroup	prep_in	13	SENT_212	[p13l1195t2841r1584b2942],
23	of	IN	O	of	_	0	SENT_212	[p13l1621t2840r1718b2920],
24	patients	NNS	O	patient	prep_of	22	SENT_212	[p13l1734t2842r2083b2941],
25	.	.	O	.	_	0	SENT_212	[p13l1734t2842r2083b2941],

1	sermu	NN	O	sermu	_	0	SENT_213	[p13l8t3116r276b3166],
2	.	.	O	.	_	0	SENT_213	[p13l8t3116r276b3166],

1	MEASUREMENTS	NNS	O	measurement	_	0	SENT_214	[p13l316t3116r966b3166],
2	Detailed	JJ	O	detailed	amod	4	SENT_214	[p13l7t3214r370b3293],
3	serial	NN	O	serial	nn	4	SENT_214	[p13l399t3214r631b3292],
4	analyses	NNS	O	analysis	nsubj	15	SENT_214	[p13l658t3214r1017b3314],
5	of	IN	O	of	_	0	SENT_214	[p13l1049t3213r1149b3293],
6	the	DT	O	the	det	7	SENT_214	[p13l1159t3214r1291b3292],
7	quantity	NN	O	quantity	prep_of	4	SENT_214	[p13l1321t3215r1681b3314],
8	and	CC	O	and	_	0	SENT_214	[p13l1704t3214r1862b3293],
9	genotype	NN	O	genotype	prep_of	4	SENT_214	[p13l1890t3240r2132b3315, p13l9t3357r190b3440],
10	of	IN	O	of	_	0	SENT_214	[p13l227t3339r327b3419],
11	circulating	VBG	O	circulate	prepc_of	7	SENT_214	[p13l345t3340r813b3441],
12	tumor	NN	O	tumor	nn	13	SENT_214	[p13l845t3357r1114b3419],
13	cells	NNS	O	cell	dobj	11	SENT_214	[p13l1147t3340r1334b3418],
14	were	VBD	O	be	cop	15	SENT_214	[p13l1368t3366r1570b3419],
15	available	JJ	O	available	rcmod	1	SENT_214	[p13l1605t3340r1977b3419],
16	for	IN	O	for	prep	15	SENT_214	[p13l2013t3339r2136b3419],

1	N	NN	O	n	nn	3	SENT_215	[p13l542t3526r555b3541],
2	ENGLJ	NN	O	englj	nn	3	SENT_215	[p13l570t3526r648b3548],
3	MED	NN	O	med	_	0	SENT_215	[p13l663t3526r715b3541],
4	359	CD	NUMBER	359	dep	3	SENT_215	[p13l725t3526r790b3548],
5	;	:	O	;	_	0	SENT_215	[p13l725t3526r790b3548],
6	4	CD	NUMBER	4	num	8	SENT_215	[p13l725t3526r790b3548],
7	WWW.NEJM.ORG	NN	O	www.nejm.org	nn	8	SENT_215	[p13l822t3526r1024b3548],
8	ULY	NN	O	uly	dep	4	SENT_215	[p13l1069t3526r1112b3542],
9	24	CD	NUMBER	24	dep	8	SENT_215	[p13l1122t3526r1158b3548],
10	,	,	O	,	_	0	SENT_215	[p13l1122t3526r1158b3548],
11	2008	CD	DATE	2008	num	12	SENT_215	[p13l1169t3520r1233b3542],
12	371	CD	NUMBER	371	appos	9	SENT_215	[p13l1959t3516r2016b3539],

1	The	DT	O	the	det	6	SENT_216	[p13l702t3559r753b3583],
2	New	NNP	O	New	nn	6	SENT_216	[p13l762t3560r824b3583],
3	England	NNP	O	England	nn	6	SENT_216	[p13l833t3559r944b3590],
4	J	NNP	O	J	nn	6	SENT_216	[p13l952t3560r965b3583],
5	ouma	NN	O	ouma	nn	6	SENT_216	[p13l966t3567r1041b3583],
6	o	NN	O	o	_	0	SENT_216	[p13l1059t3567r1075b3583],
7	Medicine	NN	O	medicine	dep	6	SENT_216	[p13l1095t3559r1220b3583],

1	Copyright	NN	O	copyright	_	0	SENT_217	[p13l494t3641r629b3672],
2	©	CD	NUMBER	©	num	6	SENT_217	[p13l638t3641r661b3665],
3	2008	CD	DATE	2008	num	6	SENT_217	[p13l671t3641r736b3665],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_217	[p13l746t3641r937b3665],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_217	[p13l947t3641r1055b3665],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_217	[p13l1065t3641r1170b3672],
7	.	.	O	.	_	0	SENT_217	[p13l1065t3641r1170b3672],

1	All	DT	O	all	det	2	SENT_218	[p13l1181t3641r1223b3665],
2	rights	NNS	O	rights	nsubj	3	SENT_218	[p13l1232t3641r1306b3672],
3	reserved	VBN	O	reserve	_	0	SENT_218	[p13l1316t3641r1435b3665],
4	.	.	O	.	_	0	SENT_218	[p13l1316t3641r1435b3665],

1	The	DT	O	the	det	4	SENT_219	[p13l673t3747r718b3768],
2	NEW	NNP	O	NEW	nn	4	SENT_219	[p13l737t3749r822b3768],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_219	[p13l841t3749r1029b3768],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_219	[p13l1048t3749r1227b3775],
5	of	IN	O	of	_	0	SENT_219	[p13l1247t3747r1275b3774],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_219	[p13l1287t3749r1486b3768],

1	T79OM-negative	JJ	O	t79om-negative	_	0	SENT_220	[p14l1353t729r1724b782],

1	T79OM-positive	JJ	O	t79om-positive	_	0	SENT_221	[p14l941t858r1299b910],

1	3	CD	NUMBER	3	_	0	SENT_222	[p14l279t220r309b274],
2	"	``	O	"	punct	1	SENT_222	[p14l263t274r308b328],
3	?	.	O	?	_	0	SENT_222	[p14l263t274r308b328],

1	:	:	O	:	_	0	SENT_223	[p14l279t333r308b358],
2	.2	NN	NUMBER	.2	_	0	SENT_223	[p14l264t363r309b405],
3	en	IN	O	en	prep	2	SENT_223	[p14l278t410r309b433],
4	in	IN	O	in	pcomp	3	SENT_223	[p14l278t437r309b460],
5	cu	NNP	O	cu	pobj	4	SENT_223	[p14l279t462r309b488],
6	&	CC	O	&	_	0	SENT_223	[p14l279t489r308b506],
7	50	CD	NUMBER	50	number	8	SENT_223	[p14l279t510r322b539],
8	2	CD	NUMBER	2	conj_and	2	SENT_223	[p14l279t541r309b588],
9	E	NN	O	e	dep	8	SENT_223	[p14l268t591r308b619],
10	o	NN	O	o	dep	2	SENT_223	[p14l332t598r343b607],

1	.	.	O	.	_	0	SENT_224	[p14l263t643r308b668],

1	:	:	O	:	_	0	SENT_225	[p14l263t643r308b668],
2	.	.	O	.	_	0	SENT_225	[p14l264t672r309b703],
3	"	''	O	"	punct	1	SENT_225	[p14l264t672r309b703],

1	:	:	O	:	_	0	SENT_226	[p14l264t672r309b703],
2	'	''	O	'	_	0	SENT_226	[p14l264t672r309b703],
3	3	CD	NUMBER	3	_	0	SENT_226	[p14l279t706r308b747],
4	:	:	O	:	_	0	SENT_226	[p14l279t766r308b791],
5	.2	NN	NUMBER	.2	nn	8	SENT_226	[p14l264t797r309b838],
6	‘	CD	NUMBER	‘	num	8	SENT_226	[p14l271t841r309b877],
7	L’	NN	O	l’	nn	8	SENT_226	[p14l271t841r309b877],
8	O	NN	O	o	dep	3	SENT_226	[p14l279t881r309b910],
9	:3	CD	NUMBER	:3	dep	8	SENT_226	[p14l279t913r322b940],
10	.	.	O	.	_	0	SENT_226	[p14l279t913r322b940],

1	O	NN	O	o	_	0	SENT_227	[p14l279t945r309b973],
2	&	CC	O	&	rcmod	1	SENT_227	[p14l279t974r308b991],
3	D.	NNP	O	D.	dep	1	SENT_227	[p14l268t995r308b1023],

1	No.	NN	O	no.	_	0	SENT_228	[p14l81t1237r165b1278],
2	at	IN	O	at	_	0	SENT_228	[p14l184t1240r230b1278],
3	Risk	NN	O	risk	prep_at	1	SENT_228	[p14l249t1233r349b1278],

1	T79OM-negative	JJ	O	t79om-negative	_	0	SENT_229	[p14l76t1303r447b1356],
2	T79OM-positive	JJ	O	t79om-positive	dep	1	SENT_229	[p14l76t1367r434b1419],

1	Figure	NNP	O	Figure	_	0	SENT_230	[p14l63t1498r225b1560],
2	1	CD	NUMBER	1	dep	1	SENT_230	[p14l248t1502r289b1545],
3	.	.	O	.	_	0	SENT_230	[p14l248t1502r289b1545],

1	Correlation	NN	O	correlation	_	0	SENT_231	[p14l311t1497r605b1545],
2	between	IN	O	between	_	0	SENT_231	[p14l630t1497r851b1545],
3	the	DT	O	the	det	4	SENT_231	[p14l872t1497r957b1545],
4	Presence	NN	O	presence	prep_between	1	SENT_231	[p14l980t1501r1217b1545],
5	ofT79OM	NN	O	oft79om	nn	6	SENT_231	[p14l1237t1496r1490b1545],
6	Mutations	NNS	O	mutation	dep	4	SENT_231	[p14l1518t1498r1787b1545],
7	in	IN	O	in	_	0	SENT_231	[p14l61t1578r104b1624],
8	Tumor-Biopsy	NNP	O	Tumor-Biopsy	nn	9	SENT_231	[p14l126t1578r500b1640],
9	Specimens	NNS	O	specimen	prep_in	6	SENT_231	[p14l519t1578r809b1639],
10	and	CC	O	and	_	0	SENT_231	[p14l831t1577r925b1625],
11	Decreased	VBN	MISC	decrease	conj_and	6	SENT_231	[p14l951t1577r1227b1625],
12	Progression-free	JJ	MISC	progression-free	amod	13	SENT_231	[p14l1254t1576r1689b1640],
13	Survival	NN	O	survival	dobj	11	SENT_231	[p14l1708t1577r1936b1625],
14	.	.	O	.	_	0	SENT_231	[p14l1708t1577r1936b1625],

1	In	IN	O	in	_	0	SENT_232	[p14l64t1677r106b1720],
2	patients	NNS	O	patient	prep_in	31	SENT_232	[p14l134t1677r344b1735],
3	with	IN	O	with	_	0	SENT_232	[p14l366t1673r476b1721],
4	non	JJ	O	non	amod	8	SENT_232	[p14l503t1673r892b1721],
5	—	JJ	O	—	amod	8	SENT_232	[p14l503t1673r892b1721],
6	small-cell	NN	O	small-cell	nn	8	SENT_232	[p14l503t1673r892b1721],
7	lung	NN	O	lung	nn	8	SENT_232	[p14l919t1673r1032b1736],
8	cancer	NN	O	cancer	prep_with	2	SENT_232	[p14l1052t1690r1227b1721],
9	with	IN	O	with	_	0	SENT_232	[p14l1245t1673r1355b1721],
10	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_232	[p14l1382t1676r1524b1721],
11	mutations	NNS	O	mutation	prep_with	2	SENT_232	[p14l1548t1677r1816b1721],
12	who	WP	O	who	nsubj	14	SENT_232	[p14l1838t1673r1948b1721],
13	were	VBD	O	be	aux	14	SENT_232	[p14l1968t1690r2093b1721],
14	receiving	VBG	O	receive	rcmod	11	SENT_232	[p14l62t1757r298b1817],
15	therapy	NN	O	therapy	dobj	14	SENT_232	[p14l318t1753r517b1816],
16	with	IN	O	with	_	0	SENT_232	[p14l536t1753r645b1801],
17	gefitinib	NN	O	gefitinib	prep_with	14	SENT_232	[p14l670t1752r888b1817],
18	or	CC	O	or	_	0	SENT_232	[p14l910t1770r964b1801],
19	erlotinib	NN	O	erlotinib	conj_or	17	SENT_232	[p14l984t1753r1218b1810],
20	,	,	O	,	_	0	SENT_232	[p14l984t1753r1218b1810],
21	the	DT	O	the	det	26	SENT_232	[p14l1241t1753r1325b1801],
22	presence	NN	O	presence	nn	26	SENT_232	[p14l1349t1770r1585b1816],
23	ofthe	NN	O	ofthe	nn	26	SENT_232	[p14l1607t1752r1758b1801],
24	drugresistance	NN	O	drugresistance	nn	26	SENT_232	[p14l1780t1753r2063b1817, p14l58t1842r201b1881],
25	mutation	NN	O	mutation	nn	26	SENT_232	[p14l226t1838r464b1881],
26	T79OM	NN	O	t79om	nsubjpass	31	SENT_232	[p14l486t1836r672b1881],
27	before	IN	O	before	_	0	SENT_232	[p14l701t1833r866b1881],
28	initiation	NN	O	initiation	nn	29	SENT_232	[p14l890t1838r1121b1881],
29	oftreatment	NN	O	oftreatment	prep_before	26	SENT_232	[p14l1146t1833r1478b1881],
30	was	VBD	O	be	auxpass	31	SENT_232	[p14l1497t1850r1596b1881],
31	associated	VBN	O	associate	_	0	SENT_232	[p14l1620t1833r1897b1881],
32	with	IN	O	with	_	0	SENT_232	[p14l1920t1833r2029b1881],
33	decreased	VBN	O	decrease	amod	35	SENT_232	[p14l60t1913r327b1961],
34	progression-free	JJ	O	progression-free	amod	35	SENT_232	[p14l354t1912r790b1976],
35	survival	NN	O	survival	prep_with	31	SENT_232	[p14l813t1913r1030b1961],
36	.	.	O	.	_	0	SENT_232	[p14l813t1913r1030b1961],

1	four	CD	NUMBER	four	num	2	SENT_233	[p14l561t2194r695b2253],
2	patients	NNS	O	patient	_	0	SENT_233	[p14l723t2195r977b2269],
3	with	IN	O	with	_	0	SENT_233	[p14l1006t2195r1152b2254],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_233	[p14l1182t2199r1340b2254],
5	mutations	NNS	O	mutation	prep_with	2	SENT_233	[p14l1366t2195r1690b2253],
6	after	IN	O	after	_	0	SENT_233	[p14l1722t2194r1873b2253],
7	the	DT	O	the	det	8	SENT_233	[p14l1902t2194r2001b2253],
8	initiation	NN	O	initiation	prep_after	2	SENT_233	[p14l2032t2195r2140b2252, p14l561t2290r771b2348],
9	of	IN	O	of	_	0	SENT_233	[p14l802t2289r876b2348],
10	gefitinib	NN	O	gefitinib	nn	11	SENT_233	[p14l893t2289r1170b2364],
11	therapy	NN	O	therapy	prep_of	8	SENT_233	[p14l1202t2289r1442b2364],
12	(	CD	NUMBER	(	num	13	SENT_233	[p14l1472t2290r1608b2364],
13	Fig	NN	O	fig	dep	11	SENT_233	[p14l1472t2290r1608b2364],
14	.	.	O	.	_	0	SENT_233	[p14l1472t2290r1608b2364],

1	2A	NN	O	2a	_	0	SENT_234	[p14l1645t2294r1770b2357],
2	)	NN	O	)	dep	1	SENT_234	[p14l1645t2294r1770b2357],
3	.	.	O	.	_	0	SENT_234	[p14l1645t2294r1770b2357],

1	In	IN	O	in	_	0	SENT_235	[p14l1804t2295r1870b2347],
2	all	DT	O	all	det	4	SENT_235	[p14l1900t2290r1978b2348],
3	four	CD	NUMBER	four	num	4	SENT_235	[p14l2009t2289r2143b2348],
4	patients	NNS	O	patient	prep_in	9	SENT_235	[p14l560t2385r832b2459],
5	,	,	O	,	_	0	SENT_235	[p14l560t2385r832b2459],
6	gefitinib	NN	O	gefitinib	nn	7	SENT_235	[p14l861t2384r1137b2459],
7	treatment	NN	O	treatment	nsubjpass	9	SENT_235	[p14l1163t2397r1479b2443],
8	was	VBD	O	be	auxpass	9	SENT_235	[p14l1496t2404r1617b2444],
9	associated	VBN	O	associate	_	0	SENT_235	[p14l1643t2385r1974b2443],
10	with	IN	O	with	_	0	SENT_235	[p14l1995t2385r2141b2444],
11	a	DT	O	a	det	13	SENT_235	[p14l560t2499r593b2538],
12	profound	JJ	O	profound	amod	13	SENT_235	[p14l621t2479r919b2554],
13	decline	NN	O	decline	prep_with	9	SENT_235	[p14l949t2479r1176b2538],
14	in	IN	O	in	_	0	SENT_235	[p14l1205t2480r1267b2537],
15	the	DT	O	the	det	16	SENT_235	[p14l1297t2479r1396b2538],
16	number	NN	O	number	prep_in	13	SENT_235	[p14l1425t2480r1677b2538],
17	of	IN	O	of	_	0	SENT_235	[p14l1705t2479r1779b2538],
18	circulating	VBG	O	circulate	prepc_of	16	SENT_235	[p14l1796t2480r2143b2554],
19	tumor	NN	O	tumor	nn	20	SENT_235	[p14l561t2587r761b2633],
20	cells	NNS	O	cell	dobj	18	SENT_235	[p14l791t2575r948b2633],
21	.	.	O	.	_	0	SENT_235	[p14l791t2575r948b2633],

1	The	DT	O	the	det	2	SENT_236	[p14l982t2575r1102b2633],
2	interval	NN	O	interval	nsubjpass	7	SENT_236	[p14l1133t2575r1376b2633],
3	between	IN	O	between	_	0	SENT_236	[p14l1408t2575r1674b2634],
4	blood-sample	NN	O	blood-sample	nn	5	SENT_236	[p14l1707t2574r2141b2649],
5	analyses	NNS	O	analysis	prep_between	2	SENT_236	[p14l560t2670r827b2744],
6	was	VBD	O	be	auxpass	7	SENT_236	[p14l871t2689r992b2728],
7	dictated	VBN	O	dictate	_	0	SENT_236	[p14l1039t2669r1295b2728],
8	by	IN	O	by	_	0	SENT_236	[p14l1340t2670r1412b2744],
9	previously	RB	DATE	previously	advmod	10	SENT_236	[p14l1453t2669r1780b2744],
10	scheduled	VBN	O	schedule	amod	12	SENT_236	[p14l1823t2669r2141b2728],
11	clinical	JJ	O	clinical	amod	12	SENT_236	[p14l561t2765r794b2823],
12	visits	NNS	O	visit	agent	7	SENT_236	[p14l821t2765r1002b2835],
13	,	,	O	,	_	0	SENT_236	[p14l821t2765r1002b2835],
14	and	CC	O	and	_	0	SENT_236	[p14l1036t2764r1153b2823],
15	therefore	RB	O	therefore	advmod	19	SENT_236	[p14l1183t2764r1473b2823],
16	We	PRP	O	we	nsubj	19	SENT_236	[p14l1500t2784r1588b2823],
17	could	MD	O	could	aux	19	SENT_236	[p14l1618t2764r1793b2823],
18	not	RB	O	not	neg	19	SENT_236	[p14l1823t2777r1929b2823],
19	ascertain	VB	O	ascertain	conj_and	7	SENT_236	[p14l1954t2784r2140b2823, p14l561t2860r686b2918],

1	the	DT	O	the	det	3	SENT_237	[p14l709t2860r807b2918],
2	precise	JJ	O	precise	amod	3	SENT_237	[p14l828t2860r1052b2934],
3	timing	NN	O	timing	_	0	SENT_237	[p14l1074t2860r1293b2934],
4	in	IN	O	in	_	0	SENT_237	[p14l1312t2860r1374b2917],
5	the	DT	O	the	det	6	SENT_237	[p14l1396t2859r1495b2918],
6	decline	NN	O	decline	prep_in	3	SENT_237	[p14l1517t2859r1744b2918],
7	in	IN	O	in	_	0	SENT_237	[p14l1766t2860r1828b2917],
8	the	DT	O	the	det	9	SENT_237	[p14l1850t2859r1949b2918],
9	number	NN	O	number	prep_in	6	SENT_237	[p14l1971t2878r2140b2918, p14l561t2955r663b3013],
10	of	IN	O	of	_	0	SENT_237	[p14l696t2954r771b3013],
11	circulating	VBG	O	circulate	prepc_of	9	SENT_237	[p14l792t2955r1139b3029],
12	tumor	NN	O	tumor	nn	13	SENT_237	[p14l1172t2967r1371b3013],
13	cells	NNS	O	cell	dobj	11	SENT_237	[p14l1404t2955r1562b3013],
14	.	.	O	.	_	0	SENT_237	[p14l1404t2955r1562b3013],

1	However	RB	O	however	advmod	22	SENT_238	[p14l1600t2960r1893b3026],
2	,	,	O	,	_	0	SENT_238	[p14l1600t2960r1893b3026],
3	in	IN	O	in	_	0	SENT_238	[p14l1931t2955r1994b3012],
4	one	CD	NUMBER	one	num	5	SENT_238	[p14l2028t2973r2141b3013],
5	case	NN	O	case	prep_in	22	SENT_238	[p14l561t3069r695b3108],
6	(	CD	NUMBER	(	num	7	SENT_238	[p14l725t3050r970b3117],
7	Patient	NN	O	patient	dep	5	SENT_238	[p14l725t3050r970b3117],
8	9	CD	NUMBER	9	num	9	SENT_238	[p14l993t3054r1066b3120],
9	)	NN	O	)	dep	7	SENT_238	[p14l993t3054r1066b3120],
10	,	,	O	,	_	0	SENT_238	[p14l993t3054r1066b3120],
11	a	DT	O	a	det	14	SENT_238	[p14l1096t3069r1129b3108],
12	50	CD	PERCENT	50	number	13	SENT_238	[p14l1156t3053r1294b3108],
13	%	NN	PERCENT	%	amod	14	SENT_238	[p14l1156t3053r1294b3108],
14	decline	NN	O	decline	nsubj	22	SENT_238	[p14l1320t3049r1547b3108],
15	in	IN	O	in	_	0	SENT_238	[p14l1574t3050r1636b3107],
16	the	DT	O	the	det	17	SENT_238	[p14l1662t3050r1761b3108],
17	quantity	NN	O	quantity	prep_in	14	SENT_238	[p14l1789t3050r2056b3124],
18	of	IN	O	of	_	0	SENT_238	[p14l2080t3049r2154b3108],
19	circulating	VBG	O	circulate	prepc_of	17	SENT_238	[p14l561t3144r909b3219],
20	tumor	NN	O	tumor	nn	21	SENT_238	[p14l928t3157r1128b3203],
21	cells	NNS	O	cell	dobj	19	SENT_238	[p14l1147t3145r1286b3203],
22	was	VBD	O	be	_	0	SENT_238	[p14l1306t3164r1427b3204],
23	evident	JJ	O	evident	acomp	22	SENT_238	[p14l1450t3144r1681b3203],
24	Within	IN	O	within	dep	23	SENT_238	[p14l1695t3145r1907b3204],
25	a	DT	DURATION	a	det	26	SENT_238	[p14l1928t3164r1961b3203],
26	Week	NN	DURATION	week	pobj	24	SENT_238	[p14l1978t3145r2144b3204],
27	after	IN	O	after	dep	23	SENT_238	[p14l560t3239r714b3298],
28	the	DT	O	the	det	29	SENT_238	[p14l741t3239r841b3298],
29	initiation	NN	O	initiation	pobj	27	SENT_238	[p14l870t3240r1175b3298],
30	of	IN	O	of	_	0	SENT_238	[p14l1204t3239r1279b3298],
31	therapy	NN	O	therapy	prep_of	29	SENT_238	[p14l1294t3239r1549b3314],
32	,	,	O	,	_	0	SENT_238	[p14l1294t3239r1549b3314],
33	with	IN	O	with	_	0	SENT_238	[p14l1579t3240r1727b3298],
34	the	DT	O	the	det	35	SENT_238	[p14l1756t3239r1856b3298],
35	nadir	NN	O	nadir	prep_with	29	SENT_238	[p14l1885t3239r2059b3298],
36	at	IN	O	at	dep	23	SENT_238	[p14l2085t3251r2145b3298],
37	3	CD	DURATION	3	num	38	SENT_238	[p14l562t3339r594b3393],
38	months	NNS	NUMBER	month	pobj	36	SENT_238	[p14l638t3335r900b3393],
39	.	.	O	.	_	0	SENT_238	[p14l638t3335r900b3393],

1	Clinical	JJ	O	clinical	amod	2	SENT_239	[p14l944t3334r1192b3393],
2	progression	NN	O	progression	nsubjpass	4	SENT_239	[p14l1230t3335r1611b3409],
3	Was	VBD	O	be	auxpass	4	SENT_239	[p14l1647t3354r1768b3393],
4	associated	VBN	O	associate	_	0	SENT_239	[p14l1809t3335r2141b3393],
5	with	IN	O	with	_	0	SENT_239	[p14l557t3430r703b3488],
6	an	DT	O	a	det	7	SENT_239	[p14l727t3449r803b3488],
7	increase	NN	O	increase	prep_with	4	SENT_239	[p14l827t3430r1089b3488],
8	in	IN	O	in	_	0	SENT_239	[p14l1113t3430r1175b3487],
9	the	DT	O	the	det	10	SENT_239	[p14l1200t3429r1299b3488],
10	number	NN	O	number	prep_in	7	SENT_239	[p14l1323t3430r1575b3488],
11	of	IN	O	of	_	0	SENT_239	[p14l1598t3429r1672b3488],
12	circulating	VBG	O	circulate	prepc_of	10	SENT_239	[p14l1683t3430r2031b3504],
13	tumor	NN	O	tumor	nn	14	SENT_239	[p14l2053t3442r2140b3489, p14l561t3543r692b3583],
14	cells	NNS	O	cell	dobj	12	SENT_239	[p14l722t3524r880b3595],
15	,	,	O	,	_	0	SENT_239	[p14l722t3524r880b3595],
16	and	CC	O	and	_	0	SENT_239	[p14l915t3525r1033b3583],
17	in	IN	O	in	_	0	SENT_239	[p14l1064t3525r1126b3582],
18	one	CD	NUMBER	one	num	19	SENT_239	[p14l1159t3543r1272b3583],
19	case	NN	O	case	prep_in	29	SENT_239	[p14l1304t3544r1438b3583],
20	(	CD	NUMBER	(	num	21	SENT_239	[p14l1474t3525r1719b3592],
21	Patient	NN	O	patient	dep	19	SENT_239	[p14l1474t3525r1719b3592],
22	1	CD	NUMBER	1	num	23	SENT_239	[p14l1750t3529r1820b3595],
23	)	NN	O	)	dep	21	SENT_239	[p14l1750t3529r1820b3595],
24	,	,	O	,	_	0	SENT_239	[p14l1750t3529r1820b3595],
25	a	DT	DURATION	a	det	27	SENT_239	[p14l1855t3544r1888b3583],
26	second	JJ	DURATION	second	amod	27	SENT_239	[p14l1920t3524r2141b3583],
27	decline	NN	O	decline	nsubj	29	SENT_239	[p14l561t3620r788b3678],
28	was	VBD	O	be	cop	29	SENT_239	[p14l821t3639r942b3678],
29	evident	JJ	O	evident	conj_and	4	SENT_239	[p14l980t3620r1210b3678],
30	as	IN	O	as	mark	33	SENT_239	[p14l1242t3639r1305b3678],
31	the	DT	O	the	det	32	SENT_239	[p14l1342t3620r1441b3678],
32	tumor	NN	O	tumor	nsubj	33	SENT_239	[p14l1478t3632r1677b3678],
33	responded	VBD	O	respond	advcl	29	SENT_239	[p14l1710t3619r2043b3694],
34	to	TO	O	to	_	0	SENT_239	[p14l2079t3632r2140b3678],
35	subsequent	JJ	O	subsequent	amod	36	SENT_239	[p15l562t17r923b91],
36	chemotherapy	NN	O	chemotherapy	prep_to	33	SENT_239	[p15l943t17r1408b91],
37	.	.	O	.	_	0	SENT_239	[p15l943t17r1408b91],

1	In	IN	O	in	_	0	SENT_240	[p15l1434t22r1500b74],
2	contrast	NN	O	contrast	prep_in	39	SENT_240	[p15l1524t28r1786b75],
3	to	TO	O	to	_	0	SENT_240	[p15l1806t28r1867b75],
4	the	DT	O	the	det	5	SENT_240	[p15l1892t17r1990b75],
5	lack	NN	O	lack	prep_to	2	SENT_240	[p15l2013t17r2144b76],
6	of	IN	O	of	_	0	SENT_240	[p15l561t111r636b170],
7	a	DT	O	a	det	8	SENT_240	[p15l650t131r683b170],
8	relationship	NN	O	relationship	prep_of	5	SENT_240	[p15l711t112r1094b186],
9	between	IN	O	between	_	0	SENT_240	[p15l1124t112r1390b171],
10	absolute	JJ	O	absolute	amod	11	SENT_240	[p15l1418t112r1684b170],
11	values	NNS	O	value	prep_between	8	SENT_240	[p15l1709t112r1904b170],
12	for	IN	O	for	_	0	SENT_240	[p15l1935t111r2026b170],
13	tumor	NN	O	tumor	nn	14	SENT_240	[p15l2053t124r2140b170, p15l561t225r692b265],
14	burden	NN	O	burden	prep_for	11	SENT_240	[p15l726t207r951b265],
15	and	CC	O	and	_	0	SENT_240	[p15l986t206r1104b265],
16	the	DT	O	the	det	17	SENT_240	[p15l1140t207r1238b265],
17	quantity	NN	O	quantity	prep_to	2	SENT_240	[p15l1275t207r1543b281],
18	of	IN	O	of	_	0	SENT_240	[p15l1575t206r1650b265],
19	circulating	VBG	O	circulate	prepc_of	17	SENT_240	[p15l1672t207r2020b281],
20	tumor	NN	O	tumor	nn	21	SENT_240	[p15l2053t219r2140b265, p15l561t320r692b360],
21	cells	NNS	O	cell	dobj	19	SENT_240	[p15l717t301r874b372],
22	,	,	O	,	_	0	SENT_240	[p15l717t301r874b372],
23	as	IN	O	as	mark	24	SENT_240	[p15l905t321r969b360],
24	measured	VBN	O	measure	advcl	39	SENT_240	[p15l997t301r1308b360],
25	among	IN	O	among	_	0	SENT_240	[p15l1335t320r1558b376],
26	different	JJ	O	different	amod	27	SENT_240	[p15l1583t301r1863b360],
27	patients	NNS	O	patient	prep_among	24	SENT_240	[p15l1885t302r2139b376],
28	at	IN	O	at	_	0	SENT_240	[p15l560t409r619b455],
29	the	DT	O	the	det	30	SENT_240	[p15l646t397r745b455],
30	time	NN	O	time	prep_at	24	SENT_240	[p15l777t397r920b455],
31	of	IN	O	of	_	0	SENT_240	[p15l952t396r1026b455],
32	study	NN	O	study	nn	33	SENT_240	[p15l1045t396r1215b471],
33	enrollment	NN	O	enrollment	prep_of	30	SENT_240	[p15l1244t396r1614b467],
34	,	,	O	,	_	0	SENT_240	[p15l1244t396r1614b467],
35	a	DT	O	a	det	37	SENT_240	[p15l1649t416r1682b455],
36	close	JJ	O	close	amod	37	SENT_240	[p15l1712t397r1870b455],
37	concordance	NN	O	concordance	nsubjpass	39	SENT_240	[p15l1901t415r2140b455, p15l561t492r744b550],
38	was	VBD	O	be	auxpass	39	SENT_240	[p15l765t511r884b551],
39	observed	VBN	O	observe	_	0	SENT_240	[p15l911t491r1188b550],
40	between	IN	O	between	_	0	SENT_240	[p15l1213t492r1474b550],
41	radiographic	JJ	O	radiographic	amod	42	SENT_240	[p15l1499t491r1899b566],
42	assessment	NN	O	assessment	prep_between	39	SENT_240	[p15l1922t511r2140b550, p15l561t600r723b646],
43	of	IN	O	of	_	0	SENT_240	[p15l744t587r818b646],
44	tumor	NN	O	tumor	nn	45	SENT_240	[p15l829t600r1025b647],
45	volume	NN	O	volume	prep_of	42	SENT_240	[p15l1045t588r1272b647],
46	and	CC	O	and	_	0	SENT_240	[p15l1296t587r1412b646],
47	the	DT	O	the	det	49	SENT_240	[p15l1437t588r1535b646],
48	relative	JJ	O	relative	amod	49	SENT_240	[p15l1559t588r1783b647],
49	number	NN	O	number	prep_between	39	SENT_240	[p15l1808t588r2056b647],
50	of	IN	O	of	_	0	SENT_240	[p15l2080t587r2154b646],
51	circulating	VBG	O	circulate	prepc_of	49	SENT_240	[p15l561t682r909b757],
52	tumor	NN	O	tumor	nn	53	SENT_240	[p15l934t695r1134b741],
53	cells	NNS	O	cell	dobj	51	SENT_240	[p15l1159t682r1299b741],
54	in	IN	O	in	_	0	SENT_240	[p15l1327t683r1389b740],
55	patients	NNS	O	patient	prep_in	51	SENT_240	[p15l1415t683r1670b757],
56	who	WP	O	who	nsubjpass	58	SENT_240	[p15l1695t682r1831b741],
57	were	VBD	O	be	auxpass	58	SENT_240	[p15l1856t702r2006b742],
58	followed	VBN	O	follow	rcmod	55	SENT_240	[p15l2034t682r2140b741, p15l560t777r749b837],
59	serially	RB	O	serially	advmod	58	SENT_240	[p15l776t778r1006b852],
60	during	IN	O	during	_	0	SENT_240	[p15l1028t777r1243b852],
61	the	DT	O	the	det	62	SENT_240	[p15l1267t778r1366b836],
62	course	NN	O	course	prep_during	58	SENT_240	[p15l1392t796r1600b836],
63	of	IN	O	of	_	0	SENT_240	[p15l1627t777r1701b836],
64	therapy	NN	O	therapy	prep_of	62	SENT_240	[p15l1713t778r1962b852],
65	.	.	O	.	_	0	SENT_240	[p15l1713t778r1962b852],

1	Genotypes	NNS	O	genotype	nsubj	6	SENT_241	[p15l657t877r997b947],
2	of	IN	O	of	_	0	SENT_241	[p15l1032t872r1107b931],
3	circulating	VBG	O	circulate	prepc_of	1	SENT_241	[p15l1126t873r1474b947],
4	tumor	NN	O	tumor	nn	5	SENT_241	[p15l1505t885r1704b931],
5	cells	NNS	O	cell	dobj	3	SENT_241	[p15l1735t872r1874b931],
6	evolved	VBD	O	evolve	_	0	SENT_241	[p15l1909t872r2141b931],
7	during	IN	O	during	_	0	SENT_241	[p15l561t968r776b1042],
8	treatment	NN	O	treatment	prep_during	6	SENT_241	[p15l812t980r1142b1038],
9	,	,	O	,	_	0	SENT_241	[p15l812t980r1142b1038],
10	with	IN	O	with	_	0	SENT_241	[p15l1181t968r1326b1027],
11	the	DT	O	the	det	13	SENT_241	[p15l1364t968r1463b1026],
12	consistent	JJ	O	consistent	amod	13	SENT_241	[p15l1502t968r1828b1026],
13	presence	NN	O	presence	prep_with	6	SENT_241	[p15l1861t987r2141b1042],
14	of	IN	O	of	_	0	SENT_241	[p15l561t1062r636b1121],
15	the	DT	O	the	det	19	SENT_241	[p15l650t1063r748b1121],
16	primary	JJ	O	primary	amod	19	SENT_241	[p15l775t1063r1036b1137],
17	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_241	[p15l1058t1067r1217b1122],
18	activating	VBG	O	activate	amod	19	SENT_241	[p15l1239t1063r1553b1137],
19	mutation	NN	O	mutation	prep_of	13	SENT_241	[p15l1578t1063r1870b1121],
20	and	CC	O	and	_	0	SENT_241	[p15l1897t1062r2015b1121],
21	the	DT	O	the	det	22	SENT_241	[p15l2042t1062r2141b1121],
22	emergence	NN	O	emergence	prep_of	13	SENT_241	[p15l562t1177r905b1232],
23	of	IN	O	of	_	0	SENT_241	[p15l939t1157r1014b1216],
24	the	DT	O	the	det	27	SENT_241	[p15l1034t1158r1133b1216],
25	T79OM	NN	O	t79om	nn	27	SENT_241	[p15l1164t1162r1389b1216],
26	drug-resistance	NN	O	drug-resistance	nn	27	SENT_241	[p15l1425t1157r1920b1232],
27	mutation	NN	O	mutation	prep_of	22	SENT_241	[p15l1954t1170r2140b1216, p15l561t1253r701b1311],
28	.	.	O	.	_	0	SENT_241	[p15l1954t1170r2140b1216, p15l561t1253r701b1311],

1	T79OM	NN	O	t79om	nsubj	3	SENT_242	[p15l734t1257r956b1311],
2	was	VBD	O	be	cop	3	SENT_242	[p15l984t1272r1104b1312],
3	present	JJ	DATE	present	_	0	SENT_242	[p15l1135t1265r1368b1327],
4	at	IN	O	at	_	0	SENT_242	[p15l1395t1265r1453b1311],
5	a	DT	O	a	det	9	SENT_242	[p15l1480t1272r1513b1311],
6	very	RB	O	very	advmod	7	SENT_242	[p15l1539t1272r1669b1327],
7	low	JJ	O	low	amod	9	SENT_242	[p15l1696t1253r1810b1312],
8	allele	NN	O	allele	nn	9	SENT_242	[p15l1838t1252r2000b1311],
9	frequency	NN	O	frequency	prep_at	3	SENT_242	[p15l2031t1252r2140b1311, p15l12t1546r309b1619],

1	in	IN	O	in	_	0	SENT_243	[p15l337t1521r419b1597],
2	initial	JJ	O	initial	amod	4	SENT_243	[p15l452t1520r701b1598],
3	tumor	NN	O	tumor	nn	4	SENT_243	[p15l734t1537r998b1599],
4	specimens	NNS	O	specimen	prep_in	14	SENT_243	[p15l1029t1521r1492b1619],
5	,	,	O	,	_	0	SENT_243	[p15l1029t1521r1492b1619],
6	as	IN	O	as	nsubj	14	SENT_243	[p15l1529t1546r1614b1598],
7	determined	VBN	O	determine	partmod	6	SENT_243	[p15l1650t1520r2134b1598],
8	by	IN	O	by	_	0	SENT_243	[p15l12t1647r109b1747],
9	the	DT	O	the	det	11	SENT_243	[p15l144t1647r274b1725],
10	relative	JJ	O	relative	amod	11	SENT_243	[p15l313t1647r613b1726],
11	number	NN	O	number	agent	7	SENT_243	[p15l653t1647r985b1727],
12	of	IN	O	of	_	0	SENT_243	[p15l1022t1646r1120b1726],
13	cycles	NNS	O	cycle	prep_of	11	SENT_243	[p15l1141t1647r1381b1747],
14	required	VBN	O	require	_	0	SENT_243	[p15l1422t1647r1777b1747],
15	for	IN	O	for	_	0	SENT_243	[p15l1815t1646r1936b1726],
16	ampliﬁcation	NN	O	ampliﬁcation	prep_for	14	SENT_243	[p15l1971t1673r2133b1725, p15l11t1774r471b1875],
17	,	,	O	,	_	0	SENT_243	[p15l1971t1673r2133b1725, p15l11t1774r471b1875],
18	and	CC	O	and	_	0	SENT_243	[p15l519t1775r677b1854],
19	serial	NN	O	serial	nn	20	SENT_243	[p15l721t1775r953b1853],
20	analyses	NNS	O	analysis	nsubj	21	SENT_243	[p15l996t1775r1355b1875],
21	indicated	VBD	O	indicate	conj_and	14	SENT_243	[p15l1400t1775r1798b1854],
22	the	DT	O	the	det	24	SENT_243	[p15l1842t1775r1974b1853],
23	increased	VBN	O	increase	amod	24	SENT_243	[p15l2018t1776r2133b1853, p15l12t1903r332b1982],
24	prevalence	NN	O	prevalence	dobj	21	SENT_243	[p15l365t1903r818b2003],
25	of	IN	O	of	_	0	SENT_243	[p15l853t1902r953b1982],
26	the	DT	O	the	det	28	SENT_243	[p15l969t1903r1101b1981],
27	resistance	NN	O	resistance	nn	28	SENT_243	[p15l1135t1904r1564b1981],
28	allele	NN	O	allele	prep_of	24	SENT_243	[p15l1597t1903r1820b1981],
29	within	IN	O	within	_	0	SENT_243	[p15l1849t1903r2134b1983],
30	circulating	VBG	O	circulate	prepc_within	21	SENT_243	[p15l12t2032r480b2133],
31	tumor	NN	O	tumor	nn	32	SENT_243	[p15l516t2049r784b2111],
32	cells	NNS	O	cell	dobj	30	SENT_243	[p15l821t2032r1008b2110],
33	over	IN	O	over	_	0	SENT_243	[p15l1049t2058r1227b2111],
34	time	NN	O	time	prep_over	30	SENT_243	[p15l1264t2033r1480b2128],
35	,	,	O	,	_	0	SENT_243	[p15l1264t2033r1480b2128],
36	a	DT	O	a	det	37	SENT_243	[p15l1524t2058r1569b2110],
37	finding	NN	O	finding	appos	34	SENT_243	[p15l1606t2031r1930b2133],
38	that	WDT	O	that	nsubj	40	SENT_243	[p15l1967t2032r2139b2110],
39	was	VBD	O	be	cop	40	SENT_243	[p15l7t2186r166b2239],
40	consistent	JJ	O	consistent	rcmod	37	SENT_243	[p15l199t2161r619b2239],
41	with	IN	O	with	_	0	SENT_243	[p15l640t2160r829b2239],
42	the	DT	O	the	det	43	SENT_243	[p15l859t2160r987b2239],
43	acquisition	NN	O	acquisition	prep_with	40	SENT_243	[p15l1018t2161r1469b2260],
44	of	IN	O	of	_	0	SENT_243	[p15l1501t2159r1598b2239],
45	clinical	JJ	O	clinical	amod	47	SENT_243	[p15l1611t2160r1909b2238],
46	drug	NN	O	drug	nn	47	SENT_243	[p15l1940t2160r2137b2261],
47	resistance	NN	O	resistance	prep_of	43	SENT_243	[p15l12t2289r442b2366],
48	.	.	O	.	_	0	SENT_243	[p15l12t2289r442b2366],

1	Remarkably	RB	O	remarkably	advmod	5	SENT_244	[p15l482t2288r990b2387],
2	,	,	O	,	_	0	SENT_244	[p15l482t2288r990b2387],
3	seven	CD	NUMBER	seven	num	4	SENT_244	[p15l1034t2314r1257b2367],
4	patients	NNS	O	patient	nsubj	5	SENT_244	[p15l1291t2289r1618b2387],
5	showed	VBD	O	show	_	0	SENT_244	[p15l1657t2288r1969b2367],
6	the	DT	O	the	det	7	SENT_244	[p15l2005t2288r2134b2366],
7	emergence	NN	O	emergence	nsubj	14	SENT_244	[p15l12t2442r474b2517],
8	of	IN	O	of	_	0	SENT_244	[p15l529t2415r629b2495],
9	additional	JJ	O	additional	amod	10	SENT_244	[p15l663t2416r1100b2495],
10	EGFR	NN	ORGANIZATION	egfr	prep_of	7	SENT_244	[p15l1152t2423r1364b2496],
11	activating	VBG	O	activate	partmod	10	SENT_244	[p15l1411t2417r1833b2517],
12	mutations	NNS	O	mutation	dobj	11	SENT_244	[p15l1884t2433r2133b2495, p15l12t2545r224b2623],
13	(	RB	O	(	advmod	11	SENT_244	[p15l266t2544r528b2635],
14	Table	NNP	O	Table	xcomp	5	SENT_244	[p15l266t2544r528b2635],
15	3	CD	NUMBER	3	num	14	SENT_244	[p15l568t2550r611b2623],
16	and	CC	O	and	_	0	SENT_244	[p15l652t2544r809b2623],
17	Fig	NN	O	fig	xcomp	5	SENT_244	[p15l844t2545r997b2645],
18	.	.	O	.	_	0	SENT_244	[p15l844t2545r997b2645],

1	2A	NN	O	2a	_	0	SENT_245	[p15l1041t2550r1159b2622],
2	and	CC	O	and	_	0	SENT_245	[p15l1194t2544r1354b2623],
3	3	CD	NUMBER	3	dep	1	SENT_245	[p15l1393t2550r1463b2640],
4	,	,	O	,	_	0	SENT_245	[p15l1393t2550r1463b2640],
5	and	CC	O	and	_	0	SENT_245	[p15l1504t2544r1662b2623],
6	Table	NNP	O	Table	dep	1	SENT_245	[p15l1694t2544r1928b2623],
7	1	CD	NUMBER	1	num	6	SENT_245	[p15l1970t2550r2014b2622],
8	in	IN	O	in	_	0	SENT_245	[p15l2051t2545r2134b2622],
9	the	DT	O	the	det	12	SENT_245	[p15l12t2672r140b2750],
10	Supplementary	NNP	O	Supplementary	nn	12	SENT_245	[p15l176t2672r797b2772],
11	Appendix	NNP	O	Appendix	nn	12	SENT_245	[p15l822t2672r1268b2772],
12	)	NN	O	)	prep_in	6	SENT_245	[p15l822t2672r1268b2772],
13	.	.	O	.	_	0	SENT_245	[p15l822t2672r1268b2772],

1	Although	IN	O	although	mark	9	SENT_246	[p15l1303t2672r1695b2773],
2	these	DT	O	these	det	5	SENT_246	[p15l1729t2672r1943b2750],
3	secondary	JJ	O	secondary	amod	5	SENT_246	[p15l1978t2698r2133b2750, p15l12t2800r304b2899],
4	mutant	JJ	O	mutant	amod	5	SENT_246	[p15l345t2816r659b2879],
5	alleles	NNS	O	allele	nsubj	9	SENT_246	[p15l701t2800r967b2878],
6	were	VBD	O	be	cop	9	SENT_246	[p15l1012t2826r1213b2879],
7	typically	RB	O	typically	advmod	8	SENT_246	[p15l1262t2800r1627b2899],
8	less	JJR	O	less	advmod	9	SENT_246	[p15l1669t2800r1825b2878],
9	prevalent	JJ	O	prevalent	advcl	25	SENT_246	[p15l1873t2826r2133b2899, p15l11t2928r174b3006],
10	than	IN	O	than	_	0	SENT_246	[p15l215t2928r411b3006],
11	the	DT	O	the	det	13	SENT_246	[p15l458t2928r590b3006],
12	primary	JJ	O	primary	amod	13	SENT_246	[p15l635t2929r986b3027],
13	mutation	NN	O	mutation	prep_than	9	SENT_246	[p15l1027t2929r1443b3023],
14	,	,	O	,	_	0	SENT_246	[p15l1027t2929r1443b3023],
15	in	IN	O	in	_	0	SENT_246	[p15l1494t2929r1577b3005],
16	at	IN	O	at	quantmod	18	SENT_246	[p15l1623t2945r1702b3005],
17	least	JJS	O	least	mwe	16	SENT_246	[p15l1742t2928r1941b3006],
18	one	CD	NUMBER	one	num	19	SENT_246	[p15l1983t2954r2134b3006],
19	case	NN	O	case	prep_in	9	SENT_246	[p15l12t3082r193b3134],
20	(	CD	NUMBER	(	num	21	SENT_246	[p15l237t3057r566b3146],
21	Patient	NN	O	patient	dep	19	SENT_246	[p15l237t3057r566b3146],
22	2	CD	NUMBER	2	number	23	SENT_246	[p15l600t3062r675b3146],
23	)	CD	NUMBER	)	dep	21	SENT_246	[p15l600t3062r675b3146],
24	there	EX	O	there	expl	25	SENT_246	[p15l720t3056r937b3134],
25	was	VBD	O	be	_	0	SENT_246	[p15l972t3082r1134b3135],
26	a	DT	O	a	det	28	SENT_246	[p15l1176t3082r1220b3133],
27	clear	JJ	O	clear	amod	28	SENT_246	[p15l1258t3056r1464b3134],
28	demonstration	NN	O	demonstration	nsubj	25	SENT_246	[p15l1501t3056r2134b3134],
29	of	IN	O	of	_	0	SENT_246	[p15l12t3182r113b3262],
30	the	DT	O	the	det	31	SENT_246	[p15l128t3183r260b3261],
31	potential	NN	O	potential	prep_of	28	SENT_246	[p15l292t3183r679b3283],
32	for	IN	O	for	_	0	SENT_246	[p15l712t3182r835b3262],
33	evolution	NN	O	evolution	prep_for	31	SENT_246	[p15l866t3183r1260b3263],
34	in	IN	O	in	_	0	SENT_246	[p15l1292t3184r1376b3261],
35	the	DT	O	the	det	37	SENT_246	[p15l1409t3183r1542b3261],
36	predominant	JJ	O	predominant	amod	37	SENT_246	[p15l1573t3183r2139b3283],
37	genotype	NN	O	genotype	prep_in	33	SENT_246	[p15l12t3329r406b3413],
38	within	IN	O	within	_	0	SENT_246	[p15l445t3312r730b3391],
39	a	DT	O	a	det	42	SENT_246	[p15l773t3338r818b3390],
40	patient	NN	O	patient	nn	42	SENT_246	[p15l859t3313r1161b3412],
41	(	CD	NUMBER	(	num	42	SENT_246	[p15l1205t3313r1387b3413],
42	Fig	NN	O	fig	prep_within	37	SENT_246	[p15l1205t3313r1387b3413],
43	.	.	O	.	_	0	SENT_246	[p15l1205t3313r1387b3413],

1	3	CD	NUMBER	3	_	0	SENT_247	[p15l1440t3318r1538b3403],
2	)	NN	O	)	dep	1	SENT_247	[p15l1440t3318r1538b3403],
3	.	.	O	.	_	0	SENT_247	[p15l1440t3318r1538b3403],

1	In	IN	O	in	_	0	SENT_248	[p15l1587t3320r1675b3390],
2	this	DT	O	this	det	3	SENT_248	[p15l1720t3312r1879b3390],
3	case	NN	O	case	prep_in	8	SENT_248	[p15l1926t3338r2129b3408],
4	,	,	O	,	_	0	SENT_248	[p15l1926t3338r2129b3408],
5	sufficient	JJ	O	sufficient	amod	6	SENT_248	[p15l13t3438r425b3519],
6	DNA	NN	MISC	dna	nsubjpass	8	SENT_248	[p15l466t3446r675b3518],
7	was	VBD	O	be	auxpass	8	SENT_248	[p15l715t3465r878b3519],
8	isolated	VBN	O	isolate	_	0	SENT_248	[p15l928t3439r1262b3518],
9	from	IN	O	from	_	0	SENT_248	[p15l1310t3438r1520b3518],
10	captured	VBN	O	capture	prepc_from	8	SENT_248	[p15l1569t3439r1945b3539],
11	circulating	VBG	O	circulate	xcomp	10	SENT_248	[p15l1994t3440r2133b3517, p15l12t3568r367b3669],
12	tumor	NN	O	tumor	nn	13	SENT_248	[p15l409t3585r677b3647],
13	cells	NNS	O	cell	dobj	11	SENT_248	[p15l720t3568r907b3647],
14	to	TO	O	to	aux	15	SENT_248	[p15l955t3585r1037b3647],
15	allow	VB	O	allow	xcomp	11	SENT_248	[p15l1083t3568r1319b3647],
16	direct	JJ	O	direct	amod	17	SENT_248	[p15l1361t3568r1610b3647],
17	sequencing	NN	O	sequencing	dobj	15	SENT_248	[p15l1651t3569r2138b3669],
18	of	IN	O	of	_	0	SENT_248	[p15l12t3694r113b3774],
19	EGFR	NN	ORGANIZATION	egfr	prep_of	17	SENT_248	[p15l131t3702r362b3791],
20	,	,	O	,	_	0	SENT_248	[p15l131t3702r362b3791],
21	which	WDT	O	which	nsubj	22	SENT_248	[p15l401t3695r664b3775],
22	confirmed	VBD	O	confirm	rcmod	19	SENT_248	[p15l703t3694r1157b3774],
23	that	IN	O	that	complm	31	SENT_248	[p15l1196t3695r1368b3773],
24	the	DT	O	the	det	26	SENT_248	[p15l1402t3695r1535b3773],
25	predominant	JJ	O	predominant	amod	26	SENT_248	[p15l1573t3695r2139b3795],
26	mutation	NN	O	mutation	nsubj	31	SENT_248	[p16l12t23r397b101],
27	in	IN	O	in	_	0	SENT_248	[p16l432t23r514b100],
28	circulating	VBG	O	circulate	prepc_in	26	SENT_248	[p16l551t22r1008b123],
29	tumor	NN	O	tumor	nn	30	SENT_248	[p16l1041t39r1305b101],
30	cells	NNS	O	cell	dobj	28	SENT_248	[p16l1338t22r1521b100],
31	differed	VBD	O	differ	ccomp	22	SENT_248	[p16l1560t21r1892b101],
32	from	IN	O	from	_	0	SENT_248	[p16l1928t21r2134b101],
33	that	DT	O	that	prep_from	31	SENT_248	[p16l12t150r185b228],
34	in	IN	O	in	_	0	SENT_248	[p16l218t151r302b228],
35	the	DT	O	the	det	38	SENT_248	[p16l342t150r474b228],
36	original	JJ	O	original	amod	38	SENT_248	[p16l515t150r853b251],
37	tumor	NN	O	tumor	nn	38	SENT_248	[p16l893t167r1161b229],
38	specimen	NN	O	specimen	prep_in	33	SENT_248	[p16l1199t151r1627b250],
39	.	.	O	.	_	0	SENT_248	[p16l1199t151r1627b250],

1	DISCUSSION	NN	O	discussion	_	0	SENT_249	[p16l734t446r1412b505],

1	We	PRP	O	we	nsubj	3	SENT_250	[p16l8t670r141b741],
2	have	VBP	O	have	aux	3	SENT_250	[p16l187t663r377b742],
3	shown	VBN	O	show	_	0	SENT_250	[p16l425t663r706b742],
4	that	IN	O	that	complm	22	SENT_250	[p16l752t663r925b741],
5	the	DT	O	the	det	8	SENT_250	[p16l966t663r1099b741],
6	CTC	NNP	O	CTC	nn	8	SENT_250	[p16l1145t663r1551b762],
7	—	CD	NUMBER	—	num	8	SENT_250	[p16l1145t663r1551b762],
8	chip	NN	O	chip	nsubj	22	SENT_250	[p16l1145t663r1551b762],
9	reproducibly	RB	O	reproducibly	advmod	10	SENT_250	[p16l1599t663r2139b762],
10	isolated	VBN	O	isolate	partmod	8	SENT_250	[p16l11t791r338b870],
11	circulating	VBG	O	circulate	xcomp	10	SENT_250	[p16l368t791r824b892],
12	tumor	NN	O	tumor	nn	13	SENT_250	[p16l850t808r1114b870],
13	cells	NNS	O	cell	dobj	11	SENT_250	[p16l1140t791r1323b869],
14	in	IN	O	in	_	0	SENT_250	[p16l1353t792r1435b869],
15	sufficient	JJ	O	sufficient	amod	16	SENT_250	[p16l1466t790r1867b870],
16	quantity	NN	O	quantity	prep_in	11	SENT_250	[p16l1892t817r2133b891, p16l12t919r151b1018],
17	and	CC	O	and	_	0	SENT_250	[p16l178t918r336b997],
18	with	IN	O	with	_	0	SENT_250	[p16l365t918r560b998],
19	sufficient	JJ	O	sufficient	amod	20	SENT_250	[p16l595t917r1007b998],
20	purity	NN	O	purity	prep_with	11	SENT_250	[p16l1033t919r1293b1018],
21	to	TO	O	to	aux	22	SENT_250	[p16l1323t935r1404b997],
22	allow	VB	O	allow	ccomp	3	SENT_250	[p16l1439t918r1674b998],
23	molecular	JJ	O	molecular	amod	24	SENT_250	[p16l1704t918r2137b998],
24	analyses	NNS	O	analysis	dobj	22	SENT_250	[p16l11t1047r378b1147],
25	.	.	O	.	_	0	SENT_250	[p16l11t1047r378b1147],

1	Circulating	VBG	O	circulate	amod	3	SENT_251	[p16l414t1047r878b1148],
2	tumor	NN	O	tumor	nn	3	SENT_251	[p16l906t1064r1165b1126],
3	cells	NNS	O	cell	nsubjpass	6	SENT_251	[p16l1193t1047r1371b1125],
4	were	VBD	O	be	auxpass	6	SENT_251	[p16l1399t1073r1594b1126],
5	readily	RB	O	readily	advmod	6	SENT_251	[p16l1625t1047r1903b1147],
6	identified	VBN	O	identify	_	0	SENT_251	[p16l1929t1047r2133b1126, p16l12t1174r233b1254],
7	in	IN	O	in	_	0	SENT_251	[p16l262t1176r345b1253],
8	all	DT	O	all	det	9	SENT_251	[p16l378t1175r483b1253],
9	patients	NNS	O	patient	prep_in	6	SENT_251	[p16l515t1176r856b1275],
10	in	IN	O	in	_	0	SENT_251	[p16l892t1176r976b1253],
11	numbers	NNS	O	number	prep_in	6	SENT_251	[p16l1009t1175r1387b1254],
12	that	WDT	O	that	nsubj	14	SENT_251	[p16l1423t1175r1596b1253],
13	were	VBD	O	be	cop	14	SENT_251	[p16l1620t1201r1822b1254],
14	higher	JJR	O	higher	rcmod	11	SENT_251	[p16l1856t1175r2137b1276],
15	than	IN	O	than	_	0	SENT_251	[p16l12t1302r208b1380],
16	those	DT	O	those	prep_than	14	SENT_251	[p16l265t1302r497b1381],
17	identified	VBN	O	identify	partmod	16	SENT_251	[p16l553t1301r970b1381],
18	with	IN	O	with	_	0	SENT_251	[p16l1022t1302r1217b1382],
19	previously	RB	DATE	previously	advmod	20	SENT_251	[p16l1272t1302r1711b1402],
20	available	JJ	O	available	amod	21	SENT_251	[p16l1762t1302r2134b1382],
21	methods	NNS	O	method	prep_with	17	SENT_251	[p16l12t1430r385b1509],
22	by	IN	O	by	_	0	SENT_251	[p16l422t1430r520b1530],
23	a	DT	O	a	det	24	SENT_251	[p16l550t1456r594b1508],
24	factor	NN	O	factor	agent	6	SENT_251	[p16l626t1429r877b1509],
25	of	IN	O	of	_	0	SENT_251	[p16l910t1429r1009b1509],
26	approximately	RB	O	approximately	advmod	28	SENT_251	[p16l1025t1430r1641b1530],
27	1O0	JJ	O	1o0	amod	28	SENT_251	[p16l1675t1434r1953b1509],
28	.6	NN	NUMBER	.6	prep_of	24	SENT_251	[p16l1675t1434r1953b1509],
29	'	''	O	'	_	0	SENT_251	[p16l1675t1434r1953b1509],
30	9	CD	NUMBER	9	tmod	6	SENT_251	[p16l1675t1434r1953b1509],

1	The	DT	O	the	det	2	SENT_252	[p16l137t1558r298b1636],
2	use	NN	O	use	nsubjpass	19	SENT_252	[p16l335t1584r475b1638],
3	of	IN	O	of	_	0	SENT_252	[p16l514t1557r613b1637],
4	the	DT	O	the	det	9	SENT_252	[p16l632t1558r765b1636],
5	allele	NN	O	allele	nn	9	SENT_252	[p16l801t1557r1395b1658],
6	—	CD	NUMBER	—	num	9	SENT_252	[p16l801t1557r1395b1658],
7	specif1c	NN	O	specif1c	nn	9	SENT_252	[p16l801t1557r1395b1658],
8	SARMS	NN	O	sarm	nn	9	SENT_252	[p16l1433t1564r1752b1642],
9	assay	NN	O	assay	prep_of	2	SENT_252	[p16l1792t1584r2019b1658],
10	to	TO	O	to	aux	11	SENT_252	[p16l2051t1575r2133b1637],
11	identify	VB	O	identify	infmod	9	SENT_252	[p16l11t1685r344b1786],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_252	[p16l378t1693r591b1766],
13	mutations	NNS	O	mutation	dobj	11	SENT_252	[p16l625t1687r1060b1765],
14	in	IN	O	in	_	0	SENT_252	[p16l1102t1687r1185b1764],
15	rare	JJ	O	rare	amod	17	SENT_252	[p16l1226t1712r1393b1764],
16	cell	NN	O	cell	nn	17	SENT_252	[p16l1435t1686r1580b1764],
17	populations	NNS	O	population	prep_in	11	SENT_252	[p16l1619t1686r2132b1786],
18	was	VBD	O	be	auxpass	19	SENT_252	[p16l7t1840r166b1894],
19	made	VBN	O	make	_	0	SENT_252	[p16l199t1814r424b1893],
20	possible	JJ	O	possible	acomp	19	SENT_252	[p16l453t1814r789b1914],
21	by	IN	O	by	_	0	SENT_252	[p16l821t1814r916b1914],
22	the	DT	O	the	det	24	SENT_252	[p16l942t1814r1071b1892],
23	recurrent	JJ	O	recurrent	amod	24	SENT_252	[p16l1102t1831r1484b1893],
24	nature	NN	O	nature	agent	19	SENT_252	[p16l1511t1831r1777b1894],
25	of	IN	O	of	_	0	SENT_252	[p16l1809t1813r1906b1893],
26	these	DT	O	these	det	27	SENT_252	[p16l1919t1814r2134b1892],
27	mutations	NNS	O	mutation	prep_of	24	SENT_252	[p16l12t1944r470b2039],
28	,	,	O	,	_	0	SENT_252	[p16l12t1944r470b2039],
29	with	IN	O	with	_	0	SENT_252	[p16l523t1943r718b2022],
30	only	RB	O	only	quantmod	31	SENT_252	[p16l770t1943r954b2043],
31	2	CD	NUMBER	2	prep_with	19	SENT_252	[p16l1000t1949r1047b2021],
32	of	IN	O	of	_	0	SENT_252	[p16l1100t1942r1200b2022],
33	31	CD	NUMBER	31	num	34	SENT_252	[p16l1233t1949r1329b2022],
34	patients	NNS	O	patient	prep_of	31	SENT_252	[p16l1379t1944r1720b2043],
35	carrying	VBG	O	carry	partmod	34	SENT_252	[p16l1774t1944r2138b2044],
36	mutations	NNS	O	mutation	dobj	35	SENT_252	[p16l12t2072r446b2150],
37	identified	VBN	O	identify	partmod	36	SENT_252	[p16l513t2070r930b2150],
38	by	IN	O	by	_	0	SENT_252	[p16l996t2071r1093b2171],
39	sequencing	NN	O	sequencing	agent	37	SENT_252	[p16l1156t2072r1641b2172],
40	that	WDT	O	that	nsubj	42	SENT_252	[p16l1704t2071r1876b2149],
41	were	VBD	O	be	cop	42	SENT_252	[p16l1933t2097r2134b2150],
42	absent	JJ	O	absent	rcmod	39	SENT_252	[p16l11t2199r293b2278],
43	from	IN	O	from	_	0	SENT_252	[p16l333t2198r543b2278],
44	the	DT	O	the	det	46	SENT_252	[p16l589t2199r721b2278],
45	assay	NN	O	assay	nn	46	SENT_252	[p16l766t2225r993b2299],
46	panel	NN	O	panel	prep_from	42	SENT_252	[p16l1032t2199r1289b2299],
47	.	.	O	.	_	0	SENT_252	[p16l1032t2199r1289b2299],

1	Together	RB	O	together	_	0	SENT_253	[p16l1337t2199r1723b2300],
2	with	IN	O	with	_	0	SENT_253	[p16l1761t2199r1956b2278],
3	the	DT	O	the	det	6	SENT_253	[p16l2001t2199r2134b2277],
4	CTC	NNP	O	CTC	nn	6	SENT_253	[p16l12t2326r440b2426],
5	—	CD	NUMBER	—	num	6	SENT_253	[p16l12t2326r440b2426],
6	chip	NN	O	chip	prep_together_with	12	SENT_253	[p16l12t2326r440b2426],
7	,	,	O	,	_	0	SENT_253	[p16l12t2326r440b2426],
8	the	DT	O	the	det	10	SENT_253	[p16l488t2326r620b2404],
9	SARMS	NN	O	sarm	nn	10	SENT_253	[p16l663t2332r982b2410],
10	assay	NN	O	assay	nsubj	12	SENT_253	[p16l1026t2352r1253b2426],
11	may	MD	O	may	aux	12	SENT_253	[p16l1289t2352r1468b2426],
12	allow	VB	O	allow	_	0	SENT_253	[p16l1504t2326r1739b2406],
13	for	IN	O	for	_	0	SENT_253	[p16l1777t2325r1899b2405],
14	noninvasive	JJ	O	noninvasive	amod	15	SENT_253	[p16l1938t2352r2133b2405, p16l11t2456r345b2534],
15	genotyping	NN	O	genotyping	prep_for	12	SENT_253	[p16l385t2456r874b2556],
16	in	IN	O	in	_	0	SENT_253	[p16l910t2456r993b2533],
17	patients	NNS	O	patient	prep_in	15	SENT_253	[p16l1031t2456r1372b2555],
18	with	IN	O	with	_	0	SENT_253	[p16l1409t2455r1604b2534],
19	non	JJ	O	non	amod	25	SENT_253	[p16l1644t2455r2133b2534],
20	—	JJ	O	—	amod	21	SENT_253	[p16l1644t2455r2133b2534],
21	small	JJ	O	small	amod	25	SENT_253	[p16l1644t2455r2133b2534],
22	—	NN	O	—	nn	25	SENT_253	[p16l1644t2455r2133b2534],
23	cell	NN	O	cell	nn	25	SENT_253	[p16l12t2583r152b2661],
24	lung	NN	O	lung	nn	25	SENT_253	[p16l185t2583r371b2684],
25	cancer	NN	O	cancer	prep_with	12	SENT_253	[p16l403t2609r688b2679],
26	,	,	O	,	_	0	SENT_253	[p16l403t2609r688b2679],
27	which	WDT	O	which	nsubjpass	30	SENT_253	[p16l724t2583r978b2662],
28	could	MD	O	could	aux	30	SENT_253	[p16l1013t2583r1239b2662],
29	be	VB	O	be	auxpass	30	SENT_253	[p16l1273t2583r1367b2662],
30	repeated	VBN	O	repeat	rcmod	25	SENT_253	[p16l1401t2583r1754b2683],
31	at	IN	O	at	_	0	SENT_253	[p16l1787t2600r1864b2661],
32	therapeutic	JJ	O	therapeutic	amod	33	SENT_253	[p16l1894t2583r2133b2661, p16l11t2712r263b2811],
33	decision	NN	O	decision	prep_at	30	SENT_253	[p16l298t2711r1020b2812],
34	—	CD	NUMBER	—	num	35	SENT_253	[p16l298t2711r1020b2812],
35	mal	NN	O	mal	npadvmod	36	SENT_253	[p16l298t2711r1020b2812],
36	<	JJR	O	<	amod	33	SENT_253	[p16l298t2711r1020b2812],
37	ing	CD	NUMBER	ing	num	38	SENT_253	[p16l298t2711r1020b2812],
38	points	NNS	O	point	dep	36	SENT_253	[p16l1054t2712r1323b2811],
39	during	IN	O	during	_	0	SENT_253	[p16l1365t2711r1653b2812],
40	a	DT	O	a	det	41	SENT_253	[p16l1689t2737r1733b2789],
41	patient	NN	O	patient	poss	43	SENT_253	[p16l1769t2712r2132b2811],
42	’s	POS	O	’s	_	0	SENT_253	[p16l1769t2712r2132b2811],
43	course	NN	O	course	prep_during	30	SENT_253	[p16l12t2865r292b2918],
44	of	IN	O	of	_	0	SENT_253	[p16l334t2838r434b2918],
45	therapy	NN	O	therapy	prep_of	43	SENT_253	[p16l457t2839r791b2939],
46	.	.	O	.	_	0	SENT_253	[p16l457t2839r791b2939],

1	Genotyping	NN	O	genotyping	nsubj	6	SENT_254	[p16l838t2840r1350b2940],
2	of	IN	O	of	_	0	SENT_254	[p16l1388t2838r1488b2918],
3	circulating	VBG	O	circulate	prepc_of	1	SENT_254	[p16l1511t2839r1978b2940],
4	tumor	NN	O	tumor	nn	5	SENT_254	[p16l2016t2856r2133b2918, p16l12t2993r188b3045],
5	cells	NNS	O	cell	dobj	3	SENT_254	[p16l244t2967r431b3045],
6	appeared	VBD	O	appear	_	0	SENT_254	[p16l490t2967r882b3066],
7	to	TO	O	to	aux	10	SENT_254	[p16l941t2984r1022b3045],
8	be	VB	O	be	cop	10	SENT_254	[p16l1082t2967r1178b3045],
9	more	RBR	O	more	advmod	10	SENT_254	[p16l1236t2993r1456b3045],
10	sensitive	JJ	O	sensitive	xcomp	6	SENT_254	[p16l1516t2968r1879b3046],
11	than	IN	O	than	mark	31	SENT_254	[p16l1938t2967r2134b3045],
12	analysis	NN	O	analysis	nsubj	31	SENT_254	[p16l11t3094r351b3194],
13	of	IN	O	of	_	0	SENT_254	[p16l393t3093r492b3173],
14	free	JJ	O	free	amod	18	SENT_254	[p16l513t3093r675b3173],
15	plasma	NN	O	plasma	nn	18	SENT_254	[p16l713t3094r1023b3194],
16	DNA	NN	O	dna	nn	18	SENT_254	[p16l1059t3101r1267b3173],
17	(	NN	O	(	nn	18	SENT_254	[p16l1308t3100r1760b3190],
18	P	NN	O	p	prep_of	12	SENT_254	[p16l1308t3100r1760b3190],
19	=	JJ	O	=	amod	18	SENT_254	[p16l1308t3100r1760b3190],
20	0.009	CD	NUMBER	0.009	num	21	SENT_254	[p16l1308t3100r1760b3190],
21	)	NN	O	)	dep	19	SENT_254	[p16l1308t3100r1760b3190],
22	,	,	O	,	_	0	SENT_254	[p16l1308t3100r1760b3190],
23	and	CC	O	and	_	0	SENT_254	[p16l1804t3094r1961b3173],
24	the	DT	O	the	det	26	SENT_254	[p16l2001t3094r2134b3172],
25	concomitant	JJ	O	concomitant	amod	26	SENT_254	[p16l12t3224r558b3302],
26	quantification	NN	O	quantification	conj_and	18	SENT_254	[p16l592t3222r1208b3323],
27	of	IN	O	of	_	0	SENT_254	[p16l1246t3222r1346b3302],
28	circulating	VBG	O	circulate	prepc_of	26	SENT_254	[p16l1367t3223r1834b3324],
29	tumor	NN	O	tumor	nn	30	SENT_254	[p16l1869t3240r2137b3302],
30	cells	NNS	O	cell	dobj	28	SENT_254	[p16l12t3351r199b3429],
31	provided	VBD	O	provide	ccomp	10	SENT_254	[p16l241t3351r616b3450],
32	an	DT	O	a	det	34	SENT_254	[p16l656t3377r759b3429],
33	important	JJ	O	important	amod	34	SENT_254	[p16l799t3352r1240b3450],
34	context	NN	O	context	dobj	31	SENT_254	[p16l1276t3367r1593b3429],
35	in	IN	O	in	_	0	SENT_254	[p16l1628t3352r1711b3428],
36	which	WDT	O	which	nsubj	38	SENT_254	[p16l1747t3351r2010b3430],
37	to	TO	O	to	aux	38	SENT_254	[p16l2051t3368r2133b3429],
38	interpret	VB	O	interpret	prepc_in	34	SENT_254	[p16l11t3480r389b3579],
39	genotyping	NN	O	genotyping	nn	40	SENT_254	[p16l423t3480r914b3580],
40	results	NNS	O	result	dobj	38	SENT_254	[p16l950t3479r1257b3558],
41	.	.	O	.	_	0	SENT_254	[p16l950t3479r1257b3558],

1	The	DT	O	the	det	2	SENT_255	[p16l137t3607r298b3685],
2	analysis	NN	O	analysis	_	0	SENT_255	[p16l344t3607r683b3707],
3	of	IN	O	of	_	0	SENT_255	[p16l733t3606r833b3686],
4	circulating	VBG	O	circulate	prepc_of	2	SENT_255	[p16l862t3607r1328b3708],
5	tumor	NN	O	tumor	nn	6	SENT_255	[p16l1372t3624r1640b3686],
6	cells	NNS	O	cell	dobj	4	SENT_255	[p16l1684t3607r1871b3685],
7	commonly	RB	O	commonly	advmod	4	SENT_255	[p16l1920t3633r2133b3686, p17l13t21r280b121],

1	identiﬁed	VBD	O	identiﬁed	_	0	SENT_256	[p17l315t20r723b100],
2	the	DT	O	the	det	5	SENT_256	[p17l765t21r896b99],
3	T79OM	NN	O	t79om	nn	5	SENT_256	[p17l933t27r1231b100],
4	drug-resistance	NN	O	drug-resistance	nn	5	SENT_256	[p17l1275t21r1923b122],
5	mutation	NN	O	mutation	dobj	1	SENT_256	[p17l1966t47r2131b100, p17l13t149r260b226],
6	in	IN	O	in	_	0	SENT_256	[p17l298t149r380b225],
7	a	DT	O	a	det	8	SENT_256	[p17l420t174r464b225],
8	majority	NN	O	majority	prep_in	1	SENT_256	[p17l502t149r864b247],
9	of	IN	O	of	_	0	SENT_256	[p17l900t147r999b226],
10	patients	NNS	O	patient	prep_of	8	SENT_256	[p17l1019t149r1360b247],
11	who	WP	O	who	nsubj	12	SENT_256	[p17l1399t148r1580b227],
12	had	VBD	O	have	rcmod	10	SENT_256	[p17l1622t148r1779b226],
13	clinical	JJ	O	clinical	amod	15	SENT_256	[p17l1820t148r2133b225],
14	tumor	NN	O	tumor	nn	15	SENT_256	[p17l13t293r281b355],
15	progression	NN	O	progression	dobj	12	SENT_256	[p17l320t277r831b377],
16	while	IN	O	while	_	0	SENT_256	[p17l871t276r1105b355],
17	receiving	VBG	O	receive	prepc_while	12	SENT_256	[p17l1150t277r1540b377],
18	therapy	NN	O	therapy	dobj	17	SENT_256	[p17l1580t276r1901b376],
19	with	IN	O	with	_	0	SENT_256	[p17l1937t276r2132b355],
20	tyrosine	NN	O	tyrosine	nn	22	SENT_256	[p17l13t404r358b503],
21	kinase	NN	O	kinase	nn	22	SENT_256	[p17l403t403r682b483],
22	inhibitors	NNS	O	inhibitor	prep_with	17	SENT_256	[p17l726t403r1171b482],
23	.	.	O	.	_	0	SENT_256	[p17l726t403r1171b482],

1	Unexpectedly	RB	O	unexpectedly	advmod	10	SENT_257	[p17l1221t403r1815b503],
2	,	,	O	,	_	0	SENT_257	[p17l1221t403r1815b503],
3	use	NN	O	use	nsubj	10	SENT_257	[p17l1865t429r2005b483],
4	of	IN	O	of	_	0	SENT_257	[p17l2051t402r2150b482],
5	the	DT	O	the	det	9	SENT_257	[p17l13t532r146b610],
6	highly	RB	O	highly	advmod	7	SENT_257	[p17l190t532r461b633],
7	sensitive	JJ	O	sensitive	amod	9	SENT_257	[p17l502t533r865b611],
8	allele-specific	JJ	O	allele-specific	amod	9	SENT_257	[p17l908t531r1501b632],
9	assay	NN	O	assay	prep_of	3	SENT_257	[p17l1542t558r1770b632],
10	showed	VBD	O	show	_	0	SENT_257	[p17l1809t532r2132b611],

1	372	CD	NUMBER	372	num	4	SENT_258	[p17l150t708r207b731],
2	N	NN	O	n	nn	4	SENT_258	[p17l933t718r947b733],
3	ENGLJ	NN	O	englj	nn	4	SENT_258	[p17l962t718r1040b740],
4	MED359	NN	O	med359	_	0	SENT_258	[p17l1054t718r1182b740],
5	;	:	O	;	_	0	SENT_258	[p17l1054t718r1182b740],
6	4	CD	NUMBER	4	num	8	SENT_258	[p17l1054t718r1182b740],
7	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	8	SENT_258	[p17l1214t718r1415b740],
8	JULY	NNP	DATE	JULY	dep	4	SENT_258	[p17l1446t718r1504b740],
9	24,2008	CD	DATE	24,2008	num	8	SENT_258	[p17l1514t712r1623b740],

1	The	DT	O	the	det	4	SENT_259	[p17l935t751r986b775],
2	New	NNP	O	New	nn	4	SENT_259	[p17l995t752r1057b775],
3	England	NNP	O	England	nn	4	SENT_259	[p17l1066t751r1177b782],
4	Journal	NNP	O	Journal	_	0	SENT_259	[p17l1186t751r1283b775],
5	of	IN	O	of	_	0	SENT_259	[p17l1293t751r1322b775],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_259	[p17l1329t751r1454b775],

1	Copyright	NN	O	copyright	_	0	SENT_260	[p17l729t833r863b864],
2	©	CD	NUMBER	©	num	6	SENT_260	[p17l872t833r896b857],
3	2008	CD	DATE	2008	num	6	SENT_260	[p17l906t833r969b857],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_260	[p17l979t833r1170b857],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_260	[p17l1180t833r1288b857],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_260	[p17l1299t833r1404b864],
7	.	.	O	.	_	0	SENT_260	[p17l1299t833r1404b864],

1	All	DT	O	all	det	2	SENT_261	[p17l1415t833r1456b857],
2	rights	NNS	O	rights	nsubj	3	SENT_261	[p17l1465t833r1540b864],
3	reserved	VBN	O	reserve	_	0	SENT_261	[p17l1549t833r1667b857],
4	.	.	O	.	_	0	SENT_261	[p17l1549t833r1667b857],

1	DETECTION	NN	O	detection	_	0	SENT_262	[p17l308t875r499b894],
2	OF	IN	O	of	_	0	SENT_262	[p17l514t875r553b894],
3	MUTATIONS	NNP	O	MUTATIONS	prep_of	1	SENT_262	[p17l567t875r762b894],
4	IN	IN	O	in	_	0	SENT_262	[p17l778t875r815b894],
5	EGFR	NN	O	egfr	prep_in	1	SENT_262	[p17l830t875r901b894],
6	IN	IN	O	in	dep	1	SENT_262	[p17l914t875r950b894],
7	CIRCULATING	VBG	O	circulate	pcomp	6	SENT_262	[p17l965t875r1196b894],
8	LUNG-CANCER	NN	O	lung-cancer	nn	9	SENT_262	[p17l1211t875r1456b894],
9	CELLS	NNS	O	cell	dobj	7	SENT_262	[p17l1468t875r1563b894],

1	Table	NNP	O	Table	_	0	SENT_263	[p17l120t997r194b1022],
2	3	CD	NUMBER	3	dep	1	SENT_263	[p17l203t999r226b1021],
3	.	.	O	.	_	0	SENT_263	[p17l203t999r226b1021],

1	Analysis	NN	O	analysis	_	0	SENT_264	[p17l235t996r347b1029],
2	of	IN	O	of	_	0	SENT_264	[p17l356t996r469b1022],
3	'	''	O	'	_	0	SENT_264	[p17l356t996r469b1022],
4	EGFR	NN	O	egfr	nn	5	SENT_264	[p17l356t996r469b1022],
5	Mutations	NNS	O	mutation	prep_of	1	SENT_264	[p17l479t997r618b1022],
6	in	IN	O	in	dep	1	SENT_264	[p17l628t997r651b1021],
7	Circulating	VBG	O	circulate	pcomp	6	SENT_264	[p17l662t996r811b1029],
8	Tumor	NN	O	tumor	nn	9	SENT_264	[p17l819t999r911b1022],
9	Cells	NNS	O	cell	dobj	7	SENT_264	[p17l919t996r983b1022],
10	and	CC	O	and	_	0	SENT_264	[p17l993t996r1042b1022],
11	Free	JJ	O	free	amod	13	SENT_264	[p17l1054t999r1111b1022],
12	Plasma	NN	O	plasma	nn	13	SENT_264	[p17l1122t996r1219b1022],
13	DNA	NN	O	dna	dobj	7	SENT_264	[p17l1230t999r1297b1021],
14	and	CC	O	and	_	0	SENT_264	[p17l1305t996r1354b1022],
15	the	DT	O	the	det	16	SENT_264	[p17l1364t996r1408b1022],
16	Concordance	NN	O	concordance	dobj	7	SENT_264	[p17l1416t996r1595b1022],
17	with	IN	O	with	_	0	SENT_264	[p17l1604t996r1662b1022],
18	Tumor	NN	O	tumor	nn	19	SENT_264	[p17l1671t999r1764b1022],
19	Mutation	NN	O	mutation	prep_with	16	SENT_264	[p17l1774t997r1923b1022],
20	.	.	O	.	_	0	SENT_264	[p17l1774t997r1923b1022],

1	*	NN	O	*	_	0	SENT_265	[p17l1774t997r1923b1022],
2	4	CD	NUMBER	4	dep	1	SENT_265	[p17l94t2958r109b2966],
3	.	.	O	.	_	0	SENT_265	[p17l94t2958r109b2966],

1	Concordance	NN	O	concordance	_	0	SENT_266	[p17l1850t1071r2030b1097],
2	with	IN	O	with	_	0	SENT_266	[p17l1859t1109r1917b1134],
3	Tumor	NN	O	tumor	nn	5	SENT_266	[p17l1928t1111r2021b1134],
4	M	NN	O	m	nn	5	SENT_266	[p17l1870t1149r1893b1171],
5	utation	NN	O	utation	prep_with	1	SENT_266	[p17l1898t1147r2012b1180],
6	:	:	O	:	_	0	SENT_266	[p17l1898t1147r2012b1180],
7	§	CD	NUMBER	§	dep	5	SENT_266	[p17l1898t1147r2012b1180],
8	:	:	O	:	_	0	SENT_266	[p17l1898t1147r2012b1180],

1	Patient	NN	O	patient	nn	2	SENT_267	[p17l157t1110r251b1134],
2	No.	NN	O	no.	_	0	SENT_267	[p17l263t1111r317b1139],
3	,	,	O	,	_	0	SENT_267	[p17l263t1111r317b1139],
4	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_267	[p17l330t1111r406b1134],
5	Mutation	NN	O	mutation	nn	6	SENT_267	[p17l418t1110r541b1134],
6	Status	NN	O	status	appos	2	SENT_267	[p17l553t1111r646b1139],
7	,	,	O	,	_	0	SENT_267	[p17l553t1111r646b1139],

1	and	CC	O	and	dep	2	SENT_268	[p17l226t1146r276b1172],
2	Response	NN	O	response	_	0	SENT_268	[p17l289t1149r419b1179],
3	to	TO	O	to	_	0	SENT_268	[p17l428t1151r455b1172],
4	Therapy	NN	O	therapy	nn	5	SENT_268	[p17l465t1146r576b1179],
5	SARMS	NNS	O	sarm	prep_to	2	SENT_268	[p17l1101t1148r1203b1172],
6	Assay	NN	O	assay	nn	7	SENT_268	[p17l1213t1149r1293b1179],
7	Results	NNS	O	result	dep	5	SENT_268	[p17l1305t1146r1421b1180],
8	?	.	O	?	_	0	SENT_268	[p17l1305t1146r1421b1180],

1	Circulating	VBG	O	circulate	_	0	SENT_269	[p17l800t1204r947b1237],
2	Tumor	NN	O	tumor	nn	3	SENT_269	[p17l956t1206r1049b1229],
3	Cells	NNS	O	cell	nsubj	8	SENT_269	[p17l1058t1204r1121b1229],
4	Free	JJ	O	free	amod	7	SENT_269	[p17l1460t1206r1515b1229],
5	Plasma	NN	O	plasma	nn	7	SENT_269	[p17l1528t1204r1623b1229],
6	primary	JJ	O	primary	amod	7	SENT_269	[p17l749t1264r852b1295],
7	mutation	NN	O	mutation	dep	3	SENT_269	[p17l738t1302r860b1325],
8	primary	JJ	O	primary	xcomp	1	SENT_269	[p17l1308t1264r1411b1295],

1	T790M	NN	O	t790m	_	0	SENT_270	[p17l952t1301r1046b1325],
2	other	JJ	O	other	amod	4	SENT_270	[p17l1120t1300r1191b1325],
3	mutation	NN	O	mutation	nn	4	SENT_270	[p17l1297t1302r1419b1325],
4	T790M	NN	O	t790m	dep	1	SENT_270	[p17l1523t1301r1616b1325],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_271	[p17l122t1359r198b1383],
2	mutation	NN	O	mutation	_	0	SENT_271	[p17l209t1360r329b1383],
3	present	JJ	DATE	present	dep	2	SENT_271	[p17l342t1362r443b1390],
4	and	CC	O	and	_	0	SENT_271	[p17l453t1357r501b1383],
5	response	NN	O	response	dep	2	SENT_271	[p17l514t1366r636b1390],
6	during	IN	O	during	_	0	SENT_271	[p17l221t1395r309b1428],
7	therapyfl	NN	O	therapyfl	prep_during	5	SENT_271	[p17l317t1395r431b1428],

1	UN	NNP	ORGANIZATION	UN	_	0	SENT_272	[p17l1337t1455r1379b1478],

1	None	NN	O	none	nsubj	2	SENT_273	[p17l1260t1512r1333b1534],
2	detected	VBD	O	detect	_	0	SENT_273	[p17l1343t1510r1457b1534],
3	None	NN	O	none	dobj	2	SENT_273	[p17l1260t1569r1333b1592],
4	detected	VBN	O	detect	partmod	3	SENT_273	[p17l1343t1567r1457b1592],

1	Del	NNP	O	Del	_	0	SENT_274	[p17l1338t1624r1380b1650],

1	None	NN	O	none	nsubj	2	SENT_275	[p17l1260t1684r1333b1707],
2	detected	VBD	O	detect	_	0	SENT_275	[p17l1343t1682r1457b1707],

1	Del	NNP	O	Del	_	0	SENT_276	[p17l1338t1740r1380b1765],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_277	[p17l122t1800r198b1823],
2	mutation	NN	O	mutation	_	0	SENT_277	[p17l209t1800r329b1823],
3	present	JJ	DATE	present	dep	2	SENT_277	[p17l342t1802r443b1830],
4	and	CC	O	and	_	0	SENT_277	[p17l453t1798r501b1823],
5	disease	NN	O	disease	nn	6	SENT_277	[p17l512t1798r613b1823],
6	progression	NN	O	progression	dep	2	SENT_277	[p17l625t1806r677b1830, p17l221t1837r334b1868],

1	during	IN	O	during	_	0	SENT_278	[p17l346t1835r435b1868],
2	therapy	NN	O	therapy	nn	3	SENT_278	[p17l443t1835r557b1868],
3	§	NN	O	§	pobj	1	SENT_278	[p17l443t1835r557b1868],

1	Del	NNP	PERSON	Del	nn	2	SENT_279	[p17l779t1893r820b1918],
2	Del	NNP	PERSON	Del	_	0	SENT_279	[p17l779t1951r820b1976],

1	None	NN	O	none	nsubj	2	SENT_280	[p17l701t2010r773b2033],
2	detected	VBD	O	detect	_	0	SENT_280	[p17l783t2008r898b2033],

1	L858R	NN	O	l858r	_	0	SENT_281	[p17l759t2067r841b2091],
2	Del	NNP	PERSON	Del	nn	13	SENT_281	[p17l779t2123r820b2149],
3	Del	NNP	PERSON	Del	nn	13	SENT_281	[p17l779t2181r820b2205],
4	Del	NNP	PERSON	Del	nn	13	SENT_281	[p17l779t2238r820b2263],
5	Del	NNP	PERSON	Del	nn	13	SENT_281	[p17l779t2295r820b2321],
6	Del	NNP	PERSON	Del	nn	13	SENT_281	[p17l779t2353r820b2378],
7	Del	NNP	PERSON	Del	nn	13	SENT_281	[p17l779t2411r820b2436],
8	Del	NNP	PERSON	Del	nn	13	SENT_281	[p17l779t2468r820b2494],
9	Del	NNP	PERSON	Del	nn	13	SENT_281	[p17l779t2526r820b2551],
10	Del	NNP	PERSON	Del	nn	13	SENT_281	[p17l779t2584r820b2609],
11	Del	NNP	PERSON	Del	nn	13	SENT_281	[p17l779t2641r820b2666],
12	UN	NNP	O	UN	nn	13	SENT_281	[p17l1337t1895r1379b1918],
13	Del	NNP	O	Del	dep	1	SENT_281	[p17l1338t1951r1379b1976],
14	L858R	NN	O	l858r	dep	1	SENT_281	[p17l1319t2010r1400b2033],

1	None	NN	O	none	nsubj	2	SENT_282	[p17l1260t2068r1333b2091],
2	detected	VBD	O	detect	_	0	SENT_282	[p17l1343t2066r1457b2091],
3	None	NN	O	none	dobj	2	SENT_282	[p17l1260t2126r1333b2149],
4	detected	VBN	O	detect	partmod	3	SENT_282	[p17l1343t2123r1457b2149],

1	Del	NNP	O	Del	_	0	SENT_283	[p17l1338t2181r1379b2205],

1	None	NN	O	none	nsubj	2	SENT_284	[p17l1260t2240r1333b2263],
2	detected	VBD	O	detect	_	0	SENT_284	[p17l1343t2238r1457b2263],
3	None	NN	O	none	nsubj	6	SENT_284	[p17l1260t2298r1333b2321],
4	detected	VBN	O	detect	partmod	3	SENT_284	[p17l1343t2295r1457b2321],
5	None	NN	O	none	dobj	4	SENT_284	[p17l1260t2355r1333b2378],
6	detected	VBD	O	detect	ccomp	2	SENT_284	[p17l1342t2353r1457b2378],

1	Del	NNP	O	Del	_	0	SENT_285	[p17l1338t2411r1379b2436],

1	None	NN	O	none	nsubj	2	SENT_286	[p17l1260t2471r1332b2494],
2	detected	VBD	O	detect	_	0	SENT_286	[p17l1342t2468r1457b2494],
3	None	NN	O	none	nsubj	6	SENT_286	[p17l1260t2528r1332b2551],
4	detected	VBN	O	detect	partmod	3	SENT_286	[p17l1342t2526r1457b2551],
5	None	NN	O	none	dobj	4	SENT_286	[p17l1260t2586r1332b2609],
6	detected	VBD	O	detect	ccomp	2	SENT_286	[p17l1342t2584r1457b2609],

1	Del	NNP	O	Del	_	0	SENT_287	[p17l1338t2641r1379b2666],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_288	[p17l122t2701r198b2724],
2	mutation	NN	O	mutation	_	0	SENT_288	[p17l208t2702r329b2724],
3	absent	JJ	O	absent	amod	2	SENT_288	[p17l341t2699r431b2724],
4	26	CD	NUMBER	26	tmod	3	SENT_288	[p17l171t2759r202b2782],
5	43	CD	NUMBER	43	num	6	SENT_288	[p17l170t2817r200b2839],
6	44	CD	NUMBER	44	dep	2	SENT_288	[p17l170t2873r202b2896],

1	No	DT	O	no	det	2	SENT_289	[p17l982t2759r1021b2782],
2	None	NN	O	none	nsubj	3	SENT_289	[p17l1260t2759r1332b2782],
3	detected	VBD	O	detect	_	0	SENT_289	[p17l1342t2757r1457b2782],
4	No	DT	O	no	dep	5	SENT_289	[p17l982t2817r1021b2840],
5	No	DT	O	no	dobj	3	SENT_289	[p17l982t2873r1021b2896],

1	None	NN	O	none	nsubj	2	SENT_290	[p17l701t2759r773b2782],
2	detected	VBD	O	detect	_	0	SENT_290	[p17l783t2757r898b2782],
3	None	NN	O	none	nsubj	6	SENT_290	[p17l701t2817r773b2840],
4	detected	VBN	O	detect	partmod	3	SENT_290	[p17l783t2814r898b2840],
5	None	NN	O	none	dobj	4	SENT_290	[p17l1260t2817r1332b2840],
6	detected	VBD	O	detect	ccomp	2	SENT_290	[p17l1342t2814r1457b2840],
7	None	NN	O	none	nsubj	10	SENT_290	[p17l701t2873r773b2896],
8	detected	VBN	O	detect	partmod	7	SENT_290	[p17l783t2871r898b2896],
9	None	NN	O	none	dobj	8	SENT_290	[p17l1260t2873r1332b2896],
10	detected	VBD	O	detect	ccomp	6	SENT_290	[p17l1342t2871r1457b2896],

1	Listed	VBN	O	list	csubj	3	SENT_291	[p17l146t2956r224b2981],
2	are	VBP	O	be	cop	3	SENT_291	[p17l237t2965r277b2981],
3	patients	NNS	O	patient	_	0	SENT_291	[p17l290t2958r396b2989],
4	in	IN	O	in	_	0	SENT_291	[p17l410t2958r431b2981],
5	Group	NNP	O	Group	nn	6	SENT_291	[p17l444t2958r530b2989],
6	A	NNP	O	A	prep_in	3	SENT_291	[p17l541t2958r567b2986],
7	,	,	O	,	_	0	SENT_291	[p17l541t2958r567b2986],
8	for	IN	O	for	_	0	SENT_291	[p17l579t2956r617b2981],
9	whom	WP	O	whom	rel	12	SENT_291	[p17l626t2956r709b2981],
10	genotypes	NNS	O	genotype	nsubj	12	SENT_291	[p17l722t2961r860b2989],
11	were	VBD	O	be	cop	12	SENT_291	[p17l872t2965r934b2981],
12	available	JJ	O	available	rcmod	6	SENT_291	[p17l946t2956r1063b2981],
13	from	IN	O	from	_	0	SENT_291	[p17l1074t2956r1137b2981],
14	at	IN	O	at	quantmod	16	SENT_291	[p17l1151t2961r1175b2981],
15	least	JJS	O	least	mwe	14	SENT_291	[p17l1187t2956r1249b2981],
16	two	CD	NUMBER	two	num	18	SENT_291	[p17l1258t2961r1307b2981],
17	ofthe	NN	O	ofthe	nn	18	SENT_291	[p17l1319t2956r1397b2981],
18	following	NN	O	following	prep_from	12	SENT_291	[p17l1408t2956r1540b2989],
19	:	:	O	:	_	0	SENT_291	[p17l1408t2956r1540b2989],
20	circulating	VBG	O	circulate	parataxis	3	SENT_291	[p17l1551t2956r1694b2989],
21	tumor	NN	O	tumor	nn	22	SENT_291	[p17l1704t2961r1789b2981],
22	cells	NNS	O	cell	dobj	20	SENT_291	[p17l1800t2956r1866b2986],
23	,	,	O	,	_	0	SENT_291	[p17l1800t2956r1866b2986],
24	plasma	NN	O	plasma	dobj	20	SENT_291	[p17l1880t2956r1984b2989],
25	,	,	O	,	_	0	SENT_291	[p17l1880t2956r1984b2989],
26	and	CC	O	and	_	0	SENT_291	[p17l1998t2956r2045b2981],
27	tumor-biopsy	JJ	O	tumor-biopsy	amod	28	SENT_291	[p17l143t2993r326b3026],
28	specimens	NNS	O	specimen	conj_and	22	SENT_291	[p17l338t2995r491b3026],
29	.	.	O	.	_	0	SENT_291	[p17l338t2995r491b3026],

1	Molecular	JJ	O	molecular	amod	2	SENT_292	[p17l505t2993r641b3018],
2	analyses	NNS	O	analysis	nsubjpass	9	SENT_292	[p17l651t2993r765b3026],
3	ofcirculating	VBG	O	ofcirculate	partmod	2	SENT_292	[p17l777t2993r955b3026],
4	tumor	NN	O	tumor	nn	5	SENT_292	[p17l965t2998r1051b3018],
5	cells	NNS	O	cell	dobj	3	SENT_292	[p17l1061t2993r1119b3018],
6	and	CC	O	and	_	0	SENT_292	[p17l1132t2993r1180b3018],
7	plasma	NN	O	plasma	conj_and	5	SENT_292	[p17l1194t2993r1291b3026],
8	were	VBD	O	be	auxpass	9	SENT_292	[p17l1302t3002r1365b3018],
9	performed	VBN	O	perform	_	0	SENT_292	[p17l1378t2993r1518b3026],
10	within	IN	O	within	_	0	SENT_292	[p17l1530t2993r1611b3018],
11	6	CD	DURATION	6	num	12	SENT_292	[p17l1625t2995r1639b3018],
12	months	NNS	NUMBER	month	prep_within	9	SENT_292	[p17l1652t2993r1754b3018],
13	after	IN	O	after	_	0	SENT_292	[p17l1767t2993r1828b3018],
14	the	DT	O	the	det	16	SENT_292	[p17l1837t2993r1880b3018],
15	initial	JJ	O	initial	amod	16	SENT_292	[p17l1892t2993r1964b3018],
16	quantitation	NN	O	quantitation	prep_after	9	SENT_292	[p17l1977t3002r2054b3026, p17l143t3032r237b3055],
17	ofcirculating	VBG	O	ofcirculate	partmod	16	SENT_292	[p17l249t3030r423b3063],
18	tumor	NN	O	tumor	nn	19	SENT_292	[p17l433t3035r517b3055],
19	cells	NNS	O	cell	dobj	17	SENT_292	[p17l526t3030r591b3055],
20	.	.	O	.	_	0	SENT_292	[p17l526t3030r591b3055],

1	Del	NNP	O	Del	nsubj	2	SENT_293	[p17l605t3030r646b3055],
2	denotes	VBZ	O	denote	_	0	SENT_293	[p17l658t3030r763b3055],
3	deletions	NNS	O	deletion	dobj	2	SENT_293	[p17l775t3030r896b3055],
4	in	IN	O	in	_	0	SENT_293	[p17l908t3032r929b3055],
5	exon	NN	O	exon	prep_in	3	SENT_293	[p17l941t3039r1001b3055],
6	19	CD	NUMBER	19	num	5	SENT_293	[p17l1015t3032r1051b3060],
7	,	,	O	,	_	0	SENT_293	[p17l1015t3032r1051b3060],
8	NA	NNP	O	NA	dep	11	SENT_293	[p17l1065t3032r1106b3055],
9	not	RB	O	not	neg	10	SENT_293	[p17l1118t3035r1160b3055],
10	applicable	JJ	O	applicable	amod	8	SENT_293	[p17l1171t3030r1305b3063],
11	due	JJ	O	due	conj_and	2	SENT_293	[p17l1316t3030r1365b3055],
12	to	TO	O	to	_	0	SENT_293	[p17l1374t3035r1401b3055],
13	unavailable	JJ	O	unavailable	amod	15	SENT_293	[p17l1413t3030r1561b3055],
14	tumor	NN	O	tumor	nn	15	SENT_293	[p17l1571t3035r1655b3055],
15	specimen	NN	O	specimen	prep_to	11	SENT_293	[p17l1665t3032r1801b3063],
16	,	,	O	,	_	0	SENT_293	[p17l1665t3032r1801b3063],
17	SARMS	NNP	O	SARMS	nn	22	SENT_293	[p17l1813t3032r1912b3055],
18	Scorpion	NNP	O	Scorpion	nn	22	SENT_293	[p17l1924t3032r2043b3063],
19	Amplification	NNP	O	Amplification	nn	22	SENT_293	[p17l143t3067r325b3100],
20	Refractory	NNP	O	Refractory	nn	22	SENT_293	[p17l340t3067r475b3100],
21	Mutation	NN	O	mutation	nn	22	SENT_293	[p17l488t3069r610b3092],
22	System	NNP	O	System	appos	15	SENT_293	[p17l623t3069r728b3100],
23	,	,	O	,	_	0	SENT_293	[p17l623t3069r728b3100],
24	and	CC	O	and	_	0	SENT_293	[p17l741t3067r789b3092],
25	UN	NNP	ORGANIZATION	UN	nn	26	SENT_293	[p17l804t3069r846b3092],
26	sample	NN	O	sample	dep	27	SENT_293	[p17l861t3067r957b3100],
27	unavailable	JJ	O	unavailable	conj_and	2	SENT_293	[p17l970t3067r1123b3092],
28	for	IN	O	for	_	0	SENT_293	[p17l1134t3067r1171b3092],
29	analysis	NN	O	analysis	prep_for	27	SENT_293	[p17l1182t3067r1296b3100],
30	.	.	O	.	_	0	SENT_293	[p17l1182t3067r1296b3100],

1	The	DT	O	the	det	2	SENT_294	[p17l143t3104r193b3129],
2	primary	JJ	O	primary	nsubjpass	7	SENT_294	[p17l206t3106r309b3137],
3	activating	VBG	O	activate	partmod	2	SENT_294	[p17l320t3106r451b3137],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_294	[p17l464t3106r539b3129],
5	mutations	NNS	O	mutation	dobj	3	SENT_294	[p17l551t3106r689b3129],
6	are	VBP	O	be	auxpass	7	SENT_294	[p17l701t3113r741b3129],
7	listed	VBN	O	list	_	0	SENT_294	[p17l754t3104r824b3129],
8	when	WRB	O	when	advmod	9	SENT_294	[p17l836t3104r907b3129],
9	present	JJ	DATE	present	advcl	7	SENT_294	[p17l921t3109r1028b3137],
10	,	,	O	,	_	0	SENT_294	[p17l921t3109r1028b3137],
11	including	VBG	O	include	_	0	SENT_294	[p17l1042t3104r1168b3137],
12	the	DT	O	the	det	16	SENT_294	[p17l1177t3104r1220b3129],
13	presence	NN	O	presence	nn	16	SENT_294	[p17l1233t3113r1353b3137],
14	or	CC	O	or	_	0	SENT_294	[p17l1365t3113r1392b3129],
15	absence	NN	O	absence	nn	16	SENT_294	[p17l1403t3104r1513b3129],
16	ofthe	NN	O	ofthe	prep_including	7	SENT_294	[p17l1525t3104r1601b3129],
17	specific	JJ	O	specific	amod	22	SENT_294	[p17l1613t3104r1715b3137],
18	drug	NN	O	drug	nn	22	SENT_294	[p17l1726t3104r1937b3137],
19	—	NN	O	—	nn	22	SENT_294	[p17l1726t3104r1937b3137],
20	resistance	NN	O	resistance	nn	22	SENT_294	[p17l1726t3104r1937b3137],
21	allele	NN	O	allele	nn	22	SENT_294	[p17l1949t3104r2017b3129],
22	T790M	NN	O	t790m	dep	16	SENT_294	[p17l143t3143r246b3166],
23	.	.	O	.	_	0	SENT_294	[p17l143t3143r246b3166],

1	In	IN	O	in	_	0	SENT_295	[p17l261t3143r283b3166],
2	all	DT	O	all	det	3	SENT_295	[p17l297t3141r323b3166],
3	cases	NNS	O	case	prep_in	16	SENT_295	[p17l336t3150r417b3171],
4	,	,	O	,	_	0	SENT_295	[p17l336t3150r417b3171],
5	other	JJ	O	other	amod	7	SENT_295	[p17l430t3141r502b3166],
6	activating	VBG	O	activate	amod	7	SENT_295	[p17l512t3143r644b3174],
7	mutations	NNS	O	mutation	nsubj	16	SENT_295	[p17l656t3143r793b3166],
8	that	WDT	O	that	nsubjpass	10	SENT_295	[p17l805t3141r858b3166],
9	are	VBP	O	be	auxpass	10	SENT_295	[p17l870t3150r910b3166],
10	listed	VBN	O	list	rcmod	7	SENT_295	[p17l922t3141r991b3166],
11	as	IN	O	as	_	0	SENT_295	[p17l1005t3150r1032b3166],
12	“	CD	NUMBER	“	prep_as	10	SENT_295	[p17l1045t3141r1143b3166],
13	other	JJ	O	other	amod	12	SENT_295	[p17l1045t3141r1143b3166],
14	"	``	O	"	punct	16	SENT_295	[p17l1045t3141r1143b3166],
15	were	VBD	O	be	cop	16	SENT_295	[p17l1154t3150r1218b3166],
16	present	JJ	DATE	present	_	0	SENT_295	[p17l1231t3146r1332b3174],
17	at	IN	O	at	_	0	SENT_295	[p17l1343t3146r1367b3166],
18	a	DT	O	a	det	21	SENT_295	[p17l1378t3150r1391b3166],
19	lower	JJR	O	lower	amod	21	SENT_295	[p17l1404t3141r1477b3166],
20	allele	NN	O	allele	nn	21	SENT_295	[p17l1487t3141r1555b3166],
21	frequency	NN	O	frequency	prep_at	16	SENT_295	[p17l1566t3141r1698b3174],
22	than	IN	O	than	_	0	SENT_295	[p17l1708t3141r1768b3166],
23	that	DT	O	that	det	26	SENT_295	[p17l1779t3141r1833b3166],
24	ofthe	NN	O	ofthe	nn	26	SENT_295	[p17l1844t3141r1922b3166],
25	primary	JJ	O	primary	amod	26	SENT_295	[p17l1935t3143r2038b3174],
26	mutation	NN	O	mutation	prep_than	21	SENT_295	[p17l146t3181r276b3204],
27	.	.	O	.	_	0	SENT_295	[p17l146t3181r276b3204],

1	Listed	VBN	O	list	_	0	SENT_296	[p17l146t3216r224b3241],
2	is	VBZ	O	be	cop	4	SENT_296	[p17l238t3218r257b3241],
3	the	DT	O	the	det	4	SENT_296	[p17l268t3216r310b3241],
4	concordance	NN	O	concordance	dep	1	SENT_296	[p17l321t3216r496b3241],
5	between	IN	O	between	_	0	SENT_296	[p17l509t3216r619b3241],
6	the	DT	O	the	det	10	SENT_296	[p17l631t3216r673b3241],
7	presence	NN	O	presence	nn	10	SENT_296	[p17l686t3225r807b3249],
8	ofthe	NN	O	ofthe	nn	10	SENT_296	[p17l818t3216r896b3241],
9	primary	JJ	O	primary	amod	10	SENT_296	[p17l909t3218r1011b3249],
10	mutation	NN	O	mutation	prep_between	4	SENT_296	[p17l1023t3218r1145b3241],
11	in	IN	O	in	_	0	SENT_296	[p17l1159t3218r1181b3241],
12	the	DT	O	the	det	14	SENT_296	[p17l1193t3216r1235b3241],
13	tumor	NN	O	tumor	nn	14	SENT_296	[p17l1246t3221r1331b3241],
14	specimen	NN	O	specimen	prep_in	10	SENT_296	[p17l1342t3218r1471b3249],
15	and	CC	O	and	_	0	SENT_296	[p17l1485t3216r1533b3241],
16	that	IN	O	that	complm	17	SENT_296	[p17l1543t3216r1597b3241],
17	in	IN	O	in	conj_and	4	SENT_296	[p17l1609t3218r1631b3241],
18	circulating	VBG	O	circulate	pcomp	17	SENT_296	[p17l1644t3216r1786b3249],
19	tumor	NN	O	tumor	nn	20	SENT_296	[p17l1796t3221r1882b3241],
20	cells	NNS	O	cell	dobj	18	SENT_296	[p17l1892t3216r1950b3241],
21	(	VBP	O	(	dep	1	SENT_296	[p17l1965t3218r2002b3249],
22	C	NN	O	c	dobj	21	SENT_296	[p17l1965t3218r2002b3249],
23	)	CD	NUMBER	)	nsubj	1	SENT_296	[p17l1965t3218r2002b3249],

1	Iii	NNP	O	Iii	_	0	SENT_297	[p17l95t3218r110b3249],
2	and	CC	O	and	_	0	SENT_297	[p17l145t3253r192b3278],
3	free	JJ	O	free	amod	5	SENT_297	[p17l205t3253r255b3278],
4	plasma	NN	O	plasma	nn	5	SENT_297	[p17l268t3253r364b3286],
5	DNA	NN	O	dna	conj_and	1	SENT_297	[p17l378t3255r443b3278],
6	(	NN	O	(	nn	7	SENT_297	[p17l456t3255r501b3286],
7	P	NN	O	p	dep	1	SENT_297	[p17l456t3255r501b3286],
8	)	CD	NUMBER	)	dep	7	SENT_297	[p17l456t3255r501b3286],
9	.	.	O	.	_	0	SENT_297	[p17l456t3255r501b3286],

1	§	NN	O	§	nn	2	SENT_298	[p17l94t3290r105b3323],
2	Patients	NNS	O	patient	nsubjpass	11	SENT_298	[p17l146t3292r253b3315],
3	who	WP	O	who	nsubj	5	SENT_298	[p17l264t3290r320b3315],
4	were	VBD	O	be	aux	5	SENT_298	[p17l330t3299r394b3315],
5	receiving	VBG	O	receive	rcmod	2	SENT_298	[p17l407t3292r527b3323],
6	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_298	[p17l540t3292r615b3315],
7	tyrosine	NN	O	tyrosine	nn	9	SENT_298	[p17l625t3292r733b3323],
8	kinase	NN	O	kinase	nn	9	SENT_298	[p17l746t3290r830b3315],
9	inhibitors	NNS	O	inhibitor	dobj	5	SENT_298	[p17l843t3290r970b3315],
10	were	VBD	O	be	auxpass	11	SENT_298	[p17l982t3299r1045b3315],
11	classified	VBN	O	classify	_	0	SENT_298	[p17l1057t3290r1181b3315],
12	as	IN	O	as	_	0	SENT_298	[p17l1194t3299r1221b3315],
13	having	VBG	O	have	prepc_as	11	SENT_298	[p17l1235t3290r1324b3323],
14	either	CC	O	either	preconj	16	SENT_298	[p17l1335t3290r1413b3315],
15	a	DT	O	a	det	16	SENT_298	[p17l1423t3299r1436b3315],
16	response	NN	O	response	nsubj	25	SENT_298	[p17l1449t3299r1571b3323],
17	or	CC	O	or	_	0	SENT_298	[p17l1582t3299r1610b3315],
18	disease	NN	O	disease	nn	19	SENT_298	[p17l1621t3290r1722b3315],
19	progression	NN	O	progression	nsubj	25	SENT_298	[p17l1734t3292r1894b3323],
20	at	IN	O	at	_	0	SENT_298	[p17l1907t3295r1931b3315],
21	the	DT	O	the	det	24	SENT_298	[p17l1941t3290r1984b3315],
22	time	NN	O	time	nn	24	SENT_298	[p17l1994t3292r2055b3315],
23	ofthe	NN	O	ofthe	nn	24	SENT_298	[p17l144t3327r222b3352],
24	analysis	NN	O	analysis	prep_at	19	SENT_298	[p17l234t3327r339b3360],
25	ofcirculating	VBG	O	ofcirculate	ccomp	13	SENT_298	[p17l351t3327r530b3360],
26	tumor	NN	O	tumor	nn	27	SENT_298	[p17l540t3332r625b3352],
27	cells	NNS	O	cell	dobj	25	SENT_298	[p17l636t3327r702b3352],
28	.	.	O	.	_	0	SENT_298	[p17l636t3327r702b3352],

1	1	CD	NUMBER	1	num	2	SENT_299	[p17l94t3364r111b3397],
2	]	CD	NUMBER	]	nsubj	8	SENT_299	[p17l94t3364r111b3397],
3	A	DT	O	a	det	5	SENT_299	[p17l143t3366r163b3389],
4	plasma	NN	O	plasma	nn	5	SENT_299	[p17l175t3364r271b3397],
5	specimen	NN	O	specimen	dep	2	SENT_299	[p17l284t3366r412b3397],
6	was	VBD	O	be	cop	8	SENT_299	[p17l424t3373r475b3390],
7	not	RB	O	not	neg	8	SENT_299	[p17l489t3369r532b3390],
8	available	JJ	O	available	_	0	SENT_299	[p17l543t3364r660b3390],
9	for	IN	O	for	_	0	SENT_299	[p17l671t3364r709b3390],
10	this	DT	O	this	det	11	SENT_299	[p17l719t3364r768b3390],
11	patient	NN	O	patient	prep_for	8	SENT_299	[p17l781t3366r882b3397],
12	.	.	O	.	_	0	SENT_299	[p17l781t3366r882b3397],

1	|	NN	O	|	nsubjpass	16	SENT_300	[p17l97t3399r103b3435],
2	|	CD	NUMBER	|	num	1	SENT_300	[p17l97t3399r103b3435],
3	The	DT	O	the	det	4	SENT_300	[p17l143t3401r193b3427],
4	mutation	NN	O	mutation	dep	1	SENT_300	[p17l206t3403r327b3427],
5	in	IN	O	in	_	0	SENT_300	[p17l341t3403r363b3426],
6	the	DT	O	the	det	8	SENT_300	[p17l375t3401r417b3427],
7	primary	JJ	O	primary	amod	8	SENT_300	[p17l430t3403r533b3434],
8	tumor	NN	O	tumor	prep_in	1	SENT_300	[p17l543t3406r628b3427],
9	was	VBD	O	be	auxpass	10	SENT_300	[p17l638t3410r689b3427],
10	detected	VBN	O	detect	_	0	SENT_300	[p17l701t3401r816b3427],
11	by	IN	O	by	_	0	SENT_300	[p17l830t3401r858b3434],
12	high-performance	JJ	O	high-performance	amod	14	SENT_300	[p17l870t3401r1112b3435],
13	liquid	JJ	O	liquid	amod	14	SENT_300	[p17l1124t3401r1197b3434],
14	chromatography	NN	O	chromatography	agent	10	SENT_300	[p17l1210t3401r1436b3435],
15	but	CC	O	but	_	0	SENT_300	[p17l1448t3401r1491b3427],
16	was	VBD	O	be	conj_but	10	SENT_300	[p17l1501t3410r1551b3427],
17	below	IN	O	below	_	0	SENT_300	[p17l1564t3401r1643b3427],
18	the	DT	O	the	det	20	SENT_300	[p17l1652t3401r1695b3427],
19	level	NN	O	level	nn	20	SENT_300	[p17l1708t3401r1765b3427],
20	ofdetection	NN	O	ofdetection	prep_below	16	SENT_300	[p17l1777t3401r1939b3427],
21	by	IN	O	by	_	0	SENT_300	[p17l1953t3401r1981b3434],
22	standard	JJ	O	standard	amod	24	SENT_300	[p17l1993t3406r2058b3427, p17l144t3446r204b3471],
23	sequencing	NN	O	sequencing	nn	24	SENT_300	[p17l217t3448r372b3479],
24	analysis	NN	O	analysis	prep_by	20	SENT_300	[p17l383t3446r497b3479],
25	.	.	O	.	_	0	SENT_300	[p17l383t3446r497b3479],

1	The	DT	O	the	det	9	SENT_301	[p17l143t3483r193b3508],
2	presence	NN	O	presence	nn	9	SENT_301	[p17l206t3492r326b3515],
3	ofa	NN	O	ofa	nn	9	SENT_301	[p17l337t3483r386b3508],
4	mutation	NN	O	mutation	nn	9	SENT_301	[p17l400t3485r522b3508],
5	ofunknown	NN	O	ofunknown	nn	9	SENT_301	[p17l535t3483r695b3508],
6	signiﬁcance	NN	O	signiﬁcance	nn	9	SENT_301	[p17l708t3483r869b3515],
7	(	CD	NUMBER	(	num	9	SENT_301	[p17l883t3485r983b3515],
8	S885L	NN	O	s885l	nn	9	SENT_301	[p17l883t3485r983b3515],
9	)	NN	O	)	nsubjpass	19	SENT_301	[p17l883t3485r983b3515],
10	that	WDT	O	that	nsubjpass	13	SENT_301	[p17l996t3483r1050b3508],
11	was	VBD	O	be	auxpass	13	SENT_301	[p17l1060t3492r1111b3508],
12	not	RB	O	not	neg	13	SENT_301	[p17l1124t3488r1167b3508],
13	included	VBN	O	include	rcmod	9	SENT_301	[p17l1179t3483r1293b3508],
14	in	IN	O	in	_	0	SENT_301	[p17l1307t3485r1329b3508],
15	the	DT	O	the	det	17	SENT_301	[p17l1341t3483r1383b3508],
16	SARMS	NN	O	sarm	nn	17	SENT_301	[p17l1395t3485r1496b3508],
17	assay	NN	O	assay	prep_in	13	SENT_301	[p17l1508t3492r1581b3515],
18	was	VBD	O	be	auxpass	19	SENT_301	[p17l1590t3492r1641b3508],
19	reported	VBN	O	report	_	0	SENT_301	[p17l1655t3483r1768b3515],
20	in	IN	O	in	_	0	SENT_301	[p17l1782t3485r1803b3508],
21	the	DT	O	the	det	23	SENT_301	[p17l1815t3483r1858b3508],
22	primary	JJ	O	primary	amod	23	SENT_301	[p17l1871t3485r1974b3515],
23	tumor	NN	O	tumor	prep_in	19	SENT_301	[p17l1984t3488r2020b3508, p17l146t3528r206b3544],
24	.	.	O	.	_	0	SENT_301	[p17l1984t3488r2020b3508, p17l146t3528r206b3544],

1	An	DT	O	a	det	4	SENT_302	[p17l218t3521r253b3544],
2	additional	JJ	O	additional	amod	4	SENT_302	[p17l266t3519r400b3544],
3	tumor	NN	O	tumor	nn	4	SENT_302	[p17l412t3524r497b3544],
4	specimen	NN	O	specimen	nsubj	7	SENT_302	[p17l508t3521r637b3552],
5	was	VBD	O	be	cop	7	SENT_302	[p17l649t3528r700b3544],
6	not	RB	O	not	neg	7	SENT_302	[p17l714t3524r757b3544],
7	available	JJ	O	available	_	0	SENT_302	[p17l768t3519r886b3544],
8	for	IN	O	for	_	0	SENT_302	[p17l896t3519r933b3544],
9	SARMS	NN	O	sarm	nn	10	SENT_302	[p17l944t3521r1045b3544],
10	analysis	NN	O	analysis	prep_for	7	SENT_302	[p17l1057t3519r1171b3552],
11	.	.	O	.	_	0	SENT_302	[p17l1057t3519r1171b3552],

1	N	NN	O	n	nn	3	SENT_303	[p17l592t3664r605b3679],
2	ENGLJ	NN	O	englj	nn	3	SENT_303	[p17l620t3664r698b3686],
3	MED	NN	O	med	_	0	SENT_303	[p17l713t3664r765b3679],
4	359	CD	NUMBER	359	dep	3	SENT_303	[p17l775t3664r841b3686],
5	;	:	O	;	_	0	SENT_303	[p17l775t3664r841b3686],
6	4	CD	NUMBER	4	dep	3	SENT_303	[p17l775t3664r841b3686],
7	WWW	NNP	O	WWW	dep	6	SENT_303	[p17l872t3664r1073b3686],
8	.	.	O	.	_	0	SENT_303	[p17l872t3664r1073b3686],

1	NEjM	NNP	O	NEjM	nn	4	SENT_304	[p17l872t3664r1073b3686],
2	,	,	O	,	_	0	SENT_304	[p17l872t3664r1073b3686],
3	ORG	NNP	O	ORG	appos	4	SENT_304	[p17l872t3664r1073b3686],
4	JULY	NNP	DATE	JULY	_	0	SENT_304	[p17l1104t3664r1162b3686],
5	24	CD	DATE	24	num	4	SENT_304	[p17l1171t3664r1207b3686],
6	,	,	DATE	,	_	0	SENT_304	[p17l1171t3664r1207b3686],
7	2008	CD	DATE	2008	num	8	SENT_304	[p17l1219t3658r1282b3680],
8	373	CD	NUMBER	373	appos	4	SENT_304	[p17l2008t3654r2064b3677],

1	The	DT	O	the	det	4	SENT_305	[p17l752t3721r803b3745],
2	New	NNP	O	New	nn	4	SENT_305	[p17l812t3722r874b3745],
3	England	NNP	O	England	nn	4	SENT_305	[p17l883t3721r993b3752],
4	Journal	NNP	O	Journal	_	0	SENT_305	[p17l1002t3721r1099b3745],
5	of	IN	O	of	_	0	SENT_305	[p17l1109t3721r1138b3745],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_305	[p17l1144t3721r1269b3745],

1	Downloaded	VBN	O	download	_	0	SENT_306	[p17l195t3762r364b3785],
2	from	IN	O	from	_	0	SENT_306	[p17l373t3762r437b3785],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_306	[p17l446t3762r564b3792],
4	at	IN	O	at	_	0	SENT_306	[p17l574t3766r597b3785],
5	UW-Madison	NN	O	uw-madison	prep_at	3	SENT_306	[p17l606t3762r789b3785],
6	on	IN	O	on	_	0	SENT_306	[p17l798t3769r830b3785],
7	J	NN	O	j	prep_on	1	SENT_306	[p17l839t3762r851b3785],
8	annary	JJ	O	annary	amod	7	SENT_306	[p17l853t3769r941b3792],
9	5	CD	NUMBER	5	tmod	8	SENT_306	[p17l951t3762r973b3790],
10	,	,	O	,	_	0	SENT_306	[p17l951t3762r973b3790],
11	2014	CD	DATE	2014	dobj	1	SENT_306	[p17l984t3762r1056b3785],
12	.	.	O	.	_	0	SENT_306	[p17l984t3762r1056b3785],

1	For	IN	O	for	_	0	SENT_307	[p17l1067t3762r1113b3785],
2	personal	JJ	O	personal	amod	3	SENT_307	[p17l1121t3762r1234b3792],
3	use	NN	O	use	pobj	1	SENT_307	[p17l1243t3769r1286b3785],
4	only	RB	O	only	advmod	3	SENT_307	[p17l1296t3762r1361b3792],
5	.	.	O	.	_	0	SENT_307	[p17l1296t3762r1361b3792],

1	No	DT	O	no	det	3	SENT_308	[p17l1372t3762r1411b3785],
2	other	JJ	O	other	amod	3	SENT_308	[p17l1421t3762r1489b3785],
3	uses	NNS	O	use	_	0	SENT_308	[p17l1498t3769r1553b3785],
4	without	IN	O	without	_	0	SENT_308	[p17l1563t3762r1664b3785],
5	permission	NN	O	permission	prep_without	3	SENT_308	[p17l1672t3762r1825b3792],
6	.	.	O	.	_	0	SENT_308	[p17l1672t3762r1825b3792],

1	Copyright	NN	O	copyright	_	0	SENT_309	[p17l544t3803r679b3834],
2	©	CD	NUMBER	©	num	6	SENT_309	[p17l688t3803r711b3827],
3	2008	CD	DATE	2008	num	6	SENT_309	[p17l722t3803r786b3827],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_309	[p17l796t3803r986b3827],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_309	[p17l996t3803r1104b3827],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_309	[p17l1115t3803r1219b3834],
7	.	.	O	.	_	0	SENT_309	[p17l1115t3803r1219b3834],

1	All	DT	O	all	det	2	SENT_310	[p17l1231t3803r1272b3827],
2	rights	NNS	O	rights	nsubj	3	SENT_310	[p17l1281t3803r1356b3834],
3	reserved	VBN	O	reserve	_	0	SENT_310	[p17l1365t3803r1484b3827],
4	.	.	O	.	_	0	SENT_310	[p17l1365t3803r1484b3827],

1	The	DT	O	the	det	4	SENT_311	[p18l673t81r718b102],
2	NEW	NNP	O	NEW	nn	4	SENT_311	[p18l737t83r822b102],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_311	[p18l841t83r1029b102],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_311	[p18l1048t83r1227b109],
5	of	IN	O	of	_	0	SENT_311	[p18l1247t81r1275b108],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_311	[p18l1287t83r1486b102],

1	that	IN	O	that	_	0	SENT_312	[p18l12t305r186b384],
2	a	DT	O	a	det	3	SENT_312	[p18l218t332r263b384],
3	subgroup	NN	O	subgroup	prep_that	10	SENT_312	[p18l301t305r707b407],
4	of	IN	O	of	_	0	SENT_312	[p18l747t304r847b385],
5	patients	NNS	O	patient	prep_of	3	SENT_312	[p18l866t306r1209b406],
6	with	IN	O	with	_	0	SENT_312	[p18l1245t305r1442b385],
7	the	DT	O	the	det	9	SENT_312	[p18l1480t305r1614b384],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_312	[p18l1650t312r1864b386],
9	mutation	NN	O	mutation	prep_with	5	SENT_312	[p18l1896t322r2147b385, p18l12t434r182b512],
10	harbor	VBP	O	harbor	conj_and	10	SENT_312	[p18l215t433r508b512],
11	rare	JJ	O	rare	amod	13	SENT_312	[p18l538t459r706b511],
12	T79OM	NN	O	t79om	nn	13	SENT_312	[p18l735t439r1039b512],
13	alleles	NNS	O	allele	dobj	10	SENT_312	[p18l1072t433r1339b511],
14	both	CC	O	both	preconj	10	SENT_312	[p18l1374t433r1573b512],
15	before	IN	O	before	_	0	SENT_312	[p18l1606t432r1876b512],
16	exposure	NN	O	exposure	prep_before	10	SENT_312	[p18l1909t459r2147b533, p18l13t588r185b641],
17	to	TO	O	to	_	0	SENT_312	[p18l218t579r298b641],
18	tyrosine	NN	O	tyrosine	nn	20	SENT_312	[p18l333t563r665b662],
19	kinase	NN	O	kinase	nn	20	SENT_312	[p18l699t562r968b641],
20	inhibitors	NNS	O	inhibitor	prep_to	16	SENT_312	[p18l1000t562r1405b641],
21	and	CC	O	and	_	0	SENT_312	[p18l1439t562r1594b641],
22	during	IN	O	during	_	0	SENT_312	[p18l1627t562r1907b663],
23	clini	NNS	O	clinus	prep_during	10	SENT_312	[p18l1937t562r2147b640],
24	—	CD	NUMBER	—	num	26	SENT_312	[p18l1937t562r2147b640],
25	cal	JJ	O	cal	amod	26	SENT_312	[p18l13t690r132b768],
26	response	NN	O	response	nsubj	10	SENT_312	[p18l156t716r555b790],
27	.	.	O	.	_	0	SENT_312	[p18l156t716r555b790],

1	T79OM	NN	O	t79om	nsubjpass	3	SENT_313	[p18l582t696r882b769],
2	is	VBZ	O	be	auxpass	3	SENT_313	[p18l908t691r973b768],
3	thought	VBN	O	think	_	0	SENT_313	[p18l1001t690r1340b791],
4	to	TO	O	to	aux	5	SENT_313	[p18l1361t707r1442b769],
5	emerge	VB	O	emerge	xcomp	3	SENT_313	[p18l1470t716r1778b791],
6	through	IN	O	through	_	0	SENT_313	[p18l1804t690r2148b791],
7	selective	JJ	O	selective	amod	8	SENT_313	[p18l13t818r372b897],
8	pressure	NN	O	pressure	prep_through	5	SENT_313	[p18l403t844r769b918],
9	during	IN	O	during	_	0	SENT_313	[p18l802t818r1092b919],
10	therapy	NN	O	therapy	prep_during	5	SENT_313	[p18l1121t818r1457b918],
11	,	,	O	,	_	0	SENT_313	[p18l1121t818r1457b918],
12	although	IN	O	although	mark	16	SENT_313	[p18l1495t818r1883b919],
13	it	PRP	O	it	nsubjpass	16	SENT_313	[p18l1915t819r1974b896],
14	has	VBZ	O	have	aux	16	SENT_313	[p18l2001t818r2145b896],
15	been	VBN	O	be	auxpass	16	SENT_313	[p18l13t946r215b1025],
16	reported	VBN	O	report	advcl	5	SENT_313	[p18l262t946r630b1046],
17	in	IN	O	in	_	0	SENT_313	[p18l677t947r760b1024],
18	rare	JJ	O	rare	amod	19	SENT_313	[p18l807t972r975b1024],
19	cases	NNS	O	case	prep_in	16	SENT_313	[p18l1023t972r1246b1024],
20	in	IN	O	in	_	0	SENT_313	[p18l1295t947r1378b1024],
21	patients	NNS	O	patient	prep_in	19	SENT_313	[p18l1423t947r1767b1046],
22	Without	IN	O	without	_	0	SENT_313	[p18l1811t946r2153b1026],
23	previous	JJ	O	previous	amod	25	SENT_313	[p18l11t1076r375b1175],
24	drug	NN	O	drug	nn	25	SENT_313	[p18l436t1075r641b1176],
25	eXposure	NN	O	exposure	prep_without	16	SENT_313	[p18l696t1079r1286b1175],
26	,25	CD	NUMBER	,25	num	27	SENT_313	[p18l696t1079r1286b1175],
27	>	JJR	O	>	dep	25	SENT_313	[p18l696t1079r1286b1175],
28	26	CD	NUMBER	26	dep	27	SENT_313	[p18l696t1079r1286b1175],
29	and	CC	O	and	_	0	SENT_313	[p18l1344t1075r1503b1154],
30	the	DT	O	the	det	31	SENT_313	[p18l1561t1075r1695b1153],
31	mutation	NN	O	mutation	nsubj	32	SENT_313	[p18l1753t1076r2148b1154],
32	confers	VBZ	O	confer	conj_and	3	SENT_313	[p18l12t1202r328b1283],
33	additional	JJ	O	additional	amod	35	SENT_313	[p18l361t1203r801b1283],
34	transforming	VBG	O	transform	amod	35	SENT_313	[p18l833t1202r1416b1305],
35	properties	NNS	O	property	dobj	32	SENT_313	[p18l1443t1204r1884b1304],
36	when	WRB	O	when	advmod	53	SENT_313	[p18l1913t1203r2148b1283],
37	combined	VBN	O	combine	prep	53	SENT_313	[p18l12t1332r433b1411],
38	in	IN	O	in	pcomp	37	SENT_313	[p18l470t1333r553b1409],
39	cis	NN	O	ci	pobj	38	SENT_313	[p18l594t1334r682b1410],
40	with	IN	O	with	_	0	SENT_313	[p18l712t1332r906b1411],
41	the	DT	O	the	det	44	SENT_313	[p18l944t1332r1076b1410],
42	more	JJR	O	more	amod	44	SENT_313	[p18l1114t1358r1332b1411],
43	common	JJ	O	common	amod	44	SENT_313	[p18l1371t1358r1749b1411],
44	EGFR	NN	ORGANIZATION	egfr	prep_with	39	SENT_313	[p18l1787t1338r1997b1412],
45	activating	VBG	O	activate	partmod	44	SENT_313	[p18l2028t1358r2147b1410, p18l12t1461r335b1561],
46	mutations	NNS	O	mutation	dobj	45	SENT_313	[p18l377t1461r917b1539],
47	.27	CD	NUMBER	.27	npadvmod	48	SENT_313	[p18l377t1461r917b1539],
48	Thus	RB	O	thus	advmod	45	SENT_313	[p18l959t1460r1196b1556],
49	,	,	O	,	_	0	SENT_313	[p18l959t1460r1196b1556],
50	T79OM	NN	O	t79om	nsubj	53	SENT_313	[p18l1244t1466r1548b1539],
51	may	MD	O	may	aux	53	SENT_313	[p18l1596t1486r1776b1560],
52	initially	RB	O	initially	advmod	53	SENT_313	[p18l1817t1460r2153b1560],
53	arise	VB	O	arise	dep	35	SENT_313	[p18l11t1589r216b1667],
54	by	IN	O	by	_	0	SENT_313	[p18l260t1588r358b1689],
55	virtue	NN	O	virtue	prep_by	53	SENT_313	[p18l392t1589r645b1668],
56	of	IN	O	of	_	0	SENT_313	[p18l690t1587r790b1668],
57	its	PRP$	O	its	poss	58	SENT_313	[p18l815t1589r914b1667],
58	oncogenicity	NN	O	oncogenicity	prep_of	55	SENT_313	[p18l961t1589r1515b1690],
59	and	CC	O	and	_	0	SENT_313	[p18l1553t1588r1712b1668],
60	may	MD	O	may	aux	62	SENT_313	[p18l1756t1614r1936b1689],
61	rapidly	RB	O	rapidly	advmod	62	SENT_313	[p18l1975t1614r2147b1689, p18l11t1717r168b1818],
62	emerge	VB	O	emerge	conj_and	32	SENT_313	[p18l199t1743r513b1819],
63	as	IN	O	as	_	0	SENT_313	[p18l547t1744r633b1796],
64	a	DT	O	a	det	66	SENT_313	[p18l669t1744r713b1796],
65	dominant	JJ	O	dominant	amod	66	SENT_313	[p18l747t1717r1174b1797],
66	allele	NN	O	allele	prep_as	62	SENT_313	[p18l1202t1717r1426b1796],
67	after	IN	O	after	_	0	SENT_313	[p18l1460t1716r1664b1796],
68	treatment	NN	O	treatment	prep_after	62	SENT_313	[p18l1695t1734r2142b1797],
69	.	.	O	.	_	0	SENT_313	[p18l1695t1734r2142b1797],

1	The	DT	O	the	det	2	SENT_314	[p18l8t1845r170b1923],
2	presence	NN	O	presence	nsubj	22	SENT_314	[p18l216t1871r594b1945],
3	of	IN	O	of	_	0	SENT_314	[p18l642t1844r742b1924],
4	rare	JJ	O	rare	amod	6	SENT_314	[p18l770t1871r939b1923],
5	T79OM	NN	O	t79om	nn	6	SENT_314	[p18l983t1851r1287b1924],
6	alleles	NNS	O	allele	prep_of	2	SENT_314	[p18l1335t1845r1601b1923],
7	in	IN	O	in	_	0	SENT_314	[p18l1650t1846r1734b1923],
8	pretreatment	NN	O	pretreatment	nn	10	SENT_314	[p18l1780t1862r2147b1945, p18l12t1991r231b2052],
9	tumor	NN	O	tumor	nn	10	SENT_314	[p18l261t1991r526b2053],
10	specimens	NNS	O	specimen	prep_in	6	SENT_314	[p18l559t1975r1001b2074],
11	did	VBD	O	do	aux	13	SENT_314	[p18l1038t1974r1172b2053],
12	not	RB	O	not	neg	13	SENT_314	[p18l1205t1991r1347b2053],
13	preclude	VB	O	preclude	_	0	SENT_314	[p18l1375t1974r1734b2074],
14	dramatic	JJ	O	dramatic	amod	15	SENT_314	[p18l1770t1974r2149b2053],
15	responses	NNS	O	response	dobj	13	SENT_314	[p18l12t2129r437b2203],
16	to	TO	O	to	_	0	SENT_314	[p18l489t2120r571b2182],
17	tyrosine	NN	O	tyrosine	nn	19	SENT_314	[p18l622t2104r971b2203],
18	kinase	NN	O	kinase	nn	19	SENT_314	[p18l1021t2103r1301b2182],
19	inhibitors	NNS	O	inhibitor	prep_to	13	SENT_314	[p18l1350t2103r1774b2182],
20	but	CC	O	but	_	0	SENT_314	[p18l1827t2103r1967b2182],
21	did	VBD	O	do	aux	22	SENT_314	[p18l2013t2103r2148b2182],
22	have	VB	O	have	conj_but	13	SENT_314	[p18l12t2232r199b2312],
23	a	DT	O	a	det	26	SENT_314	[p18l231t2259r276b2311],
24	significantly	RB	O	significantly	advmod	25	SENT_314	[p18l308t2231r841b2334],
25	adverse	JJ	O	adverse	amod	26	SENT_314	[p18l868t2232r1178b2312],
26	effect	NN	O	effect	dobj	22	SENT_314	[p18l1211t2231r1449b2311],
27	on	IN	O	on	_	0	SENT_314	[p18l1476t2258r1582b2312],
28	progressionfree	NN	O	progressionfree	nn	29	SENT_314	[p18l1613t2233r2147b2334, p18l12t2359r175b2438],
29	survival	NN	O	survival	prep_on	26	SENT_314	[p18l229t2360r585b2440],
30	.	.	O	.	_	0	SENT_314	[p18l229t2360r585b2440],

1	We	PRP	O	we	nsubj	2	SENT_315	[p18l639t2368r772b2438],
2	speculate	VBP	O	speculate	_	0	SENT_315	[p18l826t2360r1228b2460],
3	that	IN	O	that	complm	10	SENT_315	[p18l1280t2360r1453b2438],
4	this	DT	O	this	det	6	SENT_315	[p18l1501t2360r1661b2438],
5	molecular	JJ	O	molecular	amod	6	SENT_315	[p18l1715t2360r2151b2439],
6	marker	NN	O	marker	nsubj	10	SENT_315	[p18l12t2489r325b2569],
7	may	MD	O	may	aux	10	SENT_315	[p18l363t2515r543b2590],
8	be	VB	O	be	cop	10	SENT_315	[p18l580t2489r677b2569],
9	a	DT	O	a	det	10	SENT_315	[p18l718t2516r763b2568],
10	Way	NN	O	way	ccomp	2	SENT_315	[p18l797t2516r966b2590],
11	of	IN	O	of	_	0	SENT_315	[p18l1004t2488r1104b2569],
12	distinguishing	JJ	O	distinguishing	amod	13	SENT_315	[p18l1127t2489r1766b2591],
13	patients	NNS	O	patient	prep_of	10	SENT_315	[p18l1802t2490r2145b2590],
14	who	WP	O	who	nsubj	16	SENT_315	[p18l7t2618r192b2697],
15	are	VBP	O	be	cop	16	SENT_315	[p18l239t2644r368b2696],
16	likely	JJ	O	likely	rcmod	10	SENT_315	[p18l414t2618r648b2718],
17	to	TO	O	to	aux	18	SENT_315	[p18l691t2635r773b2697],
18	have	VB	O	have	xcomp	16	SENT_315	[p18l821t2618r1012b2697],
19	a	DT	O	a	det	21	SENT_315	[p18l1058t2644r1103b2696],
20	prolonged	JJ	O	prolonged	amod	21	SENT_315	[p18l1147t2618r1587b2719],
21	response	NN	O	response	dobj	18	SENT_315	[p18l1634t2644r2017b2718],
22	to	TO	O	to	_	0	SENT_315	[p18l2065t2635r2147b2697],
23	erlotinib	NN	O	erlotinib	prep_to	18	SENT_315	[p18l12t2746r382b2826],
24	or	CC	O	or	_	0	SENT_315	[p18l418t2772r507b2826],
25	gefitinib	NN	O	gefitinib	conj_or	23	SENT_315	[p18l537t2745r911b2848],
26	from	IN	O	from	_	0	SENT_315	[p18l947t2745r1158b2826],
27	those	DT	O	those	prep_from	10	SENT_315	[p18l1192t2746r1425b2826],
28	Whose	WP$	O	whose	poss	29	SENT_315	[p18l1454t2746r1730b2826],
29	response	NN	O	response	nsubj	32	SENT_315	[p18l1765t2772r2148b2847],
30	is	VBZ	O	be	cop	32	SENT_315	[p18l11t2876r79b2953],
31	short	JJ	O	short	amod	32	SENT_315	[p18l124t2875r587b2954],
32	—	NN	O	—	rcmod	27	SENT_315	[p18l124t2875r587b2954],
33	lived	VBD	O	live	rcmod	32	SENT_315	[p18l124t2875r587b2954],
34	and	CC	O	and	_	0	SENT_315	[p18l627t2875r788b2954],
35	Who	WP	O	who	nsubj	39	SENT_315	[p18l825t2875r1011b2954],
36	may	MD	O	may	aux	39	SENT_315	[p18l1053t2901r1235b2975],
37	be	VB	O	be	cop	39	SENT_315	[p18l1273t2875r1370b2954],
38	appropriate	JJ	O	appropriate	amod	39	SENT_315	[p18l1411t2876r1920b2975],
39	candidates	NNS	O	candidate	ccomp	2	SENT_315	[p18l1962t2901r2147b2953, p18l13t3004r313b3084],
40	for	IN	O	for	_	0	SENT_315	[p18l349t3003r468b3084],
41	second	JJ	ORDINAL	second	amod	43	SENT_315	[p18l501t3004r1285b3106],
42	—	NN	O	—	nn	43	SENT_315	[p18l501t3004r1285b3106],
43	generation	NN	O	generation	prep_for	39	SENT_315	[p18l501t3004r1285b3106],
44	,	,	O	,	_	0	SENT_315	[p18l501t3004r1285b3106],
45	irreversible	JJ	O	irreversible	amod	48	SENT_315	[p18l1324t3004r1780b3084],
46	tyrosine	NN	O	tyrosine	nn	48	SENT_315	[p18l1815t3005r2148b3105],
47	kinase	NN	O	kinase	nn	48	SENT_315	[p18l12t3133r292b3212],
48	inhibitors	NNS	O	inhibitor	prep_for	39	SENT_315	[p18l328t3133r752b3212],
49	or	CC	O	or	_	0	SENT_315	[p18l791t3159r881b3212],
50	combination	NN	O	combination	conj_or	43	SENT_315	[p18l914t3133r1464b3212],
51	targeted	VBN	O	target	partmod	50	SENT_315	[p18l1501t3133r2147b3234],
52	—	NN	O	—	nn	56	SENT_315	[p18l1501t3133r2147b3234],
53	thera	NN	O	thera	nn	56	SENT_315	[p18l1501t3133r2147b3234],
54	—	CD	NUMBER	—	num	56	SENT_315	[p18l1501t3133r2147b3234],
55	py	NN	O	py	nn	56	SENT_315	[p18l11t3287r110b3362],
56	regimens	NNS	O	regimen	dep	51	SENT_315	[p18l138t3262r555b3363],
57	.	.	O	.	_	0	SENT_315	[p18l138t3262r555b3363],

1	Although	IN	O	although	mark	15	SENT_316	[p18l591t3261r993b3363],
2	amplification	NN	O	amplification	nsubjpass	15	SENT_316	[p18l1026t3260r1600b3362],
3	of	IN	O	of	_	0	SENT_316	[p18l1635t3260r1734b3341],
4	the	DT	O	the	det	7	SENT_316	[p18l1749t3261r1881b3340],
5	c-met	NN	O	c-met	nn	7	SENT_316	[p18l1915t3278r2153b3340],
6	proto	NN	O	proto	nn	7	SENT_316	[p18l11t3407r698b3491],
7	—	NN	O	—	prep_of	2	SENT_316	[p18l11t3407r698b3491],
8	oncogene	NN	O	oncogene	nn	11	SENT_316	[p18l11t3407r698b3491],
9	(	CD	NUMBER	(	num	11	SENT_316	[p18l745t3396r993b3481],
10	MET	NN	O	met	nn	11	SENT_316	[p18l745t3396r993b3481],
11	)	NN	O	)	dep	7	SENT_316	[p18l745t3396r993b3481],
12	has	VBZ	O	have	aux	15	SENT_316	[p18l1040t3390r1186b3468],
13	recently	RB	DATE	recently	advmod	15	SENT_316	[p18l1230t3390r1572b3490],
14	been	VBN	O	be	auxpass	15	SENT_316	[p18l1610t3390r1812b3469],
15	reported	VBN	O	report	_	0	SENT_316	[p18l1854t3407r2147b3490, p18l13t3517r109b3596],
16	as	IN	O	as	_	0	SENT_316	[p18l144t3543r229b3595],
17	a	DT	DURATION	a	det	19	SENT_316	[p18l267t3543r312b3595],
18	second	JJ	DURATION	second	amod	19	SENT_316	[p18l348t3517r641b3596],
19	mechanism	NN	O	mechanism	prep_as	15	SENT_316	[p18l677t3517r1172b3595],
20	of	IN	O	of	_	0	SENT_316	[p18l1209t3516r1309b3596],
21	acquired	VBN	O	acquire	amod	22	SENT_316	[p18l1326t3517r1691b3617],
22	resistance	NN	O	resistance	prep_of	19	SENT_316	[p18l1727t3518r2148b3595],
23	to	TO	O	to	_	0	SENT_316	[p18l12t3663r94b3725],
24	tyrosine	NN	O	tyrosine	nn	26	SENT_316	[p18l137t3647r485b3746],
25	kinase	NN	O	kinase	nn	26	SENT_316	[p18l525t3646r805b3725],
26	inhibitors	NNS	O	inhibitor	prep_to	22	SENT_316	[p18l844t3646r1466b3742],
27	,19	CD	NUMBER	,19	num	28	SENT_316	[p18l844t3646r1466b3742],
28	’	NN	O	’	dep	26	SENT_316	[p18l844t3646r1466b3742],
29	2	CD	NUMBER	2	number	30	SENT_316	[p18l844t3646r1466b3742],
30	°	CD	NUMBER	°	dep	28	SENT_316	[p18l844t3646r1466b3742],
31	we	PRP	O	we	nsubj	34	SENT_316	[p18l1503t3672r1621b3725],
32	did	VBD	O	do	aux	34	SENT_316	[p18l1662t3646r1797b3725],
33	not	RB	O	not	neg	34	SENT_316	[p18l1837t3663r1981b3725],
34	detect	VB	O	detect	rcmod	22	SENT_316	[p18l2017t3646r2147b3725, p19l12t38r171b99],

1	it	PRP	O	it	nsubj	24	SENT_317	[p19l215t22r274b99],
2	in	IN	O	in	_	0	SENT_317	[p19l318t22r402b99],
3	pretreatment	NN	O	pretreatment	nn	7	SENT_317	[p19l451t38r1020b121],
4	tumor	NN	O	tumor	nn	7	SENT_317	[p19l1065t21r1648b121],
5	—	CD	NUMBER	—	num	7	SENT_317	[p19l1065t21r1648b121],
6	biopsy	NN	O	biopsy	nn	7	SENT_317	[p19l1065t21r1648b121],
7	specimens	NNS	O	specimen	prep_in	1	SENT_317	[p19l1696t22r2146b121],
8	or	CC	O	or	_	0	SENT_317	[p19l13t176r102b229],
9	in	IN	O	in	_	0	SENT_317	[p19l160t151r244b228],
10	circulating	VBG	O	circulate	conj_or	7	SENT_317	[p19l306t150r776b251],
11	tumor	NN	O	tumor	nn	12	SENT_317	[p19l835t167r1104b229],
12	cells	NNS	O	cell	dobj	10	SENT_317	[p19l1164t150r1352b228],
13	collected	VBN	O	collect	partmod	12	SENT_317	[p19l1417t150r1799b229],
14	during	IN	O	during	_	0	SENT_317	[p19l1861t150r2152b251],
15	therapy	NN	O	therapy	prep_during	13	SENT_317	[p19l12t278r336b378],
16	using	VBG	O	use	xcomp	13	SENT_317	[p19l370t279r608b379],
17	a	DT	O	a	det	20	SENT_317	[p19l643t304r688b356],
18	quantitative	JJ	O	quantitative	amod	20	SENT_317	[p19l726t279r1239b378],
19	PCR	NN	O	pcr	nn	20	SENT_317	[p19l1276t284r1469b361],
20	assay	NN	O	assay	dobj	16	SENT_317	[p19l1496t304r1725b378],
21	(	CD	NUMBER	(	num	22	SENT_317	[p19l1763t278r1973b369],
22	data	NNS	O	datum	npadvmod	23	SENT_317	[p19l1763t278r1973b369],
23	not	RB	O	not	neg	24	SENT_317	[p19l2010t295r2153b357],
24	shown	VBN	O	show	_	0	SENT_317	[p19l13t406r347b497],
25	)	NN	O	)	dobj	24	SENT_317	[p19l13t406r347b497],
26	.	.	O	.	_	0	SENT_317	[p19l13t406r347b497],

1	The	DT	O	the	det	4	SENT_318	[p19l138t535r300b613],
2	most	RBS	O	most	advmod	3	SENT_318	[p19l382t552r599b614],
3	unexpected	JJ	O	unexpected	amod	4	SENT_318	[p19l677t535r1170b635],
4	observation	NN	O	observation	nsubj	10	SENT_318	[p19l1253t535r1757b614],
5	in	IN	O	in	_	0	SENT_318	[p19l1838t536r1922b613],
6	our	PRP$	O	we	poss	7	SENT_318	[p19l2005t561r2151b614],
7	study	NN	O	study	prep_in	4	SENT_318	[p19l13t664r245b765],
8	was	VBD	O	be	cop	10	SENT_318	[p19l270t691r433b744],
9	the	DT	O	the	det	10	SENT_318	[p19l470t664r604b743],
10	emergence	NN	O	emergence	_	0	SENT_318	[p19l639t690r1103b766],
11	of	IN	O	of	_	0	SENT_318	[p19l1139t663r1239b744],
12	additional	JJ	O	additional	amod	15	SENT_318	[p19l1254t664r1694b744],
13	activating	VBG	O	activate	amod	15	SENT_318	[p19l1727t665r2152b766],
14	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_318	[p19l11t799r224b872],
15	mutations	NNS	O	mutation	prep_of	10	SENT_318	[p19l250t794r687b872],
16	in	IN	O	in	_	0	SENT_318	[p19l721t794r805b871],
17	circulating	VBG	O	circulate	prepc_in	15	SENT_318	[p19l838t793r1308b894],
18	tumor	NN	O	tumor	nn	19	SENT_318	[p19l1338t810r1607b872],
19	cells	NNS	O	cell	dobj	17	SENT_318	[p19l1637t793r1826b871],
20	during	IN	O	during	_	0	SENT_318	[p19l1861t793r2152b894],
21	therapy	NN	O	therapy	prep_during	17	SENT_318	[p19l12t921r349b1021],
22	.	.	O	.	_	0	SENT_318	[p19l12t921r349b1021],

1	Although	IN	O	although	mark	7	SENT_319	[p19l397t921r807b1022],
2	the	DT	O	the	det	4	SENT_319	[p19l853t921r986b999],
3	SARMS	NN	O	sarm	nn	4	SENT_319	[p19l1035t927r1355b1004],
4	assay	NN	O	assay	nsubj	7	SENT_319	[p19l1404t947r1633b1021],
5	can	MD	O	can	aux	7	SENT_319	[p19l1675t938r1975b1000],
6	not	RB	O	not	neg	7	SENT_319	[p19l1675t938r1975b1000],
7	determine	VB	O	determine	advcl	33	SENT_319	[p19l2016t921r2147b1000, p19l12t1050r351b1127],
8	Whether	IN	O	whether	complm	13	SENT_319	[p19l416t1049r773b1128],
9	two	CD	NUMBER	two	num	11	SENT_319	[p19l839t1066r998b1128],
10	different	JJ	O	different	amod	11	SENT_319	[p19l1069t1048r1447b1128],
11	mutations	NNS	O	mutation	nsubj	13	SENT_319	[p19l1510t1050r1948b1128],
12	are	VBP	O	be	cop	13	SENT_319	[p19l2018t1075r2148b1127],
13	present	JJ	DATE	present	dep	7	SENT_319	[p19l11t1194r332b1277],
14	on	IN	O	on	_	0	SENT_319	[p19l374t1203r481b1256],
15	the	DT	O	the	det	16	SENT_319	[p19l527t1177r661b1255],
16	same	JJ	O	same	prep_on	13	SENT_319	[p19l709t1203r931b1255],
17	or	CC	O	or	_	0	SENT_319	[p19l978t1203r1068b1256],
18	on	IN	O	on	dep	7	SENT_319	[p19l1112t1203r1218b1256],
19	separate	JJ	O	separate	amod	20	SENT_319	[p19l1266t1194r1623b1277],
20	alleles	NNS	O	allele	pobj	18	SENT_319	[p19l1670t1177r1961b1273],
21	,	,	O	,	_	0	SENT_319	[p19l1670t1177r1961b1273],
22	the	DT	O	the	det	23	SENT_319	[p19l2014t1177r2148b1255],
23	patient	NN	O	patient	nsubj	33	SENT_319	[p19l11t1306r315b1405],
24	for	IN	O	for	_	0	SENT_319	[p19l351t1304r475b1384],
25	whom	WP	O	whom	dobj	27	SENT_319	[p19l508t1305r781b1385],
26	we	PRP	O	we	nsubj	27	SENT_319	[p19l817t1331r935b1385],
27	had	VBD	O	have	prepc_for	23	SENT_319	[p19l977t1305r1134b1384],
28	sufficient	JJ	O	sufficient	amod	29	SENT_319	[p19l1176t1304r1591b1385],
29	DNA	NN	O	dna	dobj	27	SENT_319	[p19l1625t1312r1835b1385],
30	for	IN	O	for	_	0	SENT_319	[p19l1872t1304r1996b1384],
31	direct	JJ	O	direct	amod	32	SENT_319	[p19l2035t1305r2147b1384, p19l12t1451r175b1512],
32	sequencing	NN	O	sequencing	prep_for	29	SENT_319	[p19l235t1435r724b1535],
33	had	VBD	O	have	_	0	SENT_319	[p19l786t1434r943b1513],
34	mutually	RB	O	mutually	advmod	35	SENT_319	[p19l1007t1434r1393b1534],
35	exclusive	JJ	O	exclusive	amod	36	SENT_319	[p19l1453t1434r1831b1513],
36	mutations	NNS	O	mutation	dobj	33	SENT_319	[p19l1896t1451r2147b1513, p19l12t1563r225b1641],
37	in	IN	O	in	_	0	SENT_319	[p19l282t1563r366b1640],
38	the	DT	O	the	det	40	SENT_319	[p19l421t1562r555b1640],
39	original	JJ	O	original	amod	40	SENT_319	[p19l611t1562r952b1663],
40	tumor	NN	O	tumor	prep_in	33	SENT_319	[p19l1007t1579r1277b1641],
41	and	CC	O	and	_	0	SENT_319	[p19l1328t1562r1487b1641],
42	in	IN	O	in	_	0	SENT_319	[p19l1541t1563r1625b1640],
43	circulating	VBG	O	circulate	prep_in	33	SENT_319	[p19l1682t1562r2152b1663],
44	tumor	NN	O	tumor	nn	45	SENT_319	[p19l12t1707r282b1770],
45	cells	NNS	O	cell	nsubj	46	SENT_319	[p19l325t1690r512b1769],
46	(	VBP	O	(	ccomp	43	SENT_319	[p19l565t1691r748b1792],
47	Fig	NN	O	fig	dobj	46	SENT_319	[p19l565t1691r748b1792],
48	.	.	O	.	_	0	SENT_319	[p19l565t1691r748b1792],

1	3	CD	NUMBER	3	_	0	SENT_320	[p19l802t1697r901b1782],
2	)	NN	O	)	dep	1	SENT_320	[p19l802t1697r901b1782],
3	.	.	O	.	_	0	SENT_320	[p19l802t1697r901b1782],

1	We	PRP	O	we	nsubj	3	SENT_321	[p19l948t1698r1082b1769],
2	therefore	RB	O	therefore	advmod	3	SENT_321	[p19l1127t1689r1518b1770],
3	presume	VBP	O	presume	_	0	SENT_321	[p19l1562t1716r1934b1791],
4	that	IN	O	that	complm	12	SENT_321	[p19l1979t1690r2153b1769],
5	the	DT	O	the	det	6	SENT_321	[p19l12t1819r146b1898],
6	identification	NN	O	identification	nsubj	12	SENT_321	[p19l212t1818r799b1899],
7	of	IN	O	of	_	0	SENT_321	[p19l866t1818r967b1899],
8	different	JJ	O	different	amod	11	SENT_321	[p19l1016t1818r1395b1899],
9	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_321	[p19l1454t1826r1668b1899],
10	activating	VBG	O	activate	amod	11	SENT_321	[p19l1727t1820r2152b1921],
11	mutations	NNS	O	mutation	prep_of	6	SENT_321	[p19l12t1949r449b2028],
12	represents	VBZ	O	represent	ccomp	3	SENT_321	[p19l490t1965r934b2049],
13	the	DT	O	the	det	14	SENT_321	[p19l976t1948r1109b2027],
14	emergence	NN	O	emergence	dobj	12	SENT_321	[p19l1149t1974r1613b2050],
15	of	IN	O	of	_	0	SENT_321	[p19l1653t1947r1753b2028],
16	different	JJ	O	different	amod	18	SENT_321	[p19l1775t1947r2153b2028],
17	tumor	NN	O	tumor	nn	18	SENT_321	[p19l12t2094r282b2156],
18	clones	NNS	O	clone	prep_of	14	SENT_321	[p19l325t2077r619b2156],
19	.	.	O	.	_	0	SENT_321	[p19l325t2077r619b2156],

1	In	IN	O	in	_	0	SENT_322	[p19l669t2085r758b2155],
2	some	DT	O	some	det	3	SENT_322	[p19l805t2103r1030b2156],
3	patients	NNS	O	patient	prep_in	7	SENT_322	[p19l1075t2078r1443b2177],
4	,	,	O	,	_	0	SENT_322	[p19l1075t2078r1443b2177],
5	additional	JJ	O	additional	amod	6	SENT_322	[p19l1493t2077r1933b2156],
6	mutations	NNS	O	mutation	nsubj	7	SENT_322	[p19l1979t2103r2147b2156, p19l12t2207r308b2286],
7	emerged	VBD	O	emerge	_	0	SENT_322	[p19l351t2206r721b2308],
8	during	IN	O	during	_	0	SENT_322	[p19l762t2206r1052b2308],
9	tumor	NN	O	tumor	nn	10	SENT_322	[p19l1090t2223r1359b2286],
10	progression	NN	O	progression	prep_during	7	SENT_322	[p19l1394t2207r1909b2308],
11	after	IN	O	after	_	0	SENT_322	[p19l1948t2205r2151b2285],
12	chemotherapy	NN	O	chemotherapy	prep_after	7	SENT_322	[p19l13t2334r641b2434],
13	.	.	O	.	_	0	SENT_322	[p19l13t2334r641b2434],

1	Therefore	RB	O	therefore	advmod	7	SENT_323	[p19l704t2333r1147b2430],
2	,	,	O	,	_	0	SENT_323	[p19l704t2333r1147b2430],
3	such	JJ	O	such	amod	4	SENT_323	[p19l1215t2334r1410b2413],
4	mutations	NNS	O	mutation	nsubjpass	7	SENT_323	[p19l1471t2335r1909b2413],
5	may	MD	O	may	aux	7	SENT_323	[p19l1972t2360r2153b2434],
6	be	VB	O	be	auxpass	7	SENT_323	[p19l12t2463r110b2543],
7	associated	VBN	O	associate	_	0	SENT_323	[p19l142t2463r589b2543],
8	With	IN	O	with	mark	11	SENT_323	[p19l616t2463r813b2543],
9	drug	NN	O	drug	nn	10	SENT_323	[p19l846t2463r1425b2565],
10	—	NN	O	—	nsubj	11	SENT_323	[p19l846t2463r1425b2565],
11	induced	VBD	O	induce	advcl	7	SENT_323	[p19l846t2463r1425b2565],
12	shifts	NNS	O	shift	dobj	11	SENT_323	[p19l1458t2462r1699b2542],
13	in	IN	O	in	_	0	SENT_323	[p19l1732t2464r1816b2541],
14	tumorcell	NN	O	tumorcell	nn	15	SENT_323	[p19l1848t2480r2147b2543, p19l12t2592r159b2671],
15	populations	NNS	O	population	prep_in	11	SENT_323	[p19l198t2592r738b2693],
16	,	,	O	,	_	0	SENT_323	[p19l198t2592r738b2693],
17	reflecting	VBG	O	reflect	partmod	11	SENT_323	[p19l785t2591r1209b2694],
18	clonal	JJ	O	clonal	amod	19	SENT_323	[p19l1247t2592r1508b2672],
19	selection	NN	O	selection	dobj	17	SENT_323	[p19l1549t2592r1930b2672],
20	during	IN	O	during	_	0	SENT_323	[p19l1971t2592r2147b2672, p19l11t2723r151b2823],
21	treatment	NN	O	treatment	prep_during	17	SENT_323	[p19l189t2738r636b2801],
22	.	.	O	.	_	0	SENT_323	[p19l189t2738r636b2801],

1	The	DT	O	the	det	2	SENT_324	[p19l138t2850r302b2929],
2	mutation	NN	O	mutation	nsubjpass	6	SENT_324	[p19l359t2851r760b2930],
3	of	IN	O	of	_	0	SENT_324	[p19l817t2849r919b2930],
4	EGFR	NN	ORGANIZATION	egfr	prep_of	2	SENT_324	[p19l954t2857r1171b2931],
5	is	VBZ	O	be	auxpass	6	SENT_324	[p19l1220t2851r1287b2929],
6	thought	VBN	O	think	_	0	SENT_324	[p19l1345t2850r1698b2952],
7	to	TO	O	to	aux	12	SENT_324	[p19l1749t2867r1832b2930],
8	be	VB	O	be	cop	12	SENT_324	[p19l1890t2850r1988b2930],
9	an	DT	O	a	det	12	SENT_324	[p19l2044t2876r2148b2929],
10	early	JJ	O	early	amod	12	SENT_324	[p19l12t2979r224b3080],
11	molecular	JJ	O	molecular	amod	12	SENT_324	[p19l278t2979r723b3059],
12	event	NN	O	event	xcomp	6	SENT_324	[p19l779t2996r1009b3059],
13	in	IN	O	in	_	0	SENT_324	[p19l1062t2980r1148b3057],
14	the	DT	O	the	det	15	SENT_324	[p19l1208t2979r1343b3058],
15	genesis	NN	O	genesis	prep_in	12	SENT_324	[p19l1402t2980r1723b3081],
16	of	IN	O	of	_	0	SENT_324	[p19l1785t2978r1887b3059],
17	nonsmall	JJ	O	nonsmall	amod	21	SENT_324	[p19l1928t3005r2152b3059, p19l13t3108r444b3186],
18	—	NN	O	—	nn	21	SENT_324	[p19l1928t3005r2152b3059, p19l13t3108r444b3186],
19	cell	NN	O	cell	nn	21	SENT_324	[p19l1928t3005r2152b3059, p19l13t3108r444b3186],
20	lung	NN	O	lung	nn	21	SENT_324	[p19l502t3108r699b3209],
21	cancer	NN	O	cancer	prep_of	15	SENT_324	[p19l756t3134r1044b3186],
22	in	IN	O	in	_	0	SENT_324	[p19l1100t3109r1184b3186],
23	nonsmokers	NNS	O	nonsmoker	prep_in	21	SENT_324	[p19l1243t3108r1783b3187],
24	on	IN	O	on	_	0	SENT_324	[p19l1845t3134r1953b3187],
25	the	DT	O	the	prep_on	23	SENT_324	[p19l2013t3108r2148b3186],

1	Figure	NN	O	figure	_	0	SENT_325	[p20l84t174r303b257],
2	2	CD	NUMBER	2	number	3	SENT_325	[p20l330t179r368b237],
3	(	CD	NUMBER	(	dep	1	SENT_325	[p20l402t172r641b259],
4	facing	VBG	O	face	partmod	1	SENT_325	[p20l402t172r641b259],
5	page	NN	O	page	nn	6	SENT_325	[p20l669t179r882b258],
6	)	NN	O	)	dobj	4	SENT_325	[p20l669t179r882b258],
7	.	.	O	.	_	0	SENT_325	[p20l669t179r882b258],

1	Serial	JJ	O	serial	amod	2	SENT_326	[p20l912t173r1108b238],
2	Analyses	NNS	O	analysis	_	0	SENT_326	[p20l1136t173r1453b259],
3	of	IN	O	of	_	0	SENT_326	[p20l1482t172r1564b238],
4	Circulating	VBG	O	circulate	prepc_of	2	SENT_326	[p20l1575t173r1966b258],
5	Tumor	NN	O	tumor	nn	6	SENT_326	[p20l77t287r313b346],
6	Cells	NNS	O	cell	dobj	4	SENT_326	[p20l338t281r508b346],
7	during	IN	O	during	_	0	SENT_326	[p20l537t281r771b366],
8	Therapy	NN	O	therapy	prep_during	4	SENT_326	[p20l795t281r1102b366],
9	.	.	O	.	_	0	SENT_326	[p20l795t281r1102b366],

1	Panel	NN	O	panel	nn	2	SENT_327	[p20l85t410r271b475],
2	A	NN	O	a	nsubj	3	SENT_327	[p20l302t415r352b474],
3	shows	VBZ	O	show	dep	12	SENT_327	[p20l381t410r603b476],
4	serial	NN	O	serial	nn	5	SENT_327	[p20l637t410r820b475],
5	analyses	NNS	O	analysis	nsubj	6	SENT_327	[p20l855t410r1154b496],
6	ofthe	VBP	O	ofthe	ccomp	3	SENT_327	[p20l1186t410r1390b475],
7	numbers	NNS	O	number	dobj	6	SENT_327	[p20l1423t410r1739b476],
8	of	IN	O	of	_	0	SENT_327	[p20l1770t410r1848b475],
9	circulating	VBG	O	circulate	prepc_of	7	SENT_327	[p20l1865t417r2061b476, p20l84t519r279b605],
10	tumor	NN	O	tumor	nn	11	SENT_327	[p20l304t531r529b584],
11	cells	NNS	O	cell	dobj	9	SENT_327	[p20l556t519r709b584],
12	(	VBP	O	(	_	0	SENT_327	[p20l748t524r982b604],
13	CTCs	NNS	O	ctc	dobj	12	SENT_327	[p20l748t524r982b604],
14	)	CD	NUMBER	)	num	13	SENT_327	[p20l748t524r982b604],
15	per	IN	O	per	_	0	SENT_327	[p20l1023t541r1136b604],
16	milliliter	NN	O	milliliter	nn	20	SENT_327	[p20l1166t519r1460b584],
17	(	CD	NUMBER	(	num	20	SENT_327	[p20l1494t519r1625b604],
18	red	JJ	O	red	amod	20	SENT_327	[p20l1494t519r1625b604],
19	curve	NN	O	curve	nn	20	SENT_327	[p20l1659t524r1874b604],
20	)	NN	O	)	prep_per	13	SENT_327	[p20l1659t524r1874b604],
21	and	CC	O	and	_	0	SENT_327	[p20l1913t519r2038b584],
22	the	DT	O	the	det	25	SENT_327	[p20l77t627r189b692],
23	radiographic	JJ	O	radiographic	amod	25	SENT_327	[p20l223t627r675b713],
24	tumor	NN	O	tumor	nn	25	SENT_327	[p20l700t640r924b692],
25	burden	NN	O	burden	dobj	12	SENT_327	[p20l955t627r1201b692],
26	in	IN	O	in	_	0	SENT_327	[p20l1238t633r1294b691],
27	centimeters	NNS	O	centimeter	prep_in	25	SENT_327	[p20l1327t633r1752b692],
28	(	CD	NUMBER	(	num	31	SENT_327	[p20l1792t627r1966b713],
29	blue	JJ	O	blue	amod	31	SENT_327	[p20l1792t627r1966b713],
30	curve	NN	O	curve	nn	31	SENT_327	[p20l80t741r296b821],
31	)	NN	O	)	nsubj	12	SENT_327	[p20l80t741r296b821],
32	in	IN	O	in	_	0	SENT_327	[p20l335t741r391b799],
33	four	CD	NUMBER	four	num	34	SENT_327	[p20l423t735r570b800],
34	patients	NNS	O	patient	prep_in	31	SENT_327	[p20l600t741r885b820],
35	with	IN	O	with	_	0	SENT_327	[p20l914t735r1062b800],
36	non	JJ	O	non	amod	40	SENT_327	[p20l1099t735r1625b800],
37	—	JJ	O	—	amod	40	SENT_327	[p20l1099t735r1625b800],
38	small-cell	NN	O	small-cell	nn	40	SENT_327	[p20l1099t735r1625b800],
39	lung	NN	O	lung	nn	40	SENT_327	[p20l1661t735r1813b821],
40	cancer	NN	O	cancer	prep_with	34	SENT_327	[p20l1841t758r2078b800],
41	with	IN	O	with	_	0	SENT_327	[p20l77t844r225b909],
42	EGFR	NN	ORGANIZATION	egfr	nn	43	SENT_327	[p20l263t849r455b909],
43	mutations	NNS	O	mutation	prep_with	34	SENT_327	[p20l487t849r871b920],
44	,	,	O	,	_	0	SENT_327	[p20l487t849r871b920],
45	as	IN	O	as	mark	46	SENT_327	[p20l905t866r976b909],
46	measured	VBN	O	measure	dep	31	SENT_327	[p20l1012t844r1360b909],
47	at	IN	O	at	_	0	SENT_327	[p20l1395t856r1457b909],
48	multiple	JJ	O	multiple	amod	50	SENT_327	[p20l1490t844r1782b928],
49	time	NN	O	time	nn	50	SENT_327	[p20l1809t849r1970b909],
50	points	NNS	O	point	prep_at	46	SENT_327	[p20l84t958r303b1036],
51	during	IN	O	during	_	0	SENT_327	[p20l336t951r568b1037],
52	the	DT	O	the	det	54	SENT_327	[p20l595t951r707b1017],
53	course	NN	O	course	nn	54	SENT_327	[p20l737t975r973b1017],
54	oftreatment	NN	O	oftreatment	prep_during	46	SENT_327	[p20l1003t951r1452b1017],
55	with	IN	O	with	_	0	SENT_327	[p20l1478t951r1626b1017],
56	gefitinib	NN	O	gefitinib	prep_with	46	SENT_327	[p20l1661t951r1973b1037],
57	,	,	O	,	_	0	SENT_327	[p20l1661t951r1973b1037],
58	another	DT	O	another	det	63	SENT_327	[p20l81t1059r359b1124],
59	chemotherapy	NN	O	chemotherapy	nn	63	SENT_327	[p20l386t1059r903b1145],
60	agent	NN	O	agent	nn	63	SENT_327	[p20l932t1072r1129b1145],
61	(	CD	NUMBER	(	num	63	SENT_327	[p20l1166t1059r1478b1145],
62	chemo	NN	O	chemo	nn	63	SENT_327	[p20l1166t1059r1478b1145],
63	)	NN	O	)	prep_with	46	SENT_327	[p20l1166t1059r1478b1145],
64	,	,	O	,	_	0	SENT_327	[p20l1166t1059r1478b1145],
65	or	CC	O	or	_	0	SENT_327	[p20l1511t1083r1583b1124],
66	an	DT	O	a	det	71	SENT_327	[p20l1612t1083r1690b1124],
67	experimental	JJ	O	experimental	amod	71	SENT_327	[p20l1723t1066r1963b1144, p20l84t1168r325b1233],
68	agent	NN	O	agent	nn	71	SENT_327	[p20l360t1180r557b1254],
69	(	CD	NUMBER	(	num	71	SENT_327	[p20l593t1173r781b1253],
70	exp	NN	O	exp	nn	71	SENT_327	[p20l593t1173r781b1253],
71	)	NN	O	)	prep_with	46	SENT_327	[p20l593t1173r781b1253],
72	.	.	O	.	_	0	SENT_327	[p20l593t1173r781b1253],

1	The	DT	O	the	det	2	SENT_328	[p20l811t1168r945b1233],
2	duration	NN	O	duration	nsubjpass	7	SENT_328	[p20l974t1168r1274b1233],
3	of	IN	O	of	_	0	SENT_328	[p20l1308t1167r1385b1233],
4	each	DT	O	each	det	5	SENT_328	[p20l1403t1168r1562b1233],
5	therapy	NN	O	therapy	prep_of	2	SENT_328	[p20l1593t1168r1863b1253],
6	is	VBZ	O	be	auxpass	7	SENT_328	[p20l1894t1174r1943b1233],
7	indicated	VBN	O	indicate	_	0	SENT_328	[p20l1978t1174r2062b1232, p20l80t1276r337b1341],
8	by	IN	O	by	_	0	SENT_328	[p20l374t1276r448b1362],
9	the	DT	O	the	det	11	SENT_328	[p20l473t1276r586b1341],
10	gray	JJ	O	gray	amod	11	SENT_328	[p20l616t1299r763b1362],
11	bars	NNS	O	bar	agent	7	SENT_328	[p20l794t1276r961b1341],
12	.	.	O	.	_	0	SENT_328	[p20l794t1276r961b1341],

1	The	DT	O	the	det	2	SENT_329	[p20l991t1276r1124b1341],
2	genotypes	NNS	O	genotype	nsubjpass	8	SENT_329	[p20l1155t1289r1522b1362],
3	of	IN	O	of	_	0	SENT_329	[p20l1554t1276r1632b1341],
4	circulating	VBG	O	circulate	prepc_of	2	SENT_329	[p20l1649t1276r2025b1362],
5	tumor	NN	O	tumor	nn	6	SENT_329	[p20l77t1397r302b1449],
6	cells	NNS	O	cell	dobj	4	SENT_329	[p20l328t1384r481b1449],
7	are	VBP	O	be	auxpass	8	SENT_329	[p20l515t1407r619b1449],
8	shown	VBN	O	show	_	0	SENT_329	[p20l651t1384r878b1449],
9	for	IN	O	for	_	0	SENT_329	[p20l911t1384r1011b1449],
10	various	JJ	O	various	amod	12	SENT_329	[p20l1036t1390r1295b1449],
11	time	NN	O	time	nn	12	SENT_329	[p20l1325t1390r1485b1449],
12	points	NNS	O	point	prep_for	8	SENT_329	[p20l1518t1390r1760b1469],
13	.	.	O	.	_	0	SENT_329	[p20l1518t1390r1760b1469],

1	Mutations	NNS	O	mutation	nsubj	5	SENT_330	[p20l1799t1390r2005b1449, p20l77t1498r254b1558],
2	in	IN	O	in	_	0	SENT_330	[p20l289t1498r345b1557],
3	brackets	NNS	O	bracket	prep_in	1	SENT_330	[p20l381t1493r677b1558],
4	are	VBP	O	be	cop	5	SENT_330	[p20l710t1515r815b1558],
5	those	DT	O	those	_	0	SENT_330	[p20l842t1493r1039b1558],
6	that	WDT	O	that	nsubj	8	SENT_330	[p20l1067t1493r1208b1558],
7	were	VBD	O	be	cop	8	SENT_330	[p20l1234t1515r1402b1558],
8	present	JJ	DATE	present	rcmod	5	SENT_330	[p20l1435t1505r1702b1577],
9	at	IN	O	at	_	0	SENT_330	[p20l1731t1505r1795b1558],
10	low	JJ	O	low	amod	12	SENT_330	[p20l1826t1493r1945b1558],
11	allele	NN	O	allele	nn	12	SENT_330	[p20l1974t1493r2055b1558, p20l84t1600r200b1666],
12	frequencies	NNS	O	frequency	prep_at	8	SENT_330	[p20l228t1600r667b1685],
13	.	.	O	.	_	0	SENT_330	[p20l228t1600r667b1685],

1	In	IN	O	in	_	0	SENT_331	[p20l705t1607r763b1664],
2	Panel	NN	O	panel	nn	3	SENT_331	[p20l802t1600r987b1666],
3	B	NN	O	b	prep_in	13	SENT_331	[p20l1026t1607r1086b1677],
4	,	,	O	,	_	0	SENT_331	[p20l1026t1607r1086b1677],
5	SARMS	NN	O	sarm	nn	6	SENT_331	[p20l1121t1605r1383b1666],
6	analysis	NN	O	analysis	nsubj	13	SENT_331	[p20l1417t1600r1694b1686],
7	of	IN	O	of	_	0	SENT_331	[p20l1726t1600r1804b1666],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_331	[p20l1824t1606r2017b1666],
9	genotypes	NNS	O	genotype	prep_of	6	SENT_331	[p20l80t1721r449b1794],
10	in	IN	O	in	_	0	SENT_331	[p20l483t1715r539b1772],
11	Patient	NN	O	patient	prep_in	9	SENT_331	[p20l578t1715r825b1773],
12	9	CD	NUMBER	9	num	11	SENT_331	[p20l854t1715r890b1774],
13	shows	VBZ	O	show	_	0	SENT_331	[p20l922t1708r1143b1774],
14	an	DT	O	a	det	20	SENT_331	[p20l1176t1732r1254b1773],
15	increased	VBN	O	increase	amod	20	SENT_331	[p20l1291t1708r1628b1773],
16	abundance	NN	O	abundance	nn	20	SENT_331	[p20l1662t1708r2055b1773],
17	ofthe	NN	O	ofthe	nn	20	SENT_331	[p20l80t1816r284b1882],
18	T79OM	NN	O	t79om	nn	20	SENT_331	[p20l311t1821r562b1882],
19	drug-resistance	JJ	O	drug-resistance	amod	20	SENT_331	[p20l598t1817r1155b1903],
20	allele	NN	O	allele	dobj	13	SENT_331	[p20l1186t1817r1368b1882],
21	during	IN	O	during	_	0	SENT_331	[p20l1397t1817r1631b1903],
22	disease	NN	O	disease	nn	23	SENT_331	[p20l1659t1817r1923b1882],
23	progression	NN	O	progression	prep_during	20	SENT_331	[p20l84t1931r526b2011],
24	.	.	O	.	_	0	SENT_331	[p20l84t1931r526b2011],

1	Arrows	NNS	O	arrow	nsubj	2	SENT_332	[p20l556t1929r808b1990],
2	denote	VBP	O	denote	_	0	SENT_332	[p20l840t1925r1086b1990],
3	the	DT	O	the	det	5	SENT_332	[p20l1114t1925r1226b1990],
4	cycle	NN	O	cycle	nn	5	SENT_332	[p20l1256t1925r1429b2011],
5	ofthreshold	NN	O	ofthreshold	nsubj	9	SENT_332	[p20l1459t1925r1891b1990],
6	for	IN	O	for	_	0	SENT_332	[p20l1923t1925r2023b1990],
7	amplification	NN	O	amplification	nn	8	SENT_332	[p20l81t2033r553b2118],
8	cycles	NNS	O	cycle	prep_for	5	SENT_332	[p20l586t2033r797b2119],
9	(	VBP	O	(	ccomp	2	SENT_332	[p20l837t2038r956b2119],
10	Ct	NN	O	ct	nn	11	SENT_332	[p20l837t2038r956b2119],
11	)	NN	O	)	dobj	9	SENT_332	[p20l837t2038r956b2119],
12	required	VBN	O	require	partmod	11	SENT_332	[p20l997t2033r1289b2118],
13	for	IN	O	for	_	0	SENT_332	[p20l1321t2033r1421b2098],
14	detection	NN	O	detection	nn	17	SENT_332	[p20l1448t2033r1783b2098],
15	ofthe	NN	O	ofthe	nn	17	SENT_332	[p20l1817t2033r2022b2098],
16	primary	JJ	O	primary	amod	17	SENT_332	[p20l84t2147r359b2227],
17	mutation	NN	O	mutation	prep_for	12	SENT_332	[p20l391t2147r712b2207],
18	(	CD	NUMBER	(	num	19	SENT_332	[p20l754t2142r894b2226],
19	Del	NNP	O	Del	dep	2	SENT_332	[p20l754t2142r894b2226],
20	or	CC	O	or	_	0	SENT_332	[p20l928t2164r1001b2207],
21	Deletion	NN	O	deletion	conj_or	19	SENT_332	[p20l1034t2142r1354b2218],
22	,	,	O	,	_	0	SENT_332	[p20l1034t2142r1354b2218],
23	referring	VBG	O	refer	partmod	2	SENT_332	[p20l1391t2140r1696b2227],
24	to	TO	O	to	_	0	SENT_332	[p20l1722t2154r1791b2207],
25	the	DT	O	the	det	27	SENT_332	[p20l1819t2142r1931b2207],
26	grouped	VBN	O	group	amod	27	SENT_332	[p20l80t2250r376b2335],
27	exon	NN	O	exon	prep_to	23	SENT_332	[p20l410t2273r572b2315],
28	19	CD	NUMBER	19	num	29	SENT_332	[p20l610t2255r683b2315],
29	deletions	NNS	O	deletion	amod	27	SENT_332	[p20l714t2250r1065b2335],
30	)	CD	NUMBER	)	dep	29	SENT_332	[p20l714t2250r1065b2335],
31	and	CC	O	and	_	0	SENT_332	[p20l1104t2250r1229b2315],
32	the	DT	O	the	det	34	SENT_332	[p20l1261t2249r1373b2315],
33	T79OM	NN	O	t79om	nn	34	SENT_332	[p20l1400t2254r1650b2315],
34	mutation	NN	O	mutation	dep	29	SENT_332	[p20l1689t2256r2034b2326],
35	,	,	O	,	_	0	SENT_332	[p20l1689t2256r2034b2326],
36	as	IN	O	as	appos	30	SENT_332	[p20l81t2381r152b2422],
37	compared	VBN	O	compare	_	0	SENT_332	[p20l184t2357r541b2442],
38	with	IN	O	with	prepc_compared_with	36	SENT_332	[p20l572t2357r720b2423],
39	the	DT	O	the	det	42	SENT_332	[p20l751t2357r863b2422],
40	exon	NN	O	exon	nn	42	SENT_332	[p20l894t2381r1055b2422],
41	2	CD	NUMBER	2	num	42	SENT_332	[p20l1090t2364r1125b2421],
42	control	NN	O	control	pobj	36	SENT_332	[p20l1156t2357r1427b2422],
43	.	.	O	.	_	0	SENT_332	[p20l1156t2357r1427b2422],

1	ACt	NN	O	act	nsubj	2	SENT_333	[p20l1457t2362r1587b2422],
2	reflects	VBZ	O	reflect	_	0	SENT_333	[p20l1619t2357r1883b2422],
3	the	DT	O	the	det	4	SENT_333	[p20l1913t2357r2025b2422],
4	difference	NN	O	difference	dobj	2	SENT_333	[p20l80t2465r438b2531],
5	in	IN	O	in	_	0	SENT_333	[p20l471t2472r526b2530],
6	allele	NN	O	allele	nn	7	SENT_333	[p20l561t2466r743b2531],
7	frequency	NN	O	frequency	prep_in	4	SENT_333	[p20l772t2465r1128b2551],
8	between	IN	O	between	_	0	SENT_333	[p20l1158t2466r1456b2531],
9	the	DT	O	the	det	11	SENT_333	[p20l1487t2466r1599b2531],
10	primary	JJ	O	primary	amod	11	SENT_333	[p20l1633t2472r1909b2551],
11	mutation	NN	O	mutation	prep_between	7	SENT_333	[p20l84t2580r405b2639],
12	and	CC	O	and	_	0	SENT_333	[p20l440t2574r566b2639],
13	T79OM	NN	O	t79om	conj_and	11	SENT_333	[p20l596t2578r846b2639],
14	in	IN	O	in	_	0	SENT_333	[p20l885t2580r941b2638],
15	the	DT	O	the	det	17	SENT_333	[p20l972t2574r1084b2639],
16	tumor-biopsy	JJ	O	tumor-biopsy	amod	17	SENT_333	[p20l1112t2574r1597b2660],
17	specimen	NN	O	specimen	prep_in	11	SENT_333	[p20l1626t2580r1992b2659],
18	,	,	O	,	_	0	SENT_333	[p20l1626t2580r1992b2659],
19	the	DT	O	the	det	22	SENT_333	[p20l77t2682r189b2747],
20	circulating	VBG	O	circulate	amod	22	SENT_333	[p20l220t2682r595b2768],
21	tumor	NN	O	tumor	nn	22	SENT_333	[p20l621t2695r845b2747],
22	cells	NNS	O	cell	conj_and	4	SENT_333	[p20l872t2682r1025b2747],
23	that	WDT	O	that	nsubjpass	25	SENT_333	[p20l1055t2682r1195b2747],
24	were	VBD	O	be	auxpass	25	SENT_333	[p20l1221t2705r1389b2747],
25	isolated	VBN	O	isolate	rcmod	22	SENT_333	[p20l1422t2682r1696b2747],
26	at	IN	O	at	_	0	SENT_333	[p20l1731t2695r1793b2747],
27	the	DT	O	the	det	28	SENT_333	[p20l1819t2682r1931b2747],
28	time	NN	O	time	prep_at	25	SENT_333	[p20l77t2796r237b2856],
29	of	IN	O	of	_	0	SENT_333	[p20l268t2789r345b2856],
30	response	NN	O	response	prep_of	28	SENT_333	[p20l366t2813r689b2875],
31	to	TO	O	to	_	0	SENT_333	[p20l716t2803r785b2856],
32	gefitinib	NN	O	gefitinib	nn	33	SENT_333	[p20l816t2789r1110b2876],
33	therapy	NN	O	therapy	prep_to	25	SENT_333	[p20l1138t2791r1422b2876],
34	,	,	O	,	_	0	SENT_333	[p20l1138t2791r1422b2876],
35	and	CC	O	and	_	0	SENT_333	[p20l1457t2791r1582b2856],
36	the	DT	O	the	det	39	SENT_333	[p20l1613t2791r1725b2856],
37	circulating	VBG	O	circulate	amod	39	SENT_333	[p20l1755t2791r2039b2856, p20l83t2905r188b2984],
38	tumor	NN	O	tumor	nn	39	SENT_333	[p20l215t2911r438b2964],
39	cells	NNS	O	cell	dobj	2	SENT_333	[p20l465t2898r619b2964],
40	that	WDT	O	that	nsubjpass	42	SENT_333	[p20l648t2899r789b2964],
41	were	VBD	O	be	auxpass	42	SENT_333	[p20l815t2922r982b2964],
42	isolated	VBN	O	isolate	rcmod	39	SENT_333	[p20l1016t2898r1290b2964],
43	at	IN	O	at	_	0	SENT_333	[p20l1324t2911r1387b2964],
44	the	DT	O	the	det	47	SENT_333	[p20l1413t2898r1525b2964],
45	time	NN	O	time	nn	47	SENT_333	[p20l1553t2905r1713b2964],
46	ofdisease	NN	O	ofdisease	nn	47	SENT_333	[p20l1743t2898r1962b2964, p20l80t3030r237b3071],
47	progression	NN	O	progression	prep_at	42	SENT_333	[p20l270t3013r712b3092],
48	.	.	O	.	_	0	SENT_333	[p20l270t3013r712b3092],

1	Luminescence	NN	O	luminescence	nsubjpass	3	SENT_334	[p20l751t3013r1263b3072],
2	was	VBD	O	be	auxpass	3	SENT_334	[p20l1290t3030r1424b3071],
3	measured	VBN	O	measure	_	0	SENT_334	[p20l1460t3006r1808b3072],
4	quantitatively	RB	O	quantitatively	advmod	3	SENT_334	[p20l1841t3030r2042b3091, p20l77t3115r383b3200],
5	in	IN	O	in	_	0	SENT_334	[p20l413t3121r470b3179],
6	relative	JJ	O	relative	amod	8	SENT_334	[p20l507t3115r761b3180],
7	light	JJ	O	light	amod	8	SENT_334	[p20l794t3115r947b3201],
8	units	NNS	O	unit	prep_in	3	SENT_334	[p20l979t3121r1173b3180],
9	.	.	O	.	_	0	SENT_334	[p20l979t3121r1173b3180],

1	basis	NN	O	basis	_	0	SENT_335	[p20l11t3484r224b3564],
2	of	IN	O	of	dep	1	SENT_335	[p20l264t3483r364b3564],
3	the	DT	O	the	nsubj	4	SENT_335	[p20l383t3484r516b3563],
4	transforming	VBG	O	transform	pcomp	2	SENT_335	[p20l554t3483r1137b3586],
5	potential	NN	O	potential	dobj	4	SENT_335	[p20l1169t3484r1560b3585],
6	of	IN	O	of	_	0	SENT_335	[p20l1596t3483r1696b3564],
7	these	DT	O	these	det	8	SENT_335	[p20l1715t3484r1940b3563],
8	mutations	NNS	O	mutation	prep_of	5	SENT_335	[p20l1977t3510r2145b3564, p20l11t3615r307b3693],
9	in	FW	O	in	nn	10	SENT_335	[p20l365t3615r449b3692],
10	vitro	FW	O	vitro	dep	8	SENT_335	[p20l500t3615r699b3693],
11	and	CC	O	and	_	0	SENT_335	[p20l757t3614r916b3693],
12	in	IN	O	in	conj_and	10	SENT_335	[p20l972t3615r1055b3692],
13	mouse	NN	O	mouse	nn	14	SENT_335	[p20l1112t3640r1394b3693],
14	models	NNS	O	model	pobj	12	SENT_335	[p20l1451t3614r1965b3693],
15	.27	CD	NUMBER	.27	advmod	4	SENT_335	[p20l1451t3614r1965b3693],
16	'	''	O	'	_	0	SENT_335	[p20l1451t3614r1965b3693],
17	3	CD	NUMBER	3	number	18	SENT_335	[p20l1451t3614r1965b3693],
18	°	CD	NUMBER	°	dobj	4	SENT_335	[p20l1451t3614r1965b3693],
19	Although	IN	O	although	prep	18	SENT_335	[p20l2019t3614r2145b3692, p21l11t31r322b132],

1	most	RBS	O	most	advmod	2	SENT_336	[p21l354t48r571b110],
2	non	JJ	O	non	amod	3	SENT_336	[p21l598t31r1245b110],
3	—	NN	O	—	_	0	SENT_336	[p21l598t31r1245b110],
4	small	JJ	O	small	amod	6	SENT_336	[p21l598t31r1245b110],
5	—	NN	O	—	nn	6	SENT_336	[p21l598t31r1245b110],
6	cell	NN	O	cell	dep	3	SENT_336	[p21l598t31r1245b110],
7	lung	NN	O	lung	nn	8	SENT_336	[p21l1275t31r1470b132],
8	cancers	NNS	O	cancer	nsubj	9	SENT_336	[p21l1500t57r1822b109],
9	appear	VBP	O	appear	dep	3	SENT_336	[p21l1856t57r2149b131],
10	to	TO	O	to	aux	11	SENT_336	[p21l11t176r91b238],
11	have	VB	O	have	xcomp	9	SENT_336	[p21l135t159r319b238],
12	a	DT	O	a	det	16	SENT_336	[p21l361t185r406b237],
13	single	JJ	O	single	amod	16	SENT_336	[p21l448t159r690b260],
14	clonal	JJ	O	clonal	amod	16	SENT_336	[p21l734t159r985b238],
15	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_336	[p21l1025t165r1232b239],
16	mutation	NN	O	mutation	dobj	11	SENT_336	[p21l1268t160r1648b238],
17	that	WDT	O	that	nsubj	19	SENT_336	[p21l1691t159r1857b237],
18	is	VBZ	O	be	cop	19	SENT_336	[p21l1894t160r1958b237],
19	evident	JJ	O	evident	rcmod	16	SENT_336	[p21l2004t160r2145b238, p21l12t286r195b365],
20	at	IN	O	at	_	0	SENT_336	[p21l228t303r307b364],
21	multiple	JJ	O	multiple	amod	22	SENT_336	[p21l344t286r702b386],
22	sites	NNS	O	site	prep_at	19	SENT_336	[p21l746t287r933b364],
23	of	IN	O	of	_	0	SENT_336	[p21l978t285r1078b365],
24	metastatic	JJ	O	metastatic	amod	25	SENT_336	[p21l1103t287r1552b364],
25	disease	NN	O	disease	prep_of	22	SENT_336	[p21l1595t286r1930b382],
26	,	,	O	,	_	0	SENT_336	[p21l1595t286r1930b382],
27	rare	JJ	O	rare	amod	28	SENT_336	[p21l1978t312r2147b364],
28	cases	NNS	O	case	nsubj	33	SENT_336	[p21l12t440r231b492],
29	of	IN	O	of	_	0	SENT_336	[p21l268t413r367b493],
30	bronchoalveolar	JJ	O	bronchoalveolar	amod	31	SENT_336	[p21l384t414r1068b493],
31	cancer	NN	O	cancer	prep_of	28	SENT_336	[p21l1100t440r1377b492],
32	may	MD	O	may	aux	33	SENT_336	[p21l1408t440r1586b514],
33	present	VB	DATE	present	dep	3	SENT_336	[p21l1614t431r1930b514],
34	with	IN	O	with	_	0	SENT_336	[p21l1954t414r2147b494],
35	multifocal	JJ	O	multifocal	amod	36	SENT_336	[p21l11t542r450b623],
36	tumors	NNS	O	tumor	prep_with	33	SENT_336	[p21l486t560r814b640],
37	,	,	O	,	_	0	SENT_336	[p21l486t560r814b640],
38	each	DT	O	each	nsubj	39	SENT_336	[p21l856t543r1046b622],
39	harboring	VBG	O	harbor	dep	3	SENT_336	[p21l1082t543r1511b645],
40	different	JJ	O	different	amod	42	SENT_336	[p21l1544t542r1914b623],
41	EGFR	NN	ORGANIZATION	egfr	nn	42	SENT_336	[p21l1943t550r2153b624],
42	mutations	NNS	O	mutation	dobj	39	SENT_336	[p21l11t673r640b751],
43	.17	CD	NUMBER	.17	num	44	SENT_336	[p21l11t673r640b751],
44	v25	CD	NUMBER	v25	nsubjpass	50	SENT_336	[p21l11t673r640b751],
45	Circulating	VBG	O	circulate	partmod	44	SENT_336	[p21l700t672r1190b773],
46	tumor	NN	O	tumor	nn	47	SENT_336	[p21l1244t689r1513b751],
47	cells	NNS	O	cell	dobj	45	SENT_336	[p21l1569t672r1756b750],
48	may	MD	O	may	aux	50	SENT_336	[p21l1816t698r1996b772],
49	be	VB	O	be	auxpass	50	SENT_336	[p21l2049t672r2146b751],
50	derived	VBN	O	derive	rcmod	42	SENT_336	[p21l11t799r322b879],
51	from	IN	O	from	_	0	SENT_336	[p21l369t798r581b878],
52	multiple	JJ	O	multiple	amod	54	SENT_336	[p21l629t799r987b899],
53	disease	NN	O	disease	nn	54	SENT_336	[p21l1036t799r1348b878],
54	sites	NNS	O	site	prep_from	50	SENT_336	[p21l1398t800r1584b877],
55	with	IN	O	with	_	0	SENT_336	[p21l1630t799r1826b879],
56	different	JJ	O	different	amod	57	SENT_336	[p21l1875t798r2145b878, p21l11t945r146b1006],
57	responses	NNS	O	response	prep_with	50	SENT_336	[p21l181t954r607b1028],
58	to	TO	O	to	_	0	SENT_336	[p21l650t945r731b1007],
59	therapy	NN	O	therapy	prep_to	50	SENT_336	[p21l773t928r1097b1028],
60	and	CC	O	and	_	0	SENT_336	[p21l1131t928r1290b1007],
61	be	VB	O	be	auxpass	62	SENT_336	[p21l1331t928r1428b1007],
62	associated	VBN	O	associate	conj_and	50	SENT_336	[p21l1467t928r1914b1007],
63	with	IN	O	with	_	0	SENT_336	[p21l1950t928r2147b1008],
64	an	DT	O	a	det	65	SENT_336	[p21l10t1083r114b1135],
65	evolution	NN	O	evolution	prep_with	62	SENT_336	[p21l155t1057r551b1136],
66	in	IN	O	in	_	0	SENT_336	[p21l591t1058r675b1135],
67	tumor	NN	O	tumor	nn	68	SENT_336	[p21l716t1074r985b1136],
68	genotypes	NNS	O	genotype	prep_in	65	SENT_336	[p21l1022t1074r1461b1158],
69	that	WDT	O	that	nsubjpass	73	SENT_336	[p21l1504t1057r1678b1135],
70	can	MD	O	can	aux	73	SENT_336	[p21l1713t1074r2013b1136],
71	not	RB	O	not	neg	73	SENT_336	[p21l1713t1074r2013b1136],
72	be	VB	O	be	auxpass	73	SENT_336	[p21l2049t1057r2146b1136],
73	appreciated	VBN	O	appreciate	rcmod	65	SENT_336	[p21l10t1185r509b1286],
74	by	IN	O	by	_	0	SENT_336	[p21l554t1185r651b1286],
75	a	DT	O	a	det	78	SENT_336	[p21l690t1212r734b1264],
76	single	JJ	O	single	amod	78	SENT_336	[p21l779t1185r1032b1287],
77	tissue	NN	O	tissue	nn	78	SENT_336	[p21l1077t1186r1325b1265],
78	biopsy	NN	O	biopsy	agent	73	SENT_336	[p21l1369t1185r1650b1286],
79	performed	VBN	O	perform	partmod	78	SENT_336	[p21l1688t1184r2147b1286],
80	at	IN	O	at	_	0	SENT_336	[p21l10t1330r89b1391],
81	the	DT	O	the	det	82	SENT_336	[p21l123t1313r254b1391],
82	time	NN	O	time	prep_at	79	SENT_336	[p21l293t1314r484b1391],
83	of	IN	O	of	_	0	SENT_336	[p21l524t1312r623b1392],
84	presentation	NN	O	presentation	prep_of	82	SENT_336	[p21l642t1314r1195b1413],
85	.	.	O	.	_	0	SENT_336	[p21l642t1314r1195b1413],

1	The	DT	O	the	det	2	SENT_337	[p21l1236t1313r1396b1391],
2	absence	NN	O	absence	nsubj	6	SENT_337	[p21l1434t1313r1768b1392],
3	of	IN	O	of	_	0	SENT_337	[p21l1807t1312r1906b1392],
4	treatment	NN	O	treatment	nn	5	SENT_337	[p21l1927t1330r2145b1391, p21l11t1442r597b1521],
5	—	NN	O	—	prep_of	2	SENT_337	[p21l1927t1330r2145b1391, p21l11t1442r597b1521],
6	induced	VBD	O	induce	_	0	SENT_337	[p21l1927t1330r2145b1391, p21l11t1442r597b1521],
7	genetic	JJ	O	genetic	amod	8	SENT_337	[p21l651t1443r961b1543],
8	change	NN	O	change	nsubj	10	SENT_337	[p21l1016t1442r1322b1543],
9	may	MD	O	may	aux	10	SENT_337	[p21l1377t1468r1557b1542],
10	explain	VB	O	explain	ccomp	6	SENT_337	[p21l1608t1442r1922b1542],
11	why	WRB	O	why	advmod	28	SENT_337	[p21l1972t1442r2151b1542],
12	recent	JJ	O	recent	amod	14	SENT_337	[p21l11t1586r277b1647],
13	clinical	JJ	O	clinical	amod	14	SENT_337	[p21l315t1569r629b1647],
14	trials	NNS	O	trial	nsubj	28	SENT_337	[p21l672t1569r892b1647],
15	of	IN	O	of	_	0	SENT_337	[p21l937t1568r1037b1648],
16	first	JJ	ORDINAL	first	amod	21	SENT_337	[p21l1060t1568r1433b1647],
17	—	NN	O	—	nn	21	SENT_337	[p21l1060t1568r1433b1647],
18	line	NN	O	line	nn	21	SENT_337	[p21l1060t1568r1433b1647],
19	tyrosine	NN	O	tyrosine	nn	21	SENT_337	[p21l1475t1570r1824b1669],
20	kinase	NN	O	kinase	nn	21	SENT_337	[p21l1865t1569r2146b1649],
21	inhibitors	NNS	O	inhibitor	prep_of	14	SENT_337	[p21l10t1698r435b1777],
22	in	IN	O	in	_	0	SENT_337	[p21l478t1699r562b1776],
23	patients	NNS	O	patient	prep_in	21	SENT_337	[p21l603t1699r947b1798],
24	with	IN	O	with	_	0	SENT_337	[p21l987t1698r1183b1777],
25	EGFR	NN	ORGANIZATION	egfr	nn	26	SENT_337	[p21l1225t1704r1438b1778],
26	mutations	NNS	O	mutation	prep_with	23	SENT_337	[p21l1474t1699r1911b1777],
27	have	VBP	O	have	aux	28	SENT_337	[p21l1956t1698r2147b1777],
28	shown	VBN	O	show	advcl	10	SENT_337	[p21l12t1827r296b1906],
29	a	DT	O	a	det	31	SENT_337	[p21l328t1853r372b1905],
30	high	JJ	O	high	amod	31	SENT_337	[p21l402t1827r598b1928],
31	concordance	NN	O	concordance	dobj	28	SENT_337	[p21l631t1827r1178b1906],
32	between	IN	O	between	_	0	SENT_337	[p21l1212t1827r1571b1906],
33	tumor	NN	O	tumor	nn	34	SENT_337	[p21l1604t1844r1873b1906],
34	genotype	NN	O	genotype	prep_between	31	SENT_337	[p21l1901t1853r2145b1928, p21l11t1972r193b2055],
35	and	CC	O	and	_	0	SENT_337	[p21l250t1955r408b2034],
36	clinical	JJ	O	clinical	amod	37	SENT_337	[p21l465t1955r780b2033],
37	response	NN	O	response	dobj	28	SENT_337	[p21l835t1960r1516b2055],
38	,21	CD	NUMBER	,21	number	39	SENT_337	[p21l835t1960r1516b2055],
39	»	CD	NUMBER	»	dep	37	SENT_337	[p21l835t1960r1516b2055],
40	31	CD	NUMBER	31	num	41	SENT_337	[p21l835t1960r1516b2055],
41	»	NN	O	»	dep	39	SENT_337	[p21l835t1960r1516b2055],
42	32	CD	NUMBER	32	npadvmod	43	SENT_337	[p21l835t1960r1516b2055],
43	as	IN	O	as	advmod	28	SENT_337	[p21l1573t1981r1659b2033],
44	compared	VBN	O	compare	_	0	SENT_337	[p21l1718t1955r2147b2055],
45	with	IN	O	with	prepc_compared_with	28	SENT_337	[p21l6t2084r202b2163],
46	earlier	JJR	O	earlier	amod	47	SENT_337	[p21l236t2084r511b2162],
47	second-line	NN	O	second-line	pobj	28	SENT_337	[p21l542t2084r1034b2163],
48	and	CC	O	and	_	0	SENT_337	[p21l1066t2084r1225b2163],
49	third	JJ	ORDINAL	third	amod	52	SENT_337	[p21l1257t2084r1665b2163],
50	—	NN	O	—	nn	52	SENT_337	[p21l1257t2084r1665b2163],
51	line	NN	O	line	nn	52	SENT_337	[p21l1257t2084r1665b2163],
52	studies	NNS	O	study	conj_and	47	SENT_337	[p21l1700t2084r2026b2180],
53	,	,	O	,	_	0	SENT_337	[p21l1700t2084r2026b2180],
54	in	IN	O	in	_	0	SENT_337	[p21l2063t2085r2147b2162],
55	which	WDT	O	which	rel	60	SENT_337	[p21l6t2212r271b2291],
56	multiple	JJ	O	multiple	amod	57	SENT_337	[p21l325t2212r684b2312],
57	courses	NNS	O	course	nsubj	60	SENT_337	[p21l739t2238r1063b2292],
58	of	IN	O	of	_	0	SENT_337	[p21l1121t2211r1221b2291],
59	chemotherapy	NN	O	chemotherapy	prep_of	57	SENT_337	[p21l1259t2212r1873b2312],
60	separated	VBD	O	separate	rcmod	52	SENT_337	[p21l1926t2238r2145b2312, p21l11t2341r228b2421],
61	the	DT	O	the	det	64	SENT_337	[p21l281t2341r414b2420],
62	diagnostic	JJ	O	diagnostic	amod	64	SENT_337	[p21l467t2341r919b2443],
63	tumor	NN	O	tumor	nn	64	SENT_337	[p21l970t2358r1239b2421],
64	specimen	NN	O	specimen	dobj	60	SENT_337	[p21l1290t2342r1698b2442],
65	from	IN	O	from	_	0	SENT_337	[p21l1749t2340r1961b2421],
66	the	DT	O	the	det	68	SENT_337	[p21l2013t2341r2147b2420],
67	clinical	JJ	O	clinical	amod	68	SENT_337	[p21l12t2469r327b2547],
68	evaluation	NN	O	evaluation	prep_from	60	SENT_337	[p21l370t2469r814b2549],
69	of	IN	O	of	_	0	SENT_337	[p21l857t2468r958b2548],
70	responsiveness	NN	O	responsiveness	prep_of	68	SENT_337	[p21l982t2470r1626b2569],
71	to	TO	O	to	_	0	SENT_337	[p21l1671t2486r1753b2548],
72	tyrosine	NN	O	tyrosine	nn	74	SENT_337	[p21l1798t2470r2147b2569],
73	kinase	NN	O	kinase	nn	74	SENT_337	[p21l11t2598r285b2678],
74	inhibitors	NNS	O	inhibitor	prep_to	60	SENT_337	[p21l325t2598r934b2678],
75	.3334	CD	NUMBER	.3334	tmod	60	SENT_337	[p21l325t2598r934b2678],
76	Therefore	RB	O	therefore	advmod	80	SENT_337	[p21l971t2597r1404b2695],
77	,	,	O	,	_	0	SENT_337	[p21l971t2597r1404b2695],
78	genotype	NN	O	genotype	nn	79	SENT_337	[p21l1449t2598r2145b2700, p21l11t2727r108b2807],
79	—	NN	O	—	nsubj	80	SENT_337	[p21l1449t2598r2145b2700, p21l11t2727r108b2807],
80	directed	VBD	O	direct	dep	60	SENT_337	[p21l1449t2598r2145b2700, p21l11t2727r108b2807],
81	clinical	JJ	O	clinical	amod	82	SENT_337	[p21l153t2727r468b2806],
82	trials	NNS	O	trial	nsubj	88	SENT_337	[p21l515t2727r734b2806],
83	of	IN	O	of	_	0	SENT_337	[p21l784t2726r885b2807],
84	molecularly	RB	O	molecularly	advmod	85	SENT_337	[p21l912t2727r1421b2828],
85	targeted	VBN	O	target	amod	86	SENT_337	[p21l1464t2727r1821b2829],
86	agents	NNS	O	agent	prep_of	82	SENT_337	[p21l1867t2744r2144b2829],
87	may	MD	O	may	aux	88	SENT_337	[p21l11t2882r191b2957],
88	benefit	VB	O	benefit	ccomp	80	SENT_337	[p21l223t2855r529b2936],
89	from	IN	O	from	_	0	SENT_337	[p21l560t2855r772b2936],
90	“	CD	NUMBER	“	num	92	SENT_337	[p21l812t2856r1014b2935],
91	real	JJ	O	real	amod	92	SENT_337	[p21l812t2856r1014b2935],
92	time	NN	O	time	nn	95	SENT_337	[p21l1050t2857r1286b2935],
93	”	JJ	O	”	amod	95	SENT_337	[p21l1050t2857r1286b2935],
94	tumor	NN	O	tumor	nn	95	SENT_337	[p21l1327t2873r1596b2936],
95	genotyping	NN	O	genotyping	prep_from	88	SENT_337	[p21l1629t2857r2141b2958],
96	,	,	O	,	_	0	SENT_337	[p21l1629t2857r2141b2958],

1	374	CD	NUMBER	374	num	4	SENT_338	[p21l149t3033r206b3056],
2	N	NN	O	n	nn	4	SENT_338	[p21l934t3043r948b3058],
3	ENGLJ	NN	O	englj	nn	4	SENT_338	[p21l963t3043r1041b3065],
4	MEo359	NN	O	meo359	_	0	SENT_338	[p21l1055t3043r1183b3065],
5	;	:	O	;	_	0	SENT_338	[p21l1055t3043r1183b3065],
6	4	CD	NUMBER	4	num	7	SENT_338	[p21l1055t3043r1183b3065],
7	WWW	NNP	O	WWW	dep	4	SENT_338	[p21l1215t3043r1322b3059],
8	.	.	O	.	_	0	SENT_338	[p21l1215t3043r1322b3059],

1	NE	NN	O	ne	nn	3	SENT_339	[p21l1215t3043r1322b3059],
2	M.ORG	NN	O	m.org	nn	3	SENT_339	[p21l1337t3043r1416b3059],
3	JULY	NN	DATE	july	_	0	SENT_339	[p21l1447t3043r1505b3065],
4	24	CD	DATE	24	dep	3	SENT_339	[p21l1515t3043r1551b3065],
5	,	,	O	,	_	0	SENT_339	[p21l1515t3043r1551b3065],
6	2oo8	CD	NUMBER	2oo8	appos	4	SENT_339	[p21l1562t3037r1625b3059],

1	The	DT	O	the	det	5	SENT_340	[p21l936t3076r987b3100],
2	New	NNP	O	New	nn	5	SENT_340	[p21l996t3077r1058b3100],
3	England	NNP	O	England	nn	5	SENT_340	[p21l1067t3076r1178b3107],
4	Journal	NNP	O	Journal	nn	5	SENT_340	[p21l1187t3076r1284b3100],
5	o	NN	O	o	_	0	SENT_340	[p21l1294t3084r1309b3100],
6	edicine	NN	O	edicine	dep	5	SENT_340	[p21l1360t3076r1455b3100],

1	Copyright	NN	O	copyright	_	0	SENT_341	[p21l729t3158r863b3189],
2	©	CD	NUMBER	©	num	6	SENT_341	[p21l872t3158r896b3182],
3	2008	CD	DATE	2008	num	6	SENT_341	[p21l906t3158r970b3182],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_341	[p21l980t3158r1171b3182],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_341	[p21l1181t3158r1289b3182],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_341	[p21l1300t3158r1405b3189],
7	.	.	O	.	_	0	SENT_341	[p21l1300t3158r1405b3189],

1	All	DT	O	all	det	3	SENT_342	[p21l1416t3158r1457b3182],
2	ri	FW	O	ri	nn	3	SENT_342	[p21l1466t3158r1486b3182],
3	ts	FW	O	ts	_	0	SENT_342	[p21l1520t3162r1541b3182],
4	reserved	VBN	O	reserve	partmod	3	SENT_342	[p21l1551t3158r1669b3182],
5	.	.	O	.	_	0	SENT_342	[p21l1551t3158r1669b3182],

1	DETECTION	NN	O	detection	_	0	SENT_343	[p21l279t3201r469b3220],
2	OF	IN	O	of	_	0	SENT_343	[p21l484t3201r524b3220],
3	MUTATIONS	NNP	O	MUTATIONS	prep_of	1	SENT_343	[p21l538t3201r733b3220],
4	IN	IN	O	in	_	0	SENT_343	[p21l748t3201r785b3220],
5	EGFR	NN	ORGANIZATION	egfr	prep_in	1	SENT_343	[p21l800t3201r871b3220],
6	IN	IN	O	in	dep	1	SENT_343	[p21l884t3201r922b3220],
7	CIRCULATING	VBG	O	circulate	pcomp	6	SENT_343	[p21l937t3201r1168b3220],
8	LUNG-CANCER	NN	O	lung-cancer	nn	10	SENT_343	[p21l1182t3201r1427b3220],
9	C	NN	O	c	nn	10	SENT_343	[p21l1439t3201r1457b3220],
10	S	NN	O	s	dobj	7	SENT_343	[p21l1522t3201r1535b3220],

1	.	.	O	.	_	0	SENT_344	[p22l1891t387r1913b431],

1	oZ	NN	O	oz	_	0	SENT_345	[p22l1891t387r1913b431],
2	290	CD	NUMBER	290	dep	1	SENT_345	[p22l1889t442r1920b510],
3	.	.	O	.	_	0	SENT_345	[p22l1891t1209r1913b1253],

1	oz	NN	O	oz	_	0	SENT_346	[p22l1891t1209r1913b1253],
2	290	CD	NUMBER	290	dep	1	SENT_346	[p22l1889t1263r1920b1331],
3	.	.	O	.	_	0	SENT_346	[p22l1891t2040r1913b2083],

1	oZ	NN	O	oz	_	0	SENT_347	[p22l1891t2040r1913b2083],
2	w_u	NN	O	w_u	dep	1	SENT_347	[p22l1889t2094r1920b2162],
3	.	.	O	.	_	0	SENT_347	[p22l1889t2094r1920b2162],

1	HU	NNP	O	HU	dep	40	SENT_348	[p22l1889t2094r1920b2162],
2	$	$	MONEY	$	dep	1	SENT_348	[p22l1841t82r1861b664],
3	§	CD	MONEY	§	num	2	SENT_348	[p22l1841t82r1861b664],
4	m	NN	O	m	dep	2	SENT_348	[p22l1841t82r1861b664],
5	§	CD	NUMBER	§	num	4	SENT_348	[p22l1841t82r1861b664],
6	:	:	O	:	_	0	SENT_348	[p22l1841t82r1861b664],
7	§	CD	NUMBER	§	dep	2	SENT_348	[p22l1841t82r1861b664],
8	Emmmm	NNP	O	Emmmm	dep	7	SENT_348	[p22l1841t82r1861b664],
9	:	:	O	:	_	0	SENT_348	[p22l1841t82r1861b664],
10	m	NN	O	m	nn	12	SENT_348	[p22l1841t82r1861b664],
11	~	NN	O	~	nn	12	SENT_348	[p22l1841t82r1861b664],
12	Rm	NN	O	rm	dep	2	SENT_348	[p22l1841t82r1861b664],
13	~	NN	O	~	nn	18	SENT_348	[p22l1841t82r1861b664],
14	m	NN	O	m	nn	18	SENT_348	[p22l1841t82r1861b664],
15	~	NN	O	~	nn	18	SENT_348	[p22l1841t82r1861b664],
16	H	NN	O	h	nn	18	SENT_348	[p22l1841t82r1861b664],
17	~	NN	O	~	nn	18	SENT_348	[p22l1841t82r1861b664],
18	m	NN	O	m	dep	12	SENT_348	[p22l1841t82r1861b664],
19	:	:	O	:	_	0	SENT_348	[p22l1841t82r1861b664],
20	HmH2	NN	O	hmh2	dep	2	SENT_348	[p22l1841t82r1861b664],
21	:	:	O	:	_	0	SENT_348	[p22l1841t82r1861b664],
22	m	NN	O	m	nn	37	SENT_348	[p22l1841t677r1861b689],
23	N	NN	O	n	nn	37	SENT_348	[p22l1841t706r1861b717],
24	m	NN	O	m	nn	37	SENT_348	[p22l1841t737r1861b747],
25	m	NN	O	m	nn	37	SENT_348	[p22l1841t766r1861b777],
26	H	NN	O	h	nn	37	SENT_348	[p22l1841t795r1861b805],
27	mvnvmvmwHwmmmmmmmmHmm	NN	O	mvnvmvmwhwmmmmmmmmhmm	nn	37	SENT_348	[p22l1841t910r1861b1492],
28	~	NN	O	~	nn	37	SENT_348	[p22l1841t910r1861b1492],
29	nNm	NN	O	nnm	nn	37	SENT_348	[p22l1841t910r1861b1492],
30	~	NN	O	~	nn	37	SENT_348	[p22l1841t910r1861b1492],
31	m	NN	O	m	nn	37	SENT_348	[p22l1841t910r1861b1492],
32	~	NN	O	~	nn	37	SENT_348	[p22l1841t910r1861b1492],
33	HNmHnHmHmHHH	NN	O	hnmhnhmhmhhh	nn	37	SENT_348	[p22l1841t910r1861b1492],
34	m	NN	O	m	nn	37	SENT_348	[p22l1841t1505r1861b1517],
35	N	NN	O	n	nn	37	SENT_348	[p22l1841t1534r1861b1545],
36	m	NN	O	m	nn	37	SENT_348	[p22l1841t1565r1861b1576],
37	m	NN	O	m	dep	20	SENT_348	[p22l1841t1594r1861b1605],
38	H	NN	O	h	dep	40	SENT_348	[p22l1841t1623r1861b1633],
39	miiiivﬁkmmm2	CD	NUMBER	miiiivﬁkmmm2	num	38	SENT_348	[p22l1841t1741r1861b2323],
40	$	$	MONEY	$	dep	57	SENT_348	[p22l1841t1741r1861b2323],
41	~	CD	MONEY	~	num	40	SENT_348	[p22l1841t1741r1861b2323],
42	Rm	NN	O	rm	nn	45	SENT_348	[p22l1841t1741r1861b2323],
43	~	NN	O	~	nn	45	SENT_348	[p22l1841t1741r1861b2323],
44	mS	NN	O	m	nn	45	SENT_348	[p22l1841t1741r1861b2323],
45	~	NN	O	~	dep	40	SENT_348	[p22l1841t1741r1861b2323],
46	2:2	CD	NUMBER	2:2	num	47	SENT_348	[p22l1841t1741r1861b2323],
47	mi	NNS	O	mi	dep	45	SENT_348	[p22l1841t1741r1861b2323],
48	:	:	O	:	_	0	SENT_348	[p22l1841t1741r1861b2323],
49	m	NN	O	m	nn	53	SENT_348	[p22l1841t2336r1861b2348],
50	N	NN	O	n	nn	53	SENT_348	[p22l1841t2365r1861b2376],
51	m	NN	O	m	nn	53	SENT_348	[p22l1841t2396r1861b2407],
52	m	NN	O	m	nn	53	SENT_348	[p22l1841t2425r1861b2436],
53	H	NN	O	h	dep	45	SENT_348	[p22l1841t2454r1861b2464],
54	________________________	CD	NUMBER	________________________	num	55	SENT_348	[p22l1818t94r1833b773],
55	u	NN	O	u	dep	53	SENT_348	[p22l1818t909r1833b1601],
56	________________________	CD	NUMBER	________________________	num	57	SENT_348	[p22l1818t909r1833b1601],
57	L	NN	O	l	dep	58	SENT_348	[p22l1818t1740r1833b2432],
58	_______________________	CD	NUMBER	_______________________	_	0	SENT_348	[p22l1818t1740r1833b2432],

1	8	CD	NUMBER	8	_	0	SENT_349	[p22l1727t1646r1748b1689],
2	.	.	O	.	_	0	SENT_349	[p22l1727t1646r1748b1689],

1	.	.	O	.	_	0	SENT_350	[p22l1727t1646r1748b1689],

1	.28	CD	NUMBER	.28	_	0	SENT_351	[p22l1644t913r1664b996],
2	?	.	O	?	_	0	SENT_351	[p22l1644t913r1664b996],

1	o8	NN	O	o8	nn	3	SENT_352	[p22l1646t1646r1667b1688],
2	__	NN	O	__	nn	3	SENT_352	[p22l1588t913r1610b1010],
3	o	NN	O	o	nsubj	4	SENT_352	[p22l1588t913r1610b1010],
4	_	VBD	O	_	_	0	SENT_352	[p22l1588t913r1610b1010],
5	$	$	MONEY	$	dep	9	SENT_352	[p22l1588t913r1610b1010],
6	_	CD	MONEY	_	num	9	SENT_352	[p22l1588t913r1610b1010],
7	uo	NN	O	uo	nn	9	SENT_352	[p22l1588t913r1610b1010],
8	8	CD	NUMBER	8	num	9	SENT_352	[p22l1565t1646r1586b1688],
9	»	NN	O	»	dobj	4	SENT_352	[p22l1565t1646r1586b1688],

1	a3ua	NN	O	a3ua	_	0	SENT_353	[p22l1511t2564r1694b2588],
2	:	:	O	:	_	0	SENT_353	[p22l1511t2564r1694b2588],
3	>	JJR	O	>	amod	4	SENT_353	[p22l1511t2564r1694b2588],
4	saugum1	NN	O	saugum1	dep	1	SENT_353	[p22l1511t2564r1694b2588],
5	:	:	O	:	_	0	SENT_353	[p22l1492t84r1514b182],
6	o	NN	O	o	dep	1	SENT_353	[p22l1492t84r1514b182],
7	:	:	O	:	_	0	SENT_353	[p22l1492t84r1514b182],
8	m_wn	JJ	O	m_wn	amod	9	SENT_353	[p22l1492t84r1514b182],
9	_	NN	O	_	dep	6	SENT_353	[p22l1492t84r1514b182],
10	82	CD	NUMBER	82	dep	9	SENT_353	[p22l1485t1646r1505b1701],
11	:	:	O	:	_	0	SENT_353	[p22l1403t349r1433b499],
12	o_mmo	NN	O	o_mmo	dep	6	SENT_353	[p22l1403t349r1433b499],
13	.	.	O	.	_	0	SENT_353	[p22l1403t349r1433b499],

1	_	NN	O	_	nn	4	SENT_354	[p22l1403t349r1433b499],
2	mo.	NN	O	mo.	nn	4	SENT_354	[p22l1403t349r1433b499],
3	_	NN	O	_	nn	4	SENT_354	[p22l1403t349r1433b499],
4	n	NN	O	n	_	0	SENT_354	[p22l1403t349r1433b499],
5	_	RB	O	_	dep	4	SENT_354	[p22l1403t349r1433b499],
6	as	IN	O	as	_	0	SENT_354	[p22l1406t509r1426b533],
7	U	NNP	O	U	prep_as	5	SENT_354	[p22l1404t542r1426b560],
8	.	.	O	.	_	0	SENT_354	[p22l1404t561r1426b596],

1	_	NN	O	_	_	0	SENT_355	[p22l1404t561r1426b596],
2	.	.	O	.	_	0	SENT_355	[p22l1404t561r1426b596],

1	U	NNP	O	U	nn	2	SENT_356	[p22l1404t561r1426b596],
2	umcoammm	NNP	O	umcoammm	_	0	SENT_356	[p22l1404t1174r1433b1297],
3	as	IN	O	as	_	0	SENT_356	[p22l1406t1307r1426b1331],
4	U	NNP	O	U	prep_as	2	SENT_356	[p22l1404t1340r1426b1358],
5	.	.	O	.	_	0	SENT_356	[p22l1404t1358r1426b1394],

1	_	NN	O	_	_	0	SENT_357	[p22l1404t1358r1426b1394],
2	.	.	O	.	_	0	SENT_357	[p22l1404t1358r1426b1394],

1	U	NNP	O	U	nn	4	SENT_358	[p22l1404t1358r1426b1394],
2	oo	NNP	O	oo	nn	4	SENT_358	[p22l1404t1646r1425b1701],
3	~	NN	O	~	nn	4	SENT_358	[p22l1404t1646r1425b1701],
4	H	NN	O	h	_	0	SENT_358	[p22l1404t1646r1425b1701],
5	:	:	O	:	_	0	SENT_358	[p22l1410t1764r1432b1862],
6	o	NN	O	o	dep	4	SENT_358	[p22l1410t1764r1432b1862],
7	:	:	O	:	_	0	SENT_358	[p22l1410t1764r1432b1862],
8	o	NN	O	o	nn	9	SENT_358	[p22l1410t1764r1432b1862],
9	_	NN	O	_	dep	6	SENT_358	[p22l1410t1764r1432b1862],
10	.	.	O	.	_	0	SENT_358	[p22l1410t1764r1432b1862],

1	.5	CD	NUMBER	.5	num	4	SENT_359	[p22l1410t1764r1432b1862],
2	m.	NN	NUMBER	m.	nn	4	SENT_359	[p22l1261t865r1289b926],
3	€	NN	O	€	nn	4	SENT_359	[p22l1261t865r1289b926],
4	n	NN	O	n	_	0	SENT_359	[p22l1261t865r1289b926],
5	_	VBG	O	_	partmod	4	SENT_359	[p22l1261t865r1289b926],
6	mxan	NN	O	mxan	dobj	5	SENT_359	[p22l1261t1845r1289b1906],

1	.	.	O	.	_	0	SENT_360	[p22l1211t855r1233b957],

1	£	NNP	O	£	_	0	SENT_361	[p22l1211t855r1233b957],
2	:	:	O	:	_	0	SENT_361	[p22l1211t855r1233b957],
3	_	CD	NUMBER	_	num	5	SENT_361	[p22l1211t855r1233b957],
4	EwU	NN	O	ewu	nn	5	SENT_361	[p22l1211t855r1233b957],
5	oEw	NN	O	oew	dep	1	SENT_361	[p22l1211t1689r1233b1774],
6	;	:	O	;	_	0	SENT_361	[p22l1211t1689r1233b1774],
7	U	NNP	O	U	nn	9	SENT_361	[p22l1211t1689r1233b1774],
8	£	NNP	O	£	nn	9	SENT_361	[p22l1211t1922r1233b2024],
9	_	NNP	O	_	dep	5	SENT_361	[p22l1211t1922r1233b2024],
10	.	.	O	.	_	0	SENT_361	[p22l1211t1922r1233b2024],

1	__	NN	O	__	nn	4	SENT_362	[p22l1211t1922r1233b2024],
2	EwU	NN	O	ewu	nn	4	SENT_362	[p22l1211t1922r1233b2024],
3	om	NN	O	om	nn	4	SENT_362	[p22l1164t654r1184b696],
4	»	NN	O	»	_	0	SENT_362	[p22l1164t654r1184b696],
5	8	CD	NUMBER	8	dep	4	SENT_362	[p22l1164t730r1184b773],
6	.	.	O	.	_	0	SENT_362	[p22l1164t730r1184b773],

1	.	.	O	.	_	0	SENT_363	[p22l1164t730r1184b773],

1	omm	NN	O	omm	nn	2	SENT_364	[p22l1164t807r1184b849],
2	oom	NN	O	oom	_	0	SENT_364	[p22l1164t884r1184b926],
3	omm	NN	O	omm	nn	5	SENT_364	[p22l1164t960r1184b1002],
4	SN	NN	O	sn	nn	5	SENT_364	[p22l1164t1037r1184b1079],
5	omH	NN	O	omh	dep	2	SENT_364	[p22l1164t1114r1184b1154],
6	SN	NN	O	sn	nn	10	SENT_364	[p22l1164t1692r1184b1734],
7	8N	NN	O	8n	nn	10	SENT_364	[p22l1164t1775r1184b1817],
8	omH	NN	O	omh	nn	10	SENT_364	[p22l1164t1859r1184b1899],
9	ooH	NN	O	ooh	nn	10	SENT_364	[p22l1164t1942r1184b1983],
10	o	NN	O	o	dep	2	SENT_364	[p22l1164t2032r1184b2046],

1	.	.	O	.	_	0	SENT_365	[p22l985t1754r990b1757],

1	.....	NNP	O	.....	nn	2	SENT_366	[p22l1010t1749r1113b1761],
2	.....	NNP	O	.....	_	0	SENT_366	[p22l1010t1749r1113b1761],
3	.	.	O	.	_	0	SENT_366	[p22l1010t1749r1113b1761],

1	;	:	O	;	_	0	SENT_367	[p22l1010t1749r1113b1761],
2	_	NN	O	_	_	0	SENT_367	[p22l949t1716r982b1798],
3	>	JJR	O	>	dep	2	SENT_367	[p22l949t1716r982b1798],
4	_	CD	NUMBER	_	num	5	SENT_367	[p22l949t1716r982b1798],
5	o.	NN	O	o.	nn	6	SENT_367	[p22l949t1716r982b1798],
6	mD	NN	O	md	dep	3	SENT_367	[p22l949t1716r982b1798],
7	.	.	O	.	_	0	SENT_367	[p22l904t1716r940b1813],

1	~	NN	O	~	_	0	SENT_368	[p22l904t1716r940b1813],
2	_	CD	NUMBER	_	num	3	SENT_368	[p22l904t1716r940b1813],
3	w.	NN	O	w.	dep	1	SENT_368	[p22l904t1716r940b1813],
4	.	.	O	.	_	0	SENT_368	[p22l904t1716r940b1813],

1	.3	NN	NUMBER	.3	_	0	SENT_369	[p22l904t1716r940b1813],
2	.	.	O	.	_	0	SENT_369	[p22l904t1716r940b1813],

1	.	.	O	.	_	0	SENT_370	[p22l881t1733r907b1777],

1	_	NN	O	_	_	0	SENT_371	[p22l881t1733r907b1777],
2	.	.	O	.	_	0	SENT_371	[p22l881t1733r907b1777],

1	.5	CD	NUMBER	.5	num	3	SENT_372	[p22l881t1733r907b1777],
2	M	NN	O	m	nn	3	SENT_372	[p22l873t1805r900b1808],
3	__	NN	O	__	_	0	SENT_372	[p22l825t909r862b1005],
4	>	JJR	O	>	dep	3	SENT_372	[p22l825t909r862b1005],
5	_	CD	NUMBER	_	num	6	SENT_372	[p22l825t909r862b1005],
6	omt	NN	O	omt	dep	4	SENT_372	[p22l825t909r862b1005],
7	.	.	O	.	_	0	SENT_372	[p22l825t909r862b1005],

1	_	RB	O	_	dep	4	SENT_373	[p22l825t909r862b1005],
2	_	CD	NUMBER	_	num	4	SENT_373	[p22l818t1767r855b1849],
3	>	JJR	O	>	amod	4	SENT_373	[p22l818t1767r855b1849],
4	_	NN	O	_	_	0	SENT_373	[p22l818t1767r855b1849],
5	.	.	O	.	_	0	SENT_373	[p22l818t1767r855b1849],

1	ooE	NN	O	ooe	_	0	SENT_374	[p22l818t1767r855b1849],
2	_	NN	O	_	dep	1	SENT_374	[p22l839t1907r861b1944],
3	.	.	O	.	_	0	SENT_374	[p22l839t1907r861b1944],

1	u.o	NN	O	u.o	_	0	SENT_375	[p22l839t1907r861b1944],
2	.	.	O	.	_	0	SENT_375	[p22l791t935r817b979],

1	_	NN	O	_	nsubj	2	SENT_376	[p22l791t935r817b979],
2	wo	MD	O	will	_	0	SENT_376	[p22l791t935r817b979],
3	_	RB	O	_	advmod	2	SENT_376	[p22l800t1792r822b1828],
4	.	.	O	.	_	0	SENT_376	[p22l800t1792r822b1828],

1	a.o	NN	O	a.o	_	0	SENT_377	[p22l800t1792r822b1828],
2	3	CD	NUMBER	3	dep	1	SENT_377	[p22l745t832r766b861],
3	.	.	O	.	_	0	SENT_377	[p22l745t832r766b861],

1	.	.	O	.	_	0	SENT_378	[p22l745t832r766b861],

1	.	.	O	.	_	0	SENT_379	[p22l743t870r767b959],

1	=	JJ	O	=	_	0	SENT_380	[p22l743t870r767b959],
2	u	FW	O	u	nn	6	SENT_380	[p22l743t870r767b959],
3	_	FW	O	_	nn	6	SENT_380	[p22l743t870r767b959],
4	....	FW	O	....	nn	6	SENT_380	[p22l743t870r767b959],
5	n	NN	O	n	nn	6	SENT_380	[p22l743t870r767b959],
6	_	NN	O	_	dep	1	SENT_380	[p22l743t870r767b959],
7	H	NN	O	h	dep	6	SENT_380	[p22l745t1821r766b1832],
8	.	.	O	.	_	0	SENT_380	[p22l743t1842r767b1931],

1	_	NN	O	_	_	0	SENT_381	[p22l743t1842r767b1931],
2	.	.	O	.	_	0	SENT_381	[p22l743t1842r767b1931],

1	o	NN	O	o	_	0	SENT_382	[p22l743t1842r767b1931],
2	_	NN	O	_	dep	1	SENT_382	[p22l743t1842r767b1931],
3	.	.	O	.	_	0	SENT_382	[p22l743t1842r767b1931],

1	~	NN	O	~	_	0	SENT_383	[p22l743t1842r767b1931],
2	.	.	O	.	_	0	SENT_383	[p22l743t1842r767b1931],

1	_	NN	O	_	_	0	SENT_384	[p22l743t1842r767b1931],
2	+	CC	O	+	_	0	SENT_384	[p22l882t953r902b965],
3	I.	NN	O	i.	nn	6	SENT_384	[p22l1084t520r1101b541],
4	n	NN	O	n	nn	6	SENT_384	[p22l1069t519r1082b535],
5	w	NN	O	w	nn	6	SENT_384	[p22l1043t520r1065b535],
6	o	NN	O	o	conj_+	1	SENT_384	[p22l1025t519r1040b535],
7	.	.	O	.	_	0	SENT_384	[p22l1014t520r1023b535],

1	.	.	O	.	_	0	SENT_385	[p22l1014t520r1023b535],

1	M	NN	O	m	_	0	SENT_386	[p22l978t520r1004b542],
2	Pu	NNP	O	Pu	nn	3	SENT_386	[p22l963t519r976b535],
3	W.	NNP	O	W.	dep	1	SENT_386	[p22l911t519r960b539],
4	a	DT	O	a	dep	3	SENT_386	[p22l897t519r911b535],
5	.	.	O	.	_	0	SENT_386	[p22l886t520r895b535],

1	.	.	O	.	_	0	SENT_387	[p22l886t520r895b535],

1	4:4	CD	NUMBER	4:4	_	0	SENT_388	[p22l855t512r876b541],
2	:	:	O	:	_	0	SENT_388	[p22l855t512r876b541],
3	M	NN	O	m	dep	1	SENT_388	[p22l821t512r853b541],

1	(	NN	O	(	nn	2	SENT_389	[p22l821t1518r876b1547],
2	u.	NN	O	u.	_	0	SENT_389	[p22l821t1518r876b1547],
3	|	CD	NUMBER	|	dep	2	SENT_389	[p22l821t1518r876b1547],
4	:	:	O	:	_	0	SENT_389	[p22l821t1518r876b1547],
5	>	JJR	O	>	amod	6	SENT_389	[p22l821t1518r876b1547],
6	)	NN	O	)	dep	2	SENT_389	[p22l821t1518r876b1547],
7	.	.	O	.	_	0	SENT_389	[p22l886t1525r1004b1549],

1	|	NN	O	|	nsubj	5	SENT_390	[p22l886t1525r1004b1549],
2	9	CD	NUMBER	9	num	4	SENT_390	[p22l886t1525r1004b1549],
3	]	NN	O	]	nn	4	SENT_390	[p22l886t1525r1004b1549],
4	.3	NN	NUMBER	.3	dep	1	SENT_390	[p22l886t1525r1004b1549],
5	l.	VBD	O	l.	_	0	SENT_390	[p22l886t1525r1004b1549],
6	|	CD	NUMBER	|	dobj	5	SENT_390	[p22l886t1525r1004b1549],
7	.	.	O	.	_	0	SENT_390	[p22l886t1525r1004b1549],

1	lB	NN	O	lb	_	0	SENT_391	[p22l886t1525r1004b1549],
2	[	CD	NUMBER	[	num	1	SENT_391	[p22l886t1525r1004b1549],
3	a	DT	O	a	dep	1	SENT_391	[p22l886t1525r1004b1549],
4	.	.	O	.	_	0	SENT_391	[p22l1014t1525r1101b1547],

1	lo	FW	O	lo	nn	2	SENT_392	[p22l1014t1525r1101b1547],
2	|	FW	O	|	_	0	SENT_392	[p22l1014t1525r1101b1547],
3	.	.	O	.	_	0	SENT_392	[p22l1014t1525r1101b1547],

1	uI	NN	O	uus	_	0	SENT_393	[p22l1014t1525r1101b1547],
2	'	''	O	'	_	0	SENT_393	[p22l1014t1525r1101b1547],
3	lJ	NNP	O	lJ	dep	1	SENT_393	[p22l1014t1525r1101b1547],
4	_	IN	O	_	amod	3	SENT_393	[p22l1014t1525r1101b1547],

1	The	DT	O	the	det	4	SENT_394	[p22l722t2746r773b2770],
2	New	NNP	O	New	nn	4	SENT_394	[p22l782t2747r844b2770],
3	England	NNP	O	England	nn	4	SENT_394	[p22l853t2746r964b2777],
4	Joumal	NNP	O	Joumal	_	0	SENT_394	[p22l973t2746r1070b2770],
5	of	IN	O	of	_	0	SENT_394	[p22l1080t2746r1109b2770],
6	Medicine	NNP	O	Medicine	nn	8	SENT_394	[p22l1116t2746r1241b2770],
7	an	DT	O	a	det	8	SENT_394	[p22l687t755r713b794],
8	em	NN	O	em	prep_of	4	SENT_394	[p22l687t846r713b886],
9	e	SYM	O	e	dep	10	SENT_394	[p22l684t951r707b1053],
10	_	CD	NUMBER	_	dep	4	SENT_394	[p22l684t951r707b1053],
11	.	.	O	.	_	0	SENT_394	[p22l684t951r707b1053],

1	_	NN	O	_	_	0	SENT_395	[p22l684t951r707b1053],
2	:	:	O	:	_	0	SENT_395	[p22l684t951r707b1053],
3	_	CD	NUMBER	_	num	5	SENT_395	[p22l684t951r707b1053],
4	gao	NN	O	gao	nn	5	SENT_395	[p22l684t951r707b1053],
5	em	NN	O	em	dep	1	SENT_395	[p22l687t1695r713b1734],
6	.	.	O	.	_	0	SENT_395	[p22l687t1695r713b1734],

1	e	LS	O	e	dep	2	SENT_396	[p22l684t1877r707b1979],
2	_	NN	O	_	_	0	SENT_396	[p22l684t1877r707b1979],
3	.	.	O	.	_	0	SENT_396	[p22l684t1877r707b1979],

1	_	NN	O	_	_	0	SENT_397	[p22l684t1877r707b1979],
2	:	:	O	:	_	0	SENT_397	[p22l684t1877r707b1979],
3	_	CD	NUMBER	_	num	4	SENT_397	[p22l684t1877r707b1979],
4	gao	NNS	O	gao	dep	1	SENT_397	[p22l684t1877r707b1979],
5	"	``	O	"	dep	4	SENT_397	[p22l671t746r678b805],
6	.	.	O	.	_	0	SENT_397	[p22l671t746r678b805],

1	.	.	O	.	_	0	SENT_398	[p22l671t1692r678b1739],
2	"	''	O	"	_	0	SENT_398	[p22l671t1692r678b1739],

1	.	.	O	.	_	0	SENT_399	[p22l671t1692r678b1739],

1	oom	NN	O	oom	nn	4	SENT_400	[p22l639t652r659b694],
2	8	CD	NUMBER	8	num	4	SENT_400	[p22l639t741r659b783],
3	*	NN	O	*	nn	4	SENT_400	[p22l639t741r659b783],
4	com	NN	O	com	_	0	SENT_400	[p22l639t830r659b872],
5	8N	NN	O	8n	nn	7	SENT_400	[p22l639t919r659b961],
6	ooH	NN	O	ooh	nn	7	SENT_400	[p22l639t1007r659b1048],
7	omm	NN	O	omm	dep	4	SENT_400	[p22l639t1612r659b1654],
8	oom	NN	O	oom	nn	15	SENT_400	[p22l639t1678r659b1720],
9	SN	NN	O	sn	nn	15	SENT_400	[p22l639t1744r659b1786],
10	SN	NN	O	sn	nn	15	SENT_400	[p22l639t1810r659b1852],
11	omH	NN	O	omh	nn	15	SENT_400	[p22l639t1877r659b1917],
12	ooH	NN	O	ooh	nn	15	SENT_400	[p22l639t1943r659b1983],
13	om	NN	O	om	nn	15	SENT_400	[p22l639t2016r659b2044],
14	o	NN	O	o	nn	15	SENT_400	[p22l639t2090r659b2103],
15	egqiownl	NN	O	egqiownl	dep	4	SENT_400	[p22l437t1525r576b1549],

1	NENGLJ	NN	O	nenglj	nn	2	SENT_401	[p22l562t2713r668b2735],
2	MED359	NN	O	med359	_	0	SENT_401	[p22l683t2713r811b2735],
3	;	:	O	;	_	0	SENT_401	[p22l683t2713r811b2735],
4	4	CD	NUMBER	4	num	5	SENT_401	[p22l683t2713r811b2735],
5	WWW	NNP	O	WWW	dep	2	SENT_401	[p22l843t2713r1044b2735],
6	.	.	O	.	_	0	SENT_401	[p22l843t2713r1044b2735],

1	NE	NNS	O	ne	nsubj	2	SENT_402	[p22l843t2713r1044b2735],
2	}	VBP	O	}	_	0	SENT_402	[p22l843t2713r1044b2735],
3	M.ORG	NN	O	m.org	nn	4	SENT_402	[p22l843t2713r1044b2735],
4	JULY24	NN	O	july24	dobj	2	SENT_402	[p22l1075t2713r1179b2735],
5	,	,	O	,	_	0	SENT_402	[p22l1075t2713r1179b2735],
6	2008	CD	DATE	2008	appos	4	SENT_402	[p22l1190t2707r1253b2729],

1	28	CD	NUMBER	28	_	0	SENT_403	[p22l422t898r442b980],
2	?	.	O	?	_	0	SENT_403	[p22l422t898r442b980],

1	A	DT	O	a	_	0	SENT_404	[p22l418t993r447b995],
2	+	CC	O	+	rcmod	1	SENT_404	[p22l418t993r447b995],
3	.	.	O	.	_	0	SENT_404	[p22l389t895r413b981],

1	xm	NN	O	xm	_	0	SENT_405	[p22l389t895r413b981],
2	:	:	O	:	_	0	SENT_405	[p22l389t895r413b981],
3	u	FW	O	u	nn	4	SENT_405	[p22l389t895r413b981],
4	_	FW	O	_	dep	1	SENT_405	[p22l393t993r397b995],
5	28	CD	NUMBER	28	dep	4	SENT_405	[p22l332t956r353b1039],
6	?	.	O	?	_	0	SENT_405	[p22l332t956r353b1039],

1	.	.	O	.	_	0	SENT_406	[p22l298t966r327b1026],

1	__	NN	O	__	nsubj	3	SENT_407	[p22l298t966r327b1026],
2	wo	MD	O	will	aux	3	SENT_407	[p22l298t966r327b1026],
3	_	VB	O	_	_	0	SENT_407	[p22l298t966r327b1026],
4	éﬁs	NNS	O	éﬁs	nsubj	5	SENT_407	[p22l266t957r290b1034],
5	o.	VB	O	o.	ccomp	3	SENT_407	[p22l219t832r242b861],
6	_	NN	O	_	dobj	5	SENT_407	[p22l219t832r242b861],
7	.	.	O	.	_	0	SENT_407	[p22l219t832r242b861],

1	.	.	O	.	_	0	SENT_408	[p22l219t832r242b861],

1	u	NN	O	u	_	0	SENT_409	[p22l218t870r242b959],
2	:	:	O	:	_	0	SENT_409	[p22l218t870r242b959],
3	u	FW	O	u	nn	6	SENT_409	[p22l218t870r242b959],
4	___	FW	O	___	nn	6	SENT_409	[p22l218t870r242b959],
5	nn	NN	O	nn	nn	6	SENT_409	[p22l218t870r242b959],
6	_	NN	O	_	dep	1	SENT_409	[p22l218t870r242b959],
7	m	NN	O	m	nn	8	SENT_409	[p22l220t1819r241b1834],
8	E33	NN	O	e33	dep	6	SENT_409	[p22l218t1842r242b1931],
9	.	.	O	.	_	0	SENT_409	[p22l218t1842r242b1931],

1	28	CD	NUMBER	28	_	0	SENT_410	[p22l324t1792r345b1874],
2	$	$	MONEY	$	dep	4	SENT_410	[p22l324t1792r345b1874],
3	__	CD	MONEY	__	num	4	SENT_410	[p22l324t1947r352b2019],
4	2o	NN	O	2o	dep	1	SENT_410	[p22l324t1947r352b2019],
5	&	CC	O	&	rcmod	4	SENT_410	[p22l324t1947r352b2019],
6	.	.	O	.	_	0	SENT_410	[p22l289t1809r315b1853],

1	_	NN	O	_	nn	4	SENT_411	[p22l289t1809r315b1853],
2	3	CD	NUMBER	3	num	4	SENT_411	[p22l289t1809r315b1853],
3	ﬁn	NN	O	ﬁn	nn	4	SENT_411	[p22l289t1973r316b2016],
4	(	NN	O	(	_	0	SENT_411	[p22l296t539r351b568],
5	W3	NN	O	w3	nn	7	SENT_411	[p22l296t539r351b568],
6	)	CD	NUMBER	)	num	7	SENT_411	[p22l296t539r351b568],
7	Jaiawagq	NNP	O	Jaiawagq	dep	4	SENT_411	[p22l361t546r479b569],
8	.	.	O	.	_	0	SENT_411	[p22l489t546r576b568],

1	loLuf	NN	O	loluf	_	0	SENT_412	[p22l489t546r576b568],
2	'	''	O	'	_	0	SENT_412	[p22l489t546r576b568],
3	I	PRP	O	I	nsubj	4	SENT_412	[p22l489t546r576b568],
4	]	VBP	O	]	rcmod	1	SENT_412	[p22l489t546r576b568],
5	_	IN	O	_	prep	4	SENT_412	[p22l489t546r576b568],

1	O	NN	O	o	_	0	SENT_413	[p22l241t596r262b610],
2	—	CD	NUMBER	—	number	3	SENT_413	[p22l242t612r261b622],
3	4	CD	NUMBER	4	dep	1	SENT_413	[p22l242t612r261b622],
4	o	NN	O	o	dep	3	SENT_413	[p22l288t612r308b624],
5	'	''	O	'	_	0	SENT_413	[p22l288t612r308b624],
6	‘	CD	NUMBER	‘	num	7	SENT_413	[p22l288t612r308b624],
7	oo	NN	O	oo	dep	1	SENT_413	[p22l334t612r355b624],
8	l	NN	O	l	tmod	7	SENT_413	[p22l381t611r401b623],
9	\	CD	NUMBER	\	num	11	SENT_413	[p22l381t611r401b623],
10	\	NN	O	\	nn	11	SENT_413	[p22l427t611r447b624],
11	D	NN	O	d	dep	1	SENT_413	[p22l427t611r447b624],
12	U	NNP	O	U	nn	13	SENT_413	[p22l473t613r493b624],
13	‘	NNP	O	‘	dep	11	SENT_413	[p22l473t613r493b624],
14	!	.	O	!	_	0	SENT_413	[p22l473t613r493b624],

1	V	NN	O	v	nn	2	SENT_414	[p22l520t611r539b625],
2	’	NN	O	’	_	0	SENT_414	[p22l520t611r539b625],
3	1	CD	NUMBER	1	num	2	SENT_414	[p22l566t613r586b624],
4	"	``	O	"	punct	3	SENT_414	[p22l566t613r586b624],
5	!	.	O	!	_	0	SENT_414	[p22l566t613r586b624],

1	O	NN	O	o	_	0	SENT_415	[p22l606t611r627b625],

1	(	NN	O	(	nn	2	SENT_416	[p22l296t1518r435b1547],
2	u.	NN	O	u.	_	0	SENT_416	[p22l296t1518r435b1547],
3	|	JJ	O	|	dep	2	SENT_416	[p22l296t1518r435b1547],
4	3	CD	NUMBER	3	num	5	SENT_416	[p22l296t1518r435b1547],
5	)	NN	O	)	dep	3	SENT_416	[p22l296t1518r435b1547],
6	.	.	O	.	_	0	SENT_416	[p22l296t1518r435b1547],

1	|	NN	O	|	nn	2	SENT_417	[p22l296t1518r435b1547],
2	a1au1	NN	O	a1au1	_	0	SENT_417	[p22l296t1518r435b1547],

1	Copyright	NN	O	copyright	_	0	SENT_418	[p22l515t2828r649b2859],
2	©	CD	NUMBER	©	num	6	SENT_418	[p22l658t2828r682b2852],
3	2008	CD	DATE	2008	num	6	SENT_418	[p22l692t2828r756b2852],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_418	[p22l766t2828r957b2852],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_418	[p22l967t2828r1076b2852],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_418	[p22l1086t2828r1191b2859],
7	.	.	O	.	_	0	SENT_418	[p22l1086t2828r1191b2859],

1	All	DT	O	all	det	2	SENT_419	[p22l1202t2828r1243b2852],
2	rights	NNS	O	rights	nsubj	3	SENT_419	[p22l1252t2828r1327b2859],
3	reserved	VBN	O	reserve	_	0	SENT_419	[p22l1337t2828r1455b2852],
4	.	.	O	.	_	0	SENT_419	[p22l1337t2828r1455b2852],

1	The	DT	O	the	det	4	SENT_420	[p22l816t2870r862b2891],
2	NEW	NNP	O	NEW	nn	4	SENT_420	[p22l880t2872r966b2891],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_420	[p22l985t2872r1173b2891],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_420	[p22l1192t2872r1372b2898],
5	of	IN	O	of	_	0	SENT_420	[p22l1391t2870r1419b2897],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_420	[p22l1431t2872r1630b2891],

1	either	CC	O	either	preconj	5	SENT_421	[p23l1244t44r1340b75],
2	in	IN	O	in	_	0	SENT_421	[p23l1353t45r1385b74],
3	the	DT	O	the	det	4	SENT_421	[p23l1400t44r1451b75],
4	form	NN	O	form	prep_in	5	SENT_421	[p23l1466t44r1547b75],
5	of	IN	O	of	_	0	SENT_421	[p23l1562t44r1601b75],
6	coincident	JJ	O	coincident	amod	8	SENT_421	[p23l1608t44r1782b75],
7	tumor	NN	O	tumor	nn	8	SENT_421	[p23l1795t51r1899b75],
8	biopsy	NN	O	biopsy	pobj	5	SENT_421	[p23l1912t44r2020b83],
9	or	CC	O	or	_	0	SENT_421	[p23l2033t54r2068b75],
10	the	DT	O	the	det	11	SENT_421	[p23l1244t94r1295b125],
11	analysis	NN	O	analysis	conj_or	5	SENT_421	[p23l1310t95r1442b133],
12	of	IN	O	of	_	0	SENT_421	[p23l1459t94r1497b125],
13	circulating	VBG	O	circulate	prepc_of	11	SENT_421	[p23l1506t94r1687b134],
14	tumor	NN	O	tumor	nn	15	SENT_421	[p23l1701t101r1805b125],
15	cells	NNS	O	cell	dobj	13	SENT_421	[p23l1819t94r1901b125],
16	.	.	O	.	_	0	SENT_421	[p23l1819t94r1901b125],

1	Direct	JJ	O	direct	amod	2	SENT_422	[p23l1293t145r1396b175],
2	sequencing	NN	O	sequencing	ccomp	36	SENT_422	[p23l1412t145r1601b184],
3	of	IN	O	of	_	0	SENT_422	[p23l1617t144r1656b175],
4	an	DT	O	a	det	7	SENT_422	[p23l1665t154r1706b175],
5	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_422	[p23l1722t147r1805b175],
6	mutation	NN	O	mutation	nn	7	SENT_422	[p23l1819t145r1972b175],
7	indiM	NN	O	indim	prep_of	2	SENT_422	[p23l1989t144r2066b175, p23l131t220r157b232],
8	I	PRP	O	I	dep	14	SENT_422	[p23l177t220r179b232],
9	E	NNP	O	E	nn	11	SENT_422	[p23l205t220r213b232],
10	L.	NNP	O	L.	nn	11	SENT_422	[p23l229t220r239b232],
11	L.	NNP	O	L.	dep	8	SENT_422	[p23l255t220r265b232],
12	5	CD	NUMBER	5	num	11	SENT_422	[p23l279t218r289b234],
13	I	PRP	O	I	dep	14	SENT_422	[p23l303t220r305b232],
14	L.	FW	O	l.	dep	2	SENT_422	[p23l321t220r331b232],
15	G	NN	O	g	nn	16	SENT_422	[p23l349t218r357b234],
16	E	NN	O	e	dep	14	SENT_422	[p23l375t220r385b232],
17	_	CD	NUMBER	_	number	18	SENT_422	[p23l401t220r405b222],
18	9	CD	NUMBER	9	dep	16	SENT_422	[p23l419t220r445b232],
19	,	,	O	,	_	0	SENT_422	[p23l419t220r445b232],
20	,	,	O	,	_	0	SENT_422	[p23l419t220r445b232],
21	E	NN	O	e	nn	23	SENT_422	[p23l467t220r475b232],
22	Q	NNP	O	Q	nn	23	SENT_422	[p23l489t220r499b232],
23	A	NNP	O	A	appos	2	SENT_422	[p23l515t215r921b236],
24	,	,	O	,	_	0	SENT_422	[p23l515t215r921b236],
25	,	,	O	,	_	0	SENT_422	[p23l515t215r921b236],
26	,	,	O	,	_	0	SENT_422	[p23l515t215r921b236],
27	C	NN	O	c	appos	2	SENT_422	[p23l945t220r969b232],
28	,	,	O	,	_	0	SENT_422	[p23l945t220r969b232],
29	E	NN	O	e	appos	2	SENT_422	[p23l996t220r1019b232],
30	,	,	O	,	_	0	SENT_422	[p23l996t220r1019b232],
31	L.	NNP	O	L.	nn	32	SENT_422	[p23l1041t220r1051b232],
32	G	NNP	O	G	appos	2	SENT_422	[p23l1065t218r1075b234],
33	,	,	O	,	_	0	SENT_422	[p23l1095t220r1105b232],
34	,	,	O	,	_	0	SENT_422	[p23l1123t220r1125b232],
35	E	NN	O	e	nsubj	36	SENT_422	[p23l1141t218r1151b234],
36	cates	VBZ	O	cate	_	0	SENT_422	[p23l1244t201r1326b225],
37	that	IN	O	that	complm	43	SENT_422	[p23l1347t195r1413b225],
38	the	DT	O	the	nsubj	43	SENT_422	[p23l1432t194r1483b225],
39	captured	VBN	O	capture	partmod	38	SENT_422	[p23l1504t194r1650b233],
40	circulating	VBG	O	circulate	xcomp	39	SENT_422	[p23l1670t194r1851b234],
41	tumor	NN	O	tumor	nn	42	SENT_422	[p23l1870t201r1974b225],
42	cells	NNS	O	cell	dobj	40	SENT_422	[p23l1993t194r2066b225],
43	represent	VBP	O	represent	ccomp	36	SENT_422	[p23l1244t251r1400b283],
44	a	DT	O	a	det	48	SENT_422	[p23l1410t255r1428b275],
45	largely	RB	O	largely	advmod	48	SENT_422	[p23l1439t244r1552b284],
46	pure	JJ	O	pure	amod	48	SENT_422	[p23l1563t254r1637b283],
47	tumor	NN	O	tumor	nn	48	SENT_422	[p23l1650t244r1888b275],
48	—	NN	O	—	dobj	43	SENT_422	[p23l1650t244r1888b275],
49	derived	VBN	O	derive	partmod	48	SENT_422	[p23l1650t244r1888b275],
50	cell	NN	O	cell	nn	51	SENT_422	[p23l1901t244r1958b275],
51	population	NN	O	population	dobj	49	SENT_422	[p23l1969t254r2066b283, p23l1243t294r1343b325],
52	.	.	O	.	_	0	SENT_422	[p23l1969t254r2066b283, p23l1243t294r1343b325],

1	Further	JJ	O	further	amod	2	SENT_423	[p23l1358t294r1480b325],
2	characterization	NN	O	characterization	nsubj	10	SENT_423	[p23l1492t294r1752b325],
3	of	IN	O	of	_	0	SENT_423	[p23l1765t294r1804b325],
4	such	JJ	O	such	amod	5	SENT_423	[p23l1811t294r1883b325],
5	precursors	NNS	O	precursor	prep_of	2	SENT_423	[p23l1896t304r2066b333],
6	of	IN	O	of	_	0	SENT_423	[p23l1244t344r1283b375],
7	metastasis	NN	O	metastasis	nn	8	SENT_423	[p23l1292t345r1495b375],
8	”	NN	O	”	prep_of	5	SENT_423	[p23l1292t345r1495b375],
9	may	MD	O	may	aux	10	SENT_423	[p23l1512t354r1582b383],
10	provide	VB	O	provide	_	0	SENT_423	[p23l1595t344r1719b383],
11	important	JJ	O	important	amod	12	SENT_423	[p23l1735t345r1906b383],
12	opportunities	NNS	O	opportunity	dobj	10	SENT_423	[p23l1920t351r2066b383, p23l1244t395r1330b425],
13	for	IN	O	for	_	0	SENT_423	[p23l1344t394r1390b425],
14	diagnostic	JJ	O	diagnostic	amod	17	SENT_423	[p23l1402t394r1569b434],
15	and	CC	O	and	_	0	SENT_423	[p23l1581t394r1641b425],
16	therapeutic	JJ	O	therapeutic	conj_and	14	SENT_423	[p23l1654t394r1834b433],
17	interventions	NNS	O	intervention	prep_for	10	SENT_423	[p23l1846t395r2064b425],
18	.	.	O	.	_	0	SENT_423	[p23l1846t395r2064b425],

1	However	RB	O	however	advmod	21	SENT_424	[p23l1243t447r1397b481],
2	,	,	O	,	_	0	SENT_424	[p23l1243t447r1397b481],
3	optimization	NN	O	optimization	nsubjpass	21	SENT_424	[p23l1422t445r1639b483],
4	and	CC	O	and	_	0	SENT_424	[p23l1662t444r1723b475],
5	automation	NN	O	automation	nsubjpass	21	SENT_424	[p23l1746t445r1937b475],
6	of	IN	O	of	_	0	SENT_424	[p23l1960t444r1999b475],
7	the	DT	O	the	det	8	SENT_424	[p23l2015t444r2067b475],
8	device	NN	O	device	prep_of	3	SENT_424	[p23l1244t494r1346b525],
9	for	IN	O	for	_	0	SENT_424	[p23l1364t494r1412b525],
10	capturing	VBG	O	capture	prepc_for	8	SENT_424	[p23l1429t495r1592b534],
11	circulating	VBG	O	circulate	xcomp	10	SENT_424	[p23l1609t494r1790b534],
12	tumor	NN	O	tumor	nn	13	SENT_424	[p23l1807t501r1911b525],
13	cells	NNS	O	cell	dobj	11	SENT_424	[p23l1928t494r2001b525],
14	for	IN	O	for	_	0	SENT_424	[p23l2020t494r2068b525],
15	high	JJ	O	high	amod	18	SENT_424	[p23l1244t544r1525b584],
16	—	NN	O	—	nn	18	SENT_424	[p23l1244t544r1525b584],
17	throughput	NN	O	throughput	nn	18	SENT_424	[p23l1244t544r1525b584],
18	processing	NN	O	processing	prep_for	11	SENT_424	[p23l1540t545r1722b584],
19	will	MD	O	will	aux	21	SENT_424	[p23l1737t544r1801b575],
20	be	VB	O	be	auxpass	21	SENT_424	[p23l1820t544r1857b575],
21	required	VBN	O	require	_	0	SENT_424	[p23l1875t544r2016b583],
22	to	TO	O	to	aux	23	SENT_424	[p23l2034t551r2066b575],
23	allow	VB	O	allow	xcomp	21	SENT_424	[p23l1243t594r1333b625],
24	large	JJ	O	large	amod	26	SENT_424	[p23l1344t594r1520b634],
25	—	NN	O	—	nn	26	SENT_424	[p23l1344t594r1520b634],
26	scale	NN	O	scale	iobj	23	SENT_424	[p23l1344t594r1520b634],
27	clinical	JJ	O	clinical	amod	28	SENT_424	[p23l1534t594r1652b625],
28	trials	NNS	O	trial	dobj	23	SENT_424	[p23l1665t594r1748b625],
29	that	WDT	O	that	nsubj	30	SENT_424	[p23l1763t594r1828b625],
30	use	VBP	O	use	rcmod	28	SENT_424	[p23l1840t605r1893b625],
31	this	DT	O	this	det	33	SENT_424	[p23l1907t594r1967b625],
32	novel	JJ	O	novel	amod	33	SENT_424	[p23l1981t594r2067b625],
33	technology	NN	O	technology	dobj	30	SENT_424	[p23l1244t644r1435b684],
34	.	.	O	.	_	0	SENT_424	[p23l1244t644r1435b684],

1	-55	CD	NUMBER	-55	_	0	SENT_425	[p23l496t139r1095b153],
2	-	:	O	-	_	0	SENT_425	[p23l496t139r1095b153],
3	‘	CD	NUMBER	‘	num	4	SENT_425	[p23l496t139r1095b153],
4	ATET	NN	O	atet	dep	1	SENT_425	[p23l496t139r1095b153],
5	|	CD	NUMBER	|	num	7	SENT_425	[p23l496t139r1095b153],
6	IE	JJ	O	ie	amod	7	SENT_425	[p23l496t139r1095b153],
7	|	NN	O	|	dep	4	SENT_425	[p23l496t139r1095b153],
8	3	CD	MONEY	3	number	10	SENT_425	[p23l496t139r1095b153],
9	£	NN	MONEY	£	dep	10	SENT_425	[p23l496t139r1095b153],
10	J	NN	O	j	amod	7	SENT_425	[p23l496t139r1095b153],
11	¥	NN	O	¥	nn	16	SENT_425	[p23l496t139r1095b153],
12	J	NN	PERCENT	j	nn	16	SENT_425	[p23l496t139r1095b153],
13	%	NN	PERCENT	%	nn	16	SENT_425	[p23l496t139r1095b153],
14	|	CD	NUMBER	|	num	16	SENT_425	[p23l496t139r1095b153],
15	3EE	NN	O	3ee	nn	16	SENT_425	[p23l496t139r1095b153],
16	£	NN	O	£	dep	4	SENT_425	[p23l496t139r1095b153],
17	.	.	O	.	_	0	SENT_425	[p23l496t139r1095b153],

1	L	NN	O	l	_	0	SENT_426	[p23l496t139r1095b153],
2	‘	NN	O	‘	dep	1	SENT_426	[p23l496t139r1095b153],
3	.	.	O	.	_	0	SENT_426	[p23l496t139r1095b153],

1	E	NN	O	e	_	0	SENT_427	[p23l496t139r1095b153],
2	£	CD	NUMBER	£	num	3	SENT_427	[p23l496t139r1095b153],
3	<	JJR	O	<	dep	1	SENT_427	[p23l496t139r1095b153],
4	.9	CD	NUMBER	.9	dep	3	SENT_427	[p23l496t139r1095b153],
5	.	.	O	.	_	0	SENT_427	[p23l496t139r1095b153],

1	EE	NNP	O	EE	_	0	SENT_428	[p23l496t139r1095b153],
2	&	CC	O	&	_	0	SENT_428	[p23l496t139r1095b153],
3	£	NNP	O	£	conj_and	1	SENT_428	[p23l496t139r1095b153],
4	<	JJR	O	<	dep	1	SENT_428	[p23l496t139r1095b153],
5	»	CD	NUMBER	»	num	6	SENT_428	[p23l496t139r1095b153],
6	llTE	NN	O	llte	dep	1	SENT_428	[p23l496t139r1095b153],

1	Supported	VBN	O	support	_	0	SENT_429	[p23l1277t727r1408b756],
2	by	IN	O	by	_	0	SENT_429	[p23l1420t727r1449b756],
3	grants	NNS	O	grant	prep_by	1	SENT_429	[p23l1460t732r1541b756],
4	from	IN	O	from	_	0	SENT_429	[p23l1554t727r1616b750],
5	the	DT	O	the	det	7	SENT_429	[p23l1628t727r1668b750],
6	National	NNP	ORGANIZATION	National	nn	7	SENT_429	[p23l1679t727r1790b750],
7	Institutes	NNPS	ORGANIZATION	Institutes	prep_from	3	SENT_429	[p23l1802t727r1923b750],
8	of	IN	ORGANIZATION	of	_	0	SENT_429	[p23l1936t727r1966b750],
9	Health	NNP	ORGANIZATION	Health	prep_of	3	SENT_429	[p23l1972t727r2066b755],
10	;	:	O	;	_	0	SENT_429	[p23l1972t727r2066b755],
11	the	DT	O	the	det	13	SENT_429	[p23l1243t764r1283b787],
12	Doris	NNP	PERSON	Doris	nn	13	SENT_429	[p23l1295t765r1364b787],
13	Duke	NNP	PERSON	Duke	prep_by	1	SENT_429	[p23l1376t764r1450b792],
14	,	,	O	,	_	0	SENT_429	[p23l1376t764r1450b792],
15	Ellison	NNP	PERSON	Ellison	conj_and	3	SENT_429	[p23l1463t764r1559b792],
16	,	,	O	,	_	0	SENT_429	[p23l1463t764r1559b792],
17	and	CC	O	and	_	0	SENT_429	[p23l1573t764r1620b787],
18	Monell	NNP	O	Monell	nn	19	SENT_429	[p23l1631t764r1720b787],
19	Foundations	NNPS	O	Foundations	conj_and	3	SENT_429	[p23l1732t764r1899b792],
20	;	:	O	;	_	0	SENT_429	[p23l1732t764r1899b792],
21	the	DT	O	the	det	22	SENT_429	[p23l1912t764r1952b787],
22	ESSCO	NNP	O	ESSCO	prep_by	1	SENT_429	[p23l1964t766r2068b787],
23	—	CD	NUMBER	—	num	22	SENT_429	[p23l1964t766r2068b787],
24	MGH	NNP	ORGANIZATION	MGH	nn	26	SENT_429	[p23l1242t804r1311b825],
25	Research	NNP	ORGANIZATION	Research	nn	26	SENT_429	[p23l1324t802r1440b826],
26	Fund	NNP	ORGANIZATION	Fund	dep	22	SENT_429	[p23l1453t802r1525b830],
27	;	:	O	;	_	0	SENT_429	[p23l1453t802r1525b830],
28	the	DT	O	the	det	30	SENT_429	[p23l1539t802r1579b825],
29	National	NNP	ORGANIZATION	National	nn	30	SENT_429	[p23l1592t802r1702b825],
30	Foundation	NNP	ORGANIZATION	Foundation	prep_by	1	SENT_429	[p23l1715t802r1862b825],
31	for	IN	ORGANIZATION	for	_	0	SENT_429	[p23l1875t802r1912b825],
32	Cancer	NNP	ORGANIZATION	Cancer	nn	33	SENT_429	[p23l1924t804r2013b825],
33	Research	NNP	ORGANIZATION	Research	prep_for	30	SENT_429	[p23l2025t804r2067b826, p23l1244t839r1333b867],
34	;	:	O	;	_	0	SENT_429	[p23l2025t804r2067b826, p23l1244t839r1333b867],
35	and	CC	O	and	_	0	SENT_429	[p23l1343t839r1389b862],
36	the	DT	O	the	det	40	SENT_429	[p23l1398t839r1437b862],
37	Howard	NNP	ORGANIZATION	Howard	nn	40	SENT_429	[p23l1446t839r1547b862],
38	Hughes	NNP	ORGANIZATION	Hughes	nn	40	SENT_429	[p23l1556t839r1653b869],
39	Medical	NNP	ORGANIZATION	Medical	nn	40	SENT_429	[p23l1661t839r1763b862],
40	Institute	NNP	ORGANIZATION	Institute	conj_and	3	SENT_429	[p23l1771t840r1886b862],
41	.	.	O	.	_	0	SENT_429	[p23l1771t840r1886b862],

1	SARMS	NN	O	sarm	nn	3	SENT_430	[p23l1897t841r1991b864],
2	assay	NN	O	assay	nn	3	SENT_430	[p23l2001t847r2068b869],
3	reagents	NNS	O	reagent	nsubjpass	5	SENT_430	[p23l1243t882r1351b906],
4	were	VBD	O	be	auxpass	5	SENT_430	[p23l1360t884r1420b900],
5	provided	VBN	O	provide	_	0	SENT_430	[p23l1429t877r1541b906],
6	by	IN	O	by	_	0	SENT_430	[p23l1550t877r1579b906],
7	DxS	NN	O	dx	agent	5	SENT_430	[p23l1587t879r1644b900],
8	.	.	O	.	_	0	SENT_430	[p23l1587t879r1644b900],

1	Dr.	NNP	O	Dr.	nn	2	SENT_431	[p23l1276t916r1314b937],
2	Sequist	NNP	PERSON	Sequist	nsubj	3	SENT_431	[p23l1326t915r1418b944],
3	reports	VBZ	O	report	_	0	SENT_431	[p23l1427t919r1518b944],
4	receiving	VBG	O	receive	xcomp	3	SENT_431	[p23l1528t915r1644b944],
5	grant	NN	O	grant	nn	6	SENT_431	[p23l1652t919r1722b944],
6	support	NN	O	support	dobj	4	SENT_431	[p23l1730t919r1829b944],
7	from	IN	O	from	_	0	SENT_431	[p23l1837t914r1899b937],
8	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	4	SENT_431	[p23l1908t916r2067b937],
9	and	CC	O	and	_	0	SENT_431	[p23l1243t952r1290b975],
10	Genentech	NNP	ORGANIZATION	Genentech	prep_from	4	SENT_431	[p23l1304t952r1448b979],
11	;	:	O	;	_	0	SENT_431	[p23l1304t952r1448b979],
12	Drs.	NNP	O	Drs.	nn	13	SENT_431	[p23l1464t954r1515b975],
13	Iafrate	NNP	PERSON	Iafrate	nsubj	20	SENT_431	[p23l1531t952r1622b980],
14	,	,	O	,	_	0	SENT_431	[p23l1531t952r1622b980],
15	Settleman	NNP	O	Settleman	appos	13	SENT_431	[p23l1639t952r1774b980],
16	,	,	O	,	_	0	SENT_431	[p23l1639t952r1774b980],
17	and	CC	O	and	_	0	SENT_431	[p23l1790t952r1837b975],
18	Haber	NNP	PERSON	Haber	conj_and	15	SENT_431	[p23l1852t952r1936b980],
19	,	,	O	,	_	0	SENT_431	[p23l1852t952r1936b980],
20	receiving	VBG	O	receive	parataxis	3	SENT_431	[p23l1952t952r2068b981],
21	Fl8	NN	O	fl8	dobj	20	SENT_431	[p23l122t980r206b1012],
22	"	''	O	"	punct	21	SENT_431	[p23l122t980r206b1012],
23	"	``	O	"	punct	20	SENT_431	[p23l122t980r206b1012],
24	e	SYM	O	e	dep	84	SENT_431	[p23l122t980r206b1012],
25	3	LS	NUMBER	3	dep	84	SENT_431	[p23l217t981r239b1004],
26	-	:	O	-	_	0	SENT_431	[p23l217t981r239b1004],
27	Traclngs	FW	O	traclngs	nn	31	SENT_431	[p23l250t979r366b1012],
28	°	FW	O	°	nn	31	SENT_431	[p23l377t978r408b1004],
29	f	FW	O	f	nn	31	SENT_431	[p23l377t978r408b1004],
30	EGFR	NN	ORGANIZATION	egfr	nn	31	SENT_431	[p23l414t981r491b1004],
31	N	NN	O	n	dep	40	SENT_431	[p23l503t979r653b1004],
32	“	CD	NUMBER	“	num	33	SENT_431	[p23l503t979r653b1004],
33	cle	NN	O	cle	dep	31	SENT_431	[p23l503t979r653b1004],
34	°	CD	NUMBER	°	dep	40	SENT_431	[p23l503t979r653b1004],
35	tide	NN	O	tide	nn	40	SENT_431	[p23l503t979r653b1004],
36	Sequencmg	NN	O	sequencmg	nn	40	SENT_431	[p23l663t979r826b1012],
37	ﬁ	NN	O	ﬁ	nn	40	SENT_431	[p23l835t978r900b1004],
38	'	''	O	'	_	0	SENT_431	[p23l835t978r900b1004],
39	°	NN	O	°	nn	40	SENT_431	[p23l835t978r900b1004],
40	m	NN	O	m	dep	84	SENT_431	[p23l835t978r900b1004],
41	the	DT	O	the	det	42	SENT_431	[p23l911t979r955b1004],
42	T	NN	O	t	dep	40	SENT_431	[p23l964t981r1055b1004],
43	"	''	O	"	punct	42	SENT_431	[p23l964t981r1055b1004],
44	m	NN	O	m	dep	40	SENT_431	[p23l964t981r1055b1004],
45	°	CD	NUMBER	°	num	44	SENT_431	[p23l964t981r1055b1004],
46	"	``	O	"	punct	48	SENT_431	[p23l964t981r1055b1004],
47	research	NN	O	research	nn	48	SENT_431	[p23l1243t989r1351b1012],
48	support	NN	O	support	dep	44	SENT_431	[p23l1360t994r1459b1019],
49	from	IN	O	from	_	0	SENT_431	[p23l1466t989r1528b1012],
50	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	48	SENT_431	[p23l1535t991r1702b1017],
51	;	:	O	;	_	0	SENT_431	[p23l1535t991r1702b1017],
52	Drs.	NNP	O	Drs.	nn	57	SENT_431	[p23l1711t991r1762b1012],
53	Bell	NNP	PERSON	Bell	nn	57	SENT_431	[p23l1772t989r1827b1017],
54	,	,	O	,	_	0	SENT_431	[p23l1772t989r1827b1017],
55	Settleman	NNP	O	Settleman	appos	57	SENT_431	[p23l1838t989r1973b1017],
56	,	,	O	,	_	0	SENT_431	[p23l1838t989r1973b1017],
57	Lynch	NNP	PERSON	Lynch	dep	48	SENT_431	[p23l1983t989r2065b1019],
58	,	,	O	,	_	0	SENT_431	[p23l1983t989r2065b1019],
59	and	CC	O	and	_	0	SENT_431	[p23l120t1020r169b1046],
60	Circulating	VBG	O	circulate	amod	62	SENT_431	[p23l180t1020r331b1053],
61	Tumor	NN	O	tumor	nn	62	SENT_431	[p23l340t1023r431b1046],
62	Cells	NNS	O	cell	dep	84	SENT_431	[p23l441t1020r507b1046],
63	Of	IN	O	of	dep	62	SENT_431	[p23l517t1020r549b1046],
64	Patient	NN	O	patient	pobj	63	SENT_431	[p23l556t1021r652b1046],
65	2	CD	NUMBER	2	num	64	SENT_431	[p23l661t1023r686b1046],
66	-	:	O	-	_	0	SENT_431	[p23l661t1023r686b1046],
67	and	CC	O	and	_	0	SENT_431	[p23l1243t1027r1290b1050],
68	Haber	NNP	PERSON	Haber	pobj	63	SENT_431	[p23l1299t1027r1383b1055],
69	,	,	O	,	_	0	SENT_431	[p23l1299t1027r1383b1055],
70	receiving	VBG	O	receive	dep	84	SENT_431	[p23l1394t1027r1510b1056],
71	royalties	NNS	O	royalty	dobj	70	SENT_431	[p23l1519t1027r1626b1056],
72	as	IN	O	as	_	0	SENT_431	[p23l1636t1034r1661b1050],
73	coinventors	NNS	O	coinventor	prep_as	70	SENT_431	[p23l1671t1027r1819b1050],
74	on	IN	O	on	_	0	SENT_431	[p23l1829t1034r1860b1050],
75	a	DT	O	a	det	78	SENT_431	[p23l1870t1034r1883b1050],
76	patent	NN	O	patent	nn	78	SENT_431	[p23l1891t1032r1972b1056],
77	awardAnalysis	NN	O	awardanalysis	nn	78	SENT_431	[p23l1980t1027r2067b1050, p23l119t1070r232b1103],
78	ofa	NN	O	ofa	prep_on	73	SENT_431	[p23l244t1070r294b1096],
79	tumor-biopsy	JJ	O	tumor-biopsy	amod	80	SENT_431	[p23l305t1070r492b1103],
80	specimen	NN	O	specimen	tmod	70	SENT_431	[p23l503t1073r635b1103],
81	from	IN	O	from	_	0	SENT_431	[p23l647t1070r712b1096],
82	Patient	NN	O	patient	prep_from	80	SENT_431	[p23l727t1073r822b1096],
83	2	CD	NUMBER	2	nsubj	84	SENT_431	[p23l833t1073r847b1095],
84	shows	VBZ	O	show	dep	20	SENT_431	[p23l859t1070r944b1096],
85	a	DT	O	a	advmod	86	SENT_431	[p23l957t1079r970b1096],
86	ed	VBN	O	ed	dep	84	SENT_431	[p23l1243t1064r1272b1087],
87	50	CD	NUMBER	50	dobj	86	SENT_431	[p23l1286t1064r1327b1106],
88	?	.	O	?	_	0	SENT_431	[p23l1286t1064r1327b1106],

1	the	DT	O	the	dep	9	SENT_432	[p23l1337t1064r1376b1087],
2	di	FW	O	di	nn	4	SENT_432	[p23l1391t1064r1510b1106],
3	§	FW	O	§	nn	4	SENT_432	[p23l1391t1064r1510b1106],
4	C0V9YY	NN	O	c0v9yy	nsubj	9	SENT_432	[p23l1391t1064r1510b1106],
5	Of	IN	O	of	_	0	SENT_432	[p23l1524t1064r1553b1087],
6	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_432	[p23l1562t1066r1624b1106],
7	mutfltioné	NN	O	mutfltioné	nn	8	SENT_432	[p23l1637t1065r1774b1106],
8	»	NN	O	»	prep_of	9	SENT_432	[p23l1637t1065r1774b1106],
9	licensed	VBD	O	license	dep	30	SENT_432	[p23l1789t1064r1893b1087],
10	to	TO	O	to	_	0	SENT_432	[p23l1908t1069r1932b1087],
11	Ge11ZYfI1	NN	O	ge11zyfi1	nn	13	SENT_432	[p23l1947t1066r2067b1106],
12	€	CD	NUMBER	€	num	13	SENT_432	[p23l1947t1066r2067b1106],
13	T751	NN	O	t751	prep_to	9	SENT_432	[p23l119t1112r364b1139],
14	_	CD	NUMBER	_	num	15	SENT_432	[p23l119t1112r364b1139],
15	|	NN	O	|	dobj	9	SENT_432	[p23l119t1112r364b1139],
16	759de	CD	NUMBER	759de	num	19	SENT_432	[p23l119t1112r364b1139],
17	|	NN	O	|	nn	19	SENT_432	[p23l119t1112r364b1139],
18	insS	NN	O	inss	nn	19	SENT_432	[p23l119t1112r364b1139],
19	mutation	NN	O	mutation	dep	15	SENT_432	[p23l378t1115r502b1137],
20	that	WDT	O	that	nsubj	22	SENT_432	[p23l514t1112r568b1137],
21	is	VBZ	O	be	cop	22	SENT_432	[p23l580t1115r599b1137],
22	distinct	JJ	O	distinct	rcmod	15	SENT_432	[p23l611t1112r715b1137],
23	from	IN	O	from	_	0	SENT_432	[p23l725t1112r790b1137],
24	the	DT	O	the	det	27	SENT_432	[p23l802t1112r845b1137],
25	Del	NNP	O	Del	nn	27	SENT_432	[p23l859t1112r901b1137],
26	746_750	CD	NUMBER	746_750	num	27	SENT_432	[p23l916t1114r1031b1139],
27	mutation	NN	O	mutation	prep_from	22	SENT_432	[p23l1043t1115r1167b1137],
28	Genetlcsr	NNP	O	Genetlcsr	nn	29	SENT_432	[p23l1243t1104r1361b1130],
29	Wh	NNP	O	Wh	nsubj	30	SENT_432	[p23l1373t1102r1451b1144],
30	‘	VBD	O	‘	_	0	SENT_432	[p23l1373t1102r1451b1144],
31	°	CD	NUMBER	°	number	32	SENT_432	[p23l1373t1102r1451b1144],
32	_	CD	NUMBER	_	num	37	SENT_432	[p23l1373t1102r1451b1144],
33	h	NN	O	h	nn	37	SENT_432	[p23l1373t1102r1451b1144],
34	WaS_n	NN	O	was_n	nn	37	SENT_432	[p23l1462t1107r1564b1144],
35	°	CD	NUMBER	°	num	37	SENT_432	[p23l1462t1107r1564b1144],
36	t	NN	O	t	nn	37	SENT_432	[p23l1462t1107r1564b1144],
37	mV	NN	O	mv	dobj	30	SENT_432	[p23l1575t1102r1679b1125],
38	°	CD	NUMBER	°	nsubj	39	SENT_432	[p23l1575t1102r1679b1125],
39	lVed	VBD	O	lved	rcmod	37	SENT_432	[p23l1575t1102r1679b1125],
40	In	IN	O	in	_	0	SENT_432	[p23l1691t1109r1715b1124],
41	thls	NNS	O	thl	prep_in	39	SENT_432	[p23l1727t1102r1775b1125],
42	Stud	NNP	O	Stud	dep	41	SENT_432	[p23l1788t1102r1861b1144],
43	?	.	O	?	_	0	SENT_432	[p23l1788t1102r1861b1144],
44	"	''	O	"	punct	30	SENT_432	[p23l1788t1102r1861b1144],

1	DIS	NN	O	di	dep	201	SENT_433	[p23l1874t1104r1926b1125],
2	‘	CD	NUMBER	‘	dep	201	SENT_433	[p23l1874t1104r1926b1125],
3	T	NN	O	t	dep	201	SENT_433	[p23l1938t1102r2066b1144],
4	°	CD	NUMBER	°	dep	201	SENT_433	[p23l1938t1102r2066b1144],
5	mPkm_S	NN	O	mpkm_s	dep	201	SENT_433	[p23l1938t1102r2066b1144],
6	present	JJ	DATE	present	dep	201	SENT_433	[p23l121t1159r224b1187],
7	in	IN	O	in	dep	201	SENT_433	[p23l236t1156r258b1179],
8	the	DT	O	the	dep	201	SENT_433	[p23l270t1154r313b1179],
9	analysis	NN	O	analysis	dep	201	SENT_433	[p23l325t1154r432b1187],
10	of	IN	O	of	dep	201	SENT_433	[p23l444t1154r474b1179],
11	circulating	VBG	O	circulate	dep	201	SENT_433	[p23l481t1154r625b1187],
12	tumor	NN	O	tumor	dep	201	SENT_433	[p23l635t1159r721b1179],
13	cells	NNS	O	cell	dep	201	SENT_433	[p23l732t1154r791b1179],
14	(	VBP	O	(	dep	201	SENT_433	[p23l806t1156r896b1187],
15	CTCS	NN	O	ctc	dep	201	SENT_433	[p23l806t1156r896b1187],
16	)	CD	NUMBER	)	dep	201	SENT_433	[p23l806t1156r896b1187],
17	The	DT	O	the	dep	201	SENT_433	[p23l917t1154r968b1179],
18	27	CD	NUMBER	27	dep	201	SENT_433	[p23l980t1156r1010b1179],
19	nucleotides	NNS	O	nucleotide	dep	201	SENT_433	[p23l1023t1154r1182b1179],
20	and	CC	O	and	dep	201	SENT_433	[p23l1243t1139r1290b1162],
21	Toner	NNP	PERSON	Toner	dep	201	SENT_433	[p23l1304t1141r1383b1167],
22	’	CD	NUMBER	’	dep	201	SENT_433	[p23l1304t1141r1383b1167],
23	being	VBG	O	be	dep	201	SENT_433	[p23l1400t1139r1472b1169],
24	coinventors	NNS	O	coinventor	dep	201	SENT_433	[p23l1486t1144r1633b1162],
25	of	IN	O	of	dep	201	SENT_433	[p23l1648t1139r1678b1162],
26	the	DT	O	the	dep	201	SENT_433	[p23l1688t1139r1727b1162],
27	CTC	NNP	ORGANIZATION	CTC	dep	201	SENT_433	[p23l1742t1139r1863b1169],
28	'	POS	O	'	_	0	SENT_433	[p23l1742t1139r1863b1169],
29	Chlp	JJ	O	chlp	dep	201	SENT_433	[p23l1742t1139r1863b1169],
30	technology	NN	O	technology	dep	201	SENT_433	[p23l1878t1139r2025b1169],
31	’	NN	O	’	dep	201	SENT_433	[p23l1878t1139r2025b1169],
32	11	CD	NUMBER	11	dep	201	SENT_433	[p23l2041t1139r2066b1162],
33	'	''	O	'	_	0	SENT_433	[p23l2041t1139r2066b1162],
34	'	''	O	'	_	0	SENT_433	[p23l901t1175r906b1179],
35	ll	NN	O	ll	dep	201	SENT_433	[p23l1408t1177r1424b1199],
36	‘	NN	O	‘	dep	201	SENT_433	[p23l1460t1177r1464b1181],
37	'	''	O	'	_	0	SENT_433	[p23l1526t1177r1529b1181],
38	‘	CD	NUMBER	‘	dep	201	SENT_433	[p23l1622t1177r1626b1181],
39	h	NN	O	h	dep	201	SENT_433	[p23l1694t1177r1718b1199],
40	'	''	O	'	_	0	SENT_433	[p23l1694t1177r1718b1199],
41	h	NN	O	h	dep	201	SENT_433	[p23l1734t1177r1749b1199],
42	'	''	O	'	_	0	SENT_433	[p23l1871t1177r1874b1181],
43	l	NN	O	l	dep	201	SENT_433	[p23l1923t1177r1930b1199],
44	'	''	O	'	_	0	SENT_433	[p23l1986t1177r1989b1181],
45	h	NN	O	h	dep	201	SENT_433	[p23l2029t1177r2052b1199],
46	'	''	O	'	_	0	SENT_433	[p23l2029t1177r2052b1199],
47	that	WDT	O	that	dep	201	SENT_433	[p23l119t1195r173b1221],
48	were	VBD	O	be	dep	201	SENT_433	[p23l183t1204r248b1221],
49	deleted	VBN	O	delete	dep	201	SENT_433	[p23l259t1195r360b1221],
50	in	IN	O	in	dep	201	SENT_433	[p23l374t1198r395b1220],
51	the	DT	O	the	dep	201	SENT_433	[p23l407t1195r451b1221],
52	tumor	NN	O	tumor	dep	201	SENT_433	[p23l461t1200r548b1221],
53	(	NN	O	(	dep	201	SENT_433	[p23l561t1195r642b1228],
54	black	JJ	O	black	dep	201	SENT_433	[p23l561t1195r642b1228],
55	box	NN	O	box	dep	201	SENT_433	[p23l654t1195r709b1228],
56	)	NN	O	)	dep	201	SENT_433	[p23l654t1195r709b1228],
57	are	VBP	O	be	dep	201	SENT_433	[p23l723t1204r764b1221],
58	present	JJ	DATE	present	dep	201	SENT_433	[p23l776t1200r880b1228],
59	in	IN	O	in	dep	201	SENT_433	[p23l891t1198r913b1220],
60	the	DT	O	the	dep	201	SENT_433	[p23l925t1195r968b1221],
61	DNA	NN	MISC	dna	dep	201	SENT_433	[p23l982t1197r1048b1220],
62	in	IN	O	in	dep	201	SENT_433	[p23l1059t1198r1081b1220],
63	the	DT	O	the	dep	201	SENT_433	[p23l1093t1195r1136b1221],
64	censed	VBN	O	cense	dep	201	SENT_433	[p23l1243t1177r1330b1200],
65	to	TO	O	to	dep	201	SENT_433	[p23l1340t1182r1364b1200],
66	Ce	VB	MISC	ce	dep	201	SENT_433	[p23l1375t1179r1406b1200],
67	Pomt	NNP	MISC	Pomt	dep	201	SENT_433	[p23l1426t1179r1494b1200],
68	Diagnostics	NNPS	MISC	Diagnostics	dep	201	SENT_433	[p23l1502t1179r1661b1206],
69	’	NNP	O	’	dep	201	SENT_433	[p23l1502t1179r1661b1206],
70	W	NNP	O	W	dep	201	SENT_433	[p23l1671t1185r1694b1200],
71	1C	NN	O	1c	dep	201	SENT_433	[p23l1712t1184r1732b1200],
72	was	VBD	O	be	dep	201	SENT_433	[p23l1758t1184r1807b1200],
73	not	RB	O	not	dep	201	SENT_433	[p23l1818t1182r1860b1200],
74	mm	NN	O	mm	dep	201	SENT_433	[p23l1869t1184r1922b1200],
75	Ved	NNP	O	Ved	dep	201	SENT_433	[p23l1931t1177r1973b1200],
76	In	IN	O	in	dep	201	SENT_433	[p23l1984t1184r2008b1199],
77	t	NN	O	t	dep	201	SENT_433	[p23l2019t1182r2028b1200],
78	ls	NNS	O	l	dep	201	SENT_433	[p23l2047t1184r2066b1200],
79	_	VBP	O	_	dep	201	SENT_433	[p23l678t1240r682b1243],
80	_	CD	NUMBER	_	dep	201	SENT_433	[p23l800t1240r804b1243],
81	_	CD	NUMBER	_	dep	201	SENT_433	[p23l854t1240r857b1243],
82	_	NN	O	_	dep	201	SENT_433	[p23l968t1240r971b1243],
83	study	NN	O	study	dep	201	SENT_433	[p23l1244t1214r1318b1244],
84	;	:	O	;	_	0	SENT_433	[p23l1244t1214r1318b1244],
85	Drs.	NNP	O	Drs.	dep	201	SENT_433	[p23l1332t1216r1384b1237],
86	Tompkins	NNP	PERSON	Tompkins	dep	201	SENT_433	[p23l1398t1214r1534b1244],
87	,	,	O	,	_	0	SENT_433	[p23l1398t1214r1534b1244],
88	Toner	NNP	PERSON	Toner	dep	201	SENT_433	[p23l1548t1216r1628b1242],
89	,	,	O	,	_	0	SENT_433	[p23l1548t1216r1628b1242],
90	and	CC	O	and	dep	201	SENT_433	[p23l1643t1214r1689b1237],
91	Haber	NNP	PERSON	Haber	dep	201	SENT_433	[p23l1703t1214r1787b1242],
92	,	,	O	,	_	0	SENT_433	[p23l1703t1214r1787b1242],
93	receiving	VBG	O	receive	dep	201	SENT_433	[p23l1802t1215r1918b1244],
94	consulting	NN	O	consulting	dep	201	SENT_433	[p23l1931t1214r2068b1244],
95	CTCs	NNS	O	ctc	dep	201	SENT_433	[p23l120t1239r192b1262],
96	(	VBP	O	(	dep	201	SENT_433	[p23l207t1237r258b1270],
97	red	JJ	O	red	dep	201	SENT_433	[p23l207t1237r258b1270],
98	box	NN	O	box	dep	201	SENT_433	[p23l272t1237r336b1270],
99	)	NN	O	)	dep	201	SENT_433	[p23l272t1237r336b1270],
100	,	,	O	,	_	0	SENT_433	[p23l272t1237r336b1270],
101	whereas	IN	O	whereas	dep	201	SENT_433	[p23l348t1237r462b1262],
102	the	DT	O	the	dep	201	SENT_433	[p23l473t1237r516b1262],
103	15-nucleotide	JJ	O	15-nucleotide	dep	201	SENT_433	[p23l529t1237r717b1262],
104	deletion	NN	O	deletion	dep	201	SENT_433	[p23l729t1237r840b1262],
105	In	IN	O	in	dep	201	SENT_433	[p23l854t1246r875b1262],
106	DNA	NN	MISC	dna	dep	201	SENT_433	[p23l890t1239r956b1262],
107	In	IN	O	in	dep	201	SENT_433	[p23l968t1246r989b1262],
108	the	DT	O	the	dep	201	SENT_433	[p23l1001t1237r1045b1262],
109	CTCs	NNS	MISC	ctc	dep	201	SENT_433	[p23l1056t1239r1128b1262],
110	fees	NNS	O	fee	dep	201	SENT_433	[p23l1243t1252r1292b1275],
111	from	IN	O	from	dep	201	SENT_433	[p23l1305t1252r1367b1275],
112	Ceupomt	NNP	ORGANIZATION	Ceupomt	dep	201	SENT_433	[p23l1379t1252r1498b1275],
113	Diagnostics	NNPS	ORGANIZATION	Diagnostics	dep	201	SENT_433	[p23l1508t1252r1666b1281],
114	;	:	O	;	_	0	SENT_433	[p23l1508t1252r1666b1281],
115	and	CC	O	and	dep	201	SENT_433	[p23l1679t1252r1726b1275],
116	Dr.	NNP	O	Dr.	dep	201	SENT_433	[p23l1738t1254r1775b1275],
117	Lynch	NNP	PERSON	Lynch	dep	201	SENT_433	[p23l1789t1252r1871b1281],
118	’	CD	NUMBER	’	dep	201	SENT_433	[p23l1789t1252r1871b1281],
119	receiving	VBG	O	receive	dep	201	SENT_433	[p23l1885t1252r2001b1281],
120	com	NN	O	com	dep	201	SENT_433	[p23l2012t1259r2067b1275],
121	(	CD	NUMBER	(	dep	201	SENT_433	[p23l123t1279r203b1312],
122	black	JJ	O	black	dep	201	SENT_433	[p23l123t1279r203b1312],
123	b	NN	O	b	dep	201	SENT_433	[p23l215t1279r271b1312],
124	°	NN	O	°	dep	201	SENT_433	[p23l215t1279r271b1312],
125	X	NN	O	x	dep	201	SENT_433	[p23l215t1279r271b1312],
126	)	NN	O	)	dep	201	SENT_433	[p23l215t1279r271b1312],
127	ls	VBZ	O	l	dep	201	SENT_433	[p23l286t1281r305b1304],
128	Presem	NNP	O	Presem	dep	201	SENT_433	[p23l319t1284r421b1312],
129	l	NN	O	l	dep	201	SENT_433	[p23l433t1281r455b1304],
130	"	''	O	"	dep	201	SENT_433	[p23l433t1281r455b1304],
131	the	DT	O	the	dep	201	SENT_433	[p23l467t1279r510b1304],
132	t	NN	O	t	dep	201	SENT_433	[p23l521t1284r607b1304],
133	”	NN	O	”	dep	201	SENT_433	[p23l521t1284r607b1304],
134	m	NN	O	m	dep	201	SENT_433	[p23l521t1284r607b1304],
135	°	CD	NUMBER	°	dep	201	SENT_433	[p23l521t1284r607b1304],
136	r	NN	O	r	dep	201	SENT_433	[p23l521t1284r607b1304],
137	DNA	NN	O	dna	dep	201	SENT_433	[p23l620t1281r685b1304],
138	(	NN	O	(	dep	201	SENT_433	[p23l699t1279r750b1312],
139	red	JJ	O	red	dep	201	SENT_433	[p23l699t1279r750b1312],
140	b	NN	O	b	dep	201	SENT_433	[p23l764t1279r828b1312],
141	°	NN	O	°	dep	201	SENT_433	[p23l764t1279r828b1312],
142	X	NN	O	x	dep	201	SENT_433	[p23l764t1279r828b1312],
143	)	SYM	O	)	dep	201	SENT_433	[p23l764t1279r828b1312],
144	-	:	O	-	_	0	SENT_433	[p23l764t1279r828b1312],
145	The	DT	O	the	dep	201	SENT_433	[p23l839t1279r891b1304],
146	t	NN	O	t	dep	201	SENT_433	[p23l901t1281r998b1312],
147	"	''	O	"	dep	201	SENT_433	[p23l901t1281r998b1312],
148	aCl	NN	O	acl	dep	201	SENT_433	[p23l901t1281r998b1312],
149	"	''	O	"	dep	201	SENT_433	[p23l901t1281r998b1312],
150	‘	CD	NUMBER	‘	dep	201	SENT_433	[p23l901t1281r998b1312],
151	g	NN	O	g	dep	201	SENT_433	[p23l901t1281r998b1312],
152	°	FW	O	°	dep	201	SENT_433	[p23l1009t1279r1038b1304],
153	f	FW	O	f	dep	201	SENT_433	[p23l1009t1279r1038b1304],
154	CTC5	NN	O	ctc5	dep	201	SENT_433	[p23l1045t1281r1117b1304],
155	rep	NN	O	rep	dep	201	SENT_433	[p23l1131t1288r1183b1312],
156	‘	CD	NUMBER	‘	dep	201	SENT_433	[p23l1131t1288r1183b1312],
157	sulting	JJ	O	sulting	dep	201	SENT_433	[p23l1244t1289r1333b1319],
158	fees	NNS	O	fee	dep	201	SENT_433	[p23l1341t1289r1390b1312],
159	from	IN	O	from	dep	201	SENT_433	[p23l1399t1289r1461b1312],
160	Astraleneca	NNP	LOCATION	Astraleneca	dep	201	SENT_433	[p23l1469t1291r1635b1317],
161	,	,	O	,	_	0	SENT_433	[p23l1469t1291r1635b1317],
162	Genentech	NNP	ORGANIZATION	Genentech	dep	201	SENT_433	[p23l1645t1289r1789b1317],
163	,	,	O	,	_	0	SENT_433	[p23l1645t1289r1789b1317],
164	OSI	NNP	ORGANIZATION	OSI	dep	201	SENT_433	[p23l1799t1291r1844b1312],
165	Pharma	NNP	ORGANIZATION	Pharma	dep	201	SENT_433	[p23l1852t1289r1958b1317],
166	,	,	O	,	_	0	SENT_433	[p23l1852t1289r1958b1317],
167	Chugai	NNP	ORGANIZATION	Chugai	dep	201	SENT_433	[p23l1968t1289r2065b1319],
168	,	,	O	,	_	0	SENT_433	[p23l1968t1289r2065b1319],
169	resents	VBZ	O	resent	dep	201	SENT_433	[p23l121t1325r220b1346],
170	direct	JJ	O	direct	dep	201	SENT_433	[p23l232t1320r311b1346],
171	nucleotide	NN	O	nucleotide	dep	201	SENT_433	[p23l323t1320r468b1346],
172	sequencing	NN	O	sequencing	dep	201	SENT_433	[p23l479t1323r638b1354],
173	of	IN	O	of	dep	201	SENT_433	[p23l649t1320r679b1346],
174	DNA	NN	O	dna	dep	201	SENT_433	[p23l687t1322r753b1345],
175	lysed	VBN	O	lyse	dep	201	SENT_433	[p23l765t1320r832b1353],
176	from	IN	O	from	dep	201	SENT_433	[p23l844t1320r909b1346],
177	cells	NNS	O	cell	dep	201	SENT_433	[p23l922t1320r981b1346],
178	captured	VBN	O	capture	dep	201	SENT_433	[p23l993t1320r1114b1353],
179	on	IN	O	on	dep	201	SENT_433	[p23l1126t1329r1159b1346],
180	and	CC	O	and	dep	201	SENT_433	[p23l1243t1327r1290b1350],
181	Roche	NNP	PERSON	Roche	dep	201	SENT_433	[p23l1304t1327r1390b1351],
182	,	,	O	,	_	0	SENT_433	[p23l1304t1327r1390b1351],
183	No	NNP	O	No	dep	201	SENT_433	[p23l1405t1329r1441b1350],
184	other	JJ	O	other	dep	201	SENT_433	[p23l1456t1327r1524b1350],
185	potential	JJ	O	potential	dep	201	SENT_433	[p23l1537t1327r1652b1356],
186	eonﬂiet	NN	O	eonﬂiet	dep	201	SENT_433	[p23l1667t1327r1767b1350],
187	of	IN	O	of	dep	201	SENT_433	[p23l1780t1327r1809b1350],
188	interest	NN	O	interest	dep	201	SENT_433	[p23l1818t1327r1915b1350],
189	televant	NN	O	televant	dep	201	SENT_433	[p23l1928t1327r2030b1350],
190	to	TO	O	to	dep	201	SENT_433	[p23l2042t1332r2067b1350],
191	the	DT	O	the	dep	201	SENT_433	[p23l119t1362r162b1387],
192	CTC-chip	NN	MISC	ctc-chip	dep	201	SENT_433	[p23l174t1362r307b1395],
193	,	,	O	,	_	0	SENT_433	[p23l174t1362r307b1395],
194	indicating	VBG	O	indicate	dep	201	SENT_433	[p23l321t1362r458b1395],
195	a	DT	O	a	dep	201	SENT_433	[p23l469t1371r481b1387],
196	high	JJ	O	high	dep	201	SENT_433	[p23l494t1362r551b1395],
197	degree	NN	O	degree	dep	201	SENT_433	[p23l564t1362r657b1395],
198	of	IN	O	of	dep	201	SENT_433	[p23l668t1362r698b1387],
199	captured	VBN	O	capture	dep	201	SENT_433	[p23l705t1362r826b1395],
200	tumor-cell	JJ	O	tumor-cell	dep	201	SENT_433	[p23l837t1362r978b1387],
201	purity	NN	O	purity	_	0	SENT_433	[p23l993t1365r1077b1395],
202	.	.	O	.	_	0	SENT_433	[p23l993t1365r1077b1395],

1	this	DT	O	this	det	2	SENT_434	[p23l1243t1364r1291b1387],
2	article	NN	O	article	nsubjpass	4	SENT_434	[p23l1301t1364r1381b1387],
3	was	VBD	O	be	auxpass	4	SENT_434	[p23l1389t1372r1437b1387],
4	reported	VBN	O	report	_	0	SENT_434	[p23l1448t1364r1564b1394],
5	.	.	O	.	_	0	SENT_434	[p23l1448t1364r1564b1394],

1	We	PRP	O	we	nsubj	2	SENT_435	[p23l1275t1404r1315b1425],
2	thank	VBP	O	thank	_	0	SENT_435	[p23l1325t1402r1401b1425],
3	the	DT	O	the	det	4	SENT_435	[p23l1409t1402r1449b1425],
4	patients	NNS	O	patient	dobj	2	SENT_435	[p23l1458t1402r1560b1431],
5	for	IN	O	for	_	0	SENT_435	[p23l1571t1402r1607b1425],
6	their	PRP$	O	they	poss	7	SENT_435	[p23l1616t1402r1677b1425],
7	participation	NN	O	participation	prep_for	2	SENT_435	[p23l1686t1402r1852b1431],
8	in	IN	O	in	_	0	SENT_435	[p23l1861t1402r1886b1424],
9	the	DT	O	the	det	10	SENT_435	[p23l1896t1402r1935b1425],
10	study	NN	O	study	prep_in	7	SENT_435	[p23l1946t1402r2018b1431],
11	.	.	O	.	_	0	SENT_435	[p23l1946t1402r2018b1431],

1	REFERENCES	NNS	O	reference	_	0	SENT_436	[p23l19t1599r682b1660],

1	1	LS	NUMBER	1	_	0	SENT_437	[p23l15t1778r90b1857],
2	.	.	O	.	_	0	SENT_437	[p23l15t1778r90b1857],

1	Greenman	NNP	PERSON	Greenman	nn	2	SENT_438	[p23l209t1774r744b1857],
2	C	NNP	PERSON	C	_	0	SENT_438	[p23l787t1774r884b1877],
3	,	,	O	,	_	0	SENT_438	[p23l787t1774r884b1877],
4	Stephens	NNP	PERSON	Stephens	nn	5	SENT_438	[p23l935t1768r1385b1883],
5	P	NN	PERSON	p	appos	2	SENT_438	[p23l1428t1774r1506b1877],
6	,	,	O	,	_	0	SENT_438	[p23l1428t1774r1506b1877],
7	Smith	NNP	PERSON	Smith	nn	8	SENT_438	[p23l1559t1768r1854b1857],
8	R	NNP	O	R	appos	2	SENT_438	[p23l1896t1774r1997b1877],
9	,	,	O	,	_	0	SENT_438	[p23l1896t1774r1997b1877],
10	et	FW	O	et	nn	11	SENT_438	[p23l2048t1786r2138b1857],
11	al.	FW	O	al.	appos	2	SENT_438	[p23l11t1914r124b2005],
12	.	.	O	.	_	0	SENT_438	[p23l11t1914r124b2005],

1	Patterns	NN	O	pattern	_	0	SENT_439	[p23l193t1922r605b2005],
2	of	IN	O	of	_	0	SENT_439	[p23l672t1914r789b2005],
3	somatic	JJ	O	somatic	amod	4	SENT_439	[p23l831t1916r1226b2005],
4	mutation	NN	O	mutation	prep_of	1	SENT_439	[p23l1288t1916r1748b2005],
5	in	IN	O	in	_	0	SENT_439	[p23l1810t1916r1908b2003],
6	human	JJ	O	human	prep_in	1	SENT_439	[p23l1970t1914r2131b2005, p23l11t2093r235b2154],

1	cancer	NN	O	cancer	nn	2	SENT_440	[p23l300t2093r629b2154],
2	genomes	NNS	O	genome	_	0	SENT_440	[p23l690t2093r1167b2180],
3	.	.	O	.	_	0	SENT_440	[p23l690t2093r1167b2180],

1	Nature	NNP	O	Nature	_	0	SENT_441	[p23l1236t2073r1581b2154],
2	2007	CD	DATE	2007	num	1	SENT_441	[p23l1646t2071r2127b2172],
3	;	:	O	;	_	0	SENT_441	[p23l1646t2071r2127b2172],
4	446	CD	NUMBER	446	dep	1	SENT_441	[p23l1646t2071r2127b2172],
5	:	:	O	:	_	0	SENT_441	[p23l1646t2071r2127b2172],

1	2	LS	NUMBER	2	_	0	SENT_442	[p23l9t2372r92b2451],
2	.	.	O	.	_	0	SENT_442	[p23l9t2372r92b2451],

1	Papadopoulos	NNP	PERSON	Papadopoulos	nn	2	SENT_443	[p23l207t2360r914b2475],
2	N	NNP	O	N	_	0	SENT_443	[p23l1005t2370r1114b2471],
3	,	,	O	,	_	0	SENT_443	[p23l1005t2370r1114b2471],
4	Kinzler	NNP	PERSON	Kinzler	nn	5	SENT_443	[p23l1209t2360r1583b2453],
5	KW	NNP	O	KW	appos	2	SENT_443	[p23l1670t2370r1872b2471],
6	,	,	O	,	_	0	SENT_443	[p23l1670t2370r1872b2471],
7	Vogelstein	NNP	PERSON	Vogelstein	nn	10	SENT_443	[p23l1965t2368r2131b2451, p23l11t2509r407b2626],
8	B.	NNP	O	B.	nn	10	SENT_443	[p23l460t2517r554b2600],
9	The	NNP	O	The	nn	10	SENT_443	[p23l613t2509r801b2600],
10	role	NN	O	role	appos	2	SENT_443	[p23l856t2509r1044b2600],
11	of	IN	O	of	_	0	SENT_443	[p23l1101t2509r1217b2600],
12	companion	NN	O	companion	nn	13	SENT_443	[p23l1252t2511r1821b2624],
13	diagnostics	NNS	O	diagnostic	prep_of	10	SENT_443	[p23l1878t2509r2131b2626, p23l11t2660r365b2749],
14	in	IN	O	in	_	0	SENT_443	[p23l438t2660r536b2747],
15	the	DT	O	the	det	16	SENT_443	[p23l607t2658r763b2749],
16	development	NN	O	development	prep_in	13	SENT_443	[p23l835t2658r1480b2773],
17	and	CC	O	and	_	0	SENT_443	[p23l1545t2658r1730b2749],
18	use	NN	O	use	prep_in	13	SENT_443	[p23l1800t2688r1965b2749],
19	of	IN	O	of	_	0	SENT_443	[p23l2038t2658r2153b2749],
20	mutation	NN	O	mutation	prep_of	16	SENT_443	[p23l11t2807r934b2924],
21	—	CD	NUMBER	—	num	20	SENT_443	[p23l11t2807r934b2924],
22	targeted	VBN	O	target	partmod	20	SENT_443	[p23l11t2807r934b2924],
23	cancer	NN	O	cancer	nn	24	SENT_443	[p23l1003t2837r1332b2898],
24	therapies	NNS	O	therapy	dobj	22	SENT_443	[p23l1397t2807r1886b2922],
25	.	.	O	.	_	0	SENT_443	[p23l1397t2807r1886b2922],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_444	[p23l1957t2817r2139b2898],
2	Biotechnol	NNP	PERSON	Biotechnol	_	0	SENT_444	[p23l9t2956r553b3047],
3	2006	CD	DATE	2006	num	2	SENT_444	[p23l593t2964r1391b3065],
4	;	:	O	;	_	0	SENT_444	[p23l593t2964r1391b3065],
5	24:985	CD	NUMBER	24:985	number	6	SENT_444	[p23l593t2964r1391b3065],
6	—	CD	NUMBER	—	dep	2	SENT_444	[p23l593t2964r1391b3065],
7	95	CD	NUMBER	95	dep	6	SENT_444	[p23l593t2964r1391b3065],
8	.	.	O	.	_	0	SENT_444	[p23l593t2964r1391b3065],

1	3	LS	NUMBER	3	_	0	SENT_445	[p23l11t3116r88b3195],
2	.	.	O	.	_	0	SENT_445	[p23l11t3116r88b3195],

1	Ashworth	NNP	PERSON	Ashworth	_	0	SENT_446	[p23l205t3104r702b3195],
2	TR	NN	O	tr	dep	1	SENT_446	[p23l773t3112r949b3201],
3	.	.	O	.	_	0	SENT_446	[p23l773t3112r949b3201],

1	A	DT	O	a	det	2	SENT_447	[p23l1027t3114r1104b3193],
2	case	NN	O	case	_	0	SENT_447	[p23l1177t3134r1387b3195],
3	of	IN	O	of	_	0	SENT_447	[p23l1464t3104r1579b3195],
4	cancer	NN	O	cancer	prep_of	2	SENT_447	[p23l1634t3134r1965b3195],
5	in	IN	O	in	_	0	SENT_447	[p23l2036t3106r2133b3193],
6	which	WDT	O	which	rel	15	SENT_447	[p23l7t3252r314b3343],
7	cells	NNS	O	cell	nsubjpass	15	SENT_447	[p23l351t3252r571b3343],
8	similar	JJ	O	similar	amod	7	SENT_447	[p23l611t3252r971b3343],
9	to	TO	O	to	_	0	SENT_447	[p23l1004t3272r1098b3343],
10	those	DT	O	those	prep_to	8	SENT_447	[p23l1137t3252r1409b3343],
11	in	IN	O	in	_	0	SENT_447	[p23l1444t3254r1541b3341],
12	the	DT	O	the	det	13	SENT_447	[p23l1577t3252r1733b3343],
13	tumors	NNS	O	tumor	prep_in	10	SENT_447	[p23l1769t3272r2129b3343],
14	were	VBD	O	be	auxpass	15	SENT_447	[p23l7t3430r243b3491],
15	seen	VBN	O	see	rcmod	4	SENT_447	[p23l296t3430r516b3491],
16	in	IN	O	in	_	0	SENT_447	[p23l567t3402r665b3489],
17	the	DT	O	the	det	18	SENT_447	[p23l717t3400r872b3491],
18	blood	NN	O	blood	prep_in	15	SENT_447	[p23l925t3400r1209b3491],
19	after	IN	O	after	_	0	SENT_447	[p23l1260t3400r1498b3491],
20	death	NN	O	death	prep_after	15	SENT_447	[p23l1547t3400r1854b3491],
21	.	.	O	.	_	0	SENT_447	[p23l1547t3400r1854b3491],

1	Aust	IN	O	aust	_	0	SENT_448	[p23l1907t3410r2139b3491],

1	Med	VBN	O	med	_	0	SENT_449	[p23l9t3549r296b3654],
2	]	CD	NUMBER	]	num	3	SENT_449	[p23l9t3549r296b3654],
3	1869	CD	DATE	1869	dobj	1	SENT_449	[p23l337t3557r959b3658],
4	;	:	O	;	_	0	SENT_449	[p23l337t3557r959b3658],
5	14:146	CD	NUMBER	14:146	dep	3	SENT_449	[p23l337t3557r959b3658],
6	.	.	O	.	_	0	SENT_449	[p23l337t3557r959b3658],

1	4	LS	NUMBER	4	_	0	SENT_450	[p24l9t39r90b118],
2	.	.	O	.	_	0	SENT_450	[p24l9t39r90b118],

1	Zieglschmid	NNP	O	Zieglschmid	nn	2	SENT_451	[p24l207t27r835b144],
2	V	NNP	O	V	_	0	SENT_451	[p24l890t37r975b138],
3	,	,	O	,	_	0	SENT_451	[p24l890t37r975b138],
4	Hollmann	NNP	PERSON	Hollmann	nn	5	SENT_451	[p24l1042t27r1559b118],
5	C	NNP	O	C	appos	2	SENT_451	[p24l1620t35r1716b138],
6	,	,	O	,	_	0	SENT_451	[p24l1620t35r1716b138],
7	Bocher	NNP	PERSON	Bocher	nn	9	SENT_451	[p24l1782t27r2135b118],
8	o.	NNP	O	o.	nn	9	SENT_451	[p24l11t183r116b266],
9	Detection	NN	O	detection	appos	2	SENT_451	[p24l163t177r654b266],
10	of	IN	O	of	_	0	SENT_451	[p24l698t175r813b266],
11	disseminated	VBN	O	disseminate	amod	13	SENT_451	[p24l836t175r1514b266],
12	tumor	NN	O	tumor	nn	13	SENT_451	[p24l1557t195r1870b266],
13	cells	NNS	O	cell	prep_of	9	SENT_451	[p24l1909t175r2130b266],
14	in	IN	O	in	_	0	SENT_451	[p24l11t326r108b413],
15	peripheral	JJ	O	peripheral	amod	16	SENT_451	[p24l148t324r668b439],
16	blood	NN	O	blood	prep_in	13	SENT_451	[p24l712t324r1025b415],
17	.	.	O	.	_	0	SENT_451	[p24l712t324r1025b415],

1	Crit	NNP	O	Crit	_	0	SENT_452	[p24l1074t326r1262b415],
2	Rev	NN	O	rev	dep	1	SENT_452	[p24l1298t332r1482b421],
3	Clin	NNP	O	Clin	nn	5	SENT_452	[p24l1520t324r1727b415],
4	Lab	NNP	O	Lab	nn	5	SENT_452	[p24l1769t324r1947b415],
5	Sci	NNP	O	Sci	dep	1	SENT_452	[p24l1994t326r2133b415],

1	5	CD	NUMBER	5	_	0	SENT_453	[p24l13t634r88b713],
2	.	.	O	.	_	0	SENT_453	[p24l13t634r88b713],

1	Allard	NNP	PERSON	Allard	nn	3	SENT_454	[p24l205t622r520b713],
2	W	NNP	O	W	nn	3	SENT_454	[p24l563t630r736b733],
3	]	NN	O	]	_	0	SENT_454	[p24l563t630r736b733],
4	,	,	O	,	_	0	SENT_454	[p24l563t630r736b733],
5	Matera	NNP	PERSON	Matera	nn	6	SENT_454	[p24l785t632r1136b713],
6	J	NNP	PERSON	J	appos	3	SENT_454	[p24l1169t630r1235b733],
7	,	,	O	,	_	0	SENT_454	[p24l1169t630r1235b733],
8	Miller	NNP	PERSON	Miller	nn	9	SENT_454	[p24l1284t622r1591b713],
9	MC	NNP	O	MC	appos	3	SENT_454	[p24l1629t630r1829b733],
10	,	,	O	,	_	0	SENT_454	[p24l1629t630r1829b733],
11	et	FW	O	et	nn	12	SENT_454	[p24l1882t642r1973b713],
12	al.	FW	O	al.	appos	3	SENT_454	[p24l2012t622r2126b713],
13	.	.	O	.	_	0	SENT_454	[p24l2012t622r2126b713],

1	Tumor	NN	O	tumor	nn	2	SENT_455	[p24l7t779r346b862],
2	cells	NNS	O	cell	nsubj	3	SENT_455	[p24l416t771r636b862],
3	circulate	VBP	O	circulate	_	0	SENT_455	[p24l712t771r1144b862],
4	in	IN	O	in	_	0	SENT_455	[p24l1216t773r1314b860],
5	the	DT	O	the	det	7	SENT_455	[p24l1387t771r1541b862],
6	peripheral	JJ	O	peripheral	amod	7	SENT_455	[p24l1612t771r2133b886],
7	blood	NN	O	blood	prep_in	3	SENT_455	[p24l13t920r296b1011],
8	of	IN	O	of	_	0	SENT_455	[p24l344t920r461b1011],
9	all	DT	O	all	det	11	SENT_455	[p24l486t920r609b1011],
10	major	JJ	O	major	amod	11	SENT_455	[p24l654t922r948b1035],
11	carcinomas	NNS	O	carcinoma	prep_of	7	SENT_455	[p24l993t922r1573b1011],
12	but	CC	O	but	_	0	SENT_455	[p24l1622t920r1787b1011],
13	not	RB	O	not	_	0	SENT_455	[p24l1828t940r1995b1011],
14	in	IN	O	in	_	0	SENT_455	[p24l2036t922r2132b1009],
15	healthy	JJ	O	healthy	amod	16	SENT_455	[p24l11t1069r385b1184],
16	subjects	NNS	O	subject	conj_negcc	7	SENT_455	[p24l427t1069r827b1184],
17	or	CC	O	or	_	0	SENT_455	[p24l876t1099r979b1160],
18	patients	NNS	O	patient	conj_negcc	7	SENT_455	[p24l1021t1071r1423b1184],
19	with	IN	O	with	_	0	SENT_455	[p24l1468t1069r1696b1160],
20	nonmalignant	JJ	O	nonmalignant	amod	21	SENT_455	[p24l1741t1099r2131b1160, p24l11t1218r377b1335],
21	diseases	NNS	O	disease	prep_with	3	SENT_455	[p24l401t1218r846b1309],
22	.	.	O	.	_	0	SENT_455	[p24l401t1218r846b1309],

1	Clin	NNP	O	Clin	nn	3	SENT_456	[p24l882t1218r1090b1309],
2	Cancer	NNP	O	Cancer	nn	3	SENT_456	[p24l1119t1226r1470b1309],
3	Res	NNP	O	Res	_	0	SENT_456	[p24l1496t1226r1672b1315],
4	2004	CD	DATE	2004	num	3	SENT_456	[p24l1703t1226r2127b1327],
5	;	:	O	;	_	0	SENT_456	[p24l1703t1226r2127b1327],
6	10	CD	NUMBER	10	dep	3	SENT_456	[p24l1703t1226r2127b1327],
7	:	:	O	:	_	0	SENT_456	[p24l1703t1226r2127b1327],

1	6	CD	NUMBER	6	_	0	SENT_457	[p24l11t1527r91b1606],
2	.	.	O	.	_	0	SENT_457	[p24l11t1527r91b1606],

1	Cristofanilli	NNP	PERSON	Cristofanilli	nn	2	SENT_458	[p24l209t1515r825b1606],
2	M	NNP	O	M	_	0	SENT_458	[p24l866t1525r993b1626],
3	,	,	O	,	_	0	SENT_458	[p24l866t1525r993b1626],
4	Budd	NNP	PERSON	Budd	nn	5	SENT_458	[p24l1044t1515r1302b1606],
5	GT	NN	O	gt	appos	2	SENT_458	[p24l1349t1523r1520b1626],
6	,	,	O	,	_	0	SENT_458	[p24l1349t1523r1520b1626],
7	Ellis	NNP	PERSON	Ellis	nn	9	SENT_458	[p24l1571t1515r1789b1606],
8	M	NNP	O	M	nn	9	SENT_458	[p24l1834t1525r1995b1624],
9	]	NN	O	]	appos	2	SENT_458	[p24l1834t1525r1995b1624],
10	,	,	O	,	_	0	SENT_458	[p24l1834t1525r1995b1624],
11	et	FW	O	et	nn	12	SENT_458	[p24l2048t1535r2139b1606],
12	al.	FW	O	al.	appos	2	SENT_458	[p24l11t1664r124b1755],
13	.	.	O	.	_	0	SENT_458	[p24l11t1664r124b1755],

1	Circulating	VBG	O	circulate	_	0	SENT_459	[p24l189t1664r761b1781],
2	tumor	NN	O	tumor	nn	3	SENT_459	[p24l816t1684r1130b1755],
3	cells	NNS	O	cell	dobj	1	SENT_459	[p24l1185t1664r1435b1775],
4	,	,	O	,	_	0	SENT_459	[p24l1185t1664r1435b1775],
5	disease	NN	O	disease	nn	6	SENT_459	[p24l1500t1664r1864b1755],
6	progression	NN	O	progression	dobj	1	SENT_459	[p24l1921t1694r2131b1779, p24l11t1815r465b1930],
7	,	,	O	,	_	0	SENT_459	[p24l1921t1694r2131b1779, p24l11t1815r465b1930],
8	and	CC	O	and	_	0	SENT_459	[p24l504t1813r688b1904],
9	survival	NN	O	survival	dobj	1	SENT_459	[p24l721t1813r1112b1904],
10	in	IN	O	in	_	0	SENT_459	[p24l1143t1815r1239b1902],
11	metastatic	JJ	O	metastatic	amod	13	SENT_459	[p24l1272t1815r1797b1904],
12	breast	NN	O	breast	nn	13	SENT_459	[p24l1830t1813r2139b1904],
13	cancer	NN	O	cancer	prep_in	9	SENT_459	[p24l13t1992r364b2053],
14	.	.	O	.	_	0	SENT_459	[p24l13t1992r364b2053],

1	N	NN	O	n	nn	3	SENT_460	[p24l407t1972r494b2053],
2	Engl	NNP	O	Engl	nn	3	SENT_460	[p24l530t1962r757b2079],
3	J	NNP	O	J	nsubj	4	SENT_460	[p24l785t1972r829b2067],
4	Med	VBD	O	med	_	0	SENT_460	[p24l862t1962r1080b2053],
5	2004	CD	DATE	2004	dobj	4	SENT_460	[p24l1119t1970r1965b2071],
6	;	:	O	;	_	0	SENT_460	[p24l1119t1970r1965b2071],
7	351:781	CD	NUMBER	351:781	number	8	SENT_460	[p24l1119t1970r1965b2071],
8	—	CD	NUMBER	—	dep	5	SENT_460	[p24l1119t1970r1965b2071],
9	91	CD	NUMBER	91	dep	8	SENT_460	[p24l1119t1970r1965b2071],
10	.	.	O	.	_	0	SENT_460	[p24l1119t1970r1965b2071],

1	7	CD	NUMBER	7	_	0	SENT_461	[p24l13t2123r80b2202],
2	.	.	O	.	_	0	SENT_461	[p24l13t2123r80b2202],

1	Braun	NNP	PERSON	Braun	nn	2	SENT_462	[p24l207t2119r506b2202],
2	S	NNP	O	S	_	0	SENT_462	[p24l559t2119r637b2222],
3	,	,	O	,	_	0	SENT_462	[p24l559t2119r637b2222],
4	Marth	NNP	PERSON	Marth	nn	5	SENT_462	[p24l690t2111r1003b2202],
5	C.	NNP	O	C.	appos	2	SENT_462	[p24l1052t2119r1149b2202],
6	Circulating	VBG	O	circulate	partmod	5	SENT_462	[p24l1205t2111r1777b2228],
7	tumor	NN	O	tumor	nn	8	SENT_462	[p24l1822t2131r2135b2202],
8	cells	NNS	O	cell	dobj	6	SENT_462	[p24l13t2371r117b2415],
9	in	IN	O	in	_	0	SENT_462	[p24l136t2372r182b2415],
10	metastatic	JJ	O	metastatic	amod	12	SENT_462	[p24l199t2372r449b2415],
11	breast	NN	O	breast	nn	12	SENT_462	[p24l466t2371r613b2416],
12	cancer	NN	O	cancer	prep_in	6	SENT_462	[p24l628t2386r784b2415],
13	—	CD	NUMBER	—	dep	12	SENT_462	[p24l798t2397r858b2401],
14	toward	IN	O	toward	_	0	SENT_462	[p24l873t2371r1040b2416],
15	individualized	JJ	O	individualized	amod	16	SENT_462	[p24l13t2443r363b2488],
16	treatment	NN	O	treatment	prep_toward	13	SENT_462	[p24l393t2442r654b2487],
17	?	.	O	?	_	0	SENT_462	[p24l393t2442r654b2487],

1	N	NN	O	n	nn	3	SENT_463	[p24l683t2447r725b2488],
2	Engl	NNP	O	Engl	nn	3	SENT_463	[p24l753t2443r863b2500],
3	J	NNP	O	J	nsubj	4	SENT_463	[p24l887t2447r908b2494],
4	Med	VBD	O	med	_	0	SENT_463	[p24l935t2443r1040b2487],
5	2004	CD	DATE	2004	dobj	4	SENT_463	[p24l13t2519r401b2568],
6	;	:	O	;	_	0	SENT_463	[p24l13t2519r401b2568],
7	351:824	CD	NUMBER	351:824	num	8	SENT_463	[p24l13t2519r401b2568],
8	-6	CD	NUMBER	-6	dep	5	SENT_463	[p24l13t2519r401b2568],
9	.	.	O	.	_	0	SENT_463	[p24l13t2519r401b2568],

1	8	CD	NUMBER	8	_	0	SENT_464	[p24l12t2590r52b2630],
2	.	.	O	.	_	0	SENT_464	[p24l12t2590r52b2630],

1	Cristofanilli	NNP	PERSON	Cristofanilli	nn	2	SENT_465	[p24l109t2585r407b2630],
2	M	NNP	O	M	_	0	SENT_465	[p24l420t2589r481b2639],
3	,	,	O	,	_	0	SENT_465	[p24l420t2589r481b2639],
4	Hayes	NNP	PERSON	Hayes	nn	5	SENT_465	[p24l500t2589r643b2641],
5	DF	NNP	O	DF	appos	2	SENT_465	[p24l659t2589r737b2639],
6	,	,	O	,	_	0	SENT_465	[p24l659t2589r737b2639],
7	Budd	NNP	PERSON	Budd	nn	8	SENT_465	[p24l755t2585r880b2630],
8	GT	NN	O	gt	appos	2	SENT_465	[p24l896t2589r980b2639],
9	,	,	O	,	_	0	SENT_465	[p24l896t2589r980b2639],
10	et	FW	O	et	nn	11	SENT_465	[p24l999t2595r1042b2629],
11	al.	FW	O	al.	appos	2	SENT_465	[p24l13t2656r68b2700],
12	.	.	O	.	_	0	SENT_465	[p24l13t2656r68b2700],

1	Circulating	VBG	O	circulate	dep	8	SENT_466	[p24l94t2656r371b2713],
2	tumor	NN	O	tumor	nn	3	SENT_466	[p24l392t2665r544b2701],
3	cells	NNS	O	cell	dobj	1	SENT_466	[p24l566t2656r687b2700],
4	:	:	O	:	_	0	SENT_466	[p24l566t2656r687b2700],
5	a	DT	O	a	det	8	SENT_466	[p24l711t2671r736b2700],
6	novel	JJ	O	novel	amod	8	SENT_466	[p24l758t2656r886b2701],
7	prognostic	JJ	O	prognostic	amod	8	SENT_466	[p24l908t2670r1039b2713, p24l13t2728r160b2772],
8	factor	NN	O	factor	_	0	SENT_466	[p24l188t2727r331b2772],
9	for	IN	O	for	prep	8	SENT_466	[p24l357t2727r427b2772],
10	newly	RB	O	newly	pcomp	9	SENT_466	[p24l453t2727r595b2783],
11	diagnosed	VBN	O	diagnose	partmod	8	SENT_466	[p24l621t2727r874b2784],
12	metastatic	JJ	O	metastatic	amod	14	SENT_466	[p24l902t2736r1039b2771, p24l14t2799r144b2842],
13	breast	NN	O	breast	nn	14	SENT_466	[p24l175t2798r324b2843],
14	cancer	NN	O	cancer	dobj	11	SENT_466	[p24l353t2812r523b2842],
15	.	.	O	.	_	0	SENT_466	[p24l353t2812r523b2842],

1	J	NNP	O	J	nn	3	SENT_467	[p24l551t2802r572b2849],
2	Clin	NNP	O	Clin	nn	3	SENT_467	[p24l602t2798r702b2843],
3	Oncol	NNP	O	Oncol	_	0	SENT_467	[p24l733t2798r877b2843],
4	2005	CD	DATE	2005	num	3	SENT_467	[p24l908t2802r1038b2851],
5	;	:	O	;	_	0	SENT_467	[p24l908t2802r1038b2851],
6	23:1420	CD	NUMBER	23:1420	number	7	SENT_467	[p24l13t2874r291b2915],
7	-30	CD	NUMBER	-30	dep	3	SENT_467	[p24l13t2874r291b2915],
8	.	.	O	.	_	0	SENT_467	[p24l13t2874r291b2915],

1	[	NNP	O	[	_	0	SENT_468	[p24l321t2874r554b2924],
2	Erratum	NNP	O	Erratum	nn	6	SENT_468	[p24l321t2874r554b2924],
3	,	,	O	,	_	0	SENT_468	[p24l321t2874r554b2924],
4	J	NNP	O	J	appos	6	SENT_468	[p24l575t2874r596b2921],
5	Clin	NNP	O	Clin	nn	6	SENT_468	[p24l617t2870r718b2914],
6	Oncol	NNP	O	Oncol	dep	1	SENT_468	[p24l741t2870r885b2914],
7	2005	CD	DATE	2005	rcmod	6	SENT_468	[p24l908t2874r1038b2923],
8	;	:	O	;	_	0	SENT_468	[p24l908t2874r1038b2923],
9	23:4808	CD	NUMBER	23:4808	dep	7	SENT_468	[p24l13t2945r235b2992],
10	.	.	O	.	_	0	SENT_468	[p24l13t2945r235b2992],
11	]	SYM	O	]	dep	7	SENT_468	[p24l13t2945r235b2992],

1	9	CD	NUMBER	9	_	0	SENT_469	[p24l13t3016r50b3055],
2	.	.	O	.	_	0	SENT_469	[p24l13t3016r50b3055],

1	Smerage	JJ	O	smerage	amod	2	SENT_470	[p24l110t3015r316b3068],
2	JB	NN	O	jb	_	0	SENT_470	[p24l334t3015r403b3065],
3	,	,	O	,	_	0	SENT_470	[p24l334t3015r403b3065],
4	Hayes	NNP	PERSON	Hayes	nn	5	SENT_470	[p24l429t3015r573b3067],
5	DF	NNP	O	DF	appos	2	SENT_470	[p24l596t3015r675b3055],
6	.	.	O	.	_	0	SENT_470	[p24l596t3015r675b3055],

1	The	DT	O	the	det	5	SENT_471	[p24l700t3011r790b3055],
2	measurement	NN	O	measurement	nn	5	SENT_471	[p24l814t3026r1039b3056, p24l13t3092r138b3127],
3	and	CC	O	and	_	0	SENT_471	[p24l156t3083r245b3127],
4	therapeutic	JJ	O	therapeutic	nn	5	SENT_471	[p24l267t3083r544b3139],
5	implications	NNS	O	implication	_	0	SENT_471	[p24l564t3083r869b3139],
6	of	IN	O	of	_	0	SENT_471	[p24l892t3083r948b3127],
7	circulating	VBG	O	circulate	prepc_of	5	SENT_471	[p24l960t3084r1039b3127, p24l13t3153r215b3210],
8	tumour	NN	O	tumour	nn	9	SENT_471	[p24l233t3162r416b3198],
9	cells	NNS	O	cell	dobj	7	SENT_471	[p24l435t3153r542b3197],
10	in	IN	O	in	_	0	SENT_471	[p24l562t3154r609b3197],
11	breast	NN	O	breast	nn	12	SENT_471	[p24l629t3153r778b3197],
12	cancer	NN	O	cancer	prep_in	7	SENT_471	[p24l795t3168r965b3197],
13	.	.	O	.	_	0	SENT_471	[p24l795t3168r965b3197],

1	Br	NN	O	br	nn	3	SENT_472	[p24l987t3157r1041b3197],
2	J	NN	O	j	nn	3	SENT_472	[p24l7t3228r28b3275],
3	Cancer	NN	O	cancer	_	0	SENT_472	[p24l46t3228r216b3269],
4	2006	CD	DATE	2006	dep	3	SENT_472	[p24l234t3228r563b3277],
5	;	:	O	;	_	0	SENT_472	[p24l234t3228r563b3277],
6	94:8	CD	NUMBER	94:8	num	7	SENT_472	[p24l234t3228r563b3277],
7	-12	CD	NUMBER	-12	dep	3	SENT_472	[p24l234t3228r563b3277],
8	.	.	O	.	_	0	SENT_472	[p24l234t3228r563b3277],

1	10	CD	NUMBER	10	_	0	SENT_473	[p24l15t3300r77b3340],
2	.	.	O	.	_	0	SENT_473	[p24l15t3300r77b3340],

1	Smirnov	NNP	PERSON	Smirnov	nn	2	SENT_474	[p24l110t3296r315b3340],
2	DA	NNP	PERSON	DA	_	0	SENT_474	[p24l334t3299r421b3349],
3	,	,	O	,	_	0	SENT_474	[p24l334t3299r421b3349],
4	Zweitzig	NNP	O	Zweitzig	nn	5	SENT_474	[p24l445t3296r653b3352],
5	DR	NN	O	dr	appos	2	SENT_474	[p24l673t3299r761b3349],
6	,	,	O	,	_	0	SENT_474	[p24l673t3299r761b3349],
7	Foulk	NN	PERSON	foulk	nn	8	SENT_474	[p24l786t3295r926b3340],
8	BW	NN	O	bw	appos	2	SENT_474	[p24l944t3299r1037b3349],
9	,	,	O	,	_	0	SENT_474	[p24l944t3299r1037b3349],
10	et	FW	O	et	nn	11	SENT_474	[p24l13t3375r57b3410],
11	al.	FW	O	al.	appos	2	SENT_474	[p24l75t3366r130b3410],
12	.	.	O	.	_	0	SENT_474	[p24l75t3366r130b3410],

1	Global	JJ	O	global	amod	4	SENT_475	[p24l155t3366r317b3411],
2	gene	NN	O	gene	nn	4	SENT_475	[p24l337t3380r450b3423],
3	expression	NN	O	expression	nn	4	SENT_475	[p24l472t3367r732b3422],
4	profiling	NN	O	profiling	_	0	SENT_475	[p24l752t3366r974b3423],
5	of	IN	O	of	_	0	SENT_475	[p24l994t3366r1050b3411],
6	circulating	VBG	O	circulate	prepc_of	4	SENT_475	[p24l13t3437r280b3494],
7	tumor	NN	O	tumor	nn	8	SENT_475	[p24l298t3446r450b3482],
8	cells	NNS	O	cell	dobj	6	SENT_475	[p24l469t3437r590b3481],
9	.	.	O	.	_	0	SENT_475	[p24l469t3437r590b3481],

1	Cancer	NNP	O	Cancer	nn	2	SENT_476	[p24l613t3441r783b3482],
2	Res	NNP	O	Res	_	0	SENT_476	[p24l801t3441r886b3484],
3	2005	CD	DATE	2005	num	2	SENT_476	[p24l908t3441r1038b3490],
4	;	:	O	;	_	0	SENT_476	[p24l908t3441r1038b3490],
5	65:4993	CD	NUMBER	65:4993	number	6	SENT_476	[p24l13t3512r254b3553],
6	-7	CD	NUMBER	-7	dep	2	SENT_476	[p24l13t3512r254b3553],
7	.	.	O	.	_	0	SENT_476	[p24l13t3512r254b3553],

1	11	CD	NUMBER	11	_	0	SENT_477	[p24l15t3585r77b3623],
2	.	.	O	.	_	0	SENT_477	[p24l15t3585r77b3623],

1	Nagrath	NN	MISC	nagrath	nn	2	SENT_478	[p24l107t3579r308b3636],
2	S	NN	O	s	_	0	SENT_478	[p24l328t3583r366b3633],
3	,	,	O	,	_	0	SENT_478	[p24l328t3583r366b3633],
4	Sequist	NNP	O	Sequist	nn	5	SENT_478	[p24l388t3580r565b3635],
5	LV	NNP	O	LV	appos	2	SENT_478	[p24l579t3583r646b3633],
6	,	,	O	,	_	0	SENT_478	[p24l579t3583r646b3633],
7	Maheswaran	NNP	O	Maheswaran	nn	8	SENT_478	[p24l665t3579r979b3624],
8	S	NNP	O	S	appos	2	SENT_478	[p24l998t3583r1037b3633],
9	,	,	O	,	_	0	SENT_478	[p24l998t3583r1037b3633],
10	et	FW	O	et	nn	11	SENT_478	[p24l13t3659r57b3694],
11	al.	FW	O	al.	appos	2	SENT_478	[p24l74t3650r130b3695],
12	.	.	O	.	_	0	SENT_478	[p24l74t3650r130b3695],

1	Isolation	NN	O	isolation	_	0	SENT_479	[p24l153t3650r369b3695],
2	of	IN	O	of	_	0	SENT_479	[p24l389t3650r446b3695],
3	rare	JJ	O	rare	prep_of	1	SENT_479	[p24l456t3665r551b3694],
4	circulating	VBG	O	circulate	partmod	1	SENT_479	[p24l572t3650r838b3707],
5	tumour	NN	O	tumour	nn	6	SENT_479	[p24l858t3659r1041b3695],
6	cells	NNS	O	cell	dobj	4	SENT_479	[p24l13t3722r120b3766],
7	in	IN	O	in	_	0	SENT_479	[p24l137t3723r184b3766],
8	cancer	NN	O	cancer	nn	9	SENT_479	[p24l200t3736r360b3766],
9	patients	NNS	O	patient	prep_in	6	SENT_479	[p24l374t3723r568b3778],
10	by	IN	O	by	_	0	SENT_479	[p24l586t3722r641b3778],
11	microchip	NN	O	microchip	nn	13	SENT_479	[p24l655t3722r903b3778],
12	techclinical	JJ	O	techclinical	amod	13	SENT_479	[p24l920t3722r1039b3766, p24l1116t2371r1294b2415],
13	response	NN	O	response	agent	4	SENT_479	[p24l1312t2385r1529b2427],
14	to	TO	O	to	_	0	SENT_479	[p24l1547t2380r1593b2416],
15	gefitinib	NN	O	gefitinib	nn	16	SENT_479	[p24l1611t2371r1823b2428],
16	therapy	NN	O	therapy	prep_to	13	SENT_479	[p24l1842t2371r2033b2427],
17	.	.	O	.	_	0	SENT_479	[p24l1842t2371r2033b2427],

1	Science	NNP	O	Science	_	0	SENT_480	[p24l2056t2372r2141b2416, p24l1116t2457r1223b2487],
2	2004	CD	DATE	2004	num	1	SENT_480	[p24l1242t2447r1713b2497],
3	;	:	O	;	_	0	SENT_480	[p24l1242t2447r1713b2497],
4	304:1497	CD	NUMBER	304:1497	number	5	SENT_480	[p24l1242t2447r1713b2497],
5	-500	CD	NUMBER	-500	dep	1	SENT_480	[p24l1242t2447r1713b2497],
6	.	.	O	.	_	0	SENT_480	[p24l1242t2447r1713b2497],

1	14	CD	NUMBER	14	_	0	SENT_481	[p24l1117t2521r1182b2559],
2	.	.	O	.	_	0	SENT_481	[p24l1117t2521r1182b2559],

1	Pao	NNP	O	Pao	nn	2	SENT_482	[p24l1210t2519r1298b2559],
2	W	NNP	O	W	_	0	SENT_482	[p24l1322t2519r1384b2569],
3	,	,	O	,	_	0	SENT_482	[p24l1322t2519r1384b2569],
4	Miller	NNP	PERSON	Miller	nn	5	SENT_482	[p24l1410t2515r1565b2559],
5	V	NNP	O	V	appos	2	SENT_482	[p24l1586t2519r1629b2569],
6	,	,	O	,	_	0	SENT_482	[p24l1586t2519r1629b2569],
7	Zakowski	NNP	O	Zakowski	nn	8	SENT_482	[p24l1656t2515r1900b2560],
8	M	NNP	O	M	appos	2	SENT_482	[p24l1923t2519r1985b2569],
9	,	,	O	,	_	0	SENT_482	[p24l1923t2519r1985b2569],
10	et	FW	O	et	nn	11	SENT_482	[p24l2014t2525r2059b2559],
11	al.	FW	O	al.	appos	2	SENT_482	[p24l2081t2515r2139b2559],
12	.	.	O	.	_	0	SENT_482	[p24l2081t2515r2139b2559],

1	EGF	NN	ORGANIZATION	egf	nn	4	SENT_483	[p24l1114t2589r1216b2630],
2	receptor	NN	O	receptor	nn	4	SENT_483	[p24l1248t2594r1455b2641],
3	gene	NN	O	gene	nn	4	SENT_483	[p24l1484t2599r1598b2642],
4	mutations	NNS	O	mutation	nsubjpass	17	SENT_483	[p24l1629t2586r1882b2630],
5	are	VBP	O	be	cop	6	SENT_483	[p24l1913t2600r1987b2629],
6	common	JJ	O	common	_	0	SENT_483	[p24l2019t2599r2141b2630, p24l1115t2670r1225b2701],
7	in	IN	O	in	_	0	SENT_483	[p24l1249t2657r1297b2700],
8	lung	NN	O	lung	nn	9	SENT_483	[p24l1320t2656r1432b2713],
9	cancers	NNS	O	cancer	prep_in	6	SENT_483	[p24l1454t2671r1640b2700],
10	from	IN	O	from	_	0	SENT_483	[p24l1665t2656r1786b2701],
11	“	CD	NUMBER	“	prep_from	9	SENT_483	[p24l1812t2659r1970b2701],
12	never	RB	O	never	advmod	9	SENT_483	[p24l1812t2659r1970b2701],
13	smokers	NNS	O	smoker	dep	9	SENT_483	[p24l1993t2656r2142b2701, p24l1116t2731r1211b2771],
14	”	CD	NUMBER	”	tmod	6	SENT_483	[p24l1993t2656r2142b2701, p24l1116t2731r1211b2771],
15	and	CC	O	and	_	0	SENT_483	[p24l1250t2727r1341b2772],
16	are	VBP	O	be	auxpass	17	SENT_483	[p24l1377t2742r1452b2771],
17	associated	VBN	O	associate	conj_and	6	SENT_483	[p24l1488t2727r1750b2772],
18	with	IN	O	with	_	0	SENT_483	[p24l1783t2727r1896b2772],
19	sensitivity	NN	O	sensitivity	prep_with	17	SENT_483	[p24l1933t2728r2141b2772, p24l1115t2799r1177b2854],
20	of	IN	O	of	_	0	SENT_483	[p24l1202t2798r1259b2843],
21	tumors	NNS	O	tumor	prep_of	19	SENT_483	[p24l1275t2807r1452b2843],
22	to	TO	O	to	_	0	SENT_483	[p24l1479t2807r1525b2843],
23	gefitinib	NN	O	gefitinib	prep_to	17	SENT_483	[p24l1552t2798r1769b2855],
24	and	CC	O	and	_	0	SENT_483	[p24l1794t2798r1885b2843],
25	erlotinib	NN	O	erlotinib	conj_and	23	SENT_483	[p24l1911t2798r2139b2843],
26	.	.	O	.	_	0	SENT_483	[p24l1911t2798r2139b2843],

1	Proc	NNP	O	Proc	nn	7	SENT_484	[p24l1114t2874r1222b2914],
2	Natl	NNP	O	Natl	nn	7	SENT_484	[p24l1239t2870r1343b2914],
3	Acad	NNP	O	Acad	nn	7	SENT_484	[p24l1359t2870r1479b2914],
4	Sci	NNP	O	Sci	nn	7	SENT_484	[p24l1499t2871r1567b2914],
5	U	NNP	O	U	nn	7	SENT_484	[p24l1584t2874r1623b2914],
6	S	NNP	O	S	nn	7	SENT_484	[p24l1642t2874r1665b2914],
7	A	NNP	O	A	_	0	SENT_484	[p24l1683t2874r1720b2914],
8	2004	CD	DATE	2004	num	7	SENT_484	[p24l1737t2874r2141b2923, p24l1117t2945r1186b2985],
9	;	:	O	;	_	0	SENT_484	[p24l1737t2874r2141b2923, p24l1117t2945r1186b2985],
10	101	CD	NUMBER	101	num	12	SENT_484	[p24l1737t2874r2141b2923, p24l1117t2945r1186b2985],
11	:	:	O	:	_	0	SENT_484	[p24l1737t2874r2141b2923, p24l1117t2945r1186b2985],
12	l330611	CD	NUMBER	l330611	dep	7	SENT_484	[p24l1737t2874r2141b2923, p24l1117t2945r1186b2985],
13	.	.	O	.	_	0	SENT_484	[p24l1737t2874r2141b2923, p24l1117t2945r1186b2985],

1	15	CD	NUMBER	15	_	0	SENT_485	[p24l1117t3017r1179b3055],
2	.	.	O	.	_	0	SENT_485	[p24l1117t3017r1179b3055],

1	Sequist	NNP	O	Sequist	nn	2	SENT_486	[p24l1212t3012r1389b3067],
2	LV	NNP	O	LV	_	0	SENT_486	[p24l1409t3015r1476b3065],
3	,	,	O	,	_	0	SENT_486	[p24l1409t3015r1476b3065],
4	Bell	NNP	ORGANIZATION	Bell	nn	5	SENT_486	[p24l1501t3011r1594b3055],
5	DW	NNP	ORGANIZATION	DW	appos	2	SENT_486	[p24l1616t3015r1714b3065],
6	,	,	O	,	_	0	SENT_486	[p24l1616t3015r1714b3065],
7	Lynch	NNP	PERSON	Lynch	nn	9	SENT_486	[p24l1740t3011r1883b3067],
8	T	NN	O	t	nn	9	SENT_486	[p24l1905t3015r1968b3065],
9	]	NN	O	]	appos	2	SENT_486	[p24l1905t3015r1968b3065],
10	,	,	O	,	_	0	SENT_486	[p24l1905t3015r1968b3065],
11	Haber	NNP	ORGANIZATION	Haber	nn	12	SENT_486	[p24l1994t3011r2144b3056],
12	DA	NNP	ORGANIZATION	DA	appos	2	SENT_486	[p24l1114t3087r1201b3127],
13	.	.	O	.	_	0	SENT_486	[p24l1114t3087r1201b3127],

1	Molecular	JJ	O	molecular	amod	2	SENT_487	[p24l1230t3083r1477b3128],
2	predictors	NNS	O	predictor	_	0	SENT_487	[p24l1502t3083r1750b3139],
3	of	IN	O	of	_	0	SENT_487	[p24l1778t3083r1835b3127],
4	response	NN	O	response	prep_of	2	SENT_487	[p24l1852t3097r2068b3139],
5	to	TO	O	to	_	0	SENT_487	[p24l2096t3092r2142b3127],
6	epidermal	JJ	O	epidermal	amod	10	SENT_487	[p24l1116t3153r1361b3209],
7	growth	NN	O	growth	nn	10	SENT_487	[p24l1379t3153r1558b3210],
8	factor	NN	O	factor	nn	10	SENT_487	[p24l1576t3153r1719b3198],
9	receptor	NN	O	receptor	nn	10	SENT_487	[p24l1736t3162r1938b3209],
10	antagonists	NNS	O	antagonist	prep_to	2	SENT_487	[p24l1955t3163r2141b3210, p24l1115t3225r1230b3268],
11	in	IN	O	in	_	0	SENT_487	[p24l1250t3225r1297b3268],
12	non	JJ	O	non	amod	18	SENT_487	[p24l1316t3224r1670b3269],
13	—	JJ	O	—	amod	18	SENT_487	[p24l1316t3224r1670b3269],
14	small	JJ	O	small	amod	18	SENT_487	[p24l1316t3224r1670b3269],
15	—	NN	O	—	nn	18	SENT_487	[p24l1316t3224r1670b3269],
16	cell	NN	O	cell	nn	18	SENT_487	[p24l1316t3224r1670b3269],
17	lung	NN	O	lung	nn	18	SENT_487	[p24l1688t3224r1798b3281],
18	cancer	NN	O	cancer	prep_in	10	SENT_487	[p24l1816t3239r1986b3268],
19	.	.	O	.	_	0	SENT_487	[p24l1816t3239r1986b3268],

1	J	NNP	O	J	nn	3	SENT_488	[p24l2003t3228r2024b3275],
2	Clin	NNP	O	Clin	nn	3	SENT_488	[p24l2042t3224r2142b3269],
3	Oncol	NNP	O	Oncol	_	0	SENT_488	[p24l1115t3295r1259b3340],
4	2007	CD	DATE	2007	num	3	SENT_488	[p24l1278t3299r1657b3348],
5	;	:	O	;	_	0	SENT_488	[p24l1278t3299r1657b3348],
6	25:587	CD	NUMBER	25:587	number	7	SENT_488	[p24l1278t3299r1657b3348],
7	-95	CD	NUMBER	-95	dep	3	SENT_488	[p24l1278t3299r1657b3348],
8	.	.	O	.	_	0	SENT_488	[p24l1278t3299r1657b3348],

1	16	CD	NUMBER	16	_	0	SENT_489	[p24l1117t3372r1180b3410],
2	.	.	O	.	_	0	SENT_489	[p24l1117t3372r1180b3410],

1	Kobayashi	NNP	LOCATION	Kobayashi	nn	2	SENT_490	[p24l1211t3366r1461b3422],
2	S	NNP	LOCATION	S	_	0	SENT_490	[p24l1487t3370r1525b3420],
3	,	,	O	,	_	0	SENT_490	[p24l1487t3370r1525b3420],
4	Boggon	NNP	PERSON	Boggon	nn	6	SENT_490	[p24l1552t3370r1741b3423],
5	T	NN	O	t	nn	6	SENT_490	[p24l1764t3370r1828b3420],
6	]	NN	O	]	appos	2	SENT_490	[p24l1764t3370r1828b3420],
7	,	,	O	,	_	0	SENT_490	[p24l1764t3370r1828b3420],
8	Dayaram	NN	ORGANIZATION	dayaram	nn	9	SENT_490	[p24l1855t3370r2073b3422],
9	T	NN	ORGANIZATION	t	appos	2	SENT_490	[p24l2096t3370r2139b3420],
10	,	,	O	,	_	0	SENT_490	[p24l2096t3370r2139b3420],
11	et	FW	O	et	nn	12	SENT_490	[p24l1116t3447r1159b3481],
12	al.	FW	O	al.	appos	2	SENT_490	[p24l1191t3437r1246b3481],
13	.	.	O	.	_	0	SENT_490	[p24l1191t3437r1246b3481],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_491	[p24l1283t3441r1403b3482],
2	mutation	NN	O	mutation	_	0	SENT_491	[p24l1435t3438r1658b3482],
3	and	CC	O	and	_	0	SENT_491	[p24l1692t3437r1781b3482],
4	resistance	NN	O	resistance	conj_and	2	SENT_491	[p24l1816t3438r2061b3481],
5	of	IN	O	of	_	0	SENT_491	[p24l2096t3437r2152b3482],
6	non	JJ	O	non	amod	12	SENT_491	[p24l1115t3508r1481b3553],
7	—	JJ	O	—	amod	12	SENT_491	[p24l1115t3508r1481b3553],
8	small	JJ	O	small	amod	12	SENT_491	[p24l1115t3508r1481b3553],
9	—	NN	O	—	nn	12	SENT_491	[p24l1115t3508r1481b3553],
10	cell	NN	O	cell	nn	12	SENT_491	[p24l1115t3508r1481b3553],
11	lung	NN	O	lung	nn	12	SENT_491	[p24l1511t3508r1620b3565],
12	cancer	NN	O	cancer	prep_of	2	SENT_491	[p24l1649t3522r1808b3552],
13	to	TO	O	to	_	0	SENT_491	[p24l1837t3518r1883b3553],
14	geﬁtinib	NN	O	geﬁtinib	prep_to	2	SENT_491	[p24l1914t3508r2139b3565],
15	.	.	O	.	_	0	SENT_491	[p24l1914t3508r2139b3565],

1	N	NN	O	n	nn	3	SENT_492	[p24l1114t3583r1156b3624],
2	Engl	NNP	O	Engl	nn	3	SENT_492	[p24l1173t3579r1317b3636],
3	]	NNP	O	]	nsubj	4	SENT_492	[p24l1173t3579r1317b3636],
4	Med	VBD	O	med	_	0	SENT_492	[p24l1334t3579r1439b3624],
5	2005	CD	DATE	2005	dobj	4	SENT_492	[p24l1459t3583r1871b3632],
6	;	:	O	;	_	0	SENT_492	[p24l1459t3583r1871b3632],
7	352:786	CD	NUMBER	352:786	number	8	SENT_492	[p24l1459t3583r1871b3632],
8	—	CD	NUMBER	—	dep	5	SENT_492	[p24l1459t3583r1871b3632],
9	92	CD	NUMBER	92	dep	8	SENT_492	[p24l1459t3583r1871b3632],
10	.	.	O	.	_	0	SENT_492	[p24l1459t3583r1871b3632],

1	17	CD	NUMBER	17	_	0	SENT_493	[p24l1117t3656r1175b3694],
2	.	.	O	.	_	0	SENT_493	[p24l1117t3656r1175b3694],

1	Kwak	NNP	PERSON	Kwak	nn	2	SENT_494	[p24l1211t3650r1347b3696],
2	EL	NNP	O	EL	_	0	SENT_494	[p24l1369t3654r1444b3704],
3	,	,	O	,	_	0	SENT_494	[p24l1369t3654r1444b3704],
4	Sordella	NNP	PERSON	Sordella	nn	5	SENT_494	[p24l1474t3650r1671b3695],
5	R	NNP	PERSON	R	appos	2	SENT_494	[p24l1696t3654r1744b3704],
6	,	,	O	,	_	0	SENT_494	[p24l1696t3654r1744b3704],
7	Bell	NNP	ORGANIZATION	Bell	nn	8	SENT_494	[p24l1772t3650r1865b3694],
8	DW	NNP	ORGANIZATION	DW	appos	2	SENT_494	[p24l1890t3654r1988b3704],
9	,	,	O	,	_	0	SENT_494	[p24l1890t3654r1988b3704],
10	et	FW	O	et	nn	11	SENT_494	[p24l2017t3660r2061b3694],
11	al.	FW	O	al.	appos	2	SENT_494	[p24l2084t3650r2139b3694],
12	.	.	O	.	_	0	SENT_494	[p24l2084t3650r2139b3694],

1	Irreversible	JJ	O	irreversible	amod	2	SENT_495	[p24l1114t3722r1390b3767],
2	inhibitors	NNS	O	inhibitor	_	0	SENT_495	[p24l1407t3722r1648b3767],
3	of	IN	O	of	_	0	SENT_495	[p24l1667t3722r1723b3766],
4	the	DT	O	the	det	7	SENT_495	[p24l1730t3722r1805b3766],
5	EGF	NN	ORGANIZATION	egf	nn	7	SENT_495	[p24l1822t3726r1923b3766],
6	receptor	NN	O	receptor	nn	7	SENT_495	[p24l1941t3731r2144b3778],
7	nology	NN	O	nology	prep_of	2	SENT_495	[p25l13t14r188b71],
8	.	.	O	.	_	0	SENT_495	[p25l13t14r188b71],

1	Nature	NNP	O	Nature	_	0	SENT_496	[p25l209t18r376b59],
2	2007	CD	DATE	2007	num	1	SENT_496	[p25l396t18r806b68],
3	;	:	O	;	_	0	SENT_496	[p25l396t18r806b68],
4	450:1235	CD	NUMBER	450:1235	number	5	SENT_496	[p25l396t18r806b68],
5	-9	CD	NUMBER	-9	dep	1	SENT_496	[p25l396t18r806b68],
6	.	.	O	.	_	0	SENT_496	[p25l396t18r806b68],

1	12	CD	NUMBER	12	_	0	SENT_497	[p25l15t92r79b130],
2	.	.	O	.	_	0	SENT_497	[p25l15t92r79b130],

1	Lynch	NNP	PERSON	Lynch	nn	3	SENT_498	[p25l108t86r252b142],
2	T	NN	O	t	nn	3	SENT_498	[p25l276t90r340b140],
3	]	NN	O	]	_	0	SENT_498	[p25l276t90r340b140],
4	,	,	O	,	_	0	SENT_498	[p25l276t90r340b140],
5	Bell	NNP	ORGANIZATION	Bell	nn	6	SENT_498	[p25l368t86r461b130],
6	DW	NNP	ORGANIZATION	DW	appos	3	SENT_498	[p25l486t90r584b140],
7	,	,	O	,	_	0	SENT_498	[p25l486t90r584b140],
8	Sordella	NNP	PERSON	Sordella	nn	9	SENT_498	[p25l615t86r812b131],
9	R	NNP	PERSON	R	appos	3	SENT_498	[p25l837t90r885b140],
10	,	,	O	,	_	0	SENT_498	[p25l837t90r885b140],
11	et	FW	O	et	nn	12	SENT_498	[p25l915t95r959b130],
12	al.	FW	O	al.	appos	3	SENT_498	[p25l982t86r1037b130],
13	.	.	O	.	_	0	SENT_498	[p25l982t86r1037b130],

1	Activating	VBG	O	activate	amod	2	SENT_499	[p25l11t157r257b213],
2	mutations	NNS	O	mutation	_	0	SENT_499	[p25l300t157r543b201],
3	in	IN	O	in	_	0	SENT_499	[p25l588t157r635b200],
4	the	DT	O	the	det	7	SENT_499	[p25l680t156r754b200],
5	epidermal	JJ	O	epidermal	amod	7	SENT_499	[p25l799t156r1040b212],
6	growth	NN	O	growth	nn	7	SENT_499	[p25l13t227r188b284],
7	factor	NN	O	factor	prep_in	2	SENT_499	[p25l207t227r347b272],
8	receptor	NN	O	receptor	nn	10	SENT_499	[p25l365t236r564b283],
9	underlying	VBG	O	underlie	amod	10	SENT_499	[p25l582t227r842b284],
10	responsiveness	NN	O	responsiveness	dep	2	SENT_499	[p25l859t241r1039b283, p25l14t299r205b343],
11	of	IN	O	of	_	0	SENT_499	[p25l231t298r287b343],
12	non	JJ	O	non	amod	18	SENT_499	[p25l301t298r659b343],
13	—	JJ	O	—	amod	18	SENT_499	[p25l301t298r659b343],
14	small	JJ	O	small	amod	18	SENT_499	[p25l301t298r659b343],
15	—	NN	O	—	nn	18	SENT_499	[p25l301t298r659b343],
16	cell	NN	O	cell	nn	18	SENT_499	[p25l301t298r659b343],
17	lung	NN	O	lung	nn	18	SENT_499	[p25l683t298r791b355],
18	cancer	NN	O	cancer	prep_of	10	SENT_499	[p25l814t312r970b342],
19	to	TO	O	to	_	0	SENT_499	[p25l994t307r1039b343],
20	gefitinib	NN	O	gefitinib	prep_to	10	SENT_499	[p25l13t369r232b426],
21	.	.	O	.	_	0	SENT_499	[p25l13t369r232b426],

1	N	NN	O	n	nn	3	SENT_500	[p25l253t373r295b414],
2	Engll	NNP	O	Engll	nn	3	SENT_500	[p25l311t369r452b426],
3	Med	NNP	O	Med	_	0	SENT_500	[p25l467t369r572b414],
4	2004	CD	DATE	2004	num	3	SENT_500	[p25l590t373r1030b422],
5	;	:	O	;	_	0	SENT_500	[p25l590t373r1030b422],
6	350:2129	CD	NUMBER	350:2129	number	7	SENT_500	[p25l590t373r1030b422],
7	-39	CD	NUMBER	-39	dep	3	SENT_500	[p25l590t373r1030b422],
8	.	.	O	.	_	0	SENT_500	[p25l590t373r1030b422],

1	13	CD	NUMBER	13	_	0	SENT_501	[p25l15t447r77b485],
2	.	.	O	.	_	0	SENT_501	[p25l15t447r77b485],

1	Paez	NNP	PERSON	Paez	nn	2	SENT_502	[p25l108t445r217b485],
2	JG	NNP	O	JG	_	0	SENT_502	[p25l231t445r305b495],
3	,	,	O	,	_	0	SENT_502	[p25l231t445r305b495],
4	Jéinne	NNP	ORGANIZATION	Jéinne	nn	5	SENT_502	[p25l322t445r462b492],
5	PA	NN	ORGANIZATION	pa	appos	2	SENT_502	[p25l480t445r556b495],
6	,	,	O	,	_	0	SENT_502	[p25l480t445r556b495],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_502	[p25l577t445r659b485],
8	JC	NNP	PERSON	JC	appos	2	SENT_502	[p25l673t445r742b495],
9	,	,	O	,	_	0	SENT_502	[p25l673t445r742b495],
10	et	FW	O	et	nn	11	SENT_502	[p25l765t450r809b485],
11	al.	FW	O	al.	appos	2	SENT_502	[p25l824t441r880b485],
12	.	.	O	.	_	0	SENT_502	[p25l824t441r880b485],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_503	[p25l901t445r1046b488],
2	mutations	NNS	O	mutation	_	0	SENT_503	[p25l13t512r255b556],
3	in	IN	O	in	_	0	SENT_503	[p25l274t512r321b555],
4	lung	NN	O	lung	nn	5	SENT_503	[p25l339t511r447b568],
5	cancer	NN	O	cancer	prep_in	2	SENT_503	[p25l464t526r632b555],
6	:	:	O	:	_	0	SENT_503	[p25l464t526r632b555],
7	correlation	NN	O	correlation	dep	2	SENT_503	[p25l653t511r915b556],
8	with	IN	O	with	mark	10	SENT_503	[p25l931t511r1040b556],
9	may	MD	O	may	aux	10	SENT_503	[p25l1115t29r1216b70],
10	circumvent	VB	O	circumvent	dep	7	SENT_503	[p25l1231t15r1503b59],
11	acquired	VBN	O	acquire	amod	12	SENT_503	[p25l1516t14r1727b70],
12	resistance	NN	O	resistance	dobj	10	SENT_503	[p25l1743t15r1988b58],
13	to	TO	O	to	_	0	SENT_503	[p25l2004t23r2051b59],
14	gefitinib	NN	O	gefitinib	prep_to	10	SENT_503	[p25l2067t29r2142b71, p25l1115t86r1282b130],
15	.	.	O	.	_	0	SENT_503	[p25l2067t29r2142b71, p25l1115t86r1282b130],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_504	[p25l1314t90r1422b130],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_504	[p25l1449t86r1553b131],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_504	[p25l1580t86r1700b130],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_504	[p25l1730t87r1797b131],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_504	[p25l1825t90r1864b130],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_504	[p25l1893t90r1917b130],
7	A	NNP	O	A	_	0	SENT_504	[p25l1946t90r1983b130],
8	2005	CD	DATE	2005	num	7	SENT_504	[p25l2010t90r2140b140],
9	;	:	O	;	_	0	SENT_504	[p25l2010t90r2140b140],
10	102:7665	CD	NUMBER	102:7665	number	11	SENT_504	[p25l1117t160r1415b201],
11	-70	CD	NUMBER	-70	dep	7	SENT_504	[p25l1117t160r1415b201],
12	.	.	O	.	_	0	SENT_504	[p25l1117t160r1415b201],

1	18	CD	NUMBER	18	_	0	SENT_505	[p25l1117t232r1181b272],
2	.	.	O	.	_	0	SENT_505	[p25l1117t232r1181b272],

1	Pao	NNP	O	Pao	nn	2	SENT_506	[p25l1210t231r1295b272],
2	W	NNP	O	W	_	0	SENT_506	[p25l1315t231r1375b281],
3	,	,	O	,	_	0	SENT_506	[p25l1315t231r1375b281],
4	Miller	NNP	ORGANIZATION	Miller	nn	5	SENT_506	[p25l1397t227r1546b271],
5	VA	NNP	ORGANIZATION	VA	appos	2	SENT_506	[p25l1562t231r1641b281],
6	,	,	O	,	_	0	SENT_506	[p25l1562t231r1641b281],
7	Politi	NNP	PERSON	Politi	nn	8	SENT_506	[p25l1664t227r1793b272],
8	KA	NN	O	ka	appos	2	SENT_506	[p25l1812t231r1901b281],
9	,	,	O	,	_	0	SENT_506	[p25l1812t231r1901b281],
10	et	FW	O	et	nn	11	SENT_506	[p25l1925t237r1968b271],
11	al.	FW	O	al.	appos	2	SENT_506	[p25l1985t227r2041b272],
12	.	.	O	.	_	0	SENT_506	[p25l1985t227r2041b272],

1	Acquired	VBN	O	acquire	csubjpass	11	SENT_507	[p25l2062t231r2141b271, p25l1116t298r1273b354],
2	resistance	NN	O	resistance	dobj	1	SENT_507	[p25l1303t299r1547b342],
3	of	IN	O	of	_	0	SENT_507	[p25l1579t298r1635b342],
4	lung	NN	O	lung	nn	5	SENT_507	[p25l1654t298r1764b355],
5	adenocarcinomas	NNS	O	adenocarcinoma	prep_of	2	SENT_507	[p25l1793t298r2142b343, p25l1115t384r1213b413],
6	to	TO	O	to	_	0	SENT_507	[p25l1234t378r1280b413],
7	gefitinib	NN	O	gefitinib	prep_to	1	SENT_507	[p25l1300t369r1512b426],
8	or	CC	O	or	_	0	SENT_507	[p25l1533t383r1583b414],
9	erlotinib	NN	O	erlotinib	prep_to	1	SENT_507	[p25l1601t369r1811b414],
10	is	VBZ	O	be	auxpass	11	SENT_507	[p25l1831t370r1868b413],
11	associated	VBN	O	associate	_	0	SENT_507	[p25l1888t369r2142b414],
12	with	IN	O	with	_	0	SENT_507	[p25l1113t441r1223b486],
13	a	DT	DURATION	a	det	15	SENT_507	[p25l1248t456r1273b485],
14	second	JJ	DURATION	second	amod	15	SENT_507	[p25l1299t441r1467b485],
15	mutation	NN	O	mutation	prep_with	11	SENT_507	[p25l1492t442r1716b486],
16	in	IN	O	in	_	0	SENT_507	[p25l1741t442r1788b485],
17	the	DT	O	the	det	20	SENT_507	[p25l1814t441r1889b485],
18	EGFR	NN	ORGANIZATION	egfr	nn	20	SENT_507	[p25l1914t445r2058b488],
19	kinase	NN	O	kinase	nn	20	SENT_507	[p25l2078t441r2141b486, p25l1115t526r1224b555],
20	domain	NN	O	domain	prep_in	15	SENT_507	[p25l1244t511r1444b556],
21	.	.	O	.	_	0	SENT_507	[p25l1244t511r1444b556],

1	PLoS	NNP	O	PLoS	nn	2	SENT_508	[p25l1466t515r1583b556],
2	Med	NNP	O	Med	_	0	SENT_508	[p25l1602t511r1708b556],
3	2005	CD	DATE	2005	num	2	SENT_508	[p25l1727t515r2065b564],
4	;	:	O	;	_	0	SENT_508	[p25l1727t515r2065b564],
5	2	CD	NUMBER	2	number	6	SENT_508	[p25l1727t515r2065b564],
6	(	CD	NUMBER	(	dep	2	SENT_508	[p25l1727t515r2065b564],
7	3	CD	NUMBER	3	num	8	SENT_508	[p25l1727t515r2065b564],
8	)	NN	O	)	dep	6	SENT_508	[p25l1727t515r2065b564],
9	:	:	O	:	_	0	SENT_508	[p25l1727t515r2065b564],
10	e73	NN	O	e73	dep	6	SENT_508	[p25l1727t515r2065b564],
11	.	.	O	.	_	0	SENT_508	[p25l1727t515r2065b564],

1	N	NN	O	n	nn	2	SENT_509	[p25l934t654r948b669],
2	ENGLJMED359	NN	O	engljmed359	_	0	SENT_509	[p25l963t654r1183b676],
3	;	:	O	;	_	0	SENT_509	[p25l963t654r1183b676],
4	4	CD	NUMBER	4	num	6	SENT_509	[p25l963t654r1183b676],
5	WWW.NEJM.ORG	NN	O	www.nejm.org	nn	6	SENT_509	[p25l1215t654r1416b676],
6	JULY24	NN	O	july24	dep	2	SENT_509	[p25l1447t654r1551b676],
7	,	,	O	,	_	0	SENT_509	[p25l1447t654r1551b676],
8	2008	CD	DATE	2008	appos	6	SENT_509	[p25l1562t648r1625b670],
9	The	DT	O	the	det	12	SENT_509	[p25l936t687r987b711],
10	New	NNP	O	New	nn	12	SENT_509	[p25l996t688r1058b711],
11	England	NNP	O	England	nn	12	SENT_509	[p25l1067t687r1178b718],
12	Journal	NNP	O	Journal	dep	8	SENT_509	[p25l1187t687r1284b711],
13	of	IN	O	of	_	0	SENT_509	[p25l1294t687r1323b711],
14	Medicine	NNP	O	Medicine	prep_of	12	SENT_509	[p25l1330t687r1455b711],

1	Copyright	NN	O	copyright	_	0	SENT_510	[p25l729t769r863b800],
2	©	CD	NUMBER	©	num	6	SENT_510	[p25l872t769r896b793],
3	2008	CD	DATE	2008	num	6	SENT_510	[p25l906t769r970b793],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_510	[p25l980t769r1171b793],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_510	[p25l1181t769r1290b793],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_510	[p25l1300t769r1405b800],
7	.	.	O	.	_	0	SENT_510	[p25l1300t769r1405b800],

1	All	DT	O	all	det	2	SENT_511	[p25l1416t769r1457b793],
2	rights	NNS	O	rights	nsubj	3	SENT_511	[p25l1466t769r1541b800],
3	reserved	VBN	O	reserve	_	0	SENT_511	[p25l1551t769r1669b793],
4	.	.	O	.	_	0	SENT_511	[p25l1551t769r1669b793],

1	DETECTION	NN	O	detection	_	0	SENT_512	[p25l451t875r641b894],
2	OF	IN	O	of	_	0	SENT_512	[p25l657t875r696b894],
3	MUTATIONS	NNP	O	MUTATIONS	prep_of	1	SENT_512	[p25l710t875r905b894],
4	IN	IN	O	in	_	0	SENT_512	[p25l921t875r958b894],
5	EGFR	NN	O	egfr	prep_in	1	SENT_512	[p25l973t875r1044b894],
6	IN	IN	O	in	dep	1	SENT_512	[p25l1057t875r1094b894],
7	CIRCULATING	VBG	O	circulate	pcomp	6	SENT_512	[p25l1109t875r1340b894],
8	LUNG-CANCER	NN	O	lung-cancer	nn	9	SENT_512	[p25l1355t875r1600b894],
9	CELLS	NNS	O	cell	dobj	7	SENT_512	[p25l1612t875r1708b894],

1	19	CD	NUMBER	19	_	0	SENT_513	[p25l10t1042r71b1080],
2	.	.	O	.	_	0	SENT_513	[p25l10t1042r71b1080],

1	Engelman	NNP	ORGANIZATION	Engelman	nn	2	SENT_514	[p25l102t1037r348b1092],
2	IA	NNP	ORGANIZATION	IA	_	0	SENT_514	[p25l363t1041r432b1089],
3	,	,	O	,	_	0	SENT_514	[p25l363t1041r432b1089],
4	Zejnullahu	NNP	PERSON	Zejnullahu	nn	5	SENT_514	[p25l454t1037r714b1092],
5	K	NNP	PERSON	K	appos	2	SENT_514	[p25l734t1041r783b1089],
6	,	,	O	,	_	0	SENT_514	[p25l734t1041r783b1089],
7	Mitsudomi	NNP	ORGANIZATION	Mitsudomi	nn	8	SENT_514	[p25l805t1037r1024b1080, p25l8t1107r72b1149],
8	T	NN	ORGANIZATION	t	appos	2	SENT_514	[p25l98t1110r141b1159],
9	,	,	O	,	_	0	SENT_514	[p25l98t1110r141b1159],
10	et	FW	O	et	nn	11	SENT_514	[p25l173t1116r216b1150],
11	al.	FW	O	al.	appos	2	SENT_514	[p25l242t1107r297b1150],
12	.	.	O	.	_	0	SENT_514	[p25l242t1107r297b1150],

1	MET	NN	O	met	nn	2	SENT_515	[p25l327t1110r442b1150],
2	amplification	NN	O	amplification	nsubj	3	SENT_515	[p25l469t1106r799b1162],
3	leads	VBZ	O	lead	_	0	SENT_515	[p25l827t1107r948b1150],
4	to	TO	O	to	_	0	SENT_515	[p25l979t1116r1024b1150],
5	gefitinib	JJ	O	gefitinib	amod	6	SENT_515	[p25l8t1176r218b1232],
6	resistance	NN	O	resistance	prep_to	3	SENT_515	[p25l235t1177r477b1220],
7	in	IN	O	in	_	0	SENT_515	[p25l493t1177r540b1219],
8	lung	NN	O	lung	nn	9	SENT_515	[p25l556t1177r664b1232],
9	cancer	NN	O	cancer	prep_in	6	SENT_515	[p25l679t1191r837b1220],
10	by	IN	O	by	_	0	SENT_515	[p25l853t1177r907b1232],
11	activating	VBG	O	activate	prepc_by	3	SENT_515	[p25l920t1177r1024b1220, p25l6t1247r157b1302],
12	ERBB3	NN	O	erbb3	nn	13	SENT_515	[p25l169t1250r332b1293],
13	signaling	NN	O	signaling	dobj	11	SENT_515	[p25l349t1247r587b1302],
14	.	.	O	.	_	0	SENT_515	[p25l349t1247r587b1302],

1	Science	NNP	O	Science	_	0	SENT_516	[p25l606t1247r782b1290],
2	2007	CD	DATE	2007	num	1	SENT_516	[p25l796t1250r1022b1299],
3	;	:	O	;	_	0	SENT_516	[p25l796t1250r1022b1299],
4	316	CD	NUMBER	316	num	6	SENT_516	[p25l796t1250r1022b1299],
5	:	:	O	:	_	0	SENT_516	[p25l796t1250r1022b1299],
6	1039-43	CD	NUMBER	1039-43	dep	1	SENT_516	[p25l10t1320r211b1360],
7	.	.	O	.	_	0	SENT_516	[p25l10t1320r211b1360],

1	20	CD	NUMBER	20	_	0	SENT_517	[p25l8t1391r74b1430],
2	.	.	O	.	_	0	SENT_517	[p25l8t1391r74b1430],

1	Bean	NNP	O	Bean	nn	2	SENT_518	[p25l102t1390r222b1430],
2	J	NNP	O	J	_	0	SENT_518	[p25l234t1391r266b1439],
3	,	,	O	,	_	0	SENT_518	[p25l234t1391r266b1439],
4	Brennan	NNP	PERSON	Brennan	nn	5	SENT_518	[p25l285t1390r491b1430],
5	C	NNP	O	C	appos	2	SENT_518	[p25l508t1390r555b1439],
6	,	,	O	,	_	0	SENT_518	[p25l508t1390r555b1439],
7	Shih	NNP	O	Shih	nn	8	SENT_518	[p25l577t1387r684b1430],
8	JY	NN	O	jy	appos	2	SENT_518	[p25l696t1391r759b1439],
9	,	,	O	,	_	0	SENT_518	[p25l696t1391r759b1439],
10	et	FW	O	et	nn	11	SENT_518	[p25l780t1396r823b1430],
11	al.	FW	O	al.	appos	2	SENT_518	[p25l838t1387r892b1430],
12	.	.	O	.	_	0	SENT_518	[p25l838t1387r892b1430],

1	MET	NN	O	met	nn	2	SENT_519	[p25l911t1390r1026b1429],
2	amplification	NN	O	amplification	nsubj	3	SENT_519	[p25l8t1456r337b1512],
3	occurs	VBZ	O	occur	conj_or	3	SENT_519	[p25l385t1471r541b1500],
4	with	IN	O	with	_	0	SENT_519	[p25l587t1457r697b1500],
5	or	CC	O	or	_	0	SENT_519	[p25l744t1471r794b1500],
6	without	IN	O	without	_	0	SENT_519	[p25l837t1457r1027b1500],
7	T79OM	NN	O	t79om	nn	8	SENT_519	[p25l7t1530r176b1570],
8	mutations	NNS	O	mutation	prep_with	3	SENT_519	[p25l204t1527r449b1570],
9	in	IN	O	in	_	0	SENT_519	[p25l478t1527r524b1569],
10	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_519	[p25l552t1530r695b1573],
11	mutant	JJ	O	mutant	amod	13	SENT_519	[p25l717t1536r893b1570],
12	lung	NN	O	lung	nn	13	SENT_519	[p25l918t1527r1027b1582],
13	tumors	NNS	O	tumor	prep_in	8	SENT_519	[p25l9t1606r181b1640],
14	with	IN	O	with	_	0	SENT_519	[p25l205t1597r315b1640],
15	acquired	VBN	O	acquire	amod	16	SENT_519	[p25l340t1597r548b1652],
16	resistance	NN	O	resistance	prep_with	3	SENT_519	[p25l574t1597r815b1640],
17	to	TO	O	to	_	0	SENT_519	[p25l841t1606r887b1640],
18	gef1tinib	NN	O	gef1tinib	prep_to	16	SENT_519	[p25l912t1596r1024b1652, p25l9t1667r120b1710],
19	or	CC	O	or	_	0	SENT_519	[p25l139t1681r187b1710],
20	erlotinib	NN	O	erlotinib	conj_or	18	SENT_519	[p25l204t1667r419b1710],
21	.	.	O	.	_	0	SENT_519	[p25l204t1667r419b1710],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_520	[p25l438t1670r544b1710],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_520	[p25l560t1667r660b1710],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_520	[p25l675t1667r792b1710],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_520	[p25l811t1667r877b1710],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_520	[p25l893t1671r932b1710],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_520	[p25l949t1670r973b1710],
7	A	NNP	O	A	_	0	SENT_520	[p25l990t1671r1027b1709],
8	2007	CD	DATE	2007	num	7	SENT_520	[p25l8t1740r434b1789],
9	;	:	O	;	_	0	SENT_520	[p25l8t1740r434b1789],
10	104:20932	CD	NUMBER	104:20932	number	11	SENT_520	[p25l8t1740r434b1789],
11	-7	CD	NUMBER	-7	dep	7	SENT_520	[p25l8t1740r434b1789],
12	.	.	O	.	_	0	SENT_520	[p25l8t1740r434b1789],

1	21	CD	NUMBER	21	_	0	SENT_521	[p25l8t1812r73b1850],
2	.	.	O	.	_	0	SENT_521	[p25l8t1812r73b1850],

1	Sequist	NNP	O	Sequist	nn	2	SENT_522	[p25l104t1807r280b1862],
2	LV	NNP	O	LV	_	0	SENT_522	[p25l303t1811r369b1859],
3	,	,	O	,	_	0	SENT_522	[p25l303t1811r369b1859],
4	Martins	NNP	PERSON	Martins	nn	5	SENT_522	[p25l397t1807r589b1850],
5	RG	NNP	O	RG	appos	2	SENT_522	[p25l616t1810r703b1859],
6	,	,	O	,	_	0	SENT_522	[p25l616t1810r703b1859],
7	Spigel	NNP	PERSON	Spigel	nn	8	SENT_522	[p25l735t1807r879b1862],
8	D	NNP	O	D	appos	2	SENT_522	[p25l904t1810r954b1859],
9	,	,	O	,	_	0	SENT_522	[p25l904t1810r954b1859],
10	et	FW	O	et	nn	11	SENT_522	[p25l984t1816r1027b1850],
11	al.	FW	O	al.	appos	2	SENT_522	[p25l8t1877r63b1920],
12	.	.	O	.	_	0	SENT_522	[p25l8t1877r63b1920],

1	First-line	JJ	O	first-line	amod	2	SENT_523	[p25l96t1877r312b1920],
2	gefitinib	NN	O	gefitinib	_	0	SENT_523	[p25l343t1876r552b1932],
3	in	IN	O	in	_	0	SENT_523	[p25l583t1877r630b1919],
4	advanced	JJ	O	advanced	amod	8	SENT_523	[p25l661t1877r883b1920],
5	nonsmall-cell	JJ	O	nonsmall-cell	amod	8	SENT_523	[p25l914t1891r1024b1920, p25l9t1947r245b1990],
6	lung	NN	O	lung	nn	8	SENT_523	[p25l265t1947r373b2002],
7	cancer	NN	O	cancer	nn	8	SENT_523	[p25l392t1961r550b1990],
8	patients	NNS	O	patient	prep_in	2	SENT_523	[p25l567t1947r760b2002],
9	harboring	VBG	O	harbor	partmod	2	SENT_523	[p25l782t1947r1027b2002],
10	somatic	JJ	O	somatic	amod	12	SENT_523	[p25l9t2017r198b2060],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_523	[p25l232t2020r374b2063],
12	mutations	NNS	O	mutation	dobj	9	SENT_523	[p25l403t2017r662b2060],
13	.	.	O	.	_	0	SENT_523	[p25l403t2017r662b2060],

1	J	NNP	O	J	nn	3	SENT_524	[p25l694t2021r715b2067],
2	Clin	NNP	O	Clin	nn	3	SENT_524	[p25l748t2017r847b2060],
3	Oncol	NNP	O	Oncol	_	0	SENT_524	[p25l882t2017r1025b2060],
4	2008	CD	DATE	2008	num	3	SENT_524	[p25l8t2090r389b2139],
5	;	:	O	;	_	0	SENT_524	[p25l8t2090r389b2139],
6	26:2442	CD	NUMBER	26:2442	number	7	SENT_524	[p25l8t2090r389b2139],
7	—	CD	NUMBER	—	dep	3	SENT_524	[p25l8t2090r389b2139],
8	9	CD	NUMBER	9	dep	7	SENT_524	[p25l8t2090r389b2139],
9	.	.	O	.	_	0	SENT_524	[p25l8t2090r389b2139],

1	22	CD	NUMBER	22	_	0	SENT_525	[p25l8t2162r75b2200],
2	.	.	O	.	_	0	SENT_525	[p25l8t2162r75b2200],

1	Therasse	NN	O	therasse	nn	2	SENT_526	[p25l101t2157r316b2200],
2	P	NN	O	p	_	0	SENT_526	[p25l352t2160r389b2209],
3	,	,	O	,	_	0	SENT_526	[p25l352t2160r389b2209],
4	Arbuck	NNP	O	Arbuck	nn	5	SENT_526	[p25l426t2157r604b2200],
5	SG	NNP	O	SG	appos	2	SENT_526	[p25l639t2160r718b2209],
6	,	,	O	,	_	0	SENT_526	[p25l639t2160r718b2209],
7	Eisenhauer	NNP	PERSON	Eisenhauer	nn	8	SENT_526	[p25l757t2157r1026b2200],
8	EA	NN	PERSON	ea	appos	2	SENT_526	[p25l8t2231r88b2279],
9	,	,	O	,	_	0	SENT_526	[p25l8t2231r88b2279],
10	et	FW	O	et	nn	11	SENT_526	[p25l114t2236r158b2270],
11	al.	FW	O	al.	appos	2	SENT_526	[p25l177t2227r232b2270],
12	.	.	O	.	_	0	SENT_526	[p25l177t2227r232b2270],

1	New	NNP	O	New	nn	2	SENT_527	[p25l257t2231r367b2270],
2	guidelines	NNS	O	guideline	nsubj	4	SENT_527	[p25l387t2227r638b2282],
3	to	TO	O	to	aux	4	SENT_527	[p25l662t2236r708b2270],
4	evaluate	VB	O	evaluate	_	0	SENT_527	[p25l732t2227r927b2270],
5	the	DT	O	the	det	6	SENT_527	[p25l950t2227r1025b2270],
6	response	NN	O	response	dobj	4	SENT_527	[p25l8t2311r223b2352],
7	to	TO	O	to	_	0	SENT_527	[p25l257t2305r302b2340],
8	treatment	NN	O	treatment	prep_to	4	SENT_527	[p25l337t2306r575b2340],
9	in	IN	O	in	_	0	SENT_527	[p25l605t2297r652b2339],
10	solid	JJ	O	solid	amod	11	SENT_527	[p25l687t2297r802b2340],
11	tumors	NNS	O	tumor	prep_in	8	SENT_527	[p25l835t2306r1023b2340],
12	:	:	O	:	_	0	SENT_527	[p25l835t2306r1023b2340],
13	European	JJ	ORGANIZATION	european	amod	14	SENT_527	[p25l8t2371r240b2422],
14	Organization	NNP	ORGANIZATION	Organization	dep	8	SENT_527	[p25l262t2367r584b2422],
15	for	IN	ORGANIZATION	for	_	0	SENT_527	[p25l606t2366r675b2410],
16	Research	NNP	ORGANIZATION	Research	prep_for	14	SENT_527	[p25l695t2367r915b2413],
17	and	CC	ORGANIZATION	and	_	0	SENT_527	[p25l936t2367r1025b2410],
18	Treatment	NN	ORGANIZATION	treatment	dep	8	SENT_527	[p25l7t2440r259b2480],
19	of	IN	ORGANIZATION	of	_	0	SENT_527	[p25l276t2436r332b2480],
20	Cancer	NN	ORGANIZATION	cancer	prep_of	18	SENT_527	[p25l342t2440r520b2489],
21	,	,	O	,	_	0	SENT_527	[p25l342t2440r520b2489],
22	National	NNP	ORGANIZATION	National	nn	24	SENT_527	[p25l542t2437r752b2480],
23	Cancer	NNP	ORGANIZATION	Cancer	nn	24	SENT_527	[p25l771t2440r939b2480],
24	Institute	NNP	ORGANIZATION	Institute	appos	8	SENT_527	[p25l956t2441r1024b2479, p25l9t2507r161b2550],
25	of	IN	O	of	_	0	SENT_527	[p25l178t2506r234b2550],
26	the	DT	O	the	det	28	SENT_527	[p25l241t2507r315b2550],
27	United	NNP	LOCATION	United	nn	28	SENT_527	[p25l332t2507r494b2550],
28	States	NNPS	LOCATION	States	prep_of	24	SENT_527	[p25l512t2510r666b2559],
29	,	,	O	,	_	0	SENT_527	[p25l512t2510r666b2559],
30	National	NNP	ORGANIZATION	National	nn	32	SENT_527	[p25l685t2507r896b2550],
31	Cancer	NNP	ORGANIZATION	Cancer	nn	32	SENT_527	[p25l912t2510r1024b2550, p25l9t2591r80b2620],
32	Institute	NNP	ORGANIZATION	Institute	appos	8	SENT_527	[p25l96t2577r301b2620],
33	of	IN	ORGANIZATION	of	_	0	SENT_527	[p25l320t2576r375b2620],
34	Canada	NNP	ORGANIZATION	Canada	prep_of	32	SENT_527	[p25l383t2577r576b2620],
35	.	.	O	.	_	0	SENT_527	[p25l383t2577r576b2620],

1	J	NNP	O	J	nn	4	SENT_528	[p25l592t2581r613b2627],
2	Natl	NNP	O	Natl	nn	4	SENT_528	[p25l629t2577r731b2620],
3	Cancer	NNP	O	Cancer	nn	4	SENT_528	[p25l749t2580r917b2620],
4	Inst	NNP	O	Inst	_	0	SENT_528	[p25l932t2581r1027b2620],
5	2000	CD	DATE	2000	num	4	SENT_528	[p25l8t2650r389b2699],
6	;	:	O	;	_	0	SENT_528	[p25l8t2650r389b2699],
7	92:205	CD	NUMBER	92:205	number	8	SENT_528	[p25l8t2650r389b2699],
8	-16	CD	NUMBER	-16	dep	4	SENT_528	[p25l8t2650r389b2699],
9	.	.	O	.	_	0	SENT_528	[p25l8t2650r389b2699],

1	23	CD	NUMBER	23	_	0	SENT_529	[p25l8t2722r71b2760],
2	.	.	O	.	_	0	SENT_529	[p25l8t2722r71b2760],

1	Whitcombe	NNP	PERSON	Whitcombe	nn	2	SENT_530	[p25l101t2717r373b2760],
2	D	NNP	PERSON	D	_	0	SENT_530	[p25l385t2720r434b2769],
3	,	,	O	,	_	0	SENT_530	[p25l385t2720r434b2769],
4	Theakerl	NNP	O	Theakerl	appos	2	SENT_530	[p25l448t2717r675b2769],
5	,	,	O	,	_	0	SENT_530	[p25l448t2717r675b2769],
6	Guy	NNP	O	Guy	nn	7	SENT_530	[p25l690t2720r784b2772],
7	SP	NN	O	sp	appos	2	SENT_530	[p25l795t2720r856b2769],
8	,	,	O	,	_	0	SENT_530	[p25l795t2720r856b2769],
9	Brown	JJ	PERSON	brown	amod	10	SENT_530	[p25l871t2720r1025b2761],
10	T	NN	O	t	appos	2	SENT_530	[p25l7t2790r48b2839],
11	,	,	O	,	_	0	SENT_530	[p25l7t2790r48b2839],
12	Little	JJ	O	little	amod	14	SENT_530	[p25l67t2787r186b2830],
13	S.	NNP	O	S.	nn	14	SENT_530	[p25l204t2790r241b2830],
14	Detection	NN	O	detection	appos	2	SENT_530	[p25l260t2787r485b2830],
15	of	IN	O	of	_	0	SENT_530	[p25l502t2786r557b2830],
16	PCR	NN	O	pcr	nn	17	SENT_530	[p25l562t2790r667b2833],
17	products	NNS	O	product	prep_of	14	SENT_530	[p25l677t2787r880b2842],
18	using	VBG	O	use	partmod	17	SENT_530	[p25l898t2787r1027b2842],
19	self-probing	JJ	O	self-probing	amod	20	SENT_530	[p25l9t2856r303b2912],
20	amplicons	NNS	O	amplicon	dobj	18	SENT_530	[p25l322t2857r571b2912],
21	and	CC	O	and	_	0	SENT_530	[p25l593t2857r681b2900],
22	fluorescence	NN	O	fluorescence	dobj	18	SENT_530	[p25l702t2856r1022b2900],
23	.	.	O	.	_	0	SENT_530	[p25l702t2856r1022b2900],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_531	[p25l7t2931r94b2970],
2	Biotechnol	NNP	PERSON	Biotechnol	_	0	SENT_531	[p25l109t2927r369b2970],
3	1999	CD	DATE	1999	num	2	SENT_531	[p25l390t2930r732b2979],
4	;	:	O	;	_	0	SENT_531	[p25l390t2930r732b2979],
5	17:804	CD	NUMBER	17:804	number	6	SENT_531	[p25l390t2930r732b2979],
6	-7	CD	NUMBER	-7	dep	2	SENT_531	[p25l390t2930r732b2979],
7	.	.	O	.	_	0	SENT_531	[p25l390t2930r732b2979],

1	24	CD	NUMBER	24	_	0	SENT_532	[p25l8t3002r74b3040],
2	.	.	O	.	_	0	SENT_532	[p25l8t3002r74b3040],

1	Kimura	NNP	PERSON	Kimura	nn	2	SENT_533	[p25l103t2997r286b3041],
2	H	NNP	PERSON	H	_	0	SENT_533	[p25l309t3001r363b3049],
3	,	,	O	,	_	0	SENT_533	[p25l309t3001r363b3049],
4	Kasahara	NNP	PERSON	Kasahara	nn	5	SENT_533	[p25l390t2997r617b3041],
5	K	NNP	PERSON	K	appos	2	SENT_533	[p25l640t3001r689b3049],
6	,	,	O	,	_	0	SENT_533	[p25l640t3001r689b3049],
7	Kawaishi	NNP	O	Kawaishi	nn	8	SENT_533	[p25l716t2997r938b3041],
8	M	NNP	O	M	appos	2	SENT_533	[p25l961t3001r1022b3049],
9	,	,	O	,	_	0	SENT_533	[p25l961t3001r1022b3049],
10	et	FW	O	et	nn	11	SENT_533	[p25l9t3076r51b3110],
11	al.	FW	O	al.	appos	2	SENT_533	[p25l64t3067r118b3110],
12	.	.	O	.	_	0	SENT_533	[p25l64t3067r118b3110],

1	Detection	NN	O	detection	_	0	SENT_534	[p25l136t3067r367b3110],
2	of	IN	O	of	_	0	SENT_534	[p25l383t3066r438b3110],
3	epidermal	JJ	O	epidermal	amod	7	SENT_534	[p25l445t3067r683b3122],
4	growth	NN	O	growth	nn	7	SENT_534	[p25l699t3067r872b3122],
5	factor	NN	O	factor	nn	7	SENT_534	[p25l888t3066r1026b3110],
6	receptor	NN	O	receptor	nn	7	SENT_534	[p25l8t3146r205b3192],
7	mutations	NNS	O	mutation	prep_of	1	SENT_534	[p25l219t3137r459b3180],
8	in	IN	O	in	_	0	SENT_534	[p25l477t3137r523b3179],
9	serum	NN	O	serum	prep_in	7	SENT_534	[p25l540t3151r688b3180],
10	as	IN	O	as	_	0	SENT_534	[p25l704t3151r751b3180],
11	a	DT	O	a	det	12	SENT_534	[p25l768t3151r793b3180],
12	predictor	NN	O	predictor	prep_as	1	SENT_534	[p25l808t3137r1027b3192],
13	of	IN	O	of	_	0	SENT_534	[p25l1099t1036r1155b1080],
14	the	DT	O	the	det	15	SENT_534	[p25l1178t1037r1251b1080],
15	response	NN	O	response	prep_of	12	SENT_534	[p25l1285t1051r1495b1092],
16	to	TO	O	to	_	0	SENT_534	[p25l1529t1046r1574b1080],
17	gefitinib	NN	O	gefitinib	prep_to	15	SENT_534	[p25l1608t1036r1813b1092],
18	in	IN	O	in	_	0	SENT_534	[p25l1847t1037r1893b1079],
19	patients	NNS	O	patient	prep_in	1	SENT_534	[p25l1925t1037r2114b1092],
20	with	IN	O	with	_	0	SENT_534	[p25l1096t1107r1204b1150],
21	non-small-cell	JJ	O	non-small-cell	amod	23	SENT_534	[p25l1221t1107r1564b1150],
22	lung	NN	O	lung	nn	23	SENT_534	[p25l1580t1107r1687b1162],
23	cancer	NN	O	cancer	prep_with	19	SENT_534	[p25l1702t1121r1867b1150],
24	.	.	O	.	_	0	SENT_534	[p25l1702t1121r1867b1150],

1	Clin	NNP	O	Clin	nn	3	SENT_535	[p25l1887t1107r1985b1150],
2	Cancer	NNP	O	Cancer	nn	3	SENT_535	[p25l2003t1110r2114b1150, p25l1099t1191r1171b1220],
3	Res	NNP	O	Res	_	0	SENT_535	[p25l1187t1180r1271b1223],
4	2006	CD	DATE	2006	num	3	SENT_535	[p25l1292t1180r1702b1229],
5	;	:	O	;	_	0	SENT_535	[p25l1292t1180r1702b1229],
6	12:3915	CD	NUMBER	12:3915	number	7	SENT_535	[p25l1292t1180r1702b1229],
7	-21	CD	NUMBER	-21	dep	3	SENT_535	[p25l1292t1180r1702b1229],
8	.	.	O	.	_	0	SENT_535	[p25l1292t1180r1702b1229],

1	25	CD	NUMBER	25	_	0	SENT_536	[p25l1098t1252r1163b1290],
2	.	.	O	.	_	0	SENT_536	[p25l1098t1252r1163b1290],

1	Bell	NNP	ORGANIZATION	Bell	nn	2	SENT_537	[p25l1193t1247r1285b1290],
2	DW	NNP	ORGANIZATION	DW	_	0	SENT_537	[p25l1309t1250r1407b1299],
3	,	,	O	,	_	0	SENT_537	[p25l1309t1250r1407b1299],
4	Gore	NNP	PERSON	Gore	appos	2	SENT_537	[p25l1435t1250r1552b1290],
5	I	PRP	O	I	dep	4	SENT_537	[p25l1577t1251r1607b1299],
6	,	,	O	,	_	0	SENT_537	[p25l1577t1251r1607b1299],
7	Okimoto	NNP	PERSON	Okimoto	nn	8	SENT_537	[p25l1636t1247r1851b1290],
8	RA	NN	O	ra	appos	2	SENT_537	[p25l1876t1250r1962b1299],
9	,	,	O	,	_	0	SENT_537	[p25l1876t1250r1962b1299],
10	et	FW	O	et	nn	11	SENT_537	[p25l1992t1255r2035b1290],
11	al.	FW	O	al.	appos	2	SENT_537	[p25l2057t1247r2112b1290],
12	.	.	O	.	_	0	SENT_537	[p25l2057t1247r2112b1290],

1	Inherited	VBN	O	inherit	_	0	SENT_538	[p25l1098t1317r1317b1360],
2	susceptibility	NN	O	susceptibility	dobj	1	SENT_538	[p25l1334t1317r1651b1372],
3	to	TO	O	to	_	0	SENT_538	[p25l1665t1326r1710b1360],
4	lung	NN	O	lung	nn	5	SENT_538	[p25l1727t1317r1834b1372],
5	cancer	NN	O	cancer	prep_to	1	SENT_538	[p25l1849t1331r2004b1360],
6	may	MD	O	may	aux	8	SENT_538	[p25l2019t1331r2118b1372],
7	be	VB	O	be	auxpass	8	SENT_538	[p25l1099t1387r1153b1430],
8	associated	VBN	O	associate	auxpass	1	SENT_538	[p25l1173t1387r1424b1430],
9	with	IN	O	with	_	0	SENT_538	[p25l1441t1387r1550b1430],
10	the	DT	O	the	det	12	SENT_538	[p25l1571t1387r1645b1430],
11	T79OM	NN	O	t79om	nn	12	SENT_538	[p25l1663t1390r1832b1430],
12	drug	NN	O	drug	prep_with	8	SENT_538	[p25l1853t1387r1968b1442],
13	resistance	NN	O	resistance	nn	14	SENT_538	[p25l1986t1387r2114b1430, p25l1099t1466r1228b1500],
14	mutation	NN	O	mutation	nsubjpass	1	SENT_538	[p25l1246t1457r1467b1500],
15	in	IN	O	in	_	0	SENT_538	[p25l1485t1457r1532b1499],
16	EGFR	NN	ORGANIZATION	egfr	prep_in	14	SENT_538	[p25l1550t1460r1701b1503],
17	.	.	O	.	_	0	SENT_538	[p25l1550t1460r1701b1503],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_539	[p25l1721t1461r1808b1500],
2	Genet	NNP	PERSON	Genet	_	0	SENT_539	[p25l1824t1460r1969b1500],
3	2005	CD	DATE	2005	num	2	SENT_539	[p25l1984t1460r2113b1509],
4	;	:	O	;	_	0	SENT_539	[p25l1984t1460r2113b1509],
5	37:1315	CD	NUMBER	37:1315	number	6	SENT_539	[p25l1099t1530r1346b1570],
6	-6	CD	NUMBER	-6	dep	2	SENT_539	[p25l1099t1530r1346b1570],
7	.	.	O	.	_	0	SENT_539	[p25l1099t1530r1346b1570],

1	26	CD	NUMBER	26	_	0	SENT_540	[p25l1098t1602r1165b1640],
2	.	.	O	.	_	0	SENT_540	[p25l1098t1602r1165b1640],

1	Inukai	NNP	PERSON	Inukai	nn	2	SENT_541	[p25l1193t1597r1349b1641],
2	M	NNP	O	M	_	0	SENT_541	[p25l1364t1601r1425b1649],
3	,	,	O	,	_	0	SENT_541	[p25l1364t1601r1425b1649],
4	Toyooka	NNP	PERSON	Toyooka	nn	5	SENT_541	[p25l1443t1597r1647b1652],
5	S	NNP	PERSON	S	appos	2	SENT_541	[p25l1664t1600r1702b1649],
6	,	,	O	,	_	0	SENT_541	[p25l1664t1600r1702b1649],
7	Ito	NNP	PERSON	Ito	nn	8	SENT_541	[p25l1721t1601r1786b1640],
8	S	NNP	O	S	appos	2	SENT_541	[p25l1805t1600r1843b1649],
9	,	,	O	,	_	0	SENT_541	[p25l1805t1600r1843b1649],
10	et	FW	O	et	nn	11	SENT_541	[p25l1864t1605r1907b1640],
11	al.	FW	O	al.	appos	2	SENT_541	[p25l1921t1597r1976b1640],
12	.	.	O	.	_	0	SENT_541	[p25l1921t1597r1976b1640],

1	Presence	NN	O	presence	_	0	SENT_542	[p25l1995t1600r2114b1640, p25l1099t1681r1206b1710],
2	of	IN	O	of	_	0	SENT_542	[p25l1227t1666r1283b1710],
3	epidermal	JJ	O	epidermal	amod	9	SENT_542	[p25l1294t1667r1538b1722],
4	growth	NN	O	growth	nn	9	SENT_542	[p25l1558t1667r1735b1722],
5	factor	NN	O	factor	nn	9	SENT_542	[p25l1756t1666r1897b1710],
6	receptor	NN	O	receptor	nn	9	SENT_542	[p25l1917t1676r2117b1722],
7	gene	NN	O	gene	nn	9	SENT_542	[p25l1099t1751r1211b1792],
8	T79OM	NN	O	t79om	nn	9	SENT_542	[p25l1226t1740r1396b1780],
9	mutation	NN	O	mutation	prep_of	1	SENT_542	[p25l1414t1737r1635b1780],
10	as	IN	O	as	_	0	SENT_542	[p25l1652t1751r1700b1780],
11	a	DT	O	a	det	13	SENT_542	[p25l1718t1751r1743b1780],
12	minor	JJ	O	minor	amod	13	SENT_542	[p25l1759t1737r1909b1780],
13	clone	NN	O	clone	prep_as	9	SENT_542	[p25l1925t1737r2051b1780],
14	in	IN	O	in	_	0	SENT_542	[p25l2069t1737r2115b1779],
15	non-small	JJ	O	non-small	amod	18	SENT_542	[p25l1099t1807r1344b1850],
16	cell	NN	O	cell	nn	18	SENT_542	[p25l1376t1807r1459b1850],
17	lung	NN	O	lung	nn	18	SENT_542	[p25l1490t1807r1598b1862],
18	cancer	NN	O	cancer	prep_in	1	SENT_542	[p25l1629t1821r1797b1850],
19	.	.	O	.	_	0	SENT_542	[p25l1629t1821r1797b1850],

1	Cancer	NN	O	cancer	_	0	SENT_543	[p25l1832t1810r2000b1850],
2	Res	NNP	O	Res	dep	1	SENT_543	[p25l2030t1810r2114b1853],
3	2006	CD	DATE	2006	num	2	SENT_543	[p25l1099t1880r1485b1929],
4	;	:	O	;	_	0	SENT_543	[p25l1099t1880r1485b1929],
5	66:7854	CD	NUMBER	66:7854	num	6	SENT_543	[p25l1099t1880r1485b1929],
6	-8	CD	NUMBER	-8	dep	1	SENT_543	[p25l1099t1880r1485b1929],
7	.	.	O	.	_	0	SENT_543	[p25l1099t1880r1485b1929],

1	27	CD	NUMBER	27	_	0	SENT_544	[p25l1098t1952r1159b1990],
2	.	.	O	.	_	0	SENT_544	[p25l1098t1952r1159b1990],

1	Godin-Heymann	NNP	PERSON	Godin-Heymann	nn	2	SENT_545	[p25l1194t1947r1602b2002],
2	N	NNP	PERSON	N	_	0	SENT_545	[p25l1631t1951r1684b1999],
3	,	,	O	,	_	0	SENT_545	[p25l1631t1951r1684b1999],
4	Bryant	NNP	PERSON	Bryant	appos	2	SENT_545	[p25l1716t1950r1876b2002],
5	I	PRP	O	I	dep	4	SENT_545	[p25l1903t1951r1932b1999],
6	,	,	O	,	_	0	SENT_545	[p25l1903t1951r1932b1999],
7	Rivera	NNP	PERSON	Rivera	nn	8	SENT_545	[p25l1964t1947r2116b1993],
8	MN	NN	O	mn	appos	2	SENT_545	[p25l1097t2021r1200b2069],
9	,	,	O	,	_	0	SENT_545	[p25l1097t2021r1200b2069],
10	et	FW	O	et	nn	11	SENT_545	[p25l1219t2026r1262b2060],
11	al.	FW	O	al.	appos	2	SENT_545	[p25l1275t2017r1329b2060],
12	.	.	O	.	_	0	SENT_545	[p25l1275t2017r1329b2060],

1	Oncogenic	JJ	MISC	oncogenic	amod	2	SENT_546	[p25l1348t2017r1607b2072],
2	activity	NN	O	activity	nsubjpass	12	SENT_546	[p25l1622t2017r1797b2072],
3	of	IN	O	of	_	0	SENT_546	[p25l1811t2016r1866b2060],
4	epidermal	JJ	O	epidermal	amod	10	SENT_546	[p25l1872t2017r2115b2072],
5	growth	NN	O	growth	nn	10	SENT_546	[p25l1099t2087r1275b2142],
6	factor	NN	O	factor	nn	10	SENT_546	[p25l1297t2086r1439b2130],
7	receptor	NN	O	receptor	nn	10	SENT_546	[p25l1460t2096r1660b2142],
8	kinase	NN	O	kinase	nn	10	SENT_546	[p25l1681t2087r1837b2130],
9	mutant	JJ	O	mutant	amod	10	SENT_546	[p25l1860t2095r2036b2130],
10	alleles	NNS	O	allele	prep_of	2	SENT_546	[p25l2055t2087r2114b2130, p25l1098t2157r1203b2200],
11	is	VBZ	O	be	auxpass	12	SENT_546	[p25l1228t2157r1265b2200],
12	enhanced	VBN	O	enhance	_	0	SENT_546	[p25l1291t2157r1523b2200],
13	by	IN	O	by	_	0	SENT_546	[p25l1548t2157r1602b2212],
14	the	DT	O	the	det	18	SENT_546	[p25l1624t2157r1698b2200],
15	T79OM	NN	O	t79om	nn	18	SENT_546	[p25l1720t2160r1889b2200],
16	drug	NN	O	drug	nn	18	SENT_546	[p25l1915t2157r2029b2212],
17	resistance	NN	O	resistance	nn	18	SENT_546	[p25l2051t2171r2114b2200, p25l1100t2227r1293b2270],
18	mutation	NN	O	mutation	agent	12	SENT_546	[p25l1327t2227r1561b2270],
19	.	.	O	.	_	0	SENT_546	[p25l1327t2227r1561b2270],

1	Cancer	NN	O	cancer	_	0	SENT_547	[p25l1598t2230r1766b2270],
2	Res	NNP	O	Res	dep	1	SENT_547	[p25l1797t2230r1882b2273],
3	2007	CD	DATE	2007	num	2	SENT_547	[p25l1917t2230r2113b2279],
4	;	:	O	;	_	0	SENT_547	[p25l1917t2230r2113b2279],
5	67	CD	NUMBER	67	num	7	SENT_547	[p25l1917t2230r2113b2279],
6	:	:	O	:	_	0	SENT_547	[p25l1917t2230r2113b2279],
7	7319-26	CD	NUMBER	7319-26	dep	1	SENT_547	[p25l1099t2300r1300b2340],
8	.	.	O	.	_	0	SENT_547	[p25l1099t2300r1300b2340],

1	28	CD	NUMBER	28	_	0	SENT_548	[p25l1098t2371r1165b2410],
2	.	.	O	.	_	0	SENT_548	[p25l1098t2371r1165b2410],

1	Greulich	NN	PERSON	greulich	nn	2	SENT_549	[p25l1194t2367r1403b2410],
2	H	NN	PERSON	h	_	0	SENT_549	[p25l1427t2371r1481b2419],
3	,	,	O	,	_	0	SENT_549	[p25l1427t2371r1481b2419],
4	Chen	NNP	PERSON	Chen	nn	5	SENT_549	[p25l1508t2367r1631b2410],
5	TH	NN	O	th	appos	2	SENT_549	[p25l1653t2370r1742b2419],
6	,	,	O	,	_	0	SENT_549	[p25l1653t2370r1742b2419],
7	Feng	NNP	O	Feng	nn	8	SENT_549	[p25l1769t2371r1885b2422],
8	W	NNP	O	W	appos	2	SENT_549	[p25l1906t2371r1966b2419],
9	,	,	O	,	_	0	SENT_549	[p25l1906t2371r1966b2419],
10	et	FW	O	et	nn	11	SENT_549	[p25l1993t2376r2037b2410],
11	al.	FW	O	al.	appos	2	SENT_549	[p25l2057t2367r2112b2410],
12	.	.	O	.	_	0	SENT_549	[p25l2057t2367r2112b2410],

1	Oncogenic	JJ	MISC	oncogenic	amod	2	SENT_550	[p25l1099t2437r1358b2492],
2	transformation	NN	O	transformation	_	0	SENT_550	[p25l1392t2436r1762b2480],
3	by	IN	O	by	_	0	SENT_550	[p25l1797t2437r1851b2492],
4	inhibitorsensitive	JJ	O	inhibitorsensitive	prep_by	2	SENT_550	[p25l1883t2437r2114b2480, p25l1100t2507r1305b2550],
5	and	CC	O	and	cc	2	SENT_550	[p25l1341t2507r1429b2550],
6	-	:	O	-	_	0	SENT_550	[p25l1466t2507r1694b2550],
7	resistant	JJ	O	resistant	amod	9	SENT_550	[p25l1466t2507r1694b2550],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_550	[p25l1726t2510r1869b2553],
9	mutants	NNS	O	mutant	dep	2	SENT_550	[p25l1900t2516r2112b2550],
10	.	.	O	.	_	0	SENT_550	[p25l1900t2516r2112b2550],

1	PLoS	NNP	O	PLoS	nn	2	SENT_551	[p25l1098t2580r1214b2620],
2	Med	NNP	O	Med	_	0	SENT_551	[p25l1233t2577r1337b2620],
3	2005	CD	DATE	2005	num	2	SENT_551	[p25l1356t2580r1750b2629],
4	;	:	O	;	_	0	SENT_551	[p25l1356t2580r1750b2629],
5	2	CD	NUMBER	2	number	6	SENT_551	[p25l1356t2580r1750b2629],
6	(	CD	NUMBER	(	dep	2	SENT_551	[p25l1356t2580r1750b2629],
7	11	CD	NUMBER	11	num	8	SENT_551	[p25l1356t2580r1750b2629],
8	)	NN	O	)	dep	6	SENT_551	[p25l1356t2580r1750b2629],
9	:	:	O	:	_	0	SENT_551	[p25l1356t2580r1750b2629],
10	e313	NN	O	e313	dep	6	SENT_551	[p25l1356t2580r1750b2629],
11	.	.	O	.	_	0	SENT_551	[p25l1356t2580r1750b2629],

1	29	CD	NUMBER	29	_	0	SENT_552	[p25l1098t2652r1163b2690],
2	.	.	O	.	_	0	SENT_552	[p25l1098t2652r1163b2690],

1	Politi	NNP	PERSON	Politi	nn	2	SENT_553	[p25l1193t2647r1320b2690],
2	K	NNP	PERSON	K	_	0	SENT_553	[p25l1335t2651r1383b2699],
3	,	,	O	,	_	0	SENT_553	[p25l1335t2651r1383b2699],
4	Zakowski	NNP	O	Zakowski	nn	5	SENT_553	[p25l1400t2647r1633b2690],
5	MF	NN	O	mf	appos	2	SENT_553	[p25l1646t2651r1734b2699],
6	,	,	O	,	_	0	SENT_553	[p25l1646t2651r1734b2699],
7	Fan	NN	O	fan	nn	8	SENT_553	[p25l1752t2651r1838b2690],
8	PD	NN	O	pd	appos	2	SENT_553	[p25l1853t2650r1932b2699],
9	,	,	O	,	_	0	SENT_553	[p25l1853t2650r1932b2699],
10	Schonfeld	NNP	ORGANIZATION	Schonfeld	nn	11	SENT_553	[p25l1951t2647r2114b2690, p25l1099t2716r1188b2760],
11	EA	NN	ORGANIZATION	ea	appos	2	SENT_553	[p25l1207t2721r1288b2769],
12	,	,	O	,	_	0	SENT_553	[p25l1207t2721r1288b2769],
13	Pao	NNP	O	Pao	nn	14	SENT_553	[p25l1311t2720r1395b2760],
14	W	NNP	O	W	appos	2	SENT_553	[p25l1414t2721r1474b2769],
15	,	,	O	,	_	0	SENT_553	[p25l1414t2721r1474b2769],
16	Varmus	NNP	PERSON	Varmus	appos	2	SENT_553	[p25l1496t2721r1679b2760],
17	HE	PRP	O	he	dep	16	SENT_553	[p25l1700t2721r1787b2760],
18	.	.	O	.	_	0	SENT_553	[p25l1700t2721r1787b2760],

1	Lung	NN	O	lung	nn	2	SENT_554	[p25l1810t2721r1933b2772],
2	adenocarcinomas	NNS	O	adenocarcinoma	nsubj	15	SENT_554	[p25l1952t2717r2114b2760, p25l1099t2787r1377b2830],
3	induced	VBN	O	induce	partmod	2	SENT_554	[p25l1410t2787r1601b2830],
4	in	IN	O	in	_	0	SENT_554	[p25l1633t2787r1679b2829],
5	mice	NNS	O	mouse	prep_in	3	SENT_554	[p25l1711t2787r1826b2830],
6	by	IN	O	by	_	0	SENT_554	[p25l1858t2787r1912b2842],
7	mutant	JJ	O	mutant	amod	9	SENT_554	[p25l1942t2795r2118b2830],
8	EGF	NN	ORGANIZATION	egf	nn	9	SENT_554	[p25l1098t2860r1198b2900],
9	receptors	NNS	O	receptor	agent	3	SENT_554	[p25l1220t2866r1443b2912],
10	found	VBN	O	find	partmod	9	SENT_554	[p25l1464t2856r1606b2900],
11	in	IN	O	in	_	0	SENT_554	[p25l1627t2857r1673b2899],
12	human	JJ	O	human	amod	14	SENT_554	[p25l1694t2857r1865b2900],
13	lung	NN	O	lung	nn	14	SENT_554	[p25l1885t2857r1993b2912],
14	cancers	NNS	O	cancer	prep_in	10	SENT_554	[p25l2013t2871r2114b2900, p25l1099t2941r1193b2970],
15	respond	VBP	O	respond	_	0	SENT_554	[p25l1218t2927r1412b2982],
16	to	TO	O	to	_	0	SENT_554	[p25l1436t2936r1482b2970],
17	a	DT	O	a	det	20	SENT_554	[p25l1506t2941r1530b2970],
18	tyrosine	NN	O	tyrosine	nn	20	SENT_554	[p25l1553t2927r1748b2982],
19	kinase	NN	O	kinase	nn	20	SENT_554	[p25l1772t2927r1929b2971],
20	inhibitor	NN	O	inhibitor	prep_to	15	SENT_554	[p25l1953t2927r2114b2970, p25l1099t3006r1168b3040],
21	or	CC	O	or	_	0	SENT_554	[p25l1197t3011r1246b3040],
22	to	TO	O	to	_	0	SENT_554	[p25l1275t3006r1320b3040],
23	down-regulation	NN	O	down-regulation	prep_to	15	SENT_554	[p25l1351t2997r1757b3052],
24	of	IN	O	of	_	0	SENT_554	[p25l1787t2996r1842b3040],
25	the	DT	O	the	det	26	SENT_554	[p25l1862t2997r1937b3040],
26	receptors	NNS	O	receptor	prep_of	23	SENT_554	[p25l1967t3011r2114b3052, p25l1099t3076r1205b3110],
27	.	.	O	.	_	0	SENT_554	[p25l1967t3011r2114b3052, p25l1099t3076r1205b3110],

1	Genes	NNS	O	gene	_	0	SENT_555	[p25l1227t3070r1375b3110],
2	Dev	JJ	O	dev	amod	1	SENT_555	[p25l1394t3070r1486b3110],
3	2006	CD	DATE	2006	tmod	2	SENT_555	[p25l1503t3070r1942b3119],
4	;	:	O	;	_	0	SENT_555	[p25l1503t3070r1942b3119],
5	20:1496	CD	NUMBER	20:1496	num	6	SENT_555	[p25l1503t3070r1942b3119],
6	-510	CD	NUMBER	-510	dep	1	SENT_555	[p25l1503t3070r1942b3119],
7	.	.	O	.	_	0	SENT_555	[p25l1503t3070r1942b3119],

1	30	CD	NUMBER	30	_	0	SENT_556	[p25l1099t3141r1164b3180],
2	.	.	O	.	_	0	SENT_556	[p25l1099t3141r1164b3180],

1	Ji	NN	O	jus	nn	2	SENT_557	[p25l1188t3137r1224b3187],
2	H	NN	O	h	_	0	SENT_557	[p25l1241t3141r1294b3189],
3	,	,	O	,	_	0	SENT_557	[p25l1241t3141r1294b3189],
4	Li	NNP	PERSON	Li	nn	5	SENT_557	[p25l1314t3137r1359b3179],
5	D	NNP	PERSON	D	appos	2	SENT_557	[p25l1375t3140r1425b3189],
6	,	,	O	,	_	0	SENT_557	[p25l1375t3140r1425b3189],
7	Chen	NNP	PERSON	Chen	nn	8	SENT_557	[p25l1446t3137r1569b3180],
8	L	NNP	PERSON	L	appos	2	SENT_557	[p25l1586t3141r1628b3189],
9	,	,	O	,	_	0	SENT_557	[p25l1586t3141r1628b3189],
10	et	FW	O	et	nn	11	SENT_557	[p25l1649t3146r1692b3180],
11	al.	FW	O	al.	appos	2	SENT_557	[p25l1707t3137r1762b3180],
12	.	.	O	.	_	0	SENT_557	[p25l1707t3137r1762b3180],

1	The	DT	O	the	det	2	SENT_558	[p25l1780t3137r1870b3180],
2	impact	NN	O	impact	_	0	SENT_558	[p25l1887t3137r2055b3192],
3	of	IN	O	of	_	0	SENT_558	[p25l2070t3136r2126b3180],
4	human	JJ	O	human	amod	8	SENT_558	[p25l78t3627r426b3716],
5	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_558	[p25l485t3633r778b3720],
6	kinase	NN	O	kinase	nn	8	SENT_558	[p25l827t3627r1147b3716],
7	domain	NN	O	domain	nn	8	SENT_558	[p25l1210t3627r1588b3714],
8	mutations	NNS	O	mutation	prep_of	2	SENT_558	[p25l1649t3627r2148b3716],
9	on	IN	O	on	_	0	SENT_558	[p26l79t60r200b120],
10	lung	NN	O	lung	nn	11	SENT_558	[p26l246t33r466b145],
11	tumorigenesis	NN	O	tumorigenesis	nn	15	SENT_558	[p26l510t33r1213b145],
12	and	CC	O	and	cc	11	SENT_558	[p26l1262t33r1441b120],
13	in	FW	O	in	nn	14	SENT_558	[p26l1487t33r1583b118],
14	vivo	FW	O	vivo	advmod	11	SENT_558	[p26l1624t33r1818b122],
15	sensitivity	NN	O	sensitivity	prep_on	8	SENT_558	[p26l1868t33r2148b120, p26l79t178r327b290],
16	to	TO	O	to	_	0	SENT_558	[p26l369t195r462b265],
17	EGFR	NN	O	egfr	nn	18	SENT_558	[p26l509t178r1234b290],
18	—	NN	O	—	prep_to	2	SENT_558	[p26l509t178r1234b290],
19	targeted	VBN	O	target	partmod	2	SENT_558	[p26l509t178r1234b290],
20	therapies	NNS	O	therapy	dobj	19	SENT_558	[p26l1282t178r1758b290],
21	.	.	O	.	_	0	SENT_558	[p26l1282t178r1758b290],

1	Cancer	NN	O	cancer	nn	2	SENT_559	[p26l1811t184r2154b265],
2	Cell	NN	O	cell	_	0	SENT_559	[p26l79t323r269b410],
3	2006	CD	DATE	2006	dep	2	SENT_559	[p26l306t329r1031b429],
4	;	:	O	;	_	0	SENT_559	[p26l306t329r1031b429],
5	9:485	CD	NUMBER	9:485	number	6	SENT_559	[p26l306t329r1031b429],
6	—	CD	NUMBER	—	dep	2	SENT_559	[p26l306t329r1031b429],
7	95	CD	NUMBER	95	dep	6	SENT_559	[p26l306t329r1031b429],
8	.	.	O	.	_	0	SENT_559	[p26l306t329r1031b429],

1	31	CD	NUMBER	31	_	0	SENT_560	[p26l79t478r207b555],
2	.	.	O	.	_	0	SENT_560	[p26l79t478r207b555],

1	Asahina	NNP	PERSON	Asahina	nn	2	SENT_561	[p26l267t468r675b555],
2	H	NNP	PERSON	H	_	0	SENT_561	[p26l719t476r828b574],
3	,	,	O	,	_	0	SENT_561	[p26l719t476r828b574],
4	Yamazaki	NNP	PERSON	Yamazaki	nn	5	SENT_561	[p26l876t468r1361b557],
5	K	NNP	PERSON	K	appos	2	SENT_561	[p26l1406t475r1504b574],
6	,	,	O	,	_	0	SENT_561	[p26l1406t475r1504b574],
7	Kinoshita	NNP	PERSON	Kinoshita	appos	2	SENT_561	[p26l1556t468r2040b557],
8	I	PRP	O	I	dep	7	SENT_561	[p26l2083t476r2144b574],
9	,	,	O	,	_	0	SENT_561	[p26l2083t476r2144b574],
10	et	FW	O	et	nn	11	SENT_561	[p26l79t630r167b700],
11	al.	FW	O	al.	appos	2	SENT_561	[p26l203t613r315b700],
12	.	.	O	.	_	0	SENT_561	[p26l203t613r315b700],

1	A	DT	O	a	det	2	SENT_562	[p26l360t620r434b698],
2	phase	NN	O	phase	_	0	SENT_562	[p26l472t613r756b725],
3	II	CD	NUMBER	ii	num	4	SENT_562	[p26l797t620r872b698],
4	trial	NN	O	trial	dep	2	SENT_562	[p26l914t613r1118b700],
5	of	IN	O	of	_	0	SENT_562	[p26l1160t611r1274b700],
6	gefitinib	NN	O	gefitinib	prep_of	4	SENT_562	[p26l1295t611r1723b725],
7	as	IN	O	as	_	0	SENT_562	[p26l1767t642r1864b700],
8	firstline	NN	O	firstline	nn	9	SENT_562	[p26l1908t611r2148b700, p26l77t758r259b845],
9	therapy	NN	O	therapy	prep_as	6	SENT_562	[p26l314t758r683b870],
10	for	IN	O	for	_	0	SENT_562	[p26l731t756r872b845],
11	advanced	JJ	O	advanced	amod	13	SENT_562	[p26l922t758r1377b845],
12	non	JJ	O	non	amod	13	SENT_562	[p26l1429t758r1930b845],
13	—	NN	O	—	prep_for	9	SENT_562	[p26l1429t758r1930b845],
14	small	JJ	O	small	amod	17	SENT_562	[p26l1429t758r1930b845],
15	cell	NN	O	cell	nn	17	SENT_562	[p26l1984t758r2150b845],
16	lung	NN	O	lung	nn	17	SENT_562	[p26l77t903r298b1015],
17	cancer	NN	O	cancer	dep	2	SENT_562	[p26l331t932r654b990],
18	with	IN	O	with	_	0	SENT_562	[p26l681t903r903b992],
19	epidermal	JJ	O	epidermal	amod	23	SENT_562	[p26l940t903r1435b1015],
20	growth	NN	O	growth	nn	23	SENT_562	[p26l1470t903r1829b1015],
21	factor	NN	O	factor	nn	23	SENT_562	[p26l1866t901r2152b990],
22	receptor	NN	O	receptor	nn	23	SENT_562	[p26l78t1065r487b1160],
23	mutations	NNS	O	mutation	prep_with	17	SENT_562	[p26l532t1048r1060b1137],
24	.	.	O	.	_	0	SENT_562	[p26l532t1048r1060b1137],

1	Br	NN	O	br	_	0	SENT_563	[p26l1112t1054r1298b1149],
2	]	CD	NUMBER	]	num	1	SENT_563	[p26l1112t1054r1298b1149],
3	Cancer	NN	O	cancer	dep	1	SENT_563	[p26l1344t1054r1685b1135],
4	2006	CD	DATE	2006	num	3	SENT_563	[p26l1730t1054r2146b1154],
5	;	:	O	;	_	0	SENT_563	[p26l1730t1054r2146b1154],
6	95	CD	NUMBER	95	num	8	SENT_563	[p26l1730t1054r2146b1154],
7	:	:	O	:	_	0	SENT_563	[p26l1730t1054r2146b1154],
8	998-1004	CD	NUMBER	998-1004	dep	1	SENT_563	[p26l79t1199r553b1280],
9	.	.	O	.	_	0	SENT_563	[p26l79t1199r553b1280],

1	32	CD	NUMBER	32	_	0	SENT_564	[p26l79t1348r211b1425],
2	.	.	O	.	_	0	SENT_564	[p26l79t1348r211b1425],

1	Inoue	NNP	PERSON	Inoue	nn	2	SENT_565	[p26l271t1346r548b1427],
2	A	NNP	O	A	_	0	SENT_565	[p26l588t1346r689b1444],
3	,	,	O	,	_	0	SENT_565	[p26l588t1346r689b1444],
4	Suzuki	NNP	ORGANIZATION	Suzuki	nn	5	SENT_565	[p26l741t1338r1077b1427],
5	T	NN	ORGANIZATION	t	appos	2	SENT_565	[p26l1116t1344r1203b1444],
6	,	,	O	,	_	0	SENT_565	[p26l1116t1344r1203b1444],
7	Fukuhara	NNP	ORGANIZATION	Fukuhara	nn	8	SENT_565	[p26l1253t1338r1729b1427],
8	T	NN	ORGANIZATION	t	appos	2	SENT_565	[p26l1767t1344r1855b1444],
9	,	,	O	,	_	0	SENT_565	[p26l1767t1344r1855b1444],
10	et	FW	O	et	nn	11	SENT_565	[p26l1906t1355r1994b1425],
11	al.	FW	O	al.	appos	2	SENT_565	[p26l2032t1338r2144b1425],
12	.	.	O	.	_	0	SENT_565	[p26l2032t1338r2144b1425],

1	Prospective	JJ	O	prospective	amod	2	SENT_566	[p26l77t1483r639b1595],
2	phase	NN	O	phase	_	0	SENT_566	[p26l677t1483r961b1595],
3	ll	NN	O	ll	nn	4	SENT_566	[p26l1000t1490r1075b1568],
4	study	NN	O	study	dep	2	SENT_566	[p26l1114t1483r1377b1595],
5	of	IN	O	of	_	0	SENT_566	[p26l1412t1481r1526b1570],
6	gefitinib	NN	O	gefitinib	prep_of	4	SENT_566	[p26l1545t1481r1972b1595],
7	for	IN	O	for	_	0	SENT_566	[p26l2013t1481r2154b1570],
8	chemotherapy	NN	O	chemotherapy	nn	9	SENT_566	[p26l79t1628r1071b1740],
9	—	NN	O	—	prep_for	6	SENT_566	[p26l79t1628r1071b1740],
10	naive	JJ	O	naive	amod	11	SENT_566	[p26l79t1628r1071b1740],
11	patients	NNS	O	patient	dep	2	SENT_566	[p26l1176t1628r1568b1740],
12	with	IN	O	with	_	0	SENT_566	[p26l1672t1628r1895b1717],
13	advanced	JJ	O	advanced	amod	15	SENT_566	[p26l2001t1628r2148b1715, p26l73t1773r414b1862],
14	non	JJ	O	non	amod	15	SENT_566	[p26l481t1773r1195b1860],
15	—	NN	O	—	prep_with	11	SENT_566	[p26l481t1773r1195b1860],
16	small	JJ	O	small	amod	20	SENT_566	[p26l481t1773r1195b1860],
17	—	NN	O	—	nn	20	SENT_566	[p26l481t1773r1195b1860],
18	cell	NN	O	cell	nn	20	SENT_566	[p26l481t1773r1195b1860],
19	lung	NN	O	lung	nn	20	SENT_566	[p26l1260t1773r1481b1885],
20	cancer	NN	O	cancer	dep	2	SENT_566	[p26l1547t1802r1868b1860],
21	with	IN	O	with	_	0	SENT_566	[p26l1928t1773r2150b1862],
22	epidermal	JJ	O	epidermal	amod	27	SENT_566	[p26l79t1918r575b2030],
23	growth	NN	O	growth	nn	27	SENT_566	[p26l649t1918r1008b2030],
24	factor	NN	O	factor	nn	27	SENT_566	[p26l1083t1916r1371b2005],
25	receptor	NN	O	receptor	nn	27	SENT_566	[p26l1442t1935r1851b2030],
26	gene	NN	O	gene	nn	27	SENT_566	[p26l1922t1947r2150b2030],
27	mutations	NNS	O	mutation	prep_with	20	SENT_566	[p26l79t2063r606b2152],
28	.	.	O	.	_	0	SENT_566	[p26l79t2063r606b2152],

1	J	NNP	O	J	nn	3	SENT_567	[p26l640t2071r683b2164],
2	Clin	NNP	O	Clin	nn	3	SENT_567	[p26l719t2063r921b2150],
3	Oncol	NNP	O	Oncol	_	0	SENT_567	[p26l959t2063r1251b2150],
4	2006	CD	DATE	2006	num	3	SENT_567	[p26l1288t2069r2081b2169],
5	;	:	O	;	_	0	SENT_567	[p26l1288t2069r2081b2169],
6	24:3340	CD	NUMBER	24:3340	number	7	SENT_567	[p26l1288t2069r2081b2169],
7	—	CD	NUMBER	—	dep	3	SENT_567	[p26l1288t2069r2081b2169],
8	6	CD	NUMBER	6	dep	7	SENT_567	[p26l1288t2069r2081b2169],
9	.	.	O	.	_	0	SENT_567	[p26l1288t2069r2081b2169],

1	33	CD	NUMBER	33	_	0	SENT_568	[p26l79t2218r207b2295],
2	.	.	O	.	_	0	SENT_568	[p26l79t2218r207b2295],

1	Bell	NNP	ORGANIZATION	Bell	nn	2	SENT_569	[p26l271t2208r457b2295],
2	DW	NNP	ORGANIZATION	DW	_	0	SENT_569	[p26l495t2214r693b2314],
3	,	,	O	,	_	0	SENT_569	[p26l495t2214r693b2314],
4	Lynch	NNP	PERSON	Lynch	nn	6	SENT_569	[p26l737t2208r1027b2320],
5	T	NN	O	t	nn	6	SENT_569	[p26l1063t2214r1191b2314],
6	]	NN	O	]	appos	2	SENT_569	[p26l1063t2214r1191b2314],
7	,	,	O	,	_	0	SENT_569	[p26l1063t2214r1191b2314],
8	Haserlat	NNP	ORGANIZATION	Haserlat	nn	9	SENT_569	[p26l1236t2208r1653b2295],
9	SM	NNP	ORGANIZATION	SM	appos	2	SENT_569	[p26l1690t2214r1864b2314],
10	,	,	O	,	_	0	SENT_569	[p26l1690t2214r1864b2314],
11	et	FW	O	et	nn	12	SENT_569	[p26l1911t2225r1999b2295],
12	al.	FW	O	al.	appos	2	SENT_569	[p26l2032t2208r2144b2295],
13	.	.	O	.	_	0	SENT_569	[p26l2032t2208r2144b2295],

1	Epidermal	JJ	O	epidermal	amod	5	SENT_570	[p26l77t2353r586b2465],
2	growth	NN	O	growth	nn	5	SENT_570	[p26l642t2353r1002b2465],
3	factor	NN	O	factor	nn	5	SENT_570	[p26l1058t2351r1346b2440],
4	receptor	NN	O	receptor	nn	5	SENT_570	[p26l1400t2370r1810b2465],
5	mutations	NNS	O	mutation	_	0	SENT_570	[p26l1864t2370r2148b2442, p26l79t2498r321b2585],
6	and	CC	O	and	_	0	SENT_570	[p26l410t2498r590b2585],
7	gene	NN	O	gene	nn	8	SENT_570	[p26l675t2527r903b2610],
8	amplification	NN	O	amplification	conj_and	5	SENT_570	[p26l988t2496r1659b2610],
9	in	IN	O	in	_	0	SENT_570	[p26l1744t2498r1841b2583],
10	nonsmall	JJ	O	nonsmall	amod	14	SENT_570	[p26l1926t2525r2149b2585, p26l80t2643r561b2730],
11	—	NN	O	—	nn	14	SENT_570	[p26l1926t2525r2149b2585, p26l80t2643r561b2730],
12	cell	NN	O	cell	nn	14	SENT_570	[p26l1926t2525r2149b2585, p26l80t2643r561b2730],
13	lung	NN	O	lung	nn	14	SENT_570	[p26l594t2643r814b2755],
14	cancer	NN	O	cancer	prep_in	8	SENT_570	[p26l845t2672r1193b2730],
15	:	:	O	:	_	0	SENT_570	[p26l845t2672r1193b2730],
16	molecular	JJ	O	molecular	amod	17	SENT_570	[p26l1230t2643r1727b2732],
17	analysis	NN	O	analysis	dep	5	SENT_570	[p26l1757t2643r2148b2755],
18	of	IN	O	of	_	0	SENT_570	[p26l79t2786r194b2875],
19	the	DT	O	the	det	22	SENT_570	[p26l259t2788r410b2875],
20	IDEAL/INTACT	NN	O	ideal/intact	nn	22	SENT_570	[p26l495t2794r1263b2888],
21	gefitinib	NN	O	gefitinib	nn	22	SENT_570	[p26l1346t2786r1773b2900],
22	trials	NNS	O	trial	prep_of	17	SENT_570	[p26l1862t2788r2144b2875],
23	.	.	O	.	_	0	SENT_570	[p26l1862t2788r2144b2875],

1	J	NNP	O	J	nn	3	SENT_571	[p26l68t2941r109b3034],
2	Clin	NNP	O	Clin	nn	3	SENT_571	[p26l145t2933r348b3020],
3	Oncol	NNP	O	Oncol	_	0	SENT_571	[p26l387t2933r677b3020],
4	2005	CD	DATE	2005	num	3	SENT_571	[p26l715t2939r1553b3039],
5	;	:	O	;	_	0	SENT_571	[p26l715t2939r1553b3039],
6	23:8081	CD	NUMBER	23:8081	number	7	SENT_571	[p26l715t2939r1553b3039],
7	—	CD	NUMBER	—	dep	3	SENT_571	[p26l715t2939r1553b3039],
8	92	CD	NUMBER	92	dep	7	SENT_571	[p26l715t2939r1553b3039],
9	.	.	O	.	_	0	SENT_571	[p26l715t2939r1553b3039],

1	34	CD	NUMBER	34	_	0	SENT_572	[p26l79t3088r211b3165],
2	.	.	O	.	_	0	SENT_572	[p26l79t3088r211b3165],

1	Tsao	NNP	PERSON	Tsao	nn	2	SENT_573	[p26l269t3084r495b3165],
2	MS	NN	O	m	_	0	SENT_573	[p26l543t3084r723b3184],
3	,	,	O	,	_	0	SENT_573	[p26l543t3084r723b3184],
4	Sakurada	NNP	ORGANIZATION	Sakurada	nn	5	SENT_573	[p26l781t3078r1241b3167],
5	A	NNP	ORGANIZATION	A	appos	2	SENT_573	[p26l1284t3086r1385b3184],
6	,	,	O	,	_	0	SENT_573	[p26l1284t3086r1385b3184],
7	Cutz	NNP	O	Cutz	nn	8	SENT_573	[p26l1440t3084r1665b3167],
8	JC	NNP	O	JC	appos	2	SENT_573	[p26l1703t3084r1843b3184],
9	,	,	O	,	_	0	SENT_573	[p26l1703t3084r1843b3184],
10	et	FW	O	et	nn	11	SENT_573	[p26l1901t3095r1988b3165],
11	al.	FW	O	al.	appos	2	SENT_573	[p26l2032t3078r2143b3165],
12	.	.	O	.	_	0	SENT_573	[p26l2032t3078r2143b3165],

1	Erlotinib	NNP	O	Erlotinib	_	0	SENT_574	[p26l77t3223r513b3310],
2	in	IN	O	in	_	0	SENT_574	[p26l551t3223r646b3308],
3	lung	NN	O	lung	nn	4	SENT_574	[p26l681t3223r903b3335],
4	cancer	NN	O	cancer	prep_in	1	SENT_574	[p26l936t3252r1259b3310],
5	—	CD	NUMBER	—	number	6	SENT_574	[p26l1288t3273r1408b3281],
6	molecular	JJ	O	molecular	dep	1	SENT_574	[p26l1441t3223r1938b3312],
7	and	CC	O	and	_	0	SENT_574	[p26l1970t3223r2150b3310],
8	clinical	JJ	O	clinical	amod	9	SENT_574	[p26l79t3368r441b3455],
9	predictors	NNS	O	predictor	dep	1	SENT_574	[p26l493t3368r994b3480],
10	of	IN	O	of	_	0	SENT_574	[p26l1052t3366r1166b3455],
11	outcome	NN	O	outcome	prep_of	6	SENT_574	[p26l1201t3385r1651b3457],
12	.	.	O	.	_	0	SENT_574	[p26l1201t3385r1651b3457],

1	N	NN	O	n	nn	3	SENT_575	[p26l1709t3375r1794b3455],
2	Engl	NNP	O	Engl	nn	3	SENT_575	[p26l1845t3368r2067b3480],
3	J	NNP	O	J	nsubj	4	SENT_575	[p26l2111t3375r2152b3469],
4	Med	VBD	O	med	_	0	SENT_575	[p26l75t3513r288b3600],
5	2005	CD	DATE	2005	dobj	4	SENT_575	[p26l327t3519r1166b3619],
6	;	:	O	;	_	0	SENT_575	[p26l327t3519r1166b3619],
7	353:133	CD	NUMBER	353:133	num	8	SENT_575	[p26l327t3519r1166b3619],
8	-44	CD	NUMBER	-44	dep	5	SENT_575	[p26l327t3519r1166b3619],
9	.	.	O	.	_	0	SENT_575	[p26l327t3519r1166b3619],

1	[	NN	O	[	nn	2	SENT_576	[p26l1224t3520r1694b3619],
2	Erratum	NN	O	erratum	nsubj	7	SENT_576	[p26l1224t3520r1694b3619],
3	,	,	O	,	_	0	SENT_576	[p26l1224t3520r1694b3619],
4	N	NN	O	n	appos	2	SENT_576	[p26l1738t3521r1822b3600],
5	Engl	NNP	O	Engl	nn	6	SENT_576	[p26l1860t3513r2152b3625],
6	]	NNP	O	]	dep	4	SENT_576	[p26l1860t3513r2152b3625],
7	Med	VBD	O	med	_	0	SENT_576	[p26l75t3658r288b3745],
8	2005	CD	DATE	2005	dobj	7	SENT_576	[p26l327t3664r1083b3764],
9	;	:	O	;	_	0	SENT_576	[p26l327t3664r1083b3764],
10	355:1746	CD	NUMBER	355:1746	dep	8	SENT_576	[p26l327t3664r1083b3764],
11	.	.	O	.	_	0	SENT_576	[p26l327t3664r1083b3764],
12	]	SYM	O	]	dep	8	SENT_576	[p26l327t3664r1083b3764],

1	35	CD	NUMBER	35	_	0	SENT_577	[p27l79t36r209b113],
2	.	.	O	.	_	0	SENT_577	[p27l79t36r209b113],

1	Steeg	NNP	PERSON	Steeg	nn	2	SENT_578	[p27l275t32r536b138],
2	PS	NNP	O	PS	_	0	SENT_578	[p27l590t32r733b113],
3	.	.	O	.	_	0	SENT_578	[p27l590t32r733b113],

1	Tumor	NN	O	tumor	nn	2	SENT_579	[p27l794t32r1124b115],
2	metastasis	NN	O	metastasis	_	0	SENT_579	[p27l1179t26r1729b113],
3	:	:	O	:	_	0	SENT_579	[p27l1179t26r1729b113],
4	mechanistic	JJ	O	mechanistic	dep	2	SENT_579	[p27l1792t26r2148b113, p27l78t171r349b258],

1	insights	NNS	O	insight	_	0	SENT_580	[p27l425t171r818b283],
2	and	CC	O	and	_	0	SENT_580	[p27l897t171r1077b258],
3	clinical	JJ	O	clinical	amod	4	SENT_580	[p27l1156t171r1518b258],
4	challenges	NNS	O	challenge	conj_and	1	SENT_580	[p27l1595t171r2144b283],
5	.	.	O	.	_	0	SENT_580	[p27l1595t171r2144b283],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_581	[p27l76t324r252b403],
2	Med	NNP	O	Med	_	0	SENT_581	[p27l282t316r495b403],
3	2006	CD	DATE	2006	num	2	SENT_581	[p27l534t322r1383b422],
4	;	:	O	;	_	0	SENT_581	[p27l534t322r1383b422],
5	12:895	CD	NUMBER	12:895	number	6	SENT_581	[p27l534t322r1383b422],
6	-904	CD	NUMBER	-904	dep	2	SENT_581	[p27l534t322r1383b422],
7	.	.	O	.	_	0	SENT_581	[p27l534t322r1383b422],

1	Copyright	NN	O	copyright	_	0	SENT_582	[p27l81t445r441b542],
2	©	CD	NUMBER	©	num	6	SENT_582	[p27l478t453r557b534],
3	2008	CD	DATE	2008	num	6	SENT_582	[p27l597t451r787b519],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_582	[p27l822t445r1363b519],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_582	[p27l1398t445r1696b519],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_582	[p27l1726t449r2005b540],
7	.	.	O	.	_	0	SENT_582	[p27l1726t449r2005b540],

1	JOURNAL	NN	O	journal	_	0	SENT_583	[p27l676t879r808b906],
2	EDITORIAL	NN	O	editorial	nn	3	SENT_583	[p27l825t879r970b899],
3	FELLOW	NN	O	fellow	dep	1	SENT_583	[p27l985t879r1094b899],

1	The	DT	O	the	det	2	SENT_584	[p27l444t921r498b947],
2	]	NN	O	]	poss	6	SENT_584	[p27l503t921r623b955],
3	oumal	JJ	O	oumal	amod	2	SENT_584	[p27l503t921r623b955],
4	’s	POS	O	’s	_	0	SENT_584	[p27l503t921r623b955],
5	editorial	NN	O	editorial	nn	6	SENT_584	[p27l633t921r752b947],
6	office	NN	O	office	nsubj	7	SENT_584	[p27l761t921r840b947],
7	invites	VBZ	O	invite	_	0	SENT_584	[p27l850t922r941b948],
8	applications	NNS	O	application	dobj	7	SENT_584	[p27l952t921r1125b955],
9	for	IN	O	for	_	0	SENT_584	[p27l1136t921r1177b947],
10	a	DT	O	a	det	16	SENT_584	[p27l1186t930r1201b947],
11	one	CD	NUMBER	one	number	12	SENT_584	[p27l1210t930r1332b954],
12	—	CD	NUMBER	—	num	16	SENT_584	[p27l1210t930r1332b954],
13	year	NN	NUMBER	year	nn	16	SENT_584	[p27l1210t930r1332b954],
14	research	NN	O	research	nn	16	SENT_584	[p27l414t965r534b991],
15	fellowship	NN	O	fellowship	nn	16	SENT_584	[p27l544t965r692b998],
16	beginning	NN	DATE	beginning	prep_for	8	SENT_584	[p27l702t965r849b999],
17	in	IN	DATE	in	_	0	SENT_584	[p27l858t966r885b991],
18	July	NNP	DATE	July	prep_in	16	SENT_584	[p27l891t965r947b998],
19	2009	CD	DATE	2009	num	18	SENT_584	[p27l955t967r1024b991],
20	from	IN	O	from	_	0	SENT_584	[p27l1035t965r1104b991],
21	individuals	NNS	O	individual	prep_from	7	SENT_584	[p27l1114t965r1269b991],
22	at	IN	O	at	_	0	SENT_584	[p27l1280t971r1306b991],
23	any	DT	O	any	det	24	SENT_584	[p27l1314t974r1363b998],
24	stage	NN	O	stage	prep_at	21	SENT_584	[p27l417t1014r490b1042],
25	of	IN	O	of	_	0	SENT_584	[p27l500t1009r534b1035],
26	training	NN	O	training	prep_of	24	SENT_584	[p27l538t1009r659b1042],
27	.	.	O	.	_	0	SENT_584	[p27l538t1009r659b1042],

1	The	DT	O	the	det	3	SENT_585	[p27l669t1009r723b1035],
2	editorial	NN	O	editorial	nn	3	SENT_585	[p27l733t1009r852b1035],
3	fellow	NN	O	fellow	nsubjpass	26	SENT_585	[p27l861t1009r949b1035],
4	will	MD	O	will	aux	5	SENT_585	[p27l956t1009r1009b1035],
5	work	VB	O	work	_	0	SENT_585	[p27l1017t1009r1092b1035],
6	on	IN	O	on	_	0	SENT_585	[p27l1100t1017r1136b1035],
7	journal	NN	O	journal	nn	8	SENT_585	[p27l1141t1009r1238b1042],
8	projects	NNS	O	project	prep_on	5	SENT_585	[p27l1247t1009r1359b1042],
9	and	CC	O	and	_	0	SENT_585	[p27l400t1053r452b1079],
10	will	MD	O	will	aux	11	SENT_585	[p27l460t1053r513b1079],
11	participate	VB	O	participate	conj_and	5	SENT_585	[p27l522t1053r674b1086],
12	in	IN	O	in	_	0	SENT_585	[p27l683t1053r711b1078],
13	the	DT	DATE	the	det	14	SENT_585	[p27l721t1053r764b1079],
14	day	NN	DATE	day	prep_in	11	SENT_585	[p27l774t1053r924b1086],
15	—	CD	NUMBER	—	num	14	SENT_585	[p27l774t1053r924b1086],
16	to	TO	O	to	_	0	SENT_585	[p27l774t1053r924b1086],
17	—	CD	NUMBER	—	num	20	SENT_585	[p27l774t1053r924b1086],
18	day	NN	NUMBER	day	nn	20	SENT_585	[p27l774t1053r924b1086],
19	editorial	NN	O	editorial	nn	20	SENT_585	[p27l932t1053r1051b1079],
20	activities	NNS	O	activity	prep_to	11	SENT_585	[p27l1060t1053r1183b1079],
21	of	IN	O	of	_	0	SENT_585	[p27l1194t1052r1227b1079],
22	the	DT	O	the	det	23	SENT_585	[p27l1231t1053r1275b1079],
23	journal	NN	O	journal	prep_of	20	SENT_585	[p27l1280t1053r1377b1086],
24	but	CC	O	but	_	0	SENT_585	[p27l443t1096r490b1123],
25	is	VBZ	O	be	auxpass	26	SENT_585	[p27l498t1097r520b1122],
26	expected	VBN	O	expect	conj_but	5	SENT_585	[p27l531t1096r654b1130],
27	in	IN	O	in	_	0	SENT_585	[p27l664t1097r691b1122],
28	addition	NN	O	addition	prep_in	26	SENT_585	[p27l701t1096r819b1122],
29	to	TO	O	to	aux	30	SENT_585	[p27l829t1102r856b1122],
30	have	VB	O	have	xcomp	26	SENT_585	[p27l866t1096r929b1123],
31	his	PRP$	O	he	amod	36	SENT_585	[p27l939t1096r980b1122],
32	or	CC	O	or	_	0	SENT_585	[p27l991t1105r1021b1122],
33	her	PRP$	O	she	amod	36	SENT_585	[p27l1029t1096r1076b1122],
34	own	JJ	O	own	amod	36	SENT_585	[p27l1085t1105r1145b1123],
35	independent	JJ	O	independent	amod	36	SENT_585	[p27l1155t1096r1335b1130],
36	projects	NNS	O	project	dobj	30	SENT_585	[p27l458t1140r579b1173],
37	.	.	O	.	_	0	SENT_585	[p27l458t1140r579b1173],

1	Please	VB	O	please	_	0	SENT_586	[p27l591t1140r678b1166],
2	send	VB	O	send	xcomp	1	SENT_586	[p27l688t1140r754b1166],
3	curriculum	NN	O	curriculum	nn	4	SENT_586	[p27l764t1140r921b1166],
4	vitae	NNS	O	vita	dobj	2	SENT_586	[p27l930t1140r995b1166],
5	and	CC	O	and	_	0	SENT_586	[p27l1005t1140r1057b1166],
6	research	NN	O	research	nn	7	SENT_586	[p27l1067t1140r1186b1166],
7	interests	NNS	O	interest	conj_and	4	SENT_586	[p27l1196t1140r1317b1166],
8	to	TO	O	to	_	0	SENT_586	[p27l475t1189r502b1210],
9	the	DT	O	the	det	12	SENT_586	[p27l512t1184r556b1210],
10	Editor	NNP	O	Editor	nn	12	SENT_586	[p27l565t1184r790b1215],
11	—	NNP	O	—	nn	12	SENT_586	[p27l565t1184r790b1215],
12	in-Chief	NNP	O	in-Chief	prep_to	2	SENT_586	[p27l565t1184r790b1215],
13	,	,	O	,	_	0	SENT_586	[p27l565t1184r790b1215],
14	10	CD	NUMBER	10	appos	12	SENT_586	[p27l803t1186r836b1210],
15	Shattuck	NNP	ORGANIZATION	Shattuck	nn	20	SENT_586	[p27l846t1184r971b1210],
16	St.	NNP	ORGANIZATION	St.	nn	20	SENT_586	[p27l980t1186r1024b1215],
17	,	,	O	,	_	0	SENT_586	[p27l980t1186r1024b1215],
18	Boston	NNP	LOCATION	Boston	appos	20	SENT_586	[p27l1035t1186r1143b1215],
19	,	,	O	,	_	0	SENT_586	[p27l1035t1186r1143b1215],
20	MA	NNP	O	MA	dep	14	SENT_586	[p27l1154t1186r1205b1209],
21	02115	CD	DATE	02115	num	20	SENT_586	[p27l1214t1186r1300b1210],

1	(	NN	O	(	nn	2	SENT_587	[p27l570t1227r629b1259],
2	fax	NN	O	fax	_	0	SENT_587	[p27l570t1227r629b1259],
3	,	,	O	,	_	0	SENT_587	[p27l570t1227r629b1259],
4	617-739-9864	CD	NUMBER	617-739-9864	num	5	SENT_587	[p27l641t1229r860b1259],
5	)	NN	O	)	appos	2	SENT_587	[p27l641t1229r860b1259],
6	,	,	O	,	_	0	SENT_587	[p27l641t1229r860b1259],
7	by	IN	O	by	_	0	SENT_587	[p27l872t1228r905b1261],
8	September	NNP	DATE	September	prep_by	2	SENT_587	[p27l914t1228r1066b1261],
9	30	CD	DATE	30	num	8	SENT_587	[p27l1075t1229r1117b1259],
10	,	,	DATE	,	_	0	SENT_587	[p27l1075t1229r1117b1259],
11	2008	CD	DATE	2008	num	8	SENT_587	[p27l1129t1229r1206b1254],
12	.	.	O	.	_	0	SENT_587	[p27l1129t1229r1206b1254],

1	N	NN	O	n	nn	3	SENT_588	[p27l542t1387r555b1402],
2	ENGLJ	NN	O	englj	nn	3	SENT_588	[p27l570t1387r648b1409],
3	MED359	NN	O	med359	_	0	SENT_588	[p27l663t1387r790b1409],
4	;	:	O	;	_	0	SENT_588	[p27l663t1387r790b1409],
5	4	CD	NUMBER	4	num	7	SENT_588	[p27l663t1387r790b1409],
6	WWW.NEJM.ORG	NN	O	www.nejm.org	nn	7	SENT_588	[p27l822t1387r1024b1409],
7	JULY24	NN	O	july24	dep	3	SENT_588	[p27l1054t1381r1233b1409],
8	,2008	CD	NUMBER	,2008	number	9	SENT_588	[p27l1054t1381r1233b1409],
9	377	CD	NUMBER	377	dep	7	SENT_588	[p27l1959t1377r2016b1400],

1	The	DT	O	the	det	4	SENT_589	[p27l702t1420r753b1444],
2	New	NNP	O	New	nn	4	SENT_589	[p27l762t1421r824b1444],
3	England	NNP	O	England	nn	4	SENT_589	[p27l833t1420r944b1451],
4	Journal	NNP	O	Journal	_	0	SENT_589	[p27l952t1420r1050b1444],
5	of	IN	O	of	_	0	SENT_589	[p27l1059t1420r1088b1444],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_589	[p27l1095t1420r1220b1444],

1	Downloaded	VBN	O	download	_	0	SENT_590	[p27l144t1461r314b1484],
2	from	IN	O	from	_	0	SENT_590	[p27l323t1461r387b1484],
3	nejmorg	NN	O	nejmorg	prep_from	1	SENT_590	[p27l396t1461r514b1491],
4	at	IN	O	at	_	0	SENT_590	[p27l524t1465r547b1484],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_590	[p27l556t1461r738b1484],
6	on	IN	O	on	_	0	SENT_590	[p27l748t1468r780b1484],
7	January	NNP	DATE	January	prep_on	1	SENT_590	[p27l789t1461r892b1491],
8	5	CD	DATE	5	num	7	SENT_590	[p27l902t1461r924b1489],
9	,	,	DATE	,	_	0	SENT_590	[p27l902t1461r924b1489],
10	2014	CD	DATE	2014	num	7	SENT_590	[p27l935t1461r1007b1484],
11	.	.	O	.	_	0	SENT_590	[p27l935t1461r1007b1484],

1	For	IN	O	for	_	0	SENT_591	[p27l1018t1461r1064b1484],
2	personal	JJ	O	personal	amod	3	SENT_591	[p27l1072t1461r1185b1491],
3	use	NN	O	use	pobj	1	SENT_591	[p27l1194t1468r1237b1484],
4	only	RB	O	only	advmod	3	SENT_591	[p27l1247t1461r1312b1491],
5	.	.	O	.	_	0	SENT_591	[p27l1247t1461r1312b1491],

1	No	DT	O	no	det	3	SENT_592	[p27l1322t1461r1362b1484],
2	other	JJ	O	other	amod	3	SENT_592	[p27l1372t1461r1440b1484],
3	uses	NNS	O	use	_	0	SENT_592	[p27l1448t1468r1504b1484],
4	without	IN	O	without	_	0	SENT_592	[p27l1514t1461r1616b1484],
5	permission	NN	O	permission	prep_without	3	SENT_592	[p27l1624t1461r1776b1491],
6	.	.	O	.	_	0	SENT_592	[p27l1624t1461r1776b1491],

1	Copyright	NN	O	copyright	_	0	SENT_593	[p27l494t1502r629b1533],
2	©	CD	NUMBER	©	num	6	SENT_593	[p27l638t1502r661b1526],
3	2008	CD	DATE	2008	num	6	SENT_593	[p27l671t1502r736b1526],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_593	[p27l746t1502r937b1526],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_593	[p27l947t1502r1055b1526],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_593	[p27l1065t1502r1170b1533],
7	.	.	O	.	_	0	SENT_593	[p27l1065t1502r1170b1533],

1	All	DT	O	all	det	2	SENT_594	[p27l1181t1502r1223b1526],
2	rights	NNS	O	rights	nsubj	3	SENT_594	[p27l1232t1502r1306b1533],
3	reserved	VBN	O	reserve	_	0	SENT_594	[p27l1316t1502r1435b1526],
4	.	.	O	.	_	0	SENT_594	[p27l1316t1502r1435b1526],

